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Preface
Preclinical MRI for Renal Health
Despite the fact that we are in an era of increased prevalence, incidence, and recognition of
renal diseases, the current options for effective prophylactic and therapeutic regimens for
kidney disorders are disappointingly sparse. A major obstacle is the inherent complexity of
the pathophysiology in renal disease. Overcoming this requires immediate innovative action
across multiple domains and requires new instruments that enable noninvasive diagnostics
and monitoring of therapy during renal diseases. The upshot is that this also creates ever-
increasing opportunities for discovery.
The development and validation of disruptive diagnostic approaches and strategies for
early interception of renal disease and renoprotection can be brought on only with a deeper
understanding of the underlying (patho)physiology. This underlines the urgent quest for
emergent biomedical imaging techniques, customized for probing all stages of renal dis-
eases. While many renal diseases involve defects at the molecular and cellular levels, these
manifest themselves at the scale of the organ system. The unique function of biomedical
imaging is to monitor all these levels simultaneously, connecting the view of biologists with
that of clinicians in vivo. This asks for approaches that are noninvasive, ubiquitous, and
applicable both preclinically and clinically—this is the forte of magnetic resonance imaging
(MRI). An increasing body of evidence indicates that MRI biomarkers have a high potential
for complementing and improving acute and chronic renal disease management. MRI is a
versatile technique, and a host of functional MRImethods have emerged that are sensitive to
pathophysiological changes associated with renal hemodynamics, oxygenation, fibrosis,
inflammation, and microstructure. To better connect MR imaging markers with (patho)-
physiology, MRI needs to be benchmarked and calibrated with integrative physiological
measurements which include the use of quantitative invasive probes. Due to the enormous
technical challenges involved, renal MRI biomarkers remain woefully underused in preclini-
cal research and in clinical practice. These scientific and technical issues constitute a substan-
tial barrier en route to the standardization and broad application of renal MRI.
The purpose of this book is to overcome these roadblocks by promoting an open-access
collection of protocols and comprehensive recommendations for preclinical renal MRI, to
be employed in translational research. The book provides answers to the common questions
regarding how renal MRI technologies emerging from the research community can be
translated into open-access, ready-to-go toolboxes that can be applied to human patients
in a way that is standardized, highly reproducible, and harmonized across centers, with the
goal of combating renal disease by substantially slowing its progression and preventing
kidney injury.
With this “from the community, to the community” approach, the book is designed to
enhance training in renal MRI sciences, to improve the reproducibility of renal imaging
research, and to boost the comparability of renal MRI studies. With this mission, the book
promotes an entirely unique opportunity for developing advanced in vivo renal phenotyp-
ing, diagnostic imaging, and therapy guidance as a link to stratified medicine. The clinical
implications of this relate to a broad spectrum of physiology, nephrology, radiology,
v
cardiology, and other associated fields of basic science and clinical research targeting renal
and cardiorenal diseases.
The chapters covered in this book are interdisciplinary in nature and bridge the gaps
between physics, physiology, and medicine. The contributions are provided by leading
international experts and hands-on scientists and serve as a foundation to substantially
boost the development of renal imaging tools, which will increase the efficacy of diagnostics,
promote the identification of new therapeutic targets and options, drive explorations into
novel renoprotective strategies, and lead to enhanced prophylactic regimens. To meet this
goal, the book provides chapters on the fundamental principles, detailed experimental
protocols and guidelines for data analysis, to successfully unlock the full potential of renal
MRI. At the same time, the book promises to help nurture a new generation of researchers
with the high potential needed for the development of next-generation renal imaging
technology, by addressing some crucial educational gaps.
The pace of discovery of preclinical MRI is heartening, drawing in new talent and
driving the transfer of results into novel preclinical applications and into the clinical arena.
The remaining challenges must be faced openly via collaborations between forward-
thinking researchers, application scientists, clinicians, and the general readership of this
book. These collaborations should be interdisciplinary, inter-institutional, and international,
as exemplified and spearheaded by imaging networks. A prominent example of this is the
renal imaging initiative PARENCHIMA, a community-driven Action of the COST
(European Cooperation in Science and Technology) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Only because of the truly interdisciplinary nature of this work, and the essential role that
having many types of expertise in close interaction has played, we got this far.
This book lives up to this mission by providing a comprehensive overview and guidance
on preclinical MRI. It is intended to take this approach to the next level and to put extra
weight behind finding a solution to the remaining problems in renal imaging research. With
this mission, the reader will learn to make sense of the terrain we currently inhabit and to
better interpret the images of the kidney that we produce using sophisticated preclinical
MRI and data analysis protocols. Inevitably, there will be breakthroughs and surprises when
you place next-generation imaging technologies and this book into the hands of highly
creative interdisciplinary teams. However, this will only happen if we recognize that moving
into the next generation of renal imaging technology is more than just a matter of buying
equipment, installing it, and then trying to operate in "core facilities" where budgetary
considerations, and not scientific goals, dominate. The ultimate potential of preclinical renal
MRI is far greater; all that is required is the imagination to apply it, following the chapters in
this book as a roadmap. We hope that the book will convey the seeds of this vision and
inspire you—as it has us—to become pioneers in this amazingly promising area.
With this perspective, we are grateful to all the authors for their outstanding work,
passion, dedication, and enthusiasm to drive this assembly of recommendations and open-
access protocols on preclinical MRI home. We all succeeded thanks to the sheer power and
momentum of interdisciplinary collaboration and teamwork. You made and make the
difference. Thank you.




Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
PART I INTRODUCTION
1 Recommendations for Preclinical Renal MRI: A Comprehensive
Open-Access Protocol Collection to Improve Training,
Reproducibility, and Comparability of Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Andreas Pohlmann, Susan J. Back, Andrea Fekete, Iris Friedli, Stefanie
Hectors, Neil Peter Jerome, Min-Chi Ku, Dario Livio Longo, Martin Meier,
Jason M. Millward, João S. Periquito, Erdmann Seeliger, Suraj D. Serai,
Sonia Waiczies, Steven Sourbron, Christoffer Laustsen,
and Thoralf Niendorf
PART II ANIMAL MODELS, PREPARATION, MONITORING,
AND PHYSIOLOGICAL INTERVENTIONS
2 Animal Models of Renal Pathophysiology and Disease. . . . . . . . . . . . . . . . . . . . . . . 27
Adam Hosszu, Tamas Kaucsar, Erdmann Seeliger, and Andrea Fekete
3 Preparation and Monitoring of Small Animals in Renal MRI . . . . . . . . . . . . . . . . . 45
Tamas Kaucsar, Adam Hosszu, Erdmann Seeliger, Henning M. Reimann,
and Andrea Fekete
4 Reversible (Patho)Physiologically Relevant Test Interventions:
Rationale and Examples. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Kathleen Cantow, Mechthild Ladwig-Wiegard, Bert Flemming,
Andrea Fekete, Adam Hosszu, and Erdmann Seeliger
5 Preparation of Ex Vivo Rodent Phantoms for Developing, Testing,
and Training MR Imaging of the Kidney and Other Organs. . . . . . . . . . . . . . . . . . 75
Jason M. Millward, João S. Periquito, Paula Ramos Delgado,
Christian Prinz, Thoralf Niendorf, and Sonia Waiczies
PART III BASIC CONCEPTS OF MEASUREMENT TECHNIQUES
6 Quantitative Assessment of Renal Perfusion and Oxygenation
by Invasive Probes: Basic Concepts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Kathleen Cantow, Roger G. Evans, Dirk Grosenick, Thomas Gladytz,
Thoralf Niendorf, Bert Flemming, and Erdmann Seeliger
7 Ultrasound and Photoacoustic Imaging of the Kidney: Basic Concepts
and Protocols. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
Sandra Meyer, Dieter Fuchs, and Martin Meier
vii
8 Hardware Considerations for Preclinical Magnetic Resonance
of the Kidney . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
Paula Ramos Delgado, Ekkehard Küstermann, André Kühne,
Jason M. Millward, Thoralf Niendorf, Andreas Pohlmann,
and Martin Meier
9 MRI Mapping of Renal T1: Basic Concept . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
Stefanie J. Hectors, Philippe Garteiser, Sabrina Doblas, Gwenaël Pagé,
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Charité—University Medicine Berlin, Berlin, Germany; Institute of Physiology and Center
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WALTER DASTRÙ • Department of Molecular Biotechnology and Health Sciences, University of
Torino, Torino, Italy
SABRINA DOBLAS • Laboratory of Imaging Biomarkers, Centre de Recherche sur
l’Inflammation, Inserm UMR 1149, Université de Paris and AP-HP, Paris, France
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Résonance Magnétique Biologique et Médicale (CRMBM), Marseille, France
NATALIE J. KORN • Radiology and Biomedical Imaging, University of California, San
Francisco, CA, USA
MIN-CHI KU • Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for
Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany
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Abstract
Renal MRI holds incredible promise for making a quantum leap in improving diagnosis and care of patients
with a multitude of diseases, by moving beyond the limitations and restrictions of current routine clinical
practice. Clinical and preclinical renal MRI is advancing with ever increasing rapidity, and yet, aside from a
few examples of renal MRI in routine use, it is still not good enough. Several roadblocks are still delaying
the pace of progress, particularly inefficient education of renal MR researchers, and lack of harmonization of
approaches that limits the sharing of results among multiple research groups.
Here we aim to address these limitations for preclinical renal MRI (predominantly in small animals), by
providing a comprehensive collection of more than 40 publications that will serve as a foundational resource
for preclinical renal MRI studies. This includes chapters describing the fundamental principles underlying a
variety of renal MRI methods, step-by-step protocols for executing renal MRI studies, and detailed guides
for data analysis. This collection will serve as a crucial part of a roadmap toward conducting renal MRI
studies in a robust and reproducible way, that will promote the standardization and sharing of data.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
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Magnetic resonance imaging (MRI) of the kidney is not brain
surgery—it’s better! It can save lives without invasive surgery,
noninvasively. This statement—a play on Donald W McRobbie’s
“MRI is not rocket science, it’s better” in MRI From Picture to
Proton—is one that Dr. Susan Back, radiologist and director of
Pediatric Genitourinary Imaging at the Children’s Hospital of
Philadelphia, would sign on to without hesitation. It’s Thursday
afternoon and she is just running an MRI scan on a 4-year-old boy
with a left kidney urinary tract dilation, which was gradually increas-
ing on ultrasound. This is the last sequence in the MRI protocol: a
contrast-enhanced dynamic 3D T1-weighted GRE sequence with a
temporal resolution of ~8 s, used for quantitative functional uro-
graphy [1]. Before, an anatomic T2-weighted MR urogram [1] was
performed to identify possible anatomic causes of obstruction
(Fig. 1), which are difficult to find with ultrasound. These renal
MRI data play a key role in the diagnosis and treatment decisions.
The configuration of the kidney on the MRI is concerning for an
ureteropelvic junction obstruction because there is an abrupt tran-
sition from the renal pelvis to the proximal ureter. However, having
this anatomic image and the functional information generated
Fig. 1 Renal MRI used for diagnosis and treatment planning of a 4-year-old boy with a left kidney urinary tract
dilation. The anatomic portion of the MR urogram study (left: postprocessed image created by superimposing
the vascular/parenchymal enhancement phase with the renal excretion phase; right: 3D rendering) depicted
the left urinary tract dilation with an abrupt transition in caliper between the dilated renal pelvis and the
proximal ureter
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using dynamic imaging shows good excretion and proves that the
kidney is not obstructed. For the decision on whether to operate,
the urologist takes a look at the quantitative functional informa-
tion. Offline analysis of the dynamic data using the Parametric MRI
software package (www.parametricmri.com) [2] provided a wide
range of quantitative parameters for assessment of renal function,
including renal transit time, calyceal transit time, volumetric differ-
ential renal function (vDRF), and Patlak differential renal function
(pDRF). The other good news is that the left kidney is functioning
similarly to the normal right kidney (vDRF: 48%/52%, pDRF:
49%/51%) so the urologist decides not to operate and the child
would be put under observation.
While this scene of renal MRI in clinical routine use vividly
illustrates the dream and ambition of many renal MRI researchers—
clinicians (nephrologists, urologists, radiologists, surgeons, etc.),
clinical scientists, MRI scientists, and basic scientists alike—it may,
to the more realistic ones, be perhaps no more than a wild phantasy.
However, for the vast majority of kidney patients worldwide, reality
couldn’t be more different: diagnosis and treatment decisions are
predominantly based on plasma and urine parameters, that are
known to be insensitive and unspecific. Information on increased
serum creatinine is literally too little too late. Currently, the esti-
mated glomerular filtration rate (eGFR; commonly calculated from
serum creatinine including variables for age, gender, race) is “the
best overall index of kidney function” [3], but it “is an unreliable
tool to assess renal function in health and disease, as well as in
clinical practice and research” [4]. It is like trying to study the
complex bio system of the vast Amazon river basin solely by taking
water samples at the mouth of the river.
1.2 Renal MRI,
Where Are You?
Renal MRI undoubtedly holds great potential to improve diagnosis
and care for millions of patients. The scientific literature reveals
hundreds of renal MRI studies, both in patients and animals, aim-
ing to demonstrate its clinical value, and to detail and validate the
observed changes in functional and structural parameters. On
reading the introductions of these studies we are typically being
reminded of the millions of patients suffering from renal disease—
acute kidney injuries (AKI) and chronic kidney diseases (CKD)—as
well as the steadily growing number of diabetes patients of which
many are inevitably en route to diabetic nephropathy. This is usually
followed by highlighting the urgent need for more sensitive and
specific bio markers, with renal MRI being a prime candidate. Yet
renal MRI is still virtually absent from the radar screen of the
nephrologist, and patients like those at the Children’s Hospital of
Philadelphia are a rare exception. What is going wrong?
1.3 Function,
Function, Function
If the three most important characteristics that determine the value
of a house are often considered to be “location, location, location,”
then the three most important characteristics of the kidney are
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“function, function, function”—rather than its structure/mor-
phology. Morphology, however, is what conventional clinical MRI
is all about in the vast majority of cases. Radiologists are trained to
detect and identify the subtle deviations from “normal” morphol-
ogy on grayscale images with different T1 or T2(T2*) weighting.
This leads to three challenges for renal MRI: (1) assessing func-
tional images, for example of perfusion or blood oxygenation,
requires new training and learning of what “normality” means;
(2) almost all renal MRI techniques provide “exotic” pseudoco-
lored parametric maps rather than conventional weighted images;
(3) interpreting changes in these MR parameters in the context of
the complex renal physiology is anything but trivial—in other
words: we don’t really know what they mean.
Particularly for the last point, preclinical research is crucial
because it enables researchers to obtain from the same organ MRI
data together with physiological parameters from invasive probes,
as well as histological data. Obvious examples are the comparison of
T1 and ADC with the degree of fibrosis from histology [5], ASL
perfusion with invasively measured renal blood flow and local flux,
or T2* with invasively measured tissue oxygenation [6]. Moreover,
in preclinical studies the application of (ir)reversible experimental
interventions permits studying the complex relationships between
MRI parameters and quantitative physiological parameters in the
context of kidney-specific control of hemodynamics and oxygena-
tion (see the chapter by Cantow K et al. “Reversible (Patho)
Physiologically Relevant Test Interventions: Rationale and Exam-
ples”). Clearly, a lot more work needs to be done to establish and
translate renal MRI into clinical practice, and preclinical research is
an essential part of this process. Shedding some light on where we
are with regard to research activity in MRI of the kidney may help
us drive forward the development of renal MRI.
1.4 Research Activity
in Renal MRI
Renal and cardiac MRI both started as niche applications, with their
own unique challenges for clinical translation, ranging from acqui-
sition to analysis and interpretation. Cardiac MRI has already
become an established clinical tool, which is supported and driven
by a dedicated international society (Society for Cardiovascular
Magnetic Resonance (SCMR), scmr.org) and guided by >10 pub-
lished consensus/position statements (scmr.org/page/guidelines).
Renal MRI, on the other hand, is struggling to get off the ground.
Conceivably, this divergence is partially due to the usefulness of
morphological MRI, which is rather different for both applications.
Unlike cardiac MRI, with its workhorse - cardiac function assess-
ment - being based on (cinematic) morphological images, renal
MRI depends on multi-parametric structural and functional infor-
mation, derived from T1, T2, BOLD, DWI, ASL, etc. A second
reason might be the availability of treatment and the nature of the
diseases. Due to the still rather limited treatment options for CKD,
performing complicated and expensive MRI exams still seems less
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critical than in cardiac disease where there are more management
options. It is expected that the emergence of new CKD treatments
will stimulate the interest in renal MRI.
It is interesting to consider exactly how much clinical and
preclinical research activity in cardiac and renal MRI there has
been, and how it has grown over the years. Using publications
listed in PubMed as an indicator, we performed tailored searches
with PubMed’sMedical Subject Headings (MeSH) to obtain lists of
literature on renal/cardiac MRI in humans/animals (Fig. 2, upper
panels). Additionally we used PubMed’s MeSH Major Topic to
restrict the searches to papers that focus on renal/cardiac MRI
while excluding articles that only mention these terms but have
another focus (Fig. 2, lower panels) (see Note 1).
The number of publications in both fields has grown consider-
ably over the years, but at very different rates. Around 1000 cardiac
MRI papers per year were published during 2014–2018; the equiv-
alent number for renal MRI papers was only around 200. After
restricting the search to papers with a main focus on MRI of the
kidney/heart the number of papers per year were 400 and
70, respectively. In other words, a lot more research activity in
renal MRI is needed. From the number of publications one can
deduce that there is considerably more clinical research than pre-
clinical research in renal MRI. Conceivably, this is partially due to
the more limited availability of preclinical MRI systems. However,
preclinical renal MRI has recently seen a rapid increase to 37% of all
renal MRI publications. This highlights the importance of animal
research in renal MRI, considering that only 5% of cardiac MRI
papers are preclinical (as of 2018).
The renal MRI research community is still rather small. While a
recent SCMR meeting attracted more than 1900 attendees [7],
international meetings on renal MRI have had approximately
150–200 attendees [8, 9]. Around 200 experts in renal MRI from
30 countries are part of PARENCHIMA (renalmri.org), a
community-driven Action in the COST program of the European
Union, with the aim to improve the reproducibility and standardi-
zation of renal MRI biomarkers. In fact, the number of research
groups active in preclinical renal MRI is only 1/5 of those active in
clinical renal MRI (see Note 2). One important conclusion from
this is that accelerating the development of renal MRI will require
more researchers and institutions to enter the field. We may ask




For a novel MRI technique, the road to routine clinical use is a
stony one, involving issues such as reimbursement, available time
for MRI, evidence needed that the new method is superior to
existing techniques, and availability of hardware/software and
trained staff. However, most renal MRI techniques are still at an
early phase of development. Here, learning how to correctly
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interpret theMRI parameters (T1, T2*, ADC, etc.) and establishing
normal ranges for these MRI parameters are only two of the items
on the to-do list.
When searching for the culprits for the slow development of
renal MRI, we also encounter the usual suspects: lack of training
and standardization. This will sound familiar to most academic
researchers. The workforce of academic research consists primarily
of PhD students, who typically start their MRI research lacking the
most relevant knowledge, and thus spend half or even more of their
3- to 4-year project learning the necessary theory, skills, hands-on
experience and the many “secret tricks” that are essential for
performing successful studies but are not found in the usual litera-
ture. This is problem #1: inefficient learning.
When designing a study, researchers encounter a further diffi-
culty. Puzzled by the great variety of protocols (and diversity of
equipment) in the literature, and often lacking an explanation for
the choice of parameters, they are forced to design their study based
on their own rationales and gut feelings. This is problem #2: lack of
standardization. This not only hampers new researchers in setting
up their studies but, even more devastatingly, has a detrimental
effect on the comparability and reproducibility of research. This is
a major obstacle to fast and efficient research and development.
When researchers finally publish their results, they do so in the
usual format of a scientific paper, which focuses on a concise
description of the problem, proposed solution, main findings, and
a discussion of the meaning and limitations of the study. Important
details about the practicalities of actually conducting the experi-
ments are usually omitted. When individuals leave the lab, most of
their crucial experience and expertise is lost. The cycle starts again
with the next student.





Let’s recap: the box of diagnostic tools available to the nephrolo-
gists is still rather poorly equipped (mostly insensitive and nonspe-
cific plasma/urine markers), and renal MRI has the potential to be a
game changer for the treatment of AKI and CKD. To address the
numerous challenges of clinical translation of renal MRI, much
more research activity is needed, and the community needs to
grow. Among the factors preventing rapid progress are inefficient
learning and lack of standardization. To overcome these roadblocks
we suggest a roadmap for improving the training and standardiza-
tion of preclinical and clinical renal MRI (Fig. 3). This combines
protocol collections in the Springer Protocols book format with
consensus-based technical recommendation papers based on the
Delphi method.
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Springer Protocols is “the world’s largest collection of protocols
of biomedical and life sciences,” currently with over 58,000 step-
by-step experimental protocols in more than 2000 books. The
protocols are published individually as electronic publications in
the PubMed cited journalMethods in Molecular Biology as well as in
the form of printed books, with each book representing a collection
of protocols for a specific topic. “Each protocol is provided in
readily-reproducible step-by-step fashion, opening with an intro-
ductory overview, a list of the materials and reagents needed to
complete the experiment, and followed by a detailed procedure that
is supported with a helpful notes section offering tips and tricks of
the trade as well as troubleshooting advice.” [10]. This format
makes Springer Protocols an excellent tool for training, and by
providing working protocols, they also help to improve the repro-
ducibility, comparability, and standardization of studies. Research-
ers are less likely to perform studies with “arbitrary” protocols and
parameters when tested and proven protocols are readily available.
Fig. 3 Suggested roadmap for improving the training and standardization of preclinical and clinical renal MRI.
It combines Springer Protocols books (excellent for training but also provides working protocols that help to
improve comparability/standardization of future studies) with consensus-based technical recommendation
papers (established tool to move toward standardization of studies). clinical ¼ human MRI, (pre)-
clinical ¼ human and animal MRI, preclinical ¼ animal MRI
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An established step toward standardization are consensus-
based technical recommendation papers published as articles in
technical journals. The process of developing expert consensus on
technical aspects is a challenge. Here the Delphi method [11] can
help to generate consensus statements: anonymous surveys that
ensure all opinions are heard, free from peer pressure, are followed
by rounds of face-to-face discussions. This iterative method permits
“reaching reliable consensus in practice guidelines on health-care-
related issues and on topics where there is little or no definitive
evidence and where opinion is important” [12].
Because step-by-step protocols and technical recommendations
address different ends of the training-standardization spectrum
(Fig. 3), both perfectly complement each other. When deciding
which step to take first, one needs to take into account the specific
situation, that is, the size of the research community, the amount of
hands-on experience available, the range of different equipment in
use, the range of different subjects/objects being investigated, and
so on. In these aspects clinical and preclinical renal MRI differ
significantly. The number of research groups active in clinical
renal MRI is five times the number of those active in preclinical
renal MRI (see Subheading 1.4). In the clinical setting the range of
setups (RF coils, field strengths) and subjects is much smaller than
in preclinical settings. Even though we highlighted pediatric renal
MRI in the introduction, the vast majority of renal MRI studies are
performed on adult subjects at 1.5 or 3.0T. In preclinical renal MRI
predominantly two species of very different size—mice and rats—
are investigated at fields strengths of 3.0T, 4.7T, 7.0T, 9.4T,
11.7T, and 16.4T, with a wide range of RF coils ranging from
human wrist coils to RX surface array + TX volume resonator
combinations tailored for mouse or rat cardiac MRI, to cryogeni-
cally cooled TX/RX surface coils. These variations in setup influ-
ence numerous factors, including the achievable signal-to-noise
ratio, the spatial resolution, and the relaxation times (T1, T2,
T2*), thus leading to substantially different MRI protocols. Both
the great technical variety and the small size of the preclinical renal
MRI community make reaching consensus-based technical recom-
mendations particularly challenging, because many different sets of
recommendations would be needed to address all commonly used
study setups. Therefore, while consensus-based technical recom-
mendations may be the natural first step for clinical renal MRI, for
preclinical MRI we decided to focus instead on creating a compre-
hensive Springer Protocols collection to improve training and com-
parability of studies.
Both, consensus-based recommendations papers and protocols
collections, can only be fully effective if they are made openly
accessible. Therefore, we are very glad that it was possible to
make these publications open-access thanks to support from the
COST Action PARENCHIMA (renalmri.org).
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2.2 Driving




The answer is, of course, “not yet,” as there is still some distance left
to drive. But a giant leap has been made already, thanks to the
COST Action PARENCHIMA (renalmri.org), which unites more
than 200 experts in renal MRI from 30 countries, and the time,
effort, and energy invested by more than 100 authors. After recent
clinical position papers (https://academic.oup.com/ndt/issue/
33/suppl_2) confirmed the demand, two projects have been imple-
mented: The consensus-based technical recommendations for clin-
ical translation of renal MRI (described in [12]) and the Springer
Protocols book on preclinical renal MRI (described in
Subheading 3).
Four papers present the results of applying the Delphi method
to clinical renal MRI: arterial spin labeling (ASL) perfusion, blood
oxygenation level dependent (BOLD) MRI, diffusion-weighed
imaging (DWI), and mapping of renal T1/T2 [13–16]. This pro-
cess generated over 160 consensus statements but also flagged
topics where experts were currently unable to agree on a recom-
mendation. These first ever technical recommendations for renal
MRI should spark research into their appropriateness, with the aim
to either prove or disprove specific recommendations. The findings
of these future studies should then be fed back into updated and
revised versions of the technical recommendations papers (Fig. 3).
We hope that this approach will gradually lead to an alignment of
the methods for measuring renal MRI biomarkers. It goes without
saying that also the spectrum of methods covered must be extended
in the future.
In the roadmap (Fig. 3), we propose to supplement these fresh
off the press, already existing publications with the respective other
parts, so that there will be step-by-step protocols as well as
consensus-based technical recommendations available for both
clinical and preclinical renal MRI. Here, the Springer Protocols for
clinical MRI of the kidney are a placeholder for any type of protocol
style journal, that is, Methods in Molecular Biology (Springer Proto-
cols), Nature Protocols, Protocol Exchange, Journal of Visualized
Experiments (JoVE), and so on. In contrast to the Springer Proto-
cols, the latter permits independent publications on specific meth-
ods, which could be advantageous for clinical renal MRI, as it
would not be necessary to publish protocols for many methods
simultaneously. Needless to say, regularly updating all protocols
and recommendations will be a challenging but, nevertheless,
very important part of advancing the progress of renal MRI.
3 The Springer Protocols Book on Preclinical Renal MRI
Since Douglas Adams’s The Hitchhiker’s Guide to the Galaxy was
first published in 1979, the number “42” has been claimed to be
the answer to the question of “life, the universe, everything.” After
more than 2 years of hard work by 90 authors, the answer to the
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question, “How can we improve the training and standardization
of preclinical renal MRI?” resulted in the 42 (other) chapters of
this Springer Protocols book Pohlmann A, Niendorf T (eds) (2020)
“Preclinical MRI of the Kidney—Methods and Protocols,”
Springer, New York. In the following subsections we describe





When we started to think about the structure and content of this
book on preclinical renal MRI (with main focus on small animals),
it immediately became clear that a simple collection of independent
chapters would not suffice, for a multitude of reasons. First,
there are many important aspects involved in renal MRI that are
relevant to any MRI method: it does not make sense that for every
individual method the protocol would include considerations and
instructions regarding the MRI hardware, animal preparation,
physiological monitoring, or image slice planning and shimming.
Second, due to the complexity of MRI it is very challenging to
include all the information about a method in a single chapter. If
the book was to become a one-stop-shop for learning renal MRI in
small animals, a concept was needed. In the following we describe




With a few exceptions, we included three chapters for each renal
MRI method:
1. There is one chapter describing the basic concepts of the
method. We believe a sound understanding of the measure-
ment concept is essential when planning, performing, analyz-
ing, and interpreting a study. This is complemented by a brief
overview of the preclinical renal applications, in order to
illustrate for what kind of questions and applications each
technique is useful for.
2. A step-by-step experimental protocol, which we know from
the many existing Springer Protocols books. These protocols are
the core of the book. For less complex methods they include
also instructions for data analysis.
3. Detailed step-by-step protocols for data analysis.
3.1.2 Generalize
Protocols by Peer Review
Although we trusted that each author had extensive experience and
described the protocols correctly and in an understandable manner,
we endeavored to make sure these were free from lab specific
techniques, assumptions and limitations, which could be due, for
example, to the (un)availability of equipment or traditions. Because
these protocols should also serve to move toward the harmoni-
zation of studies, we felt it was important to ensure that the
protocols were as universal as possible and would work in many
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labs and settings. For this reason we implemented a coauthor peer
review process, that is, every chapter had to have one or several
external coauthors from other laboratories. The roles of these
coauthors are as follows:
1. To check whether the protocol would be applicable in other
settings,
2. To check whether the steps and parameters are reasonable and
their rationale clear and correct,
3. To add example protocols for additional lab settings.
3.1.3 Avoid Magic
Numbers
Magic numbers—that is, numbers which are not explained and
whose choice appears to be arbitrary—are not only a bad idea for
software program codes but also for lab protocols. How often have
we all read scientific publications and just could not figure out why
the authors chose that particular set of measurement parameters!
Was there a clever rationale behind their choice that sadly we didn’t
know, a lab tradition which might be reasonable but perhaps not
applicable to our setting, or just a gut feeling of a student that
didn’t know how to make sense of all the different examples in the
literature?
In any case, we wanted to reduce the magic numbers in our
protocols to a minimum, so all authors were instructed to explain
the rationales for their parameter choices in generic terms. If possi-
ble, advice for adapting them to other settings (other species, other
field strengths) was to be given in the Notes section. Of course,
example parameter sets are very valuable because they may allow
readers to start straight away with a running protocol. They are also
important in terms of harmonization, as mentioned. Therefore,
examples of parameter sets for specific settings were requested,
but separately in the Notes section, for example parameter sets for
mice in a 7T MRI system and rats in a 9.4T system. For some
techniques parameter sets for rats in a clinical 3T MRI system were
also included.
3.1.4 Describe
the Pragmatic Way for Data
Analyses
It was important to us to dedicate separate chapters to the analyses
because data analysis is an essential part of each study, but it is very
rarely described in adequate detail. Statements like “T2* was calcu-
lated by pixel-wise exponential fitting to the data using an in-house
developed software written inMATLAB®” don’t really help anyone
who wants to learn how to analyze the data correctly. We are sure
many of us have used similar statements in previous journal pub-
lications, but the fault is not always entirely ours: often there is
simply no space (word limits!) and time to give a detailed descrip-
tion. Here, we wanted to make sure there was space (by having an
entire chapter solely for the analysis) and time (by rewarding the
effort and time spent in the detailed description with a first
authorship).
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It was key to present the most pragmatic approach to data
analysis. What is the point in describing how to do your own
code if there is established software available? So if analysis software
existed, authors should describe how to get it and how to use
it. Otherwise, the step-by-step instructions should focus on how
to write a software program. Including pseudo code was encour-
aged, as well as providing downloadable code examples via GitHub
or similar.
Finally, we asked to provide the readers with ideas on how to
validate that their analyses give correct results. This could include
for example a table of reference values or using synthetic test data.
3.1.5 Prevent Tunnel
Vision—A Successful
Study Needs More Than
an MRI Protocol
Indeed, performing the actual MRI study is only part of the story.
One must not forget that physiological MRI also requires consid-
eration of many factors that are less important in anatomical imag-
ing. Considerations about physiological monitoring, choosing the
right animal model, measuring at the right time of the day, and
using the most suitable anesthesia all have important implications.
For this reason, the first part of the book was dedicated to
topics like animal models, preparation, monitoring and physiologi-
cal interventions. We also questioned the need to always perform
in vivo experiments on animals for training, development, and
testing. Hence, one chapter provides a step-by-step protocol for





There are numerous questions for which it makes sense to go
multimodal. Not only ultrasound and photoacoustic imaging but
also invasive probes that provide quantitative physiological mea-
surements are extremely valuable complements. Therefore, this
book includes more than just MRI.
3.1.7 Make Access
to This Information Free
of Charge
Thanks to support from the COST Action PARENCHIMA
(renalmri.org) it was possible to make all chapters open access!
3.2 Content
of the Book
An overview of topics covered by the Springer Protocols book on
preclinical renal MRI is shown in Fig. 4. Part II contains four
chapters about animal models, preparation, monitoring, physiolog-
ical interventions, and rodent phantoms. In Part III there are
13 chapters describing the basic concepts of the techniques, fol-
lowed by Part IV with 14 step-by-step protocols for conducting
experiments. Finally, Part V contains ten chapters that address data
analysis; this includes the subsegmentation of the kidney into
morphology-based regions of interest or concentric objects, as
well as image denoising using nonlocal means (NLM) filtering.
More detailed information on the book structure and chapters
is provided below by listing all chapters in the format [chapter
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number] [chapter title] [author list]. Each chapter is PubMed-
listed as an entry in Methods Mol Biol.
3.2.1 Part I—
Introduction
1. Recommendations for Preclinical Renal MRI: A Comprehensive
Open-Access Protocol Collection to Improve Training, Reproduc-
ibility, and Comparability of Studies (Andreas Pohlmann, Susan
J. Back, Andrea Fekete, Iris Friedli, Stefanie Hectors, Neil Peter
Jerome, Min-Chi Ku, Dario Livio Longo, Martin Meier, Jason
M. Millward, João S. Periquito, Erdmann Seeliger, Suraj
D. Serai, Sonia Waiczies, Steven Sourbron, Christoffer Laust-






1. Animal Models of Renal Pathophysiology and Disease (Adam
Hosszu, Tamas Kaucsar, Erdmann Seeliger, and Andrea
Fekete).
2. Preparation and Monitoring of Small Animals in Renal MRI
(Tamas Kaucsar, AdamHosszu, Erdmann Seeliger, HenningM
Reimann, and Andrea Fekete).
Fig. 4 Overview of topics covered by the Springer Protocols book on preclinical renal MRI. There are 4 chapters
about animal models, preparation, monitoring, physiological interventions, and rodent phantoms; 13 chapters
describing the basic concepts of the techniques; 14 chapters with step-by-step protocols for experiments, and
11 data analysis protocols
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3. Reversible (Patho)physiologically Relevant Test Interventions:
Rationale and Examples (Kathleen Cantow, Mechthild
Ladwig-Wiegard, Bert Flemming, Andrea Fekete, Adam Hos-
szu, and Erdmann Seeliger).
4. Preparation of Ex Vivo Rodent Phantoms for Developing, Test-
ing, and Training MR Imaging of the Kidney and Other
Organs (Jason M. Millward, Joao Periquito, Paula Ramos Del-




5. Quantitative Assessment of Renal Perfusion and Oxygenation by
Invasive Probes: Basic Concepts (Kathleen Cantow, Roger
G. Evans, Dirk Grosenick, Thomas Gladytz, Thoralf Niendorf,
Bert Flemming, and Erdmann Seeliger).
6. Ultrasound and Photoacoustic Imaging of the Kidney: Basic
Concepts and Protocols (Sandra Meyer and Dieter Fuchs Martin
Meier).
7. Hardware Considerations for Preclinical Magnetic Resonance of
the Kidney (Paula Ramos Delgado, Ekkehard Küstermann,
André Kühne, Thoralf Niendorf, Andreas Pohlmann, andMar-
tin Meier).
8. MRI Mapping of Renal T1: Basic Concepts (Stefanie Hectors,
Sabrina Doblas, Philippe Garteiser, Gwenaël Pagé, Bernard
E. Van Beers, John C Waterton, and Octavia Bane).
9. MRI Mapping of the Blood Oxygenation Sensitive Parameter
T2* in the Kidney: Basic Concepts (Lu-Ping Li, Bradley Hack,
Erdmann Seeliger, and Pottumarthi V. Prasad).
10. Renal Diffusion Weighted Imaging (DWI) for Apparent Diffu-
sion Coefficient (ADC), Intravoxel Incoherent Motion (IVIM),
and Diffusion Tensor Imaging (DTI): Basic Concepts (Neil
Peter Jerome, Anna Caroli, and Alexandra Ljimani).
11. Dynamic Contrast Enhancement (DCE) MRI–Derived Renal
Perfusion and Filtration: Basic Concepts (Michael Pedersen,
Pietro Irrera, Walter Dastrù, Frank G Zöllner, Kevin M Ben-
nett, Scott C Beeman, G Larry Bretthorst, Joel R Garbow, and
Dario Livio Longo).
12. Noninvasive Renal Perfusion Measurement Using Arterial Spin
Labeling (ASL) MRI: Basic Concepts (Min-Chi Ku, Marı́a A
Fernández-Seara, Frank Kober, and Thoralf Niendorf).
13. Renal pH Imaging Using Chemical Exchange Saturation
Transfer (CEST)-MRI: Basic Concepts (Dario Livio Longo,
Pietro Irrera, Lorena Consolino, Phillip Zhe Sun, and Michael
T. McMahon).
14. Sodium (23Na) MRI of the Kidney: Basic Concepts (James
T. Grist, Esben Søvsø Hansen, Frank G. Zöllner, and Chris-
toffer Laustsen).
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15. Hyperpolarized Carbon (13C) MRI of the Kidneys: Basic Con-
cepts (Cornelius von Morze, Galen D. Reed, Zhen J. Wang,
Michael A. Ohliger, and Christoffer Laustsen).
16. Functional Imaging Using Fluorine (19F) MR Methods: Basic
Concepts (Sonia Waiczies, Christian Prinz, Ludger Starke,
Jason M. Millward, Paula Ramos Delgado, Jens Rosenberg,
Marc Nazaré, Helmar Waiczies, Andreas Pohlmann, and Thor-
alf Niendorf).




18. Monitoring Renal Hemodynamics and Oxygenation by Invasive
Probes: Experimental Protocol (Kathleen Cantow, Mechthild
Ladwig-Wiegard, Bert Flemming, Andreas Pohlmann, Thoralf
Niendorf, and Erdmann Seeliger).
19. Essential Practical Steps for MRI of the Kidney in Experimental
Research (Andreas Pohlmann, João dos Santos Periquito, and
Thoralf Niendorf).
20. Assessment of Renal Volume with MRI: Experimental Protocol
(Andreas Müller and Martin Meier).
21. Experimental Protocols for MRI Mapping of Renal T1 (Philippe
Garteiser, Octavia Bane, Sabrina Doblas, Iris Friedli, Stefanie
Hectors, Gwenaël Pagé, Bernard E. Van Beers, and John
C. Waterton).
22. Experimental Protocols for Mapping of Renal T2* and T2
(Andreas Pohlmann, Kaixuan Zhao, Sean B. Fain, Pottumarthi
V. Prasad, and Thoralf Niendorf).
23. Renal MRI Diffusion: Experimental Protocol (João
S. Periquito, Martin Meier, Thoralf Niendorf, Andreas Pohl-
mann, and Neil Peter Jerome).
24. Dynamic Contrast Enhanced (DCE) MRI–Derived Renal Per-
fusion and Filtration: Experimental Protocol (Pietro Irrera,
Lorena Consolino, Walter Dastrù, Michael Pedersen, Frank
G. Zöllner, and Dario Livio Longo).
25. Renal Blood Flow Using Arterial Spin Labeling (ASL) MRI:
Experimental Protocol and Principles (Kai-Hsiang Chuang,
Martin Meier, Marı́a A Fernández-Seara, Frank Kober, and
Min-Chi Ku).
26. Renal pH Mapping Using Chemical Exchange Saturation
Transfer (CEST) MRI: Experimental Protocol (Kowsalya Devi
Pavuluri, Lorena Consolino, Dario Livio Longo, Pietro Irrera,
Phillip Zhe Sun, and Michael T. McMahon).
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27. Sodium (23Na) MRI of the Kidney: Experimental Protocol
(James T. Grist, Esben Søvsø Hansen, Frank G. Zöllner, and
Christoffer Laustsen).
28. Hyperpolarized Carbon (13C) MRI of the Kidney: Experimental
Protocol (Christoffer Laustsen, Cornelius von Morze, and
Galen Reed).
29. Fluorine (19F) MRI for Assessing Inflammatory Cells in the
Kidney: Experimental Protocol (Min-Chi Ku, Adrian Schreiber,
Paula Ramos Delgado, Philipp Boehm-Sturm, Ralph Kettritz,
Thoralf Niendorf, Andreas Pohlmann, and Sonia Waiczies).
30. Fluorine (19F) MRI to Measure Renal Oxygen Tension and
Blood Volume: Experimental Protocol (Lingzhi Hu, Hua Pan,
and Samuel A. Wickline).
31. MR Elastography of the Abdomen: Experimental Protocols (Suraj
D. Serai and Meng Yin).
3.2.5 Part V—Protocols
for Advanced Analyses
32. Subsegmentation of the Kidney in Experimental MR Images
Using Morphology-Based Regions of Interest or Multiple-Layer
Concentric Objects (Leili Riazy, Bastien Milani, João
S. Periquito, Kathleen Cantow, Thoralf Niendorf, Menno
Pruijm, Erdmann Seeliger, and Andreas Pohlmann).
33. Denoising for Improved Parametric MRI of the Kidney: Protocol
for Nonlocal Means Filtering (Ludger Starke, Karsten Tabelow,
Thoralf Niendorf, and Andreas Pohlmann).
34. Analysis Protocols for MRI Mapping of Renal T1 (Philippe
Garteiser, Gwenaël Pagé, Sabrina Doblas, Octavia Bane, Stefa-
nie Hectors, Iris Friedli, Bernard E. Van Beers, and John
C. Waterton).
35. Analysis Protocols for MRI Mapping of the Blood Oxygenation
Sensitive Parameters T2* and T2 in the Kidney (João
S. Periquito, Ludger Starke, Carlota M. Santos, Andreia
C. Freitas, Nuno Loução, Pablo Garcı́a Polo, Rita G. Nunes,
Thoralf Niendorf, and Andreas Pohlmann).
36. Analysis of Renal Diffusion Weighted Imaging (DWI) Using
Apparent Diffusion Coefficient (ADC) and Intravoxel Incoher-
ent Motion (IVIM) Models (Neil Peter Jerome and João
S. Periquito).
37. Analysis Protocol for Dynamic Contrast Enhanced (DCE) MRI
of Renal Perfusion and Filtration (Frank G. Zöllner, Walter
Dastrù, Pietro Irrera, Dario Livio Longo, Kevin M Bennett,
Scott C. Beeman, G. Larry Bretthorst, and Joel R. Garbow).
38. Quantitative Analysis of Renal Perfusion by Arterial Spin
Labeling (Kai-Hsiang Chuang, Frank Kober, andMin-Chi Ku).
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39. Analysis Protocol for the Quantification of Renal pH Using
Chemical Exchange Saturation Transfer (CEST) MRI (Hahn-
sung Kim, Yin Wu, Daisy Villano, Dario Livio Longo, Michael
T. McMahon, and Phillip Zhe Sun).
40. Analysis Protocol for Renal Sodium (23Na)MR Imaging (James
T. Grist, Esben Søvsø Hansen, Frank G. Zöllner, and Christof-
fer Laustsen).
41. Analysis Methods for Hyperpolarized Carbon (13C) MRI of the
Kidney (Galen D. Reed, Natalie J. Korn, Christoffer Laustsen,
and Cornelius von Morze).
42. Data Preparation Protocol for Low Signal-to-Noise Ratio




The mission of this book was to bring together in one collection a
comprehensive assortment of protocols, methods, techniques, and
recommendations that can form a cornerstone of preclinical renal
MR. This collection will serve as an excellent starting point for new
researchers interested in breaking into the renal MR field. Expand-
ing the number of researchers is absolutely critical for realizing the
full potential of renal MR. By providing a set of carefully con-
structed protocols, we can avoid the waste of time, money and
resources by no longer “re-inventing the wheel.” This collection
will also greatly facilitate the harmonization of studies, and pro-
mote the sharing of data and results across multiple research
groups, by getting everyone onto the “same page.” These efforts
will help us break through those bottlenecks of inefficient learning
and lack of standardization. The road ahead to fully realize the
scientific and clinical possibilities of renal MR remains long, but
the end result will be well worth the effort.
4 Notes
1. The search string for clinical renal MRI was as follows:
(((“magnetic resonance imaging”[MeSH Terms]) AND
“kidney”[MeSH Terms]) AND “humans “[MeSH Terms]).
For preclinical renal MRI the last AND term was replaced
with AND “animals”[MeSH Terms]) NOT “humans”[MeSH
Terms]. For cardiac MRI the word “kidney” was replaced
with the word “heart.” For restricting the search to papers
with a main focus on MRI of the kidney/heart MeSH Terms
was replaced with MeSH Major Topic: (((“magnetic reso-
nance imaging”[MeSH Major Topic]) AND “kidney”[-
MeSH Major Topic])) . . .. We used PubMed’s MeSH terms
rather than free text search in the title/abstract to reduce the
number of false positive/negative search results. However, a
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drawback of using MeSH terms is that the indexing process
takes rather long (several studies reported average delays of
100–150 days), but it may take significantly longer in some
cases. For example, we found that several of our publications
from 2017 and after were not yet MeSH indexed. Hence, the
presented publication statistics can only be rough estimates of
the true numbers of publications. Data for the year 2019 was
excluded, because most PubMed listed publications on renal
MRI had not been indexed with MeSH Terms yet.
2. We further exploited the publication lists obtained from the
above PubMed’s searches. We defined active researchers as any-
one who published on renal MRI since 2015. After exporting
the date-restricted publications lists from PubMed in XML
format, we used an in-house developed software to extract
the affiliations of the first and last authors—these research
groups (departments of hospitals and academic institutions
were counted individually) were considered to be active players
in renal MRI. Duplicates were removed automatically (using
Matlab’s unique() function) and manually. The limitations
mentioned in Note 1 also apply here: due to the incomplete
MeSH indexing the derived statistics are only rough estimates
and data of 2019 could not be included.
Acknowledgments
This work was funded, in part (Thoralf Niendorf, Sonia Waiczies,
Andreas Pohlmann, Erdmann Seeliger and Joao Periquito), by the
German Research Foundation (Gefoerdert durch die Deutsche
Forschungsgemeinschaft (DFG), Projektnummer 394046635,
SFB 1365, RENOPROTECTION. Funded by the Deutsche For-
schungsgemeinschaft (DFG, German Research Foundation), Proj-
ect number 394046635, SFB 1365, RENOPROTECTION).
This chapter is based upon the work from COST Action PAR
ENCHIMA, supported by European Cooperation in Science and
Technology (COST). COST (www.cost.eu) is a funding agency for
research and innovation networks. COST Actions help connect
research initiatives across Europe and enable scientists to enrich
their ideas by sharing them with their peers. This boosts their
research, career, and innovation.
PARENCHIMA (renalmri.org) is a community-driven Action
in the COST program of the European Union, which unites more
than 200 experts in renal MRI from 30 countries with the aim to
improve the reproducibility and standardization of renal MRI
biomarkers.
Recommendations for Preclinical Renal MRI 21
References
1. Dickerson EC, Dillman JR, Smith EA, DiPie-
tro MA, Lebowitz RL, Darge K (2015) Pediat-
ric MR urography: indications, techniques, and
approach to review. Radiographics 35
(4):1208–1230. https://doi.org/10.1148/
rg.2015140223
2. Khrichenko D, Darge K (2010) Functional
analysis in MR urography—made simple.
Pediatr Radiol 40(2):182–199. https://doi.
org/10.1007/s00247-009-1458-4
3. National Kidney Foundation NY, USA.
https://www.kidney.org/professionals/
kdoqi/gfr_calculator. Accessed 07 Jan 2020
4. Porrini E, Ruggenenti P, Luis-Lima S,
Carrara F, Jimenez A, de Vries APJ, Torres A,
Gaspari F, Remuzzi G (2019) Estimated GFR:
time for a critical appraisal. Nat Rev Nephrol
15(3):177–190. https://doi.org/10.1038/
s41581-018-0080-9
5. Friedli I, Crowe LA, Berchtold L, Moll S,
Hadaya K, de Perrot T, Vesin C, Martin PY,
de Seigneux S, Vallee JP (2016) New magnetic
resonance imaging index for renal fibrosis
assessment: a comparison between diffusion-
weighted imaging and T1 mapping with histo-
logical validation. Sci Rep 6:30088. https://
doi.org/10.1038/srep30088
6. Pohlmann A, Arakelyan K, Hentschel J,
Cantow K, Flemming B, Ladwig M,
Waiczies S, Seeliger E, Niendorf T (2014)
Detailing the relation between renal T2* and
renal tissue pO2 using an integrated approach
of parametric magnetic resonance imaging and
invasive physiological measurements. Investig
Radiol 49(8):547–560. https://doi.org/10.
1097/RLI.0000000000000054
7. SCMR (2018) The Society for Cardiovascular
Magnetic Resonance—News 2018. scmr.org/
page/CMR2018news. Accessed 07 Jan 2020
8. Pohlmann A, Seeliger E, Grosenick D,
Waiczies S, Cantow K, Persson PB, Niendorf
T (2017) 2nd International Scientific Sympo-
sium on Functional Renal Imaging: Where
Physiology, Nephrology, Radiology and Phys-
ics Meet. www.mdc-berlin.de/renal. Accessed
07 Feb 2020
9. Francis S, Taal M, Selby N (2019) 3rd Interna-
tional Symposium on Functional Renal Imag-
ing. www.nottingham.ac.uk/go/3rdrenalmri.
Accessed 07 Feb 2020
10. SpringerNature Springer Protocols. www.
springernature.com/gp/librarians/products/
product-types/database/springerprotocols.
Accessed 10 Feb 2020
11. Dalkey N, Helmer O (1963) An experimental
application of the DELPHI method to the use
of experts. Manag Sci 9(3):458–467. https://
doi.org/10.1287/mnsc.9.3.458
12. Mendichovszky I, Pullens P, Dekkers I, Nery F,
Bane O, Pohlmann A, de Boer A, Ljimani A,
Odudu A, Buchanan C, Sharma K, Laustsen C,
Harteveld A, Golay X, Pedrosa I, Alsop D,
Fain S, Caroli A, Prasad P, Francis S,
Sigmund E, Fernandez-Seara M, Sourbron S
(2020) Technical recommendations for clinical
translation of renal MRI: a consensus project of
the cooperation in science and technology
action PARENCHIMA. MAGMA 33
(1):131–140. https://doi.org/10.1007/
s10334-019-00784-w
13. Nery F, Buchanan CE, Harteveld AA,
Odudu A, Bane O, Cox EF, Derlin K, Gach
HM, Golay X, Gutberlet M, Laustsen C,
Ljimani A, Madhuranthakam AJ, Pedrosa I,
Prasad PV, Robson PM, Sharma K,
Sourbron S, Taso M, Thomas DL, Wang DJJ,
Zhang JL, Alsop DC, Fain SB, Francis ST,
Fernandez-Seara MA (2020) Consensus-
based technical recommendations for clinical
translation of renal ASL MRI. MAGMA 33
(1):1–21. https://doi.org/10.1007/s10334-
019-00800-z
14. Bane O, Mendichovszky IA, Milani B, Dekkers
IA, Deux JF, Eckerbom P, Grenier N, Hall ME,
Inoue T, Laustsen C, Lerman LO, Liu C,
Morrell G, Pedersen M, Pruijm M, Sadowski
EA, Seeliger E, Sharma K, Thoeny H,
Vermathen P, Wang ZJ, Serafin Z, Zhang JL,
Francis ST, Sourbron S, Pohlmann A, Fain SB,
Prasad PV (2020) Consensus-based technical
recommendations for clinical translation of
renal BOLD MRI. MAGMA 33(1):199–215.
https://doi.org/10.1007/s10334-019-
00802-x
15. Ljimani A, Caroli A, Laustsen C, Francis S,
Mendichovszky IA, Bane O, Nery F,
Sharma K, Pohlmann A, Dekkers IA, Vallee
JP, Derlin K, Notohamiprodjo M, Lim RP,
Palmucci S, Serai SD, Periquito J, Wang ZJ,
Froeling M, Thoeny HC, Prasad P,
Schneider M, Niendorf T, Pullens P,
Sourbron S, Sigmund EE (2020) Consensus-
based technical recommendations for clinical
translation of renal diffusion-weighted MRI.
22 Andreas Pohlmann et al.
MAGMA 33(1):177–195. https://doi.org/
10.1007/s10334-019-00790-y
16. Dekkers IA, de Boer A, Sharma K, Cox EF,
Lamb HJ, Buckley DL, Bane O, Morris DM,
Prasad PV, Semple SIK, Gillis KA, Hockings P,
Buchanan C, Wolf M, Laustsen C, Leiner T,
Haddock B, Hoogduin JM, Pullens P,
Sourbron S, Francis S (2020) Consensus-
based technical recommendations for clinical
translation of renal T1 and T2 mapping MRI.
MAGMA 33(1):163–176. https://doi.org/
10.1007/s10334-019-00797-5
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution
and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter’s Creative Commons license,
unless indicated otherwise in a credit line to the material. If material is not included in the chapter’s Creative
Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder.
Recommendations for Preclinical Renal MRI 23
Part II
Animal Models, Preparation, Monitoring, and Physiological
Interventions
Chapter 2
Animal Models of Renal Pathophysiology and Disease
Adam Hosszu, Tamas Kaucsar, Erdmann Seeliger, and Andrea Fekete
Abstract
Renal diseases remain devastating illnesses with unacceptably high rates of mortality and morbidity
worldwide. Animal models are essential tools to better understand the pathomechanisms of kidney-related
illnesses and to develop new, successful therapeutic strategies. Magnetic resonance imaging (MRI) has been
actively explored in the last decades for assessing renal function, perfusion, tissue oxygenation as well as the
degree of fibrosis and inflammation. This chapter aims to provide a comprehensive overview of animal
models of acute and chronic kidney diseases, highlighting MRI-specific considerations, advantages, and
pitfalls, and thus assisting the researcher in experiment planning.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Key words Kidney disease, Magnetic resonance imaging (MRI), Animal models, Rodents
1 Introduction
Renal diseases remain devastating illnesses with unacceptably high
rates of mortality and morbidity worldwide. The prevalence of end
stage kidney disease is currently between 8% and 16% and is rapidly
increasing; the number of patients increased tenfold in the last four
decades [1].
Kidney diseases generate a major drain on health and
productivity-related resources for healthcare systems; thus, preven-
tion and early treatment would have an enormous social and eco-
nomic impact.
Understanding the pathologic mechanisms of renal injury is
essential for finding new targets for intervention and developing
effective treatments for patients with kidney disease [2]. Landmark
publications have outlined key areas in which progress is necessary,
specifically highlighting the need for superior diagnostic tools [3].
At present, diagnosis of kidney disease is difficult and often
involves invasive procedures such as biopsy. Conventional markers
of renal function such as serum creatinine and blood urea nitrogen
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are poorly sensitive and poorly selective. The levels of these bio-
markers can take several hours or days to reach a new steady state
and thus represent a delayed indication of functional change that
lags behind structural deterioration during the early stage of acute
kidney injury (AKI). In addition, the imbalance between oxygen
supply and demand in kidney tissue is the initiating step in the
pathophysiology of renal ischemia–reperfusion injury (IRI), and a
pivotal early element in the pathophysiology of AKI of other ori-
gins. Currently kidney biopsy is the only available method to assess
renal microstructure, but it has several disadvantages, including its
invasive nature and susceptibility to sampling bias. Thus, noninva-
sive, in vivo imaging methods such as MRI are indispensable for the
adequate assessment of kidney function, oxygenation, and struc-
ture in both preclinical and clinical setups. Importantly, several
novel techniques are available to generate MRI data by measuring
tissue properties linked to filtration, tissue oxygenation, perfusion,
fibrosis, inflammation, or tissue edema that can be used as biomar-
kers of renal disease [4]. MRI affords full kidney coverage, soft
tissue contrast that helps to differentiate the renal layers, second-to-
minute temporal resolution, support of longitudinal studies, and
high anatomical detail without the use of ionizing radiation [5, 6].
Drug discovery is a time-consuming, expensive, and high-risk
process. In order to develop one FDA approved drug in the pre-
clinical phase thousands of compounds have to be tested from
which only dozens end up in clinical trials [7]. Conducting studies
on animal models is a valuable strategy in the preparation for clinical
trials because of the high similarity between some animals and
humans in their genetics, physiology, diseases, and diagnostic
tools. Without doubt the translatability of results obtained in ani-
mal models to humans has numerous limitations, but often they
represent an indispensable approach for trying to predict the effects
of a drug in the complex human system, and also for deciding on an
appropriate dose regime for the clinical trial(s) that balances efficacy
and safety. Many mechanistic questions can be answered only
through invasive procedures or extreme exposures possible only in
animals. Moreover, due to the fact that decades may elapse between
the onset and clinical manifestations of renal diseases in humans
(e.g., diabetic kidney disease), rodent models offer a more feasible
means of experimentation because the timeline of pathogeneses are
typically much shorter (either naturally or due to tailored disease
induction).
An ideal disease model accurately mimics the human condition
genetically, experimentally and/or physiologically, but unfortu-
nately such models do not exist. One reason for the poor outcomes
in clinical trials is that most animal models do not fully recapitulate
the pathological mechanisms underlying human diseases. Human
diseases are very complex, but specific factors of a disease are
relatively easy to model, which is an advantage and disadvantage
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at the same time. All of the widely used animal models have their
particular limitations; therefore, the model used should be appro-
priate for the question being addressed [8].
The present chapter summarizes animal models of renal dis-
eases highlighting MRI-specific considerations, advantages, and
pitfalls with an aim to assist the researcher in planning an experi-
ment and choosing the best species/strain/model to address the
question being asked.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Ethical Issues
A wide range of positions exist on the debate over the ethics of
animal experiments. On one end of the spectrum people argue that
an animal should have as much right to live out a full life, free of
suffering as a human and thus all animal experimentation should
end. Others argue that while the unnecessary abuse of animals is
clearly wrong, animal experimentation must continue because of
the enormous scientific resource that animal models provide. A
detailed discussion of the growing scholarly literature in animal
research ethics is beyond the scope of this chapter; however, the
authors feel obliged to provide some fundamental guidelines for
conduct of ethical research. The authors of this chapter believe that
biomedical animal research is founded on a pivotal ethical principle:
“It is among the most noble and indeed imperative of human endea-
vors to employ scientific research to prevent, alleviate, and cure the
pain, suffering, distress, fear, anxiety, disability, infirmity and death
associated with human disease” [9]. Because the use of animal
models to understand human disease is motivated by such a high
ethical ideal, we must aim to adhere to the highest ethical standards
when conducting research.
When designing a study applying the principles of 3Rs: replace-
ment, reduction, and refinement is advised to provide a framework
for performing the most humane animal research possible.Replace-
ment means the substitution of animals with alternative techniques
or avoid the use of animals altogether. Alternative methods such as
cell cultures or novel approaches such as stem cell technologies,
tissue engineering, or modeling using artificial intelligence show
promise for replacing animals in many areas of research but often
give limited information about what happens in the whole living
animal. Reduction means to obtain information of given amount
and precision from fewer animals or more information from the
same number of animals. Proper experimental design and statistical
analysis of the proposed project is pivotal in using the optimal
number of animals. If more animals are used than is necessary for
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obtaining reliable results, then animal lives are wasted. On the other
hand, if too few animals are used then the results can be unreliable
and the experiment has to be repeated, using more animals in total.
Refinement means minimizing the incidence or severity of proce-
dures that result in distress or suffering of animals which still have
to be used. Refinement can also improve the quality of research by
reducing stress in animals. By law, any suffering or pain to an animal
must be minimized. Animals must be anaesthetized for surgery,
and, if necessary, analgesics must be administered afterward, which
will be discussed in detail in the chapter by Kaucsar T et al.
“Preparation and Monitoring of Small Animals in Renal MRI.”
3 General Guidelines for Choosing an Animal Model
3.1 Rat or Mouse? The first major decision when designing a study using an animal
model is to choose the most suitable species. Rodent models are the
most popular to resemble human disease for a number of reasons:
90% of genes are orthologous in the rat, murine, and human
genomes, small size and fast reproduction of rodents facilitates
high-throughput studies, and a very good genetic/molecular tool
box is available.
Differences within rodents must not be underestimated when
designing experiments. Inbred mouse strains are more stable,
uniform, repeatable, and better defined than outbred rat strains
such as Wistar or Sprague-Dawley where the exact genetic back-
ground of each animal is unknown [10].
While rats used to be the preferred rodent in kidney research,
this changed with the advent of murine transgenic and knockout
technologies in the past decades. Genetically modified mice provide
unique opportunities for targeted research of the impact of indi-
vidual proteins on phenotype and responsiveness to therapeutic
interventions. Gene deletion or overexpression generally results in
very predictable and precise phenotypes in mice. Furthermore, due
to their small size many more mice can be housed in a small space
than rats and are therefore cheaper to maintain; they have a short
reproductive cycle and accelerated life span.
Murine models of kidney disease do have some limitations and
disadvantages that are worth considering. Surgical procedures such
as ureteric obstruction, renal ischemia, or kidney transplantation
are widely used to model human disease. Surgical manipulations
and micropuncture studies are technically much easier to perform
in larger animals such as rats.
Moreover, the pathophysiology in rat models is often not repli-
cated in mice. For example, while humans and rats have only one
copy of the renin gene, mice either have a single gene or two copies
at the renin locus. This may be an important confounding variable
considering the central role of the renin–angiotensin–aldosterone
system in renal disease and that the plasma renin activity of mice
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with two renin genes is tenfold higher than their single-gene
counterparts [11].
Hypertension is a leading cause of kidney failure; thus, nonin-
vasive blood pressure measurements are a crucial component of
studies in the field. While the technique is fairly routine in rats, it
has been proven to be rather challenging in mice [12].
Finally, the smaller size of mice means smaller amounts of
experimental material to work with. The fundamental limitation
in MRI is signal-to-noise ratio, which is in direct correlation with
the volume of the subject. Acquiring high-resolution images of
relatively small mouse kidneys could be challenging using lower
field strength MRI machines. Furthermore, concurrent measure-
ment of multiple variables such as RNA expression, protein levels,
histology, and metabolic processes from individual animals can be
challenging.
3.2 Which Strain? The choice of the right strain is essential since disease phenotypes in
rodents are strongly influenced by species and strain. For example,
there are distinct differences in the susceptibility to ischemic AKI
among various mouse strains or even different colonies of the same
strain. 129/Sv and National Institute of Health Swiss mice have
been shown to be less sensitive to ischemic injury than C57BL/6 or
BALB/c mice [13, 14]. Most transgenic models are described to
have comparable genetic background with wild-type strains such as
C57BL/6 after at least five generations of backcross; however, the
wild-type mice from the same transgenic models may differ signifi-
cantly from ordinary C57BL/6 mice. Similarly, Brown-Norway
rats have been found to be almost completely protected against
several manifestations of IRI when compared with the commonly
used Sprague-Dawley rat model [15]. In conclusion, pilot experi-
ments always have to be performed to determine the appropriate
duration of ischemia for a new strain to be studied.
The C57BL/6 mouse strain is also relatively resistant to the
development of diabetic kidney disease (DKD). C57BL/6 mice
develop significantly less albuminuria and renal histopathological
changes than DBA/2J and KK/HIJ mice [16]. Sprague-Dawley
rats are far more sensitive to streptozotocin-induced diabetes than
nude rats [17].
The remnant kidney model or 5/6 nephrectomy model has
been used extensively in rats to study the pathogenesis of glomer-
ulosclerosis. In contrast, mouse strains such as C57BL/6 and
C57BLX Swiss-Webster mice do not develop significant glomeru-
losclerosis or increased systolic blood pressure and proteinuria in
this model. C57BL/6 mice and Wistar rats are less susceptible to
deoxycorticosterone acetate (DOCA) salt-induced hypertension
than 129/Sv mice or Sprague-Dawley rats respectively
[18, 19]. Thus, the more susceptible 129/Sv strain is
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recommended to study hypertension-associated glomerulosclerosis
in mice [20].
3.3 Sex The anatomical structure of the healthy kidney is different in the
two sexes. Females have more glomeruli in the kidneys, higher
renovascular resistance, lower absolute GFR, and lower renal
plasma flow. There are differences on the cellular level as well:
males have larger mitochondria and more lysosomes and ribosomes
in their proximal tubular cells. Although estrogen and androgen
receptors are found in renal tissue in both sexes, animal experimen-
tal models (e.g., castration, ovariectomy) suggest that sex hor-
mones are involved in the sexual dimorphism of the kidney [21].
Female sex is a protective factor in several renal diseases which
disappear after menopause. Not only the outcome of AKI is better
in females [22, 23], but the progression of renal function deterio-
ration during the aging process [24] as well as other chronic renal
diseases [25] is also slower in females compared to males. Some
studies support the protective role of female hormones (17-
β-estradiol, progesterone) [26–28]. Others highlight the negative
effect of testosterone: Park et al. found more severe renal injury
after testosterone therapy in female, ovariectomized, and castrated
male mice [29].
For the aforementioned reasons the use of female rodents is
only advised if the study specifically aims to investigate sex differ-
ences or the role of sex hormones. Duration of the estrous cycle is
4–5 days in both rats and mice; a vaginal smear has to be obtained
and stages of the estrous cycle have to be identified before starting
an experiment. C. Caligioni provides a detailed description of
assessing the reproductive status of mice [30].
3.4 Other Species Some nonrodent species are also used, although less frequently. In
theory, nonhuman primates are the most similar to human biology,
but the heterogeneity is huge among species. Close approximation
of genetic, structural, and functional features of nonhuman pri-
mates to humans make them ideal experimental models; however,
specific ethical considerations are essential [31]. These animals are
likely to sense pain, distress, and social relationships in the same way
as humans. Moreover, they are expensive to obtain and house, may
transmit diseases to humans, and can be difficult to handle due to
their strength and intelligence. Experiments with nonhuman pri-
mates are limited to a very small number of animals compared to
rodents; thus, their statistical value can be doubtful.
Work using dogs played an enormous role in the early advance-
ment of dialysis and transplantation techniques, or the use of
azathioprine in immunosuppression, and others [32]. However,
ethical considerations and strong feelings of the public have sub-
stantially limited the use of companion animals for research
purposes.
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Farm animals such as pigs are fairly similar to humans in renal
anatomy, size, and metabolism. Pigs are the subject of extensive
research especially as a potential source of kidneys for xenotrans-
plantation [33]. The size of fully grown pigs limits routine labora-
tory use; moreover, potential virus or prion transmission from pigs
to humans will possibly reduce their use as xenograft sources.
4 Models of AKI
4.1 Ischemia–
Reperfusion Injury
Renal IRI is the most common cause of AKI in patients and
temporary occlusion of renal blood flow is unavoidable during
kidney transplantation. Therefore, models that accurately and
reproducibly replicate renal IRI are indispensable for investigating
the pathomechanism of AKI and for the development of novel
therapeutic agents. There are three commonly used models of
IRI: (1) bilateral clamping of renal arteries and veins; (2) unilateral
clamping; and (3) unilateral clamping with contralateral nephrec-
tomy [34]. The bilateral model is regularly used because it is
considered most relevant to human pathology where blood supply
is typically affected in both kidneys. Some studies performed dec-
apsulation prior to renal ischemia that may have renoprotective
effects, as reported earlier [35]. However, decapsulation was not
conducted in the majority of published studies. Unilateral IRI
models without contralateral nephrectomy leave animals with a
healthy kidney which takes over the excretory function. Conse-
quently, this model allows for the study of the effect of prolonged
ischemia times without excessive postprocedure lethal outcomes.
On the other hand, this model does not allow the study of filtration
and excretory function of the affected kidney after IRI because of
the compensation achieved by the unaffected healthy kidney. In the
third model right nephrectomy is performed at the time of left
kidney IRI. Tissue from the removed right kidney can be used as
highly valuable control in studies where pretreatment that induces
or suppresses specific gene or protein expression is involved. Thus,
changes in the molecule of interest can be confirmed and quantified
in each individual animal used in the experiment. This model is
most useful when the researcher aims to test the effect of drugs or
compounds administered prior to the induction of IRI, further-
more overall survival is more reliable than with bilateral clamping
and this model closely mimics the situation occurring in renal
transplantation. Several studies suggest the protective potential of
contralateral nephrectomy against IRI by increasing blood flow and
other beneficial pleotropic effects (e.g., antiapoptotic, proliferative,
vasodilatory) in the remaining kidney [36], which should be taken
into consideration when designing an experiment.
The pathological consequences of renal IRI are proportional to
the period of ischemia which has to be determined for the
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individual species, strain, sex, and age. Shorter ischemia causes
subclinical AKI, with minor histologic change and without any
functional deterioration as assessed by serum creatinine and BUN
[37]. As ischemia duration increases clinical AKI develops with
moderate renal damage accompanied by renal failure. If the extent
of injury is mild, then the full recovery of renal function can be
expected. However, longer ischemia generally leads to lethal kidney
damage, with continuously deteriorating kidney function and the
animals die due to uremia [38]. As a guide, 30–50 min and
20–35 min of occlusion respectively is generally used in rats and
mice. Clamping time, maintenance of body temperature, and the




Renal transplantation is predominantly performed in rats due to the
challenging microsurgical techniques involved. Depending on the
aim of the study various combinations of inbred and outbred strains
model various complications of kidney transplantation such as IRI,
acute rejection, or chronic allograft nephropathy [39]. Autotrans-
plantation models are ideal for the study of alloantigen-
independent mechanisms such as IRI or the effect of cold storage
on the organ. Fisher and Lewis rat strains differ at the major
histocompatibility loci I and II which results in chronic allograft
nephropathy if no immunosuppression is applied. Thus, transplan-
tation from a Fisher donor to a Lewis recipient is the most com-
monly used model of chronic allograft nephropathy [40]. Other
strains—both as donor and recipient—include outbred strains:
Sprague-Dawley, Wistar, and Long-Evans; or inbred strains:
Lewis, Brown-Norway, and Dark Agouti [41–43].
A large number of different surgical techniques have been
reported, probably due to the technical difficulties associated with
rat renal transplantation. Detailed procedures are available in an
excellent review by Schumacher et al. which describes all technical
aspects, different techniques of vascular anastomosis, strain selec-
tion, and more [44].
4.3 Sepsis-Induced
AKI
Sepsis is a complex disease that involves at least two stages, which
should ideally be reproduced in animal models. An initial proin-
flammatory burst resulting in hypodynamic circulation with hypo-
tension and organ dysfunction is followed by compensatory
immune depression, with hyperdynamic circulation, but these can
overlap. There are three types of sepsis animal models: exogenous
toxin (e.g., LPS)-induced; alteration of endogenous protective
barriers (e.g., cecal ligation and puncture (CLP) or colon ascendens
stent peritonitis (CASP)); or exogenous bacteria-induced. The LPS
model is predominantly used in rodents as the standard CLP model
does not develop AKI, while bacterial infusion models are estab-
lished mainly in larger animals such as dogs and sheep. C. N. May’s
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group established a model of hyperdynamic sepsis in conscious
sheep. In this model sepsis is induced by intravenous infusion of
live Escherichia coli and is characterized by hypotension, tachycar-
dia, peripheral vasodilation, and AKI [45].
Advantages of LPS injection are that its simple, sterile, and
induces systemic inflammation that has many similarities with hypo-
dynamic sepsis pathophysiology in humans. The disadvantage is
that early and transient proinflammatory mediator production is
more intense than in humans. LPS causes decreased GFR, increased
BUN levels, and neutrophil infiltration in the kidney [46]. LPS
dose can be titrated to mimic different aspects of sepsis: typical LPS
doses cause systemic hypotension and decreased glomerular perfu-
sion, while lower doses do not cause systemic hypotension but




Cisplatin is a widely used anticancer drug; however, high doses have
significant toxic effects on proximal tubules. Cisplatin treatment
leads to inflammation and interstitial fibrosis, moreover renal blood
flow is also altered. Most studies use a single i.p. injection of
6–20 mg/kg cisplatin in rats, which induces AKI within 72 h and
both pathology and recovery phase are comparable to those of




Intravascular administration of iodinated X-ray contrast media
(CM) for computer tomography, MRI or angiography can induce
AKI characterized by renal tissue hypoxia due to reduced renal
blood flow and consequent oxidative stress [51]. Incidence varies
between 3% and 25% depending on several factors. Firstly, the
potential to cause CIAKI is less when CM are given intravenously
(typically in lower doses, e.g., for computed tomography or uro-
graphy) than intra-arterially (often in higher doses, e.g., for cardiac
procedures), because the renal first-pass concentration is higher for
the latter route of administration. Secondly, physicochemical prop-
erties of CM solutions such as osmolality and viscosity impinge on
their different safety profiles. Thirdly, hydration status of the
patient plays an important role. Finally, preexisting conditions
such as endothelial dysfunction, for example related to diabetes
mellitus, and impaired renal function increase the risk of
CIAKI [51].
There are a number of models that reliably induce CIAKI in
otherwise healthy animals. The clinical setting of cardiac proce-
dures is emulated by a model, in which a 1.5 mL bolus of a high
viscous CM (iodixanol 320 mg iodine/mL) is injected into the
thoracic aorta of naı̈ve rats [52–54]. A high dose of intravenously
administered iodixanol (rat: 4 g iodine/kg body weight; rabbit: 5 g
iodine/kg body weight) also induces CIAKI [55, 56].
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In order to emulate conditions of patients who are at increased
risk for CIAKI, several animal models employing a combination of
contrast agent injection and other injuries (e.g., vasodilator inhibi-
tion, dehydration, IRI, diabetes) have been studied. Vasoconstric-
tion induced by inhibition of nitric oxide synthase (e.g., L-NAME,
10 mg/kg body weight) combined with prostaglandin synthesis
inhibition (indomethacin, 10 mg/kg body weight) prior to CM
administration (iohexol, 1 g iodine/kg body weight) has been
employed in rats and mice [57]. Another reliable murine model
of CIAKI includes 30 min bilateral renal ischemia and CM admin-
istration 24 h after reperfusion [58].
4.4.3 Aristolochic Acid
and Folic Acid
Both models are useful to study AKI to chronic kidney disease
(CKD) transition. Aristolochic acid nephropathy is characterized
by proximal tubular injury, necrosis and oxidative stress resulting in
progressive interstitial fibrosis [59]. Aristolochic acid is the under-
lying cause of Balkan nephropathy and Chinese Herb
nephropathy [60].
In folic acid nephropathy folic acid crystal deposits appear in
the tubular lumen resulting in obstruction and subsequent acute
tubular necrosis, tubular dilatation and cast formation. Mitochon-
drial dysfunction and early renal fibrosis are typical features of folic
acid nephropathy as well.
4.4.4 Glycerol In rhabdomyolysis skeletal muscle breakdown leads to the release of
intracellular proteins and toxic compounds into circulation. AKI is
a recurrent complication of rhabdomyolysis, mainly caused by
inflammation and oxidative stress. Human symptoms are repro-
duced in rodents by water deprivation for 24 h followed by glycerol
administration into the hindlimb muscle [61]. Elevated BUN and
serum creatinine levels in this model are not exclusively the result of
declined renal function, but rhabdomyolysis as well, thus GFR or
creatinine clearance measurement should be preferred.




Renal fibrosis is the hallmark of progressive kidney disease that
involves glomerular sclerosis tubulointerstitial fibrosis and athero-
sclerosis. UUO in rodents can be experimentally manipulated with
respect to timing, severity and duration, while reversal of the
obstruction allows the study of recovery. Complete UUO results
in reduced renal blood flow and GFR within 24 h, followed by
hydronephrosis, inflammation and tubular cell death within days.
In 1–2 weeks severe hydronephrosis and severe fibrosis develops.
The surgical procedure is relatively straightforward. Animals
undergo amidline incision, the left ureter is located and then ligated
[62]. Because clinical congenital obstructive nephropathy involves
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only partial obstruction, models of partial UUO have been devel-
oped in neonatal mice or rats. These models are, however, techni-
cally challenging and meticulous technique is essential. In one
method a piece of silicone tubing is slit and longitudinally fitted
around the ureter forming a sleeve. Another recommended tech-
nique involves placement of a fine stainless-steel wire parallel to the
ureter. After ligation the wire is pulled out leaving a partial obstruc-
tion. The ligature can then be removed at various time points to
study recoverymechanisms. Due to functional and cellular compen-
satory mechanisms we recommend using sham-operated animals as
controls instead of the contralateral kidney (unless comparing a
therapeutic intervention on the obstructed kidney).
5.2 5/6 Nephrectomy The 5/6 nephrectomy model mimics progressive renal failure after
loss of renal mass in humans. The recommended approach is
removal of the right kidney and resection of the upper and lower
poles of the left kidney (2/3 of the kidney) [63]. The approach
where branches of the renal artery are ligated is not feasible in mice
due to their limited renal artery branching. Remnant kidneys
develop glomerulosclerosis, tubulointerstitial fibrosis, renal atro-
phy and proteinuria. Susceptibility to renal injury in the 5/6
nephrectomy model is highly variable between different strains.
C57BL/6 mice are resistant compared to 129/Sv or Swiss Webster
mice.
5.3 Models of DKD DKD is the leading cause of end-stage kidney disease worldwide.
Unfortunately, animal models that replicate all important func-
tional, structural and molecular features of human DKD are lack-
ing. In both mice and rats, type 1 diabetes mellitus (T1DM) can be
induced by streptozotocin, which is transported by GLUT2 trans-
porter and destroys pancreatic beta cells. Renal and hepatic cells
also express GLUT2, thus streptozotocin has additional direct
nephrotoxic and hepatotoxic effects apart from the injury induced
by diabetes [64]. Genetic models of T1DM such as Akita and
OVE26 mice are also available [65]. T1DM can be induced by
streptozotocin injection in DBA/2J mice, which are susceptible
to nephropathy [16]. Streptozotocin induces T1DM with hyper-
lipidemia in ApoE/ mice [66].
Models of type 2 diabetes mellitus (T2DM) utilize genetically
obese rodents such as ob/ob mice, db/db mice, or Zucker rats
[67, 68]. These animals are either leptin deficient or have inactivat-
ing mutations in the leptin receptor. High-fat diet can be useful to
investigate the mechanisms of insulin resistance, even though the
animals do not exhibit classical features of human DKD, they rarely
become hyperglycemic and high-fat diet alone may cause renal
injury. MKR mice can be used in a nonobese model of T2DM
because the insulin receptor is dysfunctional resulting in insulin
resistance, hyperglycemia and hyperlipidemia [69].




Polycystic kidney disease (PKD) is a genetic disorder associated
with cystic bile ducts, bile duct proliferation, and cystic pancreatic
ducts. There are two types of PKD in humans: the autosomal
dominant PKD (ADPKD) caused by mutations in the PKD1 or
PKD2 gene, and autosomal recessive PKD (ARPKD) caused by a
mutation in the PKHD1 gene. In ADPKD the renal parenchyma is
replaced by cysts originating from all segments of the nephron,
collecting tubules, and ducts. In ARPKD cysts originate only
from dilated collecting tubules and ducts.
In spontaneous hereditary models of PKD animals have obvi-
ous PKD phenotypes, but the responsible genes are not necessarily
orthologous with the human genes. Examples of such models are
Han:SPRD-Cy rats [70], PCK rats [71], Pcy mice [72], and Jck
mice [73].
Transgenic mouse models have also been developed. Thivierge
et al. produced a model with a bacterial artificial chromosome in
which PKD1 gene expression is increased in the kidney, heart and
liver, and the gene product PC1 is overexpressed in renal cysts
[74]. Several transgenic models have been developed by deletion
of human orthologous genes Pkd1 [75], Pkd2 [76] or Pkhd1





The SHR rat strain was generated by protracted rounds of breeding
and selection for high blood pressure. SHR rats develop hyperten-
sion at 5–6 weeks of age and systolic blood pressure of
180–200 mmHg by adulthood with high renin levels. Proteinuria
increases from 6 weeks of age, GFR decreases by 20% by 15 weeks
of age and glomerulosclerosis and tubulointerstitial fibrosis devel-
ops at around 50 weeks of age. Progression of hypertensive renal
damage in this model mirrors that seen in human hypertension






The subcutaneous implantation of a DOCA pellet, uninephrect-
omy, and supplementation of 1% NaCl in drinking water or high-
salt diet induces moderate-to-severe hypertension with renal injury
and low renin levels [81]. Angiotensin II administration can aggra-
vate renal injury. Renal pathological changes include proteinuria,




Focal segmental glomerulosclerosis (FSGS) is the primary cause of
glomerular diseases, characterized by proteinuria or nephrotic syn-
drome. Fibrotic lesions in some glomeruli (focal) or in specific parts
of a single glomerulus (segmental) are the histological features of
the disease.
In animal models FSGS can be induced by podocyte toxins
such as puromycin, aminonucleoside or adriamycin [82]. The
main disadvantage of drug-induced models is the uncertainty of
38 Adam Hosszu et al.
their similarity to human pathology of the disease as well as a robust
variability between rodent strains in susceptibility (e.g., C57BL/6
mice are far more resistant than BALB/c) [83].
Spontaneous FSGS models include the Buffalo/MWF and
Munich Wistar Fromter rat models [84, 85]. Excellent transgenic
models include the Nep25 mouse model [86], the diphtheria toxin
rat model, the Thy-1.1 mouse model [87], and others. Genetically
engineered mouse models give valuable insight to protein–protein
interactions and their role in the prognosis of FSGS. Yang et al.
provide a comprehensive review of FSGS rodent models [88].
6 Humanized Mouse Models
Many elements of mouse biological systems are different from
those of humans, especially their immune system. Humanized
mice have become important preclinical tools to accurately recapit-
ulate human biological systems. Presently there are three widely
used strains of immunodeficient mice: NOD.Cg-Prkdcsci-
dIl2rgtm1Wjl (NSG), NODShi.Cg-PrkdcscidIl2rgtm1Sug (NOG) and
C;129S4-Rag2tm1FlvIl2rgtm1Flv (BRG), which lack T, B, and NK
cells and have functionally impaired dendritic cells and macro-
phages. These mice are engrafted with human transplants including
peripheral blood mononuclear cells, a combination of bone mar-
row, liver, and thymus, or hematopoietic stem cells [89]. Huma-
nized mouse models have tremendous potential in the study of the
mechanisms of allograft rejection during transplantation or
immune-mediated renal diseases such as T1DM [90, 91].
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Chapter 3
Preparation and Monitoring of Small Animals in Renal MRI
Tamas Kaucsar, Adam Hosszu, Erdmann Seeliger, Henning M. Reimann,
and Andrea Fekete
Abstract
Renal diseases remain devastating illnesses with unacceptably high rates of mortality and morbidity
worldwide. Animal models are essential tools to better understand the pathomechanism of kidney-related
illnesses and to develop new, successful therapeutic strategies. Magnetic resonance imaging (MRI) has been
actively explored in the last decades for assessing renal function, perfusion, tissue oxygenation as well as the
degree of fibrosis and inflammation. This chapter aims to provide an overview of the preparation and
monitoring of small animals before, during, and after surgical interventions or MR imaging. Standardiza-
tion of experimental settings such as body temperature or hydration of animals and minimizing pain and
distress are essential for diminishing nonexperimental variables as well as for conducting ethical research.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Key words Magnetic resonance imaging (MRI), Kidney, Rodent surgery, Anesthesia
1 Introduction
Renal diseases are devastating illnesses with unacceptably high rates
of mortality and morbidity worldwide. End-stage renal disease is
the final stage of chronic kidney disease (CKD) characterized by
complete loss of kidney function. Global prevalence is estimated to
be 8–16% and the overall years of life lost due to premature death is
third behind AIDS and diabetes mellitus [1]. Kidney diseases create
a huge burden on healthcare systems; thus, the social and economic
impact of prevention and early treatment would be enormous.
Several publications have highlighted the need for new, effective
therapies as well as superior diagnostic tools.
At present, diagnosis of kidney disease is difficult and often
involves invasive procedures. Conventional markers of renal func-
tion such as serum creatinine and blood urea nitrogen are poorly
sensitive and poorly selective, as they represent a delayed indication
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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of functional change that lags behind structural deterioration dur-
ing the early stage of acute kidney injury (AKI). Currently kidney
biopsy is the single method to assess renal microstructure in
humans, but it is an invasive procedure and sampling bias can
alter results. Thus, noninvasive, in vivo imaging methods are crucial
for the adequate assessment of kidney function, oxygenation, and
structure in both preclinical and clinical setups. Importantly, state-
of-the-art functional MRI techniques are available to determine
tissue oxygenation, perfusion, fibrosis, inflammation, or tissue
edema that can be used as biomarkers of renal disease [2]. MRI
affords full kidney coverage, soft tissue contrast that helps to differ-
entiate the renal layers, second-to-minute temporal resolution,
support of longitudinal studies and high anatomical detail without
the use of ionizing radiation [3, 4].
However, imaging rodents can be challenging because in con-
trast to human studies, imaging of animals requires anesthesia to
physically restrain the animals and minimize their gross motion.
Anesthetic agents can profoundly alter physiology of the experi-
mental animal and may thus influence the image data acquired. It is
therefore necessary to use the most appropriate anesthetic com-
pound and to monitor the physiology of anesthetized animals
during image acquisition [5–7].
It is essential that researchers use animals in scientifically, tech-
nically, and humanely appropriate ways. Effective and appropriate
animal care before, during, and after experimentation not only is
important for the enhancement of animal well-being but can also
have a major effect on the quality of research. Hydration status, the
type of anesthesia used, or body temperature of the animals during
surgery or MRI measurements, as well as postoperative care are all
factors that can affect results, and thus should be carefully planned
prior to the intervention. Standard protocols can be modified, but
should not compromise the well-being of the animals.
This chapter summarizes preoperative procedures, advantages
and disadvantages of different anesthetic agents, monitoring of
physiological functions during surgical or imaging procedures,
and how these challenges can be successfully addressed.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Hydration
Animals can experience considerable fluid loss during surgery
mainly due to evaporation from open body cavities or blood loss.
Rodents are particularly vulnerable to intraoperative fluid loss
because of their small size and relatively small total body fluid
content. Warm, sterile isotonic fluids should be administered at
3–5% of the body weight subcutaneously or intraperitoneally
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prior to and at the end of surgery. Alternatively, isotonic fluid can
be continuously administered via intravenous infusion or even via
intra-arterial infusion in case a catheter has already been placed into
an artery for monitoring of blood pressure and heart rate. The
operative field should be irrigated with warm saline and drying
out of tissues should be avoided [8, 9]. In any case, quantity of
hydration has to be logged and/or standardized to eliminate non-
experimental variable factors. For example, with proper hydration
tubular reabsorption, an energy-dependent process can be spared.
Hence, some procedures such as ischemia will have less effect on
renal injury in well hydrated animals. Intraoperative fluid replace-
ment is also important because during the recovery phase water
intake is usually reduced, even though ad libitum water access is
usually ensured after surgery.
An ophthalmic lubricating ointment should be applied to the
eyes to protect the cornea from drying out.
3 Anesthesia
The use of anesthetics for surgical or in vivo imaging procedures
comes with an inevitable autonomic nervous system depression,
causing cardiovascular and respiratory depression, hypothermia,
and altered metabolism [10]. Different anesthetics influence these
physiological processes differently; thus, various anesthetic agents
should be selected for different experimental models. For example,
anesthesia used during renal ischemia–reperfusion injury (IRI) sur-
gery has an important impact on the extent of injury. Numerous
studies showed that anesthetics are renoprotective due to their anti-
inflammatory, antiapoptotic, or antinecrotic effect, independently
of the way of administration. Also different anesthetics impose
different effects on vasomotion (dilation and constriction). Vaso-
motion, in turn, has a direct impact on local renal blood volume
fraction, which affects the measure T2*. Furthermore, it influences
perfusion, which affects the blood oxygenation and ultimately T2*
as well. R2*—the transverse relaxation rate—can vary by more than
100% depending on the anesthetic regimen [11]. In animal experi-
ments inhalable and injectable anesthetics are both popular. Advan-
tage of inhalable anesthetics (e.g., halothane or fluranes) are that
they are rapidly eliminated through the lungs; therefore, incidence
of fatal events is lower and fast recovery can be achieved. On the
other hand, they are frequently irritant, and it is hard to set a precise
dosage; hence, it is easier to cause hypoxia, and if apnea occurs loss
of consciousness will last longer. Injectable anesthetics (barbitu-
rates, ketamine, propofol, etc.) promote a quick loss of conscious-
ness with better control of cardiopulmonary function and induce
anesthesia at a lower dose. They frequently influence blood pres-
sure, and hypothermia can also develop. Although barbiturates can
be precisely dosed through intravenous administration, the
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intraperitoneal, subcutaneous, or intramuscular injection of other
injectable anesthetics may lead to variable levels of anesthesia.
Because of the short time of action (with the exception of urethane)
repeated dosing or constant infusion of injectable anesthetics is
sometimes needed, prolonging recovery time [12]. During proce-
dures respiratory rate and alertness of the animal should be fol-
lowed. Anesthesia should be intensified at the first signs of alertness
such as movement of whiskers or reflex triggered by pinching the
toes outside the MR environment. It should be noted that deeper
anesthesia is needed for surgical interventions than for MRI alone.
3.1 Injectable
Anesthetics
Ketamine is one of the safest and most widely used injectable
anesthetics in animal surgeries because it does not require intrave-
nous access and cardiorespiratory depression occurs only at a much
higher dose than what is needed for anesthesia [13]. Ketamine is
frequently used in combination with other anesthetics like α2 ago-
nists (xylazine) or benzodiazepines to prevent muscle rigidity and
produce more stable anesthesia [7]. In these cases, the dose of
ketamine can be reduced. However, ketamine may reduce IRI in
rats in low doses, when its antioxidant capacity is the greatest
[14]. On the other hand, ketamine may be harmful at higher
doses due to its sympathomimetic effect [15]. Despite the low
cardiovascular and respiratory influence of ketamine alone [16],
cardiac influences, like hypotension with minimal respiratory
depression must also be considered when using ketamine together
with xylazine [17]. Substantial cardiovascular effects (bradycardia,
hypotension) were observed when acepromazine, buprenorphine,
or carprofen was also added to the ketamine–xylazine combination.
Nevertheless, the addition of acepromazine led to stable hemody-
namic parameters while sustaining adequate anesthesia for
performing surgical procedures [18]. Cerebral hemodynamics are
also affected by ketamine–xylazine combinations, which may cause
reduction of cerebral blood flow thus affecting brain oxygenation
and leading to interferences with several imaging procedures
[19]. Metabolic changes could also occur during ketamine–xyla-
zine anesthesia. Decreased insulin secretion by pancreatic β cells
together with the blockade of ATP-dependent potassium channels
may cause elevated levels of blood glucose and potassium [20].
Short and ultrashort acting barbiturates (pentobarbital and
thiopental, respectively) are also frequently used in animal experi-
ments. They are relatively inexpensive and have a rapid and smooth
onset of action as well as recovery [21]. On the other hand, they
have small therapeutic margin and even though they can be pre-
cisely dosed via intravenous administration, the risk of fatal events is
much higher than for ketamine [22]. However, their use is limited
in renal ischemia–reperfusion surgery, since they reduce blood
pressure and thus blood flow to the kidney. Although by lowering
pentobarbital dose there are less cardiovascular side effects, poor
anesthetic depth, and serious respiratory depression with low
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oxygen saturation can be expected during pentobarbital monoa-
nesthesia [17]. Thiopental decreased malondialdehyde levels and
reduced histopathologic damage to the kidneys after IRI in sub-
anesthetic doses [15]. Moreover, clinically high doses of thiopental
effectively protected against renal IRI [23]. What may lie behind
this renoprotective effect is that thiopental is also an antioxidant
[24] and inhibits neutrophil function [25]. Thiopental might also
depress brain metabolism and thus elevate brain glucose content in
the cortex [26]; however, pentobarbital has no effect on blood
glucose levels [20].
Propofol is a rapid acting anesthetic, with short recovery dura-
tion, thus convenient for short procedures [10]. Propofol has a
serious respiratory depressant effect and decrease in cerebral blood
flow and intracranial pressure have also been reported [27]. The
renoprotective effect of propofol via reduced production of proin-
flammatory cytokines, less neutrophil infiltration, and hence lower
reactive oxygen species accumulation is well documented [15, 28,
29]. Due to its renoprotective effect, propofol is currently not used
in experimental models of renal injury.
Urethane is extensively used alone or in combination with
ketamine and xylazine in nonrecovery procedures. Advantages are
its long-lasting (several hours) surgical plane of anesthesia [30, 31]
and least effects on cardiovascular and respiratory control com-
pared to other anesthetics [32, 33]. At least 8 h of fasting of the
animals is recommended before urethane anesthesia.
3.2 Inhalable
Anesthetics
Halogenated ethers are the preferred volatile anesthetics during
animal experiments. Due to their rapid onset and short recovery
time and low metabolism the side effects of inhalation anesthesia
can be well controlled [10]. For example, isoflurane is preferred in
cardiovascular studies, since it causes less hemodynamic depression
than injectable anesthetics [17, 34]. It also reduces peripheral
resistance thus hypotension might occur [35]. On the other
hand, the rate of respiratory depression is higher than by injectable
anesthetics; therefore, respiratory rate monitoring is indispensable
when adjusting gas concentration. By maintaining high tidal
volumes a stable oxygen saturation may be achieved during isoflur-
ane anesthesia [17]. Yet isoflurane-induced respiratory depression
results in hypercapnia, leading to substantial vasodilation in the
brain and increased baseline cerebral blood flow [36]. To maintain
physiological cerebral blood flow mechanical ventilation of the
animal is recommended. In contrast, hypercapnia has only negligi-
ble effects on vasomotion in the kidney [37]. However, vasodila-
tory effects of isoflurane may be reflected in renal T2* that has been
found substantially higher compared to other anesthetics
[11]. Metabolic changes have also been reported: isoflurane
decreases insulin production, thus leads to higher blood glucose
levels [20].
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There is increasing evidence that halogenated ethers provide
significant protection against renal IRI, which effect is differential:
desflurane being less protective than isoflurane or sevoflurane
[38]. Moreover, anesthesia with isoflurane has a preconditioning
effect on renal IRI, with the involvement of JNK and ERK protein
kinases [39]. When compared to propofol, isoflurane provided the
same level of protection against ischemia reperfusion injury and




Due to their large surface to body weight ratio rodents lose heat
rapidly especially if the abdominal cavity is exposed. Hypothermia
might further be exacerbated by the use of cold, dry gases, hair
clipping, or the administration of cold fluids. Hairless strains and
neonates which are considered exothermic in the early stages of life
are especially susceptible to hypothermia because of their dimin-
ished insulation. Hypothermia poses multiple risks during anesthe-
sia and recovery, including infection, bleeding complications and
cardiac dysfunction. These factors may be the difference between
life and death and if the animal survives, the difference between
good and unreliable data; therefore, it is highly recommended that
an external heat source be used during surgery. Adjustable heating
pads or circulating warm water blankets usually allow a good main-
tenance of body temperature. Homogeneous warming of large
surface areas of the animal’s body—instead of using planar heating
pads that provide comparably smaller contact areas—permits to
reduce the heating temperature and allows for better maintenance
of overall physiological body temperature [41]. For accurate con-
trol, a thermometer should be used to measure the temperature
rectally and—if abdominal surgery is part of the procedure—also a
second temperature probe placed close to the kidney should be
used. Here it is important to consider the possible interactions of
the temperature probe with theMRI. Conventional resistive probes
with metallic cables may suffer from electrical currents induced by
the time-varying magnetic field gradients used during imaging.
This might disturb the temperature measurement and even heat
up the cables. Use of fiber optical probes helps to avoid these issues
but some optical probes experience a sizable offset in the measured
temperature with a very strong magnetic field. For instance, a
negative offset of 4.7 C at a magnetic field strength of 9.4T was
observed with GaAs-based probes. Some heating pads can auto-
matically regulate the temperature with the help of a thermostat
[42]. Too high temperatures can cause protein denaturation and
tissue injury, which might result in death.
Kidney temperature during ischemia significantly influences
IRI. Body temperature drops after anesthesia, which mitigates IRI
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[9]. Therefore, close control and maintenance of body temperature
is needed in order to perform reproducible AKI. Ischemia should
only be initiated if the desired stable temperature is set and
maintained.
4.2 Respiration Respiratory monitoring can be achieved by observation of chest
motion, depth and character of respiration during surgical inter-
ventions. Direct visualization of the animal is not feasible during
imaging; therefore, respiratory motion detection systems that are
compatible with and safe to use for most imaging modalities should
be employed. These systems typically detect breathing motion by
compressions of a respiratory sensor placed in contact with the
chest.
During MRI, breathing often causes motion artefacts, which
can severely compromise imaging acquisitions and hence measures
to reduce or eliminate such artefacts should be taken. Gating
techniques allow for the synchronization of data acquisition with
the respiratory cycle. The largest movement of the abdomen occurs
between inspiration and expiration; therefore, this period should be
excluded from data acquisition.
4.3 Cardiovascular
System
Heart rate can be monitored using an electrocardiograph system.
Heart rate usually correlates with anesthetic depth. A pulse oxime-
ter can be used to measure arterial O2 saturation, pulse strength,
breath rate and blood flow in real time, and can thus detect hypo-
ventilation, airway obstruction, or other problems during anesthe-
sia. Pulse oximeters are not remarkably accurate in rodents, but can
detect trends and are nevertheless valuable tools. Whenever possi-
ble, cardiovascular monitoring should include continuous blood
pressure measurement. For nonrecovery experiments, direct blood
pressure (and heart rate) monitoring via a catheter in the femoral or
carotid artery connected to a pressure transducer is preferred.
Alternatively, an inflatable tail pressure cuff can be used
noninvasively [10].
5 Recovery
Proper postoperative care is needed to minimize the loss of animals,
to reduce intraexperimental variation and to offer humane condi-
tions for recovery [8]. Body temperature should be maintained
within physiological limits until the end of anesthesia, when the
animal starts to be active.
5.1 Analgesia If activity is resumed, analgesics may be given without the risk of
further respiratory depression. Opioids are most commonly used
for this purpose [9]; however, some of them can protect against
IRI. For example, morphine and naloxone inhibited superoxide
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anion production after renal IRI in rabbits [43] and naloxone alone
can also improve warm renal IRI in dogs [44]. However, bupre-
norphine, a mixed partial μ-opioid receptor agonist and κ-and
δ-opioid receptor antagonist improved animal health by reducing
postsurgical stress response, without interfering with renal
IRI [45].
Other analgesics, like α2-agonists are proven to have benefic
effect on renal IRI [46, 47]. Nonsteroidal anti-inflammatory drugs
also interfere with the renal IRI model [48, 49].
.
5.2 Antibiotics Although there is a risk for postoperative infections after surgery,
there is no indication for empiric use of antibiotic prevention
[50]. Focus has to be placed on aseptic surgical infrastructure,
cautious animal handling, and well-managed animal facilities
(SPF, etc.). If systemic antibiotic use is inevitable, then fluoroqui-
nolones and the trimethoprim–sulfonamide combination are gen-
erally recommended, since they are not harmful to the symbiotic
intestinal bacterial population of mice [51]. Gentamicin is reported
to ameliorate IRI mostly during the reperfusion phase and should
not be used in such experiments [52]. Antibiotic administration
should be delayed until complete anesthetic recovery takes place
because of hypotension and prolonged anesthesia due to their
calcium blocking action [51].
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Chapter 4
Reversible (Patho)Physiologically Relevant Test
Interventions: Rationale and Examples
Kathleen Cantow, Mechthild Ladwig-Wiegard, Bert Flemming,
Andrea Fekete, Adam Hosszu, and Erdmann Seeliger
Abstract
Renal tissue hypoperfusion and hypoxia are early key elements in the pathophysiology of acute kidney injury
of various origins, and may also promote progression from acute injury to chronic kidney disease. Here we
describe test interventions that are used to study the control of renal hemodynamics and oxygenation in
experimental animals in the context of kidney-specific control of hemodynamics and oxygenation. The
rationale behind the use of the individual tests, the physiological responses of renal hemodynamics and
oxygenation, the use in preclinical studies, and the possible application in humans are discussed.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Key words Renal hemodynamics and oxygenation, In vivo methods, Rats, Test interventions
1 Introduction
Kidney diseases are a global health burden with steadily increasing
incidence and prevalence [1–5]. Animal studies indicate that acute
kidney injuries (AKI) of various origins share one common link in
the pathophysiological chain of events, ultimately leading to AKI,
as well as to progression from AKI to chronic kidney diseases
(CKD): imbalance between renal oxygen delivery and oxygen
demand [6–14]. Renal tissue hypoperfusion and hypoxia have
also been suggested to play a pivotal role in the pathophysiology
of other kidney diseases including diabetic kidney disease [15–
19]. These pathophysiological concepts have largely been gener-
ated by preclinical studies that used either invasive quantitative
probes or noninvasive functional magnetic resonance imaging
(MRI) techniques to gain insight into renal hemodynamics and
oxygenation. Thus, making ultimate statements on the role of
renal hypoperfusion and hypoxia for these renal disorders is elusive
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_4, © The Author(s) 2021
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because in vivo assessment of renal hemodynamics and oxygenation
constitutes a challenge.
All modalities available in today’s experimental and transla-
tional research practice have inherent shortcomings and methodo-
logical constraints. Invasiveness is the major disadvantage of the
gold standard physiological probes such as perivascular flow probes
for measurement of total renal blood flow, laser-Doppler-optodes
for assessment of local tissue perfusion, and Clark-type electrodes
or fluorescence-quenching optodes for measurements of local tis-
sue partial pressure of oxygen (pO2), which precludes their use in
humans. While functional MRI including blood oxygenation-
sensitized T2* (aka blood oxygenation level-dependent MRI;
BOLD-MRI) offers noninvasive techniques to obtain insight into
renal perfusion and oxygenation, its major weakness is its qualita-
tive nature. Before it can be used for quantitative characterization
of renal tissue perfusion and oxygenation, it needs to be calibrated
with the gold standard invasive techniques in various (patho)-
physiological scenarios [20–24].
The control of renal hemodynamics and oxygenation under
physiological as well as under pathophysiological conditions is
complex and differs considerably from nonrenal tissue [8, 21, 23,
25–27]. Due to the considerable capacity of the organism’s homeo-
static control systems to—at least partially—compensate for distur-
bances of, or injury to, certain control elements, these alterations
are often not easily detectable when studied by measuring baseline
data only. In order to disentangle these complexities, dedicated
reversible test interventions are conceptually appealing. In fact,
such interventions can serve three main purposes. First, they are
used to gain more insight into the control of renal hemodynamics
and oxygenation in healthy animals and in animal models of various
kidney diseases [8, 12, 25, 28–37]. Second, the tests are used to
assess whether a given drug or contrast agent has beneficial or
unwarranted effects on the control of renal hemodynamics and
oxygenation [38–40]. Finally, dedicated reversible tests are used
to achieve calibration of functional MRI data [22, 23].
In this chapter, specifics of the control of renal hemodynamics
and oxygenation are outlined first. Then, the individual test proce-
dures are described, and the rationale behind their use, the physio-
logical response of renal hemodynamics and oxygenation, the use in
preclinical studies and the possible application in humans are
discussed.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
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2 Specifics of Renal Hemodynamics and Oxygenation
Renal hemodynamics and oxygenation offer a number of striking
differences when compared to nonrenal tissue. First, total renal
blood flow (RBF) is huge when compared to virtually all other
organs on a per gram basis: the kidneys receive about 20% of the
cardiac output under resting conditions. Yet the distribution of
blood perfusion differs substantially between the layers: while
100% of blood flowing into the kidney reaches the cortex, only
15% of blood that previously passes through the cortex, will reach
the medulla. Even intralayer (cortex, outer medulla, and inner
medulla) perfusion is quite heterogeneous [8, 41, 42]. In accor-
dance with the high total RBF, the kidneys’ oxygen extraction (the
difference between the O2 content in the renal arterial and the renal
venous blood) is low as compared to the majority of nonrenal
tissues. Yet the partial pressure of oxygen (pO2) is low in the
medulla and also varies considerably within the respective layers,
in accordance with the different blood flow distribution [21, 23,
26, 43–47].
Second, the kidney differs from all other organs with regard to
the relationship between metabolism and perfusion. More than
26 thousand millimoles of sodium (Na+) are filtered in the human
glomeruli every day, equivalent to more than 1.5 kg of table salt. To
achieve sodium balance, the amount of salt excreted by the kidneys
must exactly match the amount of ingested salt minus the amount
of extrarenal loss. Thus, more than 99% of the filtered sodium must
usually be reabsorbed from the tubules. Tubular resorption relies
on active transport processes, which account for about 85% of the
kidney’s energy expenditure and therefore its O2 consumption.
The more sodium is filtered in the glomeruli, the more must be
reabsorbed. As glomerular filtration rate (GFR), under the majority
of circumstances, increases with increasing RBF, renal O2 con-
sumption also usually increases with increasing renal perfusion.
This is in contradistinction to all other organs, where metabolism
determines perfusion [8, 48].
Third, hormones such as angiotensin II and epinephrine, sym-
pathetic vasomotor nerves, and paracrine mediators such as nitric
oxide or adenosine, that control resistance vessels in nonrenal
tissues, impinge on intrarenal resistance vessels too, thereby alter-
ing renal O2 delivery. However, in the kidney, they additionally
affect tubular sodium resorption and thus O2 consumption. Fur-
thermore, their effect on postglomerular vessels can result in diver-
gent responses of RBF and GFR. Finally, adenosine exerts
vasodilation in virtually all nonrenal vascular beds, but vasoconstric-
tion in the renal cortex [8, 25, 48, 49].
Fourth, the kidney is equipped with efficient mechanisms of
autoregulation, that is, the ability to dampen or even to abolish the
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effects that changes in renal arterial pressure would otherwise
inevitably have on RBF and GFR. The almost perfect autoregula-
tion of RBF and GFR probably relies on the fact that not just one,
but three mechanisms are involved. The first one, the myogenic
response (aka Bayliss effect) acts not only on renal resistance vessels
but also on brain and gut vessels. The second mechanism, the
tubuloglomerular feedback (TGF), and the third one, hitherto
just named “third mechanism”, are kidney-specific. Renal autore-
gulatory mechanisms, in particular the TGF and the third mecha-
nism, have been suggested to serve the purpose of balancing O2
delivery, that is, RBF with metabolic and O2 demands arising from
tubular reabsorption. The outer medulla is particularly prone to
imbalance between O2 delivery and demand since this layer exhibits
a high O2 demand but low pO2 [21, 34, 35, 50–52].
Fifth, intrarenal perfusion is also affected by changes in tubular
volume. The tubular volume fraction is quite large and can rapidly
change due to alterations in GFR, in tubular outflow toward the
pelvis, in tubular fluid resorption, and modulation of the trans-
mural pressure gradient. Since the renal capsule is rather tough,
changes in tubular volume will result in circular distension or
compression of intrarenal vessels [23, 36].
Finally, in addition to the heterogeneous intrarenal blood per-
fusion, three other factors substantially contribute to the low tissue
pO2 and, in particular, to the “physiological hypoxia” in the
medulla. First, there is a considerable shunt diffusion of O2 from
arteries to veins in the cortex and from descending to ascending
vasa recta in the medulla [53–55]. Second, the Fåhræus–Lindqvist
effect lowers the hematocrit in the vasa recta supplying the medulla,
which lowers the O2 content of blood perfusing parts of the
medulla [41, 42]. Third, plasma skimming at intrarenal vessel
branches results in different hematocrit and therefore O2 content
of blood perfusing the daughter vessels [41, 56].
3 Dedicated Reversible Test Interventions
3.1 Short Periods
of Occlusion
of the Renal Artery or
Renal Vein
Occlusions of the renal artery (alternatively: the suprarenal aorta)
or of the renal vein emulate clinical conditions in which deficient
renal perfusion results in deterioration of intrarenal oxygenation. If
maintained for longer periods of time these conditions can cause
AKI [57–59]. The rationale for performing both of these tests is
that renal arterial occlusion and renal venous occlusion have similar
effects with regard to renal perfusion and oxygenation, yet oppos-
ing effects with regard to intrarenal blood volume. With the onset
of aortic occlusion, the inflow of blood into the kidney is abruptly
stopped while outflow via the renal vein continues until pressures in
intrarenal vessels and in the vena cava are equalized. With the onset
of renal venous occlusion, outflow of blood is abruptly stopped
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while inflow via the artery does not cease until the arterial pressure-
induced distension of intrarenal vessels is counterbalanced by the
resistance of the renal tissue including the rather tough capsule
[22, 39, 60].
In both cases, renal tissue perfusion rapidly decreases and even-
tually approaches zero flow. As renal O2 consumption remains
unaltered at the early stage of occlusions, a rapid and massive
decline in renal tissue pO2 results, which, in turn, also reduces
blood pO2 and the O2 saturation of hemoglobin (StO2) in the
intrarenal (micro)vasculature. This intrarenal deoxygenation of
hemoglobin (Hb) is aggravated by a progressive rightward shift of
the oxyHb dissociation curve during the occlusion due to the
intrarenal accumulation of carbon dioxide (CO2) [22, 39, 60].
Yet the opposing changes of renal blood volume have an impact
on renal tissue oxygenation. The decrease in tissue pO2 at the onset
of the venous occlusion is much slower than at the onset of the
arterial occlusion. While renal O2 consumption is similar during
both kinds of occlusions, the transiently maintained inflow of oxy-
genated blood at the onset of venous occlusion increases the intrar-
enal reservoir of O2 [22, 39, 60].
The opposing changes in renal blood volume have a massive
impact on the changes in blood oxygenation-sensitized T2* (and its
reciprocal value, R2*), because T2* reflects the amount of deoxy-
genated Hb (deoxyHb) per tissue volume (voxel) [23]. In case of
the venous occlusion with its increase in the vascular volume frac-
tion and thus the increasing amount of deoxyHb per volume, tissue
T2* massively decreases [60]. With the arterial occlusion’s decrease
of deoxyHb per volume, the decrease in T2* is small. In fact, it was
found significantly smaller than the decrease in T2* measured
during hypoxemia (8% inspiratory oxygen fraction), which is dia-
metrically opposed to the effects of arterial occlusion versus hypox-
emia on tissue pO2 (see Fig. 1) [22, 23, 36].
Short-time (1–3 min) occlusions of the renal artery (or of the
suprarenal aorta) have been used in several studies for different
scientific purposes. In order to gauge the effects on T2* and T2 of
bolus injections of an X-ray contrast medium into the thoracic aorta
of healthy rats, the effect of arterial occlusion (and that of hypox-
emia) was quantified in the same rats [36]. En route to calibration
of T2* with quantitative physiological measurements by means of a
dedicated hybrid MR-PHYSIOL setup (see the chapter by Cantow
K et al. “Monitoring Renal Hemodynamics and Oxygenation by
Invasive Probes: Experimental Protocol”), suprarenal aortic occlu-
sion was used [22]. In order to ascertain that the superparamag-
netic iron oxide nanoparticle (USPIO) preparation, ferumoxytol is
suitable as a contrast medium for MR-based assessment of the renal
blood volume fraction; its possible unwarranted effects on control
of renal hemodynamics and oxygenation were tested by interven-
tions including suprarenal aortic occlusion in rats (see Fig. 2)
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[38]. Implementing a setup that combines classical invasive probes
for RBF, tissue perfusion, and pO2 with newly developed near
infrared spectroscopy (NIRS) techniques that enable monitoring
of the amount of Hb per tissue volume and the O2 saturation of Hb
(StO2) of intrarenal blood (termed PHYSIOL-NIRS), aortic occlu-
sion was used as one of the test interventions [39]. By means of a
dedicated deconvolution procedure developed by our group, the
time course of RBF upon the release of the occlusion can be
analyzed. This “step-response” analysis allows us to determine the
strength of each of the three mechanisms of RBF autoregulation in
the whole kidney in vivo, in both healthy rats and rat models of AKI
[30, 34, 35].
Short-time (1–3 min) occlusions of the renal vein were also
used for different purposes. In order to establish an optimum dose
of the USPIO ferumoxytol in rats for the purpose of T2*-based
quantification of the renal blood volume fraction in a 9.4T small
animal scanner, renal venous occlusion was chosen as the combined
effects of the decrease in O2 delivery and the increase in the blood
volume fraction; thus, deoxyHb per volume was expected to result
in a most prominent decrease in T2* (see Fig. 3) [60].
Both renal arterial occlusion and renal venous occlusion was
performed in the same healthy rats in the PHYSIOL-NIRS setup in
order to directly compare their effects [39].
As the implementation of vascular occluders necessitates invasive
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Fig. 1 Comparison of relative changes in renal cortical and medullary tissue pO2 quantified by invasive gold
standard fluorescence quenching optodes (left panel) versus relative changes in renal cortical and medullary
T2* (so-called BOLD-MRI, right panel), during short-term occlusion of the suprarenal aorta and short-term
hypoxia (8% inspiratory O2 fraction), respectively, in anesthetized rats. Data are mean  SEM, redrawn from
Refs. 22, 36
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Fig. 2 In order to study whether the USPIO preparation, ferumoxytol (FO), exerts unwarranted effects on
regulation of renal hemodynamics and oxygenation, a short-term suprarenal aortic occlusion was employed as
test intervention in anesthetized rats [38]. Here, the relative changes (mean  SEM) in hemodynamics and
tissue oxygenation are depicted with FO dosages of 6, 10, and 41 mg Fe/kg body mass, or vehicle (Control)


















   




   















































































































































































































































































































Dynamic changes in renal arterial pressure according to different
time courses of pressure reduction followed by pressure restora-
tion—be it staircasewise or rampwise changes—enable insights into
control of renal hemodynamics and oxygenation including the
degree of autoregulation’s efficiency and the contributions of the
three autoregulatory mechanisms in vivo. This is achieved by a
servocontrol system developed by our group, that was utilized to
help disentangle the complexities of renal physiology and patho-
physiology [30, 31, 33, 34]. Moreover, a study that employed such
an intervention in a rat model that emulates an early stage of
diabetic kidney disease (a type 1 diabetes mellitus–like model
induced by administration of streptozotocin 4 weeks before obtain-
ing the data on renal perfusion and oxygenation) unmasked altera-
tions in the control of renal perfusion and oxygenation that would
have gone undetected when only baseline data had been obtained
[32]. Data on medullary tissue pO2 obtained by invasive probes in
this model have been inconsistent, which, among other reasons,
may be caused by the spatial heterogeneity of pO2 within the renal
medulla [15–17]. A recent study did not find any significant differ-
ences in baseline data on RBF and cortical andmedullary tissue pO2
among healthy control rats, diabetic rats, and diabetic rats treated
with the antidiabetic liraglutide (a glucagon-like peptide 1 agonist
approved for patients suffering from type 2 diabetes). However, as
depicted by Fig. 4, the response to ramp-wise reduction and resto-
ration of renal arterial pressure differed considerably among these
groups [32].
Again, as the implementation of a vascular occluder necessitates




in the Inspiratory Gas
Mixture
Hyperoxia, hypoxia, and hypercapnia primarily alter blood oxyge-
nation. Renal O2 delivery is determined by renal perfusion and by
the arterial O2 content. The latter is determined, among other
factors, by the inspiratory fraction of oxygen (FiO2), and, due to
the effect of CO2 on the oxyHb dissociation curve, also by the
inspiratory fraction of CO2 (FiCO2).
Increasing the FiO2 from 21% (normoxia) to 100% (hyperoxia)
results in a substantial increase in arterial pO2 (usually four- to
fivefold), whereas the increase in arterial O2 content is very small,
because most of the Hb in arterial blood is already O2 saturated
under normoxic conditions. Yet the increase in arterial pO2
enhances the driving force for diffusion of O2 from intrarenal
vessels to tissue as well as from intrarenal arteries to veins. As a
consequence, the increase in renal tissue pO2 is substantial,
whereby medullary pO2 increases less than cortical pO2, due to
arteriovenous diffusive O2 shunting, which reduces the O2 content
of arterial blood that perfuses the medulla [22, 26, 39, 53–
55]. Renal T2* changes exerted by hyperoxia are small
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[22]. While the amount of deoxyHb in arterial blood is barely
changed, the increase in blood pO2 in intrarenal veins that results
from the higher arteriovenous pO2 difference decreases venous
deoxyHb. While primarily altering blood oxygenation, the hyper-
oxic stimulus has also secondary effects: it results in vasoconstric-
tion, preferentially in nonrenal vascular beds, which leads to an
increase in arterial pressure [22, 31, 39].
The primary effect of reducing the FiO2 (typically to either 8%
or 10%, with durations of 3–12 min, in rat studies) is a decrease in
oxygenation of arterial blood (hypoxemia) with the consequent
reduction in renal O2 supply. With ongoing O2 consumption, this
does per se result in a decrease in renal tissue pO2. Yet renal O2
supply is further diminished by hypoxia-induced extrarenal vasodi-
lation that results in a drop in arterial pressure with ensuing
decrease in RBF [22, 31, 39, 59]. Whether this is aggravated of
alleviated by constriction or dilation, respectively, of the renal vas-
culature depends on the degree of hypoxia: in anesthetized rats,
FiO2 of 8% results in renal vasoconstriction while 10% results in
vasodilation [22, 31, 39]. The combined effect of hypoxemia and












































































































Fig. 4 Changes of invasively measured parameters of renal hemodynamics and oxygenation during ramp-wise
reduction in renal perfusion pressure followed by ramp-wise pressure restoration in anesthetized rats.
Conductance values (the reciprocal of vascular resistance) were calculated by dividing the respective
perfusion values by renal perfusion pressure, in order to distinguish flow changes that result from passive
circular distension/compression of vessels from those actively exerted by vascular smooth muscles. Three
groups were studied: a healthy control group, a group in which a diabetes mellitus type 1-like disorder
(DM) was induced by streptozotocin 4 weeks before obtaining the data, and a third group in which DM was
induced and the antidiabetic liraglutide administered for 3 weeks (DM + LIRA). Values (mean SEM) are given
as relative changes from baseline [32]
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reduced RBF on renal O2 supply leads to a major mismatch with O2
consumption, that massively reduces tissue pO2 as well as T2* (see
Fig. 1) [22, 39]. A further secondary effect of arterial hypoxemia is
increased ventilation triggered by arterial chemoreceptors. The
ensuing decrease in arterial pCO2 shifts the oxyHb dissociation
curve to the left, that is, O2 is hindered from being released by
Hb, which further aggravates the tissue hypoxia [61, 62].
With the hypercapnic stimulus (increasing FiCO2 to 5%) the
opposite effect is achieved, namely a rightward shift of the oxyHb
dissociation curve. This would per se result in a decrease in StO2
and an increase in blood and tissue pO2. However, while the
increase in tissue pO2 is substantial, the StO2 decrease is meagre
[39]. The major reason that StO2 does not decrease much is that
increased pCO2 of arterial blood is a very strong stimulus for
ventilation, again mediated by arterial chemoreceptors [61, 62].
Hyperoxic, hypoxic, and hypercapnic tests have been used in a
multitude of preclinical in vivo studies. With regard to the kidney
this includes but is not limited to studies on the control of renal
hemodynamics and oxygenation in healthy animals and models of
kidney diseases [26, 27, 31, 53–55, 59], experiments that aimed at
calibration of T2* bymeans of theMR-PHYSIOL setup (see Fig. 5),
[22] studies on the T2* effect of an X-ray contrast medium, [36]
assessment of possible unwarranted effects of the USPIO ferumox-
ytol, [38] and experiments en route to the PHYSIOL-NIRS
setup [39].
Fig. 5 Time courses of selected invasively measured data and MR parameters acquired simultaneously
throughout baseline, a period of hypoxia (FiO2 ¼ 8%), and recovery in anesthetized rats by means of a
dedicated MR-PHYSIOL hybrid setup (for details see text). Data (mean  SEM) are relative changes from
baseline, redrawn from Ref. 22
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Given the broad therapeutic use of pure oxygen, short-term
tests with 100% FiO2 should pose no problem for studies in
humans, whereas hypoxic challenges are precluded in humans, for
obvious ethical reasons. Hypercapnia has been used for decades in
humans, in particular, for the study of cerebrovascular reactivity,
and should thus be employed in preclinical and clinical studies on






Furosemide is the “classic” loop diuretic: its major action is the
inhibition of the sodium–potassium–two-chloride cotransporter in
the apical membrane of tubular epithelial cells of the thick ascend-
ing limb of Henle’s loop. The primary effect is an increase in urine
flow rate and in urinary sodium and potassium excretion. As less
tubular resorption necessitates less renal O2 consumption, admin-
istration of furosemide leads to an increase in renal tissue pO2
[65, 66]. In accordance, increases in renal T2* (or decreases in its
reciprocal value R2*) have been observed in a multitude of preclini-
cal as well as clinical studies (see Fig. 6) [37, 66–69]. It must be
noted, however, that the increase in T2* upon furosemide does not
solely rely on improved oxygenation. First, the increase in tubular
fluid downstream of the thick ascending limb will increase the
transmural pressure gradient, thereby compressing intrarenal
Fig. 6 Effect of injections of furosemide (5 mg/kg body mass), hydralazine (5 mg/kg), angiotensin II (0.5 μg/
min/kg), and saline (repeatability) on renal BOLD as recorded by means of a 1.5 T clinical MR scanner
(Magnetom Avanto, Siemens Healthcare), using a multiple gradient echo sequence (TR ¼ 300 ms, TE ¼ 5,
10, 20, 30, and 40 ms, voxel size 0.6  0.6 mm in-plane and 5 mm slice thickness) in rats in vivo. Data are
mean  SEM of median ROI values [37]
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vessels with the ensuing decrease in the amount of deoxyHb per
tissue volume. Second, furosemide inhibits the TGF, thereby
compromising renal autoregulation with the possible consequence
of an increase in RBF [34, 35, 50].
The use of the furosemide test in both preclinical and clinical
MR studies is nowadays as widespread that it is almost regarded as a
gold standard. However, whether it fulfils all expectations regard-
ing its use as a diagnostic tool in patients suffering from various
kidney diseases, remains to be seen [68].
Administration of furosemide is a reversible intervention inso-
far as its direct effects vanish with the excretion of the drug.
However, it leaves the organism with deficits in water, sodium,
and potassium. These should ideally be replenished—be it per os
or by means of infusions of a balanced electrolyte solution.
Bolus injections of adenosine cause a rapid drop in arterial
pressure due to its vasodilatory effect on nonrenal resistance vessels.
In the renal cortical vascular bed, it exerts vasoconstriction
[39, 49]. The consequence of these two effects is a substantial
decrease in RBF followed by a smaller decrease in cortical tissue
pO2. All these effects vanish rapidly, lasting less than a minute for
the hemodynamics and less than 2 min for the cortical pO2 in
rats [39].
Whereas the role of adenosine in various renal control mechan-
isms including the TGF as well as the potentially beneficial effect of
adenosine receptor antagonists for prevention of X-ray contrast
media-induced AKI have been intensively studied, [49, 70] the
adenosine test has seldom been used to study renal hemodynamics
and oxygenation. This may appear surprising, as injections of aden-
osine—be it intravenously or into coronary arteries—in patients
suffering from coronary disease is quite established
[71, 72]. While the risk for a decrease in renal cortical pO2 in
patients must not be ignored—even if it is lasting less than 2 min,
the test should at least find wider use in preclinical studies.
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Chapter 5
Preparation of Ex Vivo Rodent Phantoms for Developing,
Testing, and Training MR Imaging of the Kidney and Other
Organs
Jason M. Millward, João S. Periquito, Paula Ramos Delgado,
Christian Prinz, Thoralf Niendorf, and Sonia Waiczies
Abstract
Here we describe a simple and inexpensive protocol for preparing ex vivo rodent phantoms for use in MR
imaging studies. The experimental animals are perfused and fixed with formaldehyde, and then wrapped
with gauze and sealed with liquid latex. This yields a phantom that preserves all organs in situ, and which
avoids the need to keep fixed animals and organs in containers that have dimensions very different from
living animals. This is especially important for loading inMR detectors, and specifically the RF coils, they are
usually used with. The phantom can be safely stored and conveniently reused, and can provideMR scientists
with a realistic phantom with which to establish protocols in preparation for preclinical in vivo studies—for
renal, brain, and body imaging. The phantom also serves as an ideal teaching tool, for trainees learning how
to perform preclinical MRI investigations of the kidney and other target organs, while avoiding the need for
handling living animals, and reducing the total number of animals required.
This protocol chapter is part of the PARENCHIMA initiative “MRI Biomarkers for CKD” (CA16103), a
community-driven Action of the European Cooperation in Science and Technology (COST) program of
the European Union, which aims to improve the reproducibility and standardization of renal MRI
biomarkers.
Key words Ex vivo methods, Rat, Mouse, Phantom, Magnetic resonance imaging (MRI), Kidney
1 Introduction
Prior to starting any preclinical in vivo MRI study, it is essential to
invest time to test novel imaging techniques, optimize MR pulse
sequence parameters and develop a workflow tailored to address the
specific scientific questions at hand [1]. Much of this work can be
done without using living animals, by constructing synthetic phan-
toms using materials that have similar MR properties as the tissue of
interest (e.g., agarose). Ultimately, a point is reached when the
limitations of synthetic phantoms impede progress, and phantoms
that are more biologically realistic are needed. In some cases this
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_5, © The Author(s) 2021
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can be accomplished using ex vivo tissue samples removed from
experimental animals postmortem. The tissues are chemically fixed
(usually with formaldehyde), and samples embedded in tubes or
containers for imaging. However, this removes the organs from
their surrounding environment. In the case of renal MR, it is
advantageous to image the kidney in situ, within its biological
context, including the surrounding organs and perirenal fat. The
typical solution for this problem is to use ex vivo phantoms, which
consist of the intact experimental animal (usually rats or mice)
placed inside a sealed container along with the fixation solution.
This solution is suboptimal. The containers used generally have a
cylindrical or rectangular shape, which is substantially different
from the shape of an animal. This can be problematic given the
space constraints of the MR hardware (e.g., RF coil diameter, size
of the animal holding bed). In some cases the container size may
mean that a larger field of view needs to be acquired than would
otherwise be necessary for a living animal. It may also be difficult, or
impossible, to use surface RF coils to scan samples embedded in a
container. For example, when scanning the brain or the kidney,
positioning the sample such that the target organ is as close as
possible to the RF coil could be problematic if the container is in
the way. Furthermore, the additional mass of the fixation liquid in a
container with a rat or mouse body can substantially change the
loading in the coil, which could cause problems with matching and
tuning. The shape of the container can also cause other problems;
the curved and conical shapes of typical laboratory plastic tubes can
interfere with shimming the main magnetic field B0.
Here we describe a simple and inexpensive method to prepare
ex vivo phantoms using mice or rats that are perfused and chemi-
cally fixed, covered in gauze and sealed with latex. This solution
results in a phantom that preserves the biological context of the
organs of interest, and which is much more similar to the original
animal in terms of dimensions and loading. It avoids the use of
containers of toxic formaldehyde solution. The phantoms can be
readily used by imaging scientists and scientists from related fields
who are not trained in the handling of living experimental animals.
This makes the phantom an ideal teaching tool for educating
trainees learning how to perform preclinical studies, while also
avoiding the confounding effects of motion artifacts. Finally, the
phantoms can be easily stored and reused for extended periods of
time. This will substantially reduce the total number of animals
required for developing new MRI methods, and will facilitate
more efficient and effective in vivo studies, thus consistent with
the 3R principles of animal research [2, 3].
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
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2 Materials
2.1 Animals The method described here can be used for any animal strain. The
choice of strain depends on the specific needs of the researcher.
Ideally, the specific rat or mouse strain should be consistent with
the strain that will be used for the corresponding in vivo experi-
ments. Most importantly the size and geometry of the animal
should be comparable to that of the animal used for in vivo experi-
ments, to ensure that the loading will be similar between phantom
and in vivo experiments.
2.2 Perfusion
and Dissection
All steps of the protocol should be conducted in accordance with
procedures approved by the local Animal Welfare Department and
authorities and conform to guidelines to minimize discomfort to
animals (86/609/EEC).
The perfusion should be done in a lab environment equipped
for dealing with hazardous fumes, using a chemical fume hood
(alternatively fume extraction dome hoods) due to the respiratory
hazards of formaldehyde. The lab should also have appropriate
mechanisms in place for disposing of formaldehyde liquid waste,
solid materials contaminated with formaldehyde (e.g., paper tis-
sues), as well as animal carcasses (e.g., freezer for temporary stor-
age; capacity for incineration).
1. Anesthesia (e.g., ketamine–xylazine various suppliers). Or
alternative for terminal anesthesia, as per individual institu-
tional experimental animal use guidelines.
2. Surgical instruments (scissors, rongeurs, forceps, hemostat).
3. Syringes (1 ml, 20 ml, 60 ml); needles (26 Gauge, 23 Gauge
Butterfly).
4. 70% ethanol in a spray bottle.
5. Solutions for perfusion: phosphate buffered saline (PBS);
formaldehyde solution (e.g., 4% aq. paraformaldehyde [PFA]).
6. Airtight plastic container for storage of the animal during the
post-fixation step (see Note 1).
2.3 Latex Covering 1. Liquid latex (e.g., 0.3% ammonia prevulcanized, low-viscos-
ity—various suppliers).
2. Surgical gauze.
3. 3-O surgical suture (e.g., Ethicon.com, product code C003D).
4. Fine paintbrushes.
5. Hair dryer.




1. Administer a terminal dose of anesthetic—here we used an
intraperitoneal injection of a mixture of ketamine (100 mg/
kg) and xylazine (5 mg/kg) diluted in 0.9% NaCl. We used the
same dose for mouse and rat, adjusted for individual body
weight.
2. Confirm that the animal has reached the required depth of
anesthesia, for example by checking for absence of a reflex
response to stimulation of the hind paws.
3. Place the animal in supine position on a work surface (e.g.,
Styrofoam covered with aluminum foil), and fix the extremities
of the animal to the surface.
4. Apply 70% ethanol to the ventral surface, taking care not to
spray the facial region.
5. With forceps, grasp the sternum, and make an incision into the
thoracic cavity with large scissors.
6. Carefully expand the thoracic space with the scissors, taking
care not to cut any major blood vessels. Cut down the ribs at
the lateral sides to allow for blood drainage. Carefully separate
the heart from the surrounding connective tissue. Cut through
the diaphragm, and expose the inferior vena cava and the
descending aorta. Attach a hemostat clamp to the sternum,
and reflect backward to reveal the now opened thoracic cavity.
7. Visualize the separation between the left and right ventricles
(slight color difference). Insert the needle into the left ventri-
cle of the heart. Take care not to insert the needle too far, or
you will enter the right ventricle. *MOUSE—inject a total
volume of 20 ml PBS, using a 20 ml syringe with a 26G needle.
*RAT—inject a total volume of 180 ml PBS, using 60 ml
syringes attached to a tube connected to a 23G butterfly nee-
dle. After inserting the needle into the heart, use a hemostat to
clamp the butterfly needle. Cut the inferior vena cava.
8. Start PBS perfusion by slowly depressing the plunger, alterna-
tively use a perfusion pump if available. Observe the color
change in the liver: as a sign that the perfusion is correct, the
deep red color changes to dull brown as the blood is drained
(seeNote 2) *RAT—after finishing with the first 60 ml syringe,
replace the empty syringe with a filled one. Repeat with a third
syringe to complete the full 180 ml volume.
9. Start fixation by perfusing with 4% PFA (see Note 3) (this step
should be done under a ventilation system, to avoid exposure
to the hazardous PFA fumes). *MOUSE—switch from the
20 ml PBS syringe to a syringe filled with 20 ml PFA. Reinsert
the needle in the left ventricle, into the same injection point,
78 Jason M. Millward et al.
used by the previous needle (look for a small dark spot).
*RAT—attach the 60 ml syringe with PFA directly to the
tube connected to the butterfly needle. At this point the exsan-
guination and perfusion is complete.
10. Postfixation. Place the animal body into a sealable plastic con-
tainer and fill with PFA and stored at room temperature for
approximately 1 week (see Note 1).
3.2 Disarticulation Removal of the extremities (disarticulation) can be performed at
the discretion of the researcher, depending on the objective, and
depending on the space constraints of the specific hardware (RF coil
diameter, dimensions of the animal holding bed) that the animal
phantom is to be used with. In some cases it may be sufficient to
secure the forelimb and hind limb into position by suturing them to
the body, before wrapping the body with gauze. Regardless, the tail
should be removed. In addition, it may be necessary to remove the
skin, in order to tailor the size of the phantom to the hardware
dimensions. Here we describe in detail how to perform the disar-
ticulation on a rat. In the mouse, this is easily accomplished using
standard surgical scissors.
1. Remove the skin around the joint of the forelimb and the
shoulder (scapular joint) with surgical scissors. Using a scalpel,
dissect the musculature around the scapula (Fig. 1a). Using the
fingers, feel for the location of the joint (Fig. 1b). When the
joint is exposed, use rongeurs to separate the scapula, and
remove the entire forelimb (Fig. 1c). Repeat the process on
the other side.
2. The procedure for the hind limbs is similar. Remove the skin
around the joint of the femur and hip. Using a scalpel, dissect
the musculature around the femur, and feel for the location of
the ball and socket hip joint (where the femur fits in the
acetabulum of the pelvis). When the joint is exposed, cut the
tendons with a scalpel, or cut the bone directly using rongeurs
(Fig. 1a). Repeat on the other side.
3. Use a scalpel to dissect the musculature of the tail at the
proximal end. Expose the coccyx, and separate the tail using
rongeurs. The disarticulation is now complete.
4. Proceed with removing the skin of the remaining body. Using
scissors, cut through the skin at the level of the neck—the skin
of the head can remain in place. Remove the skin and any
extraneous tissue from the exposed thoracic cavity and the
dorsal thoracic region. Use the fingers to separate the skin
and expand the subcutaneous space in the dorsal lumbar
region. Make a midline cut of the skin with scissors, and use a
scalpel to separate the rest of the skin from the underlying
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tissue. Continue removing skin from the ventral lumbar region,
taking care not to pierce the peritoneum.
5. The skin of the head can remain in place, since the head will not
be covered with gauze. Remove the ears (exposing the auditory
cavity), trim the whiskers and remove extraneous tissue from
the lower mandible region.
3.3 Coating
with Gauze and Latex
In the next steps the fixed and disarticulated body will be wrapped
in gauze and covered in liquid latex.
1. Starting from the neck, tightly wrap the thoracic region with
gauze. It may be necessary to fill part of the thoracic cavity that
was opened during the perfusion step with gauze, in order to
eliminate empty space and have a securely wrapped phantom.
Continue wrapping the lumbar/sacral region with gauze; a
Fig. 1 Schematic for disarticulation. The location of the cut-points for removing the forelimb and hind limb is
depicted by the gray lines (a). After cutting the overlying musculature, the joint of the scapula can be visualized
(b). The forelimb is reflected back, and the joint cut using rongeurs (c)
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small extension of gauze can remain at the posterior end to
serve as a grip when applying the latex.
2. Firmly attach the gauze to the underlying muscle tissue using
standard surgical sutures (Fig. 2a). The phantom is now ready
to be covered with latex (Fig. 2b).
3. Pour some liquid latex into a suitable container; for example, a
plastic weigh boat used with a standard laboratory scale is ideal.
Using a flat paintbrush, apply the first coat of latex directly to
the gauze (Fig. 2b, c). All surfaces should be completely
Fig. 2Workflow for preparation of the phantom. The rat body is wrapped tightly with gauze, which is then fixed
securely to the underlying musculature using surgical sutures (a). The entire body is covered with gauze,
except for the head, which remains unwrapped (scale bar ¼ 22 cm) (b). Liquid latex is applied directly to the
surface of the phantom using a paintbrush (c, d). The phantom is place on an improvised holder, here a
laboratory tube rack with pipettes. A hair dryer is used to accelerate the drying process (e). An example of a
completed, labeled mouse phantom (f)
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covered, although avoid excessive latex. It is preferable to apply
the latex with a brush, rather than simply submerging the
phantom in latex.
4. Generously apply latex to the head, taking care to fill the
auditory cavity and the oral cavity.
5. Place the phantom on a support to dry, allowing air to circu-
late. Here we improvised a support using a laboratory tube rack
and pipettes (Fig. 2d).
6. Use a standard hair dryer to apply warm air (c. 5–10 min), to
accelerate the drying of the latex (Fig. 2d). Allow additional
time (c. 20 min) to dry at room temperature.
7. The phantom will be easier to handle once the first coat of latex
is dry. Then, apply a second coat of liquid latex, ensuring that
all gaps are completely covered. Make sure that the oral cavity is
completely sealed. Apply the latex generously; the objective is
to ensure that there is a complete watertight seal over the entire
surface. Repeat the drying process with the hair dryer, and
allow to air dry completely at room temperature.
8. The phantom is now finished. It is possible to write on the
surface of the dry latex with a permanent felt-tipped marker, for
example to record useful information about the animal
(Fig. 2f).
9. The phantom can be used at room temperature, for example
inside the MRI scanner, for extended periods. Long-term stor-
age should be at 4 C.
4 Example Images
In Fig. 3 we show representative images of MRI scans of the ex vivo
phantoms. These scans were performed on a Bruker Biospec 9.4
Tesla USR94/20 animal MRI scanner (Bruker Biospin, Ettlingen,
Germany).
4.1 Rat MRI scans targeting the rat kidney were acquired in the coronal
(Fig. 3a, b) and sagittal (Fig. 3d, e) planes. The identical MRI
hardware setup (including the RF coils) and pulse sequence para-
meters were used to acquire the images of the ex vivo phantom
(Fig. 3a, d) and an in vivo rat of the same strain and approximate
mass as the animal used to prepare the phantom (Fig. 3b, e). The
in vivo scans were done as described in the chapter by Pohlmann A
et al. “Experimental Protocol for MRI Mapping of the Blood
Oxygenation-Sensitive Parameters T2
* and T2 in the Kidney.”
The ex vivo and in vivo scans show a comparable level of detail,
and the kidneys (denoted by “K”) can be seen in relation to the
surrounding tissues. MRI sequence parameters are listed inNote 4.
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4.2 Mouse MRI scans targeting the mouse brain were acquired in the coronal
plane in the ex vivo phantom (Fig. 3c, f). A mid-brain slice shows
good contrast between gray matter and white matter structures,
and the skull can be seen on the exterior of the brain (Fig. 3c). A
lower brain slice (from a more inferior level) shows the brain in
relation to surrounding tissue structures, for example the eyes
(denoted by “E”) (Fig. 3f). MRI sequence parameters are listed in
Note 5.
Fig. 3 Representative ex vivo and in vivo MR images. MRI scans targeting the rat kidney were acquired in the
coronal (a, b) and sagittal (d, e) planes. Identical MRI hardware and pulse sequence parameters were used to
acquire the images of the ex vivo phantom (a, d) and in vivo images of a rat of the same strain and
approximate mass as the animal used to prepare the phantom (b, e). The kidneys are denoted by “K.” MRI
scans targeting the mouse brain were acquired in the coronal plane in the ex vivo phantom (c, f). Images show
the brain in relation to surrounding structures such as the skull, and the eyes (denoted by “e”)
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5 Notes
1. The container should be large enough that the animal is
completely submerged in the formaldehyde solution and also
suited for preserving the shape of the animal (e.g., curvature of
the body) during postfixation.
2. Ensure that no PBS leaks from the mouth and nose region: this
is a sign that the needle has shifted position into the right
ventricle (and that the PBS is being perfused into the respira-
tory circulation, not the systemic circulation). If this occurs,
remove the needle and reposition into the left ventricle.
3. Formaldehyde fixation solutions such as 4% aq. PFA or 10%
neutral buffered formalin are widely used, but other fixation
solutions may be substituted, as suit the needs of the experi-
menter. One variation is to add 8 mM of gadolinium-based
contrast agent, to change the relaxation properties of the tissue
in the ex vivo preparation [4]. Another alternative is to use a
zinc-based fixation solution [5].
4. MR images of the rat ex vivo and in vivo were acquired using a
RARE sequence: TR ¼ 540 ms, TE ¼ 12 ms,
FOV ¼ 70  52  35 mm, matrix ¼ 128  172  5, number
of averages ¼ 4, slice thickness ¼ 0.7 mm. acquisition
time ¼ 1 min 9 s.
5. MR images of the mouse ex vivo phantom were acquired using
a FLASH sequence: TR ¼ 50 ms, TE ¼ 8 ms,
FOV ¼ 20 20 12 mm, matrix ¼ 160  160  96, number
of averages ¼ 4, slice thickness ¼ 12 mm, acquisition
time ¼ 56 min 32 s.
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Part III
Basic Concepts of Measurement Techniques
Chapter 6
Quantitative Assessment of Renal Perfusion
and Oxygenation by Invasive Probes: Basic Concepts
Kathleen Cantow, Roger G. Evans, Dirk Grosenick, Thomas Gladytz,
Thoralf Niendorf, Bert Flemming, and Erdmann Seeliger
Abstract
Renal tissue hypoperfusion and hypoxia are early key elements in the pathophysiology of acute kidney injury
of various origins, and may also promote progression from acute injury to chronic kidney disease. Here we
describe basic principles of methodology to quantify renal hemodynamics and tissue oxygenation by means
of invasive probes in experimental animals. Advantages and disadvantages of the various methods are
discussed in the context of the heterogeneity of renal tissue perfusion and oxygenation.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by a separate chapter describing the experimental procedure and
data analysis.
Key words Renal hemodynamics and oxygenation, In vivo methods, Quantitative invasive probes
1 Introduction
Kidney diseases are a global health burden with steadily increasing
prevalence and incidence [1–5]. Animal studies have provided evi-
dence that acute kidney injury (AKI) of various origins shares a
common link in the pathophysiological chain of events, ultimately
leading to AKI, as well as to progression from AKI to chronic
kidney disease (CKD): imbalance between renal oxygen delivery
and oxygen demand [3, 6–13]. Renal tissue hypoperfusion and
hypoxia have also been suggested to play a pivotal role in the
pathophysiology of other kidney diseases including diabetic kidney
disease [14–16].
The majority of the preclinical studies that generated this con-
cept utilized a set of invasive probes to measure renal hemodynam-
ics and oxygenation in anesthetized animals [12, 14, 17–20]. These
methods have also been used (1) to study mechanisms of
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physiological control of renal hemodynamics and oxygenation and
(2) the effects of various substances on this control in healthy
animals, (3) to test several putative preventive or therapeutic
approaches for AKI and CKD in animal models, and (4) for the
purpose of calibrating functional magnetic resonance imaging
(MRI) including renal blood oxygenation level-dependent MRI
(BOLD-MRI) that makes use of the quantitative MR parameter
T2*, which is a surrogate for blood oxygenation [18–28].
The invasive probes typically include (1) a perivascular flow
probe for measurement of total renal blood flow, (2) laser-Doppler-
optodes for assessment of local tissue perfusion, (3) Clark-type
electrodes or fluorescence-quenching optodes for measurements
of local tissue partial pressure of oxygen (pO2), and (4) devices
for invasive measurement of arterial blood pressure. These methods
are considered the gold standard for the study of renal hemody-
namics and oxygenation, because the methods, with the exception
of the laser-Doppler fluxmetry, provide calibrated quantitative data
[25, 29, 30]. Step-by-step protocols for application of these tech-
niques in two setups, one for stand-alone experiments in labora-
tories for integrative physiology, and the other for experiments
within small-animal MR scanners by use of a hybrid setup, are
provided in the chapter by Cantow K et al. “Monitoring Renal
Hemodynamics and Oxygenation by Invasive Probes: Experimen-
tal Protocol”.
As with all established modalities available in today’s experi-
mental and translational research, these techniques have shortcom-
ings and methodological limitations. In particular, their
invasiveness, for obvious ethical reasons, precludes their use in
humans. The invasiveness is, furthermore, a considerable hurdle
for implementation of these methods in long-term and longitudinal
studies: although invasive probes have been used in conscious,
chronically instrumented animals [22, 24, 31–37], the vast major-
ity of studies has been performed in “terminal experiments” in
anesthetized animals. This is a major limitation of all invasive tech-
niques because the measurements are by necessity potentially con-
founded by the effects of anesthesia (see the chapter by Kaucsar T
et al. “Preparation and Monitoring of Small Animals in Renal
MRI”).
The measurement of intrarenal tissue perfusion and tissue oxy-
genation is quite challenging, because of their vast spatial hetero-
geneity both among the renal layers (cortex, outer medulla, and
inner medulla) and within the layers. In this chapter, the causes and
the degree for this spatial variability are outlined first, before the
basic principles of methodology to quantify renal hemodynamics
and oxygenation by means of invasive probes in experimental ani-
mals are described together with a discussion of the pros and cons
of the various methods.
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This introduction chapter is complemented by a separate chap-
ter describing the experimental procedure, which is part of
this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Heterogeneity of Intrarenal Perfusion and Oxygenation—Causes and Degree
of Variability
Intrarenal local tissue pO2 is determined by the balance between
local O2 supply and local O2 consumption. Additionally, determi-
nants of local O2 diffusion play a role. Local O2 supply depends on
local blood perfusion, local vessel density, and local blood pO2 and
blood O2 content. Local O2 consumption is foremost determined
by local metabolic demand. Blood perfusion within the kidney is
much more heterogeneous than within most other organs, due to
its particular vascular architecture [8, 38–40].
From the branches of the renal artery that enter the kidney at its
hilus, interlobar arteries arise, which align with the medullary–corti-
cal axis. From interlobar arteries emerge arcuate arteries that run
along the boundary between the cortex and the medulla, that is,
perpendicular to the medullary–cortical axis. From the latter, inter-
lobular arteries branch off at regular intervals at angles of about
90 degrees, so that they all enter the renal cortex. For this reason,
virtually all the blood flowing into the kidney perfuses the cortex first
[8, 25, 38, 41–43]. The interlobular arteries are in close proximity to
interlobular veins, together forming what might be called “vascular
bundles” that run in parallel at regular distances from the cortico-
medullary boundary toward the capsule. Within the cortex, interlob-
ular arteries branch off into afferent (preglomerular) arterioles, from
which glomerular capillaries arise that, in turn, rejoin into efferent
(postglomerular) arterioles. The efferent arterioles from the subcap-
sular and mid-cortical glomeruli branch off into networks of peri-
tubular capillaries. The efferent arterioles of the deep cortical
(juxtamedullary) glomeruli, however, branch off at about the corti-
comedullary boundary to form capillary-like vessels, the descending
vasa recta [38–40]. These very straight and exceptionally long vessels
descend toward the papilla. The descending vasa recta provide virtu-
ally all blood that perfuses the medulla. As a consequence, only
10–15% of blood that previously passes through the cortex, will
reach the medulla, and the vascular density is much lower in the
medulla than the cortex [8, 25, 38, 41–43]. The descending vasa
recta are in close proximity with the ascending vasa recta, thus
forming distinct “vascular bundles” that run in parallel at regular
distances through the medulla [38–40].
These particularities of the intrarenal vascular architecture have
a number of salient consequences with regard to local blood
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perfusion and thus the local O2 supply. First, the striking difference
in the quantity of blood perfusion between the cortex and the
medulla, together with the difference in their vascular densities, is
one of the major reasons for the low tissue pO2 in the medulla.
Second, the Fåhræus–Lindqvist effect that lowers the hematocrit
and thereby the O2 content of blood in the vasa recta that supply
the medulla, contributes to low medullary O2 delivery
[39, 40]. Third, diffusive shunting of O2 between the arcuate and
interlobular arteries and their respective veins in the cortex as well
as between the descending and ascending vasa recta in the medulla,
owing to the close proximities of the respective vessels, are a further
major reason behind the “physiological hypoxia” of the medulla.
Thus, blood pO2 is higher in the venous vessels than in the capil-
laries these venous vessels drain. Fourth, due to the particular
vascular architecture with distinct “vascular bundles” that comprise
arterial vessels with high pO2 and venous vessels with relatively high
pO2 (due mainly to the low fractional O2 extraction of the renal
tissue), there are huge differences in local pO2 even within a given
renal layer under physiological conditions [25, 41, 43–47]. Fifth,
plasma skimming at intrarenal vessel branches results in different
hematocrit and therefore O2 content of blood perfusing the daugh-
ter vessels, which also contributes to the local pO2 differences
[39, 48].
The schematic shown in Fig. 1 depicts the range of local pO2
values as measured by invasive Clark-type electrodes in the kidneys
of rats and dogs under physiological conditions in vivo [43–
45]. These measurements reveal that local tissue pO2 levels in the
cortex vary dramatically, foremost according to the distance to the
“vascular bundles” of interlobular arteries and veins: pO2 values
range from 10 mmHg at the greatest distance from two neighbor-
ing “bundles,” to up to 70 mmHg around the “bundles.” In
Fig. 1 Scheme depicting the range of intrarenal tissue partial pressure of oxygen (pO2). The red curve depicts
values at the greatest distance from two neighboring “vascular bundles,” the blue one that directly adjacent to
“vascular bundles” (for details see text); OS (outer stripe), IS (inner stripe). Original data were obtained by
measurements in in anesthetized dogs and rats [43–45]
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addition, local cortical tissue pO2 varies with the distance to the
arcuate arteries located at the corticomedullary boundary. Also, the
range of tissue pO2 variability in the outer medulla is huge (see
Fig. 1): whereas pO2 is less than 10 mmHg in locations at maxi-
mum distance from the “vascular bundles” of descending and
ascending vasa recta, pO2 is up to 75 mmHg in close proximity to
these “bundles.” In the inner medulla, tissue pO2 is rather homog-
enous: in general, it usually amounts to less than 15 mmHg.
The huge differences in tissue pO2 among the renal layers not
only reflect the differences in O2 supply but also the different O2
consumption of the distinct sections of the tubules located in the
respective renal layers. Tubular resorption relies on active transport
processes, which account for about 85% of the kidney’s energy
expenditure and, therefore, its O2 consumption [8, 49]. The proxi-
mal tubule and the distal convoluted tubule, which constitute the
majority of tubular segments within the cortex, consume much O2
because a huge amount of osmolytes is resorbed by active transport
in these segments. On the other hand, tubular sections such as the
thin descending and the thin ascending limbs of Henle’s loop and
the medullary collecting duct, which are the most abundant tubular
sections within the medulla, feature very low to nonexisting active
transport. Yet the thick ascending limbs of Henle’s loop, which are
located in the outer medulla, consume much O2, because of their
active resorption of osmolytes [8, 25, 41, 43–47, 50]. The high O2
demands of the thick ascending limbs in relation to the rather low
O2 supply of the outer medulla, consequent to its particular vascu-
lar architecture, exposes this renal layer to the greatest risk for
hypoxic tissue damage [6–14, 43, 51, 52].
3 Methods: Methodologic Principles, Advantages, and Disadvantages
Techniques for invasive measurements of renal hemodynamics and
oxygenation comprise readily (commercially) available methods
and devices that are employed in many laboratories of integrative
kidney physiology worldwide, but also techniques that are estab-
lished only in one or a few laboratories. The widely used methods
are described first. They include (1) perivascular flow probes for
measurement of total renal blood flow, (2) laser-Doppler-optodes
for assessment of local tissue perfusion, (3) Clark-type electrodes
for measurements of local tissue pO2, (4) fluorescence-quenching
optodes for the same purpose, (5) devices for invasive measurement
of arterial blood pressure, and (6) pimonidazole adduct immuno-
histochemistry for assessment of renal tissue hypoxia.
The pimonidazole technique is included here because of its
widespread usage, although it is an exceptional case for two rea-
sons. First, in contrast to the other techniques, this approach does
not allow investigators to monitor a given parameter over time, but
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only provides a snapshot: Pimonidazole is injected at a single time
point in vivo, and pimonidazole adducts formed in severely hypoxic
tissue are visualized in ex vivo samples [53–55]. Second, although
the technique has been used for two decades, it was subjected to
close scrutiny only recently [55]. Upon this careful investigation
major pitfalls were identified and detailed—which, at least in part,
cast doubts on the reliability of previously published results—and
methods to address and overcome these issues have been
proposed [55].
In the final part of this chapter, a few selected examples of
methods are discussed that are not (yet) generally available but
presently established in only one or a few laboratories.
3.1 Transonic Flow
Probes
Today’s gold standard for whole kidney blood flow measurements
is a flow probe attached to the renal artery or to the renal vein that
makes use of ultrasound transit time differences. This method was
established in the late 1970s and provides continuous absolute
measurements of blood flow (in mL per min) independent of the
actual flow velocity profile, the actual vessel diameter, and the actual
hematocrit [56]. The commercially available device (Transonic™,
Transonic Systems Inc.) comprises an electronic flow detection unit
(flowmeter) and perivascular probes [57, 58]. The flow probe
consists of two ultrasonic transducers and a fixed acoustic reflector
(see Fig. 2a). The flow probe is positioned on the blood vessel so




Fig. 2 Photographs of typical probes for invasive measurements. (a) Perivascular
Transonic™ flow probe for measurement of total renal blood flow. (b) Combined
fluorescence-quenching-laser-Doppler probe (OxyLite/OxyFlo™) for simulta-
neous measurements of local tissue pO2 and assessment of local tissue perfu-
sion in the same circumscribed area. (c) Clark-type electrode for measurement
of local tissue pO2
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the transducers and the metallic reflector. Probes are available in
various sizes to fit the dimensions of the blood vessel of interest.
The flowmeter directs the flow probe through measurement
cycles [57, 58]. First, a wide beam of ultrasound is emitted by the
downstream transducer. It intersects the vessel in the upstream
direction, is reflected by the acoustic reflector, then intersects the
vessel again before being received by the upstream transducer. The
flowmeter records the transit time. Then, the transit–receive
sequence is repeated, but with the transmitting and receiving func-
tions of the transducers reversed, that is, the vessel is bisected by the
beam in the downstream direction. The transit time during the
upstream cycle is higher than during the downstream cycle, because
the ultrasound beam travels against the blood flow in the first, and
with the blood flow in the latter cycle. The difference in the transit
times is directly proportional to blood volume flow. Due to the
wide ultrasonic beams, all flowing blood is accounted for; thus, the
transit time is sampled at all points across the vessel diameter, and
the volume flow measurement is independent of the flow velocity
profile [57, 58].
An accurate measure of volumetric flow is obtained by the
perivascular probes even when the vessel is smaller than the acoustic
window, because the parts of the ultrasonic beam that do not
intersect the vessel do not contribute to the signal [57, 58]. How-
ever, air effectively blocks ultrasound transmission, and even small
air bubbles compromise measurement accuracy. Therefore, all
spaces between the vessel and probe must be filled with a suitable
acoustic coupling agent. In case of “terminal experiments” in
anesthetized animals, where the abdomen is opened, this can be
achieved by simply filling the abdominal cavity with isotonic saline
(at 37 C) [27]. Acoustic coupling gels can also be used and are
available from the supplier of the probes. Fatty tissue also affects the
ultrasonic beam; thus, the vessel of interest must be thoroughly
prepared by gently removing fatty tissue [27].
Measurements of total renal blood flow by means of Tran-
sonic™ devices have also been performed in chronically instrumen-
ted animals [22, 31, 33, 58, 59]. Here, the perivascular probe
becomes encapsulated by tissue, which stabilizes its position. En
route to calibration of functional MRI for the study of renal hemo-
dynamics and oxygenation, an integrated multimodality approach
was developed that enables measurements of invasive gold standard
parameters and functional MR parameters simultaneously for the
same kidney in an ultrahigh field small animal scanner
(MR-PHYSIOL) [25–28]. For such a setup, a special Transonic™
flow probe is used: its acoustic reflector is made of Macor ceramics
instead of stainless steel or brass to meet the safety and compatibil-
ity requirements of MRI (see the chapter by Cantow K et al.
“Monitoring Renal Hemodynamics and Oxygenation by Invasive
Probes: Experimental Protocol”).
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With the introduction of the Transonic™ technique, all other
methods used for quantitative assessment of total renal blood flow
in experimental animals including but not limited to electromag-
netic probes and microsphere techniques were rendered obsolete.
3.2 Laser-Doppler
Optodes
In the 1970s, laser-Doppler probes were developed that estimate
local blood perfusion within circumscribed areas of tissue
[60, 61]. For this purpose, pulsed light of a distinct wavelength
(e.g., 785 nm) is guided via an optical fiber into the tissue subjacent
to the tip of the fiber, where it is scattered within the tissue. A
fraction of the light encounters erythrocytes, is reflected, and is fed
back via the fiber to the photodetecting device of the apparatus.
From the amount of reflected light the concentration of erythro-
cytes per tissue volume is estimated. Because erythrocytes move
with the bloodstream, the reflected light becomes frequency shifted
due to the Doppler effect. The photodetected signal comprises a
broad spectrum of Doppler frequency shifted signals from which
the average velocity of erythrocytes is derived. An estimate of
microvascular blood perfusion is than calculated by the apparatus
as the product of mean erythrocyte velocity and mean erythrocyte
concentration in the volume of tissue under illumination from the
probe [61].
The most important limitation of the laser-Doppler technique
is that it can only provide arbitrary, nonabsolute, units for blood
perfusion rather than an absolute value of blood flow, which is why
the method is often termed laser-Doppler-fluxmetry [25]. This is
due to the fact that the actual sampling volume could only be
determined if it were possible to identify which erythrocytes have
interacted with the light reflected from the tissue. The latter
depends on the optical scattering and absorption coefficients of
the tissue. Since these coefficients vary considerably with regard
to the local microvasculature and its perfusion at the time of mea-
surement, it is impossible to determine the actual sampling volume
and thus the blood flow in absolute terms [61].
Estimated mean sampling depths for mammal tissues range
from 0.5–1.5 mm, corresponding to “captured” volumes of
roughly 1 mm3 of tissue. However, these values must be lower in
regions with large light absorption due to large amounts of ery-
throcytes per volume such as the renal cortex, and lower in the
inner medulla with its low amount of erythrocytes per volume [38–
40, 61].
Considering the rather small volume of tissue for which the
laser-Doppler data are obtained versus the heterogeneity of intrar-
enal perfusion, extrapolation of the results of one area to other
areas, even of the same renal layer, is unfeasible. Because of the
impossibility to provide absolute data, laser-Doppler-fluxmetry
allows investigators only to report relative changes occurring
while the optode is fixed in place. Therefore, only continuous and










































































































































































































Fig. 4 Time courses of invasively measured parameters of renal hemodynamics and oxygenation in two
groups of anesthetized rats that both received a 1.5 mL bolus injection of an X-ray contrast medium (iodixanol
320 mg iodine per mL) into the thoracic aorta at time 0. In the blue group, a low dose of nitrite was
administered by continuous infusion, while in the red group saline was infused (control). Conductance values
(the reciprocal of vascular resistance) were calculated by dividing the respective perfusion values by arterial
blood pressure, in order to distinguish flow changes that result from passive circular distension/compression
of vessels from those actively exerted by vascular smooth muscles. Values (mean SEM) are given as relative
changes from baseline. Redrawn from Ref. 20
Fig. 3 Original tracings of invasively measured parameters of renal hemodynamic and oxygenation in an
anesthetized rat (left panel) and sketch of the left kidney with the locations of the used probes (right panel).
The rat was exposed to staircasewise reductions in renal perfusion pressure followed by staircasewise
pressure restorations performed by means of a servo-controlled inflatable occluder placed around the
suprarenal aorta (pressure servo) [22]. This was done under normoxic (inspiratory fraction of O2, FiO2 ¼ 0.2),
hyperoxic (FiO2 ¼ 1.0), and hypoxic (FiO2 ¼ 0.1) conditions
quantifiable changes relative to baseline (control) measurements
are recorded, typically induced by acute interventions such as
changes in renal arterial pressure or the inspiratory O2 fraction, or
by the administration of drugs (see Figs. 3 and 4) [18–20, 22, 23,
25, 28, 62]. Yet even interpretation of changes in laser-Doppler
data recorded during such maneuvers must be done with due
caution: they could rely on changes in local hematocrit, for exam-
ple, due to changes in plasma skimming, rather than changes in
blood flow [25, 39, 48].
In many studies on renal hemodynamics, data from two probes
are recorded, one placed within the cortex and the other one in the
(outer) medulla. This approach has been also employed in chroni-
cally instrumented rats [22]. It must be noted, that the potential
tissue injury inflicted by the insertion of the optodes (usual tip
diameters range from 50 to 300 μm) may confound the results.
Laser-Doppler fluxmetry devices are supplied by various manufac-
turers. Oxford Optronics, Ltd., provides combined fluorescence-
quenching and laser-Doppler optodes (OxyLite/OxyFlo™) that
enable simultaneous recordings of local tissue pO2 (vide infra)
and of relative changes in local tissue perfusion in the same circum-
scribed area of renal tissue (see Fig. 2b).
3.3 Clark-Type
Electrodes
These polarographic electrodes were developed in the 1950s by
Clark and colleagues [63]. The electrodes consist of a noble metal
(e.g., silver, gold, platinum) which reduces O2 due to a negative
polarizing voltage. The difference in voltage between the reference
electrode (anode) and the measuring electrode (cathode) is propor-
tional to the amount of O2 molecules being reduced on the cath-
ode. This enables quantification of tissue pO2 (absolute values in
mmHg). The critical technical advance was electrical insulation of
the anode and cathode with a gas-permeable but liquid-
impermeable membrane. This approach provided the foundation
for the development of miniaturized versions (see Fig. 2c) with tips
as small as 1–5 μm, that enable quantification of pO2 even in
specific vascular and tubular elements of the kidney
[64, 65]. Using such small electrodes, Lübbers, Baumg€artl, and
colleagues were the first to document the vast heterogeneity of
renal tissue pO2 among as well as within the renal layers that is
depicted by Fig. 1 [43–45]. These authors generated “spatial
maps” with the frequency distribution of pO2 values (“pO2 histo-
grams”) from the cortex to the inner medulla, by moving the
electrodes through the renal tissues using a nanostepper technique
(step width 50 μm).
While “pO2 histograms” have also been obtained in a few
recent studies [66, 67], the majority of studies uses fixed electrodes,
making sure that the tips remain at the same location within the
kidney throughout the experiment. Often, one electrode is placed
within the cortex and the other one in the (outer) medulla. The
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tissue volume that is “captured” by the electrodes has probably
about the same diameter as the tip of the electrode; thus, standard
electrodes of 10 μm diameter obtain pO2 values that are repre-
sentative for a relatively small tissue volume only [67]. In the face of
the spatial heterogeneity of intrarenal pO2, this constitutes a major
limitation of this technique. On the other hand, the potential tissue
injury inflicted by the insertion of these small electrodes is less than
with bigger electrodes or fluorescence quenching optodes that
enable better “spatial averaging” (vide infra) [24, 35, 67]. Another
drawback of Clark-type electrodes is O2 consumption due to their
electrochemical reduction, which is particularly unfavorable in areas
with a fragile balance between O2 delivery and demand such as the
renal medulla [67–70].
Furthermore, it is not technically feasible to make repeated
measurements in the same anesthetized animal over time-frames
longer than a few hours. Yet, recently, a telemetric method using
carbon paste electrodes has been developed that allows assessment
of renal tissue pO2 in conscious rats [35]. This method provides
exquisite temporal resolution [24]. The major limitations of the
method are (1) that it requires considerable skill and expertise to
construct and implant the devices, (2) that tissue pO2 can only be
monitored at a single location in each animal, and (3) that only




In the 1990s, a fiber-optic oxygen-sensing device was developed
that measures pO2 from the lifetime of fluorescence of a (ruthe-
nium- or platinum-based) luminophore at the tip of an optode
[70, 71]. The probe is connected to a pO2 meter developed by
Oxford Optronics, Ltd., that generates short pulses of blue LED
light, which are transmitted via the fiber to the tip of the optode
[70]. The resulting emission of fluorescent light is quenched by the
presence of O2 molecules. The OxyLite™ instrument measures the
lifetime of each pulse of fluorescence, which is approximately
inversely proportional to the pO2 according to the Stern-Volmer
equation at pO2 values between 0 and 100 mmHg [68, 71].
Direct comparisons between Clark-type electrodes and
quenching optodes reveal their respective advantages and disadvan-
tages [67, 68, 70]. Both techniques share the disadvantage of
invasiveness, and the advantage of enabling absolute quantification
of pO2 (in mmHg). Advantages of the optode include the absence
of O2 consumption and a greater accuracy at low pO2, which is of
particular importance when it comes to measurements in the renal
medulla. In contrast to the electrodes that “capture” a tissue vol-
ume that is approximately equal to their tip diameter, optodes do
not “capture” a proper volume. The pO2 measured by the optodes
is that within the probe-head (at the tip) of the optode itself, which
covers a circular area of 230 μm diameter [67, 68, 70]. The larger
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diameter of the optodes as compared with that of standard pO2
electrodes increases the risk for tissue damage. On the other hand,
it facilitates a favorable “spatial averaging” of renal tissue pO2 values
in the face of their huge spatial heterogeneity. In fact, “pO2histo-
grams” of renal cortical pO2 obtained in rabbits by a fluorescence
optode were more tightly distributed than those provided by a
Clark-type electrode, which may aid detection of (patho)-
physiologically significant changes in intrarenal oxygenation
[67]. Finally, the optodes have been proven to be MR compatible
and MR safe [25, 26].
As mentioned earlier, combined fluorescence-quenching-laser-
Doppler probes (OxyLite/OxyFlo™) enable simultaneous mea-
surements of local tissue pO2 and assessment of local tissue perfu-




It is mandatory for in vivo studies in anesthetized experimental
animals, be it studies on control of renal hemodynamics and oxy-
genation or on every other functional parameter, to monitor car-
diovascular variables such as arterial blood pressure and heart rate
throughout the experiment in order to ascertain that physiological
cardiovascular control is maintained. In anesthetized animals this is
best achieved by use of invasive techniques: a fluid-filled catheter
inserted into a conduit artery (e.g., femoral or carotid arteries)
connected to one of the various commercially available pressure
transducers and quantitatively calibrated via a recording device (see
the chapter by Cantow K et al. “Monitoring Renal Hemodynamics
and Oxygenation by Invasive Probes: Experimental Protocol”).
Direct intra-arterial measurements in unanesthetized animals is
the most physiologically relevant means of arterial pressure deter-
mination. Telemetric pressure monitoring is the gold standard in
conscious animals, and various telemetric devices are commercially
available [72, 73]. A limitation of this technique is that implanta-
tion surgery and maintenance of catheters require considerable skill
[72]. The tail-cuff method is a simple noninvasive plethysmo-
graphic technique to assess arterial pressure in conscious rats and
mice [74, 75]. Since the conditions for tail-cuff measurements
necessarily involve heating and restraint of the animal, which almost
inevitably alter the measured parameter (arterial pressure), the




This method was originally developed for detection of hypoxia in
tumors, but subsequently adapted for use in the kidney [53]. For
this technique, pimonidazole (usually 60 mg/kg of body mass) is
administered to the experimental animal in vivo [54]. Pimonidazole
forms adducts within hypoxic (<approximately 10 mmHg) cells.
These adducts are immunohistochemically visualized in ex vivo
samples of the kidney. The advantage of this technique is that it
provides good spatial resolution of renal tissue hypoxia at the
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cellular level. Its major limitations include (1) that it detects severe
hypoxia only, with a cutoff of about 10mmHg, (2) that hypoxia can
only be assessed postmortem, and (3) only at a single time point.
Those using this technique must also be aware of twomajor sources
of false-positive detection of hypoxia, as recently revealed
[55]. Firstly, pimonidazole adducts can form postmortem in cells
that were not hypoxic in the living animal. For this reason, it is
recommended that kidney tissue be perfusion fixed, rather than
immersion fixed. Secondly, when the standard (mouse) monoclonal
antibody is used, false positive staining has been observed in dam-
aged rat kidney tissue, presumably as a result of the anti-mouse
secondary antibody binding to mouse-like antigens in the damaged
tissue. This problem can be avoided by use of a newly commercially
available polyclonal anti-pimonidazole antibody raised in
rabbits [55].
3.7 Examples
of Methods That Are
Not Generally Available
3.7.1 Bladder pO2
It is not technically feasible to measure renal tissue pO2 in humans.
It can also be technically difficult to measure renal tissue pO2 in
experimental animals unless they are deeply anesthetized. However,
it is technically feasible to measure the pO2 of urine in both experi-
mental animals and man. There has been a long history of interest
in this approach for monitoring renal medullary tissue oxygenation
[76]. However, with the recent development of fiber-optic probes
that can be inserted into a standard Foley bladder catheter, it has
been possible to subject this method to close scrutiny [77]. Avail-
able evidence now indicates that urinary pO2 can provide a good
estimate of renal medullary pO2 [77]. Because this technique can
be deployed in humans equipped with a bladder catheter, it pro-
vides a translational pathway for development of approaches to
improve renal medullary oxygenation in human patients at risk of
AKI. It is also noteworthy that low urinary pO2 during cardiac
surgery requiring cardiopulmonary bypass predicts development
of postoperative AKI. In light of this, urinary pO2 measurements
may provide a real-time measure of medullary oxygenation and
predict the risk of AKI in critically ill patients. The major limitation
of this approach is that the combination of low urine flow and high
arterial pO2 can confound the relationship between urinary pO2
and medullary pO2 [77].
3.7.2 Near Infrared
Spectroscopy
Near infrared spectroscopy (NIRS), together with models for dif-
fuse optical imaging affords the measurement of (1) tissue concen-
trations of oxygenated hemoglobin (oxyHb) and deoxygenated
hemoglobin (deoxyHb), (2) oxygen saturation of Hb (StO2)
within tissues, and (3) tissue blood volume fraction in vivo. In
particular, spatially resolved reflectance NIRS (SRR-NIRS),
together with Monte-Carlo simulations of diffuse light propaga-
tion, has been applied to monitor these parameters within renal
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cortical tissue [78]. Quantification of the underlying absorption
and reduced scattering coefficients of the tissue is based on analyz-
ing the decrease of the intensity of diffusely remitted light with
increasing distance from the light injection point. Recording tech-
niques for the renal cortex of anesthetized rats have been estab-
lished, with a linear fiber array placed on the ventral surface of the
exposed kidney. Measurements have been done at selected near-
infrared wavelengths between about 670 and 850 nm by multi-
plexing millisecond pulses from the different laser sources in time.
In this way, quantitative measurements of renal cortex parameters
have been achieved at a repetition rate of multiple Hz [78].
SRR-NIRS has been successfully combined with “classical”
invasive techniques to study renal hemodynamics and oxygenation
in rats [78]. Thus, SRR-NIRS-derived parameters such as the
amount of Hb per tissue volume and StO2 were obtained simulta-
neously with parameters including total renal blood flow, local
cortical tissue perfusion and tissue pO2 in the same kidney. Control
of renal hemodynamics and oxygenation was studied by dedicated
reversible test interventions including brief occlusions of the renal
artery or the renal vein, short-term hypoxia, hyperoxia, and hyper-
capnia, and administration of adenosine. The results demonstrate
that the combined approach, by providing different but comple-
mentary information, enables a more comprehensive characteriza-
tion of renal hemodynamics and oxygenation [78].
The SRR-NIRS technique could also serve to help calibrate
renal T2* MRI. This MR surrogate parameter for blood oxygena-
tion is related to the amount of deoxyHb per tissue volume. Con-
founders of the T2* to tissue pO2 relationship include the vascular
volume fraction, the local hematocrit, and shifts of the oxyHb
dissociation curve [25–28]. Since SRR-NIRS enables quantitative
monitoring of the amount of Hb per tissue volume and of StO2 it is
an ideal candidate to unravel and quantify the contributions of
confounding factors to renal T2* MRI.
By extending the wavelength range beyond 900 nm, the tissue
water content can additionally be assessed, which, together with
the reduced scattering coefficients at the different wavelengths, can
serve as a surrogate for other (patho)physiologically relevant para-
meters such as the tubular volume fraction.
Application of SRR-NIRS in reflection mode constrains mea-
surements to the renal cortex of rats. Recently it was demonstrated
that changes of rat medullary Hb parameters can also be assessed by
SRR-NIRS in transmission mode using an additional fiber placed
on the dorsal surface of the kidney [79].
3.7.3 Intravital
Microscopy
Perhaps the “final frontier” in methods for assessing renal oxygena-
tion are techniques that provide cellular resolution, in real time, in
living animals. Hirakawa and colleagues have recently reported use
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of a technique they call “intravital phosphorescence lifetime imag-
ing microscopy” [47]. This technique allows cellular pO2 in the
renal cortex of live animals to be resolved to the level of individual
tubular cross-sections. It requires injection of a molecule whose
phosphorescence is quenched by O2. Thus, pO2 can be measured
by assessing the decay curve of the phosphorescence. Such probes
are available that accumulate intracellularly or are retained within
the vasculature. Thus, it is possible to use this approach to assess the
heterogeneity of renal blood and tissue pO2 in real time with
unprecedented cellular resolution. Currently, the technique is lim-
ited for use in the superficial cortex.
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Chapter 7
Ultrasound and Photoacoustic Imaging of the Kidney: Basic
Concepts and Protocols
Sandra Meyer, Dieter Fuchs, and Martin Meier
Abstract
Noninvasive, robust, and reproducible methods to image kidneys are provided by different imaging
modalities. A combination of modalities (multimodality) can give better insight into structure and function
and to understand the physiology of the kidney. Magnetic resonance imaging can be complemented by a
multimodal imaging approach to obtain additional information or include interventional procedures. In the
clinic, renal ultrasound has been essential for the diagnosis and management of kidney disease and for the
guidance of invasive procedures for a long time. Adapting ultrasound to preclinical requirements and for
translational research, the combination with photoacoustic imaging expands the capabilities to obtain
anatomical, functional, and molecular information from animal models. This chapter describes the basic
concepts of how to image kidneys using different and most appropriate modalities.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by two separate chapters describing the experimental procedure and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Ultrasound imaging (US), Photoacoustic
imaging (PA), Multimodality, Doppler, Contrast, Animals, Rats, Mice
1 Introduction
Magnetic resonance imaging, while very powerful by itself, can be
complemented by a multimodal imaging approach to streamline
workflow processes, obtain additional information, or include
interventional procedures. Ultrasound and computed tomography
are modalities of primary choice in renal imaging on patients, with
the disadvantage of computed tomography exposing the body to
harmful irradiation. Due to its fast, cost-effective, versatile, and
nonionizing characteristics, ultrasound imaging is well-established
in the clinical practice, often used for first-line diagnostics and
follow-ups and as a complementary method to MRI.
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_7, © The Author(s) 2021
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In the clinic, renal ultrasound has been essential for the diag-
nosis and management of kidney disease and for the guidance of
invasive procedure for decades. Nevertheless, new developments to
advance clinical diagnostics and medical treatments are required
and strongly rely on appropriate preclinical models. Adapting the
ultrasound technology to match preclinical requirements for trans-
lational studies and combining it with photoacoustic imaging,
expands the researchers’ capabilities to obtain anatomical, func-
tional, and molecular information from their animal models.
MRI has the advantage of superior soft-tissue contrast, which
facilitates and enables the detection and characterization of renal
lesions. This chapter will give an introduction to how detailed
kidney images can be created, blood flow visualized and quantified,
and capillary as well as renal function assessed in vivo, noninvasively,
and in real time using high-frequency ultrasound.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Measurement Concepts of Ultrasound and Photoacoustics
The basic principle of ultrasound imaging relies on detecting differ-
ences in tissue density by using sound waves with frequencies above
the range of human hearing—typically in the MHz range. Using
piezoelectric elements short, harmless ultrasound pulses are sent into
the body. These sound waves are partially reflected back to the
transducer by different layers of tissue and the return signals (often
referred to as “echo”—hence the term “echography” which is used
as a synonym to ultrasound) are recorded. Based on the time it takes
for the echo to travel into the tissue and back and the strength of the
signal, an image can be computed and displayed in real time. The
resulting two-dimensional, grayscale image of an area of interest is
referred to as Brightness Mode or B-Mode. Tissue closest to the
transducer is displayed at the top and structures further away are
shown below; a scale provides depth and size information in real
time. With increasing density more echo is recorded resulting in a
brighter signal on the screen; therefore, dense structures (e.g., skin)
are represented in white and light gray tones, whereas ultrasound gel
used for coupling and fluid-filled structures inside the body appear
black. Most tissues and organs are displayed in a range of grayscales
in between and have a characteristic appearance (“speckle pattern”)
that aids in their identification. B-Mode is the standard imaging
mode on ultrasound systems and worked with the most because it
allows for effective visualization of anatomical structures. It can be
complemented by additional imaging modes to obtain functional
information which are outlined in more detail in Subheading 3.
110 Sandra Meyer et al.
In ultrasound, the frequency of the sound waves sent into the
tissue is of importance as it determines image resolution and pene-
tration depth. In a clinical setting, renal ultrasound scans on adult
patients are normally performed with a 3–6 MHz curved array
transducer where the term “curved” describes the shape of the
transducer surface. Routine measurements include determining
the length of the kidney in a sagittal view, the measurement of
cortex thickness and of blood flow in the renal and interlobar
arteries [1].
By using an appropriate setup and ultrasound imaging system,
these parameters and a variety of others can be obtained in preclini-
cal animal models. Dedicated small-animal micro-ultrasound sys-
tems provide high spatial resolution down to 30 μm by employing
higher frequencies of up to 70 MHz. While early systems for small
animal imaging were equipped with mechanical probes, state-of-
the-art micro-ultrasound systems are working with digital linear
array (flat transducer surface) probes and are suitable for a broad
range of applications [2]. In addition to providing higher resolu-
tion than clinical machines, ultrasound systems dedicated to pre-
clinical research also:
1. Allow for controlled transducer positioning (Fig. 1a, c) and
include a setup for image-guided injections. While clinical
ultrasound and also injections are performed handheld, a sta-
tionary setup is superior in most preclinical applications.
2. Include an integrated animal handling solution for physiologi-
cal monitoring and anesthesia. These are crucial components
for any kind of imaging focusing on functional analysis (blood
flow, perfusion, etc.) and should be controlled and recorded
carefully at all times to ensure reproducibility. However, some
ultrasound applications to evaluate anatomy can be performed
on conscious animals when appropriately restrained or trained.
Since ultrasound relies on the detection of soundwaves, no
contrast agent is required to visualize anatomical structures, 3D
volumes, or to assess blood flow velocities. It is noteworthy that
anatomical structures and volumes measured with dedicated small
animal ultrasound match results acquired with dedicated small
animal MRI or μCT systems [3].
Above and beyond the capabilities of micro-ultrasound to
gather anatomical and functional information, photoacoustic imag-
ing can also be applied in a preclinical setting to add molecular
information. Photoacoustic imaging is a hybrid imaging modality
that combines the strengths of optical and ultrasound imaging and
can be used to monitor endogenous parameters such as blood
content or oxygen saturation or various exogenous contrast agents.
In this imaging approach (Fig. 2), short (a few nanoseconds)
pulses of near-infrared laser light are transmitted into the tissue and
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are selectively absorbed according to the optical properties of the
tissue components. Light absorption results in a thermoelastic
expansion creating a sound wave that can be localized by the
ultrasound transducer and at the same resolution as the ultrasound
image [4].
Fig. 1 Standard renal exam: animal and transducer positioning; (a) transverse position for left kidney imaging,
(b) transverse US B-Mode image of the left kidney with length measurement, (c) sagittal position for left kidney
imaging, (d) sagittal US B-Mode image of the left kidney with length measurement. Note the millimeter scale
on the right and the physiological monitoring (ECG in green, respiration in yellow) below the US images
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3 Overview of Applications
This section provides an overview of applications of high-frequency
ultrasound and photoacoustic imaging in preclinical renal research.
Examples of specific disease models and howmultimodal imaging is
applied are summarized in a brief review of selected publications in
Table 1.
Fig. 2 Photoacoustic imaging; (a) the photoacoustic effect, (b) coregistered B-Mode image providing
anatomical information (left) and photoacoustic image displaying oxygen saturation (right) in the spleen and
left kidney
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Table 1
Examples of specific disease models and how multimodal imaging is applied




l Kidney and cyst volume
Evaluation of kidneys in B-mode, power
Doppler, and 3D
l Quantification of kidney volume,
number of cysts and cyst volume
l US-based kidney volumes correlated
strongly with kidney weights
l US provided superior information in






l Anatomical and blood
flow analysis
l Renal RI and PI;
l RI and PI were higher in the ob/ob mice
(RI 1.50; PI 0.81) at 21 weeks
compared to lean controls (RI 0.69; PI
1.18)






l Tumor volume l Validation of noninvasive imaging tools
for monitoring of tumor growth in an
orthotopic renal cell carcinoma
xenograft
l Tumor volumes determined by hrUS,
μCT, and MRI showed a very good
correlation with each other and with
caliper measurements at autopsy









l To establish orthotopic xenograft models
by ultrasound-guided injections into the
adrenal gland and kidney (subcapsular)
l Tumor location, size, and relation to the
adrenal gland and kidney were
monitored accurately and weekly in US
l Technique is efficient, with up to 10 mice
injected per 2-h session
l Mice had fast recovery times of less than







Evaluate hydronephrosis l Total renal length (RL) and renal pelvic
anterior–posterior diameter (APD) were
measured. Hydronephrosis was scored
by the ratio of APD to RL
l US permits easy stratification of mice into
consistent pathological study groups
composed of mild, moderate, and
severe kidneys. This approach
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Table 1
(continued)






l Identification of concurrent
abdominal lesions
l Underlying etiologies included
pyelonephritis secondary to a preputial
gland abscess and ascending urinary
tract infections; cystolithiasis, infiltrative
abdominal neoplasia with invasion of
the renal pelvis, hilum, and parenchyma
and surrounding lymph nodes; mouse









l Longitudinal measurement of oxygen
saturation shows differences between
mild and severe renal injury
l Kidney volume was also determined
l PA provided a sensitive measure of
change in sO2 in the acute phase of AKI,
with the sO2 at 24 h after AKI being









l Contrast-enhanced ultrasonography with
high-resolution parametric perfusion
maps can monitor changes in renal







l Study hemorrhagic shock
changes with
microimaging
l After 1 h of ischemia, B-mode images
documented slight changes in kidney
echogenicity
l Color and PW-Doppler analysis showed a
reduction in renal blood flow in kidneys
during the hypoperfusion with a
progressive and significant change from





Monitor reflux with US
contrast
l Reflux was detected in the proximal
ureters and the renal pelvis bilaterally in
C3H/HeJ mice
l Contrast-enhanced ultrasound
cystograms were established in-vivo
[18]
BALB mice Contrast agent
biodistribution in US and
photoacoustic imaging
l A dual imaging contrast agent was
developed to monitor kidney perfusion
and organ distribution as well as whole-
body biodistribution
[9]
Chronic kidney disease and
cardiovascular disease
(induced in C57BL/6J mice
by 5/6 nephrectomy)
Assess cardiac dimensions and
function
l Cardiac dysfunction and dilatation of the
left ventricle was observed 8 weeks after
partial nephrectomy
l A treatment reversed cardiac dilatation
and significantly improved cardiac
dysfunction
[19]




B-Mode, as introduced in Measurement concepts (2.), is used to
locate the kidneys in the abdomen, observe the surrounding tissue
and anatomical structure and to obtain organ size.
When viewed using ultrasound, the kidneys are located lateral
of the abdominal aorta. The right kidney is positioned slightly more
cranial in the thoracic cavity then the left kidney, and both can be
identified by their characteristic appearance in ultrasound: the
medulla in the medial portion of the kidney is darker than the
cortex and surrounding the cortex, the kidney capsule appears as
a bright thin line. Once the appearance of kidneys and surrounding
in ultrasound are familiar, it is easy to identify any changes: Cysts are
liquid-filled structures and therefore are visible as black, round
structures with in the tissue. Hydronephrosis is qualitatively recog-
nized as distension and dilatation of the renal pelvis and a method
to quantify hydronephrosis based on the proportion of renal paren-
chyma in a longitudinal ultrasound image as been established [5]
and underlying etiologies have been studied [6]. Tumor masses will
appear in a different grayscale than the surrounding tissue and
when becoming larger will distort the regular bean shaped form
of the kidney. The observation and sizing of the kidney in 2D
images can be performed in the transverse (Fig. 1a, b) and sagittal
imaging (Fig. 1c, d) plane as required, based on preference. Moving
through the whole organ in in both imaging planes in 2D allows to
systematically screen for changes inside and also in the surround-
ings (e.g., ascites in the peritoneum). In addition, ultrasound imag-
ing also may be used to study cardiovascular disease linked to
chronic kidney disease [19].
Most preclinical ultrasound systems also allow to gather three-
dimensional information. The principle for 3D image acquisition is
similar between ultrasound andMRI where both acquire sequential
2D images with a known distance between them, determining the
resolution along the z-axis (slice thickness). In ultrasound imaging
a motor needs to be attached to move the probe across the area of
interest along the z-axis and acquire a stack of images (Fig. 3). The
consecutive 2D slices can be compiled into a 3D view, displayed in
various ways, and analyzed to obtain accurate volume information
of the kidneys and also cysts or tumor masses within.
3.2 Visualization
of Blood Flow
When ultrasound waves are reflected by moving blood a frequency
shift (Doppler shift) of the return ultrasound signal is induced that
allows to display and measure blood flow. Most ultrasound systems
are equipped with several imaging modes that use this Doppler
effect to display blood flow in 2D images and allow for measuring
blood flow velocities.
Color Doppler mode, overlaid on top of a B-Mode image for
anatomical reference, displays blood flow in the area of interest in
gradients of red and blue (Fig. 4b). The color gradients indicate
both the direction and mean velocity of the Doppler shift: blood
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flowing toward the transducer is represented by a gradient between
red (lowest velocity) and white (highest velocity) and blood flowing
away from the transducer is represented by a gradient between blue
(lowest velocity) and white (highest velocity). BART is an acronym
commonly used to remember the colors associated with the direc-
tion of flow: Blue Away, Red Toward. Color Doppler mode is a very
useful tool to identify the major and cortical vessels in the kidney
and accurately guide the positioning for flow measurements, which
are performed in pulsed-wave (PW) Doppler mode. To obtain a
measurement, a Doppler sample volume (point where the blood
flow should be measured) is placed within the vessel and the system
generates a PW Doppler spectrum that displays time on the x-axis
and flow velocity on the y-axis (Fig. 4d). Once PW Doppler
spectrums of the renal artery and vein have been recorded, velocity
measurements such as peak systolic velocity (PSV), end-diastolic
velocity (EDV), and the velocity time integral (VTI) can be added.
Based on these measurements, relevant parameters will be calcu-
lated as an indicator for vascular function.
l The resistive index (RI) is an example of additional analysis that
may be useful. A RI of 0 is calculated for continuous flow
patterns and an RI of 1 indicates a strongly pulsating flow with
no flow during diastole. In the clinic an RI of the renal
Fig. 3 Schematic workflow for 3D US image acquisition and processing
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artery ¼ 0.6 is observed in healthy adults and a rise in RI is seen
as an indicator for renal disease.
RI ¼ PSV  EDV
PSV
l The pulsatility index (PI) is another parameter often calculated
in clinical renal diagnosis.
PI ¼ PSV  EDV
VTI mean velocity
Power Doppler mode is another tool used to display and
analyze blood flow within an area of interest. It is similar to color
Doppler mode in detecting the occurring Doppler shift, but instead
Fig. 4 Assessment of blood flow; (a) power Doppler signal in transverse view of the left kidney is overlaid with
the B-mode image, (b) Blood flow in the interlobal vessels as visualized in Color Doppler Mode, in this image
red and blue colors indicate arterial and venous flow, respectively; (c) three-dimensional rendering of Power
Doppler signal of a healthy kidney, (d) pulse-waved Doppler profile of renal artery flow, peak systolic (PSV),
and lowest diastolic velocity (LDV) measurements are shown, the sample positioning is indicated in the scout
image above the flow profile
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of displaying blood flow direction, it color-codes flow from orange
to yellow according to signal intensity and is most useful for smaller
vessels having slower blood flow (Fig. 4a).
It is crucial for PW Doppler mode and all other Doppler
imaging modes, that an appropriate angle is achieved between the
transmitted ultrasound beam and the blood flowing through the
vessel; the imaging plane should be adjusted such that the angle
between these two is less than 60  to provide an accurate velocity
measurement.
Color and power Doppler information can also be acquired in
3D, visualizing the blood vessel structure in the entire organ
(Fig. 4c). The amount of Doppler signal in a 3D volume can then
be calculated. With the right animal setup, imaging both kidneys at
the same time is feasible.
3.3 Perfusion
Imaging
While Doppler imaging can be used to visualize blood flow in the
renal artery and vein and also in the interlobar and arcuate vessels,
monitoring perfusion of the kidney at capillary level requires the
use of ultrasound contrast agents. Ultrasound contrast agents are
very small gas bubbles (microbubbles) about 2–3 μm in diameter
and encapsulated by a polymer or lipid shell (Fig. 5a). Several
contrast imaging modes can be used for the detection of these
microbubbles in the area of interest. Linear contrast enhanced
ultrasound, the first contrast mode used at frequencies above
15 MHz, primarily relies on subtraction of background informa-
tion to display the increase in echo due to the wash-in of contrast
agent. Newer generation systems allow to monitor perfusion in
real-time based on nonlinear fundamental detection with ampli-
tude modulation, resulting in a higher sensitivity [7].
While ultrasound imaging to monitor perfusion requires a
contrast agent and therefore intravenous access, photoacoustic
imaging allows for the detection of hemoglobin and its oxygen
saturation status (Fig. 2). Based on the change of hemoglobin’s
optical properties dependent on oxygen bound to the heme group,
one can assess tissue oxygenation at a level matching BOLD (blood
oxygen level–dependent) MRI [8]. It should be noted that ultra-
sound contrast agent and photoacoustic imaging of hemoglobin
are nontoxic and harmless to the animal.
3.4 Molecular
Information
Ultrasound and photoacoustic contrast agents can also be used for
molecular imaging. Ultrasound contrast agents can be targeted to
assess biomarker expression (Fig. 5c) but are exclusively tailored to
vascular endothelium as the contrast agent does not leave the
vasculature. Photoacoustic contrast agents, dyes or nanometer-
sized particles, can be used for specifically targeting extravascular
targets or for assessing glomeruli function and to study
biodistribution [9].
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3.5 Interventional
Procedures
In contrast to other imaging modalities, in ultrasound and photo-
acoustic imaging the animal is accessible throughout the imaging
session, allowing for various interventional procedures to be per-
formed during an imaging session (Fig. 6). Using a so-called
in-plane needle visualization technique, it is possible to follow the
movement of a needle inside the animal in B-mode and ensure
accurate placement of the needle tip for injections or aspiration.
Image guided injections allow to place cells to create orthotopic
tumor models or apply drug treatments precisely without the need
for more invasive surgery [10]. Switching to image guided injec-
tions is an important step in the refinement of animal procedures
and helps to shorten recovery time and minimize discomfort and
Fig. 5 Perfusion assessment of both mouse kidneys; (a) schematic model of a microbubble used for US
contrast imaging; (b) animal and transducer position, (c) B-mode image, left and right kidney are outlined; (d)
schematic binding of targeted contrast agent to a biomarker; Non-linear contrast image of both kidneys before
(e) and after contrast injection (f). After contrast injection; for analysis, regions of interest in cortex and
medulla of left (blue) and right (red) kidney are selected (g); a graph displays the contrast signal in these
regions of interest (h)
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complications as the procedure can be performed with only light
anesthesia and the procedure itself does not require postoperative
analgesia. In addition the success of any given injection or aspira-




The protocol outlined below depicts a standard renal ultrasound
exam that can be performed on various ultrasound systems. If
available, a system dedicated for small animal imaging using high-
frequency linear transducers is be preferred due its superior resolu-
tion and sensitivity. For rats a transducer with a 50 or 75 μm
resolution is appropriate and for mice a transducer with 40 μm
resolution should be used. Despite the similar principle of various
ultrasound systems, the availability of imaging modes, settings and
Fig. 6 Image guided injection into the left kidney of a mouse; (a) animal and needle positioning, (b) penetration
of the skin, (c) the needle tip (marked with an asterisk) is positioned in the medulla of the kidney, (d) after
injection of US contrast agent and needle retraction, injection site is marked with an asterisk
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analysis tools may vary. Please refer to instructions provided by the
manufacturer for system-specific information and tailored work
protocols.
While some brief ultrasound scans (e.g., for linear measure-
ments, screening for pathologies or anatomical alterations) can be
performed on awake animals, more comprehensive renal exams
including flow measurements or volumetric analysis normally
require the use of anesthesia. A brief description of isoflurane
anesthesia is included below, but researchers should always carefully
follow local rules and regulations.
In order to ensure reproducibility and to streamline workflow
in longitudinal studies, it is recommended to store settings for all
imaging modes and applications, stick to the same anesthesia type
and level, as well as monitor the animal’s physiologic parameters.
1. Switch on the flow of oxygen or medical air (the latter preferred
for contrast enhanced ultrasound imaging) and set it to 1 L/
min, place the animal in the induction box and turn on iso-
flurane at 4–5% until anesthesia is induced. Once a sufficient
level of anesthesia is reached (loss of righting reflex), transfer
the animal onto the imaging table and reduce isoflurane to
1.5–2% during imaging (depending on the animal model), or
higher for interventional procedures. Make sure to switch the
flow of anesthesia gas from the knock out box to the mask.
2. Place the animal in supine position if the renal exam is part of an
abdominal scan; a prone position may be used to evaluate
kidney structure, dimensions and volume, this position is also
more suitable for image-guided injections.
3. Prepare the animal: apply eye ointment, tape the paws to the
ECG leads using a small amount of ECG gel for coupling,
insert a rectal probe to monitor body temperature and remove
the hair in the area of interest. Animal physiology should be
carefully monitored throughout the imaging session and
adjustments made as necessary; for example, an additional
heat lamp can be used to maintain body temperature.
4. Remove hair from the area of interest using a dedicated clipper
and/or hair removal cream.
5. Apply a sufficient amount of prewarmed ultrasound gel, place
the transducer in transverse position below the ribcage and
start imaging in B-mode. Check the transducer orientation.
In a supine position the imaging convention needs to be fol-
lowed similar to MRI imaging, that is, with a transverse imag-
ing plane the head should be behind the image, tail toward the
viewer, animal’s left on the right side of the screen.
6. Locate the area of interest by moving from the lower end of the
ribcage toward the lower abdomen. The right kidney can be
localized caudally of and adjacent to the liver. The left kidney is
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located caudally of the stomach and in close proximity to spleen
and the tail of the pancreas (Fig. 1a).
7. The image can be optimized by adjusting the field of view to fit
the kidney, focus and gain. Localize the widest, middle part of
the kidney and center the organ on the screen using the micro-
manipulators of the animal station. When imaging in a supine
position, the animal table may be tilted sideways to bring the
kidney closer to the transducer and remove shadowing caused
by the intestinal tract. Save a B-Mode video clip of the trans-
verse view for analysis (Fig. 1b).
8. Switch on color Doppler to display the blood flow in the renal
artery and vein. Adjust the Doppler window to fit the position
and size of the organ and fine-tune the transducer position to
locate the vessels. Save a video clip, then activate pulsed-wave
Doppler mode to measure blood flow in the renal artery by
placing the Sample Volume gate within the artery. Align the
angle of the PW Doppler with the direction of blood flow as
indicated by color Doppler mode—you may need to reposition
the transducer to obtain an angle smaller than 60. Velocity,
gain and baseline may be adjusted to display the flow profile
and should be saved as presets in longitudinal studies. Save the
blood flow profile for analysis (Fig. 4d).
9. With the transverse view centered on the screen, the sagittal
view of the kidney can be displayed by rotating the transducer
90. Confirm the longest extension of the kidney is displayed
by a mid-lateral movement and save a B-Mode video clip of the
sagittal view for analysis (Fig. 1d).
10. If required, intrarenal flow in the interlobar arteries can also be
displayed and measured. Starting from the sagittal view, the
transducer should be adjusted to the coronal plane. Fine-tune
the positioning until the vessel structure (in B-Mode) and flow
pattern (in color Doppler mode, Fig. 4b)) can be visualized,
then switch on pulse-waved Doppler to record the flow
pattern.
11. In addition a 3D data set of the area of interest can be obtained
either in the transverse or sagittal view. Most commonly a 3D
motor is used to move the transducer perpendicular to the
imaging plane to acquire a stack of images (Fig. 3). Select a
start and end position or scanning range and start 3D acquisi-
tion. Respiration gating may be applied to avoid movement
artifacts due to the breathing of the animal. Once completed
the data set can be processed to display a 3D view of the organ
and saved for analysis.
12. A combined 3D acquisition of B-Mode and power Doppler or
color Doppler may be used to also obtain blood flow informa-
tion for the whole organ (Fig. 4c). In this case, power or color
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Doppler should be activated before starting the 3D acquisition
and the size of the window should be enlarged to cover the
region of interest, the use of respiration gating and a wall filter
is recommended to avoid respiration artifacts.
13. Confirm all images required for analysis have been saved. Wipe
off the ultrasound gel, turn off the isoflurane and release the




Studying kidney perfusion in ultrasound imaging requires the intra-
venous injection of a contrast agent. Administration can be per-
formed either as a continuous infusion using a pump, or as bolus
injection, which can be delivered by hand but using a pump is
recommended to ensure reproducibility. In addition it is possible
to study reperfusion by applying a short ultrasound pulse to destroy
the contrast agent within the field of view and record subsequent
reperfusion. Here we would like to outline a basic perfusion study
that can be included in an imaging session in combination with the
standard exam. To allow for comparison, the imaging procedure
should be standardized as much as possible. For a detailed review of
contrast imaging in small animals and various parameters that
should be considered, please refer to [11].
1. Before anesthetizing the animal, follow the instructions
provided by the manufacturer to reconstitute the US contrast
agent. Prepare a tail vein catheter (butterfly needle suitable for
the contrast agent, fine tubing connected to syringe filled with
saline).
2. Start animal anesthesia as described above. Once the animal has
been moved to the animal table and eye ointment has been
applied, insert the saline filled butterfly needle into the tail vein
and fix the catheter with tape or tissue glue. Position and
prepare the animal for imaging to obtain anatomical and
blood flow information as described above using the
22–55 MHz probe (see Subheading 4.1).
3. Switch ultrasound transducer if required for high sensitivity
detection (e.g., 15–24 MHz transducer for 2–3 μm phospho-
lipid shell bubbles). Contrast imaging for one kidney can be
performed in various positions, if perfusion of both kidneys
should be observed at the same time, a prone position may be
used (Fig. 5c, d). Position the animal as required and apply a
small amount of gel. Avoid air bubbles as these may cause
artifacts.
4. Start the nonlinear contrast (NLC) mode, adjust the imaging
window, and adjust the gain so that a small amount of back-
ground signal is visible in the area of interest (Fig. 5e). Check
the frame rate of the image acquisition and adjust the video clip
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length to allow for sufficient acquisition time (e.g., 30 s), locate
the prospective saving option on the system. If required,
acquire a 3D data set before contrast injection and do not
move the animal or transducer. Once the settings have been
optimized it is advised to store the settings as presets.
5. Fill a new syringe with contrast agent, flush the catheter with
15 μL of saline and change to the syringe containing the
contrast agent. Start the video clip with automatic storage
option. After 3 s inject the bolus of 50 μL of contrast agent
within 3 s using a pump for accurate injection rates. Within a
few seconds a signal increase in the area of interest should be
visible and the video clip will be stored automatically (Fig. 5f).
6. Change back to the syringe containing saline and flush the
catheter with 15 μL and if required, record a second 3D data
set using the previous settings. Circulating contrast agent will
be observed for approximately 10–15 min. Once the contrast
agent has been cleared a second bolus injection can be per-
formed if required. After completing the contrast acquisition





In addition to 2D and 3D ultrasound imaging showing renal
anatomy, blood flow, and perfusion, photoacoustic (PA) imaging
can add additional information by visualizing endogenous as well as
exogenous contrast agents.
1. Anesthesia and animal preparation for PA imaging are identical
to the procedure described above, but in order to obtain the
best possible PA images the animal should be placed either in a
lateral decubitus position or prone position to image both
kidneys. In a prone position white gauze may be placed under-
neath the flanks of the animal to ensure reproducible position-
ing as well as optimizing light delivery.
2. Depending on the system, choose the appropriate photoacous-
tic transducer or the ultrasound transducer with laser fiber
combination. Apply enough gel to the recess of the transducer
so that it is overflowing and ensure that no bubbles are present.
3. Apply a generous amount of prewarmed, bubble-free gel to the
animal. Lower the transducer into the gel just until contact is
made and an image appears in B-Mode. Position the animal or
transducer such that the skin line appears horizontal and at the
recommended distance from the transducer. This ensures opti-
mized and reproducible light delivery into the tissue, resulting
in accurate photoacoustic data.
4. To limit the field of view to the target, adjust image depth,
depth offset, and image width. If required, record ultrasound
images in B-Mode or Doppler modes as described above.
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5. Switch from B-mode to PA-mode, and start imaging at a single
wavelength (e.g., 800 nm). First, increase the PA gain to deter-
mine if there is any signal present that may bemissed with lower
gain. Adjust the gain so that low-level signal can still be seen
while keeping background signal (often referred to as “noise”)
to a minimum.
6. To compensate for light attenuation at depth, adjust the time
gain compensation or fluence correction. Try to “even out” the
signal throughout the depth of the image. For example, the
signal at the surface of the skin can be quenched while applying
a slight boost with increasing depth. All settings should be
saved and reapplied in future imaging sessions.
7. Switch to oxygen detection and record a video clip for Oxygen
Saturation analysis, a 3D data set may also be obtained.
8. If required, also obtain a spectral scan or a multiwavelength
scans in 2D and 3D based on previously established protocols
for imaging exogenous contrast agents such as dyes (e.g., Evans
Blue) or nanoparticles.




Image guided interventions can be added to any imaging session as
an additional step to locally administer a drug or implement cells.
This procedure can be performed independently and is a fast and
reliable procedure to replace a surgical intervention. Please refer to
Subheading 4.1 for instructions on anesthesia, animal preparation,
and imaging and follow these additional steps:
1. An analgesic treatment may be applied before the start of the
procedure.
2. Prepare a syringe for injection and attach a 30G 1 in. needle. If
the use of a different needle is required, please ensure the
length of the shaft is sufficient for the needle to pass under
the probe without the needle hub pressing against the probe
casing. Fix the syringe in an injectionmount to allow for precise
control of the needle movement directly under the transducer,
for best visualization of the needle tip the bevel should be
facing upward.
3. If available, an additional micromanipulator can be placed
between transducer and transducer mount, this allows to fine-
tune the probe position for clear identification of the needle tip
during the procedure.
4. Adjust the positioning of the needle and transducer. The nee-
dle should be aligned with and parallel to the ultrasound beam,
which can be checked by placing the needle in some ultrasound
gel and lowering the transducer into it (Fig. 6c). When
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positioned correctly, the whole length and tip of the needle
should be visible on the live image as a bright line. Once a good
alignment has been achieved, movement of the needle and
probe in the Y-axis should be avoided.
5. The animal may be taped to the electrodes in a prone position
or in a lateral decubitus position (Fig. 6a) to inject into the
contralateral kidney. In this case, taping the lower front and
hind paw and tail to the electrodes will allow to monitor the
animal’s physiology.
6. Apply a generous amount of bubble-free gel to the area of
interest. Lower transducer into the gel and bring the kidney
into view. Adjust the position to have some space on the left for
needle positioning.
7. If desired, set the ultrasound system up to record a long video
clip by adjusting the length of the video and enable prospective
saving, start recording before inserting the needle or injection
as required.
8. Advance the needle forward into the gel until it is visible. By
tilting and moving it up or down, the projected needle path
should point to the target area within the kidney. If large blood
vessels or critical organs lie within the needle pathway, reposi-
tion the animal to avoid unnecessary damage of tissue.
9. Advance the needle quickly to push through the skin, then
gently move forward to place the needle tip in the target
structure (Fig. 6b). If the needle slightly bends out of view
during the injection, the Y-axis micromanipulator can be used
to readjust the image. Perform the injection and wait shortly to
allow for distribution then slowly retract the needle (Fig. 6d). If
desired, save a video clip of the procedure.
10. End the ultrasound exam as described above and monitor the
recovery of the animal. Check the animal for signs of pain or
complications in regular intervals as indicated in the animal
protocol (i.e., up to 24 h after injection).
4.5 Analysis All commercially available ultrasound systems dedicated to in vivo
imaging provide measurement tools for comprehensive image anal-
ysis that cover a broad range of standard applications. As data is
mostly stored in proprietary file formats, analysis tools are a funda-
mental part of the system capabilities and convenient to use, no
other third party or open source software is normally used for
standard analysis. Therefore no detailed step-by-step instructions
are given below. Instead the type of measurements routinely per-
formed are outlined below and were applicable, calculations are
mentioned. Depending on the ultrasound system that is used,
measurements will either be added directly during the exam, after-
ward on the ultrasound system itself or on a dedicated offline
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analysis software. Please refer to the user instructions to ensure all
data required for analysis is saved. Modern preclinical ultrasound
and photoacoustic equipment allow for extracting the image data as
DICOM or raw formats, making the data accessible in nonpropri-
etary image analysis programs.
1. The length of the kidney in a sagittal and transverse 2D
B-Mode images can be measured in mm using a line
measurement.
2. In standard clinical exams, kidney volume is often calculated
using the ellipsoid formula: LengthWidthDepth 0.523.
Using a 3D motor and appropriate settings a more accurate
volume of the kidneys can be obtained. Depending on the
software, various ways of volume reconstructions are available.
Mostly the user is required to outline the organ in a few,
selected frames on either the video clip or reconstructed 3D
view. Based on this information an outline of the organ is
created and the volume calculated. In addition to the total
kidney volume, sub-volumes can be added to measure cysts,
tumors or other anatomical structures. Most software packages
also allow to copy volume reconstructions between imaging
modes and will quantify additional parameters. In 3D Power
and Color Doppler images, percent vascularity can be
measured in the volume of interest. Various display options
are available to visualize results.
3. In PA imaging, the PA signal intensity can be measured within
an area of interest at a single wavelength and build in algo-
rithms allow to also calculate oxygen saturation and hemoglo-
bin content in 2D and 3D. If required, signal from endogenous
or exogenous contrast agents can be separated from back-
ground using automated spectral unmixing tools.
4. Flow analysis of the renal artery or intrarenal arteries routinely
include measuring peak systolic (PSV) and lowest diastolic
(LDV) as well as the velocity-time-integral. If not automated
in the analysis software, the Resistive Index can be calculated
manually based on the first two parameters: (PSV  LDV)/
PSV.
5. A basic perfusion analysis includes outlining areas of interest,
for example in the kidney cortex, medulla or a tumor, to display
the wash in curve of the contrast agent. Based on this curve, the
time to peak, a relative measure for blood flow, and peak
enhancement, a relative measure for blood volume, can be
measured. If 3D data is recorded, it is also possible to observe
the contrast signal before and after contrast injection and cal-
culate the parameter percent agent.
6. For presentation purposes, ultrasound and photoacoustic
imaging analysis software allows for annotations and color
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coding of anatomical structures and further editing for educa-
tional purposes or publishing.
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Chapter 8
Hardware Considerations for Preclinical Magnetic
Resonance of the Kidney
Paula Ramos Delgado, Ekkehard Küstermann, André Kühne,
Jason M. Millward, Thoralf Niendorf, Andreas Pohlmann,
and Martin Meier
Abstract
Magnetic resonance imaging (MRI) is a noninvasive imaging technology that offers unparalleled anatomical
and functional detail, along with diagnostic sensitivity. MRI is suitable for longitudinal studies due to the
lack of exposure to ionizing radiation. Before undertaking preclinical MRI investigations of the kidney, the
appropriate MRI hardware should be carefully chosen to balance the competing demands of image quality,
spatial resolution, and imaging speed, tailored to the specific scientific objectives of the investigation. Here
we describe the equipment needed to perform renal MRI in rodents, with the aim to guide the appropriate
hardware selection to meet the needs of renal MRI applications.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
This chapter on hardware considerations for renal MRI in small animals is complemented by two separate
publications describing the experimental procedure and data analysis.
Key words Magnetic Resonance Imaging (MRI), Kidney, Mice, Rats, Hardware, RF coils, Renal MRI
1 Introduction
The detection, staging, and monitoring of kidney diseases
(KD) using measurements of renal function and structure is critical
in clinical nephrology. The use of animal models in kidney research
promotes the understanding of disease and therapy mechanisms.
While current imaging modalities such as computed tomography or
ultrasound can provide some information on structural changes in
the kidney, these approaches offer limited insights into functional
changes.
Magnetic resonance imaging (MRI) is a noninvasive imaging
technology that offers an unparalleled level of anatomical and
functional detail, along with diagnostic sensitivity. MRI is suitable
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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for longitudinal studies due to the lack of exposure to ionizing
radiation. Together with established imaging techniques, novel
approaches such as dynamic contrast-enhanced MRI
(DCE-MRI), arterial spin labeling (ASL), blood oxygen level
dependent MRI (BOLD), and diffusion-weighted imaging (DWI)
can provide a broad characterization of the kidney, including renal
vascular perfusion, oxygenation, and glomerular filtration rate.
For performing dedicated MRmeasurements of the kidney, the
appropriate MRI hardware should be carefully chosen to balance
the competing demands of image quality, spatial resolution and
imaging speed, tailored to the specific scientific objectives of the
investigation. This chapter is intended to outline the key hardware
components of an MRI scanner and to provide an overview of
currently established technologies, with the goal to guide the
appropriate hardware selection that meets the needs of preclinical
MRI of the kidney.
This chapter on hardware considerations for renal MRI in small
animals is part of the book Pohlmann A, Niendorf T (eds) (2020)
Preclinical MRI of the Kidney–Methods and Protocols. Springer,
New York.
2 Static Magnetic Field Strength (B0)
A superconducting magnet that generates a constant homogeneous
magnetic field is the core hardware component of an MRI scanner.
This strength of this static magnetic field (B0) is proportional to the
net polarization produced within the sample. The detected MR
signal on a receive RF coil depends on B0
2, whereas the noise
increases linearly with B0 [1]. B0 governs the signal-to-noise ratio
(SNR), which is the currency for MR image quality. This provides
strong motivation and momentum to move to increasingly higher
magnetic field strengths for preclinical and clinical renal MRI appli-
cations [2–4]. The proportionality of SNR with B0 is linear in the
quasi-static regime, as demonstrated theoretically [5, 6] and exper-
imentally [7]. For higher magnetic field strengths, wave propaga-
tion and the increasing resonance frequencies must be considered
[2]. Additionally, an experimental study on intrinsic SNR beha-
viour with increasing B0 field strengths (3.0, 7.0, and 9.4 T) in the
human brain reported a superlinear increase in SNR (SNR / B1:650 )
[7]. This observation was also confirmed in a simulation study [8].
Relaxation time constants of biological tissues also change with
the magnetic field strength, thus influencing the SNR as well as the
contrast-to-noise ratio (CNR), which ultimately has an impact on
the image quality. The longitudinal relaxation time (T1) increases
nonlinearly with increasing B0 [1, 9–11]. The transversal relaxation
(T2) and T2* decrease at different slopes linearly [1, 9, 12–
14]. These dependencies on B0 are responsible for the reduced
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T1-weighted contrast and increased BOLD effect at higher mag-
netic field strengths (see Note 1). MRI methods based on T2*-
weighting (e.g., susceptibility weighted imaging, BOLD) will
benefit from the T2* shortening, and thus increase in sensitivity at
high magnetic field strengths, which underlies their broad applica-
tion in renal MRI. An example of renal T2*-mapping (R
∗
2 ¼ 1=T∗2 Þ
is the study of oxygenation and haemodynamics in renal disorders
(for a review see [15]). MR spectroscopy also benefits from the
enhanced signal dispersion achieved at higher magnetic field
strengths, which results in better resolved spectra, and permits
improved accuracy of metabolite identification and quantification
[1, 16].
However, MRI at high magnetic field strengths is susceptible to
more severe B0 and B1 inhomogeneities, compared to lower field
strengths. These inhomogeneities are primarily due to differences
in the magnetic susceptibility at tissue interfaces. Susceptibility
artifacts present themselves as T2*-induced signal losses (or even
signal voids) in areas with very high B0 gradients, low phase-
encoding bandwidth-related image distortion and off-resonance
effects caused by ΔB0-induced frequency dispersions. MRI of the
kidney poses additional challenges due to the anatomical context.
The kidneys are adjacent to bowels, in close proximity to skin/fat/
muscle boundaries (e.g., perirenal fat) or in areas containing cavities
might be particularly prone to susceptibility artifacts.
Artifacts are visible as signal losses at interfaces between fat and
tissue or air and tissue (susceptibility artifacts), image blurring, image
distortion, and broadening of spectral lines in MRS, which interferes
with the reliable differentiation of metabolites. B0 inhomogeneities
can be mitigated using B0 shimming (see Subheading 3).
B1 inhomogeneities lead to variations in the flip angle driven by
the RF pulse excitation. B1 inhomogeneities affect tissue contrast
and SNR, appearing as signal intensity variations or losses across the
field of view. Nonuniformities in B1 are caused by the RF coil (e.g.,
surface RF coil, see Subheading 4) or by the creation of standing
waves and constructive/destructive interferences within the object
under investigation, due to the reduction of the effective wave-
length which at higher field strengths becomes shorter, and can
approach the dimensions of the specific anatomical structures under
study [17]. While the RF wavelength inside tissue at 3.0 T
(~128 MHz) is about 30 cm, at 7.0 T (~300 MHz) it is reduced
to about 13 cm [18] and to 6.5 cm at 14.0 T (~600 MHz). In
preclinical renal MRI, this is not a major concern, as the size of the
abdomen in small animals is typically much smaller than the RF
wavelength.
RF power requirements for spin excitation increase quadrati-
cally with B0. This imposes major concerns, especially for human
applications, since the RF power deposition can easily reach the
regulatory limits specified by IEC guidelines for the specific
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absorption rate (SAR) [16]. This constraint can be adressed by
modification and adaptation of MR pulse sequences, acquisition
strategies, and RF coils [18, 19]. In the case of preclinical studies,
these issues have received less attention since there are no enforced
SAR guidelines for small animals. Nevertheless, the physiological
effects of tissue heating due to heavy RF deposition in experimental
animals could be a serious confounding factor in preclinical studies




The SNR gains resulting from increasing B0, field have been com-
putationally estimated for brain MRI to range from B0
1.2 (close to
the brain surface) up to B0
2.1 (at the center of the head)
[8]. Pohmann et al. [7] investigated the field dependence of SNR
for magnetic field strengths ranging between 3.0 T and 9.4 T using
gradient echo techniques, and reported that SNR increases super-
linearly (B0
1.65). Using this relationship, the calculated relative
SNR (normalized for the typical case of a 3.0 T scanner) and
resolution gains (in μm, in-plane resolution 1 mm) corresponding
to all static magnetic field strengths from 1.5 T to 21.1 T are shown
in Table 1.
The increase in SNR provided by higher magnetic field
strengths can be invested in enhanced spatial resolution or
improvements in imaging speed. The triad of B0, spatial resolution,
and imaging speed form the so-called SNR conundrum in which
the competing constraints of SNR, CNR, spatial resolution, and
imaging speed govern the image quality. For example, increasing
the matrix size for a certain field of view will increase the spatial
resolution—which will permit the visualization of more subtle
anatomical structures in the kidney—but at a cost of reducing the
SNR, or signal intensity per pixel/voxel. Although resolution in the
frequency-encoding direction can be conveniently enhanced by
increasing the matrix size without major scan time penalty, increas-
ing spatial resolution along the phase-encoding direction substan-
tially prolongs the scan time. Boosting the SNR is also possible by
modifying the size of the field of view or the slice thickness: the
larger these parameters are, the more signal is acquired. Another
way to further increase SNR is signal averaging, which reduces the
noise but comes at the cost longer scan times. Depending on the
individual experimental context, longer scan times may be a reason-
able price to pay (especially for ex vivo studies). For in vivo studies,
animal welfare considerations call for the minimum scan time pos-
sible to achieve the scientific objective, and shorter scans promote
higher throughput of individual animals to improve the experimen-
tal sample size.
Additional strategies to gain SNR include the use of
SNR-promoting rapid imaging techniques such as RARE imaging,
and dedicated RF coil technology, including cryogenically cooled
RF coils (see Subheading 4).





To provide guidance as to which B0 is necessary or sufficient for
preclinical MRI of the kidney, a total of 121 publications published
over the past 10 years were reviewed. Of these, 66 publications
reported on renal MRI in rats, and 55 in mice. Figure 1 shows the
number of publications found per magnetic field strength for renal
MRI in rats and mice. In rats, a total of 25 publications (38%) were
performed at 3.0 T, closely followed by 9.4 T with 20 papers (30%).
In mice the preferred magnetic field strength was 7.0 T (25 pub-
lications, 46%). The magnetic field strengths of 9.4 T (8 papers,
15%), 3.0 T (7 papers, 13%), and 11.7 T (6 publications, 11%) were
also used for MRI studies of mouse kidney.
Figure 2 illustrates the number of publications per magnetic
field strength, listed by year for rats andmice. In rats, the number of
studies performed at 3.0 and 9.4 T was quite stable for the last
7 years. Studies at 4.7 T (7 papers, 11%) were also widely reported,
as shown in the trends displayed since 2009. The use of field
strengths of 1.5 and 7.0 T (7 and 6 publications, respectively)
varied during the period under investigation. In contrast, 7.0 T
was established as the typical magnetic field strength for preclinical
MRI of the kidney in mice during this period. In the last few years,
11.7 T and 16.4 T have also emerged asMR systems suitable for the
study of the mouse kidney.
Table 1
Relative SNR and resolution gain with increasing static magnetic field strength
Magnetic field, B0 (T) Relative SNR gain Resolution gain (in-plane 1 mm) (μm2)
1.5 0.3 (1550  1550)
3.0 1.0 (495  495)
4.7 2.1 (235  235)
7.0 4.0 (122  122)
9.4 6.6 (75  75)
11.7 9.4 (52  52)
14.0 12.7 (39  39)
16.4 16.5 (30  30)
17.6 18.5 (27  27)
21.1 25.0 (20  20)
SNR values were computed as proportional to B1.65. The relative SNR gain was calculated relative to that of 3.0 T
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3 Gradient Systems
To enable the spatial localisation of the MR signal, magnetic field
gradients are used, which are provided by gradient coils. Gradient
coils produce a linear variation of the magnetic field as a function of
the spatial position (X-, Y-, and Z-direction) modifying the reso-
nance frequency for spatial encoding of the MR signal.
Typical parameters governing the performance of the gradient
system are the peak gradient strength, the rise time, and the slew
rate. The peak gradient strength is the maximum achievable gradi-
ent strength (in mT/m). Typical peak gradient amplitudes in pre-
clinical scanners are in the range of 200–1000 mT/m. Clinical
scanners used for preclinical MRI of the kidney provide maximum
gradient amplitudes ranging between 45 mT/m and
82 mT/m. The gradient rise time is the time needed to change
the gradient field from zero to the peak amplitude (in ms). The
gradient slew rate is the most important parameter, and refers to the
speed at which a gradient can be switched. It is defined as the peak
gradient strength divided by the gradient rise time (in T/m/s).
This defines the maximum scanning speed, since it influences the
minimum achievable repetition time (TR) and echo time (TE), as
well as the echo spacing in fast imaging techniques such as RARE or
EPI (seeNote 2). Typical slew rates in preclinical scanners are in the
range of 640–9000 T/m/s. Clinical scanners used for preclinical
MRI of the kidney offer slew rates ranging between 150 T/m/
s and 200 T/m/s. Gradient coils can be driven in two modes:
(a) constant rise time, in which the slew rate is adapted for each
gradient amplitude and (b) maximum slew rate, where the rise is
adjusted for each gradient amplitude.
Fig. 1 Number of publications per magnetic field strength for renal MRI in rats and mice, within a total of
121 reports on preclinical renal MRI published in the past 10 years
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Fig. 2 Number of selected publications ordered by magnetic field strength and year, within a total of
121 reports published in the past 10 years (2009–2018) for preclinical renal MRI in rats and mice
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The duty cycle defines the amount of time during which the
gradient system can be run at maximum power amplitude (in %
time). This parameter depends not only on the gradient system
specifications mentioned above but also on the specificMR imaging
technique used. Typical duty cycles in existing preclinical scanners
can reach almost 100%. For this purpose, gradient coils are water-
cooled to ensure proper heat dissipation and temperature
management.
The accuracy of the spatial representation depends on the
quality of the linear magnetic field gradients and on the homoge-
neity of the static magnetic field (typically given in parts per million,
ppm). Any deviation will appear as object distortion in the image,
and thus a correction procedure called “shimming” is typically
performed. During system installation, the manufacturer places
small metal plates inside the scanner bore to improve the uniformity
of the main magnetic field in a static and permanent manner—this
is “passive” shimming. The distribution of these ferromagnetic
pieces is adjusted over several iterations until the achieved magnetic
field uniformity meets the vendor’s specification. In addition to
passive shimming, resistive shim coils are used for B0 homogeniza-
tion. These adjustments are performed with a shim calibration tool
on an empty magnet, and therefore the B0 homogeneity becomes
impaired as soon as a sample or subject (human or animal) is placed
inside the magnet bore.
An “active” shimming procedure can be conducted during
measurement adjustments with every MR scan. This is crucial for
techniques such as fat suppression or MR spectroscopy, since the
introduction of any matter—an object or animal—inevitably intro-
duces local magnetic field perturbations of the main static magnetic
field, which then must be actively compensated for. Especially at the
boundaries between tissue and air-filled areas, where magnetic field
distortions are pronounced due to the different magnetic suscepti-
bility which can cause severe signal losses and image distortions.
Corrective magnetic fields produced by electrical RF coils, desig-
nated as shim gradients [20] which are superimposed upon the
main magnetic field. Typically, the shim gradient system contains
a set of first-order gradients which impose linear field changes in the
X-, Y-, and Z-directions, and some second order gradients, which
create spherical harmonics in the Z2, ZX, ZY X2-Y2, and XY direc-
tions [21]. Some MR systems are also equipped with more sophis-
ticated shim gradients which provide third and fourth order
correction terms [22].
Depending on the specific pulse sequence and imaging
technique used, the scientist has to adjust these magnetic field
corrections to meet certain quality prequisites. Especially with
T2*-weighted sequences (e.g., gradient-echo or EPI sequences)
the image quality improves with improved B0 homogeneity. MR
spectroscopic methods are even more demanding [23]. Usually,
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state-of-the-art MR systems provide automated methods to per-
form the B0 shimming task, but the user still needs to check the
performance and correct the shim settings manually if necessary.
For B0 shimming a global approach covering the entire FOV, or
a localized shim covering a target area can be used. In general, the
smaller the region of interest the better the achievable B0 homoge-
neity. In the case of renal MRI, the B0 homogeneity achieved after
shimming across one kidney will be better than that for the whole
abdomen, with air-filled lungs and gut. In the case of tissues that are
moving due to respiration, cardiac activity or peristaltic motion, the
magnetic field distortions change over time, which require different
strategies. The time-averaged global shim would be the fastest and
easiest solution, if this is sufficient. Alternatively, shimming—and
also data acquisition—would be performed in synchrony with the
breathing by using a trigger signal from a physiological
monitor [24].
4 Radio Frequency (RF) Coils
Besides the static magnetic field and the spatial encoding with the
gradient system,MRI requires transmission of RF pulses and recep-
tion of the MR signal from the sample or subject.
For signal excitation, the RF transmit resonator, or RF coil,
sends RF pulses with a particular frequency, bandwidth, shape,
duration, amplitude, and phase modulation to tilt the net magneti-
zation vector oriented in parallel with the main magnetic field
during equilibrium. B0 (typically assigned as the Z-direction), is
tilted into the perpendicular transverse (X-Y) plane by a given flip
angle α. After excitation, the magnetization precesses back to equi-
librium and induces a signal in the RF receive coil (for a compre-
hensive review see [25]).
Depending on the transmission and reception capabilities,
three general types of RF coils are commonly used: (1) transmit-
receive (Tx/Rx) or transceiver RF coils, (2) transmit-only (Tx) RF
coils, and (3) receive-only (Rx) RF coils. These generally have two
types of geometry: (1) volume RF coils and (2) surface RF coils.
Both RF coil types and geometries determine the amount of tissue
or organ coverage and sensitivity to the MR signal.
Volume RF resonators are designed to produce a uniform RF
field over a large field-of-view (FOV), and are typically used as
transmit-receive RF coils or transmit RF coils (using a surface RF
coil for reception). The most widely used type of volume RF coils in
both human and preclinical MRI are birdcage resonators [26, 27]
driven in quadrature mode. This means that two spatially orthogo-
nal RF channels are used for RF transmission as well as signal
reception. This RF coil configuration provides a 41.4% SNR gain
over simple single channel or “linear” RF coils, due to the coherent
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signal increases which scale linearly with the number of channels,
while the incoherent noise increases with the square root of the
number of channels. For example, Chang et al. [28] used this RF
coil setup in a renal hypoxia study in a mouse model after myocar-
dial infarction of different sizes using BOLD MRI. Other types of
volume resonators include saddle RF coils, Helmholtz RF coils, and
the transverse electromagnetic (TEM) resonators, among others.
Smaller anatomical coverage and FOVs, but enhanced SNR, are
provided by surface RF coils. Due to the principle of reciprocity, the
closer the position of the RF coil is to the tissue of interest, the
higher is the attainable SNR. However, the sensitivity drops with
increasing distance to the RF coil surface, which thus results in a
reduced FOV, and an inhomogeneous sensitivity profile
[29]. Within a short distance of typically up to ~1 cm, a surface
RF coil outperforms a volume RF coil in terms of sensitivity. Since
the kidneys are located beneath the skin, surface RF coils positioned
directly above are used for optimal signal reception in renal MRI.
This is advantageous not only for X-nuclei MR imaging (see Sub-
heading 5) but also for other applications with low SNR, such as
perfusion or diffusion-weighted imaging.
Surface RF coils may be used as transmit/receive devices or as
receive-only RF coils in conjunction with a volume RF coil used for
homogeneous RF transmission. The first option is technically very
simple since only one RF coil is necessary, which occupies less space.
In the case of small animal imaging, it is most likely a simple single-
turn loop with at least two tunable capacitances for tuning and
matching. Images will show a strong spatially varying SNR decay,
due to the addition of the inhomogeneous excitation and reception
profiles [30]. This effect may be mitigated, for example, by using
adiabatic excitation RF pulses [31].
The second option involves the use of two RF coils (Tx: volume
RF coil, Rx: surface RF coil) which are tuned to the same resonant
frequency. To avoid RF coupling between both coils, the surface RF
coil must be detuned during transmission while the volume RF coil
must be detuned during reception. Thus, both RF coils must
include an option, using active and passive diodes, to allow for
tuning and detuning during the MR experiment. This is the most
common setup, since it improves the SNR in comparison with a
Tx/Rx volume RF coil, while still maintaining a homogeneous B1.
For example, Hüper et al. [32] used a four-element quadrature
surface receive RF coil in combination with a transmit volume RF
coil to investigate renal perfusion in acute and chronic renal allo-
graft rejection in translational mouse models. The use of the surface
RF coil improved the SNR from 15 (with a standard transceive
volume RF coil) to 35.
Further SNR gains in small animal MRI are achieved with
arrays of surface RF coils for signal reception [33], which are
typically used together with a volume RF coil for signal excitation
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(see Notes 3 and 4). The use of RF coil arrays for brain imaging is
especially widespread, and these are routinely offered by manufac-
turers. State-of-the-art small-animal MRI systems are usually
equipped with 4–16 Rx channels, to which custom-tailored RF
coils may be connected. Less popular are metamaterial-inspired
RF coils, which have been developed for superficial tissue imaging
in order to provide the best compromise of high SNR over a large
FOV, while using only one receive channel [34].
Depending on the size of the sample and the RF coil, and their
corresponding temperatures and resistances, their noise electronic
contribution varies [35–37]. This factor is even more crucial in
preclinical applications where the noise contribution of the RF
coil, capacitors, sample, shield, receive electronics, and transmission
lines are important [26]. This fact is exploited in small-animal
imaging by the use of cryogenically cooled (cryo-cooled) RF
coils. By lowering the temperature of the receiver chain, the noise
contributions corresponding to temperatures and resistances can be
reduced [38–40], thus achieving a significant increase in SNR,
which has been reported in the literature (for a review see [15]).
Unfortunately, only negligible effects are achieved in human MR
[15, 41]. With increasing size of the sample, the relative contribu-
tion to the noise increases, and eventually becomes the dominating
noise source—this is the default situation for human MR. Thus,
only small animal MR applications will benefit from this cooling
approach, since the noise contributions from the sample and RF
coil are in the same order of magnitude. The SNR gain achieved
with such cryo-cooled RF coils is higher at lower static magnetic
fields [15, 26, 42]. A recognized limitation of cryo-cooled surface
RF coils is that only transceive capabilities are supported, resulting
in nonuniform excitation and reception profiles, which might ham-
per quantitative measurements.
Another option for the small-animal MR imaging of the kidney
is the use of clinical scanners together with RF coils tailored for the
human hand/wrist or knee. These are typically 8- to 16-element RF
coil arrays which provide quasi-homogeneous excitation and recep-
tion profiles. Although these RF coils have a small size, they are not
optimized for small-animal imaging and are not designed with
matching/tuning capabilities. Moreover, RF coils tailored for
rodent imaging are designed for a broad range of loadings (i.e.,
from almost empty to full loading, with a typical frequency-
diameter product in the range 2–30 MHz · m [26]), in comparison
to the clinical setups. Therefore, these clinical RF coils will achieve a
lower efficiency than that of dedicated RF coils designed for pre-
clinical MR systems. Alternatively, RF coils tailored for renal MRI
of small rodents provided by RF coil manufactures can be
connected with clinical MR scanners to enhance the fill factor
and SNR.
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In the following subsections, examples of possible RF coil
setups are shown from different vendors. A list of the available





Due to the considerable anatomical homology with humans, rats
have become one of the most commonly use rodents in animal
research, particularly, in preclinical MRI. With a weight of
150–450 g, both clinical and preclinical MR systems and RF coils
can be used to perform renal MR experiments:
Clinical MR System
– Tx/Rx wrist RF coil (e.g., Siemens eight-channel wrist RF coil,
Fig. 3A).
– Tx/Rx knee RF coil (e.g., Siemens 15-channel knee RF coil,
Fig. 3B).
Preclinical MR System
– Tx/Rx volume resonator (e.g., Bruker Biospin, Ettlingen, Ger-
many, quadrature rat body RF coil with inner diameter
(ID) ¼ 72 mm (Fig. 3C), 82 mm or 86 mm; RAPID Biomed,
Rimpar, Germany 2  4-channel volumetric rat array with
ID ¼ 72 mm).
– Tx/Rx quadrature volume resonator (e.g., MRI.TOOLS
GmbH, Berlin, Germany, supporting an ID ranging from
54 mm to 86 mm and magnetic field strengths of 3.0 T, 4.7 T,
7.0 T, 9.4 T, and 11.T (Fig. 3D).
– Rx surface RF coil (e.g., 2  2 RAPID Biomed, Rimpar, Ger-
many) rat cardiac surface array RF coil; 4  1 element (e.g.,
Bruker Biospin, Ettlingen, Germany) rat cardiac surface array
RF coil, Fig. 3E) in combination with Tx volume resonator
(e.g., Bruker rat body RF coils with ID 72 mm (Fig. 3F),





Mice are the most commonly used rodent in biomedical research.
Their genetic similarity to humans has made them extremely useful,
allowing the development of mouse models of many human dis-
eases. Mice have an average weight of 15–40 g, making them too
small for standard human RF coils:
Clinical System
– There are no standard human RF coils that are small enough to
be suitable for mice MRI. Alternatively, a Tx/Rx quadrature
volume resonator (MRI.TOOLS GmbH, Berlin, Germany),
supporting an ID ranging from 30 mm to 45 mm and magnetic
field strengths of 3.0 and 7.0 T can be used for renal MRI with
clinical MR scanners (Fig. 4A).
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Preclinical System
– Tx/Rx volume resonator (Bruker Biospin, Ettlingen, Germany)
quadrature mouse body RF coil with ID ¼ 35 mm, Fig. 4B);
2  4 -channel volumetric mouse array (RAPID Biomed, Rim-
par, Germany) with 35 mm ID.
– Tx/Rx quadrature volume resonator (MRI.TOOLS GmbH,
Berlin, Germany, supporting an ID ranging from 30 mm to
45 mm and magnetic field strengths of 3.0 T, 4.7 T, 7.0 T,
9.4 T, and 11.T (Fig. 4A).
– Rx surface RF coil (e.g., RAPID Biomed, Rimpar, Germany)
2  2 mouse cardiac surface array RF coil; 2  2 element mouse
cardiac surface array RF coil (e.g., Bruker Biospin, Ettlingen,
Germany, Fig. 4B) in combination with Tx volume resonator
(e.g., Bruker Biospin, Ettlingen, Germany) quadrature mouse
body RF coils with ID 72 mm (as shown in Fig. 4E), 82 mm or
86 mm).
– Tx/Rx 2  2 element array rat/mouse CryoProbe (e.g., Bruker
Biospin, Ettlingen, Germany, Fig. 4C).
Table 2
List of vendors of MR equipment and RF coils
Vendor Website
Clinical MRI Canon Medical Systems us.medical.canon
General Electric Medical Systems Inc. www.gehealthcare.com
MRI Devices Corp. www.allmri.com
MR Instruments Inc. www.mrinstruments.com
MRI.TOOLS GmbH www.mritools.de
NOVA Medical Inc. www.novamedical.com
RAPID Biomedical GmbH www.rapidbiomed.de
Philips Medical Systems www.medical.philips.com
ScanMed www.scanmed.com
Siemens Medical Systems www.siemens-healthineers.com
Tesla Engineering Limited www.tesla.co.uk
Preclinical MRI Bruker BioSpin MRI GmbH www.bruker.com
Doty Scientific, Inc. www.dotynmr.com
MR Solutions www.mrsolutions.com
MRI.TOOLS GmbH www.mritools.de
RAPID Biomedical GmbH www.rapidbiomed.de
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5 Multinuclear Imaging
The most frequent MRI method in biomedical research is proton
(1H) imaging. Hydrogen is the most abundant nucleus in living
organisms. It also is the nucleus which is the most sensitive to
interactions with an external magnetic field, due to its high gyro-
magnetic ratio (γ ¼ 42.576 MHz/T).
Fig. 3 Example RF coils suitable for kidney MRI of the rat. (a) Siemens 8-channel wrist RF coil, (b) Siemens
15-channel knee RF coil, (c) Bruker quadrature rat body RF coil with inner diameter (ID) 72 mm, (d) MRI.TOOLS
GmbH quadrature rat body RF coil with ID of 72 mm, (e) 4 1 element Bruker rat cardiac Rx surface array RF
coil, (f) Bruker rat body Tx volume resonator with ID 72 mm.
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Fig. 4 Example RF coils suitable for kidney MRI of the mouse. (a) MRI.TOOLS GmbH quadrature mouse body RF
coil with an ID ¼ 42 mm, (b) Bruker quadrature mouse body RF coil with 35 mm ID, (c) Bruker 2  2 element
mouse cardiac surface array RF coil, (d) Tx/Rx quadrature surface RF coil with cryo-cooling technology
(CryoProbe)
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In preclinical renal MRI, structural and functional information
is typically investigated using in vivo 1HMR imaging of the kidney.
Techniques such as T2/T2* mapping, arterial spin labeling (ASL),
dynamic contrast-enhanced imaging (DCE-MRI) or diffusion-
weighted imaging (DWI) are performed in order to study the
oxygenation, perfusion, clearance rate, and water and metabolite
motion within the kidneys.
Physiometabolic probing is supported by imaging and spectro-
scopic applications of other nuclei such as 13C, 17O, 23Na, 35Cl, 39K,
31P, and 19F [43]. The detection of X-nuclei is challening because of
the low intrinsic SNR due to the smaller γ, compared to 1H, and by
the lower abundance of these nuclei in biological tissues.
Increasing B0 is the most effective way to increase sensitivity—
the benefits of higher B0 are unique metabolic and functional
information, as well as outstanding anatomical detail [44–
47]. X-nuclei MR also benefits from the increase in SNR achieved
with cryo-cooled transceive surface RF coils, which are currently
available for 13C, 31P, 19F, and 1H [48, 49].
Changes in the biodistribution of endogenous metabolites that
can be detected with 23Na- or 31P-MR have been demonstrated to
be markers of renal disease [50–53]. For more details on preclinical
23Na-MRI protocols, see the chapters by Grist JT et al. “Sodium
(23Na) MRI of the Kidney: Basic Concept” and “Sodium (23Na)
MRI of the Kidney: Experimental Protocol.” Similarly, renal per-
fusion, oxygenation, and inflammatory cell infiltration can be inves-
tigated using 19F-MRI [54–57]. See the chapters by Grist JT et al.
“Sodium (23Na)MRI of the Kidney: Basic Concept” and “Sodium
(23Na) MRI of the Kidney: Experimental Protocol” on how to
perform 19F-MRI renal studies in rodents.
Hyperpolarization techniques have great potential for explora-
tions into renal metabolic diseases (e.g., hyperpolarized 13C-MRI),
where SNR is boosted up to a 20,000-fold compared to conven-
tional 13C-MRI [58]. Experimental protocols to perform hyperpo-
larized 13C-MRI in preclinical studies are provided in the chapters
by von Morze C et al. “Hyperpolarized Carbon (13C) MRI of the
Kidneys: Basic Concept” and by Laustsen C et al. “Hyperpolar-
ized Carbon (13C) MRI of the Kidney: Experimental Protocol.”
6 Physiological Monitoring
A major difference between clinical and preclinical MRI is the need
to anesthetize the animals prior to imaging. Since most anaesthetic
drugs produce physiological changes (temperature decrease,
depression of cardiorespiratory function, etc.), monitoring the
anaesthetized animals is a very crucial aspect in preclinical MRI
studies. Even in the most simple case, that is, the scanning of
spontaneously breathing animals without any further intervention
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or treatment, respiration and temperature of the animal has to be
monitored continuously during the scan in order to guarantee the
appropriate anaesthetic status and to avoid hypothermia. In partic-
ular, hypothermia is a critical issues in rodent imaging, since mice
have a low mass vs. a large surface which promotes heat loss
[59, 60]. This problem is less severe in rats due to their larger
weight, but it is not negligible [61]. Heating systems must be
therefore used to maintain temperature homeostasis.
Physiological monitoring of the animal is even more essential in
functional MR imaging, since changes may produce confounding
effects on the outcome of the MR experiment [62]. Careful moni-
toring and recording of physiological data should be performed at
all times during the experiment to ensure the validity of the results
and their reproducibility. The frequency of physiological monitor-
ing depends on the invasiveness of the experimental procedure as
well as the time after induction of anaesthesia. As a rule of thumb,
the more invasive the procedure and the longer the time under
anaesthesia, the more frequent the physiological monitoring of the
animal should be performed. Additionally, the correct positioning
of the animals on the animal bed systems, along with careful intu-
bation (if needed) are essential to ensure respiratory and circulatory
comfort during imaging, and to promote recovery of the animal
after the experiment.
Typical physiological parameters monitored during MR experi-
ments include temperature, heart rate, and respiration rate. Many
manufacturers already offer these three monitoring channels, and
are ready to use these signals for the purpose of gating or triggering
the MR imaging techniques. Additionally, information on blood
pressure, blood oxygen saturation, transcutaneous pCO2, or pH
can also be collected. In some cases, invasive withdrawal of blood
samples is necessary—this is a very difficult task since the sampling
has to be executed using long tubes with considerable dead
volumes and very limited visual control.
Finally, all equipment must allow for remote physiological
monitoring, and strictly comply with MR safety requirements.
Several integrated animal handling solutions for physiological mon-
itoring and anaesthesia are commercially available. Examples are
given in Table 3.
7 Practical Points to Consider When Planning a Study
The aim of this chapter is to outline the main hardware components
required for preclinical MRI of the kidney and to guide the appro-
priate hardware selection to meet the individual needs.
This section is intended to provide a summary of the prequisites
needed and to help prepare for preclinical renal MR applications:




With a 3.0 T clinical MR system, renal MRI of rats is feasible with
acceptable image quality and spatial resolution. However, if possi-
ble, we recommend to use a dedicated ultrahigh field MR system
tailored for small-animal imaging with a magnetic field strength of
7.0 or 9.4 T. The reason is that the SNR gain achieved with
preclinical MR scanners compared to that at lower B0 is instrumen-
tal for achieving good spatial and temporal resolution, as well as for
reducing the scan times needed to perform MR examinations.
7.1.2 Should I Consider
Moving to a High Magnetic
Field Strength?
As discussed above (see Subheading 2), the use of a higher magnetic
field strength results in an increase in SNR proportional to B0
(SNR / B1:650 ). This means that renal MR images will achieve
greater SNR that can be traded off for to achieve higher spatial
resolution or reduced scan time as needed (see Table 1). Also,
higher B0 increases the BOLD effect. In general, all methods
based on T2*-weighting will benefit from an increase in the mag-
netic field strength. MR spectroscopy applications also profit from
the increased B0. Therefore, we strongly recommend the use of a
high B0 for these MR applications. However, not all facilities have
such high field MR scanners readily available, in which case it might
be advisable to perform the experiments using a lower magnetic
field system, as opposed to moving animals, equipment, and per-
sonnel to another facility.
Table 3
Examples of commercially available equipment for physiological monitoring in preclinical MRI
Physiological parameter
(s) Examples of vendor equipment
Temperature Omniflex (Neoptix, Inc., Canada)
Fiber optic temperature probes (SA Instruments, Inc. Stony Brook, NY,
USA)
RightTemp (Kent Scientific Corp., Torrington, CT, USA)
MultiSens (Opsens Solutions, Canada)
Respiration rate/ECG
and gating
BioVet (m2m imaging, Cleveland, OH, USA)
Model 1030 Monitoring & Gating system (Small Animall Instruments, Inc.
Stony Brook, NY, USA)
Blood pressure CODA monitor (Kent Scientific Corp., Torrington, CT, USA)
Blood oxygen saturation,
heart rate
Pulse oximeter (SA Instruments, Inc. Stony Brook, NY, USA)
MouseOx (STARR Life Sciences Corp., USA)
Transcutateous pCO2 Capnograph (SA Instruments, Inc. Stony Brook, NY, USA)
CapnoScan (Kent Scientific Corp., Torrington, CT, USA)
Several PhysioSuite (Kent Scientific Corp., Torrington, CT, USA)
PLUGSYS (Harvard Apparatus, Holliston, MA, USA)
148 Paula Ramos Delgado et al.
7.1.3 Higher Magnetic
Fields Are All Rainbows
and Unicorns, and Should
Always Be Used, Right?
Not necessarily! Be aware that higher magnetic field strengths suffer
from greater B0 and B1 inhomogeneities than lower field strengths,
which must be corrected in order to fully benefit from the boost in
SNR. Also, due to the B0-dependent changes of the relaxation
properties, the method-specific and protocol-specific imaging para-
meters have to be adopted in order to generate similar image con-
trasts that are comparable to those achieved at lower B0. If the focus
is the transfer of MR methods from preclinical models to clinical
applications, use of the same static magnetic field strength is advis-
able. The “loss” of SNRmay be partially compensated for by the use
of cryo-cooled RF coils, which would be more cost-effective than
the procurement of a high field small animal MR scanner.
7.1.4 OK, But ... Which
B0 Is Everyone Else Using?
The move to higher magnetic field strengths is supported by a large
body of literature (see Figs. 1 and 2) which reports the most typical
magnetic field strengths for rats to be 3.0 and 9.4 T and for mice to
be 7.0 and 9.4 T. The continued use of 3.0 T scanners for rats is
mainly due to the use of readily available clinical MR systems, which
are then adapted for rat MR experiments. However, these are
typically performed using hand/wrist or knee RF coils tailored for
clinical applications in humans, and are not optimized for animal
imaging, with the main disadvantages being a loss of signal due to
incorrect loading, and the inability to match and tune the RF coil.
7.1.5 What About
the Gradient System?
Depending on the MR application of your choice, a high gradient
slew rate might be needed. Fast imaging techniques need fast
gradient switching speeds, since this parameter influences the mini-
mum achievable repetition time (TR), echo time (TE), and the
echo spacing. However, a higher slew rate means a greater mone-
tary investment will be needed at the acquisition of a new MR
scanner. Equally, the duty cycle is a crucial parameter in hardware-
demanding sequences, which generally includes all fast imaging
techniques. We recommend the procurement of a gradient system
tailored according to the individual experimental needs.
7.2 RF Coil Setup
7.2.1 Which Kind of RF
Coil Should I Use to Get
the Most Juice from My
Clinical MR Scanner?
The best option is to use a hand/wrist RF coil; a knee RF coil is a
second-best option. Both of these are RF coil arrays which provide
high SNR and full FOV coverage. However, these RF coils are
tailored for clinical applications in humans and are not optimized
for animal imaging, with the main disadvantages being a loss of
signal due to incorrect loading and the inability to match and tune
the RF coil. Also, the clinical MR system must be adapted for rat
MR experiments (mice are too small and do not provide enough
loading in clinical systems). Alternatively, dedicated RF coils
provided by RF coil vendors which are customized for renal MRI
of rats can be connected to the clinical MR scanner.
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7.2.2 Which RF Coil




The anatomical position of the kidneys suggests placement of the
RF coil in close proximity to the dorsal skin of the animal. We
recommend the use of a surface RF coil for signal reception
together with a volume RF coil for excitation. This is the most
common setup since it improves the SNR in comparison with a
Tx/Rx volume RF coil, while still maintaining a homogeneous B1.
Also, be aware that this setup needs the synchronized detuning of
the RF coils in turns in order to avoid RF coupling between the two
coils (the surface RF coil must be detuned during transmission
while the volume RF coil must be detuned during reception).
7.3 X-Nuclei
7.3.1 What If I Want
to Perform X-Nuclei
MRI/MRS?
Broadband RF chains, including the transmission path and the
receive path, together with RF coils specifically tailored for
X-nuclei are needed. Due to the typically low SNR inherent to
X-nuclei MR applications, a good option would be the use of a
cryo-cooled RF coil. Imaging of a single kidney can be performed
in mice using a mouse cryo-cooled RF coil. To image both kidneys
simultaneously in mice, a rat cryo-cooled RF coil could be used.
However, bear in mind that cryo-cooled RF coils are designed as
transceive surface RF antennae, and provide inhomogeneous trans-
mit and sensitivity profiles. Therefore, if your MR application needs
exact T1 contrasts or quantification based on absolute signal inten-




Please also see the chapter by Kaucsar T et al. “Preparation and
Monitoring of Small Animals in Renal MRI.”
7.4.1 How Should
I Position the Rodent
in the Animal Bed Prior
to the Experiment?
This depends on the kind of RF coil being used. Typically, the
kidneys are measured from the dorsal side using a combination of
a volume RF coil for RF pulse transmission and a surface RF coil to
receive the MR signal. The volume RF coil will be placed inside the
bore and fixed, while the surface RF coil is typically displaceable or
is fixed on the animal bed. The position of the animal will then be
adapted according to this setup.
7.4.2 What Is
the Essential Physiological




The essential physiological monitoring includes respiration, which
is also used for triggering, and body temperature, which should be
maintained at a normal level.
7.4.3 What Other
Physiological Parameters
Can I Measure, and Which
Equipment Should I Use?
A wide variety of MR compatible equipment exists in the market
that allows for measurement of temperature, respiration rate, blood
pressure, blood oxygen saturation and respiration rate, and trans-
cutaneous pCO2, among others. See Table 3 for exemples of com-
mercially available equipment for physiological monitoring in
preclinical MRI.
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7.5 Image
Acquisition
7.5.1 Should I Perform B0
Shimming in Every MR
Study?
Preferably, yes. Active shimming protocols homogenize the B0 field
in a small region of interest, and help to improve the performance
of T2*-weighted MR protocols such as EPI. For performing MRS
of the kidney (or any other organ), shimming should always be
completed during the MR study adjustments. In general, we rec-
ommend to always perform shimming in every renal MR study.
7.5.2 Should I Always Do
Triggering of the Signal?
What Are my Options?
Renal MR imaging should be synchronized with animal respiration,
preferably triggered to the exhalation phase [32, 63]. If possible,
the animals should be allowed to breathe spontaneously under
anaesthesia.
8 Notes
1. After the decade of the brain and the (re)discovery of the
brain–heart–kidney network, a new era of kidney imaging is
expected. The most important brain research tool is fMRI, and
it has served as strong motivation for continued technological
improvements in hardware development. Similar techniques
are valuable for renal imaging. BOLD-based and BV/BF-
based techniques greatly benefit from higher magnetic fields,
providing a higher SNR, a higher CNR, and better spatial
resolution. Nevertheless, the use of higher magnetic fields
brings new problems that call for new hardware solutions.
2. Although there is an increased demand on gradient perfor-
mance, this will exacerbate the problems associated with acous-
tic noise. New gradient designs should take into account the
acoustic noise pressure level as a parameter. Gradient systems
that are targeted to the region of interest only may be a solu-
tion. The higher gradient performance with increased band-
width, as well as the increased physiological noise, reduce the
gain in the SNR. A limit of the tissue contribution to thermal
noise may be found by new RF coil designs.
3. Modern MRI systems come equipped with multiple receiver
units allowing parallel acquisition. A combination of small, mul-
tielement receive-only RF coils with parallel imaging is a game
changer in the wayMRI data are acquired. Reducing the RF coil
size will allow for the acquisition of data from a small region of
interest with higher sensitivity, because of the close proximity of
the RF coil to the region, and thus limited noise contribution
from tissue. The use of multiple elements, which are decoupled
from each other, will help to achieve extended tissue coverage.
4. A problem associated with parallel imaging arises in the storage
and processing of large amounts of data. Therefore, consider-
able effort must be invested into the handling of “Big Data.”
Boosting the data transfer rate, the use of array processors and
the application of renal MRI will push the limits of data science.
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Chapter 9
MRI Mapping of Renal T1: Basic Concept
Stefanie J. Hectors, Philippe Garteiser, Sabrina Doblas, Gwenaël Pagé,
Bernard E. Van Beers, John C. Waterton, and Octavia Bane
Abstract
In renal MRI, measurement of the T1 relaxation time of water molecules may provide a valuable biomarker
for a variety of pathological conditions. Due to its sensitivity to the tissue microenvironment, T1 has gained
substantial interest for noninvasive imaging of renal pathology, including inflammation and fibrosis. In this
chapter, we will discuss the basic concept of T1 mapping and different T1 measurement techniques and we
will provide an overview of emerging preclinical applications of T1 for imaging of kidney disease.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers. This introduction
chapter is complemented by two separate chapters describing the experimental procedure and data analysis.
Key words Magnetic resonance imaging (MRI), Parametric imaging, T1 mapping, Kidney, Preclinical
1 Introduction
Renal pathologies may result in structural and functional changes
that could possibly be noninvasively detected by magnetic resonance
imaging (MRI) [1]. While the MRI relaxometry parameter T1, that
is, the longitudinal relaxation time, is used quite extensively for
assessment of other organs, for example in cardiac and brain MRI,
its application for the assessment of renal pathology is relatively
scarcely used. Several reports, both in the clinical [1] and preclinical
setting [2–5], have shown promise of T1 for detection and character-
ization of renal pathologies, including inflammation and fibrosis.
These results warrant further investigation of this relaxation parame-
ter for evaluation of renal pathology. In this chapter, we will discuss
the basic concept of T1 as well as emerging applications of this MRI
parameter for noninvasive characterization of renal pathologies.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_9, © The Author(s) 2021
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Magnetic resonance imaging (MRI) is based on the interaction of
nuclear spins with three types of magnetic fields: main field B0,
radiofrequency field B1, and linear gradient fields. MRI signal relies
on the physical properties of atoms with an odd number of protons
or neutrons, which possess a nuclear angular momentum (spin),
that gives rise to a magnetic dipole moment. Using classical physics,
the atom can be described as a charged sphere spinning about its
axis and giving rise to a current loop that creates the magnetic
dipole moment. Since MRI is concerned with the spin property of
protons and neutrons, and their interactions with a large magnetic
field, these particles will be referred to as “spins”. Most MRI
applications in biological specimens generate signal by manipulat-
ing the spin of single proton hydrogen (1H), although it is feasible
to generate MR images in biological samples from the signal of
other nuclei such as sodium [6], or hyperpolarized gases.
ω0 ¼ γ B0 ð1Þ
In the absence of a magnetic B0 field, nuclear spins are oriented
randomly. The presence of an external magnetic field (B0) will have
two effects on the spins: they will tend to align with the main
magnetic field B0, to create a net macroscopic magnetic moment
M0 in the direction of the field (the longitudinal direction, or
conventionally, the z-direction), and they will precess around the
main magnetic field at a well-defined frequency called the Larmor
frequency (Eq. 1, Fig. 1) where γ, the gyromagnetic ratio, is a
constant specific to each atom. Thus, a 1H atom in a magnetic
field of 1 tesla (T) ¼ 104 gauss will precess about the field with a
Larmor frequency of γ/2π ¼ 42.58 MHz/tesla [7, 8].
The presence of the static magnetic field B0 polarizes the sam-
ple of protons to a net magnetization M0 in the longitudinal
direction. However, polarization is not sufficient to obtain a large,
coherent MR signal for image reconstruction. To obtain the MR
signal, a radiofrequency field B1 is applied as a pulse of a few
milliseconds in the xy (transverse) plane.B1 is tuned to the resonant
Larmor frequency of the spins, so it excites the spins out of equi-
librium, tipping the M0 vector away from the z-axis by an angle
known as flip angle, which is dependent on the amplitude and
duration of the RF pulse (Fig. 2) [8]. The B1 induced rotation of
the magnetization toward the transverse plane causes the longitu-
dinal component of magnetization to decrease, and the transverse
component to increase.
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Fig. 1 B0 interacts with the nuclear magnetic moment μ, producing a torque that
causes the protons to precess around B0. (From Dwight Nishimura, “Principles of
Magnetic Resonance Imaging,” Stanford University Press, Palo Alto, CA, 2010)
Fig. 2 Nutation at Larmor frequency of the magnetization vector around the RF
pulse B1 applied in the transverse plane. (From Dwight Nishimura, “Principles of
Magnetic Resonance Imaging,” Stanford University, Palo Alto, CA 2010)
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When the RF B1 pulse is turned off, the magnetization pre-
cesses back to its equilibrium state, and the longitudinal compo-
nent recovers, while the transverse component decays. The Bloch
equation describes the behavior of the magnetization vector M,






 Mz M0ð Þk
T 1
ð2Þ
Solving the z-axis component of the Bloch equation, we obtain
an exponential expression for the recovery of Mz to the equilibrium
M0 magnetization (Eq. 3). The time constant T1 is known as the
spin-lattice or longitudinal relaxation time.






The reference standardmethod for measuringT1 is the inversion-
recovery spin echo method (IR-SE; see IR-SE signal curve in Fig. 3
top) that originated from early NMR experiments [9, 10]. It involves
inversion of the magnetization M0 by a 180
 RF pulse in the z direc-
tion, followed by a time delay known as inversion time (TI) during
which the equilibriummagnetization is allowed to decay. The TI ends
after the application of a 90 RFpulse, which tips themagnetization in
the x-y (transverse) plane for MR signal readout (receiving). A
180 pulse is then applied in the x direction, to rephase the precessing
spins in a “spin echo” occurring at a fixed echo time TE.
After a long repetition time (TR) that allows for the magneti-
zation to recover to equilibrium, the IR preparation is repeated
with different subsequent inversion times. For accurate work,
between 4 and 10 TI values should be used, although a T1 can be
calculated with as few as two TI values. TR is chosen to be much
longer than the longest expected T1 of interest in the tissue, in
order to allow the magnetization to fully recover to equilibrium.
For very accurate work this ratio TI/T1 is as high as 5 or even
7, although for in vivo work 3 is more common. Signal decay and
recovery can be observed on the images acquired with different TI’s
(Fig. 3 top), with signal nulling at TI null ¼ T1 ln 2, when the
inversion preparation pulse is exactly 180 and the TR> > T1 of
tissue. If expected T1 of the tissue is known, choosing a range of
TI’s before and after TInull allows for acquisition of enough data
points to fit the signal decay and recovery curve. Alternatively,
performing a series of preliminary IR-SE experiments allows iden-
tification of the signal nulling time in the tissue of interest (TInull),
and choice of optimal range of TI values for measuring T1.
IR-SE pulse sequences used currently in animal [2, 3] and
human imaging differ from the reference standard IR-SE experi-
ment described above by use of fast readout techniques. There are
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Fig. 3 T1 mapping examples in the kidneys of a control mouse (c57bl6) imaged on a 7 T Bruker Pharmascan.
Top: Inversion recovery experiment with a FAIR RARE pulse sequence, showing sequence of inversion times,
T1 color map and signal recovery curve: TE¼ 35.8 ms; recovery time¼ 10 s; NEX¼ 2; scan time 8 min 33 s;
21 inversion times (TI¼ 30 + n 200 ms, n¼ 0 . . . 20); nonselective inversion slice; matrix 128 100; FOV
40  30 mm; single 1 mm-thick slice. Bottom: Variable TR experiment with a RARE VTR pulse sequence,
showing 8 variable repetition times (200, 400, 800, 1500, 3000, 5000 ms), T1 color map and signal recovery
curve: TE 11 ms; NEX ¼ 1; scan time 8 min 43 s; matrix 128  96; FOV ¼ 40  30 mm; single 1 mm-thick
slice; no fat suppression; shallow breathing; no motion compensation
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various fast readout techniques that have been introduced for both
inversion and saturation recovery pulse sequences:
1. The Rapid Imaging with Refocused Echoes (RARE) readout,
also called fast or turbo spin-echo readout by clinical scanner
manufacturers, uses several 180 refocusing pulses within the
same TR to create an echo train. Within the echo train, each
180 pulse induces a refocused echo, comprising spin-echo and
stimulated echo contributions, which is digitized, and each
echo is acquired with a different phase encoding gradient, so
that multiple lines of k-space (multiple phase encoding steps)
can be acquired within the same TR. The number of 180
pulses is called the echo train length (ETL) or RARE factor: a
typical value is 8.
2. Echo planar imaging (EPI) uses a single RF preparation (in the
case of IR, 180-TI-90) and then acquire multiple gradient
echoes by combining a high amplitude bipolar oscillating fre-
quency encoding gradient with a low amplitude monopolar blip
phase encoding gradient. This approach permits fast acquisition
of k-space data in a single shot (all lines of k-space in the 2Dplane
are acquired for each RF preparation), or a few multiple shots
(groups of k-space lines are acquired for each RF preparation).
3. A derivative of the IR methods, the Look–Locker inversion
recovery (LL-IR) method, samples the magnetization recovery
using rapid, small flip angle imaging readouts. More details and
caveats on data acquisition and analysis with this method can be
found in the chapters by Garteiser P et al. “Experimental Pro-
tocols for MRI Mapping of Renal T1” and “Analysis Protocols
for MRI Mapping of Renal T1.” In addition to EPI, LL-IR
pulse sequences can employ other readout methods:
l Fast low angle shots (FLASH) tips the magnetization to the
transverse xy plane during the recovery period by a small
angle, in order to sample it. Magnetization is spoiled before
subsequent RF pulses. This readout method has the advan-
tage of a short TR (~3 ms) that is compatible with low flip
angles (<10) [11]. As such, the longitudinal regrowth of
the magnetization is perturbed only to a small extent. Use of
a FLASH readout requires fitting the data with a modified
version of the IR-SE equation, the Look–Locker equation
(chapter by Garteiser P et al. “Analysis Protocols for MRI
Mapping of Renal T1”). FLASH can also be used in T1
mapping methods that do not employ an inversion pulse,
like variable flip angle (see next section).
l Balanced readouts such as steady-state free precession
(SSFP) can also be used, as they tend to yield higher signal
to noise due to the reuse of magnetization from preceding
shots [12]. Use of these types of readouts also requires
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fitting the data with a Look–Locker equation or more com-
plex equations that take into account the dependence of
signal on both T1 and T2 decay. Details on acquisition and
analysis with pulse sequences using an SSFP or FISP readout
method can be found in the chapters by Garteiser P et al.
“Experimental Protocols for MRI Mapping of Renal T1”
and “Analysis Protocols for MRI Mapping of Renal T1.”
2.2 Overview of T1
Mapping Techniques
The longitudinal relaxation time T1 can be measured by a variety of
methods [13, 14]. The multiple delay inversion-recovery
(IR) method can measure T1 with high accuracy, however, it has
long acquisition times (10–15 min with current EPI readouts
[2, 3]), which makes it impractical for in vivo settings. There are
several methods that have been developed for faster T1 measure-
ment: the saturation recovery or variable TR (VTR) method, the
variable flip angle (VFA), the Look–Locker modified IR, and the
proton density (PD) method. Comprehensive description of the
most common pulse sequence implementations for each T1 mea-
surement method, acquisition protocols and corresponding analy-
sis workflows for preclinical and clithe chapters by Garteiser P et al.
“Experimental Protocols for MRI Mapping of Renal T1” and
“Analysis Protocols for MRI Mapping of Renal T1.”
2.2.1 The Saturation
Recovery or VTR Method
The saturation recovery or variable TR (VTR) method, in which
T1-weighted signal is acquired with multiple TR values (Fig. 3b)
shares the same limitations of limited spatial coverage and resolu-
tion as the IR method but allows shorter overall scan times
[15]. The magnetization is tipped 90 (from the z to the xy
plane) and the recovery is usually sampled by a RARE readout
over several repetition times TR of different durations (Fig. 3b).
2.2.2 The VFA Method In variable flip angle (VFA) methods [14–17], the RF flip angle is
varied while keeping the TR constant in a 2D or 3D spoiled
gradient echo (SPGR) acquisition. VFA is particularly useful in
dynamic contrast-enhanced MRI (DCE-MRI) experiments, as
VFA measurements allow for voxel-based baseline (precontrast
enhancement) T1 mapping with the same spatial resolution and
coverage as the DCE-MRI scan in a short amount of time.
2.2.3 The Look–Locker
Modified IR Method
The Look–Locker modified IR [18–21], decreases the acquisition
time by sampling the signal recovery curve multiple times per TR
after application of several low flip angle pulses during the acquisi-
tion. Despite shortened acquisition time, Look–Locker IR meth-
ods are still limited in spatial coverage.
2.2.4 The PD Method In the proton density (PD) approach [22], T1 is derived by com-
paring PD-weighted images with DCE baseline (precontrast)
images acquired with an SPGR pulse sequence. More information
on the use of T1 for quantitative DCE-MRI measurements can be
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found in the chapters by Li L-P et al. “MRI Mapping of the Blood
Oxygenation Sensitive Parameter T2* in the Kidney: Basic Con-
cept”; by Chuang K-H et al. “Renal Blood Flow Using Arterial
Spin Labeling (ASL) MRI: Experimental Protocol and Principles”;
and by Grist JT et al. “Analysis Protocol for Renal Sodium (23Na)
MR Imaging,” which cover the basic concept, experimental proto-
cols, and analysis techniques of DCE-MRI, respectively.
2.2.5 MR Fingerprinting Next to conventional T1 mapping techniques, T1 can also be
extracted from magnetic resonance fingerprinting techniques, a
novel MRI method that uses a pseudorandomized acquisition
scheme to generate unique signal evolutions (or “fingerprints”)
for each tissue voxel dependent on the relaxation parameters [23].
3 Overview of Applications on Preclinical and Clinical MR Instruments
T1 differs between different kidney components (cortex, medulla,
urine, etc.); it decreases when paramagnetic contrast agents such as
gadolinium chelates or oxygen (O2) are present, and it may increase
or decrease with pathology. In addition T1 tends to increase with
B0, an important consideration since animal studies have been
performed over more than an order of magnitude range in B0.
The sensitivity of T1 to the tissue microenvironment has been
employed quite extensively to assess renal structure and function,
both in clinical and preclinical studies. A comprehensive review of
clinical T1 (and T2) applications in the kidney can be found here
[24]. The use of T1 for noninvasive assessment of renal pathology in
preclinical models has already been explored in the 1980s, showing
that various effects including ischemia, tubular obstruction and
renal congestion may attribute to T1 differences in rat models of
acute and chronic renal failure [25, 26]. T1 values can be affected by
a wide variety of changes in the tissue environment, including
inflammation and fibrosis. Inflammation can coexist with fibrosis
in the kidney tissue [27], for example during rejection of trans-
planted kidneys. While clinical MRI studies are valuable for, for
example, the grading of renal fibrosis in patients, preclinical studies
with well-established animal models have the advantage of the pos-
sibility to assess dynamic changes in T1 after the onset of pathology.
Hueper et al. performed longitudinal T1 measurements on a
7 Tesla dedicated animal MR scanner in mice after transient unilat-
eral clamping of the renal pedicle, causing moderate or severe acute
kidney injury (AKI) dependent on the ischemia time [3]. T1 values
were significantly elevated after AKI, with a peak at 7 days after the
ischemic event. In mice with severe AKI, the T1 elevation persisted
until at least a month after surgery. The initial peak in T1 values is
likely attributed to increased water content due to an acute
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inflammation response. The persisting T1 increase in severe AKI
may at least partly be explained by development of fibrosis due to
inadequate renal tissue regeneration and incomplete tubular repair.
In a follow-up study, changes in T1 (and arterial spin labeling
perfusion parameters) after AKI was assessed in two mouse strains
(C57BL/6 and 129/Sv) to investigate potential effects of different
genetic backgrounds on the experimental study [5]. Overall, similar
trends of increased T1 were found in both animal models, except for
a significantly higher T1 increase in the cortex and outer stripe of
the outer medulla (OSOM) of the 129/Sv vs. C57BL/6 mice at
day 1 after moderate AKI and higher relative T1 values in the cortex
and lower relative T1 values in the inner stripe of the outer medulla
(ISOM) at day 7 after severe AKI in 129/Sv mice (Fig. 4) The same
research team also assessed multiparametric MRI parameters,
including T1, in mouse models of allogenic and isogenic renal
Fig. 4 T1 maps after 45 min ischemia reperfusion injury (IRI) for 129/Sv (upper row) and C57BL/6 mice (lower
row) at day 1, day 7 and day 28 are shown. In T1 maps spatial differences can be measured by placing ROIs in
the cortex and the outer stripe (OSOM) and inner stripe (ISOM) of the outer medulla, which is illustrated in the
contralateral normal kidney. After severe acute kidney injury, differences of T1-values between the two mouse
strains were most pronounced on day 7: this example shows higher T1-values in the ISOM and lower T1-values
in the renal cortex of C57BL/6 compared to 129/Sv mice. (Adapted from Tewes et al., “Functional MRI for
characterization of renal perfusion impairment and edema formation due to acute kidney injury in different
mouse strains” PloS One)
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transplantation [2]. Acute allograft rejection was observed in allo-
genic kidney transplants. T1 was significantly elevated in
allogenic vs. isogenic allografts. Histopathological evaluation
showed signification strong correlations of T1 with presence of
macrophages, T-cells and fibrosis (correlation coefficient r range
0.78–0.91, P < 0.01). These studies show that kidney T1 is sensi-
tive to several pathophysiological processes, including inflamma-
tion and fibrosis, which may occur simultaneously in events of
kidney injury and rejection.
The findings of the group of Hueper et al. have also been
observed by other research groups in independent studies. Jiang
et al. employed longitudinal multiparametric MRI, including T1 for
evaluation of folic acid-induced AKI in mice [4]. The experiments
were performed at a 16.4 T dedicated animal MR system (Bruker).
T1 was found to increase in both the renal cortex and medulla, most
prominently at 2 weeks after treatment, while T1 tended to regress
at 4 weeks after treatment. Histopathological evaluation showed
increased fluid content and association of tubular dilation at
2 weeks after treatment, explaining the T1 elevation.
While dedicated preclinical MRI systems are highly suitable for
high-resolution imaging of kidneys in small animals, clinical sys-
tems could also be used for preclinical renal T1 studies. Ko et al.
performed a longitudinal multiparametric MRI study after severe
bilateral ischemic-reperfusion AKI in rat kidneys on a clinical 3 T
MR scanner [28]. T1 values were elevated in both the cortex and
medulla after AKI, similar as reported in previous studies. No
significant correlations of T1 with histopathological evaluation of
different markers including macrophages and collagen deposition
were observed, possibly owing to complex pathological changes
after AKI and multiple factors attributing to the T1 changes. Hu
et al. found significant positive correlations of T1 with histological
expression of Masson’s trichrome (collagen) and alpha-smooth
muscle actin in a multiparametric MRI study in a rat model of
unilateral ureteral obstruction performed on a clinical 3 T MRI
system [29]. Friedli et al. also found significant correlations of T1
with histopathological inflammation and fibrosis in a rat model of
unilateral ureteral obstruction. The latter study was performed on a
3 T MR system [20].
Gao et al. have reported feasibility of MR fingerprinting for
imaging of healthy mouse kidneys on a preclinical 7 T MR system,
showing inherent resistance of the MR fingerprinting technique to
respiratory motion artifacts [30].
T1 may also be used as baseline measurement for DCE-MRI
acquisitions. More information on the use of T1 for quantitative
DCE-MRI measurements can be found in the chapters by Pedersen
M et al. “Dynamic Contrast Enhancement (DCE) MRI–Derived
Renal Perfusion and Filtration: Basic Concepts”; by Irrera P et al.
“Dynamic Contrast Enhanced (DCE) MRI-Derived Renal
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Perfusion and Filtration: Experimental Protocol”; and by Zöllner
FG et al. “Analysis Protocol for Dynamic Contrast Enhanced
(DCE) MRI of Renal Perfusion and Filtration,” which cover the
basic concept, experimental protocols, and analysis techniques of
DCE-MRI, respectively.
In summary, several studies have demonstrated suitability of T1
for assessment of renal pathology in preclinical models. These
promising results warrant further investigation of this MRI relaxa-
tion technique both in the preclinical and clinical settings.
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Chapter 10
MRI Mapping of the Blood Oxygenation Sensitive Parameter
T2* in the Kidney: Basic Concept
Lu-Ping Li, Bradley Hack, Erdmann Seeliger, and Pottumarthi V. Prasad
Abstract
The role of hypoxia in renal disease and injury has long been suggested but much work still remains,
especially as it relates to human translation. Invasive pO2 probes are feasible in animal models but not for
human use. In addition, they only provide localized measurements. Histological methods can identify
hypoxic tissue and provide a spatial distribution, but are invasive and allow only one-time point. Blood
oxygenation level dependent (BOLD) MRI is a noninvasive method that can monitor relative oxygen
availability across the kidney. It is based on the inherent differences in magnetic properties of
oxygenated vs. deoxygenated hemoglobin. Presence of deoxyhemoglobin enhances the spin–spin relaxa-
tion rate measured using a gradient echo sequence, known as R2* (¼ 1/T2*). While the key interest of
BOLD MRI is in the application to humans, use in preclinical models is necessary primarily to validate the
measurement against invasive methods, to better understand physiology and pathophysiology, and to
evaluate novel interventions. Application of MRI acquisitions in preclinical settings involves several chal-
lenges both in terms of logistics and data acquisition. This section will introduce the concept of BOLDMRI
and provide some illustrative applications. The following sections will discuss the technical issues associated
with data acquisition and analysis.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by two separate chapters describing the experimental procedure and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Blood oxygenation level depen-
dent (BOLD) MRI, Hypoxia
1 Introduction
All organs exist in a state of dynamically balanced oxygen supply as
determined by blood flow and arterial oxygen content and demand
as determined by metabolism. Yet renal hemodynamics and oxyge-
nation offer a number of striking differences vs. nonrenal tissues.
Most organs extract approximately 45% of available oxygen (i.e.,
difference between arterial and venous blood) while the kidney only
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_10, © The Author(s) 2021
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extracts 10–15% of available oxygen. This is in part because, on a
per gram basis, whole-kidney blood flow is higher than that of most
other tissues. The kidneys while receiving 20–25% of cardiac output
under resting conditions, only consume about 7% of the body’s
total oxygen. The major determinant of renal O2 consumption is
energy-dependent tubular sodium reabsorption. Whereas O2 con-
sumption determines perfusion in nonrenal tissues, renal O2 con-
sumption is largely determined by perfusion. Increased renal blood
flow is, in general, accompanied by increased glomerular filtration
rate, and therefore necessitates increased energy-dependent tubular
sodium reabsorption. Another particularity is the highly heteroge-
neous blood perfusion and oxygenation within the kidney. Virtually
all of the blood flowing into the kidney perfuses the cortex. The
medulla is perfused by a small fraction (about 10% of total renal
blood flow) of blood that had traversed the cortex. In accordance,
tissue partial pressure of oxygen (pO2) is very low in the medulla.
Three additional mechanisms substantially contribute to low renal
tissue pO2. (a) The particular architecture of the intrarenal vascula-
ture enables shunt diffusion of O2 from arteries to veins in the
cortex as well as from descending to ascending vasa recta in the
medulla. (b) The vascular architecture also promotes differential
distribution of erythrocytes and plasma at certain vessel branches
(plasma skimming), which results in different hematocrit and O2
content of blood perfusing the daughter vessels. (c) The Fåhræus–
Lindqvist effect lowers the hematocrit in the long and narrow vasa
recta supplying the medulla, which lowers the O2 content of blood
perfusing the medulla. At the same time, a rather high metabolic
rate and thus O2 demand is required to support active reabsorption
of sodium along medullary thick ascending limbs of Henle’s loop
(mTAL) [1]. For a comprehensive description of the causes and the
degree of the heterogeneity of intrarenal perfusion and oxygena-
tion see the chapter by Cantow K et al. “Quantitative Assessment of
Renal Perfusion and Oxygenation by Invasive Probes: Basic
Concepts.”
Given these particularities in renal oxygenation, there is an
interest in understanding the physiological mechanisms involved
in maintaining the oxygenation status within the medulla in health
and how they may be affected in disease. Acute changes to intrar-
enal O2 can be caused by both changes in O2 supply due to changes
in arterial O2 content or perfusion, changes in O2 consumption, or
a combination of the two. For example, nitric oxide (NO) regulates
blood supply by relaxing smooth muscle tension of resistance ves-
sels and inhibitors of NO formation such as L-NAME reduce renal
blood flow. The resulting reduction in renal O2 supply decreases
renal tissue oxygenation as evaluated by BOLD-MRI [2]. Alterna-
tively, loop diuretics like furosemide block the sodium–potassium–
chloride transporter in the mTAL. Inhibiting this secondary active
transport decreases the load of the primary active sodium–
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potassium pump (Na+/K+ ATPase) in the mTAL. The ensuing
decrease in O2-dependent sodium reabsorption results in an
increase in outer medullary pO2. Thus, administration of furose-
mide is most commonly used both as a validation of the measure-
ments [3, 4] and as a tubular functional paradigm in the clinic [5];
for detailed discussion of the pros and cons see the chapter by
Cantow K et al. “Reversible (Patho)Physiologically Relevant Test
Interventions: Rationale and Examples.” Early work using atrial
natriuretic peptide (ANP), which was expected to cause some
increase in blood flow, caused a significant decrease in both cortical
and medullary O2 due to the net increase in O2 consumption
related to sodium transport [6]. This illustrates the distinction
between monitoring oxygenation vs. perfusion or blood flow and
is especially relevant in the kidney.
In the setting of kidney disease, deregulation of O2 balance has
long been studied. A recent review [7] of gene responses in six
different models of acute kidney injury (gram-negative sepsis,
gram-positive sepsis, ischemia reperfusion, malignant hyperten-
sion, rhabdomyolysis, and cisplatin nephrotoxicity) found that hyp-
oxia along with oxidative stress and inflammation was the common
feature of all the disease models. These acute injuries may lead to
tubule cell death by apoptosis or necrosis and injured cells fre-
quently dedifferentiated into fibroblasts. This fibrosis can lead to
tubular atrophy and reduction in function, forcing the remaining
tubules to use more oxygen which can cause further injury [7].
Understanding the relationship between renal oxygenation and
kidney disease was predominantly based on data obtained from
preclinical models with tissue pO2 measurements using invasive
microprobes [3, 6, 8]. These probes were inserted in the kidney
to provide local and acute pO2 readings. Probe position is critical
and can be difficult to maintain in small animals. Alternately, pimo-
nidazole [9] can be used to stain tissue at severe hypoxia. This
histological staining method only captures hypoxia present at the
moment of tissue sampling. For detailed discussion of the advan-
tages and disadvantages of these methods see the chapter by Cantow
K et al. “Quantitative Assessment of Renal Perfusion and Oxygena-
tion by Invasive Probes: Basic Concepts.” BOLD MRI is a nonin-
vasive imaging technique that can be used to estimate the relative
oxygen availability in tissue. It offers both spatial information
(at reduced spatial resolution compared to histology) and temporal
resolution (typically lower than microprobes). Figure 1 illustrates
the similarity and differences between histological, microprobe,
and BOLD-MRI measurements. BOLD MRI allows for longitudi-
nal follow-up because of its noninvasive nature.
In this chapter, we will provide an overview of BOLD MRI
including the basic concept involved, and a few illustrative applica-
tions of renal BOLD MRI in rodents.
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This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)





BOLD MRI technique uses deoxyhemoglobin (deoxyHb) as an
intrinsic (or endogenous) contrast mechanism. Hemoglobin
(Hb) is the primary vehicle for transporting O2 in the blood.











































Fig. 1 (a) [10] A slice of rat kidney histologically stained for pimonidazole, showing the corticomedullary
differences. Higher staining in the medulla is related to the increased hypoxia. This method can capture the
spatial distribution of severe hypoxia within the kidney at the time of tissue sampling. (Reproduced from Zhong Z
et al., Am. J. Physiol. 275 (Renal Physiol. 44): F595–F604, 1998 with permission from American Physiological
Society). (b) [3] pO2 microelectrode data showing the temporal changes in renal medullary pO2 in a rat kidney
and illustrates the increase in pO2 following administration of furosemide. (Reproduced from Brezis M et al.,
Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F1059–F1062, 1994 with permission from American
Physiological Society). (c) [11] A representative slice of R2* map in a rat kidney showing corticomedullary
differences, even though the contrast is opposite compared to (a). The spatial resolution is also obviously lower
compared to (a). (d) [11] Shows the changes in R2* in the outer medulla and cortex after injection of furosemide.
The first two points for both curves are baseline (preinjection). Both medullary and cortical R2* drop after the
injection of furosemide and stay relatively constant over the 20-min period of observation. Error bars represent
standard deviation in the individual ROI measurements. This figure illustrates the merits of BOLD MRI in terms of
providing both spatial and temporal information of pO2 changes in kidneys. (Reproduced from Prasad PV et al.,
J. Magn. Reson. Imaging 1999; 9:842–846 with permission from John Wiley & Sons)
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which is diamagnetic. When O2 is released from Hb, it becomes
deoxyhemoglobin (deoxyHb) which behaves as a paramagnet
[12]. Since Hb is compartmentalized to the vascular system, the
presence of deoxyHb creates local magnetic susceptibility gradients
in and around blood vessels. This induces spin-dephasing so that
the effective spin–spin relaxation decay of the MR signal governed
by the relaxation time T2* will be shortened when the local
Fig. 2 [13]: Blood oxygenation level-dependent (BOLD) MRI changes qualitatively
with pO2. The deoxygenation of hemoglobin changes its magnetic
characteristics, leading to changes in a parameter of magnetic resonance
called R2* (apparent spin–spin relaxation rate). R2* can be estimated from
signal intensity measurements made at several different echo times (a–e). The
slope of Ln (intensity) vs. echo time determines R2* and is directly related to the
amount of deoxygenated blood. A decrease in the slope implies an increase in
the pO2 of blood. We can either measure the slope or obtain intensity
measurements at a single echo time (e.g., d) to detect a difference in pO2.
Because blood pO2 is thought to be in rapid equilibrium with tissue pO2, changes
in BOLD signal intensity or R2* should reflect changes in the pO2 of the tissue.
(Reproduced from Prasad PV et al., Circulation. 1996 Dec 15; 94: 3271–5 with
permission from American Heart Association)
Fig. 3 [14]: Link between tissue pO2 and T2* (or R2*), together with the potentially confounding factors
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deoxyHb concentration is increased. This results in signal loss in
T2*-weighted imaging (e.g., gradient echo (GRE) imaging) in
areas of increased deoxyHb concentration. The BOLD signal is
quantitatively measured by either the effective relaxation time T2*
(s) OR relaxation rateR2* (¼ 1/T2* and expressed in s1). T2* and
R2* can be calculated based on GRE data acquired at different echo
times (TE) and determining the slope of Ln (signal intensity) vs. TE
(Fig. 2). With the assumption that hematocrit and local blood
volume fraction remain unchanged (in fact, they might vary signifi-
cantly), a decrease of R2* corresponds to an increase of O2 satura-
tion of Hb and, assuming an unchanged oxyHb dissociation curve,
in blood pO2. Under “perfect” physiological conditions the pO2 of
capillary blood is thought to be in equilibrium with the surround-
ing tissue, and changes in observed R2* could be interpreted as an
indicator of changes in tissue pO2. In many (patho)physiological
scenarios however, the link between R2* (T2*), O2 saturation of
Hb, and tissue pO2 is confounded by changes in various factors,
which are illustrated in Fig. 3 and detailed in Subheading 2.3 [14].
The ratio of oxyHb to deoxyHb (which is the major determi-
nant of % O2 saturation of Hb under physiological conditions) is
related to the pO2 of blood and is governed by the oxyHb dissoci-
ation curve [15]. The renal medullary pO2 is in the lower range of
the curve. Hence a change in pO2 will result in relatively larger
change in the ratio of oxyHb to deoxyHb compared to a similar
change in pO2 of cortex. This makes BOLD MRI sensitive for








Two MR imaging techniques are used for renal BOLD MRI,
namely, single shot echo planar imaging (EPI) [13] and multiple
gradient echo (mGRE) sequences [4]. Functional imaging of the
human brain predominantly uses single shot EPI due to the need
for high temporal resolution and/or signal averaging. The ultrafast
nature of EPI makes it ideal for abdominal imaging to freeze
motion. It is suitable for applications with rapid changes in oxyge-
nation and whereR2* mapping is not necessary [16]. However, it is
highly sensitive to bulk magnetic susceptibility artifacts which
results in image blurring, geometrical distortion, signal loss, and
limited spatial resolution. The image distortion is amplified in
regions with poor magnetic field homogeneity such as in the vicin-
ity of bowels filled with gas. It is hardly used in preclinical setting,
especially when using high field strength MR scanners.
mGRE sequence is currently the most widely utilized acquisi-
tion method both for human [4] and preclinical [11] applications
of renal BOLDMRI. It acquires signals at multiple echo times after
each excitation pulse.R2* calculated as the slope of the straight line
fitting of Ln(SI) vs. TE or by fitting the SI vs. TE data to a single
decay monoexponential function. mGRE acquisitions provide
improved SNR (signal-to-noise ratio), spatial resolution, and
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image quality compared to single shot EPI method. However,
longer echo times with mGRE sequence also suffer from bulk
susceptibility artifacts. In preclinical setting, motion artifacts are
usually minimized using multiple averages. mGRE can suffer from
phase variations between odd and even echoes when both water
and fat components are present in renal tissue. Choice of echo times
corresponding to in-phase or out-of-phase can minimize such arti-





R2* inherently depends on many parameters, primarily including
R2 the natural spin–spin relaxation rate and a susceptibility
weighted component termed R2
0 (R2* ¼ R2 + R20). R20 is deter-
mined by the susceptibility component. In the context of BOLD
MRI, it depends on the amount of deoxyHb present within the
voxel which is determined by the combination of fractional blood
volume (fraction of the voxel occupied by blood), hematocrit, and
O2 saturation of hemoglobin.
The factors confounding the relationship betweenR2*(or T2*)
and intrarenal blood pO2 are listed in Table 1.
BOLD MRI is inherently best suited to monitor changes in
regional pO2 which is assumed to be in a dynamic equilibrium with
O2 saturation of Hb. This inherently assumes that there are no
concomitant changes in fractional blood volume, the oxyHb disso-
ciation curve, and hematocrit. While this may be valid with certain
pharmacological maneuvers, one or more of these confounders will
change in various acute scenarios. Any vasodilation or vasoconstric-
tion, either induced by pharmacologic maneuvers or by endoge-
nous control of renal vessels, alters the blood volume fraction.
Besides the vasculature, the interstitial and the tubular compart-
ments can also experience rapid volume changes and, given the
rather rigid renal capsule, can therefore modulate the blood volume
fraction. The tubular volume fraction is a unique feature of the
kidney; it is quite large and can rapidly change due to (a) changes in
glomerular filtration, (b) alterations in tubular outflow toward the
pelvis, (c) modulation of the transmural pressure gradient, and
(d) changes in resorption. This is partly the motivation to establish
R2* vs. tissue pO2 calibration relationship. However, such calibra-
tion is strictly valid only in the model it was established in, for
example, healthy animals and cannot be generalized to disease
models and other species including humans. Mathematical analyti-
cal methods can be used to model the relationship betweenR2
0 and
O2 saturation of Hb [17, 18]. However, these will require knowl-
edge of fractional blood volume and regional hematocrit for the
individual kidney. In kidneys, it is known that hematocrit is lower in
the inner medulla [19]. This explains why inner medulla in rodents
usually have low R2* values (typically lower than the cortex and
erroneously indicating more availability of oxygen). Fractional
blood volume is inherently an imaging specific concept and so
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there is very little literature on its measurement. The ideal method
to estimate fractional blood volume is by using an intravascular
contrast agent such as ultrasmall paramagnetic iron oxide
(USPIO) [20, 21]. Oxygen saturation of Hb is related to the pO2
of blood by the oxyHb dissociation curve which is influenced by
factors such as pH, pCO2, and temperature. Further the inherent
assumption that blood pO2 is in a dynamic equilibrium with sur-
rounding tissue pO2 may not hold in disease [22]. These limita-
tions of BOLD MRI need to be taken in to account when
interpreting experimental findings as illustrated recently [14]. In
order to study the detailed link between renal tissue pO2 and T2*
in vivo, an integrated approach that combines parametric MRI and
quantitative physiological measurements (MR-PHYSIOL) was pro-
posed [23]. The MR-PHYSIOL setup was used to study the rela-
tionship between renal T2* and tissue pO2 and perfusion in rats.
The findings indicate that changes in T2* qualitatively reflect
changes in renal tissue pO2 induced by maneuvers including hyper-
oxia, suprarenal aortic occlusion, and hypoxia. Yet a closer exami-
nation of the quantitative relationships between relative changes in
T2* and in tissue pO2 revealed discrepancies, indicating that, due to
the differential changes in one or more of the confounders, simple
translation of quantitative results obtained for one intervention of
renal hemodynamics and oxygenation to another intervention is
falling short of being appropriate. Also, taking the perfusion and
oxygenation heterogeneity among the kidney layer into account,
extrapolation of results obtained for one layer to others must be
made with due caution [24].
2.3.1 R2
0 Measurement Given the specific interest in the susceptibility component of spin–
spin relaxation rate for BOLDMRI, measurement ofR2
0 is desired.
While there has been some effort in directly estimating R2
0 using
Table 1
Factors confounding the relationship between R2*(or T2*), oxygen saturation of hemoglobin, and
blood pO2
Confounding factor Direction of effect Examples scenarios
Blood volume fraction Positive Vasodilation/constriction,
change in tubular volume fraction
Hematocrit Positive Plasma skimming, hemodilution
Oxygen–hemoglobin dissociation curve Changes in pH, pCO2, or temperature
Magnetic field (B0) inhomogeneity Positive Bowel gas, poor shim
T2 Positive Edema
A “positive” direction of the effect means that an increase in the confounding factor leads to an increase in R2* (decrease
in T2*) and hence an overestimation of the hypoxia
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asymmetric spin-echo sequences [25], a simpler and practical
method may be to perform a gradient echo and spin echo measure-
ment to estimate R2* and R2 separately then calculate the differ-
ence [26]. Since R2 can independently vary with certain
pharmacological maneuvers (e.g., following L-NAME [21]),
using R2
0 as the BOLD MRI parameter may be more specific to
the oxygenation related changes. A recent study illustrated the
feasibility of using R2
0 measurements to estimate blood oxygena-
tion in rat kidneys [17]. WhileR2 is not directly sensitive to BOLD
effects, there is actually an indirect dependence due to diffusion
effects of spins experiencing the field gradients generated by the
presence of deoxyHb in the microvasculature. In this regard,R2 has
been shown to be more specific to small vessels [27], while R2* is




l Bowel gas can create susceptibility artifacts in renal R2* map,
right lateral position helps minimize susceptibility artifacts from
bowel gas.
l Respiratory motion could create artifacts and usually multiple
measurements for averaging purposes can be used to minimize
these. Alternately, respiratory triggering could be used but may
increase the acquisition times.
l Studies indicate the choice of anesthesia has a large influence on
renal R2* [28]. This may be partly due to known effects of
anesthesia on respiration, temperature, blood pressure, and
hence pO2.
3 Overview of Preclinical Applications
Noninvasive BOLD MRI is primarily attractive for the use in
humans. However, there is a need for preclinical applications of
the method primarily to validate the technique against invasive
measures and better understand changes in different diseases.
Validation of renal BOLDMRI measurements is mostly carried
out by comparing the responses to certain (patho)physiologically
relevant test interventions or pharmacological maneuvers against
pO2 measurements using invasive microprobes [2, 29]. BOLD data
was compared with pimonidazole staining in 10-week-old mice
[30]. Interestingly, pimonidazole staining did not show differences
between db/db and db/mmice, even though BOLDMRI showed
significant differences (Fig. 4). This is probably related to the fact
that pimonidazole detects severe hypoxia, typically
pO2 < 10 mmHg. There was one study in swine where the invasive
probe was placed in the contralateral kidney compared to the one
where BOLD MRI measurements were made [31]. This study










































Fig. 4 [30]: (a) Pimonidazole immunohistochemical staining of the kidney of db/m and db/db mouse
(magnification 100). Strong pimonidazole (brown) staining of renal tubules was observed mainly in the
outer medulla (single arrows) both from db/m and db/db mouse. Weaker staining was seen in the cortex of
both db/db and db/m mice (double arrows). (b) A summary of R2* values obtained by BOLD MRI in the medulla
and cortex of 10-week-old db/db and db/m mice (upper panel). R2* is higher in medulla than cortex in both
db/db and db/m reflecting lower oxygenation in the medulla. The asterisk denotes a significant difference in
R2* between db/db and db/m in both cortex (P < 0.04) and medulla (P < 0.001). The lower panel shows the
pimonidazole staining score for db/db and db/m mice of similar age (10 weeks old). The medulla had stronger
staining than the cortex in both db/db and db/m reflecting increased hypoxia. No significant differences were
found in the pimonidazole staining of the medulla and cortex between db/db and the db/m mice. The lack of
significance with pimonidazole may be partly related to the fact that it is only sensitive to severe hypoxia, that
is, pO2 < 10 mmHg. (Reproduced from Prasad PV et al., Invest Radiol 2010; 45: 819–822 with permission
from Wolters Kluwers Health Inc.)
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proposed the use of R2* vs. pO2 as a calibration curve for translat-
ing BOLDMRI measurements in to pO2 estimates. More recently,
true simultaneous measurements with both BOLD MRI and inva-
sive probes were demonstrated in rats [23]. Interventions such as
hypoxia, hyperoxia, and suprarenal aortic occlusion were studied by
use of this MR-PHYSIOL setup [24]. Use of high field small animal
scanners is ideal for rodent applications in terms of signal-to-noise
ratios. However, renal BOLD MRI can also be effectively con-
ducted in rats using whole body scanners at both 1.5 [11] and
3 T [32] routinely used in humans which have more widespread
availability. Renal BOLD MRI in mice has been shown to be
feasible at 3 T using a custom surface radiofrequency loop coil for
signal reception [30, 33].
Early application of renal BOLDMRI was primarily to evaluate
acute effects of physiological or pharmacological maneuvers.
Administration of furosemide increased medullary oxygenation
predominantly due to reduction in O2 consumption [3, 6]. Given
the role of NO in essential hypertension, we have also observed
differential response to administration of L-NAME in healthy rats
compared to spontaneously hypertensive rats (SHR) [34]. Because
the reduced NO availability in SHR is related to oxidative stress, we
also observed a differential response to free radical scavenger (tem-
pol) in SHR rats compared to controls [35].
3.1 Application
to Disease Models
Acute kidney injury (AKI) is a sudden episode of kidney failure or
kidney damage that happens within a few hours or a few days of an
insult such as administration of nephrotoxins. AKI is common in
patients who are hospitalized, patients who have underlying kidney
disease, and especially in older adults. Medullary hypoxic injury
plays a major role in the pathogenesis of AKI [7], as has been
studied by both invasive probes and BOLD MRI in rat models of
X-ray contrast induced AKI and renal ischemia/reperfusion injury
[36–38].
Given the role of endothelial dysfunction in the susceptibility to
contrast induced AKI, we have studied the additive effects of
L-NAME, indomethacin (prostaglandin inhibitor) followed by
iodinated radio-contrast medium iothalamate (Fig. 5) [32]. Using
this AKI model, we compared the effects of different contrast media
based on different physicochemical properties, observed large
increases in R2* in the inner-stripe of outer medulla [39]. In a
similar model, we evaluated potential preventative maneuvers such
as preadministration of furosemide or N-acetylcysteine (NAC, an
antioxidant). We found that furosemide was effective in abolishing
the increase in R2* post-radiocontrast [40]. These observations
matched with a decrease in urinary neutrophil gelatinase associated
lipocalin (NGAL) measurements, a marker of tubular injury.
Unilateral ureteral obstruction (UUO) is a commonly used
model of renal fibrosis [41]. However, permanent ligation of ureter
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results in complete loss of renal parenchyma within couple of
weeks. A reversible unilateral ureteral obstruction (rUUO) was
proposed as a more representative model of chronic kidney disease
(CKD) [42]. In rUUOmodel, the microvascular clip used to ligate
the ureter is moved distally every 2 days for 6 days and then
removed. BOLD MRI was used to monitor the longitudinal
changes at 2 and 28 days following reversal of the UUO
[43]. This application is an illustration of the advantage of a nonin-
vasive imaging method in performing longitudinal studies within
the same animal.
Fig. 5 [32]: Averaged (mean  SE) renal R2* time course from six rats in renal medulla and cortex following
the administration of L-NAME, indomethacin, and radio-contrast iodixanol. The vertical lines indicate the time
of administration of each of chemicals. Pre: baseline; l-name: L-NAME; indo: indomethacin. Error bars
represent standard error among rats. On the top are R2* maps generated using custom Matlab (Mathworks,
Natick, MA, USA) code in one representative rat. The relative brightness in renal outer medulla suggests low
oxygenation level compared to cortex. The window settings were the same in all maps. The brightness in renal
outer medulla increases gradually after each chemical, suggesting the progressively decreasing of oxygena-
tion. The R2* maps are from baseline, following administration of L-NAME, indomethacin, and iodixanol. The
arrows show the renal outer medulla and cortex where the ROIs were placed. The renal outer medulla is
relatively brighter than renal cortex in baseline R2* map, suggesting lower oxygenation level there. Each
chemical contributes to the additional increased brightness in R2* maps in the renal outer medulla, suggesting
progressive hypoxia in the renal outer medulla. Bottom: shows the corresponding plot of R2* vs. time.
(Reproduced from Prasad PV et al., J. Magn. Reson. Imaging 2012; 36:1162–1167 with permission from
John Wiley & Sons)
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Chapter 11
Renal Diffusion-Weighted Imaging (DWI) for Apparent
Diffusion Coefficient (ADC), Intravoxel Incoherent Motion
(IVIM), and Diffusion Tensor Imaging (DTI): Basic Concepts
Neil Peter Jerome, Anna Caroli, and Alexandra Ljimani
Abstract
The specialized function of the kidney is reflected in its unique structure, characterized by juxtaposition of
disorganized and ordered elements, including renal glomerula, capillaries, and tubules. The key role of the
kidney in blood filtration, and changes in filtration rate and blood flow associated with pathological
conditions, make it possible to investigate kidney function using the motion of water molecules in renal
tissue. Diffusion-weighted imaging (DWI) is a versatile modality that sensitizes observable signal to water
motion, and can inform on the complexity of the tissue microstructure. Several DWI acquisition strategies
are available, as are different analysis strategies, andmodels that attempt to capture not only simple diffusion
effects, but also perfusion, compartmentalization, and anisotropy. This chapter introduces the basic con-
cepts of DWI alongside common acquisition schemes and models, and gives an overview of specific DWI
applications for animal models of renal disease.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers. This introduction
chapter is complemented by two separate chapters describing the experimental procedure and data analysis.
Key words MRI, Kidney, Diffusion, Diffusion-weighted imaging (DWI), Apparent diffusion coeffi-
cient (ADC), Intravoxel incoherent motion (IVIM), Mouse, Rat
1 Introduction
The dominant role of magnetic resonance imaging (MRI), and in
particular diffusion-weighted imaging (DWI), in the diagnosis and
monitoring of renal disease is driven by the ability to provide simul-
taneous assessment of kidney anatomy and function. In addition to
the potential to avoid or reduce the need for biopsy, which is invasive
and subject to sampling bias, the use of functional imaging techni-
ques such as DWI allow examination of tissue microstructure in vivo
as well as the potential for challenge protocols using administered
agents. In particular, in view of the controversial study on
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_11, © The Author(s) 2021
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gadolinium-containing MR contrast agents with regard to nephro-
genic systemic fibrosis (NSF) [1] or possible gadolinium deposits in
the central nervous system (CNS) [2], contrast-free examination
techniques are to be preferred, especially in patients with impaired
renal function.
Diffusion-weighted imaging comes in many variants, from sim-
ple to complex schemes, all based on indirect observation of water
molecular motion, that are sensitive to changes in renal perfusion
and tubular flow, alterations of cellularity arising from inflammation,
edema, or hyperplasia, and from fibrosis. A recent review of the
application of renalDWI in humans [3] gives an overviewof research
performed so far and illustrates renalDWIpotential in the clinic. The
authors in particular conclude that DWI is well-placed to investigate
decline of renal function as well as to monitor disease progression in
both acute and chronic kidney diseases,while noting that complexity
of the diffusion signal makes biological validation difficult.
The strengths of DWI are not without accompanying draw-
backs, however, which include the relatively long acquisition times
required for advanced DWI protocols, an increased susceptibility to
image artifacts, and an overall decreased spatial resolution due to
the imaging sequences used. Careful consideration of both the
research question to be addressed and the optimal acquisition
parameters to be used, together with acquisition of complementary
MRI modalities, can ameliorate some of these issues.
This chapter discusses the underlying phenomena and contrast
mechanisms of diffusion-weighted imaging. It is complemented by
two separate chapters describing experimental procedure and data
analysis, which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Diffusion Weighted Imaging Concepts
2.1 Fundamental
Concept
MRI signal arising from water protons in vivo is sensitive to the
exact nature of the tissue, including not only how the spins interact
with the tissue lattice and other spins through T1 and T2 relaxation
mechanisms, but also the tendency of water molecules to physically
move around, or diffuse, over time. The use of the term diffusion-
weighted imaging is a general catch-all term for any imaging using
pulsed field gradients for motion sensitization. DWI is sensitive to
the nature and degree of proton movement, which depends on
tissue microstructure, therefore representing an informative com-
ponent of research and clinical MRI protocols.
The use of pulsed gradient fields added to a MRI readout
sequence, in a dephase-rephase cycle commonly implemented as a
polarity-reversed pair or as equal pulses placed either side of a spin-
echo pulse, causes a loss of the MRI signal proportional to the
188 Neil Peter Jerome et al.
Fig. 1 Illustration of (a) DWI pulse sequence, showing the diffusion gradients (lower line, in blue) for a spin-
echo echo-planar readout sequence. (b) Schematic one-dimensional illustration of the net dephasing of spins
dependent on their motion. The initial gradient pulse adds an additional phase (red and blue being +/
additions to the static magnetic field) by transiently modulating the Larmor frequency of the spins. The amount
of additional phase is defined by the spin location along the gradient pulse direction (here up/down for
simplicity). During the diffusion time Δ, spins have an opportunity to diffuse according to their tissue
environment. The reverse pulse (in practice the same polarity, but acting as reversed in combination with
the 180 spin-echo pulse) restores the phase offset for spins that have not moved (upper section), whereas
moving spins do not receive equal dephase and rephase shifts, leading to a net phase shift (indicated by
remaining color) and an overall signal loss
overall mis-match of the pulses experienced by spins that have
changed location (Fig. 1). The larger the distance covered by
water molecules (and the proton spins therein) between the gradi-
ent pulses, the greater the mismatch of pulses experienced by the
spins, and the greater the overall signal destruction from the net
spin dephasing. Over time, this basic DWI concept has been imple-





In a large, single-compartment system, free diffusion of water
molecules is a truly chaotic, random phenomenon known as Brow-
nian motion, and might go on indefinitely (Fig. 2a). Here, the
average displacement of molecules over time is described by an
increasingly wide distribution, Gaussian (or normal) in nature,
centered on the starting position and characterized by a diffusion
coefficient. In biological tissues, water molecules interact with sur-
rounding structures (cell walls, extracellular matrix, and so forth),
which act as barriers causing an alteration and possible restriction in
diffusion (Fig. 2b, c). Tissue microstructure may also contain flow
elements, or structure with directional preference (Fig. 2d, e). The
observed diffusion coefficient from an imaging voxel, which may
contain a complex mix of diffusion environments, is thus an empir-
ical parameter, the apparent diffusion coefficient (ADC) measured
in mm2/s. Since tissue microstructure is a major determinant of
apparent diffusion, pathological conditions affecting microstruc-
ture cause an alteration in ADC.
Fig. 2 Schematic summary of motion types that can be investigated by diffusion imaging. Illustrative paths for
water molecules are shown for: (a) free diffusion, also called Gaussian or true diffusion, that is a random
motion; (b) apparent hindered diffusion in the tissue, where the microstructure alter true diffusion by
introducing barriers; (c) apparent diffusion restriction, for example within cells (d) pseudodiffusion, denoting
motion due to flow in vessels or tubules; and (e) diffusion directionality caused by structural elements
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The length scale of diffusion imaging, that is the average dis-
tance covered by water molecules during the DWI experiment, is
determined as a balance of the average speed of the water molecules
in their environment and the diffusion time allowed in the acquisi-
tion. Moreover, it is possible to see signal characteristic of mole-
cules whose motion is restricted to certain structures if the length
scale exceeds the structure dimensions. This, for example, allows
for the inference of intracellular water motion and thus cell size in
appropriately designed DWI protocols [4].
In the kidney, nonrandom perfusion and tubular flow, which
manifest as pseudodiffusion processes, as well as the high degree of
directional order in the renal structure, add complexity to the
investigation of water molecule motion. Specific signal interpreta-
tion models have been developed to account for an additional
(or sometimes more than one) pseudodiffusion compartment, gen-
erally possessing a pseudodiffusion coefficient of a higher magni-
tude than that of true diffusion. Similarly, additional models
assessing diffusion along multiple explicit directions have been
developed to provide information on directional motion as well as
on the relative anisotropy of the tissue.
Since the complexity of diffusion signal interpretation models is
intrinsically tied to the complexity of image acquisition protocols,
DWI acquisition and analysis cannot be considered and discussed
independently (see Note 1). The choice of acquisition parameters
will determine and/or limit the possible signal interpretation mod-
els, and therefore acquisition must be carefully designed, with the
expected analysis in mind. In particular, DWI acquisitions are often
lengthy, and there is always pressure to limit their duration when
transferred to clinical practice to minimize patient discomfort.
When planning renal DWI studies in the preclinical setting, it is
thus important to consider also their translational potential, and
the additional value that more complex acquisitions offer in relation
to the extra scan time required.
3 Diffusion Modeling
The degree of diffusion weighting applied to an image is conven-
tionally reported as its b-value, where b is a compound parameter,
expressed in s/mm2, arising from the specifics of the pulsed gradi-
ents used to sensitize the signal to spin motion. The b-value is
limited by the gradient hardware, but values of several thousand
are commonly achievable. Given that the incomplete rephasing of
displaced water molecules explicitly leads to a loss of signal,
increased diffusion weighting is ultimately limited by signal-to-
noise and in general is performed with a lower spatial resolution
than images acquired using other MRI modalities. Sufficiently high
b-values may reduce the signal to the level of background noise, and
in these cases either these data can be excluded, or an explicit noise
term added to the analysis.
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The range of b-values used in a diffusion imaging protocol
defines which diffusion components will be present and/or domi-
nate the signal, and thus will influence the analysis. The simplified
illustration in Fig. 3 gives a rough guideline to the b-value ranges
where different diffusion phenomena can be detected, though it is
important to appreciate the simplifications made when attempting
to model diffusion processes in tissue, and that b-value magnitude
alone is not sufficient to describe the experiment.
In some circumstances, such as the spatial localization of
tumors, it may be sufficient to simply observe the hyperintense
signal of highly cellular regions on a single diffusion-weighted
image of sufficient b-value to provide increased contrast (although
at lower overall signal). Diffusion-weighted images have an under-
lying T2 weighting arising from the longer TE required to allow for
inclusion of the diffusion-sensitizing pulses, which can be con-
founding where long-T2 regions (e.g., free water) can be mistaken
for low diffusion areas—this is known as the T2 shine-through effect
[5]. In most applications, however, modeling of the DWI signal
behavior, across a set of matched images varying only in the applied
b-values, removes the T2 influence and gives quantitative para-
meters that are, in theory, comparable across studies (see Note 2).
In the following sections, several diffusion signal interpretation
models relevant to renal studies are described, though this is far
from an exhaustive list of models or mathematical representations
available. Choice of DWI protocols are often selected in terms of
the additional value that they may offer in relation to their addi-
tional complexity and duration, and with a particular diffusion
model and analysis scheme in mind (see Note 3).
Fig. 3 Different diffusion weightings, summarized by the compound parameter b-value, give rise to diffusion
signal that is influenced by different diffusion regimes. Intuitive, though necessarily simplified, interpretations
of these diffusion phenomena include (1) pseudodiffusion, observed at low b-values and reflecting vessel and
tubular flow; (2) Gaussian (or random) diffusion, reflecting diffusion of water molecules in the renal tissue and
thus informing on renal microstructure and cellularity; and (3) non-Gaussian diffusion, observed at high b-
values and providing additional information on tissue microstructure. In addition to b-value, diffusion time,
delay, and direction parameters influence the observed DWI signal




The simplest and most widely used model to interpret the DWI
signal is a single compartment model, summarizing all motion
components (from diffusion, flow, etc.) in a single coefficient
(ADC, seeNote 4). The resulting ADCmaps (see Fig. 4) are derived
from the fitting of the DWI signal, across all b-values on a voxel-
wise basis, of a single-exponential model according to the following
formula:
S bð Þ ¼ S totalð Þ: exp TET 2
 
: exp b:ADCð Þ ð1Þ
where S(b) and S(total) represent the signal observed at a particular b-
value, and the overall equilibrium signal (at b ¼ 0 s/mm2 and
TE ¼ 0 ms) respectively. Since the echo time TE is usually not
varied across images with different diffusion weightings, the first
two terms are often summarized as S0, the signal at a b-value of
zero, and the formula simplifies as follows:
S bð Þ ¼ S0: exp b:ADCð Þ ð2Þ
Despite the DWI signal not being truly monoexponential, and
ADC being a purely empirical parameter summarizing different
factors contributing to the diffusion signal, ADC can still be con-
sidered as a sensitive and useful biomarker [6, 7].
The monoexponential model requires acquisition of a mini-
mum of 2 b-values. The lower value is commonly set as zero by
default, although this leads to what is known as a perfusion-
sensitive ADC; choosing a minimum b-value of approximately
Fig. 4Monoexponential ADC model. (a) Example DWI images acquired with different b-values (given in s/mm2)
from a healthy kidney, and (b) the ADC map resulting from fitting a monoexponential model. Signal-to-noise
ratio, depending on T2, spatial resolution, and the underlying diffusion itself, decreases with the increase in b-
value. (c) Schematic illustration of an ideal ADC curve fit to noiseless data. Analysis methods are discussed in
detail in the chapter by Jerome NP et al. “Analysis of Renal Diffusion-Weighted Imaging (DWI) Using Apparent
Diffusion Coefficient (ADC) and Intravoxel Incoherent Motion (IVIM) Models”
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100–200 s/mm2 removes this influence to give a perfusion-
insensitive ADC. The highest b-value is normally chosen as the
maximum value while retaining sufficient signal, commonly in the
range 700–1000 s/mm2 [8], although non-Gaussian processes
may become relevant at this upper limit (Fig. 3). The coefficient
derived from the analysis is always referred to as ADC, although it is
important to note that if the underlying signal curve is not mono-
exponential the measured ADC strongly depends on the b-values
chosen [9], and so is not necessarily comparable across studies.
Main advantages of the simple monoexponential equation is the
short acquisition time required, and the general robustness of ADC
as a marker of diffusion [10]. The monoexponential model is also
suited to DWI studies with multiple b-values, with additional data




One advanced model to interpret the diffusion imaging signal is the
intravoxel incoherent motion (IVIM) model. Originally proposed
by Le Bihan for the assessment of microcapillary perfusion in the
brain [11], the model is generally applicable if a number of assump-
tions are fulfilled, and represents a popular choice for attempting to
separate diffusion from flowing components [12].
In this model, a second compartment is included in the signal
interpretation to describe the flow-based motion of water mole-
cules in blood capillaries and tubules that, if assumed to randomly
occur in all directions, appears as an accelerated diffusion process
(Fig. 5).
The pseudodiffusion component associated with flow is
described by the pseudodiffusion coefficient D* that, since flow is
faster than diffusion, is approximately an order of magnitude larger
Fig. 5 IVIM model. (a) Schematic representation of random water motion in a voxel of renal tissue, where free
diffusion component (in blue, described by the diffusion coefficient D) is complemented by fluid flowing in
capillaries and tubules (in red, described by the pseudodiffusion coefficient D*). (b) Contributions of true
diffusion and pseudodiffusion to the observed diffusion signal decay—pseudodiffusion is substantially faster
than true diffusion, and so is only observed at low b-values
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than the true diffusion coefficientD. The components have relative
signal contributions given by the pseudodiffusion fraction ( f ), and
the overall IVIM model is described by the following equation:
S bð Þ ¼ S0: 1 fð Þ: exp b:Dð Þ þ f : exp b:D∗ð Þð Þ ð3Þ
implicitly assuming that there is no exchange between the compart-
ments, and that the associated compartmental T2 values are the
same. Since this is known not to be true in certain circumstances
[13, 14], it is important to note that the derived pseudodiffusion
coefficient D* and pseudodiffusion fraction f are nevertheless
empirical and should strictly be considered reflective of and not,
as often stated, a direct measure of perfusion or flow.
The use of the IVIM model requires substantially more
complex analyses than the monoexponential model (analyses are
discussed in the chapter by Jerome NP et al. “Analysis of Renal
Diffusion-Weighted Imaging (DWI) Using Apparent Diffusion
Coefficient (ADC) and Intravoxel Incoherent Motion (IVIM)
Models”), and more care to reliably separate pure diffusion from
pseudodiffusion components. IVIM analysis tools are increasingly
being offered byMRI manufacturers, although the choice of model
fitting methods may significantly influence the derived parameters
from the more complex model [15, 16]. Parametric maps resulting
from IVIM analysis show the similarity of D coefficient with ADC,
and the increased noise that is characteristic of the pseudodiffusion
parameters f and D* (Fig. 6).
The main feature of any DWI acquisition intended for IVIM
analysis is the increased number of b-values required, especially low
b-values that sample the signal curve before the pseudodiffusion
component has decayed (Fig. 5). Simplified versions of the IVIM
Fig. 6 Representative parametric maps resulting from DWI model fitting. (a) ADC map, resulting from
monoexponential model fitting. (b) Pure diffusion D, (c) pseudodiffusion fraction f, and (d) pseudodiffusion
D* maps, resulting from IVIM model fitting over several b-values. DWI-based parameters show contrast
between the cortex, medulla, and renal hilum. Some extreme values are seen as a consequence of respiratory
motion at the lower boundary of the kidney. Parameters associated with pseudodiffusion, f and D*, commonly
give maps with higher noise
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approach usually attempt to limit the acquisition time by using
fewer b-values, the minimum being three for a segmented fitting
that does not attempt to measure D* [15, 17–19]. Additional
complications of multiple b-value acquisitions are the increased
sensitivity to movement, and the known difficulty of providing




If the directionality (or loss thereof) of diffusion arising from tissue
structure is of interest, for example as an indication of loss of
function or invasion of relevant tissue, consideration of the diffu-
sion signal decay along specified direction, expressed as a tensor,
allows calculation of an ellipsoid that represents the diffusion prop-
agator in three dimensions. In the simplified case of isotropic
diffusion, diffusion is equal in all directions and the ellipsoid is a
sphere. Diffusion isotropy is assumed, though often unstated, in
both the monoexponential and IVIM models described above.
Conversely, in diffusion tensor imaging (DTI), diffusion-
sensitizing gradients are applied along a number of prespecified
directions, which are included in the model used to interpret the
diffusion imaging signal. In DTI, the diffusion is assumed to be
Gaussian and to follow a monoexponential signal decay.
The degree of direction-dependency of the diffusion signal is
captured by the fractional anisotropy (FA) parameter, ranging from
0 (complete isotropy) to 1 (complete anisotropy) and derived from
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where λi represent the eigenvalues of the corresponding diffusion
eigenvectors, meaning diffusion coefficients along each of the prin-
cipal ellipsoid axes, and MD represents mean diffusivity, given by
the following:
MD ¼ λ1 þ λ2 þ λ3ð Þ=3 ð5Þ
Directional diffusion coefficients can be reported for each indi-
vidual direction (λi) or along the major and minor axes of the
ellipsoid (λ1 and λtrans, the latter computed as average of the trans-
verse axes coefficients). Given their complexity and alternative for-
mulations, DTI equations used in any study should be clearly stated
[23, 24].
Similar to IVIM, DTI requires the acquisition of substantially
more images than the basic DWI scheme, although for DTI the
number of directions of the applied diffusion-sensitizing gradients
is increased rather than the number of b-values. In order to define
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the tensor, a minimum of six different directions must be acquired
alongside the b ¼ 0 image (which, not being diffusion-weighted,
has no directionality), but to reduce noise sensitivity it is common
to acquire more, up to 30 or even 60 directions. Diffusion direc-
tions are usually equally distributed over the surface of a sphere,
forming a “shell” in diffusion space (also called q-space), although
user-defined vector sets are acceptable as long as there is sufficient
sampling of the diffusion directions (Fig. 7).
The DTI technique was developed for application in the brain,
but can provide relevant information in the kidney as well. Color
and brightness of fractional anisotropy maps indicate orientation
and degree of anisotropic diffusion, and can be portrayed as small
ellipsoids, which are oriented and color-coded according to the
direction of strongest diffusion, to illustrate tissue structure (similar
to tractography in brain white matter). Maps of mean diffusivity
resemble conventional diffusion coefficient maps (Fig. 8).
Given the large number of images required for DTI analysis, it
is common to acquire only one shell in q-space, corresponding to a
single non-zero b-value chosen based on the target tissue and
expected signal-to-noise ratio. For body applications, this is much
lower than for the brain, and is commonly within the range
500–1000 s/mm2. More complex acquisition strategies are avail-
able, including multiple shells, as well as the option to retroactively
ignore the directional information and calculate ADC.
Fig. 7 Illustration of diffusion tensor imaging principles. (a) Diffusion vectors in q-space, representing diffusion
gradients of equal magnitude applied along different directions (in this case n ¼ 30) to investigate tissue
anisotropy. (b) Corresponding diffusion propagator ellipsoid, where λi represent diffusion magnitude along
each of the principal ellipsoid axes (i.e., eigenvalues of the principal eigenvectors). Measures of anisotropy,
derived from these eigenvalues, are able to describe diffusion with directional preference
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4 Diffusion Imaging in the Kidney
A more detailed review of the applications of renal diffusion imag-
ing in humans was recently conducted by the international COST
Action PARENCHIMA [3]. Much of the literature summarized
therein, predominantly using the most established ADC but also
including IVIM and DTI measures, reports a correlation between
diffusion metrics and eGFR decline [25–29] or fibrosis [30–32], in
patients with diabetes and other chronic kidney disease (CKD)
[33–38], as well as in kidney allograft recipients [30, 39, 40].
Preclinical studies also demonstrate the broad connection of
ADC with renal disease, with both ADC and DTI studies having
links to renal fibrosis from acute ureteral obstruction [41–45] and
diabetes [46, 47]. Preclinical studies also allow for study of the
effects of potential contrast agents [48–50]. The development of
novel DWI-based biomarkers may yet rely on biological validation
and an improvement in specificity [51].
5 Diffusion Acquisition Considerations
In diffusion imaging, most trade-offs are about keeping the acqui-
sition time reasonable and, similar to other MRI modalities, acquir-
ing signal-to-noise ratio sufficient to provide reliable results.
Preclinical imaging protocols are less constrained by time than
clinical protocols, and so allow for longer scanning that may take
advantage of increased averaging or alternate acquisition schemes.
Fig. 8 Representative parametric maps resulting from diffusion tensor imaging analysis of a healthy kidney. (a)
Mean diffusion (MD) map. (b) Fractional anisotropy (FA) map in gray scale. (c) FA map in color scale,
illustrating the direction of the λ1 eigenvector
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Since increasing the number of acquired averages to give suffi-
cient signal-to-noise quickly becomes prohibitive, DWI is normally
acquired with lower spatial resolution than anatomical T1- or T2-
weighted images. Number and repeats of each b-value depend on
time available and intended analysis strategy, and are thus specific to
each study and/or scanner. By default, most MR scanners will
acquire three orthogonal directions (which may or may not be
available as separate images [52]) for all nonzero b-values in order
to calculate the trace image, implicitly assuming isotropic diffusion.
Such schemes ultimately determine the exact sampling and thus the
format of the resulting data. Furthermore, most diffusion imaging
sequences allow for specification of several diffusion schemes (often
with vendor-specific names and implementations), which trade-off
between image quality and diffusion direction specifics. Such
schemes may involve multiple “shots” to acquire k-space
[31, 53], smaller field-of-view excitation through combination
pulses [54], as well as variations on the gradient scheme such as
bipolar encoding, designed to reduce distortion from eddy currents
[55, 56]. In general, diffusion-weighted images may require an
explicit postprocessing protocol as part of the analysis (seeNote 5).
Since the acquisition of high b-values requires a larger TE in
order to accommodate the pulses, the choice of the maximum b-
value is a compromise between precision of diffusion estimates over
a suitably chosen b-value range, and the available signal (see Note
6). DWI sequence variants that explicitly probe the effects of the
diffusion time Δ as well as TE illustrate the importance of not
neglecting potential influences of the acquisition parameters on
the diffusion signal [13, 57].
Other significant factors in diffusion imaging arise directly from
the use of echo-planar imaging (EPI) readout sequences, which
although suitably fast gives images which are susceptible to distor-
tion artifacts arising from high use of gradients (finite slew rates,
eddy currents, nonlinearity, and so forth) and local susceptibility
differences at tissue boundaries (and especially at tissue–air bound-
aries). Distortion correction can thus be necessary in diffusion
imaging, and may involve prospective planning (e.g., phase-reversal
images) [58] as well as retrospective processing (e.g.,
registration) [59].
Additional DWI protocols, such as those including flow com-
pensation [60], alternate strategies to EPI readout [53, 61], and
steady-state free precession sequences [62–64] and the influence of
physiological factors on the DWI [65], have been reported in
literature and may provide tools for ameliorating specific physio-
logical and instrumental factors.
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6 Notes
1. The specifics of diffusion imaging data acquisition and
intended analysis strongly influence each other, and thus
both should be borne in mind while planning a new study.
Whenever possible, overly specific acquisition protocols should
be avoided to allow for data reuse through additional retro-
spective analysis, and cross-study comparisons.
2. Many acquisition parameters influence the resulting diffusion-
related parameters, making comparison across studies challeng-
ing. In the absence of widely accepted standardized protocols,
it may be advantageous to consider the extent to which com-
parison with other studies will be possible.
3. As with all MRI studies, but of particular importance in diffu-
sion imaging, care should be taken to report the adopted
protocol as completely as possible. This necessarily includes
the acquisition scheme and parameters, but also extends to
the analysis algorithms.
4. The majority of diffusion models contain a parameter that
attempts to capture the underlying tissue diffusion—ADC,
(IVIM) D, (DTI) MD, and so on. While superficially similar
and reflective of tissue structure, they are not precisely equiva-
lent given the different assumptions implicit in the models they
derive from.
5. The most common readout for diffusion imaging is the echo
planar imaging (EPI) sequence, which is susceptible to artifacts
and distortion; an adequate post-processing scheme is
required. Analysis of DWI is discussed in more detail in the
chapter by Jerome NP et al. “Analysis of Renal Diffusion-
Weighted Imaging (DWI) Using Apparent Diffusion Coeffi-
cient (ADC) and Intravoxel Incoherent Motion (IVIM)
Models.”
6. Since diffusion contrast is created by deliberate dephasing and
thus loss of the MR signal, sufficient signal-to-noise ratio is
critical to ensure good quality data and successful analysis.
Failure to assess the signal-to-noise ratio or account for the
noise floor may introduce bias in the estimate of diffusion
parameters.
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Chapter 12
Dynamic Contrast Enhancement (DCE) MRI–Derived Renal
Perfusion and Filtration: Basic Concepts
Michael Pedersen, Pietro Irrera, Walter Dastrù, Frank G. Zöllner,
Kevin M. Bennett, Scott C. Beeman, G. Larry Bretthorst,
Joel R. Garbow, and Dario Livio Longo
Abstract
Dynamic contrast-enhanced (DCE) MRI monitors the transit of contrast agents, typically gadolinium
chelates, through the intrarenal regions, the renal cortex, the medulla, and the collecting system. In this
way, DCE-MRI reveals the renal uptake and excretion of the contrast agent. An optimal DCE-MRI
acquisition protocol involves finding a good compromise between whole-kidney coverage (i.e., 3D imag-
ing), spatial and temporal resolution, and contrast resolution. By analyzing the enhancement of the renal
tissues as a function of time, one can determine indirect measures of clinically important single-kidney
parameters as the renal blood flow, glomerular filtration rate, and intrarenal blood volumes. Gadolinium-
containing contrast agents may be nephrotoxic in patients suffering from severe renal dysfunction, but
otherwise DCE-MRI is clearly useful for diagnosis of renal functions and for assessing treatment response
and posttransplant rejection.
Here we introduce the concept of renal DCE-MRI, describe the existing methods, and provide an
overview of preclinical DCE-MRI applications to illustrate the utility of this technique to measure renal
perfusion and glomerular filtration rate in animal models.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
This introduction is complemented by two separate publications describing the experimental procedure and
data analysis.
Key words Magnetic resonance imaging (MRI), Dynamic contrast-enhanced (DCE), Kidney, Mice,
Rats, T1 mapping, Contrast agent, Perfusion, Glomerular filtration rate (GFR)
1 Introduction
Glomerular filtration rate (GFR) is a standard measure of kidney
function. In past decades, simplified plasma clearance employing
radiopharmaceuticals (51Cr-EDTA, 125I-iothalamate, 99mTc-
DTPA) was introduced and validated to provide very accurate
estimates of total GFR [1–4]. Later, alternative techniques have
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_12, © The Author(s) 2021
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been evaluated, using minute doses of nonradioactive contrast
agents, including iothalamate and iohexol [5]. Plasma clearance of
such compounds has also been applied to measure renal function.
Renal blood flow (RBF) is another important measure of the func-
tional status of a kidney. The standard tracer-based technique for
quantifying RBF is to measure clearance of substances such as
hippurate or of radiopharmaceuticals [6].
Dynamic contrast enhanced (DCE-MRI) is an alternative to
these techniques that uses gadolinium chelates as contrast agents
(CAs), providing functional information analogous to that
obtained from radionuclide studies [7, 8]. These chelates are gen-
erally considered glomerular filtration markers, since they are
removed from the circulation exclusively by glomerular filtration.
DCE-MRI measures T1-weighted signal intensity changes in
tissues over time after bolus administration of a contrast agent.
Dynamic data acquisition allows for monitoring of the contrast
agent in the renal cortex, the medulla, and the collecting system,
providing a renographic representation with underlying informa-
tion about the renal perfusion, filtration, and vascularization [9–
12]. Postprocessing analyses of these signal-vs-time curves reveal
kidney functionality in terms of filtration and perfusion, including
both heuristic nonmodel approaches and model-based quantitative
methods [13, 14]. However, while DCE-MRI is a promising tool
in animal models, its clinical utility is hampered by the risk of
developing nephrogenic systemic fibrosis in renal patients with
severely reduced glomerular filtration capacity [15]. In this chapter,
we will address the basic concept of DCE-MRI with the emphasis
on kidney disease models in rodents.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)





The standard acquisition scheme of a DCE-MRI experiment is
based on repeated T1-weighted images before and after the injec-
tion of a Gadolinium-based CA. In this way, a dynamic curve of the
signal enhancement in the kidney is recorded in a time window
wide enough (5–10min) to see the contrast range from the vascular
peak enhancement to the wash-out phase. An injection dose of
0.1 mmol Gd/kg is considered standard [16], and lower doses
are occasionally exploited to reduce concomitant T2* effects in
vessels.




In DCE-MRI, the gadolinium agents have two main advantages,
one attributed to the properties of the gadolinium-ion in response
to a magnetic field, and one attributed to the chelate that has a
biodistribution in the body which favors measurements of renal
clearance. In physical terms, the gadolinium ion is chosen having
seven unpaired electrons in its orbitals resulting in strong paramag-
netism [17–19]. Furthermore, the symmetry of the electron con-
figuration of the trivalent gadolinium ion is a hospitable
environment for electron spins, contributing to the rise of the
crucial nuclear magnetic resonance parameter called relaxation.
For these reasons, gadolinium (Gd3+) is the most common metal
ion used in paramagnetic contrast agent and its relationship is given
by 1/T1 (Measured) ¼ 1/T1 (Water) + r1 [Gd]. The relaxivity is depen-
dent on the magnetic field and temperature [20–22]. Due to its
toxicity as free ion, Gd is trapped in a molecular structure defined
by the closed/open ring that chelates the metal. These macrocyclic
and linear CAs may possess different r1, osmolarity, and molecular
size [23–25]. In addition to clinical contrast agents, several other
Gd complexes have been investigated for providing higher relaxiv-
ity or contrast efficiency [26–31]. All the contrast agents used for
mapping kidney perfusion are small molecular weight extracellular
agents and are administered intravenously [32].
2.3 Conversion
of Signal into Contrast
Agent Concentration
Contrary to nuclear medicine modalities, MRI unfortunately does
not measure changes in signal intensity in a straightforward way.
This means that measurements of injected contrast agent concen-
tration is difficult, which again severely hinders the possibility to
calculate important parameters in absolute units such as ml/min or
ml/min/g. Previous studies have taken this constraint into account
in three different ways: (1) by assuming that the signal intensity is
linearly related to the concentration of contrast agent, (2) by
making calibration of water doped with contrast agent and then
assume the same signal-vs-concentration can be applied in the
living tissue, and (3) by introducing the mathematical complex
relationship between signal and concentration. These three
approaches are here ordered with increasing difficulties in which
they can be performed, meaning that the third method is by far the
most ambitious. To be able to convert signal intensities into con-
centration, we present a step-by-procedure. First, the mathematical
equation that relates the signal into concentration relies on both
well-known constants, the employed MR imaging technique and
the pulse sequence parameters (echo-time, recovery time, flip
angle, etc.). Due to the paramagnetic properties of the contrast
agent, the magnetic relaxation time (T1) decreases in the presence
of the contrast agent. Conversion of acquired signal (enhancement)
to changes in T1 needs some mathematical understanding. In a
simple setup, DCE-MRI is performed with a T1-weighted-2D-
spoiled gradient-echo train (Fig. 1).
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First, we consider the spoiled gradient echo sequence (TFE)
without prepulses. The longitudinal component of the magnetiza-
tion is denotedMz, which relaxes back to its equilibriumM0 due to
a characteristic relaxation time (T1). The magnetization Mz is
derived by the Bloch equation, given as follows:
dM z
dt
¼ M 0 M z
T 1
ð1Þ
where M0 denotes the bulk longitudinal magnetization, and T1 is
the longitudinal relaxation time. Integration of Eq. 1 returns the
time-dependent Mz(t):Z M z
0
dM z





) M z tð Þ M 0 ¼ Aet=T 1 ð2Þ
Giving the notation that Mz(t ¼ 0) is Mz(0), we define the
constraint:
M z 0ð Þ ¼ M 0 þA ) A ¼ M z 0ð Þ M 0 ð3Þ
Resolving Eq. 2 gives the following:
M z tð Þ ¼ M 0 þ M z 0ð Þ M 0½ et=T 1
¼ M 0 1 et=T 1
h i
þM z 0þð Þet=T 1 ð4Þ
The magnetization just before the n’th pulse (denoted as
nTR) can now be determined:
Fig. 1 Pulse train for dynamic MRI using a spoiled gradient-echo sequence
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M z nTR
ð Þ ¼ M 0 1 eTR=T 1
h i
þM z n  1ð ÞTRþ
 
eTR=T 1
¼ M 0 1 E1½  þM z n  1ð ÞTRð Þ cos αE1
ð5Þ
where E ¼ eTR=T 1 , and Mz((n  1)TR) represents the magneti-
zation just after a time (n  1)TR. Eq. 5 can be developed
recursively:
M z nTR
ð Þ ¼ M 0 1 E1½  þ M 0 1 E1½  þM z n  2ð ÞTRð Þ cos αE1½  cos αE1
¼ M 0 1 E1½  þM 0 1 E1½  cos αE1 þM z n  2ð ÞTRð Þ cos αE1½ 2
¼
Xn1
i¼0 M 0 1 E1½  cos αE1½ 
i þM z 0ð Þ cos αE1½ n
¼ M 0 1 E1½ 1 cos αE1½ 
n
1 cos αE1 þM
eq
0 cos αE1½ n
ð6Þ
Herein, the geometric series is assumed:
M eqz ¼ limn!1M z nTRð Þ ! M 0
1 E1
1 cos αE1 ð7Þ
The steady-state condition can then be described as follows:
M eqz ¼ M eq0
1 E1
1 E1 cos α ð8Þ
Taking into account that steady-state condition must be ful-
filled in presence of a delay TD, employed between the TFE train
and the subsequent RF pulse, the following must apply:
M eqz ¼ M eq,0z 1 eTD=T1
h i
þM eqz eTD=T1 ð9Þ
Now, let us introduce the preparation pulse (with flip-angle β)
applied a time TPREP before the excitation pulse. M
eq
0 is taken into
account by solving:
M 0z ¼ M eq0 1 eT PREP=T1
h i
þM z βþð ÞeT PREP=T 1 ð10Þ
where Mz(β+) represents the magnetization just after the β pulse.
The magnetization before the n’th α-pulse, denoted as Mz(n,α), is
given as the combination of Eqs. 6 and 10:
Mz n, αð Þ ¼ M eq0 1 eT PREP=T 1
 
þM eq,0z eT PREP=T 1 cos β
h i
E1 cos α½ n
þM eq0 1 E1½ 
1 E1 cos α½ n
1 E1 cos α
ð11Þ
Therefore, using a heavily T1-weighted pulse sequence,
changes in signal intensity are then almost entirely dependent on
changes of T1. In these circumstances, it can be shown that Mz
eq is
almost linearly dependent on T1 relaxation rate. Note again that the
Renal Dynamic Contrast Enhanced (DCE) MRI: Basic Concepts 209
specific magnetic relaxivity of the gadolinium-agent (r) defines the
characteristic enhancement property by the equation:
[Gd] ¼ (1/T1–1/T1(0))/r, where T1(0) is the bulk relaxation time
in the tissue without the presence of contrast agent, and [Gd] is the
concentration of contrast (gadolinium) agent. In principle, this
means that a precontrast measurement of T1 (T1-mapping) should
be performed before injection of the contrast agent. One important
factor contributing to erroneous measurements of T1(0) of blood is
the inflow effect, because the coherent movement of flowing fluid
can alter T1 of the signal arising from spins therein. Placing the
central-encoding lines within the low blood flow window within
the cardiac cycle can, to some extent, minimize the problems of the
inflow effect.
2.4 Imaging Readout For dynamic acquisitions, two factors must be taken into consider-
ation: the time resolution and the contrast resolution required. For
quantitative studies of renal perfusion and GFR, based on the first-
pass of the contrast agent, a high temporal resolution is particularly
important to accurately sample the vascular phase of the kidney
(especially for renal perfusion studies) in order to measure the
arterial input function (AIF). The AIF is the signal-time-curve
usually observed in the suprarenal abdominal aorta or in a renal
artery and is used in different kinetic models in order to compen-
sate for the non-instantaneous bolus injected into the blood. The
request for a high temporal resolution explains why some studies
have been performed using a single slice acquisition scheme and not
as multislice or 3D techniques. However, the required extrapola-
tion of functional data from one slice to the whole kidney is not
always valid if the renal disease is irregularly or focally distributed.
Most of the exploited sampling techniques are gradient echo
imaging, echo-planar imaging and spiral imaging. Differences in
the sequence are represented by the ability to cover the image
space, from conventional approaches that acquire a portion of the
space every TR to entire space acquisition in every TR step. Among
them, other subtechniques exist with little changes in the sampling
approach like spoiled gradient echo, segmental echo planar imag-
ing, keyhole imaging or parallel imaging [33].
2.4.1 Gradient-Echo Gradient echo (also “gradient recalled echo,” GRE)-based
sequences are the most commonly used sequences for DCE-MRI
studies, where fast GRE sequences can be implemented in different
ways, including unbalanced, balanced steady-state, and RF-spoiled
sequences [34]. Notably, standard (unbalanced) and balanced gra-
dient echo sequences are sensitive to T2 effects that result in signal
decreases upon the accumulation of the contrast agent in the region
of interest. Therefore, spoiled GRE sequences are mostly used since
they are more sensitive to T1 effects leading to higher contrast
enhancements. A drawback of these sequences is the low SNR
(signal to noise ratio) that can be compensated by the use of 3D
acquisitions.
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2.4.2 Echo-Planar
Imaging
Echo planar imaging (EPI) allows fast image acquisition in combi-
nation with high temporal and spatial resolution, with acquisition
of several images per second [35]. On the other hand, EPI
sequences are difficult to exploit in abdomen and thorax regions
since they are sensitive to susceptibility and motion effects. These
artifacts can however be reduced by using segmented EPI
sequences with a concomitant loss in temporal resolution.
2.4.3 Keyhole Imaging Since central lines of the K-space are more sensitive to image
contrast in comparison to peripheral lines, keyhole imaging is
exploited for accelerating imaging acquisition by acquiring multiple
central K-space lines. This high-contrast but low-spatial resolution
image can then be combined with a high-resolution image to
restore the spatial information. Consequently, temporal resolution
can be increased up to three- to fourfold, despite some problems
that can be encountered in areas with large physiological move-
ments. Several partial K-space sampling techniques have been
developed and exploited in a variety of applications [36].
2.5 T1 Mapping T1 measurements can be performed along the dynamic acquisition
(precontrast and postcontrast) at every repetition time or before
and after the bolus administration using T1 mapping techniques.
Applying a radiofrequency (RF) pulse, spins will change their mag-
netization status according to the design of the pulse. The magne-
tization can be inverted or saturated (nulled), and T1-weighted
images are acquired after the inversion or time after saturation
pulse. Since the T1 calculation is the time that magnetization
takes to restore to its equilibrium (which is considered fully
restored after 5 times the T1), the two models of RF pulses are
called inversion recovery and saturation recovery. Another way to
perturb the magnetization is achieved by manipulating the flip
angle of the RF pulse at every sequence acquisition, sampling the
T1 relaxation for different angle values.
2.5.1 Saturation
Recovery
A 90 saturation pulse effectively nulls the magnetization indepen-
dently of its state before the saturation pulse. In this way, keeping
the repetition time lower than the T1, the system is unable to fully
recover to equilibrium and is said to be saturated. Thus, the T1
measurements are performed by varying the TR constantly ranging
from 0 to, at least, 2–3 times the longest T1 value expected in the
sample. The result is that saturation recovery is a very fast method
but with the drawback of a limited dynamic range and limited T1
range.
2.5.2 Inversion Recovery Inversion recovery consists of a 180 inversion pulse which rotates
the longitudinal magnetization to give the classical decay with a 90
pulse. The inversion recovery pulse sequence is repeated continu-
ously, each time applying the same inversion pulse, followed by
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different waiting times (time of inversion). The principle of this
method implies that the repetition time of the sequence must be
greater than the longest T1 since the magnetization needs to be
fully recovered before applying another inversion pulse. Inversion
recovery is a method for T1 map acquisition which produces maps
with good accuracy and intensity dynamic range but with the
drawback of being time-consuming.
2.5.3 Variable Flip
Angle (VFA)
Variable flip angle is used to acquire 3D T1 maps, and the technique
uses two or more repeated sequences with different flip angles
(ranging from a few degrees to even more than 90), sampling
the T1 relaxation for different angle values. The method is relatively
sensitive to B1 inhomogeneities; hence a field map should be
acquired. Recently, magnetization transfer effects were identified
as an additional source of variability in the obtained VFA data,
which can be reduced dramatically by use of tailored composite
RF pulses that apply the same power to the bound proton pool for
all flip angles [37].
2.6 Renal Handling
of Contrast Agents
Before analysis of the acquired DCE-MRI data, it is important to
understand how the renal segments handle the gadolinium agent
during DCE-MRI. Following an i.v. (intravenous) bolus of contrast
agent, the arterial concentration is promptly increased following a
steady decline over time, reflecting the input and output of the
agent over time. Figure 2 shows an example of dynamic
Fig. 2 Dynamic uptake curve (enhancement) in the aorta (red) and renal whole-parenchyma (yellow) following
iv bolus of a gadolinium agent. Purple dots indicate baseline values prior to bolus administration. See Fig. 3
text for MRI sequence parameters. The aorta curve shows a rapid increase followed by a decline over time
(0–800 s). The renal curve shows a first-pass vascular uptake, followed by a pattern with decreasing vascular
gadolinium-content combined with a glomerular handling of the contrast agent
212 Michael Pedersen et al.
enhancement following a bolus of a gadolinium agent, and Fig. 3
shows the handling of a gadolinium agent in the healthy and
diseased (ureteric obstructed) kidneys. Graphical presentation of
the renal enhancement is denoted as an MR renogram.
Fig. 3 Example of MR renogram, the result of DCE-MRI of pig kidneys with healthy (left) and diseased (right)
kidneys. The yellow ROIs are shown to illustrate where the dynamic curves were drawn. The data were
obtained as follows: the anaesthetized pig was placed supine in the magnet, and a surface radiofrequency coil
was used for data reception. Fast multislice anatomical images were initially acquired to localize both kidneys.
Next, an MRI renography pulse sequence was employed. The whole kidney was covered using a mutlislice
(3.0 mm thickness with zero gap) fast 3D gradient echo sequence. Other parameters included:
matrix ¼ 128  128, field of view ¼ 220  220 mm2, TR ¼ 4.3 ms, TE ¼ 1.5 ms. This scan was
accompanied by an intravenous injection of 0.05 ml/kg of Gd-DTPA-BMA (Omniscan®; GE Healthcare, Oslo,
Norway) was performed as a single bolus administered by hand 10 s after start of a dynamic gradient-echo
sequence, with a single phase acquisition time of 2.2 s. A total of 700 dynamic phases were acquired during
7 min
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The MR renogram typically consists of vascular, parenchymal,
and excretory phases [38]. The vascular phase occurs almost imme-
diately after contrast injection and provides the first segment of the
renographic curve, which is reflected by a steep linear rise. In the
cortex, this is followed by the parenchymal phase, characterized by
continuous uptake, which is represented in the intensity–time curve
as a slower linear increase up to a second peak. In the excretory
phase, contrast material is released into the collecting system calices
and constitutes the third segment of the renographic curve.
2.7 Analysis
Methods
While the experimental design of DCE-MRI is simple, extracting
true morphological or physiological parameters from a DCE time
course is extraordinarily difficult, due to a number of factors,
including intravoxel heterogeneity in tissue microstructure and
the need for pharmacokinetic (model-based) or empirical
(non-model based)modeling of theDCE-MRI signal [16, 38]. Tis-
sue heterogeneity depends upon the organ of interest and image
resolution, which are typically not varied in a single experiment.




As a descriptive approach, the dynamic time-vs-time curve of
DCE-MRI data provides information with parameters like time-
to-peak enhancement, uptake slope, area-under-the-curve and
wash-out rate. These heuristic enhancement parameters may have
some relation to physiologic parameters although they also depend
on the particular MRI system and acquisition settings, including
pulse sequence, sequence parameters, system manufacturer, and




Alternatively, various physiological pharmacokinetic models have
been proposed, usually based on long-term experiences in nuclear
medicine. These models are often attributed to situations where the
capillary bed (e.g., the blood–brain barrier) is compromised, result-
ing in extravasation of the contrast agent through the leaky capil-
laries. For example, modeling the dynamic extravasation of MRI
contrast agent can provide a measure of the extravascular uptake.
Overall, applying pharmacokinetic models allow calculation of sev-
eral measures: (1) physiologic properties (transendothelial perme-
ability, capillary surface area, lesion leakage space),
(2) pharmacokinetic parameters (compartmental transfer and rate
constants, leakage space), and (3) pathological measures (micro-
vessel density and vascular endothelial growth factor) [13, 16].Mea-
surements of these parameters using modeling are now considered
diagnostically important in tumor evaluation (grade classification)
and to recognize the onset of stroke by indirect measurements of
rCBF, rCBV, and MTT, although they usually provide limited
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insight into the underlying pathophysiology of the brain tumor or
stroke [40]. It is therefore likely that similar parameters can be
measured in the kidney. The quantitative models require additional
postprocessing steps, including contrast agent concentration calcu-
lation (e.g., based on linearity assumption between concentration
and signal changes or in previously acquired T1 maps), selection of a
major artery to derive the AIF curve, selection of the pharmacoki-
netic model (as well as of the number of the compartments and how
they are connected) to be used. In addition, the focus of the
application as well as the quality of the data will guide the selection
of the more appropriate model. Besides, the temporal resolution,
protocol injection, and acquisition time can influence the quality of
the outcomes, making it necessary to have appropriate and opti-
mized measurement protocols.
2.7.3 Model Selection All data analysis, including analysis of DCE-MRI data, involves
either explicit or implicit comparison to a model. The data are
typically considered to be the sum of the signal and noise, and the
estimated signal model parameters are of primary interest. In the
ideal case, the underlying principles of the measurement and the
signal response form the basis of the signal model. Often, however,
there are several potential signal models. The analyst must decide
which of these competing models best represents the data without
“over fitting” (i.e., fitting the noise). Even when the correct signal
model is known, the signal-to-noise ratio of the data may not
support the complexity of the correct model, requiring that simpler
models be considered.
Fig. 4 Example of parameters estimated from DCE-MRI in kidneys. Top row from left to right: plasma flow (FP),
plasma volume (VP), plasma mean transit time (PMTT). Lower row from left to right: extraction fraction (E),
permeable surface area product (PS), and tubular mean transit time (TMMT). The maps are reproduced with
permission from Zöllner et al. [39]
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Here, we consider the problem of model selection in
DCE-MRI experiments in the kidney. The importance of selecting
an appropriate DCE tracer kinetic model to measure tissue perfu-
sion and capillary permeability has already been examined in tumors
in previous reports [41, 42]. Model selection algorithms, including
Chi-square [43], Akaike information criterion (AIC) [44–46],
F-test [47–49], and the Durbin–Watson statistic [45, 50], have




An elegant solution to the model selection problem using Bayesian
probability theory-based methods has recently been described [51–
53]. Bayesian probability theory [54] provides a rigorous formalism
for model selection. To determine the optimal model amongst a
cohort of competing models, it is necessary to balance the accuracy
with which the model recapitulates the data (the goodness of fit,
characterized by the residuals) against the number of free para-
meters in each model (the complexity). Cox’s theorem [55] and
its further elaboration by Jaynes [56], state that Bayesian probabil-
ity theory is the only method of ranking hypotheses concerning
model selection that is consistent and can incorporate all of the
available prior information. Advances in computational power and
the development of Markov-chainMonte Carlo (MCMC)methods
have greatly increased the applicability of Bayesian inference to a
range of problems.
Bayesian probability theory seeks to assign a probability to the
truth of a specific hypothesis. Using a Bayesian approach, the model
selection problem treats the model itself as a parameter, for which
the posterior probability of a model, given the data and prior
information, is computed [51–53]. The posterior probability of
each model is calculated by:
P M jDIð Þ ¼ P M jIð ÞP DjMIð Þ
P DjIð Þ ð12Þ
where P(M|DI) is the posterior probability for any one of M mod-
els. The vertical bar “|” means “given the data, D and the prior
information, I.” On the right-hand side, P(M|I) is the prior proba-
bility for each of theM different models, assigned in this calculation
as a uniform prior probability. P(D|MI) is the probability for the
data, given model M and prior information I. Finally, the denomi-
nator, P(D|I) is a normalization constant that ensures the total
probability over all of the models sums to one.
An example of a joint Bayesian approach to model selection in
DCE-MRI was described recently by Beeman et al. [57], applied to
models of blood flow in cortex in a mouse model of three different
renal perfusion rates. The three cohorts ofmice studiedwere: (1)Con-
trol; (2) Losartan-treated (high renal blood flow); (3) L-NAME-trea-
ted (low renal blood flow). DCE-MRI data were analyzed on a voxel-
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by-voxel basis. Four models and model parameters were compared in
eachvoxel.Twoof themodels, thePatlak–Rutlandmodel [58] and the
two-compartmentmodelwere pharmacokinetic and two, the cumula-
tive log-logistic model with either monoexponential decay with a
constant offset or biexponential decay, were empirical. A Markov-
chain Monte Carlo simulation was run to compute the posterior
probability for the parameters and themodel. The estimated probabil-
ities of the parameters of the biexponential model, obtained using this
approach, are shown in Fig. 5.
The importance of signal-to-noise in model selection in
DCE-MRI was described recently by Duan et al. [51] In their
paper, the authors considered four established kinetic models for
analyzing DCE-MRI data collected from patients enrolled in the
EMBRACE study, an international study of MRI-guided brachy-
therapy in locally advanced cervical cancer. The models were
(1) Toft’s (TM), (2) Extended Toft’s (ETM), (3) Two-Site
Exchange (2CXM), and (4) Compartment Tissue Uptake
(CTUM). To demonstrate the importance of signal-to-noise in
DCE data analysis, noise-free in silico DCE data sets were gener-
ated for each of the four models. The temporal resolution and total
data acquisition times were identical to those of the clinical
DCE-MRI protocol, using patient-derived tissue parameters.
As expected, Bayesian model selection chose the “correct”
signal model for each of these noise-free data sets. Increasing
amounts of normally distributed (Gaussian) noise were then
added to each data set. At each noise power, 100 independent
MCMC simulations (i.e., different noise sets) were performed
and the number of “correct” selections, in which model selection
chose the model used to simulate the data, was recorded. The
number of correct model selections varied as a function of both
model complexity and noise power. With increasing levels of noise,
simpler data representations were preferred relative to more com-
plex models (Fig. 6a). Figure 6b shows model selection results for
in silico data created based on the 2XCM. The number of correct
model selections dropped rapidly with increasing noise, with a
concomitant increase in the selection of the CTUM, a simplified
version of the 2XCM. Figure 6c, d shows how the accuracy and
uncertainty of estimations of extravascular, extracellular volume
(ve), the only common parameter between the simplest model
(TM) and the most complex model (2XCM), vary with added
noise. At every noise level, the uncertainties of the estimated ve
are much smaller for the TM, relative to the 2CXM.
2.8 Practical
Considerations
The main advantage of T1-weighted DCE-MRI is that both tissue
blood flow and filtration (permeability surface) can be measured
simultaneously. One important element in the T1-weighted
DCE-MRI is the underlying model from which the calculated
parameters are derived. Many assumptions about the tissue system
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Fig. 5 (a, c) Bayesian-estimated posterior probability densities of the empirical biexponential model’s joint
fractional amplitudes of the washout and joint slow decay-rate constants, respectively, for each cohort. The
Losartan-treated (high renal blood flow) group is represented by the solid black line, the L-NAME (low renal
blood flow group) by the dashed black line, and the control group by the dotted gray line. (b, d) The difference
in the posterior probability distributions for the joint fractional amplitudes of the washout and joint slow decay-
rate constants, respectively, calculated on the high and low flow cohorts. From among the empirical/
biexponential model joint parameter estimates, the fractional amplitudes of the washout terms (a) and the
slow decay-rate constants (c) differed between mouse cohorts of high and low flow; that is, the 95%
confidence interval of the difference in the probability distributions did not overlap with 0 (b and d). (Adapted,
with permission, from Beeman, et al. [57])
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are made with respect to the nature of contrast agent kinetic mod-
eling, and these assumptions may affect the accuracy of the param-
eter calculations. In practice, a compromise must be struck between
reality and the precision of the measured data (signal-to noise ratio,
temporal resolution, etc.). The different models proposed by lead-
ing experts in this field have unfortunately been presented with a
variety of quantities, meaning that comparisons between different
groups are almost impossible. Consequently, a standardization of
quantities associated with analysis of T1-weighted DCE-MRI has
been proposed in the review by Tofts et al. [59], and later by
Sourbron [42] as part of building up a common language for the
estimation and description of physiologic parameters in the kidney.
Fig. 6 Bayesian DCE-MRI model-selection and parameter-estimation results for in silico datasets created
based on the whole-tumor averaged ROI DCE time course from a single patient in the EMBRACE study. (a) For
each of the four in silico DCE-MRI data models, the number of “correct” model selections (out of 100 different
noise representations), as a function of the noise standard deviation (SD). (b) For the two-compartment
exchange in silico DCE-MRI data model (the most complex model of the four models examined), the number of
times a given model was selected (out of 100 different noise representations) as a function of the noise
SD. (c, d) Relative percent error of ve (extracellular-extravascular volume fraction) estimated from initially
noiseless simulated TM (c) and 2CXM (d) data as a function of added noise. (Adapted with permission from
Duan et al. [51])
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For all methods proposed, the calculation of renal parameters
requires knowledge of the arterial input function, which in practice
is derived from the abdominal aorta or a renal artery with the
assumption that this represents the exact input to the renal tissue.
Delay and dispersion of the bolus that are introduced during its
passage from the site of arterial input function estimation to the
renal tissue will therefore introduce an error in the quantification of
RBF or GFR, and this error could very well vary from one region to
another because of the differences in the amount of delay and
dispersion for different kidney regions. Thus, some general approx-
imations seem useful: (1) DCE-MRI is performed under a steady-
state condition. (2) The renal relaxivity of the gadolinium-agent is
known. (3) Some conversion to gadolinium concentration can be
made. (4) An input curve is defined. (5) A mathematical analytical
model can be approximated.
Today, little is known about the potential of gadolinium-
enhanced MRI for the assessment of the regional renal blood flow
and the regional glomerular filtration rate. Nor do we know the
limitations and accuracy of this technique under different patho-
logical and pathophysiological conditions. Thirdly, we do not know
the clinical applicability of DCE-MRI and the role it may have in
clinical diagnosis. A step-by-step procedure should therefore be
initiated to exploit the abovementioned fundamental questions:
(1) The methodologies should be further validated against stan-
dard methods to obtain reproducible results in agreements to those
obtained by clinical non-MRI techniques. (2) Further animal stud-
ies should be performed to examine the accuracy and availability
under different pathological and pathophysiological conditions.
(3) Experimental studies in humans, where the DCE-MRImethods
are validated against a standard reference method.




Several studies investigated DCE-MRI approaches for assessing
renal filtration in animal models. Annet et al. estimated the GFR
in rabbit kidneys by applying a compartment model and compared
the MRI-derived estimate with the measured plasma clearance of
51Cr-EDTA [60]. Although MRI-based GFR values were lower
than those measured experimentally, a marked correlation was
observed between the two techniques. Winter et al. compared
renal perfusion values obtained by arterial spin labeling (ASL) or
DCE-MRI in healthy rats, with absolute renal cortex perfusion
estimates in close agreement with those obtained by ASL [61].
Zimmer et al. performed an inter- and intramethodical com-
parison by measuring differences in renal blood flow (RBF) in five
rats with unilateral ischemic acute kidney injury with both ASL and
DCE-MRI. Both, the FAIR-ASL approach and DCE-MRI
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deconvolution technique showed significant differences in RBF
between healthy and diseased kidneys as shown in Fig. 7
[62]. The validation of MRI-based GFR estimation by optical
imaging was proposed by Sadick et al. [63]. GFR estimation was
performed by DCE-MRI on a 3 T whole body scanner using a
dedicated animal rat volume coil and by clearance using a fluores-
cent tracer (FITC-sinistrin) and an optical imaging device. How-
ever, the correlation between optical GFR andMRI-based GFRwas
poor, probably due to the fact that measurements were performed
on different days involving two anesthesia thus affecting the physi-
ology of the animals. Zöllner et al. recently showed a simultaneous
measurement of optical and MR-based GFR in healthy rats and rats
with unilateral nephrectomy (UNX) [64]. A two-compartment
filtration model was employed to calculate a map of the tubular
flow. Subsequent, taking the cortex volume into account single
kidney GFR values were calculated with a good correlation
observed between the two methods. The reduction of GFR in the
UNX rats was about 50% and observed for both techniques.
The role played by the binding to serum proteins in the calcu-
lation of DCE-MRI derived estimates was investigated by
Notohamiprodjo et al. by administering Gadolinium-based con-
trast agents with different chemical structure [65]. The two inves-
tigated contrast agents, Gd-BOPTA and Gd-DTPA differ in their
binding affinity toward serum albumin, hence affecting both the
Fig. 7 Exemplary illustration of perfusion MRI of a rat with left-side AKI and perfusion maps. (a) True-FISP M0
image of an ASL measurement and the corresponding perfusion map (b). (c) TWIST post–contrast agent
injection image and the corresponding RBF map (d). All drawings show the same rat and the same axial slice.
Differences between the kidney with AKI and the contralateral kidney are clearly visible on the MRI images as
well as on the perfusion maps. (Reproduced with permission from Zimmer et al. [62])
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relaxivity and the pharmacokinetic properties [66–68]. In fact,
binding to the serum protein results in longer circulation times
(hence reduced filtration) and higher contrast capability that are
easily observed at low magnetic fields (0.5–1.5 T) [69–73]. There-
fore, whereas similar renal perfusion values were obtained by both
the two contrast agents, GFR estimates were not accurate when
obtained with the albumin-binding one (Gd-BOPTA), thus indi-





In the preclinical panorama, DCE-MRI has been widely used to
assess kidney function in renovascular and parenchymal diseases
that may lead to chronic kidney failure but also in acute events
like ischemia–reperfusion, toxicity, infections, or surgery. Thus,
different animal models have been explored ranging from classical
acute kidney injury (AKI) and chronic kidney disease (CKD) to
posttransplant rejection, nephrectomy, and assessment of drug
treatment [74–80]. In a murine model of unilateral renal artery
stenosis (RAS), measurements of single kidney GFR and perfusion
by a modified two-compartment model were compared to those
obtained from fluorescein isothiocyanate (FITC)-inulin clearance
and ASL, respectively. Both renal GFR and perfusion measure-
ments were in close agreement with the FITC-inulin clearance
and ASL methods, with a marked reduction in GFR and perfusion
estimates for the stenotic as compared to the control kidneys
[81]. Ischemia–reperfusion injury has been exploited to model
acute kidney damages and DCE-MRI approaches have been inves-
tigated for assessing single-kidney function in both mice and rats
[82, 83]. Significant reduction in single kidney GFR (calculated by
applying a two compartment renal filtration model) was observed
for ischemic kidneys in comparison to contralateral ones in rats
[84]. Conversely, for all the other DCE-MRI derived functional
parameters (mean transit times and renal blood volume) differences
were present, but were not significant between diseased and con-
tralateral kidneys of ischemic rats.
DCE-MRI studies have also been exploited in murine renal
transplantations studies for assessing acute rejection and evaluation
of immunosuppressive therapy [85]. In this study, a deconvolution
approach was applied to the DCE-MRI data and the plasma flow
estimate provided restored organ perfusion under Ciclosporin A
therapy in syngeneic transplants compared to controls.
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Chapter 13
Noninvasive Renal Perfusion Measurement Using Arterial
Spin Labeling (ASL) MRI: Basic Concept
Min-Chi Ku, Marı́a A. Fernández-Seara, Frank Kober, and Thoralf Niendorf
Abstract
The kidney is a complex organ involved in the excretion of metabolic products as well as the regulation of
body fluids, osmolarity, and homeostatic status. These functions are influenced in large part by alterations in
the regional distribution of blood flow between the renal cortex and medulla. Renal perfusion is therefore a
key determinant of glomerular filtration. Therefore the quantification of regional renal perfusion could
provide important insights into renal function and renal (patho)physiology. Arterial spin labeling (ASL)
based perfusionMRI techniques, can offer a noninvasive and reproducible way of measuring renal perfusion
in animal models. This chapter addresses the basic concept of ASL-MRI.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by two separate chapters describing the experimental procedure and
data analysis.
Key words Magnetic resonance imaging (MRI), Renal, Perfusion, Arterial spin labeling (ASL),
Kidney, Mice, Rats
1 Introduction
Kidneys are highly perfused organs in the body as they receive
20–25% blood of the resting cardiac output. High blood flow to
the kidneys ensures adequate delivery of plasma to be filtered by the
glomeruli, a physiological process necessary for the regulation of
homeostasis. Therefore, the changes in renal blood flow (RBF) will
also change the glomerular filtration rate (GFR) and, consequently,
the volume and composition of body fluids. Thus, even a slight
change in renal perfusion that exceeds renal autoregulation can
have a significant impact on the kidney function. The complex
interaction between RBF, renal oxygen delivery, renal oxygen con-
sumption, and GFR made measuring of renal perfusion an
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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attractive target to understand the regulation and homeostasis of
renal tissue in health and disease.
Renal perfusion, defined as the blood flow that passes through
a unit mass of renal tissue within a given time (mL/min/g) that is
also a key determinant of glomerular filtration. A unique aspect of
the renal perfusion is that the blood flow is regionally specific. Due
to the lack of a reliable technic which allowed to precisely measure
the regional RBF, it is roughly estimated that 80–85% of the total
renal blood flow supplies renal cortex, 10–15% outer medulla and
only 1–5% inner medulla [1].The cortical blood flow is tightly
regulated by well-documented mechanisms. Conversely, medullary
blood flow regulation is less understood and difficult to measure
[2]. The capillary density and surface area is higher in the medulla
than in the cortex at least in the mice. It is very challenging to
measure the medulla renal perfusion because of the complexity of
the microcirculation and its tight connection of arterioles from the
cortex. Although inner renal medulla receives less than 1–5% of the
total renal blood flow, but changes in this region can still have
major effect on electros and water homeostasis and control of
arterial blood pressure [3]. Regardless, to understand the physio-
logical regulation of renal perfusion and the role of its dysregula-
tion in separate regions will require methods that allow
quantification of renal perfusion both at the whole organ level
and at the local tissue level. Most of the imaging techniques for
assessing renal perfusion that have been used in humans and ani-
mals have significant limitations (Table 1) and by far there is still no
gold-standard technique available. For instance, renal perfusion can
be measured with dynamic contrast-enhanced MRI (DCE-MRI).
However, the major drawback of DCE-MRI is the involvement of
contrast media for the measurement of perfusion. The contrast
media are easily filtered by renal glomeruli and hence it is difficult
to obtain absolute quantification. Other known side effects, such as
the development of nephrogenic systemic fibrosis, also limit their
application to patients with renal deficits.
A noninvasive, practical, robust, and reproducible method to
measure renal perfusion is of great interest but remains elusive,
both in the clinic and basic research. The Arterial spin labeling
(ASL) MRI technique introduced three decades ago for quantify-
ing tissue perfusion [6, 7], is potentially the only available tech-
nique to meet all these needs. ASL is a MRI method generating
endogenous contrast specifically related to capillary blood flow. It is
therefore free of exogenous contrast media. By magnetically label-
ing arterial blood proton spins with inversion or saturation as a
freely diffusible endogenous tracer, ASL allows for the measure-
ment of RBF. Originally developed for measuring cerebral perfu-
sion, the use of endogenous blood signal to obtain tissue perfusion
information is particularly relevant for multiple and longitudinal
imaging of patients. This attribute is also important for preclinical
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imaging applications, as multiple tail-vein injections and/or cathe-
terizations can cause local inflammation and necrosis resulting in
reduced access to veins. The mature and reliable animal models
combined with reproducible imaging techniques are an indispens-
able part of scientifically designed kidney disease studies, and play
an important role in resolving the general bottleneck in renal
disease treatment that is usually delayed due to difficulties in imag-
ing disease progression.
The ASL approach has been rigorously studied in various pre-
clinical applications including correlating the degree of acute rejec-
tion and renal cortical blood flow in rat allograft model [8],
comparison of imaging results with histologic examination in
ischemia-induced acute kidney injury (AKI) [9], early detection of
antiangiogenic treatment responses in a mouse xenograft tumor
model [10] and validation of the pathophysiological process of
contrast-induced acute kidney injury in rats [11]. In this chapter,
we address the basic concept and the developments of renal ASL
with the emphasis on kidney disease models in rodents.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Measurement Concept
2.1 Basic Concept of
ASL-MRI
ASL provides quantitative parametric images of tissue perfusion. It
uses a modified protonmagnetization of arterial blood as an endog-
enous, freely diffusible contrast medium which determines the
delivery rate of oxygen and nutrients to the capillary bed and is
expressed as the volume of blood traveling through a gram of tissue
per minute (mL 100 g1 min1). The basic ASL experiment col-
lects two image types, referred to as the “label” (or tag) and
“control” (or nonlabeled) image respectively. The label is applied
Table 1
Overview of methods for monitoring renal blood flow [4, 5]
Invasive Noninvasive
Scintigraphy Doppler ultrasound
Positron-emission tomography (PET) Cine phase-contrast MRI
Multidetector computed tomography (CT) Arterial spin labeling (ASL) MRI
Contrast-enhanced ultrasound (Sonography)
Dynamic contrast-enhanced MRI (DCE-MRI)
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using radiofrequency (RF) pulses to alter the longitudinal magne-
tization of protons in the arterial blood before it enters the desired
imaging plane, and an image is collected after a time delay. The
control image is acquired at the same time delay without labeling
the arterial blood protons. Provided that the inverted magnetiza-
tion of the inflowing blood is the only difference between the
control and label images, a simple subtraction of the label from
the control image yields a perfusion-weighted image in which
signal intensity is proportional to perfusion. All ASL pulse
sequences consist of two components: (1) a preparation module
to magnetically label inflowing blood, and (2) an imaging readout
scheme to generate paired images of the target tissue under “con-
trol” and “tagged” conditions. ASL methods may be classified as to







There are two main labeling strategies that have been developed:
pulsed ASL (PASL) [12] and continuous ASL (CASL) (Fig. 1, left).
Pulsed and continuous ASL labeling methods differ fundamentally
in both the spatial extent and the duration of the labeling (Fig. 1,
right), and these differences give rise to the strengths and weak-
nesses of each approach [13]. PASL uses a single short pulse or a
limited number of pulses, to invert a thick slab of arterial water
spins. It can be further divided into those that label spins asymmet-
rically with respect to the plane of imaging (Signal Targeting by
Alternating Radiofrequency pulses; STAR [14] and Proximal
Inversion with Control of Off-Resonance Effects; PICORE [15]
or symmetrically (Flow-sensitive Alternating Inversion Recovery;
FAIR) [16]. In contrast, CASL techniques use a continuous radio-
frequency wave in a plane upstream of the imaging volume for
generating a flow-driven inversion of arterial blood flowing
through that plane. Later, a modified form called pseudo-
continuous arterial spin labeling (pCASL) has been developed,
that uses a long series of short RF-pulses together with a strong
slice-selection gradient, also resulting in a flow-driven inversion of
upstream blood proton spins. pCASL thus combines favorable
features of CASL (high signal-to-noise) with those of PASL
Fig. 1 Left: All ASL pulse sequences consist of two modules: a preparation module to magnetically label
flowing blood, and a readout module to generate paired images. Right: Schematic showing different labeling
modules. A single or a train of radiofrequency pulse for labeling followed by a postlabel delay before the image
is acquired within one TR.
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(lower energy deposition). Today most commercially available ASL
products are based on pCASL or a PASL variant. Table 2 shows
examples of preclinical studies using ASL for measuring RBF in
animal models and list each of the labeling and readout methods.
2.2.1 Pulsed ASL (PASL) The PASL variant (FAIR) is the major method used for measuring
renal perfusion in rodents due to its ease of implementation. FAIR
uses a single long-duration RF pulse which is applied to invert the
arterial magnetization as blood flows through the labeling plane
while a gradient is applied in the direction of arterial flow. In FAIR
ASL the magnetization is usually prepared using a global inversion
which is referred to as the “labeling” and a slice selective inversion
which is referred to as “control.” The sequence begins with a
spatially selective inversion pulse limited to a small region in and
around the imaged slice. In the standard labeling scheme the selec-
tive inversion slice (control) is in the same plane as the imaging slice
with a thickness of 1.5–5 times the thickness of the imaging slice.
The inversion pulse is usually slightly wider than the imaging slice
to minimize artifacts and ensure uniform inversion. For the “label-
ing,” the same inversion pulse is applied but without the slice-
selection gradient. This causes an inversion of spins within the
entire sensitive volume of the RF coil (Fig. 2a). By subtracting the
control image from the labeling image, a perfusion-weighted image
(PWI) is formed, which with the appropriate modeling can be
quantified using a perfusion map in units of mL/100 g/min. In
various preclinical MRI situations, for instance with dedicated small
brain birdcage transmit/receive (TX/RX) resonators, the transmit
coil used may not be long enough to provide a sufficiently global
inversion for FAIR perfusion measurements.
Table 2
Overview of renal ASL studies in rodents
Reference Scanner ASL labeling Image readout Animal model
[9] 7.0 T (Bruker) FAIR EPI Mouse
[10, 17] 7.0 T (Bruker) FAIR SE-EPI Mouse
[18] 11.5 T (Bruker) FAIR SE-EPI Mouse
[19] 11.5 T (Bruker) pCASL bSSFP Mouse
[20] 7.0 T (Bruker) FAIR bSSFP Mouse
[21] 3.0 T clinical whole body (Siemens) FAIR bSSFP Rat
[22] 3.0 T clinical whole body (Siemens) FAIR bSSFP Rat
[23] 3.0 T clinical whole body (Siemens) FAIR bSSFP Rat




CASL uses a continuous flow-driven radiofrequency inversion of
blood upstream of the imaging volume. The radiofrequency wave is
transmitted either by a dedicated, separate labeling coil or by the
volume transmit coil that is also used for imaging. The latter
approach has the advantage that no special hardware components
are required but the disadvantage of depositing high amounts of RF
energy leading to magnetization transfer contrast that has to be
properly corrected. One drawback of CASL labeling approach is the
consequently high transmitter duty-cycle requirement.
The pCASL technique has evolved from the original CASL
technique in both, brain and kidney applications [24]. pCASL
uses series of short and high-power RF and gradient pulses instead
of the long RF pulses used in CASL to generate a flow-driven
inversion. Compared to FAIR, pseudo-continuous ASL (pCASL)
provides significant advantages such as increased SNR and better
definition of the labeling bolus. FAIR (pulsed ASL) may be attrac-
tive for renal imaging because it can label closer to the tissue, but
pCASL offers the potential advantage of high SNR of the kidneys
Fig. 2 Basic principle of arterial spin labeling (ASL) acquisition. It consists of a differential technique during
which two acquisitions are carried out: one with the labeling of arterial protons (label image) and a control
image. Arterial blood is labelled by inverting its magnetization. After an inflow time (inversion time), which
allows the labeled blood to flow into the tissue of interest, an image is acquired with an appropriate readout
sequence. (a) FAIR uses a nonselective inversion pulse for the labeled images that becomes selective with the
addition of a slice selection gradient for the control. (b) The magnetic labeling of arterial protons is carried out
upstream from the volume of interest, by radiofrequency pulses. The labeled protons then migrate via the
arterial vessels toward the tissue where they pass from the capillary compartment to the extravascular
compartment (example shown: pCASL)
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and the whole abdomen, which would be desirable in some specific
applications (e.g., metastatic). An earlier study compared the
performances of FAIR and pCASL in terms of sensitivity, absolute
quantification, reproducibility, and flexibility of implementation
using healthy mice [18]. It was reported that the application of
pCASL at 11.75 T scanner had higher sensitivity compared to FAIR
(> þ20%). Finally, since pCASL can be straightforwardly used in
multislice mode and in any imaging orientation, it may be consid-
ered as a method of choice for mouse kidney perfusion studies.
2.3 Imaging Readout A typical ASL MRI acquisition combines an ASL magnetization
preparation module (labeling methods) followed by a subsequent
rapid imaging module (readouts) to capture the blood flow–
weighted contrast. These two aspects of the acquisition are inde-
pendent of each other. It is important to note that the majority of
the ASL imaging developments has focused on the optimization of
preparation module of the ASL acquisition [20].
An important prerequisite for successful kidney imaging is the
ability to get fast imaging to limit the sensitivity to motion [19]. As
such, ASL has been implemented with a wide variety of fast image
readout techniques, which in turn can be optimized according to a
specific application. The fast image readout techniques can be
broadly classified as two-dimensional (2D) or 3D acquisition
schemes. Whereas 3D readouts are generally recommended for
brain ASL, a consensus of the optimal readout module for renal
applications has yet to be established. This consideration has been
recently achieved to recommend a 2D readout in humans (unpub-
lished by PARENCHIMA ASL expert panel).
With respect to 2D readouts, to determine the optimal readout
for renal ASL, a number of factors should be considered. The
optimal readout should have a short echo time (TE) in order to
provide the highest image signal-to-noise ratio (SNR), and to
reduce the amount of signal dephasing and distortion. At longer
TEs, the short tissue intrinsic T2 and T2* in the abdomen leads to
rapid signal drop and the loss of perfusion signal. The ideal readout
should be collected in a short shot length to enable multiple slices
through the kidney to be acquired prior to the decay of the ASL
label, thus enabling whole-kidney perfusion assessment [25]. Many
ASLMRI studies have utilized either echo-planar imaging (EPI) or
true fast imaging with steady-state free precession (bSSFP; True
FISP) readouts [20] though the readout of ASL can be measured
with any method. Both EPI and bSSFP readouts are prone to
off-resonance artifacts on high field MRI scanners [20] where the
majority of animal studies are done by using such high field or ultra-
high field (> ¼ 7 T) scanners. Specifically, B0 inhomogeneity
results in increased distortion / ghosting and banding artifacts
from EPI and True FISP imaging readouts. These artifacts are
particularly problematic for abdominal imaging applications such
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as kidney where cardiac and respiratory motions well as adipose
tissue can make precise shimming difficult. In addition, the increase
in T1 relaxation times which is proportional with the field strength
can result in spoiled gradient echo images with a lower signal-to-
noise ratio (SNR) relative to these other imaging readouts. The low
SNR is specifically problematic for ASL MRI techniques as the
differential blood flow signal is typically less than 10% of the mean
tissue signal.
Though the optimization of EPI acquisitions allow for whole-
kidney coverage but nevertheless provide sub-optimal and slice-
dependent perfusion-weighted SNR and is susceptible to
off-resonance conditions mentioned above. There is an urgent
need to develop a rapid and robust ASL MRI imaging readout
that is balanced on blood flow labeling from the ASL labeling
module and also avoid B0 inhomogeneities and motion artifacts
on high field preclinical MRI scanners.
While several groups independently optimize the bSSFP image
readout and shown the advantage over EPI readouts [25], more
advanced methods now provide alternative readouts, such as 3D
gradient and spin echo (GRASE) [26, 27]. 3D GRASE has superior
SNR compared to 2D acquisitions. An alternative to 3D GRASE is
3D rapid acquisition with relaxation enhancement (RARE) com-
bined with a spiral readout trajectory (shorter echo times and
superior SNR), but can introduce through-plane blurring due to
long readout times.





The encouraging results using ASL for measuring human renal
perfusion mandate further validation of renal ASL measurements
using animal models. For example, in vivo interventional swine
model has been used with FAIR-ASL technique to track cortical
perfusion changes during pharmacologic and physiologic altera-
tions in renal blood flow [28]. For measuring renal hemodynamics
and oxygenation in X-ray contrast agent induced acute kidney
injury (CIAKI), a rat model was used. Rats were injected with
contrast media and followed by ASL measurements [29]. Other
models, for instance ischemia induced AKI in mice, was done by
transient unilateral clamping of the renal pedicle for either 35 min
for moderate AKI or 45 min for severe AKI. Using ASL, renal
perfusion impairment was found more pronounced in severe com-
pared to moderate AKI, with severe AKI causing a 33% reduction in
renal perfusion [9]. In addition, ASL can be useful for longitudinal
assessment of renal perfusion impairment due to acute and chronic
renal allograft rejection in translational mouse models [30]. By
combining with the histological assessment, perfusion impairment
can be validated and revealed its relationship to the severity of
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vascular changes and renal damage. Other applications such as
exploring the renoprotective efficacy of drug treatment in
ischemia-induced AKI or in renal allograft recipients revealed that
the renoprotective effect of the drug was associated with improved
renal perfusion [22]. Thus, noninvasive perfusion imaging might
provide insights into the underlying disease mechanisms in acute
and chronic renal allograft rejection andmight facilitate monitoring
of novel treatment strategies. Similar approach can be applied to
monitor kidney function of most common kidney diseases, such as
CIAKI, diabetic nephropathy, and kidney transplant. In addition,
ASL techniques can also be used to monitor the therapeutic
responses of treatments to common renal hypoxia disease. Figure 3
is an example of ASLmeasurement using FAIR for labeling and EPI
for image readout in a healthy mouse. Table 2 lists all examples of
preclinical studies using ASL for measuring RBF in rodent models.
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Chapter 14
Renal pH Imaging Using Chemical Exchange Saturation
Transfer (CEST) MRI: Basic Concept
Dario Livio Longo, Pietro Irrera, Lorena Consolino, Phillip Zhe Sun,
and Michael T. McMahon
Abstract
Magnetic Resonance Imaging (MRI) has been actively explored in the last several decades for assessing renal
function by providing several physiological information, including glomerular filtration rate, renal plasma
flow, tissue oxygenation and water diffusion. Within MRI, the developing field of chemical exchange
saturation transfer (CEST) has potential to provide further functional information for diagnosing kidney
diseases. Both endogenous produced molecules as well as exogenously administered CEST agents have
been exploited for providing functional information related to kidney diseases in preclinical studies. In
particular, CEST MRI has been exploited for assessing the acid-base homeostasis in the kidney and for
monitoring pH changes in several disease models. This review summarizes several CEST MRI procedures
for assessing kidney functionality and pH, for monitoring renal pH changes in different kidney injury
models and for evaluating renal allograft rejection.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers. This introduction
chapter is complemented by two separate chapters describing the experimental procedure and data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, pH, Iopamidol, Chemical
exchange saturation transfer (CEST), Acute kidney injury, Ischemia–reperfusion injury, Renal damage
1 Introduction
Renal dysfunction is recognized as a significant health problem
originating from a variety of causes leading to acute or chronic
kidney diseases. Predisposition to acute kidney injury and prema-
ture mortality are frequent outcomes for chronic kidney diseases
[1]. Moreover, according to the Global Burden of Disease 2013
study, the age-standardized death rates for chronic kidney diseases
showed one of the highest increases in the last two decades
[2]. Therefore, reliable and early diagnosis of acute and chronic
kidney diseases is needed to preserve renal functionality and
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improve patients’ outcome. Despite these premises, current clinical
evaluation of renal function is still based on measurement of serum
creatinine, which is well known to have several limitations. In fact,
an elevated serum creatinine concentration is only discovered at late
stages of the disease when renal functionality is already compro-
mised. Therefore, novel noninvasive imaging approaches are
needed for a more accurate and early diagnosis of renal physiology.
Magnetic resonance imaging (MRI) has been exploited for tissue
anatomic imaging, owing to the high spatial resolution and lack of
ionizing radiation. In research, novel MRI techniques have been
investigated for assessing multiple functional parameters of the
kidneys, including perfusion, filtration, oxygenation and tissue
elasticity [3–11]. Several reviews covering the role of these MRI
approaches for assessing renal functionality have been published
[12–15]. This additional information should enable a better char-
acterization of acute and chronic kidney diseases in comparison to
standard urine and serum-based assays.
Recently, Chemical Exchange Saturation Transfer (CEST)
MRI has emerged as a novel approach for functional and molecular
imaging with great promise for clinical translation [16–18]. In
addition, CEST MRI pH imaging has emerged as a valuable
approach for assessing extracellular pH values in several tissues,
including kidneys and tumors, providing the highest accuracy and
spatial resolution achievable so far [19]. Owing to the key role of
the kidneys in maintaining the acid-base homeostasis, CEST MRI
pH mapping has emerged as a novel and promising approach in
monitoring kidney functionality.
In this chapter, we will address the basic concept and the
developments of renal CEST pH imaging with the emphasis on
kidney disease models in rodents.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)







CEST is a new technique that enables the indirect detection of
molecules possessing mobile protons in exchange with water
[20]. Because of this, CEST makes MRI sensitive to endogenous
or exogenous molecules that possess suitable protons [21–32]. The
generation of contrast is based on a selective irradiation with a
radiofrequency pulse at the specific absorption frequency of the
exchanging proton, followed by a subsequent transfer, due to
chemical exchange with bulk water, of the saturated signal. Upon
the application of a long saturation RF (radiofrequency) pulse, the
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water signal decreases, allowing the amplification of the labeled
protons from the molecule to water. As a consequence, low con-
centration molecules can be specifically and indirectly detected,






Several classes of CEST contrast agents can be used as pH respon-
sive agents and exploited for in vivo experiments.
2.2.1 Diamagnetic CEST
Agents
Several molecules, including natural occurring molecules, possess
exchangeable protons that can be indirectly detected within the
CEST approach [39]. Most of these labile protons have chemical
exchange rates that show a strong pH dependence. Hence differ-
ences in CEST contrast can be exploited for assessing the pH of the
solution where they are dissolved. Due to the concomitant contri-
bution of concentration and exchange rate to the observed CEST
contrast, several approaches have been proposed to rule out the
concentration term, based on the ratiometric method, that is,
taking the ratio of the observed contrast, providing accurate pH
readouts [40, 41]. Most of the pH responsive diamagnetic mole-
cules investigated so far in vivo are iodinated contrast agents used
for radiographic procedures, since they have been used in the last
40 years in clinical examinations owing to their high safety profiles
[42, 43]. The presence of amide groups in their chemical structure
allow them to be exploited as CEST MRI contrast agents, upon
selective irradiation of the mobile proton pool [44].
Among the radiographic contrast media, Iopamidol (Isovue®,
Bracco Imaging, Italy) (Fig. 1) was the first agent exploited for
mapping pH thanks to the presence of two amide groups with
different resonance frequencies, at 4.2 ppm and at 5.5 ppm, respec-
tively, that can be selectively irradiated [45–47]. This chemical
peculiarity led to the development of a ratiometric approach
based on the ratio of the CEST effects at these two frequencies to
provide accurate pH measurements. In vitro experiments showed a
high pH responsiveness within the physiological range and accurate
pH measurements (Fig. 2a, b). Following intravenous administra-
tion, it can provide selective contrast at specific frequency offsets
and from the ratio of these two parametric maps it is possible to
measure renal pH map (Fig. 2c–f). To validate the approach and
test the pH-responsiveness of the agent, induced alkalinisation or
acidification of urine was obtained in mice upon providing acidic or
alkaline drinking water for a week. For control mice, mean pH
values calculated for cortex, medulla and calyx regions were:
7.0  0.11; 6.85  0.15 and 6.6  0.20, respectively. In mice
drinking acidic water a significant acidification of renal pH values
was obtained. Conversely, a marked increase of renal pH values was
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Fig. 1 Chemical structures of the reported pH-responsive CEST agents investigated for renal pH mapping
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observed upon alkaline water administration. Both observations
demonstrate the capability to measure in vivo renal pH changes
with CEST MRI.
Since the accuracy in measuring pH depends on several factors,
including chemical exchange rate, irradiation conditions (satura-
tion power and duration), and main magnetic field, quantification
of multisite pH-dependent chemical exchange properties is needed
to improve pH accuracy [48]. This characterization of chemical
exchange rates and optimal irradiation RF pulses led to the devel-
opment of an optimized saturation for each single amide proton
pools, hence resulting in a higher pH sensitivity. As a result, the
capability to measure pH was demonstrated also at magnetic field
strengths of 4.7 T, where amide resonances partially overlap. In the
study of Wu and coworkers, they demonstrated an improved pH
sensitivity, extending the pH detection range from 5.5 to 7.5, with
high resolution pH maps of the kidneys in healthy rats (Fig. 3)
[49]. More recently, the exploitation of the same ratiometric
approach for measuring in vivo pH was also demonstrated at mag-
netic fields as low as 3 T, which still preserved good pH
accuracy [50].
Fig. 2 Iopamidol ratiometric curve obtained from the rations of the CEST contrast upon irradiating at 4.2 and
5.5 ppm, respectively, showing the high pH responsiveness of Iopamidol. Irradiation power levels of 3 μT,
Iopamidol 30 mM, 7.05 T, 310 K, irradiation time 5 s (a). Calculated pH values obtained by the ratiometric
method (Iopamidol 30 mM, 7.05 T, 310 K, irradiation time 5 s, B1 3 μT) are compared with the values read on
the pH-meter (b). Representative images of in vivo renal pH mapping showing the anatomical image (c) and
the CEST contrast parametric maps overlaid to the anatomical image at 4.2 ppm (d) and 5.5 ppm (e) and the
observed pH map (f) obtained by ratioing maps (d) and (e) and using the calibration curve in (a) for calculating
the pH values. (Adapted with permission from Magnetic Resonance in Medicine 2011 (Iopamidol as a
responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: in vivo
studies in mice at 7 T. Volume: 65, Issue: 1, Pages: 202–211, DOI: https:/doi.org/10.1002/mrm.22608))
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Another similar iodinated contrast media, Iopromide (Ultra-
vist®, Bayer Healthcare, Germany), was also demonstrated and
compared to Iopamidol for measuring pH, with a pH sensitivity
that was not substantially different, although Iopamidol allows for
more precise pH measurements [51].
The exploitation of the ratiometric approach requires two dis-
tinguishable protons pools on the same molecule, therefore it is
limited to a select group of compounds possessing this feature. To
overcome this limitation, Longo and Sun proposed a novel
approach based on the irradiation of a single pool under different
radiofrequency powers [52]. The proposed approach, called ratio
of RF power mismatch or RPM, was demonstrated by using Iobi-
tridol (Omnipaque®, GE Healthcare, USA), a radiographic con-
trast medium possessing only one amide proton pool resonating at
5.5 ppm (Fig. 1). Since the measured CEST contrast is dependent
on both pH and irradiation power (B1), a strong pH dependence
was demonstrated by calculating the ratio of the CEST contrast at
two different B1 power levels. In comparison to the conventional
ratiometric approach, a good pH accuracy and an even higher pH
sensitivity were demonstrated. When investigated in healthy
kidneys, the measured pH values upon iobitridol injection strongly
correlated with the pH values obtained following iopamidol injec-
tion. Recently, to overcome the specific absorption rate (SAR)
limitations when using a continuous wave (CW) irradiation of the
mobile proton pools, a pulsed ratiometric approach has been
Fig. 3 Extension of pH detection range using the modified ratiometric analysis (red circles) versus the standard
ratiometric approach (blue squares) (a). Representative in vivo ratiometric map for the proposed approach (b).
pH map shows the renal pH gradually decreasing from the cortex, medulla to calyx (c). Maps are overlaid on
the corresponding T2-weighted image. (Adapted with permission from Magnetic Resonance in Medicine 2018
(A generalized ratiometric chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH
using Iopamidol, Volume: 79, Issue: 3, Pages: 1553–1558, DOI: https:/doi.org/10.1002/mrm.26817))
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exploited and tested on the Iodixanol (Visipaque®, GE Healthcare,
USA) X-ray contrast medium for CEST pH imaging [53].
Diamagnetic contrast agents possess resonances that are close
in frequency to the bulk water signal resulting in a reduction of
sensitivity (due to an inefficient labeling selectivity) when moving
from high to low magnetic fields. Following previous investiga-
tions, McMahon and colleagues developed new diamagnetic sys-
tems based on the imidazole, salicylate or anthranilate moieties
which possess mobile protons shifted very far from the bulk water
peak [54–56]. In particular, candidate compounds derived from
imidazole-4,5-dicarboxamides (#5 and #8, Fig. 1) show a CEST
signal shifted up to 7.8 ppm upfield by exploiting the presence of
intramolecular bond shifted hydrogens. Besides the large chemical
shift, a good pH sensitivity and a high-water solubility made com-
pound #5 suitable as a pH sensor and so it has been tested in vivo
[57]. pH imaging of the kidneys at 11.7 T resulted in average pH
values for the whole kidneys of 6.5  0.1, consistent with renal pH
values reported by radiographic contrast agents (Fig. 4).
2.2.2 Paramagnetic
CEST Agents
Paramagnetic chemical exchange saturation transfer (paraCEST)
agents typically consist of a paramagnetic metal ion and an organic
chelate based on a macrocyclic cage due to the high kinetic stability
of these metal chelates to prevent the release of the toxic free
lanthanide cation [58]. The CEST signal is therefore generated by
selective irradiation of the bound water molecule, or of the slowly
exchanging ligand protons, such as hydroxyl, amine, or amide
groups [59–62]. The main advantage of paraCEST agents in com-
parison to diamagnetic ones relies in the exceptionally large chemi-
cal shifts (MR frequency relative to the water frequency) due to the
hypershift contribution of the lanthanide metal ion. This large
range of chemical shifts increases the specificity of the exchanging
proton pools, hence reducing the adverse contributions of direct
saturation and of the endogenous semisolid macromolecular effects
[63]. Since the chemical exchange rate of the paraCEST agent can
be altered by environmental factors such as pH, changes in CEST
amplitudes can be used as well for deriving pH values.
The first demonstration of CEST detection in kidneys using a
paraCEST agent (TmDOTA-4AmC, Fig. 1) was provided by
Vinogradov et al., showing good detectability in the whole kidney
regions [64]. Later on, a Europium paraCEST pH responsive agent
(europium(III) DO3A-tris(amide) complex, Fig. 1) was exploited
to measure pH in mouse kidneys [65]. Owing to its chemical
structure, a quite large frequency shift of the ion-bound water
molecule due to the delocalization of negative charge coming
from deprotonation of phenolic residue was observed. This shift
is pH dependent, therefore an alkalinisation from 6.0 to 7.6 at
298 K leads to a 4 ppm shift in frequencies, from 50.5 to
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54.5 ppm, respectively, that can be exploited for assessing pH. By
exploiting a 9.4 T MR scanner and ensuring stable temperature
homogeneity, in vivo pH measurements were feasible in kidneys
upon the administration of a dose of 0.4 mmol/kg [66].
2.3 Imaging Readout CEST MRI techniques includes continuous wave (CW) or pulsed
train RF saturation to prepare the magnetization followed by a fast
image readout such as echo planar imaging (EPI), Rapid Imaging
with Refocused Echoes (RARE) and/or fast imaging with steady-
Fig. 4 pH calibration curve of compound #5 (a) and calibration plot using all tubes in the phantom showing
experimental versus calculated pH (b). Experimental conditions: CEST data were obtained at 6.25 mM, 25 mM,
or 50 mM concentration, saturation time¼ 3 s, saturation power¼ 5.9 μT and 37 C. pH measurements were
made with a precision of 0.1 unit. T2-weighted image (c) and pH map (d) following administration of
compound #5. (Adapted with permission from Contrast Media Molecular Imaging 2016 (Developing imidazoles
as CEST MRI pH sensors, Volume: 11, Issue: 4, Pages: 304–312, DOI: https:/doi.org/10.1002/cmmi.1693))
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state precession (FISP) [45, 67, 68]. More advanced methods now
provide more sophisticated sampling schemes, such as 3D radial or
spiral acquisitions, but those are currently available only on clinical
scanners and not on preclinical scanners, thus limiting CEST acqui-
sition in mice and rats to single slice based approaches
[69, 70]. However, recent studies have utilized multislice acquisi-




Fast spin echo (FSE) or rapid imaging with refocused echoes
(RARE) are commonly used because of the strong SNR (signal-
to-noise ratio), high tolerance to B0 inhomogeneities and moderate
to short acquisition times. These methods allow acquisitions of
several lines for full sampling the k-space for a single slice within a
single TR, which greatly reduces the acquisition time and still
preserves SNR.With single shot acquisitions, usually centric encod-
ing is exploited to maximize the SNR. Further reductions in acqui-
sition time can be achieved by adjusting the bandwidth (hence
reducing the echo times or the distance between each refocused
echo time) or by partial Fourier approaches (i.e., by acquiring only




FISP readout has been used with CEST MRI that provides robust
image readout with little distortion, although more sensitive to B0
inhomogeneity than RARE. B0 inhomogeneity might be an impor-
tant issue particularly for body applications like the kidneys.
2.3.3 Spin-Echo Echo
Planar Imaging (EPI)
CESTMRI is often combined with EPI acquisition, which provides
fast image readout after a relatively long RF saturation. Whereas
both gradient echo and spin echo EPI have been used, SE EPI is
often preferred for body application because it is less susceptible to
mild magnetic field inhomogeneity distortions that are common in
body applications. The use of an EPI readout also enables multislice
acquisitions in reasonable times.
3 Overview of Applications
CEST imaging has been exploited for assessing renal pH values in
healthy and in several models of renal damage, including either
bilateral or unilateral acute kidney injury models. Both endogenous
CEST approaches and exogenous CEST approaches have been





Since diabetic nephropathies (DNs) are associated with changes in
renal metabolites, the utility of CEST MRI to detect changes in
glucose/glycogen hydroxylic protons was investigated in murine
models of diabetic nephropathies. The study was conducted longi-
tudinally from 8 to 24 weeks on two groups of diabetic mice and on
nondiabetic mice as control. Based on the variation of glucose/
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glycogen composition and the consequent CEST effects measured
in kidney regions, a significantly increased CEST of hydroxyl meta-
bolites was observed in diabetic mice during the progression of
DN [73].
3.2 CEST pH Imaging
for Assessing Renal
Diseases
Most of the studies reported so far have exploited the
pH-responsiveness of Iopamidol for investigating the changes in
pH homeostasis following renal injuries. In one of these studies, the
pH evolution in an acute kidney injury model induced by intramus-
cular glycerol injection and consequent rhabdomyolysis was moni-
tored [74]. Renal pHmaps acquired at 1, 3, 7, 14, 21 days after the
injury reported a marked increase of pH values during the damage
evolution up to 3–7 days, followed by recovery of pH toward
baseline values at 14 and 21 days. These results were in good
agreement with morphological and Blood Urean Nitrogen
(BUN) quantification supporting this CEST MRI pH mapping
approach for investigating renal function. Furthermore, along
with the progression of the damage, a reduction of pixels where
Iopamidol was detectable was observed, suggesting that also the
percentage of CEST-detected pixels can be used as an imaging
biomarker of renal injury.
In another study, Longo and coworkers investigated a unilat-
eral kidney ischemia reperfusion injury (KIRI) model to validate
MRI-CEST pH mapping for assessing single kidney functionality
[75]. Two different times of ischemia duration, 20 and 40 min,
were applied to model moderate or severe KIRI, respectively. Fol-
lowing the damage evolution at days 0, 1, 2, 7, a significant increase
in renal pH values was observed even at day 1 in both cases.
Furthermore, in the following MRI acquisitions a clear distinction
between moderate and severe AKI is possible since a recovery of
normal acid-base balance was observed only in the moderate KIRI
mice whereas in severe KIRI mice the increased pH values did not
restore to baseline values (Fig. 5a, b). In additions, as in the
previous study, the percentage of CEST detected pixels, represent-
ing a marker of the filtration fraction, showed significant differences
between the injured kidneys and the contralateral ones, reflecting




Since the capability of CEST imaging to detect hydroxyl protons,
native glucose has also been proposed as a tracer for MRI Gluco-
CEST imaging [76–78]. Besides its exploitation in oncological
applications, it has been applied for monitoring allograft rejection
[79]. In this study, Brown Norway rat kidneys were transplanted
into Lewis rats and imaged 4 days following the surgery, before and
after glucose administration. By calculating the cortex-to-medulla
CEST ratio (CESTR), dependent on the accumulation of the
administered glucose, rats that underwent allogeneic transplant
showed the highest CESTR values compared to syngeneic trans-
plant group and to control mice.
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Fig. 5 MRI-CEST pH mapping detects renal pH changes and regional distribution of damage after moderate
and severe unilateral kidney ischemia reperfusion injury (KIRI) showing clamped (right) and contralateral
normal kidney (left). Representative MRI-CEST pH maps overimposed onto anatomical images before and after
moderate (a) and severe (b) KIRI at different time points (day 1, day 2, and day 7) showing pronounced
alkalinization and reduced filtration (noncolored pixels within the renal region, c, d) of the pH-responsive
contrast agent in clamped kidney in comparison to contralateral kidney. (Adapted with permission from: NMR
in Biomedicine 2017 (Noninvasive evaluation of renal pH homeostasis after ischemia reperfusion injury by
CEST-MRI, Volume: 30, Issue: 7, DOI: https:/doi.org/10.1002/nbm.3720))
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Chapter 15
Sodium (23Na) MRI of the Kidney: Basic Concept
James T. Grist, Esben Søvsø Hansen, Frank G. Zöllner,
and Christoffer Laustsen
Abstract
The handling of sodium by the renal system is a key indicator of renal function. Alterations in the
corticomedullary distribution of sodium are considered important indicators of pathology in renal diseases.
The derangement of sodium handling can be noninvasively imaged using sodium magnetic resonance
imaging (23Na MRI), with data analysis allowing for the assessment of the corticomedullary sodium
gradient. Here we introduce sodium imaging, describe the existing methods, and give an overview of
preclinical sodium imaging applications to illustrate the utility and applicability of this technique for
measuring renal sodium handling.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by two separate chapters describing the experimental procedure and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, 23Na, Sodium
1 Introduction
In this chapter, we describe renal sodium imaging, as acquired with
magnetic resonance imaging (MRI). An introduction to the many
methods that can be used to acquire sodium (23Na) signal is
presented, as well as the postprocessing required to quantitatively
describe the signal in terms of relaxation or concentration. Example
applications of sodium renal imaging are discussed—ranging from
the action of diuretic drugs to early sodium handling alterations in
acute kidney injury. This introduction is complemented by two
separate chapters describing the experimental procedure and data
analysis, which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_15, © The Author(s) 2021
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2 Measurement Concept
2.1 Basic Concept of
Sodium Imaging
Sodium imaging can provide quantitative measures of the 23Na
concentration in tissue [1]. It utilizes the signal from the sodium
nucleus, found in both the intra- and extracellular compartments,
to acquire images of the 23Na biodistribution. Due to the low
natural abundance of biological sodium, in comparison to water,
as well as a rapid quadrupolar relaxation and lower gyromagnetic
ratio (spin ¼ 32, γ ¼ 11:262MHzT ), approximately ¼ of protons, the
signal available is much lower than that of conventional 1H MRI
[2]. The fast quadrupolar relaxation recovers some of the disadvan-
tages of imaging 23Na, as very short repetition times (TR) can be
used, albeit the ultrafast T ∗2 relaxation imposing constraints on the
imaging technique used. Commonly, the total (meaning from both
the intra- and extracellular compartments) sodium signal is
acquired through the use of surface or RF volume coils, at high
magnetic field strengths (3–9.4 T) using gradient echo-based imag-
ing technique [3–6]. It is possible to suppress some of the extracel-
lular signal, to give an “intracellular weighted” image, with
advanced techniques such as inversion signal nulling or triple quan-
tum filtering (TQF) [7, 8]. An estimate of the difference in the
intra- and extracellular compartment sizes is feasible through the
use of T ∗2 mapping [9]. It is noted that no current use of TQF or
inversion recovery signal nulling have been undertaken in renal
studies; however, there are a number of publications in neurological
work [8, 10, 11].
2.2 Sodium Imaging
Methods
There are a number of imaging methods available for mapping the
biodistribution of sodium in the renal system. The sodium signal
detected in a simple imaging experiment is a combination of intra-
and extracellular compartments, termed the “total” sodium signal.
The three main methods used to differentiate the intra- and extra-
cellular sodium signals are triple quantum filtering, inversion recov-
ery fluid attenuation (IR), and T∗2 mapping.
2.2.1 Sodium MRI
Hardware
For signal reception, the MR scanners need to be equipped by RF
transmitters and receive RF coils tuned to the resonance frequency
of the sodium nuclei at the respective magnetic field strength.
Today, such extensions are supported by some vendors of preclini-
cal systems. In the following, hardware developments for quantita-
tive 23Na-MRI in preclinical are briefly outlined.
For the first time, Barberi et al. introduced the transmit-only
receive-only (TORO) system, the so-called dual radiofrequency
(RF) resonator, which is based on the idea of separated transmit
and receive RF elements [12]. In contrast to the standard RF
resonators in transceiver (TXRX) mode (e.g., surface coil or
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birdcage), the dual RF resonator allows for both a homogeneous
transmit B1
+ field and a highly sensitive receive B1
 field [12, 13].
Kalacycian et al. developed a homogeneous transmit-only vol-
ume resonator and a highly sensitive RO surface resonator for renal
23Na-MRI for 3 T or 9.4 T MRI scanners [14]. For this setup the
sensitivity correction needs to be performed only for the receive
profile. Furthermore, the dual resonator allows for increased 23Na-
MR signal sensitivity due to the localized signal detection using RO
surface coils. For the dedicated task of bilateral kidney imaging, a
dual resonator system (TORO) including a two-element phased
array at 9.4 T and a receiver saddle shaped RF resonator at 3 T was
implemented [13]. These systems were tailored for measuring the
absolute renal TSC in rat kidney models with high spatiotemporal
resolution, and high concentration measurement accuracy.
2.2.2 Total Sodium
Imaging
Total sodium imaging is typically performed using a gradient echo-
based technique. To ensure that the conversion from the imaging
signal to the sodium concentration is accurate, a repetition time of
approximately 2.5 times the T1 of tissue sodium (approximately
25 ms at 3 T, and longer at higher field strengths) is essential.
Further optimization of the sequence readout can be undertaken
to capture the fast T ∗2 relaxation of the sodium nucleus. For
example, an ultrashort echo time (UTE) approach such as radial
or twisted projection imaging is preferred over conventional Carte-
sian strategies. Due to the inherent low SNR of sodium acquisi-
tions, it is common to average a number of sodium scans from the
same subject; however, this may lead to long scan times.
An example of total sodium imaging pulse sequence, and renal
images, are provided in Figs. 1a and 2.
2.2.3 Triple Quantum
Filtering (TQF)
Due to the 32 spin of the sodium nucleus, a biexponential T
∗
2 is
exhibited by the isotope. A single excitation with a 90-degree hard
pulse causes a transition of spins between the outer spin states
(32 to
1
2 and  12 to 32) as well as the inner states (12 to 12 ). The
outer spin states exhibit a faster T ∗2 decay than the inner. Using
phase-cycled radiofrequency pulses it is possible to isolate the signal
of slow-moving spins in the intracellular compartment, while
removing the extracellular contribution [15].
There are a number of limitations to TQF though. The chal-
lenges include long scan times and high energy deposition required
due to a large SNR penalty of the TQF technique. Furthermore,
inhomogeneity in main magnetic field distribution can lead to
spurious results, with corrections in reconstruction required to
counter the B0-nonuniformity effects [10]. An example triple
quantum filtering sodium imaging pulse sequence is shown in
Fig. 1b.
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2.2.4 Inversion Recovery Utilizing the difference in T1 between bound and unbound
sodium, it is possible to null the signal contribution fluid compart-
ment using an inversion pulse, whilst retaining the bound signal, as
described through Eqs. 1 and 2 [7].
S TIð Þ ¼ S0 1 exp  TIT 1
  
ð1Þ
TInull ¼ ln 2ð ÞT Fluid1 ð2Þ
Fig. 1 Sodium imaging pulse sequences. (a) Total sodium imaging sequence using a 3D GRE readout.
TR ¼ Repetition time, TE ¼ Echo time. (b) Triple Quantum Filtered sodium imaging pulse sequence using a
3D GRE readout. α¼ phase of pulse 1, T1¼Mixing time 1, T2¼Mixing time 2. (c) Inversion prepared sodium
imaging pulse sequence. TI ¼ Inversion preparation time (determined experimentally)
Fig. 2 Example rodent renal 1H (left) and sodium (right) imaging acquired at 9.4 T
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where TI is the inversion time, T1 is the relaxation constant of free
sodium, S0 is the initial sodium NMR signal, and S(TI) is the signal
at TI. An example of an inversion recovery sodium imaging tech-
nique is illustrated in Fig. 1c.
2.2.5 T2* Mapping T ∗2 mapping is performed with either a multiecho based gradient
echo sequence, or many individual scans with an incremented echo
time (TE). It is currently thought that the shorter T ∗2 component
(1-5 ms at 3 T) is derived from the intracellular compartment, and
the longer (10–30 ms at 3 T) from the extracellular compartment
[9, 16]. T2* mapping therefore could be sensitive to changes in the
intracellular–extracellular renal sodium balance.
A multiecho or incremented echo series can be used to derive
both the pool sizes and T∗2 time constant for each compartment
through Eq. 3.
S TEð Þ ¼ a exp  TE
T ∗2,Short
 !




where S(TE) is the signal at a given echo time, a and b are the intra-
and extracellular pool sizes, respectively, and T∗2,Short and T
∗
2,Long
are the biexponential relaxation constants.
2.3 Imaging Readout Due to the rapid decay of the sodium signal, fast gradient echo-
based imaging methods are commonly employed for data acquisi-
tion. A large number of encoding schemes are present in the litera-
ture, encompassing Cartesian and non-Cartesian imaging
[17]. Below is a summary of most frequently applied methods.
2.3.1 3D Cartesian
Imaging
The majority of preclinical imaging has been undertaken with 3D
gradient echo Cartesian imaging, whereby a volume of k-space is
sampled using trapezoidal readout gradients. Due to the ease of
implementation on a preclinical system, this has been the sequence
of choice for a number studies in rodents [3–5]. However, as Carte-
sian imaging requires encoding in ky and kz directions prior to data
acquisition, the minimum echo time available for imaging is substan-
tially longer than in other methods available for use in future studies.
2.3.2 Ultrashort Echo
Time (UTE) Imaging
In order to shorten the echo time of acquisition, thereby increasing
the total signal available for sampling, non-Cartesian imaging tra-
jectories can be employed. Non-Cartesian trajectories are less com-
monly used in imaging, and require special design of magnetic field
gradient waveforms and a more sophisticated reconstruction pro-
cess. However, with a very short minimum echo time, 3D
non-Cartesian trajectories are better suited for probing the fast-
relaxing sodium signal. Where a 3D Cartesian sequence requires
localisation in ky and kz prior to data acquisition, a 3D
non-Cartesian acquisition starts each excitation at the center of k-
space, and data are simultaneously acquired in kx, ky, and kz. To
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ensure short TE in UTE imaging a hard RF pulse is commonly used
to excite all spins in the imaging volume. A number of trajectories
used for non-Cartesian data readout are available from literature,
for example radial imaging, twisted projection imaging (TPI), den-
sity adapted radial (DAR) imaging, and 3D CONES, briefly
described in the following.
Twisted projection imaging (TPI)was first described by Fernando
Boada in 1997, as an extension to 2D TWIRL imaging [18]. The
technique utilizes a hybrid radial-spiral sampling of k-space, allowing
for acceleration in comparison to radial imaging with an underdamp-
ing factor defined during trajectory construction. TPI requires high
gradient slew rates for image acquisition, due to the sharp transition
between the radial and spiral potions of the trajectory. Further opti-
mizations to the trajectory can be made by optimizing maximum
gradient amplitudes throughout scan time [19].
Density adapted radial (DAR) trajectories are described in
work by Nagel, whereby concentric rings of k-space are acquired
with a radial readout. DAR allows for under sampling of k-space,
shortening acquisition times in comparison to radial imaging [20].
The 3D cones approach was initially described for UTE proton
imaging and has found applications in sodium acquisitions
[21, 22]. Due to the high k-space efficiency of the trajectory, it is
possible to acquire a full imaging volume in a very short time,
leading to rapid high resolution imaging [23]. However, due to
the high k-space efficiency, the SNR of each volume is lower than a
radial acquisition; therefore, it is common practice to perform a
number of spatial averages in a single acquisition.
2.4 Reconstruction There are three main methods for reconstruction of sodium imag-
ing data, depending on the acquisition scheme used. If Cartesian
data is acquired, a Fourier transform is applied in all dimensions (x,
y,z,t). If non-Cartesian acquisitions are employed more complex
reconstruction strategies such as gridding or nonuniform fast Four-
ier transforms are used. Compensation for the oversampling of the
center of k-space is performed in non-Cartesian imaging using
precalculated density compensation functions (see Note 1).
2.5 Sodium
Phantoms
External calibration phantoms are used to convert sodium imaging
data to quantitative maps, with voxels fitted to a calibration curve
formed from measurements of signal from known concentration
phantoms as well as from regions of noise in the image.
Phantoms are generally made from agarose doped with sodium
chloride, to ensure a T1 and T2 that mimic that of tissue. However,
other designs are also possible. Phantoms are placed within the
imaging field of view before the start of the experiment to ensure
that signal is acquired from both tissue and calibration standards in
the same exam.
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2.6 Segmentation Segmentation of the kidney is commonly achieved through region
of interests initially drawn on proton anatomical imaging and trans-
ferred to the sodium images. Other methods have been proposed
for the segmentation of the renal system, in particular to measure
the corticomedullary sodium gradient, focusing on defining layers
of the kidney from an initial whole kidney region [24].






The corticomedullary sodium gradient has been studied with
sodium imaging in a number of healthy and pathological scenarios
[3–5, 25–29]. Broadly, the current preclinical literature focuses
either on the action of diuretic drugs upon the sodium gradient, or
upon acute tubular necrosis. The action of furosemide has been
estimated by acquiring longitudinal imaging before and after the
introductionof the acute diuretic. Furosemide acts as a loopdiuretic,
halting reabsorption of sodium through the loop of Henley, leading
to acute diuresis. Results from studies have shown the capability of
sodiumMRI to detect the acute renal sodium alterations induced by
furosemide, revealing a flattening of the corticomedullary sodium
gradient within minutes of administration [3, 4, 26].
Studies focusing upon the early formation of acute kidney
injury through tubular necrosis have revealed alterations in the





Although the literature is limited to the current applications of
renal sodium imaging, there is a large scope for further preclinical
studies demonstrating the power of this technique to probe disease
formation. In particular, the formation of acute kidney disease and




Acute kidney disease is heralded by a sudden loss of renal function,
and impaired reabsorption of electrolytes such as urea and sodium
[30]. Indeed, this is a key clinical problem, with a number of
patients diagnosed upon admission with AKI and leads to high
mortality rates. AKI can occur over a number of hours or days,
and is heralded by an decrease of the glomerular filtration rate,
leading to retention of nitrogenous waste [31]. Due to the increase
in waste retention, common methods for diagnosis are serum-
based measures of creatinine clearance and blood nitrogen
[31]. Further to the increase in the retention of waste, sodium
reabsorption is impaired in AKI. An initial sodium imaging study
showed a flattening of the corticomedullary sodium gradient
[32]. A particular challenge in diagnosis and management of AKI
is the direct estimation of renal health and function pre- and post-
therapy, with many imaging methods either requiring the
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introduction of potentially hazardous contrast agents, or unable to
provide physiological information [33]. Here sodium imaging may
provide a more specific measure of renal health. The initial imaging
study, mentioned above, offers a potential for further studies asses-
sing therapeutic response [32]. Assessing the angle of the cortico-
medullary sodium gradient may also provide insights in to the
degree of the insult that the disrupted kidney is facing.
3.4 Chronic Kidney
Disease
Chronic kidney disease (CKD) is characterized by a gradual loss of
kidney function over time, leading to a decrease in the intrarenal
transport of metabolites such as urea and sodium [34, 35]. A chal-
lenge in this disease is, as with AKI, both monitoring disease
progression and estimating therapeutic response. Sodium imaging
has the potential to evaluate renal function via the corticomedullary
sodium gradient, to differentiate the earliest changes in the meta-
bolic and functional mismatch that occur in the renal system prior
to the development of kidney disease [28, 32, 36]. The use of a
combined multimodal anatomical and functional imaging approach
with methods such as sodium, arterial spin labeling, BOLD,
dynamic contrast enhanced imaging, and diffusion weighted imag-
ing may provide a more complete picture of the alterations in renal
function in relation to chronic kidney disease [24, 36–42].
4 Notes
1. Example gridding and density compensation calculation func-
tions used for the reconstruction of data acquired with
non-Cartesian trajectories can be found at https://www.
ismrm.org/mri_unbound/sequence.htm.
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Chapter 16
Hyperpolarized Carbon (13C) MRI of the Kidneys: Basic
Concept
Cornelius von Morze, Galen D. Reed, Zhen J. Wang,
Michael A. Ohliger, and Christoffer Laustsen
Abstract
Existing clinical markers for renal disease are limited. Hyperpolarized (HP) 13C MRI is based on the
technology of dissolution dynamic nuclear polarization (DNP) and provides new avenues for imaging
kidney structure, function, and most notably, renal metabolism, addressing some of these prior limitations.
Changes in kidney structure and function associated with kidney disease can be evaluated using [13C]urea, a
metabolically inert tracer. Metabolic changes can be assessed using [1-13C]pyruvate and a range of other
rapidly metabolized small molecules, which mainly probe central carbon metabolism. Results from numer-
ous preclinical studies using a variety of these probes demonstrated that this approach holds great potential
for monitoring renal disease, although more work is needed to bridge intelligently into clinical studies.
Here we introduce the general concept of HP 13C MRI and review the most relevant probes and applica-
tions to renal disease, including kidney cancer, diabetic nephropathy and ischemic kidney injury.
This chapter is based upon work from the PARENCHIMA COST Action, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by two separate chapters describing the experimental procedure and
data analysis.
Key words Dynamic nuclear polarization, Kidney, Preclinical models, Carbon-13
1 Introduction
While renal MRI has traditionally been limited largely to morpho-
logic depiction of vascular disease and neoplasia, hyperpolarized
(HP) 13C MRI supplies new metabolic and/or functional insight
that could be valuable for a range of kidney diseases. The high renal
delivery of intravenously injected small molecules, which provides
extraordinary sensitivity for renal imaging of HP 13C MRI probes,
suggests great potential for application of this nascent medical
imaging modality to kidney disease.
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_16, © The Author(s) 2021
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Commonly used clinical markers for kidney disease have signif-
icant limitations, especially in the context of early disease. Serum
creatinine is frequently utilized as a functional marker, but has a
wide reference interval, and the mathematical corrections applied
for the estimation of glomerular filtration rate (GFR) are inexact.
For example, GFR is unpredictably overestimated in glomerulo-
pathic patients as a result of increased creatinine secretion [1]. Even
accurately measured GFR, such as by the “gold standard” inulin
clearance, is insensitive to early disease [2]. Blood urea nitrogen
(BUN) fluctuates due to factors unrelated to kidney function, such
as hydration status and diet. Proteinuria at baseline is a significant
risk factor for renal disease, but has poor negative predictive value
[3]. In general, clinical markers do not exhibit definitive changes
until a significant fraction of kidney function is already lost.
Medical imaging has clear potential to address these limitations
by providing localized functional data, but this has yet to be trans-
lated on a large scale. Nuclear medicine plays a significant role, with
(mercaptoacetyltriglycine) MAG3 scintigraphy estimated to
account for >400,000 renograms per year [4], commonly for
evaluation of renal function (often pre- or post-transplant), split
function, collecting duct/urinary tract obstruction, renovascular
hypertension, and renal artery stenosis. However, nuclear scans
typically have relatively poor spatial resolution and lack the rich
tissue contrast of MRI. Furthermore, these studies carry the risks
of exposure to ionizing radiation. Ultrasound is also commonly
used for assessing kidney disease [5], but is generally limited to
evaluating advanced damage reflected in alterations in kidney size
and shape, and to some extent blood flow. For patients with
impaired renal function, iodinated Computer Tomography
(CT) contrast media carry an increased risks of acute kidney injury
[6]. Gadolinium based MRI contrast media are associated with
nephrogenic systemic fibrosis [7].
HP 13C MRI has unique potential for improved, safer clinical
imaging studies of renal structure and function, and perhaps most
notably offers an unprecedented avenue toward assessing renal
metabolism in vivo. Indeed, results of numerous preclinical studies
conducted to date, as summarized below, show the clear potential
of this new approach to fill pressing unmet clinical needs for
improved markers of various diseases affecting the kidneys, both
malignant and nonmalignant. More preclinical work with realistic
renal disease models is, however, needed in order to bridge effec-
tively into clinical studies.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
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2 Measurement Concept
2.1 Basic Concept
of HP 13C MRI
HP 13C MRI is based on a transient enhancement of the nuclear
magnetism of 13C-enriched liquids, by up to five orders of magni-
tude over states readily attainable in a clinical MRI magnet, thereby
offsetting the limitation of poor sensitivity that previously ham-
pered in vivo 13C MRI. Although multiple alternate approaches
exist for producing HP material, the method of dissolution
dynamic nuclear polarization (DNP) [8] provides an especially
robust avenue for hyperpolarizing a wide variety of 13C-labeled
substrates, using commercially available instruments. In this
approach, the 13C substrate is first prepolarized in a separate mag-
net at low temperature (see Note 1), primarily through microwave
irradiation applied near the electron paramagnetic resonance (EPR)
frequency in the presence of a stable organic free radical (aka
electron paramagnetic agent or EPA, usually a trityl radical) (see
Note 2). Following a period of polarization buildup, the solid
sample is rapidly dissolved into a liquid state where it temporarily
maintains its hyperpolarization, and is quickly transferred to the
MRI scanner for intravenous injection and imaging (see Note 3).
The overall process is illustrated in Fig. 1. The transient hyperpo-
larized state persists for a period of time determined by the sub-
strate’s T1 relaxation time, an exponential time constant governing
the rate of decay of polarization (see Note 4). Inverse scaling of T1
with molecular size limits the scope of applicable probes to small
molecules, with labels preferably located distal to bonded hydrogen
atoms, which can destroy the 13Cmagnetization via 13C-1H dipolar
coupling (see Note 5). During the decay period, 13C MRI data is
collected, capitalizing on the sensitivity enhancement afforded by
hyperpolarization. Specific methods for data acquisition and pro-






HP 13C MRI offers many new possibilities for renal functional and
metabolic investigations. Dynamic images of the real-time delivery
of metabolically inert tracers such as 13C urea from arterial vascula-
ture to the kidneys can be used to quantify renal function. Real-
time in vivo processing of metabolically active HP probes by the
kidneys can be tracked by spectroscopic imaging, which yields
separate images of injected tracer(s) and their downstream meta-
bolic product(s) based on chemical shift differences. Notably, mul-
tiple probes can also be simultaneously copolarized to yield
multiparametric data sets [9], for example spanning both renal
functional and metabolic parameters. In this section, we review
the most promising HP 13C MRI probes of renal function/metab-
olism proposed to date, and the relevant associated principles.
These probes and their metabolic pathways are illustrated in Fig. 2.
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2.2.1 [13C]Urea The key osmolyte and metabolic end product urea was one of the
first 13C-labeled molecules to be hyperpolarized (T1 ¼ 45 s at 3 T)
[8] and imaged in vivo [10], and high quality dynamic images of
the kidneys and the feeding arterial vasculature can readily be
generated [11–13]. Quantitative estimates of renal function require
dynamic measurements from both the renal parenchyma and arte-
rial vasculature [11, 14]. Urea is largely reabsorbed by urea trans-
porters (UTs) expressed at the inner medullary collecting ducts
(IMCD), and accordingly renal imaging shows distinct modulation
by hydration state [13, 15], based on differential action of vaso-
pressin. Despite this significant reabsorption, it has been suggested
that urea can also be used to estimate glomerular filtration rate
(GFR) [14], based on the first-order transfer coefficient between
arterial vasculature and renal parenchyma. Secondary labeling of
[13C]urea with 15N2 is helpful in terms of prolonging both T1
(at low magnetic fields only) [16] and T2 relaxation times [12] of
urea, with the latter factor allowing imaging rat kidneys at spatial
resolutions approaching 1 mm isotropic (using refocused image
acquisition) [13]. Furthermore, relaxation mapping shows great
promise for improved contrast between the individual kidney com-
partments and various functional states [12, 13, 17]. Urea is distin-
guished by an exceptionally good safety profile among medical
imaging contrast agents, even in patients with reduced kidney
function, and therefore has potential for clinical translation for
imaging patients with kidney diseases.
Fig. 1 Illustration of the process of HP 13C MRI via dissolution dynamic nuclear polarization. The agent (e.g.,
[1-13C]pyruvate) is mixed with the EPA and cooled to 0.8 K in a magnetic field of 5 T, then irradiated at 140GHz
to transfer polarization from unpaired electrons in the EPA to the 13C nuclei. The sample is then rapidly
dissolved and transferred to the MRI scanner for intravenous injection and MR imaging
270 Cornelius von Morze et al.
Fig. 2 HP 13C MRI probes of interest for monitoring renal disease, and the associated metabolic conversions
(if any). Positions of the 13C labels are indicated by stars
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2.2.2 [1-13C]Pyruvate Pyruvate, the end product of glycolysis and key metabolic interme-
diate, is the most widely studied 13C probe, in C1-labeled form
(T1 ¼ 60s at 3 T) [18]. In the kidneys, its interconversions with
lactate (via lactate dehydrogenase, LDH) and alanine (via alanine
transaminase, ALT), as well as its decarboxylation yielding [13C]
bicarbonate (via pyruvate dehydrogenase or PDH) can readily be
tracked by spectroscopic imaging. The extent of metabolic conver-
sion observed reflects a complex series of biophysical processes,
including vascular delivery, cellular uptake (via monocarboxylate
transporters), and finally enzymatic conversion, which in turn may
be influenced by multiple factors. For the conversion via LDH, the
lactate pool size is especially important [19, 20]. For quantitative
comparison among subjects, all of these factors are usually grouped
into simple parameters such as metabolite area-under-the-curve
(AUC) ratios or related apparent first-order conversion rates (e.g.,
kpyruvate-to-lactate or kpl) [21, 22], derived from a series of dynamic
spectroscopic imaging data. From ametabolic perspective, while the
conversion to bicarbonate is clearly a net flux, the conversions to
lactate and alanine via the respective bidirectional, highly active
enzymes appear to represent largely isotopic exchange fluxes into
the respective product metabolite pools [19, 20, 23]. Because of the
high bidirectional activity of LDH (which is restricted to cyto-
plasm), the ratio of lactate to pyruvate has frequently been inter-
preted as a marker for the cytosolic free NADH/NAD+ ratio
[24]. This suggests that the conversion of HP pyruvate to lactate
is driven by this NAD(H) redox state, a parameter that is fundamen-
tally inter-connected with numerous related biochemical reactions.
2.2.3 [1,4-13C2]Fumarate Cellular uptake of injected fumarate, a tricarboxylic acid (TCA)
cycle intermediate, is ordinarily highly restricted on the timescale
of HP experiments, due to its dicarboxylate structure. Compromise
of the cellular membrane (e.g., due to necrosis) allows access of
injected HP [1,4-13C2]fumarate (a singlet due to molecular sym-
metry, with T1 ¼ 58 s at 3 T) [25] to cellular fumarase, and
consequently detectable conversion of product HP [1,4-13C2]
malate. Thus, HP fumarate has been investigated as a specific
marker of cellular necrosis with potentially significant applicability
to detection of renal tubular necrosis [26].
2.2.4 [1-13C]
Dehydroascorbate
HP [1-13C]dehydroascorbate (T1 ¼ 56 s at 3 T) [27, 28] can be
used to probe oxidative stress in a direct manner. Vitamin C, a key
physiologic antioxidant, exists in a NADP(H)-mediated equilib-
rium with its oxidized form, dehydroascorbate (DHA). Conversion
of injected HP [1-13C]DHA, which is rapidly taken up by glucose
transporters, to [1-13C]vitamin C is detectable in vivo. The
observed extent of conversion of HP DHA to vitamin C, a reaction
whose reducing power is likely mostly derived from reduced gluta-
thione (GSH), is attenuated by oxidative stress.
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2.2.5 [13C]Acetoacetate The ketone body acetoacetate, a universal oxidative fuel, rapidly
interconverts with its reduced form, beta-hydroxybutyrate, in
mitochondria via beta-hydroxybutyrate dehydrogenase. In analogy
with lactate/pyruvate, the BOHB–AcAc ratio has frequently been
interpreted as a marker of the free mitochondrial NADH–NAD+
ratio, suggesting an analogous interpretation of conversion of HP
acetoacetate [29, 30] as being driven by the mitochondrial NAD
(H) redox state. Metabolic conversion of injected [1,3-13C2]acet-
oacetate (58 s at 3 T, C1 position) can be detected in rat kidney
in vivo (via the C1 label) [29], suggesting applicability of this new
probe to interrogate mitochondrial-driven kidney disease.
3 Overview of Applications
3.1 Kidney Cancer Multiple studies have reported elevated conversion of HP [1-13C]
pyruvate to [1-13C]lactate and rapid export of [1-13C]lactate in
renal cell carcinoma (RCC), in both RCC cells ex vivo [31–33] and
in vivo in mice orthotopically implanted with human RCC cells
[34]. These findings suggest that HP [1-13C]pyruvate MRI could
have clinical value for improved characterization of kidney cancer in
patients. Moreover, a recent study showed that HP [1-13C]pyru-
vate MRI could be used to predict RCC treatment response to
mTOR inhibition, which varies greatly among individual patients,
thus potentially informing treatment decisions [35].
3.2 Diabetic
Nephropathy
Diabetes results in profound shifts in central carbon metabolism,
directly shifting several pathways accessible to HP 13C MRI.
Although diabetes is detectable using relatively simple testing,
sustained hyperglycemia over time leads to serious end-organ com-
plications including diabetic nephropathy, a significant source of
morbidity, the detection/prediction of which is a difficult clinical
problem where HP 13CMRI could be valuable. Though cancer has
been the main focus of the HP 13C MRI community, several recent
studies have reported differences in renal HP 13C signals detected
in type 1 and type 2 diabetes models as compared to normal
controls, based on multiple HP probes including [1-13C]pyruvate
[23, 36, 37], [13C]urea [38, 39], and [1-13C]DHA [40]. Not
surprisingly, standard antidiabetic agents including insulin andmet-
formin have been found to induce large renal HP signal changes as
well [29, 41, 42]. Renal HP lactate levels are attenuated with
hyperbaric [43] and antioxidant treatment [44] in diabetic rats.
HP [13C]acetate has so far failed to show any significant metabolic
change associated with the diabetic kidney [45]. Further work is
needed in animal models of frank diabetic nephropathy, which may
display changes additive to the fundamental metabolic shifts
observed in diabetes, to address this important clinical problem.
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3.3 Ischemic Kidney
Injury
Effective detection of acute kidney injury (AKI) is an unresolved
clinical problem especially affecting hospitalized patients. Rapid
treatment of AKI is critical but is impeded by existing clinical
indicators which are poor in diagnosing early AKI. Several studies
of models of ischemia reperfusion injury (i.e., unilateral renal artery
clamp) have shown clear effects of AKI on renal HP 13CMRI using
[13C]urea [46, 47], pyruvate [48], and [1-13C]pyruvate–[1-13C]
DHA combination [49], and fumarate [50]. However, these rela-
tively simple models likely do not reflect the etiology of ischemic
injuries more frequently encountered in patients, such as those
resulting from atherosclerotic disease. Further work using more
realistic models of ischemic kidney injury is needed to answer, for
example, the important question of predicting treatment response
in renal artery stenosis. Finally, HP [1,4-13C2]fumarate has also
been investigated as a probe of tissue necrosis in a toxic folic acid
model of acute tubular necrosis (ATN) [26]. A nonzero urinary
fumarase activity could potentially be used as a clinical indicator for
a hyperpolarized fumarate examination to investigate the extent
and the origin of the renal damage [50].
4 Notes
1. The state-of-the-art GE SPINLab polarizer operates at 5 T and
a temperature of 0.8 K. Microwave irradiation is applied near
the EPR frequency corresponding to this magnetic field
(~140 GHz), with a typical power of ~20 mW. A buildup
time of ~3 h is typically required.
2. Urea and many other agents including fumarate and acetoace-
tate require the addition of a glassing agent such as glycerol or
DMSO to prevent crystallization upon freezing, which
impedes the polarization process.
3. The 13C concentration is made as high as possible in the start-
ing material (in the molar range), facilitating efficient polariza-
tion, but the concentration typically drops >10-fold on
dissolution. In contrast, the concentration of the radical is
only ~15 mM in the starting material.
4. The T1 exponential decay constant of HP
13C probe is directly
proportional to its “half-life,” by a factor of ln 2 (i.e., t1/
2 ¼ 0.69  T1).
5. T1 values of 30–60 s are typical for the most useful probes, and
T1 values are magnetic field- and temperature-dependent.
274 Cornelius von Morze et al.
Acknowledgments
Grant support from National Institutes of Health (NIH)
K01DK099451 is gratefully acknowledged.
This chapter is based upon work from COST Action PARENCH-
IMA, supported by European Cooperation in Science and Tech-
nology (COST). COST (www.cost.eu) is a funding agency for
research and innovation networks. COST Actions help connect
research initiatives across Europe and enable scientists to enrich
their ideas by sharing them with their peers. This boosts their
research, career, and innovation.
PARENCHIMA (renalmri.org) is a community-driven Action in
the COST program of the European Union, which unites more
than 200 experts in renal MRI from 30 countries with the aim to
improve the reproducibility and standardization of renal MRI
biomarkers.
References
1. Shemesh O, Golbetz H, Kriss JP, Myers BD
(1985) Limitations of creatinine as a filtration
marker in glomerulopathic patients. Kidney Int
28:830–838
2. Metcalfe W (2007) How does early chronic
kidney disease progress? A background paper
prepared for the UK Consensus Conference on
early chronic kidney disease. Nephrol Dial
Transplant 22(Suppl 9):ix26–ix30. https://
doi.org/10.1093/ndt/gfm446
3. Ishani A, Grandits GA, Grimm RH, Svendsen
KH, Collins AJ, Prineas RJ, Neaton JD (2006)
Association of single measurements of dipstick
proteinuria, estimated glomerular filtration
rate, and hematocrit with 25-year incidence of
end-stage renal disease in the multiple risk fac-
tor intervention trial. J Am Soc Nephrol
17:1444–1452. https://doi.org/10.1681/
ASN.2005091012
4. Esteves FP, Taylor A, Manatunga A, Folks RD,
Krishnan M, Garcia EV (2006) 99mTc-MAG3
renography: normal values forMAG3 clearance
and curve parameters, excretory parameters,
and residual urine volume. AJR Am J Roent-
genol 187:W610–W617. https://doi.org/10.
2214/AJR.05.1550
5. O’Neill WC (2014) Renal relevant radiology:
use of ultrasound in kidney disease and
nephrology procedures. Clin J Am Soc
Nephrol 9:373–381. https://doi.org/10.
2215/CJN.03170313
6. PA MC, Stacul F, Becker CR, Adam A,
Lameire N, Tumlin JA, Davidson CJ, CIN
Consensus Working Panel (2006)
Contrast-induced nephropathy (CIN) consen-
sus working panel: executive summary. Rev
Cardiovasc Med 7:177–197
7. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE
(2007) Gadolinium-based MR contrast agents
and nephrogenic systemic fibrosis. Radiology
242:647–649. https://doi.org/10.1148/
radiol.2423061640
8. Ardenkjaer-Larsen JH, Fridlund B, Gram A,
Hansson G, Hansson L, Lerche MH,
Servin R, Thaning M, Golman K (2003)
Increase in signal-to-noise ratio of > 10,000
times in liquid-state NMR. Proc Natl Acad Sci
U S A 100:10158–10163. https://doi.org/
10.1073/pnas.1733835100
9. Wilson DM, Keshari KR, Larson PEZ, Chen
AP, Hu S, Van Criekinge M, Bok R, Nelson SJ,
Macdonald JM, Vigneron DB, Kurhanewicz J
(2010) Multi-compound polarization by DNP
allows simultaneous assessment of multiple
enzymatic activities in vivo. J Magn Reson
205:141–147. https://doi.org/10.1016/j.
jmr.2010.04.012
10. Golman K, Ardenkjaer-Larsen JH, Petersson
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Abstract
Kidney-associated pathologies would greatly benefit from noninvasive and robust methods that can
objectively quantify changes in renal function. In the past years there has been a growing incentive to
develop new applications for fluorine (19F) MRI in biomedical research to study functional changes during
disease states. 19F MRI represents an instrumental tool for the quantification of exogenous 19F substances
in vivo. One of the major benefits of 19FMRI is that fluorine in its organic form is absent in eukaryotic cells.
Therefore, the introduction of exogenous 19F signals in vivo will yield background-free images, thus
providing highly selective detection with absolute specificity in vivo. Here we introduce the concept of
19F MRI, describe existing challenges, especially those pertaining to signal sensitivity, and give an overview
of preclinical applications to illustrate the utility and applicability of this technique for measuring renal
function in animal models.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
introduction chapter is complemented by two separate chapters describing the experimental procedure and
data analysis.
Key words Magnetic resonance imaging (MRI), Fluorine (19F), Kidney, Inflammation, Tissue
oxygenation
1 Introduction
The need for methods to assess renal function that are both robust
and noninvasive is increasingly becoming recognized. One
approach is to use MRI in combination with contrast agents that
are responsive to physiological changes [1]. The most common
type of MR contrast agents are paramagnetic agents that enhance
contrast on MR images. These contrast agents act by modulating
proton (1H) relaxation, either during recovery (T1 component) or
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_17, © The Author(s) 2021
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decay (T2 component) of the MR signal. In order for a contrast
agent to be useful to identify changes in a specific physiological
phenomenon, its sensitivity to detect and quantify physiological
changes on MRI and its pharmacokinetic properties must be
balanced [2].
From a technical point of view, paramagnetic contrast agents
have a concomitant effect on all components of MR relaxation; the
interplay between T1 and T2 relaxation depends on the dose and
location of the contrast agent as well as the MR imaging sequence
used [3]. This complexity is exacerbated by intrinsic factors such as
deoxygenated blood or air cavities that may confound the signal
being investigated [4]. A case in point is when imaging cells labeled
with contrast agent: changes in contrast created by such intrinsic
tissue factors could render the labeled cells indistinguishable from
the surrounding tissue. This drawback is heightened by the signal
sensitivity constraints due to the low concentrations of contrast
agent (<μM range). As a result, any quantification of the physio-
logical observation is hampered, and in some cases, no definitive
conclusions can be made.
The use of fluorinated agents in combination with fluorine (19F)
MRI overcomes the hurdle of signal ambiguity because the 19F MR
signal is specific to the administered 19F agent. While the 19F nucleus
has similar MR sensitivity and resonance frequency as 1H, unlike 1H,
it is practically absent in vivo, that is, there are no endogenous 19F
organic forms in vivo. Therefore, any exogenous fluorinated com-
pounds introduced in vivo can be detected with high selectivity and
absolute specificity. This has been exploited to noninvasively track
cells in vivo using 19F MRI after labeling them with 19F compounds,
typically in the form of nanoparticles (NP). Interestingly, the chemi-
cal shift range for 19F is much larger than that of 1H. Organofluorine
compounds span a chemical shift range of over 350 ppm [5]. Thus
multiple 19F nuclei resonances for organofluorine compounds can be
easily separated, even under rather inhomogeneous conditions
[6]. The unique properties of 19F nuclei as well as 19F compounds
have been the driving force behind the increasing interest in 19F
MRI. However, the application of 19F MRI to a wide range of
biomedical research fields has been restricted by the low abundance
of 19F nuclei in vivo following exogenous administration. This con-
straint is compounded by the fact that the signal sensitivity of current
MR hardware remains limited, making the detection of 19F com-
pounds present at low concentrations extremely challenging. There-
fore, one strategy in 19F MRI to circumvent this is to boost the
signal-to-noise ratio (SNR) as a function of time, that is, the SNR
efficiency to enhance signal sensitivity and improve detection limits.
From a biological perspective, several key components must be
considered when using contrast agents to study renal function.
Among other physicochemical properties, size will determine the
pharmacokinetic properties of the contrast agent as well as its uptake
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by cells in vivo. For example, low-molecular-weight-gadolinium-
based contrast agents (GBCAs) are filtered through the glomerulus
and are not reabsorbed by the renal tubule. Conversely, larger con-
trast agents such as paramagnetic iron oxide particles or 19F nano-
particles commonly follow a one-compartment pharmacokinetic
model within the blood [7]. These nanoparticles are too large to
be filtered by the glomerulus and are eventually taken up by phago-
cytic blood cells. Such nanoparticles including the iron replacement
therapy ferumoxytol have a long intravascular half-life (>14 h) and
are therefore useful for vascular and perfusion-weighted MRI
[8]. Unless inflammatory processes are ongoing, these particles will
localize primarily in the liver and will eventually undergo elimination
via hepatic clearance. The clearance of nanoparticles via liver or
kidney is dependent on their size and surface properties [9] but
also on the health status of these organs, such that clearance should
be critically studied [10] especially prior to patient studies.
This introduction chapter is complemented by two separate
chapters describing the experimental procedure and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Overview of Applications
Quantitative measurements of renal function are necessary to detect
changes already during the early stages of kidney disease, to support
disease staging and to screen emerging therapeutic strategies. Non-
invasive and rapid MR methods are needed to quantify disease
components such as inflammation, hypoxia and tissue damage.
While commonly available MR contrast agents act by modulating
1H relaxation, contrast agents containing 19F have also been devel-
oped to investigate disease components such as inflammation and to
quantify pathological changes in the tissue microenvironment (e.g.,
changes in tissue oxygenation (pO2) or pH) using
19F MRI.
2.1 19F MRI to Study
Environmental
Changes in the Kidney
In Vivo
There is an abundant repertoire of exogenous MRI contrast agents
that act by modulating 1H relaxation and which are triggered by
changes in pO2, pH or temperature as well as changes in protein,
metabolite or metal ion concentrations (reviewed elsewhere [1]).
Here we focus on the application of 19F probes that elicit a desired
MR signal following changes in pO2 and pH and hold promise as
tools for screening kidney disease.
2.1.1 Renal Tissue
Oxygenation
Healthy kidneys operate under relatively low O2 conditions, requir-
ing extensive extraction of O2 from flowing blood. While several
regulatory mechanisms act to maintain oxygenation within homeo-
static limits, the kidneys are nonetheless particularly susceptible to
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hypoxic injury [11]. While O2 consumption determines perfusion
in most nonrenal tissue such as the brain, perfusion determines O2
consumption in the kidney [12]. Therefore, a sudden temporary
impairment of the blood flow to the kidney results in acute kidney
injury (AKI) as a result of impaired O2 delivery. Approaches for
identifying and treating AKI as early as possible should aim at
detecting and restoring imbalances the homeostasis between renal
oxygenation and factors such as nitric oxide that control the renal
microcirculation [13].
Noninvasive methods to measure kidney function in vivo, spe-
cifically tissue pO2 and blood perfusion, are crucial. Arterial spin
labeling MRI determines intrarenal perfusion without the need of
exogenous contrast agents, and will be reviewed in a separate
chapter of this book. MRI techniques that utilize the native 1H
contrast from blood—blood-oxygenation-level-dependent
(BOLD) MRI—have been proposed [14]. The level of renal oxy-
genation within each voxel is quantified by mapping the shortening
of 1H T2
* induced by deoxyhemoglobin—deoxyHb [15]. How-
ever, the relation of T2
* to tissue pO2 may be confounded by factors
such as hematocrit, oxyHb dissociation curve, and the vascular
volume fraction. This underscores the need for careful scrutiny of
this relation in order to make quantitative interpretations [16].
Perfluorocarbon (PFC) emulsions offer an alternative to quan-
tify changes in tissue pO2 during vascular pathology [17, 18]. More
recently PFC NPs were also employed as a theranostic strategy for
studying perfusion and treating AKI [19]. Primarily PFC NPs have
been used to assess perfusion in the renal microvasculature follow-
ing AKI [20]. 19F MRI sensitively detected decreased RBV and
pO2 in the cortical–medullary (CM) junction 24 h following uni-
lateral (left) renal ischemia–reperfusion [20], where increased T2
*
was also observed by 1H BOLDMRI (Fig. 1a). The T2
*, 19F signal,
and pO2 in the renal cortex of injured kidneys were all comparable
to the contralateral control kidney, suggesting recovery of perfu-
sion and oxygenation in this region. In the inner medulla, however,
vascular leakage and hemorrhage-induced extravascular retention
of PFC NPs (Fig. 1b, c) resulted in a false readout of reduced 1H
T2
*, increased 19F signal intensity, and unchanged pO2.
PFCs and oxygen exhibit similarly low cohesive energy densi-
ties, such that both require little energy for mutual solubility
[21]. The high oxygen-dissolving capacity of PFC emulsions
makes them ideal as O2 carriers. PFCs were, in fact, considered as
artificial blood substitutes [22]. Fluosol-DA—a mixture of per-
fluorodecalin (PFD) and perfluorotributylamine—was the first
PFC emulsion studied in humans in a trial of Japanese patients
[23]. It was soon recalled due to its rather low oxygen transport
capacity compared to that of red blood cells [24]. PFCs ultimately
failed as blood substitutes (even as next generation products
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appeared in the clinic). Although O2-deprived tissues easily extract
O2 in PFCs, the oxygen dissociation curve of PFC emulsions is
linear and monotonic, in contrast to the sigmoidal hemoglobin
dissociation curve. Therefore, most of the O2 dissolved in PFCs is
released at high O2 partial pressure in the arteries, with little O2
being available for the capillaries where O2 partial pressure is low
but needed the most [22]. Interestingly Fluosol-DA (the first PFC
that was used in patients [23]) was also used to acquire the first 19F
MR images in vivo, showing its accumulation in the rat liver
[25]. The PFC in this emulsion gives complex MR spectra and
has since been replaced by other PFCs with better imaging
properties [26].
The longitudinal relaxation rate (1/T1) of
19F in PFCs was
shown to depend linearly on O2 partial pressure [27]. This led to
the first noninvasive in vivo tissue O2 assessments in tumor tissue
and liver [28] and later in myocardial tissue [29]. The latter study
provided the first proof of concept study for rapid, noninvasive
measurements of O2 oxygen tension changes in response to ische-
mia and reperfusion [29]. It is claimed that the size of PFC nano-
particles (>100 nm) confers upon them a good safety profile
without renal toxicity, since they are not expected to be cleared
through glomerular filtration. Therefore, unlike other imaging
agents that undergo renal clearance (e.g., iodinated CT com-
pounds, gadoliniumMRI chelates), PFC emulsions do not increase
the workload of the kidney and are not immediately considered as
nephrotoxic [10].
Fig. 1 Assessing perfusion in the renal microvasculature following acute kidney injury using PFCs. (a)
Composite Representative 1H T2*-weighted image (top row), 19F spin density weighted image (middle row),
and pO2 map (bottom row) in the left control and right injured kidneys of the same mouse. (b) Fluorescence
images showing FITC-lectin labeled perfused blood vessels in control and injured kidneys (top row) and zoom-
in view of FITC-lectin (green) labeled perfused vessels in the CM junction (bottom row). (c) Fluorescence
images showing rhodamine labeled PFC NPs in injured and control kidneys (top row) and zoom-in view
showing PFC NPs (red) in the renal medulla (bottom row). Adapted from Hu L. et al. (2013) [20] with permission
from John Wiley & Sons Inc.
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2.1.2 Acid–Base
Homeostasis in the Kidney
and pH Sensors
The kidney plays a major role in acid–base homeostasis; this balance
depends on its capacity to reabsorb filtered bicarbonate, mainly
from the proximal tubule, and to excrete an equivalent amount of
protons at the distal tubule [30]. CEST MRI was originally devel-
oped to measure pH with exogenous pH-responsive MRI contrast
agents [31]. The pH in the kidney following AKI gradually
increased from 6.7 to 7.2 as measured with CEST-MRI pH-re-
sponsive probes [32]. A major drawback of paramagnetic probes is
that signal intensity is not only proportional to the pH but also to
contrast agent concentration. Particularly in tumors, in vivo pH
mapping assumes a constant contrast agent concentration across
tissue notwithstanding poor perfusion where acidolysis
occurs [33].
Approaches such as ratiometric 19F/1H probes have been
developed to overcome the issue of quantification; the signal is
normalized to the concentration of the contrast agent by means
of a concentration reporting (19F) moiety [34]. Another advantage
of 19F MR probes is the larger range in chemical shifts in 19F
(compared to 1H). These chemical shifts are highly sensitive to
the immediate surroundings, such that small chemical changes
can lead to dramatic changes in chemical shift [6]. The first 19F
MR probe identified as a candidate to probe cellular pH was the
vitamin B6 analog 6-fluoropyridoxol (6-FPOL) reported to have a
pKa in the physiological range and large chemical shift response
[35]. Subsequently the feasibility of using 6-FPOL to probe cellular
pH was demonstrated in whole blood [36]. The concept of
employing 19F MR probes for in vivo imaging was introduced
when a series of fluorinated vitamin B6 analogs with a chemical
shift sensitivity in the range 7.4–12 ppm were synthesized as pH
indicators [37]. The sensitivity of 19F MRS probes can be further
improved by incorporating paramagnetic metal ions that further
amplify the chemical shift between protonated and deprotonated
forms by the presence of covalent and dipolar contributions
[38, 39]. Iron (II) complexes were also explored to exploit the
pH-dependent spin-state population change; the 19F NMR chemi-
cal shift was in a sensitivity range of 13.9 ppm per pH unit at 37 C
[40]. More recently fluorinated nickel (II) complexes with diamag-
netic and paramagnetic properties were designed for ratiometric
pH mapping by 19F MRI [41]. Supramolecular nanostructures
formed by fluorinated peptide amphiphiles transitioning from
cylindrical to ribbon-like shape as pH increases from 4.5 to 8.0
resulting in enhancedMR signals. These nanostructures represent a
good strategy to design stimulus-responsive 19F MRI contrast
agents for responses to pH changes in vivo [42].
2.2 19F MRI to Study
Renal Inflammation
In Vivo
Together with renal tissue hypoxia and tubular injury, inflammation
is one underlying component in the pathology of AKI [43]. Studies
suggest that systemic inflammation causes ischemic injury in one
organ and that repercussions follow in distant organs downstream
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of the ischemic event [44–46] (Fig. 2). Therefore, methods that
can non-invasively quantify the level of inflammation in different
organs would be crucial to identify the causality and significance of
inflammation during both systemic and kidney-specific disease.
19F MRI is commonly used in association with an intravenous
administration of PFC emulsions to study the distribution of
inflammatory cells in vivo [26, 47–51]. 19F MRI is performed
after an in vivo labeling of inflammatory cells with a 19F com-
pound—typically in nanoparticle (NP) form. The 19F-NPs are
administered intravenously in order for them to be taken up by
inflammatory cells that are migrating through the systemic circula-
tion into inflamed organs. Typically, PFCs such as perfluoro-15-
crown-5 ether (PFCE) are used to prepare NPs for cell labeling.
PFCE is biologically stable and provides a high payload of 19F
nuclei since it contains 20 chemically equivalent 19F spins.
In a rat model of orthotopic kidney transplantation, 19F MRI
was used to study inflammation in the kidney undergoing rejection
[48]. Three days following transplantation, PFCE NPs were admi-
nistered intravenously and 1H/19F images acquired 2 and 24 h
following NP infusion (Fig. 3a). At the earlier time point, the 19F
signal was mainly found in the circulation but also in small but
roughly equal amounts in both the native and transplanted kidneys
(Fig. 3a). By day 4 posttransplantation (i.e., 24 h following PFCE
NP), the transplanted kidney underwent moderate (Grade 2) rejec-
tion and showed an intense signal in the allograft kidney and in liver
and spleen, but the 19F signal was virtually undetectable above the
level of image noise in the native kidney (Fig. 3a). T2*-weighted
Fig. 2 Inflammation as one underlying factor in the pathology of AKI. AKI can be triggered by a variety of
clinical disorders ranging from renal ischemic events to sepsis and exposure to nephrotoxic substances. The
kidney is tightly connected with the interior milieu of the body such that even the slightest of changes will be
rapidly detected and communicated between the kidney and the rest of the body
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imaging reveals hemorrhaging in the medulla on day 4 post-kidney
transplantation, which can be detected both in animals administered
ultrasmall superparamagnetic iron oxide (USPIO) NPs but also in
transplants without USPIO (saline control) (Fig. 3b). This can
confound the detection of USPIO-labeled macrophages and exhi-
bits one of the advantages of 19F MRI over iron oxide-based NPs.
Apart from labeling inflammatory cells in vivo, NPs have been
used to label specific immune cell types such as dendritic cells (DCs)
ex vivo, prior to their administration in vivo [52–54]. This kind of
labeling is particularly useful to label cellular therapies that will be
administered in patients as part of a treatment strategy [55]. In
addition to cancer patients, kidney transplantation patients would
also benefit from cell-based therapies, specifically the types of cells
inducing tolerance [56]. Monocyte-derived suppressor cell pro-
ducts are currently being investigated alongside immunosuppres-
sive therapies in kidney transplant recipients with promising results
[57]. These candidate therapies would benefit from a labeling
strategy that will enable them to be tracked in vivo over time with
19F MRI. The possibility of quantifying the 19F MR signal would
allow an objective assessment of the spatial and temporal cellular
distribution within the same individual. This kind of labeling and
19F MRI would result in absolute cell quantification, since the 19F
MR signal is generated from the cells alone, by direct detection of
the 19F spins in the cells labeled with 19F NPs, without any con-
founding background MR signal. However, several biological and
technical considerations need to be made, in order to achieve a
truly absolute MR signal quantification: not all cell types can be
labeled with the 19F NPs currently available (Subheading 3.1.1).
Fig. 3 Inflammation in the kidney in a rat model of orthotopic kidney transplantation experiencing rejection. (a)
Composite 1H/19F images of an orthotopic kidney transplant recipient 2 h post–PCE injection on POD 3 with
19F signal found in the vasculature and equally in both the native (upper) and graft (lower) kidneys (left) and
~24 h post–PCE injection with 19F signal in the allograft kidney, as well as other organs (right). (b) Allograft
kidney on POD 4 following an injection (left) of 6 mg/kg BW USPIO (upper row) or following an injection of
saline (lower row) and 24 h later (right). Adapted from Hitchens T.K. et al. (2011) [48] with permission from
John Wiley & Sons Inc.
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3 Basic Concepts of 19F MRI
3.1 19F imaging
Probes
The design and synthesis of novel fluorine-rich molecular labels and
imaging probes is an important domain for 19F MRI. For several
years, a wide range of fluorine probes has been available for experi-
mental and even clinical applications [58, 59].
3.1.1 19F Probes
for Cellular Uptake
Current procedures used to label cells with nanoparticles take
advantage of the intrinsic nature of cells to engulf foreign bodies,
a cellular property known as phagocytosis. Dendritic cells are intrin-
sically phagocytic and therefore ideal candidates for tracking with
19F MRI [52, 53, 55, 60–62]. Cells labeled with clinical grade 19F
nanoparticles have been administered as immunotherapies in can-
cer patients [55]. This tracking method could support several other
cell therapy studies, including those dealing with kidney
transplantation [63].
Enhancing cellular uptake is desirable, even for cells that are
intrinsically phagocytic. Several studies have investigated the incor-
poration of phosphatidylserine (PS) in nanoparticle-based therapeu-
tics to enhance their uptake [64]. After renal ischemia–reperfusion,
the signal from PS-containing microbubbles was two-fold higher
than that for standard lipid microbubbles [65]. Phospholipids such
as PS and phosphatidylethanolamine (PE) are important compo-
nents of biological cell membranes and are important components
for endocytosis in phagocytic cells such as DCs [66]. We previously
reported that enrichment of 19F nanoparticles with 1,2-dipalmitoyl-
sn-glycero-3-PE (DPPE) resulted in a striking increase (at least one
order of magnitude) in cytoplasmic uptake in DCs [62]. Interest-
ingly, membrane lipid-raft processes have been proposed as traffick-
ing mechanisms for transporting therapeutic cargo such as siRNA
[67] or targeting ligands [68] into the cytoplasm, circumventing the
usual endosomal uptake pathway.
Labeling cells with low intrinsic phagocytic properties (such asT
cells) will prove more difficult using the above strategy, even if the
nanoparticle size is lower than 180 nm [69]. Some research groups
claim to have labeled T cells using the same above principles [70]. T
cells are not able to internalize nanoparticles, even small iron oxide
nanoparticles (core diameter¼ 12.5 nm), as has been clearly shown
by transmission electron microscopy (TEM), considered to be a
definitive method, and also by confocal microscopy [71]. For the
latter method nanoparticles with fluorescent tags were used to cor-
roborate the in vivo 19F signals with ex vivo fluorescencemicroscopy
signals, but the authors also included a cell membrane stain
[71].This is a necessary control todistinguishmembrane association
from intracellular distribution, in light of the point spread function
contribution [72]. Another key point is that the fluorescent tag
dissociates from the fluorine label over time, both in vitro and
in vivo [73]. This has a critical impact on the interpretation of
long-term experiments validated by standard fluorescent
techniques.
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Before taking the next steps toward administering cells in vivo,
it is essential to understand how nanoparticles are recognized,
internalized, trafficked, and distributed within the specific host
cell [74]. This is critical when contemplating labeling of cells that
may ultimately be applied in vivo to patients in a therapeutic con-
text. Cells that are not intrinsically phagocytic will not readily
internalize NPs but might still exhibit a 19F MR signal ex vivo,
due to reasons such as transitional binding of NPs to the cell
membrane or incomplete clearing of noninternalized NPs from
the cell culture medium. The 19F MR signals following administra-
tion of ineffectively labeled cells with contaminating NPs would be
misrepresentative of the actual distribution of the cells in vivo.
Therefore, we need to ask the right questions regarding the specific
cell type to be labeled, and the methods used prior to transfer of the




Fluorinated probes are commonly designed with the goal of
improving signal strength by increasing the number of fluorine
atoms per molecule [59]. Linear 19F polymers such as perfluoro-
polyethers (PFPEs) are the simplest choice to achieve increased
fluorine content but the NPs produced with these polymers are
polydisperse and the presence of multiple chemical shifts presents
several peaks in the 19F spectra [76]. Superfluorinated branched 19F
probes such as 19FIT [77] and PERFECTA [78] promise several
advantages, specifically a very high fluorine nuclei density with a
single 19F spectral peak. These probes therefore afford enhanced
sensitivity and better imaging performance than linear perfluoro-
polymers. Unlike PERFECTA [78], the bispherical fluorocarbon
19FIT is water soluble [77] and therefore possesses low organ
retention, but it cannot be emulsified into nanoparticles for cell
labeling strategies. Increasing the density of 19F nuclei can only go
so far in terms of increased sensitivity of 19F probes. Ultimately, a
limit to this density will be reached.
Another strategy to promote 19F MR signal is to manipulate
the MR properties of the 19F probes in order to favor ideal condi-
tions for MR signal acquisition. One approach is to decrease the T1
of the 19F nuclei, which is typically in the range of 0.5–3 s for
diamagnetic compounds. Paramagnetic metal ions such as lantha-
nides(III) or iron(II) reduce the T1 of
19F compounds [38]. Para-
magnetic centers affect the relaxation of 19F nuclei (paramagnetic
relaxation enhancement or PRE effect) via a number of mechan-
isms, most notably electron–nucleus dipole–dipole interaction and
Curie relaxation [39], both of which are influenced by the effective
magnetic moment (μeff) of the paramagnetic metal [79]. Other
than the μeff of the metal ion, the PRE effect is also influenced by
the distance separating the 19F nuclei and the paramagnetic metal
ion [39]. While long distances will severely diminish PRE, short
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distances will substantially shorten the spin–spin relaxation time T2.
Thus T1 reduction by molecular design should be dealt with care-
fully since it could also lead to a reduction in the T2 and thereby line
broadening of the resonance, which ultimately affects sensitivity
[80]. The most sensitive metal-based probes are, in fact, not
those whose metal ions have the highest μeff, but rather those
who have the ideal distance separating 19F from the paramagnetic
metal ion (4.5–7.5 Å) thus resulting in higher T2/T1 ratios
[81]. Nonetheless even at larger 19F–M distances (>10 Å), the
PRE effect can still be notable as is the case for a DOTA-based
19F chelator [82]. In paramagnetic PFC nanoparticles, the 19F MR
relaxation enhancement has also been explained by diffusion
mechanisms attributed to the changes in Brownian motion of
PFC molecules inside the NP in conjunction with their ability to
permeate into the lipid surfactant coating [83].
Introduction of paramagnetic metals in the design of 19F
probes not only results in a decrease T1 of
19F nuclei but also
leads to paramagnetic induced chemical shifts. The CEST signal
generated by paramagnetic involvement (PARACEST) will also be
modulated by pH (Subheading 2.1.2). A macrocyclic Fe
(II) complex bearing both exchangeable 1H and 19F was shown
to behave as a ratiometric pH-responsive MRI contrast agent,
whereby the CEST, but not the 19F MR signal was pH-dependent
[84]. This enables accurate pH mapping without the use of multi-
ple probes. More recently a DOTA macrocyclic structure com-
plexed with Ni(II) metal was shown to exhibit larger separations
between the 1H CEST signal and water [85]. Though the in vivo
application of 19F PARACEST probes remains to be investigated,
the available complexes will likely provide valuable information in





One way of improving signal sensitivity is to avoid signal losses such
as those occurring during spin relaxation. Most fluorinated com-
pounds generally have long T1 relaxation times, which effectively
increases the acquisition time. Together with the fact that there is a
large range of relaxation times for 19F MR, this motivates more
reliable optimization of pulse sequences that is informed by theMR
properties of the 19F compounds under investigation. Sequence
performance is largely dependent on the relaxation times of the
addressed spin system but also on the conditions the nuclei are in,
such as tissue oxygenation level [17].
The choice of the best pulse sequence and acquisition method
is dictated by the MR properties, particularly the relaxation times,
of the nuclei being measured. The acquisition protocol for each
sequence should be optimized by tailoring detection schemes to
the properties of the nucleus—also in relation to its environment—
using relationships empirically drawn from simulations [86]. Relax-
ation times determine the time frames of signal losses, so the time
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orchestration for data acquisition should be assigned correctly.
Other parameters, such as acquisition bandwidths, should also be
properly planned to avoid recording unnecessary noise and to
achieve the highest possible SNR [87].
A number of 19F MR studies using different pulse sequences
have aimed to optimize the acquisition method to promote SNR
efficiency and signal sensitivity [17, 87–90]. A large proportion of
19F MR studies, especially those applying perfluorocarbons (PFCs)
in vivo, have employed the turbo spin echo (SE) rapid acquisition
using relaxation enhancement (RARE) sequence [26, 47, 50, 51,
91]. This method reduces acquisition time by accumulating multi-
ple echoes (dictated by the turbo factor) within a single repetition
time [92]. Optimal settings for echo train lengths and repetition
time (TR) according to measured relaxation times (T1/T2 combi-
nations) were calculated for RARE to improve sensitivity
thresholds [90].
Although RARE is commonly been for studying PFCs in vivo,
other sequences will be better suited for 19F compounds that unlike
typical PFCs have short T2 relaxation times. In such cases signal
detection might be technically challenging and will demand acqui-
sition strategies properly adapted for the compound and its envi-
ronment. Gradient echo (GE) sequences were used to maximize
SNR efficiency for imaging paramagnetic macrocyclic 19F mole-
cules complexed to lanthanides [87]. These molecules exhibit T1
values in the order of 1–15 ms and T2* values in the order of
0.4–12 ms [88]. In the latter study a radial zero echo time (ZTE)
sequence yielded a sensitivity gain of 27-fold when compared to
nonparamagnetic molecules, while the GE sequence yielded a gain
of 11-fold [88]. Additionally, the highest SNR efficiency gain was
achieved when T2/T1were close to 1, particularly for the ZTE pulse
sequence, and when T1 was in the range of 1–5 ms [88]. Even
19F
molecules with unique spectral properties will require a more indi-
vidualized adjustment of theMR parameters; such molecules might
benefit from sequences such as ultrashort echo time (UTE) that
acquire signal before the spins dephase, taking into consideration
destructive phase interference [93]. An efficient k-space sampling
strategy will be necessary to achieve maximal SNR and artifact-free
MR images [94]. To image perfluorooctyl bromide (PFOB) that
has a rich spectrum with large chemical shifts, a radial UTE with a
balanced steady-state free precession (bSSFP) pulse sequence
showed superiority above other sequences, such as SE, GE, or
bSSFP with Cartesian sampling [89]. However, radial sampling
might not always be viable since k space sampling pattern effects
need to be considered, which might altogether result in reduced
SNR efficiency [86]. Another way to speed up data acquisition is
synchronous multinuclear imaging. For this, the MR system needs
to have the architecture suited to acquire images from more than
one nucleus in a single pulse sequence [95]. Simultaneous proton
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and 19F MRI was performed in a preclinical model using a clinical
MR scanner at 3 T [95].
3.3 Hardware
Considerations
The similarity between 19F and 1H MR properties with respect to
sensitivity and resonance frequency is an advantage, from an engi-
neering perspective since similar pulse power settings can be used,
and dual-tuned radio frequency (RF) coils for 19F and 1H MRI are
more convenient to design [50, 96]. One way of improving the 19F
MR signal in vivo is to increase SNR by improving the sensitivity of
the measuring instrument. Two hardware strategies to improve
sensitivity for 19F MR are to increase the strength of the static
magnetic field (B0), and to increase the sensitivity of the RF coil
by cryogenic cooling.
3.3.1 Cryogenic Cooling The sensitivity of the RF coil is an important factor limiting SNR
and thereby the level of spatial and temporal resolution that is
targeted for 19F MRI [97]. Even when employing an RF coil with
a homogeneous transmit field (B1
+) distribution and dedicated for
brain 19F and 1HMRI, the spatial resolution of in vivo 19FMRI was
limited to approximately 600 μm [50]. This level of spatial resolu-
tion prohibits a detailed understanding of inflammation dynamics.
To overcome the sensitivity constraints in 19F MR and improve
detail of inflammatory cell location, we applied the concept of
cryogenically cooling RF coil hardware to improve SNR by reduc-
ing thermal noise [98–100]. The cryogenically cooled RF coil
(CryoProbe™) technology is commercially available for small ani-
malMRI of 1H and X-nuclei such as carbon (13C) and phosphorous
(31P). For these X-nuclei this technology is expected to be particu-
larly useful for increasing SNR. A gain in SNR of 3.0- to 3.5-fold
was reported for the 13C CryoProbe [101]. We recently compared
a 19F CryoProbe with a room temperature 19F RF coil of similar
size and reported on a maximal SNR gain of 15-fold and were able
to study inflammation at an isotropic resolution of 150 μm [100].
Surface RF coils provide a very high SNR close to the region
where they are applied. However, a decrease in signal amplitude
with increasing distance from their surface is inherent to the geom-
etry of their design. Inhomogeneities in the transmit (B1
+) field
cause a spatially varying flip angle (FA) and as a result signal
quantification is hampered. Likewise, the receive (B1
) field of
surface RF coils is position-dependent [102]. In the particular
case of the 19F CryoProbe, we observed a strong FA decrease
with increasing distance from the surface of the coil [100]. Using
a receive-only surface RF coil in combination with a volume reso-
nator used for transmission would overcome B1
+ inhomogeneities.
With this configuration the transmitted FAs will be homogeneous,
thus enabling quantification [103]. This option is not available
when using CryoProbes, since they are typically built in the form
of transceive (transmit–receive) RF coils with no active decoupling.
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Particularly for quantitative 19F MRI, a correction of the B1
+ inho-
mogeneity will be necessary when comparing concentrations of
PFC in vivo with an external standard of known 19F concentration.
Differences in the B1
+ field between the region of interest in vivo
and the external standard will result in errors when quantifying
in vivo 19F signals. Several approaches have been implemented to
correct B1
+ inhomogeneities retrospectively, even for 19F MRI
[104, 105]. These approaches typically include RF pulse sequences
for which an analytical knowledge of the signal intensity depen-
dency on the FA exists.
3.3.2 Magnetic Field
Strengths
Increasing the strength of the static magnetic field (B0) will increase
SNR of the measured signal [106], a strategy which is actively being
pursued for clinical application [107]. Intrinsic SNR is expected to
grow at least linearly with increasing B0 strengths [97, 108,
109]. The principle of reciprocity can be used at low field strengths
to calculate the receive field (B1) sensitivity of a single channel RF
coil in terms of the transmit field (B1
+) that can be easily measured
[110]. In studies performed at frequency ( f ) <1 MHz the maxi-
mum sensitivity was calculated to be proportional to the f: sensitiv-
ity / f1.75 [97, 108]. When going to higher magnetic field
strengths, the increasing f and the influence of wave propagation
need to be considered [106]. The homogeneity of the B1
+ field is
expected to decline with increasing B0, thereby influencing the
overall SNR gain. An experimental study investigating SNR depen-
dency on B0 in the human brain revealed that SNR / B01.65 in the
range of 3.0–9.4 T [109]. A recent simulation study also showed
that SNR grows superlinearly with frequency, particularly in deeper
regions of the sample; in less deep regions the SNR versus B0 trend
approached linearity [111].
An increase in magnetic field strength is particularly beneficial
for X-nuclei imaging. An increase in B0 from 9.4 to 21.1 T results in
an SNR gain of ~3 compared to a gain of ~2 for 1H MR [112]. We
recently studied the influence of increasing B0 on improving
19F
MR signal sensitivity [113]. Prior to the practical experiments, we
estimated the expected SNR gain when moving from 9.4 to 21.1 T
to be 2.7 [113]. We estimated SNR gain using the principle of
reciprocity [110] and ignoring all flip angle, sequence and
relaxation-dependent effects. The estimated SNR gain represents
a baseline expectation, based on the information available for the
specific hardware of each system. When introducing the relation-
ship of the reference power for both MR systems, we estimated an
SNR gain of ~3.8. In our practical experiments the ratio in SNR
efficiency (SNR/√t ratio) was estimated to be 7.29, when compar-
ing the best possible conditions for both 21.1 and 9.4 T, and when
including T1 relaxation effects [113]. Differences between the
actual SNR gains determined experimentally and those expected
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from simulations are conceivable, due to minor inaccuracies in the
assumptions made for the EMF simulations.
All research efforts ranging from new 19F probe design,
through optimization of 19F MR data acquisition methods up to
hardware developments hinge on the need for promoting 19F MR
signal in vivo, in order to answer crucial questions during pathology
including kidney disease. Most of the efforts devoted to discovery
and proof-of-principle research will benefit from an integration of
all available tools and technologies, in order to reach the maximum
potential for practical applications for patient health care.
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Chapter 18
MR Elastography of the Abdomen: Basic Concepts
Suraj D. Serai and Meng Yin
Abstract
Magnetic resonance elastography (MRE) is an emerging imaging modality that maps the elastic properties
of tissue such as the shear modulus. It allows for noninvasive assessment of stiffness, which is a surrogate for
fibrosis. MRE has been shown to accurately distinguish absent or low stage fibrosis from high stage fibrosis,
primarily in the liver. Like other elasticity imaging modalities, it follows the general steps of elastography:
(1) apply a known cyclic mechanical vibration to the tissue; (2) measure the internal tissue displacements
caused by the mechanical wave using magnetic resonance phase encoding method; and (3) infer the
mechanical properties from the measured mechanical response (displacement), by generating a simplified
displacement map. The generated map is called an elastogram.
While the key interest of MRE has traditionally been in its application to liver, where in humans it is FDA
approved and commercially available for clinical use to noninvasively assess degree of fibrosis, this is an area
of active research and there are novel upcoming applications in brain, kidney, pancreas, spleen, heart, lungs,
and so on. A detailed review of all the efforts is beyond the scope of this chapter, but a few specific examples
are provided. Recent application of MRE for noninvasive evaluation of renal fibrosis has great potential for
noninvasive assessment in patients with chronic kidney diseases. Development and applications of MRE in
preclinical models is necessary primarily to validate the measurement against “gold-standard” invasive
methods, to better understand physiology and pathophysiology, and to evaluate novel interventions.
Application of MRE acquisitions in preclinical settings involves challenges in terms of available hardware,
logistics, and data acquisition. This chapter will introduce the concepts of MRE and provide some
illustrative applications.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
This introduction chapter is complemented by another separate chapter describing the experimental
protocol and data analysis.
Key words Magnetic resonance elastography (MRE), Stiffness, Kidney, Preclinical imaging, MRI,
Fibrosis
1 Introduction
Elastography based imaging techniques have received substantial
attention in recent years for noninvasive assessment of tissue
mechanical properties. These techniques take advantage of changed
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_18, © The Author(s) 2021
301
soft tissue elasticity in various pathologies to yield qualitative and
quantitative information that can be used for diagnostic purposes.
Measurements are acquired in specialized imaging modes that can
detect tissue stiffness in response to an applied mechanical force
(compression or shear wave). Elasticity reflects the ability of tissue
to deform and resume its normal shape under an applied stress and
relates to tissue stiffness. Tissue stiffness in turn reflects tissue com-
position and structure. The primary desired output is to measure the
level of stiffness. The measurement that helps differentiate if the
tissue is hard or soft can give diagnostic information about the
presence of the disease.
In the liver, tissue stiffness has been shown to be elevated with
advanced fibrosis and to correlate with various stage of fibrosis [1–
3]. Tissue stiffness can be estimated by imaging with either ultra-
sound (US) or magnetic resonance imaging (MRI). US-based
elastography techniques include strain-based imaging, transient
elastography (TE), and shear wave elastography (SWE). MRI mea-
sures tissue stiffness with magnetic resonance elastography (MRE).
Other than strain-based imaging, which has largely been aban-
doned in the liver, all of these techniques (TE, SWE, and MRE)
estimate tissue stiffness by measuring the speed of a shear wave
traversing the tissue. In MRI, elastography encompasses imaging
techniques that noninvasively estimate tissue elasticity and related
mechanical properties through the application of external forces
[4]. MRE is a phase contrast-based MRI technique for observing
strain waves propagating in soft tissues (e.g., brain, heart, liver,
spleen, breast, kidney, and muscle). Mechanical shear waves with
frequencies of 40 to 200Hz are induced using either a piezoelectric
transducer or speaker coil oscillator directly coupled to the region
of interest. By using multiple phase offsets and motion encoding
gradients, MRE acquires data that allows the generation of images
that depict shear wave motion and the calculation of local values of
the tissue viscoelastic properties. In this chapter, we will provide an
overview of MRE including the basic concepts involved, and a few
illustrative applications of MRE in preclinical imaging.
This introduction chapter is complemented by a separate pub-
lication describing the experimental procedure and data analysis,
which is part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)






MRE uses mechanical shear waves to evaluate the viscoelastic prop-
erties of tissues. In the abdomen, mechanical shear waves produced
by an external driver are propagated into the tissue using an abdom-
inal driver placed over the region of interest and in contact with the
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specific abdominal organ. Tissue displacements in the range of
microns produced by propagating shear waves can be detected
because phase shifts are encoded with motion encoding gradients
in the MRE sequence. In liver, the typical frequency of shear waves
used for clinical liver MRE is 60 Hz [5]. An accurate and reproduc-
ible stiffness measurement of organs such as pancreas and kidney,
given their small size, complex geometry and boundary conditions,
heterogeneous nature of the organ, and deeply seated location,
requires 3D analysis of wave field data. For this reason, 3D MRE
is recommended for such imaging. In 3D MRE, the propagating
shear waves are imaged with a 2D multislice spin-echo echo-planar
imaging (SE-EPI) pulse sequence modified to include the motion
encoding gradients (MEG) in the X, Y, and Z directions. This is
different from the 2D MRE typically utilized for liver imaging in
which motion is encoded only in a single direction. An inversion
algorithm automatically produces stiffness maps using the phase
shift information. Shear stiffness values in kilopascals (kPa) are
displayed for selected regions of interest in the target tissue. In
renal MRE, the wave transmitting paddle is placed close to the
kidney, preferably on the dorsal side (Fig. 1).
Fig. 1 Clinical MRE set up for the kidney




It is now well known that theMRE-measured shear modulus of soft
tissue is dependent on the frequency of applied mechanical waves
[6, 7]. That is why the term “shear stiffness” is often used to
describe the shear modulus at a specific frequency. However, it
should be fully understood that the formula that calculates the
shear modulus from the measured velocity of the waves (μ ¼ ρc2,
where μ¼ shear modulus, ρ¼ density of tissue, and c¼wave speed)
is valid only in purely elastic tissues.
In a typical MR elastography configuration, an active pneu-
matic mechanical wave driver is located outside the MR elastogra-
phy room and is connected, by way of a flexible plastic (polyvinyl
chloride) tube, to a passive driver that is fastened onto the abdomi-
nal wall or the abdominal organ or interest. The passive driver
generates a continuous acoustic vibration that is transmitted
through the abdomen, with a focus on the region of interest, at a
fixed frequency, which typically lies in the range 40–400 Hz. A
phase-contrast MRI pulse sequence with motion encoding gradi-
ents is synchronized to the frequency of mechanical waves created
by the passive driver. This sequence is then used to image the
micron-level cyclic displacements caused by the propagating shear
waves to create a magnitude image, which provides anatomic infor-
mation, and a phase difference image, which provides wave motion
information. After the magnitude and phase images are created, an
inversion algorithm can be used to processes these raw data images
to create several additional images and maps. The gray-scale elasto-
gram is commonly used to provide quantitative stiffness measure-
ment, in kiloPascals. The color elastogram is generally used for
qualitative tissue stiffness evaluation. The color elastogram used
clinically has a stiffness range of 0–8 kPa. A 0–20 kPa color elasto-
gram is also created and is useful for appreciating tissue stiffness
heterogeneity. For research purposes, the range can also be adjusted
as desired. More details on image acquisition, postprocessing, and
analysis are included in the chapter by Serai SD et al. “MR Elasto-




The two types of acquisition sequences currently in use to obtain
liver stiffness values are the gradient-recalled-echo (GRE) based
(Fig. 2a) and the spin echo (SE) based with echo-planar readout
(Fig. 2b); both of which have been shown to have excellent perfor-
mance on both 1.5 and 3 T MRI scanners [8, 9]. The use of
GRE-based sequence has been demonstrated to correlate with
histological grading of liver fibrosis in previous studies and in a
recent meta-analysis [8, 10]. The traditional GRE-based MRE
acquisition works well on a 1.5 T scanner. However, the inherent
limitations of GRE-based acquisition on field strengths at 3 T or
higher are (1) enhanced sensitivity to susceptibility; T1 is longer at
the higher field strength and hence signal drops off due to a longer
echo time (TE); and (2) T2 and T2* are shorter at field strengths of
3 T and higher; hence, the relatively shorter T2 and T2* relaxation
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time of the liver requires an even shorter TE. GRE-basedMRE also
has relatively lower accuracy in obese patients due to the increased
distance from the driver to the liver. Thicker layers of fat can limit
the acoustic penetration depth in the liver and produce limitations
for encoding shear waves in the deeper areas of the liver, hence
reducing the measurable area [9]. SE-EP–based acquisition over-
comes this limitation by encoding more wavelengths per TR and
hence can show more acoustic penetration. Since chronic liver
Fig. 2 (a) Pulse sequence diagram of a typical GRE-based MRE acquisition sequence and (b) SE-EPI-
based MRE
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disease is quite frequently associated with obesity, radiologists
should be aware of the limitations of GRE-based acquisitions in
such cases. GRE-based MRE acquisition also requires relatively
longer periods of acquisition and have a higher susceptibility to
breathing motion artifacts. The current GRE-based protocol for
MRE image acquisition requires a breath hold of approximately
20 s for a single slice. Echo-planar imaging (EPI), on the other
hand, is a faster magnetic resonance imaging technique that obtains
all spatial-encoding information in a single radiofrequency
(RF) pulse, allowing shorter acquisition times with reduced motion
artifacts. SE-EPI-based images are advantageous in patients with
limited breath-holding capacity because they allow image acquisi-
tion of multiple slices within only one breath hold, and also enable
measuring larger areas of the liver due to the greater number of
waves encoded per relaxation time (TR). The drawback of SE-EPI–
based acquisition is the potential increase in susceptibility artifacts
due to an EPI-based readout. While technically more demanding,
3D-MRE offers advantages that might provide even higher diag-
nostic performance [11, 12].
3 Applications of MRE to the Abdomen
3.1 MRE
for Evaluation of Liver
Fibrosis
Liver fibrosis is an important pathological and pathogenic feature,
and the assessment of fibrosis is often necessary for prognosis, risk
stratification, clinical decision-making, and disease severity moni-
toring. Hepatic fibrosis eventually leads to cirrhosis, which is asso-
ciated with a 50% 5-year mortality due to severe complications
including variceal bleeding, hepatic failure, and development of
hepatocarcinoma. Approximately 170 million people world-wide
(3% of the global population) are infected with chronic hepatitis C
(HCV), and 10–15% will develop cirrhosis within 20 years of
infection [13]. Needle liver biopsy analyzed with connective tissue
stains has long been considered the “gold standard” to detect and
quantify hepatic fibrosis. Because of the cost, sampling variability,
need for sedation, and risk associated with biopsy, noninvasive
methods to assess liver fibrosis such as elastography are needed
[14, 15]. MRE uses low-frequency (40–80 Hz) sound waves to
induce shear waves in the liver, visualizes the shear waves by track-
ing tissue displacement using a modified phase-contrast sequence,
and measures the speed of the propagating wave with specialized
software called an inversion algorithm (Fig. 3) [16]. In Fig. 3, it can
be seen that the red to blue region is a wavelength and this wave-
length becomes longer in the presence of a stiff region for a given
excitation frequency (Fig. 4). Then these wave images are con-
verted into spatial stiffness maps (elastograms) using an inversion
algorithm. Clinically MRE of the liver is FDA approved for human
use and available on major MRI scanners. In the commercial ver-
sion, the sound waves are generated by an acoustic subwoofer
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Fig. 3 Clinical MRE of the liver: (A) The passive driver should be placed over the right lower anterior chest wall
at the level of the xiphisternum, centered on the mid-clavicular line. Once positioned, the passive driver should
be held firmly against the chest wall by a wide elastic band, placed around the torso. Check to ensure that the
band is stretched sufficiently so that the driver is not loose during full expiration. Note that the passive driver is
connected via a plastic tube to the active driver (vibration source), which is located outside the scan room. (B)
Magnitude and color-coded wave images of a successful MRE showing excellent illumination of waves
through the liver. Stiffness map shows elevated liver stiffness consistent with significant fibrosis
Fig. 4 Color (red and blue) wave images and its corresponding elastogram showing the difference in
wavelength (green arrow) of a relatively “normal” subject vs. a patient with fibrosis
(called as “active driver”) outside the scan room and are transmitted
to a plastic disk (called as “passive driver”) via a plastic tube passing
through a wave guide [5]. During liver MRE image acquisition, the
passive driver is secured by an elastic band over the right lower
anterior chest wall. Most patients can feel the vibrations generated
by the disk but do not find them uncomfortable. Identical MRE
hardware and inversion algorithms are available on scanners manu-
factured by the three major MR vendors (GE, Philips, and Siemens)
[10, 17]. MRE, as used clinically, currently has advantages over
other tissue elastographic techniques. These advantages include the
ability to further characterize tissue in terms of fat and iron content
as well as standardization across manufacturer platforms, since the
vast majority elastography hardware and software currently comes
from a single manufacturer (Resoundant Inc.; Rochester, MN).
Peer reviewed studies have shown that MRE is a robust, reliable,
repeatable, and reproducible technique for detection and staging of
liver fibrosis [10]. The accuracy of MRE has been reported to range
from 0.85 to 0.99 for differentiating different stages of liver fibrosis
[18]. The performance of MRE for differentiating mild fibrosis
(stage 1) from normal liver or inflammation is lower and the per-
formance is highest for diagnosis of cirrhosis (stage 4) [3, 10].
3.2 MRE
for Evaluation of Liver
Tumors
Motivated by the successful implementation of MRE for the study
of diffuse changes in hepatic stiffness due to fibrosis, studies have
been conducted to evaluate the potential role of MRE in character-
izing hepatic tumors as malignant tumors appear to be stiffer than
benign tumors [19–21]. In a preliminary work by Venkatesh et al.,
patients with 44 hepatic masses were evaluated with MRE and the
results were correlated with pathological diagnosis or other
accepted diagnostic criteria [20]. The stiffness of benign masses
(nine hemangiomas, three focal nodular hyperplasia, and one
hepatic adenoma) averaged 2.7 kPa, slightly higher than the mean
stiffness of normal liver parenchyma (2.3 kPa). The mean stiffness
of the malignant tumors was reported to be 10.1 kPa. The authors
reported that a cutoff value of 5 kPa completely separated all benign
liver masses from malignant lesions. Their results indicate that
MRE shows substantial promise for aiding the characterization of
liver tumors, which provides motivation for exploring the potential
for evaluating other mass lesions in the abdomen as well.
3.3 MRE
of the Spleen
for Evaluation of Portal
Hypertension
A study of 12 normal volunteers and 38 liver patients with biopsy-
proven chronic liver diseases performed by Talwalkar et al., demon-
strated higher spleen stiffness in patients with chronic liver disease
and a very strong correlation between hepatic and splenic stiffness
in these patients [22]. This may suggest that the bulk stiffness of
the spleen is strongly affected by the portal venous pressure
through a poroelasticity effect. A preclinical MRE study was per-
formed on two adult mongrel dogs immediately after and 4 weeks
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after initiating cholestatic liver disease by common bile duct liga-
tion [23]. This preclinical model is known to have portal hyperten-
sion within 4 weeks. In this study subcutaneous vascular access
ports were placed with catheter tips in the portal vein and the
right hepatic vein allowing measurement of hepatic venous pressure
gradient [23]. The MRE-assessed splenic stiffness in these dogs
rose from a mean value of 1.8 kPa to an average of 3.4 kPa. The
MRE study from the authors provide evidence to support the
hypothesis that in the absence of confounding effects, the
MRE-assessed stiffness of the spleen reflects the magnitude of the
hepatic venous pressure gradient. This also provides motivation for
the development of improved MRE techniques for the assessment
of the spleen as well as the development and validation of poroe-
lastic models that may allow the hepatic venous pressure gradient to
be estimated noninvasively from MRE-based measurements of
splenic stiffness. This would be a very significant development
because knowledge of the hepatic venous pressure gradient is con-
sidered to be very important in the management of chronic liver
disease and is very difficult to determine noninvasively. In a cross-
sectional study of 25 patients with autosomal recessive polycystic
kidney disease (ARPKD) and 25 healthy controls, ARFI based
elastography was able to distinguish between participants without
and with clinical signs of portal hypertension, namely splenomegaly
or low platelets [24].
3.4 MRE
of the Kidney
Many different disease mechanisms induce glomerular injury,
including glomerulonephritis, hypertensive nephrosclerosis and
diabetic nephropathy [25]. However, once renal damage reaches a
certain threshold, progression of renal disease is consistent, and
largely independent of the initial insult. This common pathway to
end-stage renal failure is mainly due to tubulointerstitial damage
characterized by tubular atrophy, loss of peritubular capillaries, and
interstitial fibrosis. Mechanisms leading to kidney failure via tubu-
lointerstitial damage and development of fibrosis are mostly massive
proteinuria and chronic hypoxia [26]. Fibrosis further impairs oxy-
gen diffusion and supply to tubular cells. This in turn exacerbates
fibrosis of the kidney, rendering it into a vicious cycle.
Renal fibrosis is the excessive accumulation and deposition of
extracellular matrix in the interstitial space of the kidneys. The
process of fibrogenesis in kidneys is very complicated and cannot
be attributed to any single type of cellular activity. However, it can
be described as an overall result of the kidney’s incapability to
properly regenerate the damaged tissues after renal injury. When
kidneys suffer injury, extracellular matrix deposition is an integral
part of the damage repair process. However, certain processes can
lead to excessive matrix to be deposited in the interstitial space,
which leads to scarring of the kidneys. This interferes with the
normal functioning of the kidneys and causes progressive loss of
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renal function over time due to the reduction in the number of
renal tubules. Renal fibrosis is a significant hallmark in the progres-
sion of CKD and can lead to end stage renal disease (ESRD), which
necessitates dialysis or kidney transplant Thus, in the assessment of
chronic renal failure, fibrosis is a major histological feature and may
be an important surrogate endpoint for prognosis and monitoring
of treatment response. Besides, some investigations suggest that
fibrosis might be reversible, when the cause is treated, emphasizing
the need for early detection and quantification of this fibrosis [27–
33]. Currently, renal biopsy is the gold standard for diagnosing
kidney fibrosis. In this procedure, the kidneys of the patient are
located with help of ultrasonography or X-rays. After determining
the location, a needle is inserted in the kidney either percutaneously
(called percutaneous biopsy) or after performing a cut near the
region of kidney being observed under local anesthesia (called
open biopsy) to obtain tissue samples [32, 33]. These samples are
used for histological analysis to determine the presence of renal
fibrosis.
Kidney biopsy has several limitations. It is invasive and causes
pain to the patients after the procedure is performed. It is also
associated with a prolonged hospital stay and higher costs and the
procedure suffers from intra- and inter- observer variability. Since,
only a small region from the entire kidney is used to obtain samples
leading to potential sampling error [34]. Thus a noninvasive, truly
quantitative method of interstitial renal fibrosis monitoring would
be desirable. Diffusion-weighted and Blood Oxygenation Level
Dependent (BOLD) MRI findings have been shown to be corre-
lated to renal function [35–39], but no data has been published as
to their correlation with the degree of fibrosis. Blood or urinary
markers of fibrosis are also currently evaluated but neither is used in
clinical practice yet [40].
MRI and ultrasound (US)-based methods can estimate tissue
stiffness (and thus the degree of fibrosis) by measuring the velocity
of shear waves traveling through the organ of interest
[41, 42]. US-based elastography techniques are mainly classified
under strain imaging (SI) or shear wave imaging (SWI). The basic
principle of SI is application of stress to the tissue and measuring
the resulting normal strain which is reported as Young’s modulus.
SWI-based techniques use either a dynamic vibrating device or
acoustic radiation force to generate shear waves in the tissues,
which are reported either as shear wave speed or Young’s modulus.
Techniques based on SI include strain elastography (SE) and acous-
tic radiation force impulse strain imaging (ARFI), whereas
SWI-based techniques include point shear wave elastography
(pSWE), 2D shear wave elastography (SWE), and 1D transient
elastography (TE).
Studies have used both SI and SWI to investigate renal fibrosis.
SI-based techniques are found to be beneficial for diagnosing renal
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fibrosis in allografts than native kidneys [43]. This is because exter-
nal compression can be efficiently applied to allografts located
superficially than to native kidneys which are located retroperitone-
ally thereby limiting accuracy of this technique. A study by
Menzilcioglu et al. reported that even though SE reported higher
mean strain index in CKD patients when compared to healthy
subjects, it could not differentiate between various stages of
CKD [44].
SWI-based techniques have an advantage over SI-based tech-
niques since they do not depend on external compression. How-
ever, studies using SWI have reported conflicting results. A study by
Wang et al. reported that shear wave velocity measurements did not
show any correlation with degree of renal fibrosis [45]. Few studies
have reported lower shear wave velocities in patients with CKD
than in healthy subjects [46]. It has been observed that there is a
negative correlation between shear wave velocity and progression
of CKD in kidneys whereas a positive correlation has been observed
in liver using the same SWI-based techniques [43]. Apart from
these conflicting results, US-based elastography techniques have
following limitations: (1) only provides 1D or 2D stiffness of the
kidneys; (2) requires extensive training of technicians and is still
prone to inter- and intraobserver variability; (3) highly dependent
on the body mass index of subjects; and (4) anisotropy of the
kidney can impact the results. The US-based transient elastography
(Fibroscan™ device) is able to discriminate the different stages of
liver fibrosis with a quadratic trend of the curve plotting histologic
scores versus elasticity measurements [47]. Among patients with
cirrhosis, stiffness thresholds predicting the onset of specific com-
plications (ascites, oesophageal bleeding, hepatocarcinoma, etc.)
have been identified. However, as explained with the limiations of
US based studies, this technique is limited by its 1D nature in that it
does not allow the exploration of the entire liver. MRI has advan-
tages over US since it can image organs located deep in the human
body with good image contrast and spatial resolution thereby
improving the diagnosis. It also does not involve use of any radia-
tion and therefore can be used to monitor progression of diseases
over a period of time. MRE has been successfully used to assess and
stage liver fibrosis. The shear stiffness of normal liver was found to
be approximately 2.2 kPa by several independent groups, using
vibrating frequencies of 60 Hz [1, 3]. MRE has been shown to
sucessfully discriminate the different stages of liver fibrosis, with the
same quadratic trend of the fibrosis/elasticity curve and a recom-
mended cut-off value derived from a large group of patients
[18]. MRE has the advantage of being intrinsically a 2D technique
and can be associated to conventional liver imaging at the same
time. In the kidney, evaluation of interstitial fibrosis is crucial to the
assessment of prognosis and to guide therapy for most kidney
diseases. However, how best to measure kidney fibrosis remains
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uncertain. An MRE-based technique that measures tissue stiffness,
would be a novel application for assessment of renal fibrosis. The
resulting microscopic vibrational waves passing through the organ
generate shear waves that can be imaged with motion-synchronized
MRI. The velocity of wave propagation is dependent on organ
stiffness, with stiffer fibrotic tissue leading to more rapidly moving
waves with longer wavelength. Exploratory MRE of the kidneys in
healthy volunteers has demonstrated that shear waves can be readily
generated and imaged in this organ. Unlike the liver and spleen, the
patterns of wave propagation in these structures are extremely
complex and include significant components propagating at
oblique angles relative to an axial plane of section. Given these
characteristics, it is necessary to image the pattern of wave propaga-
tion in three dimensions and to obtain data from all three polariza-
tions of motion, which requires longer imaging times. This kind of
3D/3-axis MRE acquisition is problematic if the imaging is to be
conducted during suspended respiration and using a GRE-based
acquisition method. One approach to this is to use respiratory
gating, though this can make the total acquisition times quite
long. As an alternative, EPI-based techniques can be used to signif-
icantly reduce acquisition times. EPI-based MRE sequence have
been shown to be capable of acquiring 12 wave images (four phase
offsets at each of three motion-encoding directions) with an acqui-
sition time of 8 s per slice. This technique has successfully generated
3D wave data sets with typical voxel dimensions of 4 mm (Figs. 5,
6, and 7). With a 3D extension of the inversion software, including
3D spatial filtering, the preliminary results indicate that it is quite
feasible to image tissue stiffness throughout a larger 3D region of
interest in the abdomen and has yielded provocative preliminary
results in the kidneys that motivate further development in this
organ.
Magnitude Color Sffness map (kPa) Wave images Sffness map (kPa)
Cor 2D MRE
Fig. 5MRE of the kidney of a healthy volunteer performed at 60 Hz. Magnitude, stiffness map and color-coded
wave images of a successful MRE showing excellent illumination of waves through the kidney. The stiffness of
the normal kidneys at 60 Hz ranged from 3.5 to 5 kPa
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MRE  of kidneys performed in two normal healthy volunteers.
MRE performed in coronal and axial planes at 90Hz. The doed lines on the wave 
images and sffness maps outline the kidneys. The sffness of the normal kidneys 














Fig. 6 MRE performed in coronal and axial planes at 90 Hz. The dotted lines on the wave images and stiffness
maps outline the kidneys. The stiffness of the normal kidneys at 90 Hz ranged from 5 to 7.5 kPa (Image
courtesy of Dr. Sudhakar Venkatesh, Mayo Clinic, Rochester, Minnesota, USA)
ElastogramConventional MR image
MRE  of renal gra in the right iliac fossa 4-months following transplantaon.
Sffness is similar to normal kidneys. The renal funcon was normal. Biopsy showed 
no intersal fibrosis or tubular atrophy.
Fig. 7 MRE of renal graft in the right iliac fossa acquired 4-months following transplantation. Stiffness is
similar to normal kidneys. The renal function was normal. Biopsy showed no interstitial fibrosis or tubular
atrophy (Image courtesy of Dr. Sudhakar Venkatesh, Mayo Clinic, Rochester, Minnesota, USA)
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Pilot studies of MRE have been performed in native kidneys
and kidney allografts, attempting to correlate kidney stiffness with
either fibrosis burden or kidney function [48]. Although MRE in
porcine kidneys showed a correlation between stiffness and fibrosis
in the medulla, the results of small pilot human studies have so far
been conflicting, and no studies, as yet, have assessed whether
stiffness measured by MRE predicts progression of kidney dysfunc-
tion [49]. MREmay also be helpful in the evaluation and follow-up
of patients undergoing renal transplant [50]. In a study by Orlachio
et al., real-time elastography was able to evaluate kidney fibrosis in a
noninvasive way and could be used as complementary imaging
during follow-up of renal transplant patients [51].
3.5 MRE
of the Pancreas
Pancreatic fibrosis is often associated with chronic pancreatitis,
pancreatic ductal cancer, or inflammatory pseudotumor
[52]. Since pancreatic fibrosis may affect decisions of surgical inter-
ventions and prognosis in such pathologies [53], MRE techniques
could be exploited for information concerning pancreatic fibrosis
reflected by its stiffness. Serai et al. have demonstrated that 3D
MRE of the pancreas is feasible in children with and without
pancreatic disease, in a small cohort of pediatric patients, referred
for clinical imaging with history of acute recurrent pancreatitis
(APR) or CP [12]. In this preliminary study, they observed statisti-
cally significant lower pancreas stiffness values derived from 3D
MRE in children with a history of ARP or CP as compared to
healthy control children (1 kPa vs. 1.7 kPa) [12]. The finding of
lower pancreas stiffness in ARP/CP than controls is contrary to the
findings reported in a small series of adults (mean age 55.6 years) by
An et al. [54]. In their study, a mean stiffness value of 1.1 kPa was
reported for healthy controls compared to a mean stiffness of
1.5 kPa in five patients with chronic pancreatitis. Further, a study
by Wang et al. reported mean stiffness values of 1.5 and 1.9 kPa in
adults with mild (n ¼ 30) and moderate to severe (n ¼ 16) chronic
pancreatitis respectively as classified by the Cambridge criteria
[55]. Reported stiffness values in patients were higher than the
values in healthy patients in the same study.
3.6 Other MRE Body
Applications
Since MRE is a new, multistep MR technique, there is potential for
improvement, expansion and exploration. Breast tumors are known
to be stiffer than normal breast tissue and hence manual palpation is
a recommended part of routine screening that helps in the detec-
tion of tumors [56]. MRE is being investigated in breast imaging
for the detection of breast cancer since this disease is one of the
leading causes of death in women and the current diagnostic meth-
ods are not satisfactory [57, 58]. Skeletal muscle MRE can be used
for studying the physiological response of diseased and pathological
muscles [59]. For instance, it has been found that there is a differ-
ence in the stiffness of muscles with and without neuromuscular
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disease [60]. In a recent study on patients with Duchenne muscular
dystrophy, the authors concluded that shear wave elastography
could be considered a useful noninvasive tool to monitor muscle
changes in early stages of the disease [61].
4 Influence of Perfusion on Abdominal Organs
Preliminary results from the studies relating splenic stiffness to
hepatic venous pressure gradient (HVPG) suggests that the stiff-
ness of abdominal organs may have two components: a static com-
ponent reflecting intrinsic structural properties and a dynamic
component reflecting extrinsic perfusion changes [62, 63]. To
investigate the influence of perfusion on the shear stiffness of
abdominal organs, studies of specific conditions of the liver and




Food intake is known to cause an increase in mesenteric blood flow,
which may lead to a postprandial increase in hepatic stiffness that is
different in patients with hepatic fibrosis than in normal volunteers
[65]. It has been observed that MRE-assessed liver stiffness
increases significantly (average increment of 18% with ranges from
5% up to 48%) following a test meal in patients with advanced
hepatic fibrosis, whereas fasting and postprandial liver stiffness are
similar in the normal state [65]. This finding suggests that there is a
dynamic component to the liver stiffness that is dependent on the
portal pressure. Therefore, it is very important to have hepatic
MRE examinations performed consistently in a fasting state. The
postprandial augmentation in hepatic stiffness after a test meal
known to increase mesenteric blood flow is likely due to the tran-
siently increased portal pressure in patients with hepatic fibrosis. It
is thought that mechanical distortion of the intrahepatic vascula-
ture caused by fibrosis impairs the autoregulatory mechanism for
the portal venous pressure, which may cause acceleration of the
development of portal systemic varies and stretching of hepatic
parenchyma and stellate cells that are instrumental in the progres-
sion of hepatic fibrosis. This promising observation provides moti-
vation for further studies to determine the potential value of
assessing postprandial hepatic stiffness augmentation for predicting
progression of fibrotic disease and the development of portal vari-
ces. It may also provide new insights into the natural history and
pathophysiology of chronic liver disease.
4.2 Influence
of Hydration on Renal
Stiffness
Stiffness plays an important role in diagnosing renal fibrosis. How-
ever, kidney stiffness is altered by perfusion changes in many kidney
diseases. A study by Clark et al. suggests that increasing water intake
is recommended for patients with CKD as it helps to preserve renal
function [66]. Water intake before a MRE scan can act also as a
confounding factor to estimate the stiffness of kidneys. In a recent
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study, Gandhi et al. observed a negative correlation between differ-
ence in stiffness values and changes in bladder volumes before and
after water intake [67]. This suggests that at lower bladder volume
the kidneys are still filtering the water where perfusion pressure is
high leading to an increased stiffness in the kidneys.
4.3 Stenotic
Kidney MRE
The kidney is a richly perfused organ receiving 25% of the cardiac
output. Renal occlusions, such as renal arterial stenosis, threaten
the viability of the kidney by diminishing blood flow leading to
irreversible tissue fibrosis and ultimately kidney failure. Preliminary
research has been performed to study the impact of renal arterial
stenosis on kidney stiffness in a porcine model of acute renal arterial
stenosis [68]. MRE measurements showed that the stiffness of the
kidney progressively decreased as the renal artery stenosis was
increased. The authors reported that the stiffness of the contralat-
eral kidney was observed to increase progressively, which indicates
that hemodynamics can significantly affect the mechanical proper-
ties of renal parenchyma. Fibrosis is associated with elevated tissue
stiffness. However, studies have indicated the rich perfusion of the
kidney may affect its distension and, in turn, stiffness [68]. In order
to determine the interdependent relationship between perfusion,
fibrosis and stiffness, an acute renal arterial stenosis model was
established in adult pigs by isolating the renal artery to insert a
vascular occluder and an embedded Doppler flow probe. The renal
blood flow (RBF) was gradually reduced from the baseline level to
total occlusion of 100% with MRE acquisitions performed at each
step. The cortex of the acutely stenotic kidney decreased in stiffness
as the degree of stenosis was increased to 40% and above. The
systemic blood pressure also rose during each decrement in the
RBF (from 75  3 to 96  3 mmHg). These preliminary renal
MRE results encourage the further evaluation of renal hemody-
namics on tissue stiffness, which may be due, in part, to perfusion
pressure applied to the organ. These factors may also play a com-
plicating role in detecting the presence of fibrosis due to renal
arterial stenosis, and hence may lead to new techniques to assess
tissue stiffness. The use of MRE to assess changes in tissue mechan-
ics associated with the dynamic perfusion of tissue may also provide
new insights into the natural history and pathophysiology of renal
diseases (Table 1).
5 Preclinical MRE
Increasing evidence has demonstrated that, unlike cirrhosis, the
early stages of fibrosis are treatable and reversible if appropriate
antifibrotic treatment is given [69, 70]. As antifibrotic therapies
evolve, a reliable, noninvasive assessment of hepatic fibrosis is
needed to manage patients with chronic liver disease. Being able
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to noninvasively monitor the progression of liver fibrosis helps in
understanding the natural history of liver fibrosis in patients with
chronic liver disease, determining which patients require antiviral
therapy, predicting the approximate time to the development of
cirrhosis, and discovering new directions of scientific inquiry. Simi-
larly, being able to early diagnose renal fibrosis or parencyma dam-
age would help in understanding the natural history of renal fibrosis
in patients with CKD, determining which patients require which
therapy, predicting the approximate time to the development of
renal failure, and discovering new directions of scientific inquiry.
Therefore, there are ongoing investigations using preclinical mod-
els with a reliable, noninvasive method to assess fibrosis, not only to
detect and stage the disease itself but also to monitor treatment
efficacy and optimize dosing. In recent work by Yin et al. [2]
feasibility of MRE was demonstrated on a mouse model of autoso-
mal recessive polycystic kidney disease (ARPKD), which is an inher-
ited disorder of the kidneys and liver caused by mutations in the
PKHD1 gene and an important cause of congenital hepatic fibrosis
(CHF) in humans. A renal wrapping surgery performed on eight
pigs to induce sytemic arterial hypertension, showed that MRE
derived aortic stiffness increased with mean arterial pressure [71].
Table 1
Factors confounding the tissue stiffness measured using MRE
Confounding factor
Direction




Inflammation Positive Patients with AIH
Congestion Positive Patients with Fontan
Magnetic-field (B0)
inhomogeneity
Positive Bowel gas, poor shim
Steatosis/fat Negative Patients with NAFLD,
NASH
Renal stenosis Negative Patients with renal artery
stenosis or perfusion
defects





A “positive” direction of the effect means that an increase in the confounding factor leads
to an increase in measured stiffness and hence an overestimation of the fibrosis, and a
“negative” direction of the effect means that decreases the confounding factor lead to a
potential under estimation of stiffness




l Bowel gas can create susceptibility artifacts in renal imaging;
right lateral position helps minimize susceptibility artifacts
from bowel gas.
l Respiratory motion can create artifacts and if necessary free
breathing methods may be needed to minimize them. Alter-
nately, respiratory triggering could be used, but this may
increase the acquisition time [72].
l Studies indicate the choice of anesthesia may have an effect on
quantitative MR measurements. This may be partly due to
known effects of anesthesia on respiration, temperature, blood
pressure, and pO2.
l Hemodynamic variables may modulate kidney stiffness
measured by MRE and may mask the presence of fibrosis [68].
l In liver imaging, elevated stiffness is observed “after meal” due
to postprandial effect. Such effects have not yet been reported in
measuring kidney stiffness [65].
l While performing renal MRE, renal perfusion status should be
taken into account to ensure reproducible detection [73]. Con-
founding stiffness changes due to excess water intake have been
reported [67].
l In the preclinical setting, motion artifacts can usually be mini-
mized using multiple averages.
6 Conclusion
Renal fibrosis causes a change in the anatomy of kidneys wherein
there is an excess accumulation of interstitial extracellular matrix
and reduction in the number of tubules. Elasticity imaging is an
imaging field that has received considerable attention due to its
intuitive mechanical contrast based on “palpation” and its great
diagnostic potential. Elasticity imaging techniques are based on
measuring the response of tissues to an applied excitation and
different approaches have been proposed and investigated toward
this goal. Elastography encompasses imaging techniques that non-
invasively estimate tissue elasticity and the related mechanical prop-
erties through the application of external forces. Elasticity reflects
the ability of tissue to deform and resume its normal shape under an
applied stress and relates to tissue stiffness. Tissue stiffness in turn
reflects tissue composition and structure. Fibrosis is an important
pathologic and pathogenic feature of each of these conditions, and
the assessment of fibrosis is often necessary for prognosis, risk
stratification, clinical decision-making, and disease severity moni-
toring. Due to the cost, need for sedation, and risk associated with
biopsy, noninvasive methods such as elastography to assess tissue
fibrosis are needed.
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US-based methods only provide 1-D stiffness, have lower pen-
etration depth and are highly dependent on body mass index,
anisotropy of tissues, transducer force, and intra- and inter-
observer variability. Numerous investigations have shown that it is
readily possible to performMRE in abdominal organs for detecting
specific diseases, such as hepatic fibrosis and portal hypertension,
which increase the stiffness of the liver and spleen. Other prelimi-
nary studies have demonstrated that is possible to evaluate the
mechanical properties of other abdominal structures, such as the
pancreas and kidneys. These results will further motivate future
studies incorporating MRE to study the normal and pathological
mechanics and physiology of abdominal organs.
MRE has been shown to be capable of detecting alterations in
the tissue mechanical properties of kidneys in vivo preclinical and
clinical studies. In the kidney, shear wave elastography has been
shown to be helpful in early noninvasive detection and manage-
ment of patients with chronic kidney disease (CKD). Renal MRE is
a promising noninvasive technique that might have pathologic and
prognostic significance.
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Monitoring Renal Hemodynamics and Oxygenation
by Invasive Probes: Experimental Protocol
Kathleen Cantow, Mechthild Ladwig-Wiegard, Bert Flemming,
Andreas Pohlmann, Thoralf Niendorf, and Erdmann Seeliger
Abstract
Renal tissue hypoperfusion and hypoxia are early key elements in the pathophysiology of acute kidney injury
of various origins, and may also promote progression from acute injury to chronic kidney disease. Here we
describe methods to study control of renal hemodynamics and tissue oxygenation by means of invasive
probes in anesthetized rats. Step-by-step protocols are provided for two setups, one for experiments in
laboratories for integrative physiology and the other for experiments within small-animal magnetic reso-
nance scanners.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
This experimental protocol chapter is complemented by a separate chapter describing the basic concepts of
quantitatively assessing renal perfusion and oxygenation with invasive probes.
Key words Renal hemodynamics and oxygenation, In vivo methods, Rats, Magnetic resonance
imaging (MRI)
1 Introduction
Kidney diseases are a global health burden with steadily increasing
incidence [1–5]. Animal studies indicate that acute kidney injuries
(AKI) of various origins share one common link in the pathophysi-
ological chain of events, ultimately leading to AKI, as well as to
progression from AKI to chronic kidney diseases (CKD): imbalance
between renal oxygen delivery and oxygen demand [3, 6–
13]. Renal tissue hypoperfusion and hypoxia have also been sug-
gested to play a pivotal role in the pathophysiology of other kidney
diseases including diabetic nephropathy [14–18].
Themajority of the preclinical studies that generated this concept
utilized a set of invasive probes to measure renal hemodynamics and
oxygenation in anaesthetized rats [12, 14–16, 19–22]. These probes
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typically include (1) a perivascular flow probe for measurement of
total renal blood flow, (2) laser-Doppler-probes for assessment of
local tissue perfusion, (3) Clark-type electrodes or fluorescence-
quenching optodes for measurements of local tissue partial pressure
of oxygen (pO2), and (4) devices for invasive measurement of arterial
blood pressure. These methods are considered the gold standard for
the study of renal hemodynamics and oxygenation because themeth-
ods—with the exception of the laser-Doppler—provide calibrated
quantitative data [23–25]. The methodological principles of these
techniques are detailed in the chapter by Cantow K et al. “Quantita-
tive Assessment of Renal Perfusion and Oxygenation by Invasive
Probes: Basic Concepts.” Besides the study of the pathophysiology
of AKI and CKD, these methods have also been used to study
(1) mechanisms of control of renal hemodynamics and oxygenation
in healthy rats, (2) the effects of various substances on this control,
and (3) several putative preventive or therapeutic approaches for AKI
and CKD [20–22, 26–30].
It is well known that, due to the considerable capacity of the
organism’s homeostatic control systems to—at least partially—
compensate for disturbances of, or injury to, certain control
elements, these alterations are often not easily detectable when
studied by measuring baseline data only. Therefore, the control
systems must be “challenged” in order to unmask such alterations.
This is done by dedicated test interventions (see the chapter by
Cantow K et al. “Reversible (Patho)Physiologically Relevant Test
Interventions: Rationale and Examples”) [19, 27, 28, 31].
As all established modalities available in today’s experimental
and translational research, these techniques have shortcomings and
methodological restraints, in particular, the invasiveness that pre-
clude the survival of the animals and therefor the implementation in
long-term studies, and, of course, their use in humans. Magnetic
resonance imaging (MRI) offers noninvasive techniques to obtain
insight into renal perfusion and oxygenation under (patho)-
physiological conditions. MRI affords full kidney coverage, soft
tissue contrast that helps to differentiate the renal layers, seconds
to minutes temporal resolution, support of longitudinal studies,
and high anatomical detail [24, 25, 32–34].
However, the validity and efficacy of functional MRI techni-
ques for quantitative characterization of renal tissue perfusion and
oxygenation and its changes in various (patho)physiological scenar-
ios remains to be established [24, 33, 35–37]. In particular, the
weakness of MRI, its qualitative nature, needs to be addressed by
calibration with quantitative methods, that is, the gold standard
physiological techniques. Realizing the need of tracking invasive
physiological parameters and MR parameters simultaneously for
the same kidney, an integrated multimodality approach designated
as MR-PHYSIOL was developed by our group [24, 33, 38]. It
combines the measurements by the invasive probes described above
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(hereafter called PHYSIOL) with renal functional MRI data
acquired by an ultrahigh field small animal scanner. By means of
this hybrid setup, the first steps toward calibration of the blood
oxygenation-sensitive parameter T2* (so-called blood oxygenation
level-dependent MRI, BOLD-MRI) were done. Dedicated
(patho)physiologically relevant test intervention including short
periods of suprarenal aortic occlusion, hypoxia, and hyperoxia
were applied to modulate renal perfusion and oxygenation, in
order to detail the relationship between renal T2* and tissue oxy-
genation [24, 33, 39]. Of course, the MR-PHYSIOL setup can be
used for calibration of functional MR parameters other than
oxygenation-sensitive T2* as well.
In the following, step-by-step protocols are provided for two
setups, one for stand-alone experiments in laboratories for integra-
tive physiology (PHYSIOL) and the other for experiments within
dedicated small-animal magnetic resonance scanners by use of the
hybrid setup (MR-PHYSIOL).
This experimental protocol chapter is complemented by a sep-
arate chapter describing the basic concepts, which is part of
this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals For PHYSIOL, male Wistar rats with body mass of 300–400 g are
used. ForMR-PHYSIOL, the spatial constraints dictated by the MR
environment require the use of relatively small rats (350 g). The
rats are allowed ad libitum food (standard maintenance diet) and
water and must be housed at standardized conditions (e.g., group
housed in Makrolon type IV cages with elevated lids under conven-
tional SPF conditions; for cage enrichment paper towels as nesting
material and pieces of wood for gnawing should be provided).
2.2 Surgical
Preparation
1. Anesthesia: urethane solution (Sigma-Aldrich, Steinheim, Ger-
many; 20% in distilled water).
2. Temperature controlled operation table.
3. Operation microscope (e.g., Leica MZ6; Leica Microsystems,
Wetzlar, Germany) with magnification range between 6.3
and 40.
4. Set of microsurgical instruments (including dissecting scissors,
microsurgical forceps, needle holders) and threads (including
Vicryl polyglactin 910, 4/0; Prolene 6/0; Ethicon, Norder-
stedt, Germany).
5. For blood pressure measurement: (a) a pressure transducer
(e.g., DT-XX, Viggo-Spectramed, Swindon, UK) connected
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to an amplifier (TAM-A Plugsys, Hugo Sachs Elektronik—
Harvard Apparatus, March, Germany); (b) a femoral artery
catheter designed and custom-made in our laboratory using
Portex Tubing (polythene). For MR-PHYSIOL the catheter
must be longer than 1 m to allow placing the pressure trans-
ducer well outside the bore of the MR scanner. Safety informa-
tion: Make sure that the positioning of the amplifier meets the
safety requirements of the MR environment.
6. For monitoring of total renal blood flow for PHYSIOL: a
perivascular flow probe (1RB, Transonic Systems, Ithaca, NY,
USA), for MR-PHYSIOL a perivascular flow probe
(MCV2PSB-MRI; Transonic Systems) as depicted in Fig. 1.
Please note that the flow probe employed in MR-PHYSIOL
uses an acoustic reflector made of Macor ceramics instead of a
stainless steel or brass reflector to meet the safety and compati-
bility requirements of MRI. The respective flow probe is
connected to a perivascular flow module (TS420; Transonic
Systems). Safety information: Make sure that the positioning of
the flow module meets the safety requirements of the MR
environment.
7. Combined optical laser-Doppler-Flux and pO2 probes (pO2
E-Series Sensor; Oxford Optronix, Oxford, UK) for measure-
ments of local tissue oxygenation and local tissue perfusion as
Fig. 1 Probes for monitoring of total renal blood flow. (a) Perivascular flow probe
(1RB, Transonic Systems, Ithaca, NY, USA) for PHYSIOL: the acoustic reflector is
made of steel; closing the probe’s steel “lock” prevents detachment from the
renal artery. (b) perivascular flow probe (MV2PSB-MRI; Transonic Systems) for
MR-PHYSIOL: due to the long extension leads necessary to meet MR safety
requirements, this probe has a larger body size. The reflector is made of
ceramics (it does not induce MR artifacts), is L-shaped and offers no
mechanism to lock the vessel. Therefore, a gauze is attached to the probe’s
cable, which will be fixed to the retroperitoneal muscles by means of sutures to
avoid probe displacement
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depicted in Fig. 2. The probes are attached to an OxyLite/
OxyFlo-apparatus (Oxford Optronics, Oxford, UK). Safety
information: For MR-PHYSIOL make sure that the position-
ing of the OxyLite/OxyFlo-apparatus meets the safety require-
ments of the MR environment.
8. For continuous logging of the signals from the probes for
arterial blood pressure, renal blood flow, cortical and medullary
pO2 and flux, their analog outputs must be digitized and
recorded. An analog–digital converter (e.g., DT 9800-16SE-
BNC, Data Translation GmbH, Bietigheim-Bissingen, Ger-
many) permits connection to the USB port of a PC. A dedi-
cated data acquisition software (HAEMODYN, Hugo Sachs
Elektronik—Harvard Apparatus, March, Germany) allows for
calibration of the probe signals and their continuous recording.
9. A vascular occluder (see Fig. 3): the remotely controlled
hydraulic occluder is custom-made; it was designed and man-
ufactured in our laboratory. The occluder consists of an inflat-
able tube (“head” of the occluder) connected by a catheter to a
syringe. The “head” of the occluder is made of a high-grade
silicone elastomer tube (Silikonkautschuk, Detakta Isolier-und
Messtechnik GmbH & Co KG, Germany). For the connection
between the “head” of the occluder and a regulative syringe an
inextensible extension catheter (Portex Polythene Tubing; Ref
Fig. 2 Probes for monitoring of tissue laser-Doppler-flux and pO2 (pO2 E-Series
Sensor; Oxford Optronix, Oxford, UK). (a) Unmodified probe for PHYSIOL. (b)
Modified probe for MR-PHYSIOL: the customary Luer-Lock connector is
removed, the fiber glass cores are fixed to the sheathing by means of a
clamp. Silicone tubing with its length adjusted to the distance between the
caudal and the cranial extremities of the individual kidney enables the exact
placement of the cortical probe. A patche of gauze attached to the end of silicone
tubing is used to fixed the probe on the kidney surface by Histoacryl glue to
prevent displacement
Invasive Probes for Hemodynamics and Oxygenation: Exp. Protocol 331
800/110/200; inner diameter 0.58 mm) is used. For
MR-PHYSIOL, the extension catheter must be longer than
1 m to allow remote control of the occluder from outside the
bore of the MR scanner.
10. Vascular catheter(s) for administration of fluids (e.g., isotonic
saline) and/or solutions of substances used for selective test
interventions (e.g., drugs), and for repeated blood sampling
(e.g., for measurements of blood gases and hemoximetry).
Catheters for venous and arterial insertion are made in our
laboratory using Portex Tubing (polythene).
11. For fixation and stabilization of the probes for PHYSIOL: two
micromanipulators (e.g., type M-44 and MN-153, Narishige
group, Tokyo, Japan) mounted on a rotatable magnetic pedes-
tal (e.g., type M9, World Precision Instruments, Sarasota, FL,
USA) as depicted in Fig. 4. The operation table needs a steel
surface (e.g., type Micro-g, Technical Manufacturing Corpo-
ration, Peabody, MA, USA) to fixate the magnetic pedestals in
positions required by the individual placements of the probes
within the rat. For MR-PHYSIOL: to achieve stabile positions
of the probes and to ensure safe transfer of the animal equipped
with the probes to the scanner, a custom-made portable animal
holder must be used (see Fig. 5). It was designed and built in
our laboratory using 3D CAD (Autodesk Inventor 2012;
Autodesk, San Rafael, CA, USA) and rapid prototyping (BST
1200es; Alphacam GmbH, Schorndorf, Germany). The holder
must meet the geometry of the MR setup; it has a half-pipe
shape with a section of reduced diameter to allow for the
4-element surface RF coil to be placed beneath. A mark on
the holder indicates the center of the RF coil. A bridge-like
construction, positioned at the end of the hind paws of the rat,
enables fixation of all leads that connect the physiological
Fig. 3 Custom-made remotely controlled hydraulic vascular occluder as
designed and manufactured in our laboratory. An inflatable tube (“head” of the
occluder) is connected by an inextensible catheter (about 1 m length for
MR-PHYSIOL) to a syringe. Inflation of the “head” (which is made of a high-
grade silicone elastomer tube) compresses the respective vessel due to its
fixation to the vessel by means of the (green) surgical threads
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probes with the equipment positioned outside the MR scanner
room. The portable rigid animal holder in conjunction with
the adjustable cable support bridge enables a safe transport of
the animal to the MR scanner.
12. A respiratory (anesthetic) mask through which the spontane-
ously breathing rat is provided with air or other gas mixtures at
Fig. 5 Portable animal holder for MR-PHYSIOL. The holder enables fixation and stabilization of the probes and
a safe transfer to the scanner of the animal equipped with the probes. To meet the geometry of the MR setup,
it is custom-made by our lab in a half-pipe shape with a section of reduced diameter to allow for the surface
RF coil. A bridge-like construction, positioned at the caudal end, enables fixation of all leads that connect the
physiological probes with the equipment positioned outside the MR scanner room
Fig. 4 Micromanipulators used for placement/insertion and fixation of probes for PHYSIOL. (a) micromanipula-
tor (type M-44 and MN-153, Narishige group, Tokyo, Japan) mounted on a rotatable magnetic pedestal (type
M9, World Precision Instruments, Sarasota, FL, USA). A perivascular flow probe (1RB, Transonic Systems,
Ithaca, NY, USA) is attached to its “clutch” (type M-44). (b) Detail of the “clutch” with a laser-Doppler-flux and
pO2 probe (pO2 E-Series Sensor; Oxford Optronix, Oxford, UK) attached
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a supply rate of about 1000 mL/min. Such a mask can be easily
built: take a 20 mL plastic syringe, cut off the tip approximately
15 mm from the bottom of the syringe, yielding a funnel
shaped mask. Finally deflash and smooth the cutting edges of
the mask using a file. The cone of the syringe can be connected
to the gas supplying tube (see Note 1).
13. Patches of Dacron gauze (Woven Mesh Spacer; Merck Milli-
pore, Billerica, USA).
14. Histoacryl glue (Braun Surgical GmbH, Melsungen,
Germany).
15. Medical sticky tape.
16. Silicone elastomer tubes (Silikonkautschuk, Detakta Isolier-




Magnetic resonance imaging (MRI) requires access to an ultrahigh
field MRI system including suitable accessories for the MR acquisi-
tion (radio frequency antennas), positioning, warming, and moni-
toring of physiological parameters, as well as trained personnel for
operating the MRI system. The general hardware requirements for
renal 1H MRI on rats and mice are described in the chapter by
Ramos Delgado P et al. “Hardware Considerations for Preclinical
Magnetic Resonance of the Kidney.” The methods described in this
chapter were tailored for in vivo studies in rats by means of the
dedicated MR-PHYSIOL techniques.
Due to the small size of rats in comparison with humans a much
higher spatial resolution is required to depict the kidney with
adequate detail. This, in turn, demands a high signal-to-noise
ratio (SNR), which must be achieved by use of tailored MR
equipment.
1. MR system: a dedicated small animal MR system with a mag-
netic field strength of 7 T and higher is recommended. We use a
9.4 T 20 cm bore system (Biospec 94/20, Bruker Biospin,
Ettlingen, Germany) equipped with a gradient system with
integrated shim set (B-GA12S2, Bruker Biospin, Ettlingen,
Germany; gradient amplitude 440 mT/m, max. Slew rate
3440 T/m/s).
2. Radio frequency (RF) coils: use RF coils (antennas for RF
transmission and reception) suitable for abdominal imaging,
such as a transmit/receive rat body volume coil (72 mm inner
diameter, quadrature; Bruker Biospin, Ettlingen, Germany) or
preferably a transmit only rat body volume coil (72 mm inner
diameter, linear; model T10325V3, Bruker Biospin, Ettlingen,
Germany) in combination with a receive only rat heart RF coil
array (curved, 2  2 elements; model T12814V3, Bruker
Biospin, Ettlingen, Germany). Use of the latter coil setup is
assumed here, as it allows for much higher spatial resolution
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due to its superior SNR when compared with the transmit/
receive volume coil.
3. Animal holder: an MRI animal holder designed for the size of
the rats and the geometry of the RF coils (here model T11739
with 68 mm diameter, Bruker Biospin, Ettlingen, Germany).
4. Device for sustaining the rat’s body temperature: use a circulat-
ing warm-water based heating system, consisting of a flexible
rubber blanket with integrated tubing (part no. T10964, Bru-
ker Biospin, Ettlingen, Germany) connected to a conventional
warm water bath (SC100-A10, ThermoFisher, Dreieich, Ger-
many). For alternative coil setups water pipes may be integrated
into the animal holder.
5. Monitoring of physiological parameters: for monitoring of
respiration and core body temperature throughout the entire
MR experiment use a small animal monitoring system (Model
1025, Small Animal Instruments, Inc., Stony Brook, NY,




1. Gases: O2, N2, and compressed air, as well as a gas-mixing
system (e.g., Föhr Medical Instruments GmbH, Seeheim-
Ober Beerbach, Germany) to achieve required changes in the
oxygen fraction of inspired gas mixture (FiO2). The following
gas mixtures are required during the experiment: (a) for hyp-
oxia: 10% O2–90% N2; (b) for hyperoxia: 100% O2; (c) for
normoxia: 21% O2 (air) (see Note 2).
2. Device for monitoring FiO2 and FiCO2 in gas mixtures: for
example Capnomac AGM-103 (Datex GE, Chalfont St Gils,
UK).
3. Vascular occluder as listed under 2.2.9. already.
4. Vascular catheters as listed under 2.2.10. already.
5. Solutions for fluid supplementation (e.g., isotonic saline) and
drug administration for dedicated test intervention according
to the scientific purpose of the respective study.
6. Equipment for blood sampling via vascular catheters (e.g.,
capillaries for hemoximetry).
7. Instruments for analyses of blood samples according to the
scientific purpose of the respective study, for example, regard-
ing blood gases and hemoximetry (e.g., ABL80 FLEX
CO-OX, Radiometer, Copenhagen, Denmark).
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3 Methods
Figure 6 provides schemes of (a) the rat anatomy relevant for the
placing of probes, (b) positions and fixations of probes for




For PHYSIOL, surgery is performed at the same operation table at
which the subsequent experiment is executed. For MR-PHYSIOL,
surgery must be performed outside the MR scanner room (in a
neighboring preparation room) for safety reasons.
1. Anesthetize the animal by intraperitoneal injection of urethane
(20% solution, 6 mL/kg body mass) (see Note 3).
2. After reaching the required depth of anesthesia, that is, the
state of surgical tolerance (determined by specific physiological
signs such as muscle relaxation degree, absence of the paw
withdrawal and eye lid reflexes, absence of the swallowing
reflex, and whisker movement), carefully shave the coat in the
abdominal, inguinal, and ventral neck areas of the rat (hair
clipper Elektra II GH2, Aesculap AG, Tuttlingen, Germany).
3. Place the rat in supine position on a warmed-up (39 C)
temperature-controlled operating table and fix the extremities
of the animal to the table by means of sticky tapes.
4. Make an incision into the skin of the left inguinal area (approx.
12 mm) along the natural angle of the hind leg by lifting a fold
of the skin in order to avoid an injury of the underlying blood
vessels.
Fig. 6 Schemes depicting (a) the rat anatomy relevant for the placing of probes, (b) positions and fixations of
probes for PHYSIOL, and (c) positions and fixations of probes for MR-PHYSIOL. For details see text
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5. Bluntly dissect the connective tissue until the femoral vein,
artery, and nerve are exposed.
6. Gently separate the nerve. Do not cut or damage the nerval
tissue.
7. Separate the vein from the artery by using fine tip forceps, while
trying to release an approximately 7–8 mm length vein frag-
ment from the surrounding tissue.
8. Place three pieces of 4.0 threads under the femoral artery:
situate the first thread distal (i.e., toward the leg), the second
thread proximal (i.e., toward the body) and the third one
between them.
9. Pull the first thread toward the leg and tie a ligature to the distal
artery by using a triple knot.
10. Prepare loops with loose surgical knots on the remaining two
threads.
11. Pull the second thread slightly toward the body so that the
blood flow from femoral artery is inhibited.
12. Make a tiny incision in the exposed segment of the femoral
artery behind the third thread using fine tip scissors. Fill a
catheter with tapered tip with saline.
13. Grasp the catheter with the forceps and gently insert through
the incision into the lumen of the femoral artery.
14. Tie the third knot slightly, fix catheter and arterial wall with a
forceps, relax the tensed second thread, and push the catheter
with a second forceps slowly deeper (10 mm) into the artery
in direction of the abdomen.
15. Rinse the catheter carefully with saline, and make sure that it is
patent.
16. Tie the prepared loose knot of the third and second threads.
17. Start the monitoring of arterial blood pressure.
18. For insertion of additional vascular catheters for volume sup-
plementation (e.g., by saline infusion), for test interventions by
drugs, and for blood sampling (if warranted by the specific
scientific goal of the experiment) surgically prepare the proxi-
mal external jugular vein (catheter tip toward vena brachioce-
phalica) and/or the left common carotid artery (catheter tip
toward aorta) similar to steps 5–16 detailed for the femoral
artery catheter implantation.
19. Open the abdominal cavity by a midventral incision (4–5 cm)
into the skin. Then open the abdominal cavity by an incision
along the linea alba, thereby preventing damage to the abdom-
inal organs. Carefully displace the bowel to the right side of the
abdomen to expose the aorta and the left kidney. Carefully
detach the aorta directly cranial of the renal arteries from the
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surrounding tissues without damaging the very tender lym-
phatic vessels of that area.
20. Fix the hydraulic occluder around the aorta cranial of the renal
arteries in a manner, that the occluder is well attached to the
aorta without impairing the blood flow while being deflated
(see Note 4).
21. Carefully separate the left renal artery from the renal vein using
fine tip forceps. Try to expose an approximately 6–7 mm long
fragment. Do not cut or damage the nerves.
22. For MR-PHYSIOL, transfer the animal onto the portable
animal holder such that the kidney is aligned with the mark
on the holder that indicates the center of the RF coil.
23. Start the HAEMODYN software (see Subheading 3.3).
24. Place the Transonic flow probe around the left renal artery and
start monitoring RBF. It is important that the head of the flow
probe is filled with fluid. For PHYSIOL, attach the cable of the
probe on the “clutch” of a micromanipulator (see Fig. 4a).
Position and fixate the probe (Type 1RB) by means of the
micromanipulator in the appropriate position of the artery
(see Fig. 6b). For MR-PHYSIOL, the placement of the probe
upon the artery must be done without the benefit of a micro-
manipulator. A gauze is attached to the probe cable (Type
MV2PSB-MRI) as shown in Fig. 1b. To avoid displacements
of the probe, the gauze is fixed to the retroperitoneal muscles
by sutures (see Fig. 6c) (see Note 5).
25. For PHYSIOL, attach the cortical and medullary laser-flux-
pO2 probes, respectively, at one of the two “clutches” (see
Fig. 4b) of a micromanipulator. With the help of the microma-
nipulator, the probes are placed into the renal cortex (depth
about 1–1.5 mm below the capsule) and the medulla (3–4 mm
below the capsule), respectively, as shown in Fig. 6b (see
Note 6).
26. ForMR-PHYSIOL, remove the customary Luer-Lock connec-
tors of the laser-flux-pO2 probes and carefully fix the fiber glass
cores to the sheathing using a clamp. Provide the probe with a
customary silicone tubing; its length must be adjusted to the
distance between the caudal and the cranial extremities of the
left kidney. Attach tailored patches of gauze to the end of
silicone tubing (see Fig. 2b). Measure the distance between
the caudal and the cranial extremities of the left kidney by a
caliper gauge. Based on this measurement, the cortical laser-
flux-pO2-probe must be carefully prepared so that the distance
between insertion point and the tip exactly matches the indi-
vidual kidney’s diameter minus 1.5 mm.
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27. For MR-PHYSIOL, advance the cortical laser-flux-pO2-probe
meticulously from the caudal extremity of the kidney along the
caudocranial axis (see Fig. 6c). To prevent craniocaudal dis-
placement, the patch of gauze fixed to the silicone tubing of
the probe (see Fig. 2b) must be stuck to the capsule of kidney’s
ventral surface by a thin layer of Histoacryl glue.
28. For MR-PHYSIOL, prepare the medullary laser-flux-pO2-
probe so that the distance between insertion point and the tip
exactly matches the distance 3–4 mm. Carefully advance the
medullary laser-flux-pO2-probe from the caudal extremity of
the kidney along the caudocranial axis. Stick the patch of gauze
fixed to the silicone tubing of the probe to the capsule of
kidney’s ventral surface by Histoacryl glue (see Fig. 6c).
29. For MR-PHYSIOL, carefully fix the two probes’ tubing to the
retroperitoneal muscles by sutures in order to prevent displace-
ment (see Fig. 6c).
30. Fill the abdominal cavity with warm saline (37 C). For
PHYSIOL, intermittent exchange of this fluid throughout
the experiment is done via the open abdominal wall. As the
abdomen will be closed for MR-PHYSIOL (see below), for
replenishment of abdominal saline a catheter must be placed
into the abdominal cavity. Furthermore, for MR-PHYSIOL, a
fiber-optical temperature probe is placed in close proximity to
the left kidney, in order to monitor the temperature of the
kidney throughout the experiment.
31. Connect the probes with OxyLite/OxyFlo-apparatus and start
the monitoring of tissue pO2 and laser-Doppler-flux.
32. For MR-PHYSIOL, mark the localization of the investigated
kidney’s upper and lower pole from the outside on the abdom-
inal skin using a pen. Check that the kidney (pen markings on
skin) is still aligned with the mark on the portable animal
holder that indicates the center of the RF coil—if necessary
carefully correct the animal’s position. This is essential for
optimal positioning of the rat in the MRI scanner (i.e., optimal
position of the rat’s kidney relative to the MR coil).
33. For MR-PHYSIOL, place the special bridge of the portable
animal holder right behind the rat’s hind paws and fix all the
technical extensions (temperature probe, Transonic probe,
laser-flux-pO2-probes, aortic occluder line and abdominal
flushing catheter) to the bridge (see Fig. 5). Close the abdomi-
nal cavity of the rat by continuous suture while passing all
extensions through the caudal cutting edge of the median
abdominal incision. The extensions of the laser-flux-pO2-
probes must be led through the abdominal wall using a small
incision in the left inguinal region.
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34. Place a respiratory mask loosely around the muzzle of the
spontaneously breathing rat. Open air supply to a rate of
1000 mL/min.
35. Restart the HAEMODYN software (to start a new data file)
and check the quality of all physiological signals, that is, arterial
pressure (measured caudal the aortic occlude and therefore
equivalent to renal artery pressure, RAP), renal blood flow






1. Transfer the animal into the MR scanner room using the
portable animal holder (see Note 7). Position portable animal
holder with the rat on the MR scanner’s animal bed.
2. Switch on the small animal monitoring system. Place the pneu-
matic pillow on the abdomen, and cover the animal with the
warming blanket. Watch the respiration trace on the monitor of
the small animal monitoring system and adjust pillow position
until the respiratory motion is captured well (see Note 8). Set
the trigger options of the small animal monitoring system such
that the trigger gate opens for the duration of the expiratory
phase.
3. Position the animal bed in theMR scanner such that the kidney
of interest is located at the isocenter of the magnet.
4. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.”
5. Perform localized shimming on the kidney imaging as
described in the chapter by Pohlmann A et al. “Essential Prac-
tical Steps for MRI of the Kidney in Experimental Research.”
3.3 Experimental
Procedures
A number of dedicated test procedures and the rationale behind the
usage of the respective procedure is detailed in the chapter by
Cantow K et al. “Reversible (Patho)Physiologically Relevant Test
Interventions: Rationale and Examples.” If adequate for the spe-
cific purpose of the study, reversible procedures (such as short
periods of hypoxia, hyperoxia, and suprarenal aortic occlusion) are
preferred, to keep the number of animals as small as possible as
required by the 3R principle (see the chapter by Hosszu A et al.
“Animal Models of Renal Pathophysiology and Disease”). Follow-
ing each reversible intervention, appropriate time is given for com-
plete recovery. The exact duration of the reversible intervention is
dictated by the duration and number of MR measurements.
Because MRI can interfere with parameters acquired by invasive
probes (as has been observed for laser-Doppler flux), short intervals
without MR measurements must be implemented. In the follow-
ing, an exemplary protocol is given for an MR-PHYSIOL
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experiment. It must be noted, that for these experiments, the
closest coordination among the operator(s) of the MR scanner,
the person(s) who perform the test interventions and those who
run the electronic data storage (including setting markers for events
such as start and end of an intervention) is of the essence.
1. On the PC that acquires the physiological data set a “START”
marker in the HAEMODYN software to monitor and store a
first set of baseline data.
2. On the MR system run the protocol(s) of your choice (T1-,
T2-, T2*-mapping, DWI, etc.) to acquire a set of baseline data.
Duplicate these scans for repeated measurements during/
between/after the test interventions and ensure that all para-
meters remain identical, including the shim and receiver gain.
3. Start of hypoxia. Change the gas flowing through the respira-
tory mask to 10% O2–90% N2.
4. Set markers and acquire both physiological and MR data dur-
ing the hypoxic challenge.
5. End of hypoxia.Change the gas flowing through the respiratory
mask back to air (21% O2).
6. Set markers and acquire both physiological and MR data dur-
ing the recovery.
7. Start of hyperoxia. Change the gas flowing through the respira-
tory mask to 100% O2.
8. Set markers and acquire both physiological and MR data dur-
ing the hyperoxic challenge.
9. End of hyperoxia. Change the gas flowing through the respira-
tory mask back to air (21% O2).
10. Set markers and acquire both physiological and MR data dur-
ing the recovery.
11. Start of occlusion. Inflate the remotely controlled suprarenal
aortic occluder.
12. Set markers and acquire both physiological and MR data dur-
ing the occlusion (see Note 9).
13. End of occlusion. Rapidly deflate the occluder.




1. Carefully remove the respiratory mask from the animal’s
muzzle.
2. Cut all sutures; remove the fluid from the abdominal cavity
using a pipette.
3. Control and note the overall condition of the kidney after
experiment (e.g., surface coloring and its homogeneity).
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Fig. 7 Example of data obtained with MR-PHYSIOL in anesthetized rats (adapted
from Ref. 39). Time courses of renal arterial pressure (RAP), total renal blood
flow (RBF), cortical and medullary tissue perfusion (Laser Flux), cortical and
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4. Carefully untie all sutures and knots; remove all probes and
catheters, as well as the occluder.
5. Exsanguinate the animal by cutting the abdominal aorta.
3.5 Data Analysis The analyses of MRI data acquired for MR-PHYSIOL experiments
depend on the respectiveMR protocol and are detailed in dedicated
analysis chapters for each MR method, which are part of the book
Pohlmann A, Niendorf T (eds) (2020) Preclinical MRI of the
Kidney—Methods and Protocols, Springer, New York.
Temporal alignment of MR and PHYSIOL data is achieved by
identifying the starting point of the experiment within both data
sets. For a direct comparison of theMR-PHYSIOL parameters only
PHYSIOL data acquired during the relevant MRI acquisitions can
be used. While the PHYSIOL parameters are measured with sub-
second temporal resolution the acquisition of the MR parameters
(derived from a MR image) requires much more time (e.g., about
60 s for a typical T2* mapping). PHYSIOL and MR parameters can
only be compared based on the (low) temporal resolution of the
MRI. For this purpose the average value of each physiological
parameter over the acquisition time of each MRI scan is calculated.
For PHYSIOL data that are influenced by MR acquisition (such as
Laser flux signals) the averages over the times without MR acquisi-
tion must be taken. Finally, group analyses of the results (e.g.,
relative changes of MR and PHYSIOL data; see Note 10) are
done, as shown by exemplary data obtained by MR-PHYSIOL
during a short suprarenal aortic occlusion and recovery in Fig. 7.
4 Notes
1. Instead of a respiratory (anesthetic) mask, a tracheal cannula
can be used, as it is custom-made in our lab using designed and
made in our laboratory using polythene tubing. The ventral
region of the throat and the trachea are opened surgically, the
cannula is inserted and fixated by suture.
2. As another dedicated test of control of hemodynamics and
oxygenation, hypercapnia can be used with an inspiratory frac-
tion of CO2 of 5% in air.

Fig. 7 (continued) medullary tissue partial pressure of oxygen (Tissue pO2) as
monitored by invasive methods (PHYSIOL) simultaneously with cortical and
medullary T2* data (MR) acquired by a 9.4 T small animal MR scanner during
suprarenal aortic occlusion and recovery. Date are given as relative changes
(mean  SEM) versus baseline (immediately before the occlusion)
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3. Urethane supports anesthesia throughout the surgical prepara-
tion and the MRI examination (for several hours) and leaves
cardiovascular and respiratory reflexes largely undisturbed.
4. (a) In order to prevent additional pressure on the aorta (and
therefore development of an unintended kidney ischemia) the
positioning and fixation of the aortic occluder must be per-
formed under careful monitoring of the overall condition of
the kidney (e.g., surface coloring and its homogeneity);
(b) since the occluder consists of silicone and polyethylene
and is positioned about 15 mm away from the kidney, it does
not cause artefacts in MRI that affect the kidney.
5. (a) The signal of the probe used for PHYSIOL is too weak due
to the long extension leads. For MR-PHYSIOL a probe with a
larger body size and a reflector made of ceramics instead of
metal must be used (see Fig. 1). Its reflector does not induce
MR artifacts, is L-shaped and offers no mechanism to lock the
vessel, which presents a significant challenge for the implanta-
tion if the probe. (b) The bulk of the intestine bears the risk to
cause additional pressure that can dislocate the probe and cause
probe pressure on the aorta, the renal artery and vein, or the
kidney itself. (c) Since Transonic measurements rely on ultra-
sound an appropriate coupling into tissue is of high relevance.
To this end the abdominal cavity must be filled with saline
solution (37 C) and no air bubbles must remain between
probe and vessel. An additional catheter was placed in the
abdominal cavity to replenish saline leakage in time course of
the experiment.
6. Before inserting the tip of the respective probe, a small incision
about the diameter of the probe is made into the renal capsule
by means of the tip of a hypodermic needle to facilitate inser-
tion of the rather dull tip probe.
7. Special attention during transfer must be paid to the tube/
cable extensions (aortic occluder, abdominal flushing, and all
probes). Make sure to keep tubes or cable close to the animal
bed so they cannot get caught anywhere on the way into the
magnet!
8. The peak-to-peak amplitude of the respiratory trace should
span about 2/3 of the vertical axis on the display. Any gross
movement (for instance during repositioning the pillow) will
lead to large peaks and force the monitoring system to adapt
the signal amplification, so that temporarily the signal will
become much smaller on the display. Keep an eye on the
magnification, which is given left next to the display, this will
drop to a low value such as 15—wait until it recovered back to
a value around 100 before further adjusting it.
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9. If unsuccessful, repeat the occlusion and inflate the occluder
with higher hydraulic pressure and make sure that the fluid
reservoir for the inflation is sufficiently filled. Always check
that the inflation is sufficient to bring total renal blood flow
(RBF) rapidly toward zero.
10. It is usually more practical and useful to compare relative
changes in the parameters rather than absolute changes. To
do this divide all parameter values by that of the last baseline
value (e.g., see Fig. 7).
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Chapter 20
Essential Practical Steps for MRI of the Kidney
in Experimental Research
Andreas Pohlmann, João S. Periquito, and Thoralf Niendorf
Abstract
Magnetic resonance imaging (MRI) is an emerging method to obtain valuable functional and structural
information about the kidney noninvasively. Before performing specialized MR measurements for probing
tissue structure and function, some essential practical steps are needed, which are common for most
applications. Here we describe in a step-by-step manner how to (1) achieve the double-oblique slice
orientation coronal-to-the-kidney, (2) adapt the scan protocol for avoiding aortic flow artifacts and
covering both kidneys, (3) perform localized shimming on the kidney, and (4) check perfusion in the
large renal blood vessels using time-of-flight (TOF) angiography. The procedures are tailored to preclinical
MRI but conceptionally are also applicable to human MRI.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter explains the initial and essential MRI steps that precede specific functional
and structural MR imaging techniques (T1- and T2*-mapping, DWI, ASL, etc.), which are described in
separate chapters.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Shimming, Time-of-flight
(TOF) angiography
1 Introduction
Magnetic resonance imaging (MRI) is a state-of-the-art noninva-
sive method to obtain valuable functional and structural informa-
tion about the kidney. The wide range of available contrast agent
mechanisms and the corresponding MR techniques can enable a
comprehensive characterization of the kidney. This includes mor-
phology (e.g., kidney size), tissue microstructure (e.g., diffusion-
weighted MRI, T1 mapping, elastography), and function (e.g.,
arterial spin labeling MRI for perfusion mapping or mapping of
T2* for probing blood oxygenation).
Before carrying out these specialized MR measurements, some
essential practical steps are required, which are common for most
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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applications. Here we describe in a step-by-step manner how to
(1) achieve the double oblique slice orientation coronal-to-the-
kidney, (2) adapt the scan protocol for avoiding aortic flow artifacts
and covering both kidneys, (3) perform localized shimming on the
kidney, and (4) check perfusion in the large renal blood vessels
using time-of-flight (TOF) angiography. The procedures are tai-
lored to preclinical MRI but are also conceptually applicable to
human MRI.
This experimental protocol chapter is complemented by sepa-
rate chapters describing the basic concepts, experimental protocol
and data analysis of numerous renal MR techniques, which are part
of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals These experimental protocols are tailored for rats (e.g., Wistar,
Sprague-Dawley, or Lewis) with a body mass of 250–350 g. Advice
for adaptation to mice is given where necessary.
2.2 Lab Equipment Anesthesia: For nonrecovery experiments urethane solution
(Sigma-Aldrich, Steinheim, Germany; 20% in distilled water) can
provide anesthesia for several hours with comparatively little side
effects on renal physiology, which is an important issue. For an
in-depth description and discussion of the anesthesia please refer to
the chapter by Kaucsar T et al. “Preparation and Monitoring of
Small Animals in Renal MRI.”
Monitoring several physiological parameters of the animal is
essential to ensure the anesthesia works and while the animal is
unconscious and does not feel pain, it is physiologically as close to
the normal nonanesthetized state as possible. For an in-depth
description of physiological monitoring please refer to the chapter
by Kaucsar T et al. “Preparation and Monitoring of Small Animals
in Renal MRI.”
2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The techniques described in this chapter are tailored for
a 9.4 T MR system (Biospec 94/20, Bruker Biospin, Ettlingen,
Germany), but advice for adaptation to other field strengths and
systems is given where necessary. No special or additional hardware
is required, except for the following:
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A physiological monitoring system that can track the respira-
tion, and which is connected to the MR system such that it can be
used to trigger the image acquisition.
2.4 MRI Techniques This protocol requires only standard MR techniques that should be
available on any commercial system. The shimming capabilities and
procedure are specific to the MR hardware and each vendors soft-
ware platform; in this protocol we focus on describing the shim-
ming on a Bruker BioSpec system running ParaVision 6.0.1.
1. 2D spoiled gradient-echo sequence (“FLASH” on Bruker
systems).
2. 2D spoiled gradient-echo sequence with flow compensation
and angio-mode (only one slice excitation per TR)
(“FcFLASH” on Bruker systems).




The basic protocols described here are based on default protocols
available in Bruker ParaVision, which have been adapted to the
geometry of the rat abdomen. Although it is one of the aims of
this book to also describe the reasons for the choice of parameters,
we have refrained from doing so here because the choice of para-
meters is not crucial for these protocols. Here we present working
protocols for rats on a Bruker 9.4 T system. For MRI at lower field
strengths the reduced signal-to-noise ratio (SNR) may be compen-
sated by signal averaging and/or reducing the spatial resolution.
For MRI of mice a good starting point is to reduce the FOVused in
the rat protocols to the smaller body size of the mouse while
keeping the matrix size the same. In this way the relative resolution
(voxels per animal/organ dimensions) is similar. Despite the smal-
ler voxel size the SNR is often not much worse than for the rat
protocol, because the smaller size of the mouse RF coil improves




1. Pulse sequence: 2D spoiled gradient-echo sequence (FLASH).
2. Contrast: TR ¼ 126 ms, TE ¼ 2 ms, flip angle ¼ 90,
averages ¼ 3.
3. Spatial resolution: in plane of (234 234) μm2; three packages
of seven slices with 1.0 mm thickness, slice distances of 5.0/
4.5/4.0 mm and hence slice gaps of 4.0/3.5/3.0 mm (axial/
coronal/sagittal); FOV ¼ (60  60) mm2; matrix
size ¼ 256  256 derived from a 85  128 acquisition matrix.
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4. Acceleration: 2.0 in phase encoding and frequency encoding
directions by zero-filling, 1.72 in frequency encoding direction
by partial-Fourier.
5. Sequence: bandwidth ¼ 89 kHz, trigger ¼ off, fat suppres-
sion ¼ off, flip-back ¼ on, dummy scans ¼ 10, motion sup-
pression ¼ on, duration: TA ¼ 49 s.
3.1.2 Axial Multislice
Pilot Scan
1. Pulse sequence: 2D fast spin echo sequence (RARE).
2. Contrast: TR ¼ 540 ms, TE ¼ 12 ms, effective TE ¼ 24, flip
angle ¼ 90, averages ¼ 1.
3. Spatial resolution: in plane of (407  406) μm2; eight slices of
1.0 mm thickness, a slice distance of 2.2 mm and hence a slice
gap of 1.2mm;FOV¼ (7052)mm2;matrix size¼172128
identical to the 172  128 acquisition matrix.
4. Acceleration: RARE factor (echo train length or number of
echoes per excitation) ¼ 4.
5. Sequence: bandwidth¼ 63 kHz, trigger¼ on (per phase step),
fat suppression ¼ on, flip-back ¼ on, dummy scans ¼ 2, dura-
tion: TA ¼ 17 s.
3.1.3 Coronal Pilot Scan 1. Pulse sequence: 2D fast spin echo sequence (RARE).
2. Contrast: TR ¼ 540 ms, TE ¼ 12 ms, effective TE ¼ 24, flip
angle ¼ 90, averages ¼ 1.
3. Spatial resolution: in plane of (407  406) μm2; one slice of
1.0 mm thickness; FOV ¼ (70  52) mm2; matrix
size ¼ 172  128 identical to the 172  128 acquisition
matrix.
4. Acceleration: RARE factor ¼ 4.
5. Sequence: bandwidth¼ 63 kHz, trigger¼ on (per phase step),




1. Pulse sequence: Flow compensated 2D spoiled gradient-echo
sequence (FcFLASH).
2. Contrast: TR ¼ 13 ms, TE ¼ 2.3 ms, flip angle ¼ 80,
averages ¼ 1.
3. Spatial resolution: in plane of (200  200) μm2; nine slices of
1.4 mm thickness, a slice distance of 2.1 mm and hence a slice
gap of 0.7 mm; FOV ¼ (51.2  51.2) mm2; matrix
size¼ 256 256 derived from a 183 172 acquisition matrix.
4. Acceleration: 1.5 in phase encoding direction by zero-filling,
1.4 in frequency encoding direction by partial-Fourier.
5. Sequence: bandwidth ¼ 75 kHz, angio mode ¼ yes, trig-
ger ¼ off, fat suppression ¼ off, duration: TA ¼ 20 s.
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3.1.5 Kidney
TOF-Angiography
1. Pulse sequence: Flow compensated 2D spoiled gradient-echo
sequence (FcFLASH).
2. Contrast: TR ¼ 7 ms, TE ¼ 3 ms, flip angle ¼ 80,
averages ¼ 1.
3. Spatial resolution: in plane of (200  208) μm2; 15 slices of
1.0 mm thickness, a slice distance of 0.5 mm and hence a slice
gap of0.5 mm (overlapping); FOV¼ (60 40) mm2; matrix
size¼ 300 192 derived from a 214 128 acquisition matrix.
4. Acceleration: 1.5 in phase encoding direction by zero-filling,
1.4 in frequency encoding direction by partial-Fourier.
5. Sequence: bandwidth ¼ 75 kHz, angio mode ¼ yes, trig-
ger ¼ off, fat suppression ¼ off, duration: TA ¼ 14 s.
3.2 Animal
Preparation
Anesthetize the animal and transfer it to scanner. For more
information on the choice and use of anesthesia please refer to the
chapter by Kaucsar T et al. “Preparation and Monitoring of Small
Animals in Renal MRI”.
Start the temperature monitoring system, apply some surgical
lubricant to the temperature probe and place it in the rectum of the
animal.
Attach the respiration sensor (e.g., balloon) to the abdomen of
the animal using adhesive tape. Start and setup the respiratory moni-
toring system. If necessary, adjust the position of the respiration
sensor until the amplitude of the respiration trace is sufficiently
large for the system to reliably detect the trigger points at the begin-
ning of expiration.
3.3 Pilot Scans and
Slice Positioning
Coronal to tthe Kidney
3.3.1 Slice Planning:
From Pilot Scan to the
Coronal-to-the-
Kidney Image
Here we describe how to acquire a single image slice in coronal-to-
the-kidney orientation, which is the best approach if only one
kidney is of interest. If both kidneys are of interest, each kidney
may be imaged separately using the steps described below.
However, if the experimental conditions do not allow for imag-
ing each kidney separately, then a compromise must be made. This
could be the case if, for instance, the available scan time is limited:
slice planning, shimming, and acquiring images twice may take too
long. Also, the experimental procedure might demand acquisition
of the images for both kidneys simultaneously (multislice scan), for
example when monitoring dynamic physiological processes. In
these cases shimming should be performed on a voxel enclosing
both kidneys and the image slice package orientation should be
chosen such that it depicts both kidneys in a view that is as close as
possible to coronal-to-the-kidney orientation.
1. Start with acquiring a fast pilot scan to obtain images in the
three orthogonal planes x, y, and z: load the multislice tripilot
protocol and run it with the default slice geometry and the
usual automatic adjustments (shimming and adjustments of the
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base frequency, the RF pulse reference power, and the receiver
gain). Example images are shown in Fig. 1 (see Note 1).
2. Keep a record of the reference power in the lab notebook for
later reference. Comparing the reference power to those used
in previous studies with the same setup is very helpful for early
identifying possible technical issues in an in-vivo study.
3. Load the axial multislice pilot scan, adapt the slice package
position and orientation such that it is centered on the kidney
and axial to the kidney (not to the animal’s body) (Fig. 2).
4. In the monitoring unit set the trigger delay so that the trigger
starts at the beginning of the expiratory plateau and the
Fig. 1 Slice planning on a small animal MR system (here 9.4 T Bruker Biospec with ParaVision 6. Images
obtained from the very first MR scan, a fast multislice tripilot: Shown are three selected image slices in strictly
axial (left), coronal (center), and sagittal (right) orientation with respect to the scanner coordinates. The
location of the left kidney is highlighted by the dashed yellow line. The dark stripes are saturation effects
occurring at the intersection of the slices (see Note 1)
Fig. 2 Images obtained from the fast multislice tripilot showing the planning of the axial multislice pilot scan:
The slice package should be rotated such that it is axial to the kidney in the coronal multislice tripilot images
(center)
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duration such that it covers the entire expiratory phase (Fig. 3,
see Note 2).
5. If you use a RARE protocol like described here, adjust the TR
so that it is longer that the respiratory trigger window but
shorter than the current respiration period. For the example
shown in Fig. 3, TR should be set to a value within the range
400–570 ms, in order to lie safely between 370 ms (respiratory
trigger window) and 606 ms (respiration period). Run the
scan. An example image slice is shown in Fig. 4.
6. Load the coronal pilot scan protocol and adjust the geometry:
the slice should be perpendicular to the axial multislice pilot
scan and rotated such that it runs through the center of the
kidney (Fig. 4). The frequency encoding direction should be
rostral–caudal in order to avoid aliasing. Run the scan. An
example image is shown in Fig. 5.
Fig. 4 Image obtained from the fast axial multislice pilot scan showing the
planning of the coronal pilot scan: The slice should be perpendicular to the axial
multislice pilot scan and rotated such that it runs through the center of the
kidney
Fig. 3 Setup of the respiratory triggering in the physiological monitoring system. The respiratory gate is
defined such that it spans across the expiratory phase and avoids the inspiratory motion. The above trace is for
a urethane anesthetized rat. With isoflurane anesthesia the respiratory rate is lower and a long expiratory
plateau is typical
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7. To acquire a sagittal pilot scan, duplicate the previous scan
protocol and adapt the slice orientation: The slice should be
perpendicular to the coronal pilot scan and rotated such that it
runs along the long axis of the kidney (Fig. 5). Run the scan.
An example image is shown in Fig. 6.
8. For the coronal-to-the-kidney scan, duplicate the coronal pilot
scan protocol and fine-adjust the slice orientation: The slice
should be rotated such that it runs along the long axis of the
kidney in the sagittal pilot scan (Fig. 6). Run the scan. An
example of the final image acquired in double-oblique coro-
nal-to-the-kidney orientation is shown in Fig. 7.
3.3.2 Transferring
the Coronal-to-the-Kidney
Geometry to Other Scans
1. Start from the pilot scan with coronal-to-the-kidney geometry
(Fig. 7).
2. From this protocol copy the slice orientation (see Note 3) to
the first of your special scans (e.g., DWI, T2*-mapping). Pay
attention not to copy the entire slice package geometry,
because this typically would include the FOV, slice thickness,
and number of slices, which are usually different between the
pilot scans and functional scans.
3. To illustrate how a typical result should look like, Fig. 8 shows
an example of a coronal-to-the-kidney T2-weighted image
from a multispin echo scan.
Fig. 5 Image obtained from the coronal pilot scan showing the planning of the
sagittal pilot scan: The slice should be perpendicular to the coronal pilot scan
and rotated such that it runs along the long axis of the kidney
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Fig. 6 Image obtained from the sagittal pilot scan showing the planning of the
coronal-to-the-kidney scan: The slice should be rotated such that it runs along
the long axis of the kidney
Fig. 7 Final image acquired in double-oblique coronal-to-the-kidney orientation
(The black tubular structures caudal to the kidney are implanted probes that are
not relevant in this context)
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3.3.3 Reducing Aortic
Flow Artifacts (Optional)
The coronal-to-the-kidney slice orientation will naturally vary from
animal to animal and of course between the right and left kidney.
Sometimes the aorta lies within the image slice, which can result in
unwanted flow artifacts. These artifacts can be reduced using a
saturation slice, where a block of repeated excitation and spoiling
is applied just before the imaging block in order to suppress the
signal:
1. In the protocol setup look for the field-of-view saturation
option (e.g., “FOV sat”) and enable it. This will add a satura-
tion slice with default geometry.
2. Load the abdominal TOF-angiography scan. Copy the slice
orientation (see Note 3) from the axial multislice pilot and
run the scan. An example image is shown in Fig. 9.
3. Load the following images to the viewer: the axial pilot scan,
coronal-to-the-kidney scan, and the abdominal TOF-angiogra-
phy scan (Fig. 9).
4. In the image viewer enable the display of saturation slices (gray
in Fig. 9).
5. Adjust the saturation slice thickness and orientation: place it in
approximately sagittal orientation and rotate it such that it
covers the aorta without intersecting the kidney(!).
Fig. 8 T2-weighted image acquired in double-oblique coronal-to-the-kidney
orientation
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3.3.4 Multislice
and Covering Both Kidneys
(Optional)
1. To set up a multislice protocol, simply follow the steps for a
single slice and subsequently change the number of slices to the
desired number. This should be an odd number (3,5,7, . . .), so
that the original single slice remains in the center.
2. For acquiring coronal-to-the-kidney images from both kidneys
with the same scan protocol add a second slice package. This
allows you to acquire two slice packages with arbitrary orienta-
tion, one coronal to the left kidney and one coronal to the right
kidney.
3. First plan the geometry of the slice package for one kidney and
afterward repeat the same steps for the other kidney.
4. Pay attention to where the two slice packages intersect. In the
rare case when the slices of the right and left kidney cross within
the kidney, adjust the slice orientation slightly to move the
intersection to outside of the kidney. This is important, because
otherwise the saturation effect would lead to a dark stripe
artifact in the kidney. Alternatively, split the protocol into
two, one for each kidney. This will permit acquiring images in
the desired orientations without artifacts; however, it also dou-
bles the scan time.
3.4 Localized
Shimming
Shimming is particularly important for T2*-mapping, since macro-
scopic magnetic field inhomogeneities shorten T2*, but provide no
tissue specific information—rather they overshadow the micro-
scopic T2* effects of interest and hinder quantitative intra- and
intersubject comparisons. But a good shim is also relevant for
other imaging techniques, such diffusion weighted imaging
Fig. 9 Images obtained from the axial pilot scan (left), coronal-to-the-kidney scan (center), and an abdominal
TOF-angiography scan (right) showing the planning of an optional FOV saturation slice (gray dashed lines). The
saturation slice has the purpose of reducing possible flow artifacts from the aorta, and hence should be placed
in approximately sagittal orientation and rotated such that it covers the aorta without intersecting the kidney.
Please note that in this example the aorta was not within the kidney image slice, but, nevertheless, placing a
saturation slice was performed as part of our standard operating procedure (SOP)
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(DWI) or perfusion measurements with arterial-spin-labeling
(ASL), because they are commonly based on an echo-planar-imag-
ing (EPI) sequence due to its fast imaging speed. EPI is prone to
magnetic susceptibility artifacts, which increase with the number of
echoes acquired after each excitation. Hence, this can particularly
become a problem when the number of segments is small or one in
the case of single-shot acquisition. These artifacts appear as T2*
induced signal loss (or even signal voids) in areas with very high B0
gradients, image distortion due to the inherently low phase encod-
ing bandwidth, and off-resonance effects caused by frequency dis-
persions. Therefore, EPI is in kidney regions adjacent to bowels or
in close proximity to skin/fat/muscle boundaries is particularly
challenging. To this end, it is often beneficial not to use the default
standard shim (usually on the entire field-of-view), but to perform
additional shimming tailored to the kidney.
Ideally, shimming is performed on a voxel enclosing only the
kidney of interest. When a good shim is crucial, the shim volume
may be reduced even further to a volume that is smaller than the
kidney and just a little thicker than the slice package (see Note 4).
This is the procedure we describe in the following.
However, if both kidneys are of interest and the available scan
time or experimental procedure does not allow for imaging each
kidney separately, then shimming should be performed instead on a
voxel enclosing both kidneys.
Field map-based shimming has become the standard shimming
method on preclinical and clinical MR systems. It consists of (1) the
manual definition of a shim volume, (2) the acquisition of a 3D B0
field map (usually with a dual-echo gradient-echo method), and
(3) the calculation of the shim currents needed to make the B0 field
within the shim volume as homogeneous as possible. This is the
approach we recommend and describe in the following step-by-step
instructions. Yet, in our experience, simple iterative linear (first-
order) shimming on the selected volume is usually sufficient.
The main limiting factor for achieving a good shim is the
capability of the shim coil set. For first-order (linear) shimming
no additional shim coils are needed, since the standard x/y/z
gradient coils used for imaging can double as shim coils. Higher-
order shimming (nonlinear spatial harmonics) requires additional
coils, typically one for each spatial harmonic (newer designs are
more efficient), that is, a minimum of five separate coils are
employed for second-order field correction. Therefore, it is usually
impossible to correct complex and small B0 inhomogeneities caused
by for example by bowel gas, invasive measurement probes, or
trapped air bubbles (from surgery). Considering the very small
size of a rat and mouse kidney, in practice the shimming cannot
compensate much more than a linear B0 gradient within the rodent
kidney.
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3.4.1 Planning the Shim
Volume (Bruker ParaVision)
1. Load into the viewer the images obtained from the axial pilot
scan, coronal-to-the-kidney scan, and sagittal pilot scan, as
shown in Fig. 10.
2. Open the scan protocol for which the shimming should be
performed and go to the Adjustment section of the protocol.
3. In the Adjustment > Automatic Shim tab select Mapshim.
4. In the Adjustment > Automatic Shim tab select Default Shim
Volume, then deselect it again. You now have a shim volume
geometry that is identical to the slice geometry.
5. In the Adjustment > Automatic Shim tab select a cuboid or
better the ellipsoid volume, which fits very well to the shape of
the kidney.
6. Adjust the geometry of the double-oblique shim volume, such
that the volume tightly encloses the kidney in the “coronal”
view and that it is about twice as thick as the image slice
Fig. 10 Shimming on a rat kidney on a small animal MR system (here 9.4 T Bruker Biospec with ParaVision 6).
Images obtained from the axial pilot scan (left), coronal-to-the-kidney scan (center), and an sagittal pilot scan
(right) showing the planning of the double-oblique shim volume. The shim volume tightly encloses the kidney
in “coronal” view and is about twice as thick as the imaging slice. Top panel: green outline of the ellipsoid
shim volume. Bottom panel: ellipsoid shim volume shown as blue 2D grid
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package. Figure 10 shows the ellipsoid shim volume with a
thickness of 4 mm for one image slice of 1.5 mm).
3.4.2 Shimming (Bruker
ParaVision)
1. Finish all other changes you may want to make to the scan
protocol.
2. In the Adjustment Platform select the B0 map and in the
protocol parameters enable the respiratory triggering. It is
usually OK to use the default FOV, but check that all the visible
part of the animal lies within in (see Note 5).
3. Start the acquisition of the B0 map, this usually takes a couple
of minutes. When the acquisition has finished, exit the Adjust-
ment Platform and return to the scan protocol.
4. In the Adjustment > Automatic Shim tab select Mapshim (you
probably did that already during the shim volume planning).
5. In the Adjustment > Automatic Shim tab enable Iterative
Correction of the first order shims.
6. It should be displayed that a B0 map is available (if it does not,
go back to acquiring the B0 map).
7. Apply the changes to the protocol and run the scan—shimming
will be performed as the first step of the data acquisition,
followed by a frequency adjustment (necessary after
shimming).
8. For repeating the same scan later in the experiment, copy this
protocol and make sure to change the selection of Mapshim to
Current Shim in the Adjustment > Automatic Shim tab.
9. To use the new shim for subsequent measurements, select
Current Shim in the Adjustment > Automatic Shim tab of
each of these protocols.
3.4.3 Shimming
on a Clinical MR System
(Siemens Syngo)
1. Load into the viewer localizer images acquired in the coronal-
to-the-kidney orientation, and the sagittal-to-the-kidney
orientation.
2. Open the scan protocol for which the shimming should be
performed.
3. Click on the icon for the Position Toolbar to open it.
4. In the Position Toolbar click on the Adjust Volume on/off but-
ton. The default shim volume geometry that is identical to the
slice geometry is now displayed as a green frame (Fig. 11).
5. Adjust the geometry of the shim volume, such that the volume
encloses the kidney in the “coronal” view and that it is about
twice as thick as the image slice package. Figure 11 shows the
cuboid shim volume with a thickness of 4 mm.
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6. In the scan protocol parameter setup click on the System tab and
then the Adjustments tab. Select as the B0 Shim Mode ¼ Stan-
dard or Abdominal.
7. Apply the changes to the protocol and start the scan—B0
mapping (if not already done) and shimming will be performed
as the first step of the data acquisition, followed by a frequency
adjustment (necessary after shimming).
3.5 Fast and Simple
Test of Renal Blood
Flow (Optional)
Time-of-flight (TOF) angiography is a simple technique to check
the perfusion in the large renal blood vessels. Acquiring a TOF
angiogram only requires a few seconds and it can provide very
valuable information in experiments that involve major changes in
renal blood flow, such as short-time reversible occlusions of the
renal artery, renal vein, or aorta as well as ischemia–reperfusion.
One can confirm that the vessel occlusion and reperfusion are
successful, or otherwise repeat the procedure. TOF angiography
is also essential in MRI experiments that include implanted invasive
probes (e.g., fiber-optical pO2 probes, ultrasound flow probes,
near-infrared probes) or devices for physiological interventions,
such as inflatable balloons that serve as remotely controllable
blood-vessel occluders. The reason is that these devices are rela-
tively large and if they are placed in proximity to a blood vessel they
may apply too much pressure on it, hindering or even stopping the
blood flow within it. TOF angiography can help to detect such
hypoperfusion early in the experiment, when a surgical correction
may still be possible.
3.5.1 Measurement
Concept
For correct interpretation of the TOF angiogram it is important to
understand the measurement concept. The measurement uses a
conventional gradient echo (GRE) pulse sequence with a high flip
angle (FA) and very short repetition time (TR). After a few
Fig. 11 Shimming on a rat kidney on a clinical MR system (here 3 T Siemens Skyra with Syngo). After clicking
on the Adjust Volume on/off button in the Position Toolbar the default shim volume geometry is displayed as a
green frame (left). Then the geometry of the shim volume was adjusted, such that it encloses the kidney in the
coronal-to-the-kidney view (center) and that it is about twice as thick as the image slice, as can be seen in the
sagittal-to-the-kidney scan (right). Here the size of the shim volume was (20  16  4) mm3
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excitations this results in saturation, that is, a suppression of the
signal (from stationary protons), because there is too little time for
T1 recovery from the previous excitation leading to almost no
signal being available for the next excitation. However, the fast-
moving spins of blood flowing in large vessels that cross the image
slice are not stationary—under normal blood flow conditions the
blood present in the image slice during one excitation has been
entirely replaced with new blood (from outside of the slice) before
the next excitation. That means that the water protons of the blood
are still fully “relaxed” when the excitation RF pulse is applied—
these spins have never seen an RF pulse before and hence give
maximum signal. The signal of the blood is not suppressed, because
the effective TR is infinitely long—unlike for stationary protons in
tissue to which the very short nominal TR applies.
The TOF contrast is not a quantitative measure. While in
theory there is a window of flow velocities that will create interme-
diate blood signal intensities (between maximum signal from fresh
blood to almost no signal from stationary blood), in practice the
TOF contrast has an approximately binary character: you see signal
or you do not. What flow velocity is needed to see the maximum
blood signal can be roughly estimated from the distance that blood
needs to flow (i.e., the image slice/slab thickness) and the available
time (i.e., TR). However, the vessel orientation and flow profile in
the vessel also play a role, so one cannot draw conclusions about the
actual blood flow velocity; it rather serves as a simple tool for
qualitative comparison of blood flow between (patho)physiological
states.
3.5.2 Protocol Here we describe how to perform a TOF angiography to check for
(ab)normal perfusion in the large renal blood vessels.
Please note that this protocol is not designed for creating a 3D
depiction of the renal vascular architecture via maximum-intensity
projections (MPIs)—this would require whole kidney coverage, a
higher spatial resolution, and hence a longer acquisition time.
1. In the viewer open the images obtained from the axial pilot
scan, coronal-to-the-kidney scan, and the sagittal pilot scan
(Fig. 12).
2. Load the kidney TOF-angiography protocol.
3. If you have acquired a sagittal pilot scan at the beginning of the
experiment, then copy the slice orientation from that scan (see
Note 3). Otherwise start with a default sagittal slice
orientation.
4. Plan the slice geometry sagittal with regard to the kidney, as
shown in Fig. 12.
5. Start the scan. Figure 13 shows an example image in which six
major vessels are clearly visible (in Wistar rat kidneys typically
6 or 8 vessels are seen). During temporary occlusions of the
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Fig. 13 Selected images slice obtained from the kidney TOF-angiography. Six
major vessels can be clearly seen. In experiments where a temporary occlusion
of the renal artery, vein, or aorta via a remote controlled hydraulic occluder is
performed, this scan is very useful to confirm vessel occlusion was successful
(vessels are not visible anymore) and reperfusion was successful (vessels are
visible again like above)
Fig. 12 Basic TOF angiography of a rat kidney on a small animal MR system (here 9.4 T Bruker Biospec with
ParaVision 6). Images obtained from the axial pilot scan (left), coronal-to-the-kidney scan (center), and an
sagittal pilot scan (right) showing the planning of the kidney TOF-angiography. The slice package is positioned
sagittal with regard to the kidney
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renal artery, vein, or aorta (via a remote controlled hydraulic
occluder) the vessels will disappear and reappear after successful
reperfusion.
4 Notes
1. The saturation effect is an inevitable artifact that occurs when
several crossing slices are acquired in an interleaved manner,
that is, excitation of all slices during one TR. This effect can be
avoided be acquiring all slices consecutively, however, that
significantly increases the scan time. For the initial scan this
artifact is acceptable because it only serves to localize the kid-
ney, so speed is given preference.
2. If you use a RARE protocol like described here, the TR needs
to be relatively long to allow for sufficient T1-recovery and
hence acceptable signal-to-noise ratio (SNR). Due to the long
TR it is advisable to have only one excitation per breath. To
ensure that there will be only one triggered acquisition per
breath, adjust the TR so that it is longer than the respiratory
trigger window but shorter than the current respiration period.
Alternatively, you could adjust the trigger window in the mon-
itoring software to be very short (e.g., 10 ms), but then you
will have to reverse this change for every gradient echo scan.
Youmust monitor the respiration continuously throughout the
entire experiment and, if necessary, adapt the TR accordingly.
3. With “copying the slice orientation” we mean copying the
spatial location of the center of the slice package as well as
copying its spatial orientation, that is, the angulation in all
three directions x, y, and z (or left–right, anterior–posterior,
rostral–caudal). On a system running Bruker ParaVision this is
achieved by copying the slice orientation; in contrast, copying
the slice geometry includes the FOV, slice thickness, and num-
ber of slices.
4. Considering the small size of a rat and mouse kidney and the
limited capabilities of shim coils, it is unrealistic to expect that a
“perfect” shim on the kidney can be achieved. In practice, one
aims to remove a linear B0 gradient in the kidney. Nonlinear B0
gradients within the kidney are very challenging to compensate
for, because they are only a few millimeters in size. This would
require a high-end gradient set with very high-order shims.
5. For rats the default shim volume has a reasonable size, but you
must check for your particular setup (RF coil, rat size) that it is
large enough so that there will be no aliasing artifacts in the two
phase encoding directions. If the default shim volume is much
larger than the object (possible for small mice) one can reduce
the size of the shim volume. As this will reduce the signal-to-
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noise ratio of the B0 map and hence it may be useful to increase
the number of averages. When you modify the shim volume
FOV try to maintain the isotropic voxel size, as this permits
capturing the B0 inhomogeneities in all spatial directions with
equal accuracy.
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research initiatives across Europe and enable scientists to grow
their ideas by sharing them with their peers. This boosts their
research, career and innovation.
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in the COST program of the European Union, which unites more
than 200 experts in renal MRI from 30 countries with the aim to
improve the reproducibility and standardization of renal MRI
biomarkers.
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Chapter 21
Assessment of Renal Volume with MRI: Experimental
Protocol
Andreas Müller and Martin Meier
Abstract
Renal length and volume are important parameters in the clinical assessment of patients with diabetes
mellitus, kidney transplants, or renal artery stenosis. Kidney size is used in primary diagnostics to differen-
tiate between acute (rather swollen kidneys) and chronic (rather small kidney) pathophysiology. Total
kidney volume is also an established biomarker in studies for the treatment of autosomal dominant
polycystic kidney disease (ADPKD). There are several factors influencing kidney size, and there is still a
debate on the value of the measured kidney size in terms of renal function or cardiovascular risk. The renal
volume is most often calculated by measuring the three axes of the kidney, on the assumption that the organ
resembles an ellipsoid. By default, the longitudinal and transverse diameters of the kidney are measured. In
animal models renal length and volume1 are also important parameters in the assessment of organ rejection
after transplantation and in determination of kidney failure due to renal artery stenosis, recurrent urinary
tract infections, or diabetes mellitus. In general total kidney volume (TKV) is a valuable parameter for
predicting prognosis and monitoring disease progression in animal models of human diseases like polycystic
kidney disease (PKD) or acute kidney injury (AKI) and chronic kidney disease (CKD).
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol is complemented by two separate chapters describing the basic concept and experimental
procedure.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, T2, T1, Volume
1 Introduction
Kidney size is used in primary diagnostics to differentiate between
acute (rather swollen kidneys) and chronic (rather small kidney)
pathophysiologies. Renal length and volume are important para-
meters in the clinical assessment of patients with diabetes mellitus,
kidney transplants, or renal artery stenosis. Total kidney volume
(TKV) is also qualified as a biomarker in studies for treatment of
autosomal dominant polycystic kidney disease (ADPKD). Accord-
ing to the nonbinding recommendations of the FDA this
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_21, © The Author(s) 2021
369
biomarker can be used by drug developers for the qualified context
of use in submissions of investigational new drug applications, new
drug applications, and biologics license applications (www.fda.
gov/media/93105/download). There are many factors governing
kidney size and volume.
In patients, renal volume is probably one of the most important
predictive parameters for the loss of renal function. Therefore, a
determination of kidney size is recommended for patients at risk.
For example in ADPKD patients <30 years with a combined renal
volume >1500 mL and an estimated glomerular filtration rate
(eGFR) <90 mL/min are at high risk even with otherwise normal
renal function. Such patients will need renal replacement therapy
within 20 years. In ADPKD patients renal volume measurements
have been studied extensively and provide a method for patient
stratification, monitoring of disease progression and therapeutic
efficacy [1–3].
Also, therapeutic decisions are frequently based on the size of
the kidney, and for example routinely assessed in follow-up of
patients with renal stenosis or for assessment of renal transplant
candidates [4, 5]. Therefore it is important to employ a measuring
method that provides accurate and precise results in vivo.
In animal models renal length and volume are also important
parameters in the assessment of organ rejection after transplanta-
tion and in determination of kidney failure due to renal artery
stenosis, recurrent urinary tract infections, or diabetes mellitus. In
general total kidney volume (TKV) is a valuable parameter for
predicting prognosis and monitoring disease progression in models
of polycystic kidney disease (PKD). Still, so far, no gold standard
exists for renal volumetry in vivo.
The renal volume is most often calculated by measuring the
three axes of the kidney, on the assumption that the organ resem-
bles an ellipsoid. By default, the longitudinal and transverse dia-
meters of the kidney are measured. The kidney volume is calculated
according to the following approximation formula (in humans
these kidney volume data correlate well with the body length and
age) (see Fig. 1):
volume ¼ length  width  average depth  0.5.
Conventional anatomic MRI offers easy access to high quality
image data. Kidney volume is reliably reproduced, and measure-
ments can be performed with minimal bias and low inter- and
intraoperator variability [6]. In the voxel-count method accurate
calculation is facilitated by acquisition of multiple consecutive
images sectioning the kidney. After identification of the organ
boundaries, summation of all voxel volumes lying within the
organ boundaries provides the total renal volume. While such an
approach is highly accurate, it is also time-consuming. Transferring
TKV measurement into everyday practice requires imaging techni-
ques and protocols that are widely available while easy to employ
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and fast. Furthermore methods for interpretation of results are
needed that are feasible and easy to apply. For this purpose open
source image analysis tools are available that facilitate fast and easy
determination of TKV.
For anatomical MRI of the kidney T2 weighted MRI sequences
are the modality of choice. They provide excellent contrast between
different tissues and for the different compartments of the kidney
itself. Standard spin-echo T2 weighted imaging sequences are time-
consuming due to the long repetition times TR. However, they still
offer best image quality with respect to reproducibility and inter
slice variability. Additionally such sequences can be modified easily
to perform multiecho imaging, resulting in a set of images with
different weighting that even can be used to calculate T2 maps. In
this tutorial we demonstrate the applicability of a 2D T2 weighted
multi echo MRI for accurate determination of kidney volume and
compare different standardized TKV measurement techniques
using MRI scanners developed for clinical routine imaging or dedi-
cated to (preclinical) small animal imaging.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals These experimental protocols are tailored for mice (C57BL/6J)
with a body mass of 20–30 g. Advice for adaptation to rat (Wistar,
Sprague-Dawley or Lewis) is given in Subheading 4 where
necessary.
Fig. 1 Depicting standard measurement of length and width for ellipsoidal volume approximation of a kidney
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2.2 Lab Equipment 1. Anesthesia: For standard experiments isoflurane inhalation
(CP-Pharma, Baxter) provides robust anesthesia for up to 2 h
with comparatively little side-effects on renal physiology. For a
detailed description and discussion of the anesthesia please
refer to the chapter by Kaucsar T et al. “Preparation and
Monitoring of Small Animals in Renal MRI.”
2. Gases: O2 or compressed air, as delivering system for evapo-
rated isoflurane. Besides air for use with pulse oximetry systems
for monitoring blood oxygenation, O2 gas is preferred during
the experiment on diseased animals.
3. Devices for physiological monitoring ECG, temperature and
respiration, to trigger the image acquisition: for example SAI
(Model 1030, SAII, Stony Brook, NY, US).
2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney” (open-access). The technique described in this chapter
was tailored for a 9.4 T MR system (Biospec 94/20, Bruker Bios-
pin, Ettlingen, Germany) but advice for adaptation to other field
strengths and systems (e.g., 4.7 T Varian and 3 T Siemens Skyra
human MR scanner using a wrist RF coil (for signal reception) or
knee RF coil (transmit-receive)) is given where necessary.
With preclinical MRI systems volume RF coils covering the
entire mouse or rat bodies can be used for signal transmission and
reception. However, if needed signal-to-noise ratio (SNR) can be
elevated by using dedicated surface receive RF coils (i.e., mouse
heart four-element surface RF coil or rat heart four-element surface
RF coil) in combination with linear polarized transmit only volume
RF coils.
No other special or additional hardware is required.
2.4 MRI Protocols For anatomical MRI of the kidney T2-weighted MRI sequences are
the modality of choice. Accelerated imaging techniques are avail-
able on all MRI systems. On Bruker systems they are identified by
acronyms “RARE” or “turboRARE” (for rapid acquisition relaxa-
tion enhanced). On Philips and Siemens scanners such sequences




MRI data can be analyzed easily by manual planimetry or by calcu-
lating TKV from length and width measurements with different
standardized equations2 (the “Traditional Ellipsoid,” the “Mayo
Ellipsoid,” and the “Mid-slice Method”). For this we recommend
employing the open source imaging tools ImageJ or IcY:
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For providing the ex vivo gold standard, kidney volumes can be
additionally measured post mortem, using the fluid displacement
method.
3 Methods
Renal volumes can be calculated in several ways, using the ellipsoid
formula or the voxel-count method. For the ellipsoid formula
calculation, the length is determined on the sagittal scans. The
width and thickness will be measured at the hilum on the transverse
scans. Width can also be measured at the largest transverse diame-
ter. Both volume-hilum and volume-maximum will be calculated.
Volume measurements using the ellipsoid formula can easily be
done in less than 2 min. In most clinical studies, the ellipsoid
method is commonly applied for renal volume assessment. With
this method, it is assumed that the kidney resembles an ellipsoid
structure. This leads to systematic underestimation of the renal
volume. In fact the kidney is not a true ellipsoid structure.
With the voxel-count method, the volumes of all voxels within
the boundary of the kidney are summated, thus giving the true total
volume of the kidney so that obtaining inaccurate results is highly
unlikely. For the voxel-count method, the kidney has to be seg-
mented manually. Segmentations can be done by tracing the
boundaries of the kidney on each slice. The total renal volume
will then be calculated by summation of all voxel volumes lying
within the boundaries of the kidney. Partial volume effects, which
occur if voxels contain both kidney and surrounding tissue, could
lead to overestimation of the kidney volume, if such voxels are
included within the boundaries of the kidney. To avoid such an
overestimation, the segmentation line can be drawn halfway along
the change in signal intensity between the kidney and surrounding
tissues. Semiautomatic segmentation techniques, such as region-
growing, can save time. However, such methods are not really
practical to use for most available software. Neighboring tissues
with very similar signal intensity still have to be separated manually.
Fat within the kidneys might perturb the segmentation of the
boundaries due to fat-water chemical shift artifacts when using
region-growing segmentation technique, leading to an underesti-
mation of the total volume. Semiautomatic segmentation techni-
ques are also challenging to perform on images obtained with
accelerated T2 weighted MRI sequences. While accelerated T2
weighted imaging yields good results when organ morphology is
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considered, signal to noise ratio fluctuations between the individual
slices due to spatial changes in the noise amplification intrinsic to
parallel imaging techniques cannot be entirely prevented. For this
reason, selection of threshold values and propagation has to be
done individually for each slice and is a source for investigator
bias and experimental error. Newer segmentation techniques, like
automatic contour detection, might be an option in future software
implementations.
Calculating renal volume from both coronal and sagittal scans
can help eliminating differences due to aberrations in slice
positioning.
Furthermore there is a simplified Mid-Slice Technique for
MRI. In this technique, the renal volume is calculated from the
area of a single middle slice image of the kidney multiplied by the
number of slices. The kidney volumes correlate well with stereology
and have high reproducibility comparable with manual planimetry.
However, when calculating single kidney volumes, both the
mid-slice technique and the ellipsoid formula are less accurate
than stereology and manual or semiautomatic planimetry.
Although significantly faster than manual tracing for calculating
kidney volume, this technique is slower than the standard ellipsoid
method. Volume estimates are based on a multiplier linked to the
hypothesis that the shape of the kidney is ellipsoidal.
All these approaches rely on geometrical assumptions, that




Multiecho Sequence for T2
Imaging
1. Load the 2D multislice multiecho sequence (MSME). (pre-
ferred see Note 1)
2. Set the shortest echo time (TE) and echo spacing (ΔTE) possi-
ble, under the condition that fat and water are in phase (see
Note 2). The last TE should be close to the largest expected
T2
(*) in the kidney multiplied by 1.5 (seeNote 3). The aim is to
acquire at least five echo images. Consider increasing the acqui-
sition bandwidth and using half Fourier acceleration to shorten
the first TE and ΔTE (see Note 4).
3. Choose the shortest possible repetition time (TR) for good
signal-to-noise per time (SNR/t) efficiency. TR will be limited
by the length of the echo train and the number of slices you
acquire.
4. Adapt the flip angle (FA) to the TR and T1 in order to achieve
the best possible SNR. Use the Ernst angle αE ¼ arccos (exp
(TR/T1)) as a good starting value. Then try a few smaller and
larger FAs and determine the optimal FA experimentally by
comparing the measured SNRs.
5. Set a high acquisition bandwidth (BW) to shorten ΔTE, while
keeping an eye on the SNR, which decreases with the square
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root of BW. Low SNR may be balanced out with averaging (see
Note 5).
6. Enable fat saturation. On ultrahigh field systems this works well
to avoid fat signal overlaying the kidney due to chemical shift.
At lower field strengths it might work less efficient.
7. Enable the respiration trigger (per phase step or per slice). This
is essential to reduce motion artifacts (see also Note 6), reduce
motion blurring and unwanted intensities variations among the
images acquired with different TEs.
8. Choose as phase-encoding direction the L-R direction and
adapt the geometry so that the FOV in this direction includes
the entire animal (approx. 40 mm).
9. Use frequency encoding in head-feet (rostral-caudal) direction
to avoid severe aliasing. Adjust the FOV to your needs keeping
in mind that in this direction the FOV can be smaller than the
animal and a smaller FOV permits a smaller acquisition matrix,
and in turn a shorter echo-spacing.
10. Use an appropriate slice thickness, typically around 1.0 mm.
11. Use high in-plane resolution that the SNR allows, typically
between 100 and 200 μm. Zero-filling in phase encoding
direction can be helpful to speed up acquisition. One may use
half Fourier in read direction (asymmetric echo) to further
shorten the first TE, if very short T2* (<5 ms) can occur.
Reducing the excitation pulse length to below 1 ms would
then also help to shorten TE.
12. A spin echo sequence (MSME) with an echo time of >20 ms is
very sensitive for instabilities of your system. If the system is
not stable for any reason, this can often be observed directly at
the time signal.
13. For examples of specific parameter sets please see Notes 9–13.
3.2 In Vivo MR
Imaging
After obtaining scout images in the x, y, and z planes, T2-weighted
MRI should be performed in sagittal and coronal orientation.
When selecting a certain type of MRI sequence and its para-
meters, an optimum should be established between spatial resolu-
tion, signal-to-noise ratio, and scan duration. Accuracy of the
volume measurements can be enhanced by reducing slice thickness
and/or choosing an additional section orientation transverse to the
major axis of the kidney, mostly in axial orientation.
While theoretically beneficial for discrimination of kidney size
differences, measurements in multiple orthogonal planes across the
kidney prolong examination times and increase the time required
for segmentation, thus hampering both clinical and preclinical
practice. This holds also true for application of sophisticated high
resolution T2 weighted 3D imaging techniques instead of standard
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(multislice) 2D T2 weighted MRI covering the entire kidney. Espe-
cially in preclinical studies of diseased animals, it is often more
appropriate to use solely a single slice orientation 2D MRI
approach to gather standardized images in minimum time (i.e., to
reduce length of anesthesia). If reduction of imaging time is of
particular importance, accelerated imaging techniques are recom-
mended. Such sequences should be available on all MRI systems.
On Bruker systems they are identified by acronyms “RARE” or
“turboRARE” (for rapid acquisition relaxation enhanced). On Sie-
mens scanners such sequences usually are denoted “FSE” or “TSE”
(for fast spin echo or turbo spin echo). In these measurement
techniques acceleration is facilitated mainly by recording of multi-
ple lines of k-space, that is, performing multiple phase-encoding




1. Acquire a fast pilot scan to obtain images in the three orthogo-
nal planes x, y, and z.
2. Acquire anatomical images in several oblique orientations to
facilitate planning a coronal slice orientation with regard to the
long axis of the kidney, as described in the chapter by Pohl-
mann A et al. “Essential Practical Steps for MRI of the Kidney
in Experimental Research.”
3. Perform localized shimming on the kidney as described in the
chapter by Pohlmann A et al. “Essential Practical Steps for MRI
of the Kidney in Experimental Research.”
3.2.2 Morphometric MR
Imaging
1. Load the MSME sequence, adapt the slice orientation to pro-
vide a coronal or axial view with respect to the kidney
(in scanner coordinates this is double-oblique). (caveat see
Note 8)
2. In the monitoring unit set the trigger delay so that the trigger
starts at the beginning of the expiratory plateau (no chest or
diaphragm motion) and the duration such that it covers the
entire expiratory phase, that is, until just before inhalation
starts (1/2 to 2/3 of breath-to-breath interval) (see Note 7).
3. Adapt TR to be a little shorter (about 100 ms) than the average
respiration interval that is displayed on the physiological
monitoring unit.
4. Run the MSME scan. Example images are shown in Figs. 2, 3,
and 4.
A demonstration of the volume changes that can be expected in
pathophysiological scenarios is given in Fig. 4.
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4 Notes
1. A 3D version of the turboRARE sequence is also available,
which allows thinner slices with better SNR, but tends to be
too slow for most in vivo applications.
2. The fat signal has a slightly different Larmor frequency
(fat-water shift: Δf ¼ 3.5 ppm  Larmor frequency or
Fig. 2 T2 weighted image of mouse kidneys in coronal view. For the
quantification of kidney volume, respiratory triggered, fat-saturated
T2-weighted turbo spin echo (TSE) sequences were acquired in axial and
coronal planes, covering both kidneys. The coronal plane was adjusted to the
long axis of both kidneys. Scan parameters were: TR/TE ¼ 1500/33 ms,
averages ¼ 2, matrix ¼ 256x256, field of view ¼ 35x35 mm2, slice
thickness ¼ 1 mm
Fig. 3 T2 map of mouse kidneys with AKI (left). Note the different T2 values in
cortex and medulla between left and right kidney
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146 Hz/T, for example: Δf ¼ 220 Hz at 1.5 T) than the water
signal. The faster precession of the fat protons means that with
increasing time the fat and water signal fractions within a voxel
are sometimes in phase (signals add up) and sometime out of
phase (signals subtract). This can lead to an unwanted fat-water
shift induced signal intensity modulation along the exponential
signal decay curve. This is mostly relevant for diseased kidneys
with increased fat content (e.g., diabetes), but we recommend
to generally take this into account, that is, also for healthy
kidneys. The TEs at which fat and water are in phase depend
on the field strength: TE [ms] ¼ n  (6.7069/B0[T]).
3. When establishing the MR technique you need to define an
SNR acceptance threshold for the image with the shortest
TE. The aim is to have at least three (better five or more)
number of echoes with an SNR> 5. This threshold will depend
on the expected T2
(*) values, which in turn depends on para-
meters like the magnetic field strength, shim quality, and tissue
properties (pathology). Example: For a rat imaged at 9.4 T
using a four-element rat heart array receive surface RF coil
together with a volume RF resonator for excitation in combi-
nation with interventions leading to strong hypoxia, an
SNR > 60 was needed.
4. For rats increase the FOV to the body width and keep the
matrix size the same. The relative resolution is then identical
and the SNR should also be similar, because the smaller mouse
RF coil provides better SNR.
Fig. 4 MSME permits easy detection of size differences in kidneys after acute
kidney failure
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5. A good starting point is to use the same relative resolution as
for rats. For this, reduce the FOV to the mouse body width and
keep the matrix size the same.
6. If no specific animal holder is used, it is preferable to position
the animals in left or right decubitus position to keep the
bowels away from the kidneys to mitigate susceptibility
artifacts.
7. Youmust monitor the respiration continuously throughout the
entire experiment and if necessary adapt the TR accordingly.
8. Acquiring more echoes with smaller echo spacing will be bene-
ficial because it improves the fitting when calculating a T2 map
(see Fig.3), but keep in mind the specific absorption rate (SAR)
associated with sending many 180 RF pulses in a short time
could heat up the tissue. This will usually not be detectable via a
rectal temperature probe, but measurements with a tempera-
ture probe placed in the abdomen next to the kidney showed
that significant temperature increases are possible with a multi-
spin echo sequence.
9. Ellipsoid based calculation: Example parameters for a 300 g rat
at 9.4 T (Bruker small animal system): TR ¼ [respiration inter-
val] -100 ms; receiver bandwidth ¼ 50 kHz; number of ech-
oes¼ 12; first echo¼ 10.0 ms; echo spacing 10.0 ms; TE¼ 10,
20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120 ms; averages¼ 1;
slice orientation ¼ coronal to kidney; frequency encod-
ing ¼ head-feet; FOV ¼ (38.2  48.5) mm; matrix
size ¼ 169  115 zero-filled to 169  215; resolu-
tion ¼ (0.226  0.421) mm; 1 slice with 1.4 mm thickness;
fat suppression¼ on; respiration trigger¼ per slice; acquisition
time ¼ 55–75 s (with triggering under urethane anesthesia).
10. Ellipsoid based calculation: Example parameters for a 30 g mouse
at 4.7 T (Agilent small animal system): TR ¼ [respiration
interval]  100 ms; receiver bandwidth ¼ 50 kHz; number
of echoes ¼ 12; first echo ¼ 10.0 ms; echo spacing 10.0 ms;
TE ¼ 10, ..., 120 ms; averages ¼ 1; slice orientation ¼ coronal
to kidney; frequency encoding ¼ head-feet;
FOV ¼ (30  30) mm; matrix size ¼ 128  128; resolu-
tion ¼ (0.230  0.230) mm; 1 slice with 1.0 mm thickness;
fat suppression ¼ on; respiration trigger ¼ on; acquisition
time ¼ 3.5–9.0 min (with triggering under isoflurane
anesthesia).
11. Ellipsoid based calculation: Example parameters for a 300 g rat
at 3.0 T (Siemens Skyrafit, a clinical system): Animal position:
Right decubitus; Coil: Knee; TR ¼ [respiration inter-
val]  500 ms; receiver bandwidth ¼ 399 Hz/pixel; number
of echoes ¼ 12; first echo ¼ 10.0 ms; echo spacing 10.0 ms;
TE ¼ 10, ..., 120 ms; averages ¼ 2; slice orientation ¼ axial;
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frequency encoding¼ left-right; FOV¼ (120x60) mm; matrix
size ¼ 256  128; resolution ¼ (0.470  0.470) mm; 1 slice
with 2.0 mm thickness; fat suppression ¼ on; respiration trig-
ger¼ off; acquisition time ~ 2 min. If no specific animal holder
is used, it is preferable to position the animals in left of right
decubitus position to keep the bowels away from the kidneys to
mitigate susceptibility artifacts.
12. Planimetry based calculation: Example parameters for a 300 g
rat at 9.4 T (Bruker small animal system): TR ¼ 1700 ms;
receiver bandwidth ¼ 50 kHz; number of echoes ¼ 12; first
echo ¼ 10.0 ms; echo spacing 10.0 ms; TE ¼ 10, 20, 30,
40, 50, 60, 70, 80, 90, 100, 110, 120 ms; averages ¼ 1; slice
orientation ¼ coronal to kidney; frequency encoding ¼ head-
feet; FOV¼ (38.2 48.5) mm; matrix size¼ 169 115 zero-
filled to 169  215; resolution ¼ (0.226  0.421) mm;
13 slices at 1 mm thickness; fat suppression ¼ on; respiration
trigger¼ per slice; acquisition time¼ 220–300 s (with trigger-
ing under isoflurane anesthesia).
The following images should be acquired: coronal and
transverse T2-weighted fast spin-echo sequence (TSE) and
coronal T1-weighted TSE.
The following images should be acquired: coronal and
transverse T2-weighted fast spin-echo sequence (TSE) and
coronal T1-weighted TSE.
The parameters for coronal position TSE can be as follows:
slice thickness, 2.0 mm; slice interval, 0.2 mm.
For T1 weighted turbo spin-echo (TSE): repetition time
(TR), 650 ms; echo time (TE), 10 ms; field of view (FOV),
120 mm  120 mm; band width, 250 Hz/Px; matrix,
256  256; and number of excitations (NEX), 4.0;
For T2 weighted TSE you can use: TR, 3460 ms; TE,
35 ms; FOV, 120 mm  120 mm; band width, 250 Hz/Px;
matrix, 256  256; and NEX, 4.0.
The parameters for the transverse position T2 TSE can be
as follows: slice thickness, 2.0 mm; slice interval, 0.2 mm; TR,
650 ms; TE, 10 ms; FOV, 120 mm  120 mm; band width,
250 Hz/Px; matrix, 256  256; and NEX, 4.0.
Shimming is particularly important, since macroscopic
magnetic field inhomogeneities shorten T2*, but provide no
tissue specific information—rather they overshadow the micro-
scopic T2* effects of interest and hinder quantitative intra- and
intersubject comparisons. Shimming should be performed on a
voxel enclosing only the kidney using either the default itera-
tive shimming method or based on previously recorded field
maps (recommended).
13. If the height adjusted total kidney volume (HtTKV) must be
calculated it can be done by measuring the kidneys in three
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axes. To calculate HtTKV a structural MRI or at least CT scan
is required. The height of the patient is also required for the
calculation. The total kidney volume (TKV) is determined
using an ellipsoid equation. This is clinically validated for
patients with polycystic disease, with bilateral and diffuse
small to medium sized cysts. The ellipsoid equation requires




If you are viewing images on PACs or any DICOM-Viewer it is
easiest to calculate the HtTKVwith all planes of the kidney visible at
the same time. To do this, you mostly have to select “MPR” under
the available “ViewOptions” in the specific menu.With this you can
view the kidney in the coronal, sagittal, and axial planes. The
maximum length of the kidney should be measured in the sagittal
plane.
The width and depth can be measured in the axial plane in a
slice that shows the greatest kidney width and depth.Repeat this for
both kidneys. Once you have all six measurements and the patient’s
height, you can calculate HtTKVor use one of the available online
calculators for kidney volume.
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Chapter 22
Experimental Protocols for MRI Mapping of Renal T1
Philippe Garteiser, Octavia Bane, Sabrina Doblas, Iris Friedli,
Stefanie Hectors, Gwenaël Pagé, Bernard E. Van Beers,
and John C. Waterton
Abstract
The water proton longitudinal relaxation time, T1, is a common and useful MR parameter in nephrology
research. Here we provide three step-by-step T1-mapping protocols suitable for different types of nephrol-
ogy research. Firstly, we provide a single-slice 2D saturation recovery protocol suitable for studies of global
pathology, where whole-kidney coverage is unnecessary. Secondly, we provide an inversion recovery type
imaging protocol that may be optimized for specific kidney disease applications. Finally, we also provide
imaging protocol for small animal kidney imaging in a clinical scanner.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Longitudinal relaxation time
(T1), Spin-lattice relaxation time (T1)
1 Introduction
The water proton longitudinal (or spin-lattice) relaxation time, T1
(s), is a MR parameter commonly used in biomedical imaging.
Unlike machine-dependent metrics such as “signal intensity in T1-
weightedMRI,” T1 measures a real physical process (i.e., the return
to Boltzmann equilibrium of water proton longitudinal magnetisa-
tion) measured in absolute units (s) and, for any given magnetic
field strength, independent of the machine used. Renal pathology
often results in abnormal T1 either globally (e.g., in renal failure) or
focally (e.g., in renal cancer). Moreover, disease-induced changes in
T1 can often be assigned, at least qualitatively, to pathological
changes such as fibrosis, inflammation, and oedema [1]. A second
motivation to measure T1 is in so-called dynamic experiments. In
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_22, © The Author(s) 2021
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this case the object under investigation in the MRI scanner for a
short period (e.g., 10 min) while T1 is measured repetitively, during
some intervention to perturb T1 (e.g., contrast agent administra-
tion). After administration of a contrast agent such as manganese, a
gadolinium chelate, or dioxygen, changes in T1 are linearly related
to the contrast agent concentration, which could not reliably be
determined from signal intensity changes alone.
Here we describe MRI protocols for mapping and monitoring
T1 in the kidney of small rodents in a step-by-step experimental
protocol. The rationale for choosing different acquisition para-
meters depending to the aims of the study is discussed, together
with specific parameter examples. T1 measurements for dynamic
studies are discussed in the chapter by Irrera P et al. “Dynamic





Imaging provides many useful metrics in animal models of kidney
physiology and pathophysiology. These include “extensive” or size
variables, such as renal volume (ml) or thickness (mm) of renal
cortex, and “intensive” or tissue characterisation variables, such as
the longitudinal relaxation time, T1 (s). Some investigators prefer
to report the longitudinal relaxation rate R1, the reciprocal of T1,
because from a metrology perspective R1 is a “ratio variable” while
T1 is merely an “interval variable” [2]. In this work we use T1.
“Intensive” variables can be mapped, the maps themselves being a
type of image. Such image metrics used in animal studies are
valuable in translational research, as they are directly comparable
with the imaging markers [3–5] used in studies of human subjects.
1.2 Study Design
Concepts
Great care is needed in the choice of method to map T1. No single
method is optimal for all in vivo studies. The most accurate meth-
ods (e.g., inversion recovery with long TR and short TE readout)
are neither fast nor efficient. In vivo studies involve complex trade-
offs between accuracy, speed, spatial resolution, field of view, need
for fat suppression, sensitivity to inflow, sensitivity to motion arti-
fact, biexponential T1 decay, and other confounding tissue magne-
tisation behaviours such as transverse relaxation and magnetisation
transfer. Moreover, even after a specific method is chosen, errors
can be very sensitive to pulse sequence parameters such as delays,
flip angles, spoiling and refocussing strategies, mis-set RF pulses
and so on. For the renal investigator the first question in designing
a study to measure T1 must always be: what is the aim of the study?
1. For studies of global pathology, very high spatial and temporal
resolution may be unnecessary provided that the cortex, the
zones of the medulla, and the papilla can be resolved. In such
studies a 2D image with voxel size of around 0.25mm (in mice,
e.g., [6–8]) or around 0.5 mm (in rats, e.g., [9–12]) may be
adequate. It is often desirable to acquire T1 with low
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uncertainty so that small early pathological changes can be
detected, and also to acquire accurate T1 values that are repro-
ducible between centers so that findings are generalizable. A
saturation recovery sequence with ten or more inversion times,
a 2D RARE readout, moderate spatial resolution, and a two- or
three-parameter fit, should provide T1 values which are not
biased by B1
+ errors. Alternately an inversion recovery
sequence with a 2D echo-planar readout [6, 8] may be used
although this is less time-efficient. The accuracy of the T1
acquisition and analysis method should be verified using phan-
toms of known T1 [2].
2. Studies of focal pathology may require high spatial resolution
in 3D appropriate to the disease under investigation. Low
uncertainty, high accuracy, and high reproducibility are also
likely to be important so that scan times may be relatively
long. 3D variable flip angle sequences are convenient, although
they are quite vulnerable to B1
+ errors. In these cases, phantom
studies are highly desirable to mitigate B1
+ errors, although
phantom studies do not mitigate the motion artifact error to
which these sequences are also highly vulnerable.
3. Longitudinal studies, during the development and/or treat-
ment of disease have similar demands on spatial and temporal
resolution, although if the study endpoint is the change in T1,
requirements for accuracy may be relaxed: in a significance test
of post vs pre, or treated vs untreated, systematic errors from
biased T1 measurement may partly cancel out.
4. Dynamic studies have similar demands on spatial resolution (e.g.,
high 3D resolution for focal disease) together with very good
temporal resolution to allow dynamic changes to be quantitated.
In consequence accuracy may be compromised, but since the
study endpoint relies on T1 change during the dynamic run,
bias may partly cancel out. Propagation of errors in these cases
can be exceedingly complex and requires careful simulation.
1.3 Data Quality It is highly desirable to verify the accuracy and repeatability of T1
using phantoms [2], before experimental animals are exposed to
study procedures. The design of MR phantoms can be challenging,
and while validated traceable phantoms have been developed by
metrologists for clinical MR [13–15], these are usually too large for
use in rodent MR scanners. Design considerations should include
biological, chemical, and physical stability, temperature indepen-
dence, convenience, and cost. The phantom should cover both the
expected T1 range and the spatial range, since it may be advanta-
geous to position the kidneys offset relative to the magnet’s iso-
center [16]. Nickel-doped agarose gels [17–19] are particularly
convenient as simple liquid flood phantoms may introduce artifacts
from unfamiliar MR phenomena such as radiation damping, con-
vection, excessive T2 or self-diffusion, standing waves, or abrupt
boundaries.
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Animal kidney MRI has been performed at a wide range of mag-
netic field strengths (B0) between at least 0.4 T [20] and 16.4 T
[21]. T1 increases with B0 [22]. Hence it is important to consider
B0 as an important factor in experiment design, although in practice
B0 may not be an adjustable parameter since many facilities only
have a single MRI machine operated at a single magnetic field
strength available. Higher magnetic field strengths are not always
preferable, as the scan times required to properly sample the recov-
ery of longitudinal magnetization will be somewhat longer, and
problems from motion artifact, chemical shift artifact or suscepti-
bility variation may increase. For an investigator who wishes to use
rodent renal T1 changes to study, say, the development of fibrosis or
inflammation, the relevant metric is T1 contrast-to-noise ratio per
unit time, which does not necessarily improve as field strength
increases: a high-field (9.4 T) magnet may be no better than a
conventional 3-7 T magnet. On the other hand, for an investigator
who measures the uptake of a relaxive substance such as dioxygen,
manganese, or gadolinium chelate, a high-field magnet provides a
lower baseline R1, making the induced changes ΔR1 more evident.
2.2 Physiologic
Motion
Acquisition parameters should ensure that interference from physi-
ologic motion on the signal is kept to a minimum. Indeed,
although kidneys are positioned quite low in the abdomen, they
are still subject to mild respiratory motion artifacts. It is possible to
acquire continuously under shallow breathing, taking advantage of
the slow speed of breathing in anesthetized animals [23]. With such
datasets, some of this motion can be corrected for during image
processing with appropriate coregistration strategies or by inten-
tionally skipping frames presenting a high degree of respiratory
motion from the analysis. However, because this strategy poten-
tially removes important datapoints or because it introduces physi-
ological noise into the quantitative estimation, it is still
recommended to implement motion compensation strategies at
the acquisition level. In particular, respiratory motion compensa-
tion takes advantage of a respiratory signal (acquired externally or
with MR signals such as navigators) to only allow acquisition dur-
ing the long periods of breathing motion arrest that are typical of
anesthetized animals. An example of such a setup applied to a
clinical scanner, is depicted in Fig. 1. Special care is needed to
ensure such triggering approaches are compatible with T1 mapping
protocols. In such protocols, sequence timing dictates the effective
repetition time, upon which the accuracy of the T1 computation is
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based. It is sometimes preferred to position the trigger on the
inversion (or saturation) RF pulse rather than on the slice selection
or other imaging loops [16] so that the timing of image acquisition
relative to inversion is guaranteed. The only timing affected in this
strategy is the delay between saturation or inversion slices. In
inversion recovery protocols this delay is already very long, (often
more than 10 s), so any additional delay incurred will not signifi-
cantly affect T1 accuracy, while in saturation recovery the saturation
pulse destroys the longitudinal magnetization so that preceding
delays are unable to affect T1 accuracy.
An alternative approach for respiratory motion compensation is
retrospective gating or self-gating, which is compatible with gradi-
ent echo methods such as Variable Flip Angle (VFA). In this case,
data are acquired continuously but an additional “navigator” signal
allows data displaced by respiration to be sorted or discarded. This
is marketed under the brand-name “IntraGate” (Bruker Biospin,
Ettlingen, Germany).
Because kidneys are anatomically close to the bowels, some
authors favor imaging sessions done after fasting periods [10]. Fast-
ing should only be done after considering the physiologic
Fig. 1 Scheme of the experimental setup for a respiratory-gated implementation with monitoring small animal
system SA Instruments, Inc., Stony Brook, NY11790 USA
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consequences, and from the animal welfare perspective should be of
the minimum duration consistent with the imaging aims.
3 Imaging Techniques
Conventionally, for T1 measurement, signal intensity is probed at
different time points during exponential decay back to Boltzmann
equilibrium following inversion or saturation of the longitudinal
magnetization: inversion recovery or saturation recovery. Satura-
tion can be achieved using a specific saturation pulse, or simply by
varying the repetition time TR of a conventional spin echo or
gradient echo acquisition which also incidentally saturates the mag-
netization. To reduce the total acquisition time, the Look Locker
(LL) sequence can be used. With LL sequences, the magnetization
is also prepared with an inversion or saturation pulse [24], but
instead of a single sample of the recovery curve per TR, multiple
samples are taken using a train of low flip angle pulses [25].
The inversion recovery sequence is the reference method to
calculate T1 but it suffers from long acquisition times. Therefore,
the use of Look-Locker inversion recovery is advantageous, but is
limited to single 2D slice acquisition: if multiple slices are needed,
they must be acquired sequentially.
The alternative approach involves repeating a gradient echo
acquisition at varying flip angles (VFA) while keeping TR and
other sequence parameters constant: since the signal depends sinu-
soidally on flip angle but decays exponentially with T1, the T1 can
be calculated from the Ernst equation (chapter by Garteiser P et al.
“Analysis Protocols for MRI Mapping of Renal T1”). Three-
dimensional acquisition (3D) can be performed with VFA, but
since VFA is sensitive to B1
+ inhomogeneity, the B1
+ field should
be mapped to allow correction (chapter by Garteiser P et al. “Anal-
ysis Protocols for MRI Mapping of Renal T1”). Although 3D VFA
is familiar in clinical imaging, it is not commonly employed in




Rapid acquisition with relaxation enhancement at variable TR
(RARE-VTR) is a type of saturation recovery sequence. Data are
acquired as 2D slices, so this sequence is ideal when a single slice
provides an adequate sample of the kidney, for example in the case
of homogeneous global pathology. If volumetric data are required
then a stack of slices must be acquired sequentially, which is time-
consuming.
The RARE-VTR protocol is based on the multiecho RARE
protocol, with a slice-selective 90 rf pulse followed by a train of
slice-selective 180 refocusing pulses separated by an inter-echo
time TE (Fig. 2). Each 180 pulse induces a refocused echo com-
prising spin-echo and stimulated echo contributions, which is
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digitized, and each echo experiences a different phase encode gra-
dient. Following the last echo there is a delay following which the
sequence is repeated with a repetition time TR. The number of
180 pulses is called the echo train length (ETL) or RARE factor: a
typical value is 8. TR is then varied to sample the magnetization
recovery. A saturation recovery time Tsat is defined as
TR  (ETL  TE). Thus if an investigator requires a 1282 matrix,
the entire acquisition duration would be ∑TR  128/ETL, where
∑TR is the sum of all the TR values used to sample the longitudinal
magnetization recovery. Recommended acquisition parameters are
given in section 4 below.
Because of the presence of refocusing RF pulses, this protocol is
relatively insensitive to B0 imperfections and susceptibility artifacts.
For 2D single-slice T1 mapping it is quite time-efficient, but acqui-
sition of a multislice stack requires rather long acquisition times.
3.1.2 Repetition Times The set of repetition times that are sampled needs careful consider-
ation. The TR values should be rationally selected during prelimi-
nary studies with the animal model under investigation. In
Fig. 2 Simplified timing diagram for 2D saturation recovery sequence with RARE readout. A series of 180
pulses creates f echoes at TE, 2  TE, 3  TE, and so on, where f is the RARE factor, typically f ¼ 8. During
the phase encoding (PE) step, spatial location is encoded by incrementing the Y gradient NY times so that each
echo is encoded with a different phase, thereby accelerating the k-space coverage. During the frequency
encoding (FE) readout periods, the spatial location is encoded in the frequency content of the digitized signal
from the echo. If the pulses are perfect and if neglecting the longitudinal regrowth occurring during the echo
train, all the magnetization is effectively kept in the transverse plane until the last echo (Phase cycling and
spoiling not shown)
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saturation recovery experiments, the signal starts at S0 ~ 0 at short
TRs (TR  T1) and increases with approximately linear S1/T1
dependence on TR. At longer TRs (TR  T1), the signal enters a
transition regime where the increase in signal per unit TR
diminishes. Finally at large TRs (TR  T1), the signal asymptoti-
cally approaches S1. Hence, proper TR sampling strategy should be
adopted to cover both regimes and the transition in between.
In determining the set of repetition times to use, the first
question may be to select the highest TR that is required. This
choice is mainly dictated by the expected T1 in the tissue of interest,
the available scan time and the planned postprocessing strategy.
For the first constraint, literature values or preliminary studies
may help in the determination of the expected tissue T1 at the
corresponding magnetic field strength. The longest TR should be
substantially larger than the longest expected tissue T1. Typical T1
values for cortex and medulla are in the range 1–2 s and for urine
around 3 s. There is no generally accepted consensus, but authors
typically have the maximal TR be 3–5 times the longest expected
T1, typically 8–12 s. If the investigator finds this makes the overall
study duration too long then spatial resolution can be reduced,
particularly when small focal changes are not of interest. Alterna-
tively a maximal TR of two times the longest expected T1 could be
considered, but in this case it is recommended to perform careful
simulations to ensure the propagated errors are at an acceptable
level. A special case arises in contrast agent injection studies. Here,
the distribution of the agent into the tissue of interest is quantified
by looking at the absolute change in R1 after vs before injection.
Hence, care should be taken to consider that the T1 value may be
significantly shorter after injection. It may be necessary to adopt a
different maximal TR for the pre- and postinjection scans. Contrast
agents decrease T1, hence the possible decrease in longest TR that is
afforded has the additional consequence of shortening the scan
duration. This is potentially advantageous, especially when the
dynamics of contrast agent distribution needs to be interrogated
and is slow (on the order of minutes). In this case it becomes
feasible to monitor the contrast agent distribution dynamically by
repetitively acquiring T1 maps. Temporal resolutions of under
2 min can reasonably be achieved by trading off, for example, spatial
resolution. This strategy is compatible with some contrast agent
dynamics such as in manganese-enhanced MRI [21].
The choice of the longest TR should be done in harmony with
the particular postprocessing solution that is planned. Indeed, the
dataset obtained with the longest applied TR may be used to
provide an estimate for the total equilibrium signal S1. In that
case, the mathematical problem to be solved is reduced since S1
can be inserted in the fitting equation, thereby removing a degree
of freedom and making the fit more robust. This comes at the cost
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of the necessity to acquire a scan at very long TR to ensure the
signal is close enough to equilibrium values. When such an estimate
of S1 is available, it may no longer be necessary to sample other TRs
longer than the tissue T1, concentrating instead on TR values at and
below the tissue T1 [21].
Once the largest TR to acquire has been selected, the number
of TRs should be determined. The set of TR values should span the
range of expected T1. Depending on the fitting equation that is
used, a larger number of repetition times may be required to
provide sufficient overdetermination for the fitting procedure. In
other words, there should be significantly more TRs sampled than
there are free parameters in the fitted equation. In an ideal situation
with negligible experimental noise, it may be sufficient to select
only a number of TR values equal to the number of free parameters
in the fit. However, with experimental noise, this rapidly becomes
insufficient and introduces bias into the results. Hence, when signal
to noise ratio is limited, it is recommended to acquire a larger
number of TR values. This comes at the cost of increased scan
time, since each TR is generally acquired sequentially. In saturation
recovery sequences, the fitting equation only has a limited number
of parameters (i.e., S1, R1, and maybe S0 and/or an error term);
hence, as few as four TR values are acceptable providing sufficient
signal to noise is available and sampling is appropriately selected.
In disease models the pathology evolves slowly over days or
weeks, the scan duration becomes less important, and it is possible
to increase the number of TR values to 6, 8, or even 12, although
from an ethical perspective the duration of the procedures should
always be as short as possible. The choice of TR values can even be
done a priori using Cramer-Rao lower-bound methodology. This
technique optimizes the distribution of the sampled variable
(in that case TR), for a given number of samples, an expected
noise distribution and a signal model. It was used already with
some success for cardiac T1 mapping, where it was found that at
constant number of acquired averages, increasing the SNR by
averaging a carefully selected subset of TR values could prove
beneficial relative to a set of uniformly distributed TR values
[26]. A similar approach can be proposed to optimize the repetition
times to use in kidney T1 mapping.
In typical MRI scanners, the specific TR values can be set
manually with a TR table having a user-specified number of TR
entries. Manufacturers also often provide utilities that assist the user
in prescribing the TR series. These utilities query from the user only
a minimal value, a maximal value and a number of steps, or a
minimal value, a number of steps and an estimate of the tissue T1.
These input values are then used to generate the series of TR values
to use during the acquisition.







Look-Locker (LL) is a variant of inversion recovery or saturation
recovery sequence. Data are acquired as 2D slices, and if volumetric
data are required, a stack of slices must be acquired sequentially. LL
involves sampling the magnetization using rapid, small angle imag-
ing readouts while it recovers from the inversion or a saturation RF
pulse (Fig. 3). The temporal spacing between imaging readouts
provides a rapid way to sample the longitudinal regrowth. Indeed,
each imaging shot will occur at a different time during regrowth,
hence many different recovery times can be sampled during a single
recovery event. Full longitudinal regrowth takes longer after an
inversion RF pulse than after a saturation RF pulse, however,
adopting an inversion RF pulse increases the dynamic range of the
sampled signal. Thus the choice between saturation or inversion for
the preparation of magnetization in a recovery sequence may be
dictated by the experimental necessity for short acquisition time
(for instance in dynamic experiments involving contrast agents with
rapid kinetics) or higher measurement precision.
The Modified Look-Locker Inversion Recovery (MOLLI)
sequence is an alternative when small animal renal T1 mapping is
Fig. 3 Schematic view of the look-locker inversion recovery pulse sequence (fast low flip angle spoiled
gradient echoes variant with spoiler gradient pulses omitted for simplicity). τ repetition time, Ny prescribed
number of k-space lines, Nsegments number of k space segments (acceleration factor), TI inversion recovery
time. Effective recovery times are considered at the centerline of each imaging segment. τrecovery: delay added
to enable full recovery of the longitudinal magnetization before the subsequent inversion pulse is applied. In
other variants, the fast low angle shots can be replaced by steady state free precession modules or EPI
modules (Accessory gradient lobes are not shown for clarity)
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performed using a clinical MR system. One rationale for choosing a
clinical platform for preclinical studies is the similarity between MR
protocol played out on small animals and human kidneys. MOLLI
was initially designed for myocardial T1 mapping at 1.5 T [27]. A
typical MOLLI sequence can be performed by acquiring single shot
True FISP images at different inversion times after a single inver-
sion pulse. MOLLI is routinely used clinically for T1 mapping and is
usually available on clinical MR systems equipped with a cardiac
package. The original MOLLI sequence provided by the manufac-
turers’ library is a good starting point for MOLLI optimization in
the rodent kidney. However, translating the MOLLI technique for
scanning rodent models on a clinical MR scanner requires a specific
implementation. In human, MOLLI is usually acquired in breath
hold. In rodent, a physiological monitoring system to track the
respiration and synchronize the sequence is needed (see Fig. 1).
3.2.2 Types of Readouts,
and Corresponding Specific
Points of Attention
In recovery-type sequences, several options are possible for the
imaging shots that are performed to sample the recovery period.
Fast low angle shots, where magnetization is spoiled before
subsequent RF pulses, can be used. They have the advantage of a
short TR (~3 ms) that is compatible with low flip angles (<10)
[9]. As such, they perturb the longitudinal regrowth of the magne-
tization only to a small extent.
Balanced readouts such as steady-state free precession (SSFP)
can also be used, as they tend to yield higher signal to noise due to
the conservation of magnetization from preceding shots [28]. The
SSFP condition links the TE and TR. Because FISP involves radio-
frequency phase coherence between shots, acquisition can be true-
FISP, fid mode or echo mode. It acquires innermost the phase
encoding (in-segments), then slices, then phase encoding (seg-
ments), then (optionally) averaging. SSFP is especially sensitive to
careful shimming of the B0. The segmenting can be performed
either sequentially or by interleaving phase encode steps. The inter-
leaved mode is recommended for inversion recovery experiments.
The T1 recovery sampling must then be setup by adjusting the time
between the inversion pulse and the first imaging shot. This delay is
incompressible due to the need for stabilizing the steady state
condition of the magnetization. This is either done with a half flip
angle pulse or with a starter (dummy) sequence, at the cost of a
longer delay. Unfortunately for these reasons, the implementation
of respiratory or cardiac triggering is challenging, and it is recom-
mended to proceed by gating on the saturation or inversion pulse.
Finally, echoplanar imaging (EPI) readouts have also been
proposed in that context [6, 7, 16, 29, 30]. Although they are
quite advantageous due to their speed (in single shot EPI, a full
k-space image may be acquired after a single excitation pulse), EPI
sequences for kidney T1 mapping are vulnerable to problems asso-
ciated with EPI in general, particularly if both kidneys are to be
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assessed. In particular, the EPI train is sensitive to B0 inhomogene-
ity, which can become problematic at higher magnetic field
strengths and in large bore systems. This effect is more important
for long echo train EPIs such as single shot EPI. In this situation
there is also a long effective echo time to accommodate the train
length required by the single shot mode. This can be detrimental
because it can increase the point spread function diameter (“smear-
ing”), thus reducing the effective spatial resolution [30]. The long
echo time of single shot EPI also comes at a disadvantage in kidneys
with short T ∗2 such as kidneys after injection of high concentrations
of contrast agents. EPI is also associated with signal dropouts and
geometric distortions at regions of strong magnetic susceptibility
gradients, which sometimes occur at the kidney edges [30].
These disadvantages can be mitigated by performing seg-
mented EPI acquisitions. In segmented EPI, full k-space acquisi-
tion is subdivided over several recovery periods, thereby enabling
for decreased echo times. Segmentation will, however, increase the
acquisition time, since full k-space coverage will be performed over
a greater number of recovery periods. Finally, EPI image quality is
also adversely affected by the presence of fat, which may be abun-
dant in some kidney disease models such as obesity-related disease
models. This can be remedied by applying fat saturation pulses [7].
3.2.3 Duration of Imaging
Readouts
The duration of the imaging readouts should be short relatively to
the duration of the recovery. This enables to interrogate precise
inversion recovery delays rather than long intervals during which
the longitudinal magnetization does vary substantially. Further-
more, short imaging readout durations are also advantageous
because more imaging shots can be positioned during longitudinal
regrowth. The increased number of data points yields better
numerical stability during the subsequent fitting procedure.
3.2.4 Number of Imaging
Readouts
The total number of imaging readouts that can be fit in a single
regrowth is limited by several factors. First, the imaging sequence
(excitation and readout) itself takes an incompressible minimum
amount of time. Second, there is a requirement to acquire full
images at each of the recovery delays. Hence, if only a single
k-space line is acquired at each recovery delay, this also means that
to acquire the appropriate number of k-space lines for image recon-
struction (e.g., 128), an equal number of saturation or inversion
recovery periods will be necessary. Since full relaxation needs to be
reached (typically 10 s or more) before the next inversion RF pulse
can be applied, this implies very long acquisition times (20 min or
more). Hence it is important to consider acceleration schemes such
as echoplanar imaging, where partial k-spaces are acquired during
the regrowth rather than single k-space lines. Finally, the image
acquisition readouts perturb the growing longitudinal
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magnetization: the application of the imaging RF pulses slightly
saturates the signal, which makes the signal regrow with a biased
apparent T1 (sometimes denoted T1*) that is different than the true
tissue T1. This effect can be mitigated by using smaller flip angles
and longer RF pulse repetition intervals. Postprocessing strategies
are also available to correct for that effect (cf. the chapter by
Garteiser P et al. “Analysis Protocols for MRI Mapping of Renal
T1”).
3.2.5 Repetition Time In saturation or inversion recovery type sequences, it is important
to distinguish the time between RF inversion pulses and the time
between imaging RF pulses. The time between saturation or inver-
sion must take into account the T1 of the kidney at the considered
field strength. A sufficiently long recovery period must be taken
into account to prevent to saturate the magnetization. Typically
inversion pulses are separated by 10 s [16, 28], 18 s [6, 7] or even
20 s [30].
The repetition time between imaging segments represents the
precision with which the inversion recovery will be sampled. If a
high accuracy is required for the T1, only short imaging segments
with a few to a single k-space line can be adopted. This will ensure
that there is only little confounding factor arising from the longitu-
dinal regrowth occurring during each imaging segment. Con-
versely if a lower T1 recovery sampling is acceptable, then imaging
can be noticeably accelerated by k-space segmenting.
3.2.6 Inversion Pulses Adiabatic passage pulses can be advantageous to ensure saturation
(adiabatic half passage) or inversion (adiabatic full passage). These
pulses maintain their rotation properties invariant to the Bþ1 field,
provided that the pulse B1 exceeds an adiabaticity threshold. This is
of importance in the field of kidney imaging, where the presence of
intraabdominal fat can be challenging for B1 homogeneity. Hence
adiabatic RF pulses such as the hyperbolic secant RF pulse, are often
used in T1-mapping protocols, as half passage for saturation recov-
ery experiments [23, 31] or as full passage for inversion recovery
experiments [16, 30]. However, these RF pulses tend to require
long duration and RF power levels, which may not be compatible
with all RF coils, and unless provided by the manufacturer, their
frequency and phase modulation shapes may require careful design.
Generally non selective inversion RF pulses are used. Indeed,
slice selective inversion RF pulses are exposed to inflow artifacts.
Indeed, when a slice selective RF pulse is applied, the spins entering
the imaging slice via perfusion effects, have not been resonantly
exposed to the RF pulse. Hence their presence in the imaging slice
will contribute to increase on average the magnetization. This
effect will be higher if perfusion is elevated, and is in fact the basis
for FLAIR sequences. Whenever the true tissue T1 is the parameter
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of interest, perfusion becomes a confounding factor, and inflow
artifacts should be minimized. This can be achieved either by
selecting an inversion slice that is significantly larger than the
imaging slice to minimize the inflow artifact by creating a large
region adjacent to the imaging slice that the noninverted spins need
to cross before entering the imaged slice. Alternately, a nonselective
saturation pulse may be adopted. In this case, even the spins that
enter the imaging slice by perfusion during the imaging train are
inverted, and hence they will not modify the apparent tissue T1.
Some authors recommend offsetting the position of the kidney
within the radiofrequency coil to ensure that the heart is present
within the effective region of the coil, to ensure maximally inverted
spins throughout the entire body of the animal [16].




Variable flip angle (VFA) sequences vary the flip angle of the rf
excitation pulse but keep TR constant. Data can be acquired in 3D
volume, so such sequences are ideal when the entire kidney must be
sampled, for example in the case of heterogeneous or focal pathol-
ogy (Fig. 4). However, data acquisition takes longer than for 2D
sequences, and they are not robust in the presence of B1
+
inhomogeneity.
Variable flip angle sequences are usually based on spoiled gra-
dient echo sequences (fast low angle shot) [12, 32, 33], but the
same principles can be applied with UTE sequences [34]. By virtue
of their 3D nature, they are well suited for analyzing entire kidney
volumes. However, the acquisition scheme where a single angle is
acquired at a time also limits the number of different flip angle
acquisitions that can be achieved within reasonable scanning dura-
tions. A linearization of the VFA signal provides T1 estimates based
on as little as two flip angles, although this technique is prone to
noise bias. In a study at clinical field strength of 3.0 T using a wrist
coil, flip angles of 5 and 26 were proposed for a rat model of acute
kidney injury [12]. The use of VFA-based protocols for kidney
mapping is not yet widespread at higher magnetic field strengths,
but this type of sequence is applicable in other organs [34] or in
tumor models [32, 33]. VFA schemes are also prone to B1
+ field
heterogeneity. Indeed, the effectively achieved flip angle at a specific
location in the kidney is function of not only pulse amplitude, but
also the shape and electromagnetic properties of the animal, the
radiofrequency pulse design and (to a lesser extent when volume
RF coils are used for RF transmission) RF coil coverage homoge-
neity. Thus, the B1 field may require to be mapped first. For
instance a reference T1 map using a recovery-based sequence can
be obtained and then injected into the signal equation to extract
the effective flip angle [35]. Another acquisition strategy consists of
measuring the B1
+ field directly with dual angle spin echo sequence
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4.1.1 2D RARE VTR
in Bruker ParaVision 6
1. Use the ParaVision RARE T1 saturation-recovery METHOD
“T1map_RARE protocol” (Rat/Head/Relaxometry, or
Mouse/Head/Relaxometry).
2. Set the geometry to coronal, 58  58 mm FOV (rat) or
40  30 mm FOC (mouse). These may need adjustment in
studies on large (e.g., obese) animals.
Fig. 4 3D variable flip angle protocol. TR repetition time (maintained constant for the duration of the
acquisition), TE echo time, θ flip angle (flip angle is varied during the protocol), nPEY, nPEZ number of prescribed
phase encoding lines in the Y and Z dimensions, PE phase encoding, FE frequency encoding. While the TR is
maintained and constant during acquisition, the flip angle is varied several times until a complete dataset has
been fully acquired for each prescribed flip angle. Accessory gradient lobes are not shown for clarity. Often,
investigators need to suppress the signal from fat, in which case the hard pulse would be replaced by a
spectrally selective “soft” pulse to excite 1H2O but not C
1H2 or C
1H3. During the phase-encoding (PE) step,
spatial location is encoded by incrementing X and Y gradients iX and GY multiple times nPEX and nPEY, typically
64 or 128. During this period magnetization is prephased using the Z gradient GZ, so that a gradient echo may
be formed by inverting the polarity of the gradient, yielding a return to phase at TE at the mid-point of the
gradient echo. TE is set as short as possible, typically ~2–3 ms, in order to avoid T2* weighting, and to
minimize total acquisition time. Practically, this is limited by the specification and performance of the gradient
coils and amplifiers available to the investigator. TR is also set as short as possible, ~5 ms, in order to
minimize the overall acquisition time
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3. Set the matrix size to 128  128; if acquisition length is too
large, you may decrease the phase encoding resolution.
4. Use a single 90 1.16 mm slice selection (optionally, apply
spectrally selective fat suppression).
5. Select an180 train RARE factor 8, matching pulse bandwidths
of 90 and 180, effective TE 30 ms, echo spacing 7.5 ms.
6. Set five dummy scans; no signal averaging.
7. Set TR¼ 5500, 2000, 1200, 750, 500, 300, 200, and 100 ms.





1. Use the ParaVision Fluid-Attenuated Inversion Recovery
(FLAIR) method using only the global inversion mode (Fair-
Mode set to Nonselective), using Flow-sensitive Alternating
Inversion Recovery FAIR-RARE or FAIR-EPI Bruker
methods.
2. Set the geometry to axial or coronal, 58 58 mm FOV (rat) or
40  30 mm FOV (mouse). These may need adjustment on
large (e.g., obese) animals.
3. Use a single 1 mm slice selection.
4. Set the matrix size to 128  128 matrix; if acquisition is too
long, you may diminish the spatial resolution and adopt partial
Fourier acceleration.
5. Set an TE of 36 ms (FAIR-RARE) or longer (FAIR-EPI).
6. Set the inversion pulse properties to calculated, as this provides
a full passage adiabatic pulse with appropriately good flip angle
homogeneity.
7. Use 21 inversion times starting at 30 ms with increments of
200 ms (to be adapted to the particular study at hand).
8. Select a recovery time of 10 s or greater.
9. Adjust the number of averages based on the available scan time.
10. In case of EPI usage, a careful shimming of B0 is paramount.
The manufacturer-recommended method is MapShim using
an ellipsoidal shim volume, in which a B0 map is measured
(accessible in the adjustments platform) and used to correct
the B0 with the shims coils available on the system.
11. A manufacturer-provided macro is provided for data
processing.
1. Install rat in a wrist coil with conventional pressure pad to
monitor breath rate. Figure 1 illustrates a dedicated small
animal SA Instruments system connected to a Siemens clinical
MR system.





on a Siemens Clinical
Scanner
2. Load the MOLLI sequence provided by the MRI system. The
original MOLLI 3(3)3(3)5 scheme can be applied for kidney
imaging. In this sampling scheme, multiple images are acquired
at 11 time points on the recovery curve, with three inversions
with slightly shifted inversion times, enabling a pixel-based T1
quantification.
3. Start TI at 117ms with TI increments (ΔTI) between inversion
of 80 ms.
4. The slice thickness and in-plane resolution are particularly
important to avoid partial volume effects. Use a slice with the
lowest thickness and the highest in-plane resolution allowed by
the MR system typically resulting voxel size around
0.7  1.1  3.5 mm at 3 T.
5. Set TR/TE around 711/1.09 ms.
6. Set flip angle from 28 to 35 (default flip angle of 35) T1 map
relies on kidney being aligned between all TI images. As a
consequence it is important to provide an additional motion
correction method to mitigate residual respiratory motion. It is
recommended to perform at least a rigid registration algorithm
between images from various inversion times before the pixel-
wise analysis of the relaxation curve (cf. the chapter by Gartei-
ser P et al. “Analysis Protocols forMRIMapping of Renal T1”).
Some vendors proposed on line motion correction algorithm,




1. Construct or procure a set of filled nickel/agarose phantoms
without air bubbles. Each phantom should use a vial appropri-
ate for the size of the animal abdomen (e.g., 25 mm diame-
ter  40 mm high for a mouse or 50 mm diameter  80 mm
high for a rat). Use 2% agarose, and a different concentration of
nickel chloride in each phantom. Suitable nickel concentrations
are 0 mM, 0.5M, 1mM, 2mM, and 4mM: 8mM, and 16mM
can be added if very short T1 values are expected (e.g., in
DCEMRI). Add a preservative, such as 0.05% sodium azide,
and seal.
2. Measure T1 for each phantom using the method of Subheading
4.3 and the chapter by Garteiser P et al. “Analysis Protocols for
MRI Mapping of Renal T1.” Repeat the measurements on a
different day. Temperature should be controlled carefully, for
instance by isolating the T1 phantom in an ice–water mixture,
or by inserting the phantom in a larger structure with high
thermal inertia and preequilibrated at the target temperature.
3. In consultation with a professional statistician, calculate the
repeatability and ensure the sample size is adequate to test the
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hypothesis of interest. From an ethical perspective, this is man-
datory before living animals are entered into the procedures.
4. Repeat steps 2 and 3 in a group of living animals. The group
size should be determined in consultation with a professional





1. Use a volume RF coil of suitable diameter. In dedicated pre-
clinical MRI, volume RF coils with an inner diameter of 38 mm
for mice or 72 mm for rats could be used.
2. Anesthetize the animal with isoflurane as described in the
chapter by Kaucsar T et al. “Preparation and Monitoring of
Small Animals in Renal MRI” and transfer it to the scanner.
3. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit.
4. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.”
5. Perform localized shimming on the kidney imaging as
described in the chapter by Pohlmann A et al. “Essential Prac-
tical Steps for MRI of the Kidney in Experimental Research.”
Wherever possible, appropriate tuning and matching of the
used RF coil should be done.
6. Make sure the respiratory gating is setup properly, and that the
anesthesia is stable.
7. Ensure that B1
+ is correct, that is, that the relationship between
the RF power and the desired flip angle is known in the region
of space occupied by the kidneys. In ParaVision this is per-
formed as part of the initial sequence adjustments when the
reference pulse power is calibrated.
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Chapter 23
Experimental Protocol for MRI Mapping of the Blood
Oxygenation-Sensitive Parameters T2* and T2 in the Kidney
Andreas Pohlmann, Kaixuan Zhao, Sean B. Fain,
Pottumarthi V. Prasad, and Thoralf Niendorf
Abstract
Renal hypoxia is generally accepted as a key pathophysiologic event in acute kidney injury of various origins,
and has also been suggested to play a role in the development of chronic kidney disease. Here we describe a
step-by-step experimental protocol for indirect monitoring of renal blood oxygenation in rodents via the
deoxyhemoglobin sensitive MR parameters T2* and T2—a contrast mechanism known as the blood
oxygenation level dependent (BOLD) effect. Since an absolute quantification of renal oxygenation from
T2*/T2 remains challenging, the effects of controlled and standardized variations in the fraction of inspired
oxygen are used for bench marking. This MRI method may be useful for investigating renal blood
oxygenation of small rodents in vivo under various experimental (patho)physiological conditions.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers. This experimental
protocol chapter is complemented by two separate chapters describing the basic concept and data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, T2, T2*, BOLD
1 Introduction
Renal tissue oxygenation relies on a delicate balance between deliv-
ery of O2, as determined by renal blood flow and arterial O2
content, and consumption of O2, which is predominantly deter-
mined by energy-dependent tubular reabsorption. Even under
physiological conditions, tissue partial pressure of O2 is low in the
medulla. Hence renal tissue hypoxia may result from even a small
detrimental imbalance between O2 delivery and consumption.
Based largely upon studies on animal models, intrarenal hypoxia is
generally accepted as a key pathophysiologic event in acute kidney
injury of various origins, and has also been suggested to promote its
progression to chronic kidney disease CKD.
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The parametric mapping of the transverse relaxation times T2*
and T2 (or relaxation rates R2* ¼ 1/T2* and R2 ¼ 1/T2) has the
potential to allow inferences about renal oxygenation, because both
parameters are sensitive to blood oxygenation. The underlying
mechanism is the inherent difference in the magnetic properties
of oxygenated hemoglobin (diamagnetic) vs. deoxygenated hemo-
globin (paramagnetic). The presence of deoxyhemoglobin in a
voxel decreases both relaxation times, T2* and T2. Additional
factors that influence this relationship between renal venous
blood oxygenation and renal T2* include the blood volume frac-
tion, the hematocrit and the oxygen binding curve.
Here we describe quantitative mapping of the blood
oxygenation sensitive parameter T2* in the kidney of small rodents
in a step-by-step experimental protocol. The rationale for the cho-
sen acquisition parameters is given in generic terms, together with
specific parameter examples.
Mapping of renal T2 is described as an optional component of
the experiment. This may serve two purposes. Firstly, T2* includes
the dynamic (irreversible) dephasing effects described by T2 plus
the additional effects that are due to static (reversible) dephasing
effects described by T2
0. Hence, the additional measurement of T2
permits calculation of R2
0 ¼ R2* – R2 ¼ 1/T2* – 1/T2.
Secondly, blood oxygenation affects primarily T2* (often
referred to as blood oxygenation level dependent, BOLD) but
also T2 to a lesser extent. The T2 effect is via water diffusion within
the magnetic field gradient created by deoxyhemoglobin. This
contrast mechanism results in T2 being dominated by blood oxy-
genation effects in the microvasculature, which makes it a valuable
complement to conventional T2* measurements.
The effects of controlled and standardized variations in T2*
relaxation parameters in response to the fraction of inspired oxygen
(hypoxia, hyperoxia) are used for benchmarking. This MRI method
may be useful for investigating renal blood oxygenation of rodents
in vivo under various experimental (patho)physiological conditions.
This experimental protocol chapter is complemented by two
separate chapters describing the basic concept and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals These experimental protocols are tailored for rats (Wistar, Sprague-
Dawley, or Lewis) with a body mass of 250–350 g. Advice for
adaptation to mice is given in where necessary.
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2.2 Lab Equipment Anesthesia: For nonrecovery experiments urethane solution
(Sigma-Aldrich, Steinheim, Germany; 20% in distilled water) can
provide anesthesia for several hours with comparatively little side
effects on renal physiology, which is an important issue. For an
in-depth description and discussion of the anesthesia please refer to
the chapter by Kaucsar T et al. “Preparation and Monitoring of
Small Animals in Renal MRI.”
Gases: O2, N2, and compressed air, as well as a gas-mixing
system (FMI Föhr Medical Instruments GmbH, Seeheim-Ober
Beerbach, Germany) to achieve required changes in the oxygen
fraction of inspired gas mixture (FiO2). Besides air, the following
gas mixtures are required during the experiment: 10% O2–90% N2
for hypoxia and 100% O2 for hyperoxia.
Device for FiO2 monitoring in gas mixtures: for example Cap-
nomac AGM-103 (Datex GE, Chalfont St Gils, UK).
2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter was tailored for
a 9.4 T MR system (Biospec 94/20, Bruker Biospin, Ettlingen,
Germany) but advice for adaptation to other field strengths and
systems (e.g., 3 T Siemens Skyra or GE MR 750 human MR
scanner using a wrist coil for signal reception or transmit-receive
knee RF coil is given where necessary. No special or additional
hardware is required, except for the following:
1. A physiological monitoring system that can track the respira-
tion, and which is connected to the MR system such that it can
be used to trigger the image acquisition.
2.4 MRI Techniques Repeated measurements with a gradient-echo or spin-echo method
and variable echo times (TE) would provide the most accurate T2*
and T2 but require very long acquisition times. Here we describe
fast multiecho MRI methods: multi-gradient-echo (MGE) for T2*
measurement and multi–spin-echo (also called “MSME”) for T2
assessment. They provide relaxation times that underestimate T2*
and overestimate T2. With increasing echo number additional dif-
fusion weighting is added due to the repeated magnetic field gra-
dients (NB: this effect is much more pronounced in small animal
systems because of the much stronger magnetic field gradients used
compared to clinical systems). The superposition of stimulated
echoes in multi–spin-echo imaging may lead to an overestimation
of T2. Although these biases depend on the acquisition parameters,
they are fixed and reproducible for each protocol and hence accept-
able in studies of relative differences/changes in T2* and T2, where
precision is far more important than accuracy. If needed, more
accurate T2 values can be obtained from multiecho data using
sophisticated postprocessing [1].
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1. 2D multi-gradient-echo sequence for T2*-mapping. This is a
standard sequence that should be available on all MRI systems.
(Bruker “MGE,” Siemens “gre”; HE Healthcare 2D ME
SPGR or ME FGRE) (see Note 1).
2. 2D multi-spin-echo sequence for T2-mapping (optional; Bru-
ker “MSME,” Siemens “se_mc”; GE Healthcare “T2 Map”
within the 2D ME FGRE family of sequences).
3. 3D double gradient echo sequence for acquiring a quantitative
map of the static magnetic field B0 (optional; Bruker “Field-
Map”). The reconstruction performs a phase difference calcu-
lation, phase unwrapping, and a conversion to a frequency
map. A similar sequence exists with Siemens (“AdjGreSeq”),
however there is no reconstruction applied to the data. Choos-
ing Magnitude and Phase under Reconstruction will save both
Magnitude and Phase information, but no processing is per-
formed to correct for the B0 map. Similarly, for GE Healthcare
clinical MR systems “IDEAL-IQ” allows for return of fat,
water, R2*, in-phase and out-of-phase water/fat images, but








1. Load the 2D multi–gradient-echo sequence.
2. Set the shortest echo time (TE) and echo spacing (ΔTE) possi-
ble, under the condition that fat and water are in phase (see
Note 2). The last TE should be close to the largest expected
T2
(*) in the kidney multiplied by 1.5 (seeNote 3). The aim is to
acquire ten or more echo images. Fewer TEs or larger ΔTE are
not advisable because during strong hypoxia the SNR in the
kidney at high TEs can be so low that only a few data points
above the noise level are available for the analysis. Consider
increasing the acquisition bandwidth and using half Fourier
acceleration to shorten the first TE and ΔTE (see Note 4).
3. Choose the shortest possible repetition time (TR) for good
signal-to-noise per time (SNR/t) efficiency. TR will be limited
by the length of the echo train and the number of slices you
acquire.
4. Adapt the flip angle (FA) to the TR and T1 in order to achieve
the best possible SNR. Use the Ernst angle αE ¼ arccos (exp
(TR/T1)) as a good starting value. Then try a few smaller and
larger FAs and determine the optimal FA experimentally by
comparing the measured SNRs in a phantom with a T1 compa-
rable to that of the renal cortex (1–1.2 s at 3 T).
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5. Set a high acquisition bandwidth (BW) to shorten ΔTE, while
keeping an eye on the SNR, which decreases with the square
root of BW. SNR may be increased with signal averaging. (see
Note 5).
6. Enable fat saturation. On ultrahigh field systems this works well
to avoid fat signal overlaying the kidney due to chemical shift.
At lower clinical field strengths fat saturation is less efficient.
7. Enable the respiration trigger (per slice). This is essential to
reduce motion artefacts, reduce motion blurring and unwanted
intensity variations between the images acquired with
different TEs.
8. Choose as phase-encoding direction the L-R direction and
adapt the geometry so that the FOV in this direction includes
the entire animal (approx. 40 mm).
9. Use frequency encoding in head-feet (rostral-caudal) direction
to avoid severe aliasing. Adjust the FOV to your needs keeping
in mind that in the frequency encoding direction the FOV can
be smaller than the animal and a smaller FOV permits a smaller
acquisition matrix, and in turn a shorter echo-spacing.
10. Use the lowest slice thickness the SNR allows, typically around
1.5 mm. The thinner the slices the better, as this reduces the
unwanted T2*-effects of macroscopic field inhomogeneities
associated with the large voxel size in slice direction. For adap-
tation of the geometry to mice see Note 6.
11. Use highest in-plane resolution that the SNR allows, typically
between 100 and 200 μm. The higher the resolution the
better, as this reduces the unwanted T2*-effects of macroscopic
field inhomogeneities. Zero-filling in phase encoding direction
can be helpful to speed up acquisition when monitoring of fast
oxygenation changes is required. One may use half Fourier in
the frequency encoding direction (asymmetric echo) to further
shorten the first TE, if very short T2* (<5 ms) can occur.
Reducing the excitation pulse length to below 1 ms would
then also help to shorten TE. For adaptation to mice see
Note 7.




1. Load the 2D multi–spin-echo sequence.
2. Use the same FOV, matrix size and slice thickness as for the
multi–gradient-echo sequence.
3. Adapt the repetition time (TR) to the respiration: The effective
TR will be given by the respiration trigger and will be the
respiration interval, that is, one excitation per breath. Choose
TR to be a little shorter (about 100 ms) than the average
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respiration interval that is displayed on the physiological moni-
toring unit (see Note 11).
4. Set the number of echoes to 12 (see Note 12.).
5. Set the echo spacing (ΔTE) as small as possible (more echoes
are effectively more data points for the analysis and reduce the
error; consider that with increasing number of echoes also the
SAR increases) and that the last TE is close to the largest
expected T2 in the kidney multiplied by 1.5 (see Note 3).
6. Due to the artificial increase in signal intensity of fat with a
multi–spin-echo sequence, enable fat saturation. Note that the
spectral fat saturation does not usually suppress the fat signal
completely with some of residual fat signal overlaying the kid-
ney due to chemical shift (Fig. 2).
7. Enable the respiration trigger (per slice).




1. Load the field map sequence.
2. Store the field mapping scan protocol with the default para-
meters when using a small animal system (seeNote 16) or those
adapted for a clinical system (see Notes 17 and 18). Make sure
the 3D B0 field-map has isotropic resolution and a FOV that
includes the entire MR-visible part of the animal.




1. Anesthetize the animal and transfer it to scanner. For more
information on the choice and use of anesthesia please refer
to the chapter by Kaucsar T et al. “Preparation and Monitoring
of Small Animals in Renal MRI.”
2. Start the temperature monitoring system, apply some surgical
lubricant to the temperature probe and place it in the rectum of
the animal.
3. Attach the respiration sensor (e.g., balloon) to the chest of the
animal using adhesive tape. Start and setup the respiratory
monitoring system. If necessary, adjust the position of the
respiration sensor until the amplitude of the respiration trace
is sufficiently large for the system to reliably detect the trigger




1. Acquire a fast pilot scan to obtain images in the three orthogo-
nal planes x, y, and z.
2. Acquire anatomical images in several oblique orientations to
facilitate planning a coronal slice orientation with regard to the
long axis of the kidney, as described in the chapter by Pohl-
mann A et al. “Essential Practical Steps for MRI of the Kidney
in Experimental Research.”
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3. Perform localized shimming on the kidney as described in the
chapter by Pohlmann A et al. “Essential Practical Steps for MRI
of the Kidney in Experimental Research” (see Note 19).
4. Acquire a 3D B0 field-map without adaptation of the geometry
(optional; see Note 20).
3.2.3 Baseline Condition 1. Load the T2*-mapping sequence, adapt the slice orientation to
provide a coronal or axial view with respect to the kidney
(in scanner coordinates this is double-oblique).
2. In the monitoring unit set the trigger delay so that the trigger
starts at the beginning of the expiratory plateau (no chest or
diaphragm motion) and the duration such that it covers the
entire expiratory phase, that is, until just before inhalation
starts (1/2 to 2/3 of breath-to-breath interval) (see Note 11).
3. Run the T2*-mapping scan. Example images are shown in
Fig. 1.
4. Load the T2-mapping sequence, adapt the slice orientation to
provide a coronal or axial view with respect to the kidney
(in scanner coordinates this is double-oblique).
5. Adapt TR to be a little shorter (about 100 ms) than the average
respiration interval that is displayed on the physiological
monitoring unit.
6. In the monitoring unit set the trigger delay so that the trigger
starts at the beginning of the expiratory plateau (no chest or
diaphragm motion) and the duration to a short value, such as
10 ms (Note 11).
7. Run the T2-mapping scan. Example images are shown in Fig. 2.
Fig. 1 Series of 8 T2*-weighted images of a healthy rat kidney acquired with a multi–gradient-echo sequence
at 9.4 T. Images correspond to TE ¼ 1.43, 3.57, 5.71, 7.85 ms (top row), TE ¼ 9.99, 12.13, 14.27, 16.41 ms
(bottom row)
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A demonstration of the contrast changes that can be expected
in pathophysiological scenarios is given in Fig. 3. Example para-
metric maps of T2* and T2 are shown in Fig. 4.
Fig. 2 Series of 7 T2-weighted images of a healthy rat kidney acquired with a 2D multi-spin-echo sequence at
9.4 T. Images correspond to TE ¼ 10, 20, 30, 40 ms (top row) and TE ¼ 50, 60, 70 ms (bottom row)
Fig. 3 Demonstration of the contrast changes that can be expected in pathophysiological scenarios. T2*-
weighted images (from a 2D multi–gradient-echo acquisition, TE ¼ 3.57 ms) of rat kidneys throughout an
ischemia–reperfusion experiment, together with a plot of T2* in regions-of-interest in renal cortex and medulla




1. Duplicate the two scans (T2*-mapping and T2-mapping) and
disable all adjustments (e.g., receiver gain, shimming) so that
they are not changed from the previous scan.
2. Start hypoxia by changing the gas flowing through the respira-
tory mask to 10% O2/90% N2.
3. Three minutes after the start of hypoxia run the T2*-mapping
and T2-mapping scans. Hypoxia should not exceed 5 min in
order to avoid long lasting effects.
4. Immediately after the two scans end, change the gas flowing
through the respiratory mask back to air (21% O2).
5. Wait for a recovery time of at least 5 min.
6. Start hyperoxia by changing the gas flowing through the respi-
ratory mask to 100% O2.
7. Two minutes after the start of hyperoxia run the T2*-mapping
and T2-mapping scans.
Fig. 4 Example parametric maps of T2* (a) and T2 (b) acquired in a rat at 9.4 T. Shown are the entire map with
the kidney outlined (left) as well as an overlay of the map onto an anatomical MR image (right). While the
overlays are preferable because they focus on the relevant part and do not distract the eye, looking at the
entire map can sometimes help to identify extra-renal sources of susceptibility artefacts, like here the bowel
gas below the kidney and an implanted device near the hilus, which cast “shadows” onto the renal cortex.
Beware to exclude from the ROI analysis any regions with overlaid fat signal due to chemical shift, here seen
as a thin stripe at the rostral end of the kidney
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8. Immediately after the two scans end change the gas flowing
through the respiratory mask back to air (21% O2).
9. Wait for a recovery time of at least 5 min before conducting any
further interventions.
3.2.5 Noise Scan We highly recommend acquiring one scan with the T2*-mapping
protocol and T2-mapping protocol that only contains noise. This is
the best way to estimate the noise standard deviation, which is
needed for correcting the noise bias during the data analysis (see
Note 21). Alternatively it is possible to estimate the noise standard
deviation from an ROI in the “background” of the study images,
but it is often difficult to find a suitable region outside the subject
that is large enough and artefact free.
1. Create a copy of the T2*-mapping protocol.
2. Open the protocol and in the parameter setting set either the
flip angle to 0 degrees or the reference power for the flip angle
calibration to 0 W.
3. Run the T2*-mapping scan.
4. Repeat steps 1–3 for the T2-mapping protocol.
4 Notes
1. A 3D version of this sequence is also available, which allows for
thinner slices with better SNR, but tends to be too slow for
most in vivo applications.
2. The fat signal has a slightly different Lamor frequency
(Δf ¼ 220 Hz/Tesla) than the water signal. The faster preces-
sion of the fat protons means that with increasing time the fat
and water signal fractions within a voxel are sometimes in phase
(signals add up) and sometimes out of phase (signals subtract).
This can lead to an additional unwanted variation in the signal
along the exponential decay curve. This is mostly relevant for
diseased kidneys with increased fat content (e.g., diabetes), but
we recommend to generally take this into account, that is, also
for healthy kidneys. The TEs at which fat and water are in phase
depend on the field strength: TE [ms] ¼ n · (6.7069/B0[T]).
3. Larger TEs are needed to accurately calculate longer T2
(*)
under normal or hyperoxic conditions. We recommend using
the largest expected T2
(*) in the kidney multiplied by 1.5 as the
largest TE. Since the largest T2
(*) is typically in the inner
medulla—if this region is not relevant to your research then
use the largest T2
(*) in the cortex/outer medulla. With increas-
ing TE the signal intensity decreases and may reach the noise
floor at large TEs. This can introduce a noise bias during data
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analysis. To account for this we recommend performing a
retrospective noise correction (preferred) or exclude images
acquired at larger TEs from the analysis. Both approaches are
described in the chapter by Periquito JS et al. “Analysis Proto-
cols for MRI Mapping of the Blood Oxygenation–Sensitive
Parameters T2
* and T2 in the Kidney.”
4. Renal T2* may be quite short at ultrahigh field strengths and in
particular under hypoxia, which is what one wishes to detect.
One needs to consider the shortest renal T2* that could occur
during experiment; under extreme conditions this could be
only a few milliseconds, so several TEs around that value are
needed.
5. When establishing the MR technique you need to define an
SNR acceptance threshold for the image with the shortest
TE. The aim is to have at least three (better five or more)
number of echoes with an SNR> 5. This threshold will depend
on the expected T2
(*) values, which in turn depends on para-
meters like the magnetic field strength, shim quality, and tissue
properties (pathology). Example: for a rat imaged at 9.4 T
using a 4-element rat heart array receive surface coil together
with a volume resonator for excitation in combination with
interventions leading to strong hypoxia, an SNR > 60 was
needed.
6. For mice reduce the FOV to the body width and keep the
matrix size the same. The relative resolution is then identical
and the SNR should also be similar, because the smaller mouse
RF coil gives better SNR, for example, mouse heart four-
element surface coil vs rat heart four-element surface coil.
7. A good starting point is to use the same relative resolution as
for rats. For this, reduce the FOV to the mouse body width and
keep the matrix size the same.
8. Example parameters for T2* mapping of a 300 g rat at 9.4 T
(Bruker small animal system): TR ¼ 50 ms; flip angle ¼ 16;
pulse length 1.0 ms; pulse bandwidth 5.4 kHz; receiver band-
width¼ 109 kHz; number of echoes¼ 12; first echo¼ 2.14ms;
echo spacing 2.14 ms; TE ¼ 2.14, 4.28, 6.42, 8.56, 10.7,
12.84, 14.98, 17.12, 19.26, 21.40, 23.54, 25.68 ms;
averages ¼ 4; slice orientation ¼ coronal to kidney; frequency
encoding ¼ head-feet; FOV ¼ (38.2  48.5) mm; matrix
size ¼ 169  115 zero-filled to 169  215; resolu-
tion¼ (0.226 0.421) mm; 1–3 slices with 1.4 mm thickness;
fat suppression¼ on; respiration trigger¼ per slice; acquisition
time ¼ 40–60 s (with triggering under urethane anaesthesia).
9. Example parameters for T2* mapping of a 30 g mouse at 4.7 T
(Agilent small animal system): TR ¼ 350 ms; flip angle ¼ 30;
receiver bandwidth ¼ 100 kHz; number of echoes ¼ 32; first
Experimental Protocols for Mapping of Renal T2* and T2 413
echo ¼ 2.0 ms; echo spacing 2.4 ms; TE ¼ 2.00, 4.40, 6.80,
9.20, 11.60, 14.00, 16.40, 18.80, 21.20, 23.60, 26.00, . . .,
76.40 ms; averages ¼ 4; slice orientation ¼ coronal to kidney;
frequency encoding ¼ head-feet; FOV ¼ (30  30) mm;
matrix size ¼ 128  128; resolution ¼ (0.230  0.230) mm;
1 slice with 1.0 mm thickness; fat suppression¼ on; respiration
trigger ¼ on; acquisition time ¼ 3.5–9.0 min (with triggering
under isoflurane anaesthesia).
10. Example parameters for T2* mapping of a 300 g rat at 3.0 T
(Siemens Skyrafit, a clinical system): Animal position: Right
decubitus; Coil: Knee; TR ¼ 69 ms; flip angle ¼ 30; receiver
bandwidth ¼ 320 Hz/pixel; number of echoes ¼ 12; first
echo ¼ 3.56 ms; echo spacing 3.43 ms; TE ¼ 3.56, 6.99,
10.42, 13.85, 17.28, 20.71, 24.14, 27.57, 31.00, 34.43,
37.86, 41.29 ms; averages ¼ 20; slice orientation ¼ axial; fre-
quency encoding ¼ anterior-posterior; FOV ¼ (120  60)
mm; matrix size ¼ 256  128; resolution ¼ (0.470  0.470)
mm; 3 slices with 2.0 mm thickness; fat suppression ¼ on;
respiration trigger ¼ off; acquisition time ~ 3 min. If one
desires in-phase echoes, use first echo ¼ 4.92 and echo
spacing ¼ 4.92 ms. If no specific animal holder is used, it is
preferable to position the animals in left of right decubitus
position to keep the bowels away from the kidneys to mitigate
susceptibility artifacts.
11. You must monitor the respiration continuously throughout
the entire experiment and if necessary adapt the TR
accordingly.
12. Acquiring more echoes with smaller echo spacing will be bene-
ficial because it improves the fitting, but keep in mind the SAR
associated with sending many 180 RF pulses in a short time
could heat up the tissue. This will usually not be detectable via a
rectal temperature probe, but measurements with a tempera-
ture probe placed in the abdomen next to the kidney showed
that significant temperature increases are possible with a multi–
spin-echo sequence.
13. Example parameters for T2 mapping of a 300 g rat at 9.4 T
(Bruker small animal system): TR ¼ [respiration inter-
val]  100 ms; receiver bandwidth ¼ 50 kHz; number of
echoes ¼ 12; first echo ¼ 10.0 ms; echo spacing 10.0 ms;
TE ¼ 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120 ms;
averages ¼ 1; slice orientation ¼ coronal to kidney; frequency
encoding ¼ head-feet; FOV ¼ (38.2  48.5) mm; matrix
size ¼ 169  115 zero-filled to 169  215; resolu-
tion ¼ (0.226  0.421) mm; 1 slice with 1.4 mm thickness;
fat suppression¼ on; respiration trigger¼ per slice; acquisition
time ¼ 55–75 s (with triggering under urethane anaesthesia).
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14. Example parameters for T2 mapping of a 30 g mouse at 4.7 T
(Agilent small animal system): TR ¼ [respiration interval]
-100 ms; receiver bandwidth ¼ 50 kHz; number of ech-
oes ¼ 12; first echo ¼ 10.0 ms; echo spacing 10.0 ms;
TE ¼ 10, ..., 120 ms; averages ¼ 1; slice orientation ¼ coronal
to kidney; frequency encoding ¼ head-feet; FOV ¼ (30  30)
mm; matrix size ¼ 128  128; resolu-
tion ¼ (0.230  0.230) mm; 1 slice with 2.0 mm thickness;
fat suppression ¼ on; respiration trigger ¼ on; acquisition
time ¼ 2–4 min (with triggering under isoflurane anaesthesia).
15. Example parameters for T2 mapping of a 300 g rat at 3.0 T
(Siemens Skyrafit, a clinical system): Animal position: Right
decubitus; Coil: Knee; TR ¼ [respiration interval]  500 ms;
receiver bandwidth ¼ 399 Hz/pixel; number of echoes ¼ 12;
first echo ¼ 10.0 ms; echo spacing 10.0 ms; TE ¼ 10, ...,
120 ms; averages ¼ 2; slice orientation ¼ axial; frequency
encoding ¼ left-right; FOV ¼ (120  60) mm; matrix
size ¼ 256  128; resolution ¼ (0.470  0.470) mm; 1 slice
with 2.0 mm thickness; fat suppression ¼ on; respiration trig-
ger ¼ off; acquisition time ~2 min. If no specific animal holder
is used, it is preferable to position the animals in left of right
decubitus position to keep the bowels away from the kidneys to
mitigate susceptibility artifacts.
16. Example parameters for field mapping of a 300 g rat at 9.4 T
(Bruker small animal system): use the vendors default protocol
AnyObject > AnyRegion > Adjustments > ADJ_B0MAP.
TR ¼ 20 ms; flip angle ¼ 30; first echo ¼ 1.60 ms; echo
spacing ¼ 3.57 ms; fat/water in-phase ¼ on; slice orienta-
tion ¼ main orientations (no angles) and offset ¼ 0;
FOV ¼ (58  58  58) mm; matrix size ¼ 64  64  64;
resolution ¼ (0.906  0.906  0.906) mm; respiration trig-
ger ¼ off; acquisition time ¼ 1–2 min.
17. Example parameters for field mapping of a 300 g rat at 3.0 T
(Siemens Skyrafit, a clinical system): The default setup uses the
BODY Coil. TR ¼ 20 ms; flip angle ¼ 15; in-phase echo
times, first echo ¼ 4.78 ms, and second echo ¼ 7.17 ms; slice
orientation ¼ main orientations (no angles) and offset ¼ 0;
FOV ¼ (350  350) mm; matrix size ¼ 96  96; resolu-
tion ¼ (3.6  3.6  8.0) mm; GRAPPA factor ¼ 2; respiration
trigger ¼ off; acquisition time ¼ 17 s.
18. Example parameters for field mapping of a 300 g rat at 4.7 T
(Agilent small animal system): TR ¼ 34 ms; flip angle ¼ 30;
number of echoes ¼ 8; first echo ¼ 4.23 ms; echo spacing
0.4 ms; averages ¼ 8; slice orientation ¼ coronal to kidney;
frequency encoding ¼ head-feet; FOV ¼ (30  30) mm;
matrix size ¼ 128  128; resolution ¼ (0.230  0.230) mm;
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1 slice with 2.0 mm thickness; fat suppression¼ on; respiration
trigger¼ on; acquisition time¼ 7.0–11.0 min (with triggering
under isoflurane anaesthesia).
19. Shimming is particularly important, since macroscopic mag-
netic field inhomogeneities shorten T2*, but provide no tissue
specific information—rather they overshadow the microscopic
T2* effects of interest and hinder quantitative intra- and inter-
subject comparisons. Shimming should be performed on a
voxel enclosing only the kidney using either the default itera-
tive shimming method or the Mapshim technique
(recommended).
20. This serves to keep a record of the B0 influence on the
measured T2*. It allows explanation of unusually small T2*
due to a bad shim. It may also be used later during the prost-
processing for calculating a corrected T2* by removing the
influence B0 inhomogeneities.
21. During the data analysis care must be taken to avoid noise
biasing the mapping of T2* and T2. With increasing echo
time the signal intensity in the images approaches more and
more the noise floor, where the signal is so small that it is not
detectable anymore. However, even though only noise is
detected the signal is still above 0, because of the Ricean nature
of the noise (negative values are “flipped” to the positive side).
This means that the shape of the exponential curve will not fit
well, as it expects the signal to decay toward 0. Adding an offset
parameter to the fitted curve does not solve the problem
because an offset will affect the signal intensities of all echoes,
but the noise bias only affects those echoes where the true
signal is very small. Instead a noise bias correction should be
performed, which is described in the chapter by Periquito JS
et al. “Analysis Protocols for MRI Mapping of the Blood
Oxygenation–Sensitive Parameters T2* and T2 in the Kidney.”
Please note that you may not need to perform such a noise
correction if all echo images are well above the noise floor.
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Chapter 24
Renal MRI Diffusion: Experimental Protocol
João S. Periquito, Martin Meier, Thoralf Niendorf, Andreas Pohlmann,
and Neil Peter Jerome
Abstract
Renal diffusion-weighted imaging (DWI) can be used to obtain information on the microstructure of
kidney tissue, and has the potential to provide MR-biomarkers for functional renal imaging. Here we
describe in a step-by-step experimental protocol the MRI method for measuring renal diffusion coefficients
in rodents using ADC or IVIMmodels. Both methods provide quantification of renal diffusion coefficients;
however, IVIM, a more complex model, allows for the calculation of the pseudodiffusion and fraction
introduced by tissue vascular and tubular components. DWI provides information of renal microstructure
contributing to the understanding of the physiology and the underlying processes that precede the
beginning of pathologies.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter is complemented by two separate chapters describing the basic concept and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Diffusion, ADC, IVIM
1 Introduction
Diffusion weighting imaging (DWI) is an MR imaging technique
sensitive to the motion of water molecules within a voxel of tissue.
The random movement, also known as Brownian motion, of fluid
molecules makes them spread out until a boundary stops them. In
general, extracellular water molecules will have a larger net dis-
placement over time than intracellular molecules. Intracellular
molecules have more chances to collide with cell walls, organelles,
and macromolecules. Diseases and pathologies that influence tissue
properties and structure may either increase or decrease the diffu-
sion behavior of water in tissues, which can be quantified using
DWI [1, 2].
In DWI, the image contrast is based on the displacement of
water molecules. Voxels where molecules present a larger
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displacement during the diffusion-sensitization preparation will
appear darker on the resulting image.
Sensitization to diffusion can be achieved by using an extra pair
of magnetic field gradients during the pulse sequence, generating
images with diffusion-weighting determined by the magnitude,
duration, and separation of the gradients, which can be quantified
by the acquisition parameter b-value [3].
The DWI signal decay across a series of images with different
diffusion-weightings can then be analyzed, using more or less
complex mathematical models, to quantify the diffusion para-
meters. Ideally, the acquisition should be designed considering
the signal model one wishes to use. The simplest model considers
only the apparent diffusion coefficient (ADC), an empirical param-
eter reflecting the overall water molecule motion in the tissue
averaged over one or more directions using a small number of b-
values. ADC can be estimated by fitting a monoexponential curve
to the DWI signal as a function of b-value, and fitting signal curves
on a pixel-by-pixel basis allows construction of diffusion parameter
maps [4].
Perfusion in tissue introduces a pseudodiffusion component to
the DWI signal, which cannot be quantified using the ADC model
(but it will influence the calculated ADC if low b-values are
included). A more complex model is needed to take separate out
this effect. Intravoxel incoherent motion (IVIM) intends to model
flow processes, which manifest as pseudodiffusion with a larger
coefficient, by assuming the DWI signal as a function of the b-
value is not monoexponential but biexponential. This method
requires the acquisition of several b-values before the pseudodiffu-
sion decays away, especially between b-values of 0 and 200 s/
mm2 [5].
This experimental protocol chapter is complemented by two
separate chapters describing the basic concept and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals This experimental protocol is tailored for mice (variants of C57BL/
6) with a body mass of 15–35 g. Advice for adaptation to rats is
given as Notes where necessary.
2.2 Lab Equipment
and Chemicals
1. Anesthesia: typically, 0.5–1.5% isoflurane is used for anesthesia
administered to the mice using an anesthetic gas vaporizer
(Leica Biosystems, Maryland, USA). For nonrecovery experi-
ments, urethane solution (Sigma-Aldrich, Steinheim,
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Germany; 20% in distilled water) can provide anesthesia for
several hours with comparatively fewer side effects on renal
physiology, which is an important issue. For nonrecovery
experiments urethane solution (Sigma-Aldrich, Steinheim,
Germany; 20% in distilled water) can provide anesthesia for
several hours with comparatively fewer side effects on renal
physiology, which is an important issue. For an in-depth
description and discussion of the anesthesia please refer to the
chapter by Kaucsar T et al. “Preparation and Monitoring of
Small Animals in Renal MRI.”
2. Gases: O2, N2, and compressed air, as well as a gas-mixing
system (FMI Föhr Medical Instruments GmbH, Seeheim-
Ober Beerbach, Germany) or general inhalation anesthesia
equipment, including an anesthetic vaporizer, a flow meter,
and an induction chamber.
2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter has been tailored
for MR preclinical systems at magnetic fields higher than 3 T but
advice for adaptation to other field strengths is given where neces-
sary. No special or additional hardware is required, except for the
following:
A physiological monitoring system that can track the respira-
tion and which is connected to the MR system such that it can be
used to trigger the MRI scanner with respiration. Typically, we use
the MR-compatible rodent monitoring and gating system (Small
Animal Instruments, New York, USA) equipped with an air-pillow
to monitor breathing rate.
2.4 MRI Techniques The diffusion MRI pulse sequence includes a diffusion preparation
responsible for the diffusion sensitization. Specifically, sensitisation
to diffusion and/or other motion of water molecules is achieved by
inclusion of an extra pair of magnetic field gradients during the
acquisition, generating images with varying degrees of diffusion-
weighting. The degree of diffusion weighting depends on the area
of each of the diffusion gradients (amplitude G and duration δ) as
well as the time spacing between the pair (Δ); the resulting weight-
ing is commonly specified by the compound parameter b-value
(Fig. 1). The diffusion module is followed by fast image readout
such as echo planar imaging (EPI). Other readouts are available for
DWI (seeNote 1), but DW-EPI is the standard since it provides the
higher SNR in acceptable acquisition times, and so will be used in
this chapter.




All the mentioned MR parameters are adjustable; the provided
suggestions are based on experience, but the end protocol is likely
to be adjusted from these values. For more details on what goes
toward making these decisions please refer to the chapter by Jerome
NP et al. “Renal Diffusion-Weighted Imaging (DWI) for Apparent
Diffusion Coefficient (ADC), Intravoxel Incoherent Motion
(IVIM), and Diffusion Tensor Imaging (DTI): Basic Concepts”of
this book.
3.1.1 DW-EPI for ADC 1. Load the DW-EPI sequence.
2. Sequence type: 2D Echo Planar Imaging sequence with diffu-
sion preparation module that has a defined Δ and δ and a
G which can be incremented within a single scan. This is a
standard sequence on Bruker MRI systems, called “DW-EPI.”
3. The diffusion parameters are then adjusted to allow detection
of incoherent movement of molecules. The range of displace-
ments measured with DWI is typically in the order of 1–20 μm,
allowing for quantitative measurements that reflect micromor-
phological and physiological changes in tissues. As a recom-
mendation a δ ¼ 3.5 ms and a Δ ¼ 8.5 ms should be used (see
Note 2).
4. Set up your b-values to the following values: 0, 200, 600 s/
mm2 over three orthogonal directions x: (1,0,0), y: (0,1,0) and
z: (0,0,1).
Fig. 1 Diffusion preparation (“Diffusion gradients”). The degree of diffusion weighting (measured by the “b-
value” [mm/s2]) depends on the area of the extra pair of gradients (amplitude G and duration δ) as well as the
time spacing between them (Δ): b ¼ γ2G 2δ2 Δ δ3
 
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5. Repetition time (TR): choose ~500 ms for good signal stability
and signal-to-noise per time (SNR/t) efficiency. TR will be
limited by the length of the excitation pulse, length of echo
train and the number of slices you acquire.
6. Echo time (TE): use the shortest TE. Acquisition bandwidth
should be considered to shorten the inter-echo-time.
7. Segments: as low as possible to reduce scan time, however
1 segment (single-shot) might create unacceptable distortions
on phase encoding. A high number of segments will increase
scan time and makes the acquisition more prone to motion
artifacts. As a recommendation two segments should be used
(multishot DW-EPI) with a matrix size of 172  172 with an
FOV of 30  30 mm.
8. Acquisition bandwidth (BW): ~ 350.000 Hz, one wants to
acquire as many lines of k-space as possible to minimize motion
distortions of the images. For that reason, it is advantageous to
have a low inter-echo-time. Larger inter-echo-times are not
advisable because the SNR in the kidney will be so low that
these images must be excluded.
9. Enable fat saturation. On ultrahigh field systems this works well
to avoid fat signal overlaying the kidney due to chemical shift.
At lower field strengths it might work less efficient.
10. Enable the respiration trigger (per slice). This is essential to
reduce motion artefacts, reduce motion blurring and
unwanted intensities variations among the images acquired
with different b-values (see Note 3).
11. Choose as phase-encoding direction the L-R direction and
adapt the geometry so that the FOV in this direction includes
the entire animal.
12. Use frequency encoding in head-feet (rostral-caudal) direction
to avoid severe aliasing. Adjust the FOV to your needs keeping
in mind that in this direction the FOV can be smaller than the
animal and a smaller FOV permits a smaller acquisition matrix,
and in turn a shorter echo-spacing.
13. Increase the number of averages to improve signal-to-noise
ratio by a factor of √averages, especially important for higher
b-values (use nine averages as a recommendation).
14. To reach a steady-state magnetization is advisable to use
dummy scans, two as a recommendation.
15. For an example of a specific parameter set please see Notes 4
and 5.
16. For adaptation of the geometry to rats (see Note 6).
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3.1.2 DW-EPI for IVIM 1. Load the DW-EPI sequence.
2. Use the same parameters as DWI-EPI for ADC (TE, TR,
matrix size, dummy scans, averages, bandwidth, segments).
3. Keep the same diffusion parameters as for the ADC but
increase the number of b-values from 3 to at least 7 (e.g.,
0, 50, 100, 200, 400, 600, and 740 s/mm2) to probe fast
diffusion from blood perfusion.
3.2 In Vivo DWI
3.2.1 Animal Preparation
1. Anesthetize the animal and transfer it to scanner. For an
in-depth description and discussion of the anesthesia please
refer to the chapter by Kaucsar T et al. “Preparation and
Monitoring of Small Animals in Renal MRI.”
2. Start the temperature monitoring system, apply some surgical
lubricant to the temperature probe and place it in the rectum of
the animal.
3. Attach the respiration sensor (e.g., balloon) to the chest of the
animal using adhesive tape. Start and set up the respiratory
monitoring system. If necessary, adjust the position of the
respiration sensor until the amplitude of the respiration trace
is sufficiently large for the system to reliably detect the trigger




1. Acquire a fast pilot scan to obtain images in three orthogonal
planes x, y, and z.
2. Acquire anatomical images in several oblique orientations to
facilitate planning a coronal slice orientation with regard to the
long axis of the kidney, as described in the chapter by Pohl-
mann A et al. “Essential Practical Steps for MRI of the Kidney
in Experimental Research” (open-access).
3. Perform localized shimming on the kidney as described in the
chapter by Pohlmann A et al. “Essential Practical Steps for MRI
of the Kidney in Experimental Research” (open-access). NB:
shimming is crucial for DW-EPI (see Note 7), because a poor
shim can lead to large distortions and add errors in the
measured diffusion coefficients.
4. Acquire a 3D B0 field-map without adaptation of the geometry
(optional; see Notes 8 and 9).
3.2.3 Baseline Condition 1. Load the 2D multishot EPI sequence, adapt the slice orienta-
tion to provide a coronal or axial view with respect to the
kidney (in scanner coordinates this is double-oblique).
2. In the monitoring unit set the trigger delay so that the trigger
starts at the beginning of the expiratory plateau (no chest or
diaphragm motion) and the duration such that it covers the
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entire expiratory phase, that is, until just before inhalation
starts (1/2–2/3 of breath-to-breath interval) (see Note 3).
3. In the monitoring unit set the trigger delay so that the trigger
starts at the beginning of the expiratory plateau (no chest or
diaphragm motion) and the duration to a short value, such as
10 ms (see Note 3).
4. Run the EPI scan. Example images are shown in Fig. 2.
4 Notes
1. Other readouts apart from EPI can be use in DWI such as rapid
acquisitionwith relaxation enhancement (RARE) (Fig. 3)which
is less prone to suffering from geometric distortion specially at
ultrahigh magnetic fields [6].
2. Gradients systems might differ from MR scanner to MR scan-
ner even for the same magnetic field. If the gradient system
cannot reach b-value of 600, consider to adjust δ ¼ 3.5 ms and
Fig. 2 Series of six diffusion-weighted images of a healthy mouse kidney acquired with DW-EPI sequence at
7.0 T. Images correspond to b-values: 0, 50, 100, 200, 400, and 600 mm/s2. EPI readouts are prone to
magnetic susceptibility artifacts, low-phase encoding bandwidth leads to ΔB0 induced frequency dispersions
which causes image distortion. When using a segmented EPI readout a phase deviation occurs between the
different segments in k-space leading to ghosting artefacts visible in the above images [7]
Renal MRI-Diffusion: Exp. Protocol 425
a Δ ¼ 8.5 to higher values. Record and report all diffusion
parameters used.
3. Youmust monitor the respiration continuously throughout the
entire experiment.
4. Example for ADC of a 30 g mouse at 7 T (Bruker small animal
system): TR ¼ 500 ms; 3 b-values: 0, 200, 600 s/mm2, diffu-
sion directions: 3 (orthogonal), effective TE ¼ 56.87 ms; Seg-
ments ¼ 2; averages ¼ 9; slice thickness ¼ 1.2 mm; slice
orientation ¼ axial; frequency encoding ¼ head-feet;
FOV ¼ 30  30 mm; matrix size ¼ 172  172; Band-
width ¼ 350.000 Hz; fat suppression ¼ on; scan time  80 s.
5. Example for ADC of a 270 g rat at 9.4 T (Bruker small animal
system): TR ¼ 500 ms; 3 b-values: 0, 200, 600 s/mm2, diffu-
sion directions: 3 (orthogonal), effective TE ¼ 56.87 ms; Seg-
ments ¼ 2; averages ¼ 9; slice thickness ¼ 1.2 mm; slice
orientation ¼ axial; frequency encoding ¼ head-feet;
FOV ¼ 45  45 mm; matrix size ¼ 172  172; Band-
width ¼ 350.000 Hz; fat suppression ¼ on;, scan time  80 s.
Fig. 3 Series of five diffusion-weighted images of a healthy mouse kidney acquired with single-shot DW-RARE
sequence at 9.4 T. Images correspond to b-values: 0, 200, 300, 400, and 600 mm/s2. A RARE readout can be
used to minimize the magnetic susceptibility artifacts which cause geometric distortions on DW-EPI.
DW-RARE is not commercially available, pulse programming skills are needed to implement it [6]
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6. For rats increase the FOV to the body width and keep the
matrix size the same or similar. The relative resolution is then
identical and the SNR should also be similar, because the larger
rat RF coil provides worse SNR (e.g., eight-channel rat body
phase array receive coil vs eight-channel mouse body phase
array receive coil).
7. Shimming is particularly important, since macroscopic mag-
netic field inhomogeneities affect EPI readout andmight create
severe geometric distortions. Shimming should be performed
on a voxel enclosing the kidney using either the default iterative
shimmingmethod or theMapshim technique (recommended).
8. Example parameters for field mapping of a 30 g mice at 9.4 T
(Bruker small animal system): use the vendors default protocol
AnyObject > AnyRegion > Adjustments > ADJ_B0MAP.
TR ¼ 20 ms; flip angle ¼ 30; first echo ¼ 1.60 ms; echo
spacing ¼ 3.57 ms; fat/water in-phase ¼ on; slice orienta-
tion ¼ main orientations (no angles) and offset ¼ 0;
FOC ¼ (58  58  58) mm; matrix size ¼64  64  64;
resolution ¼ (0.904  0.904  0.904) mm; respiration trig-
ger ¼ off; acquisition time ¼ 1–2 min.
9. This serves to keep a record of the B0 influence on the
measured DW-EPI images. It allows explanation of unusually
distortions due to an imperfect shim.
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Chapter 25
Dynamic Contrast Enhanced (DCE) MRI-Derived Renal
Perfusion and Filtration: Experimental Protocol
Pietro Irrera, Lorena Consolino, Walter Dastrù, Michael Pedersen,
Frank G. Zöllner, and Dario Livio Longo
Abstract
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can provide a noninvasive way for
assessing renal functional information following the administration of a small molecular weight
gadolinium-based contrast agent. This method may be useful for investigating renal perfusion and glomer-
ular filtration rates of rodents in vivo under various experimental (patho)physiological conditions. Here we
describe a step-by-step protocol for DCE-MRI studies in small animals providing practical notes on
acquisition parameters, sequences, T1 mapping approaches and procedures.
This chapters is based upon work from the COSTAction PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter is complemented by two separate chapters describing the basic concept and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Dynamic contrast-enhanced
(DCE), Contrast agent, T1 map
1 Introduction
Kidneys play an important role in fluid regulation, waste pro-
ducts elimination, and homeostasis of salts and pH. Therefore,
accurate measurement of kidney function is essential for monitor-
ing early renal injuries, disease progression, renal transplantation
and in assessing therapeutic efficacy after renal failure [1, 2]. Mag-
netic resonance imaging (MRI) has emerged as a powerful tech-
nique that combines anatomical details with functional
information. In recent years, various MRI techniques have been
investigated for assessing renal function, including dynamic
contrast-enhanced (DCE) MRI, arterial spin labelling (ASL),
blood oxygenation level dependent (BOLD), diffusion weighted
imaging (DWI), sodium imaging, chemical exchange saturation
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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transfer (CEST), and hyperpolarized MRI [3–9]. These techniques
have shown promising results for the noninvasive evaluation of
several renal function, including filtration, perfusion, oxygenation,
pH, homeostasis, and others [10–27]. Among them, DCE-MRI or
MR renography has emerged as a reliable method to reveal renal
pathophysiology, functional and hemodynamic parameters.
DCE-MRI relies on bolus administration of a gadolinium-based
contrast agent (CA) [16], which changes the intrinsic longitudinal
(T1) and transversal (T2) relaxation rates of protons in tissue. This
means that administration of CA leads to an increased signal inten-
sity on T1-weighted images or decreased signal intensity on
T2-weighted images. DCE-MRI usually refers to T1-weighted
MR imaging techniques combined with a gadolinium-based CA
using an acquisition scheme with a high temporal resolution. In the
kidney the acquired signal over time leads to an MRI renogram,
where the absolute signal intensity, in complex manner, depends on
the native T1 value, MRI sequence parameters, the specific mag-
netic relaxivity constant of the CA (the contrast agent efficiency,
dependent also on its chemical structure [28–34]) and the concen-
tration of the CA residing in the tissue [35, 36].
The main purpose of DCE-MRI is to reveal information about
extravascular permeability, blood perfusion and compartmental
kinetics. In practice, this method provides images prior and follow-
ing the administration of the CA using a continuous image acquisi-
tion protocol. In kidneys, DCE-MRI is suitable for assessing kidney
function in terms of filtration and perfusion [17]. Different post-
processing methods allow estimations of kidney function and per-
fusion, either from simple semiquantitative approaches to more
elaborated model-based analyses [37–42].
Here we describe step-by-step an experimental dynamic con-
trast enhanced (DCE) MRI protocol for monitoring the passage of
a Gd-based tracer in the kidneys of rodents. The rationale for the
choosing acquisition parameters is given in generic terms, together
with specific parameter examples.
This experimental protocol chapter is complemented by two
separate chapters describing the basic concepts and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals This experimental protocol was tailored for immune-competent
(typically C57BL/6 and Balb/C) or immune-compromised
(nude, NOD-SCID) mice with a body mass of 15–35 g. Advice
for adaptation to rats is given as Notes where necessary. All animal
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studies have to be carried out in compliance with specific legislation
covering the use of animals for scientific purposes. Therefore, all
experiments must be authorized under national regulations.
2.2 Lab Equipment
and Chemicals
1. Mouse tail illuminator/restrainer for catheterizing the tail vein.
2. Saline solution or heparin solution, 1-ml syringe, catheter (e.g.,
PE 20 polyethylene tubing) of known inner diameter to hold
the saline flush and for contrast agent bolus is required.
3. Anesthesia: please refer to the chapter by Kaucsar T et al.
“Preparation and Monitoring of Small Animals in Renal
MRI” for an in-depth description and discussion of the anes-
thesia. Typically, 0.5–1.5% isoflurane is used for anesthesia
administered to the mice using an anesthetic gas vaporizer
(Leica Biosystems, Maryland, USA). For nonrecovery experi-
ments, urethane solution (Sigma–Aldrich, Steinheim, Ger-
many; 20% in distilled water) can provide anesthesia for
several hours with comparatively fewer side effects on renal
physiology, which is an important issue. For intramuscular
anesthesia, please refer to Note 1.
4. Gases: O2, N2, and compressed air, as well as a gas-mixing
system or general inhalation anesthesia equipment, including
an anesthetic vaporizer, a flow meter, and an induction
chamber.
5. Mouse cradle.
6. Gd-based contrast agents: typically, small molecular weight
FDA-approved gadolinium-based contrast agents are
employed, such as gadoteridol (Prohance®, Bracco Imaging
SpA, Milano, Italy), gadobutrol (Gadovist®, Bayer Healthcare
Pharmaceuticals, Germany), or gadoteric acid (Dotarem®,
Guerbert, France). Such clinically available contrast agents
have stock concentrations of 0.5–1.0 mol/l that need to be
diluted for handling volumes with less error (see Note 2).
7. Small animal ventilator: animals (rats) needs to be ventilated so
the DCE-MRI acquisition can be gated to minimize the respi-
ratory motion artifacts.
8. Syringe infusion pump: an MRI-compatible single syringe
pump (Harvard Bioscience, Holliston, USA) for contrast
agent administration for allowing precise timing infusion.
2.3 MRI Hardware The general hardware requirements for renal 1HMRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter was tailored for
MRI preclinical systems at a magnetic field strength of 7 T but
advice for adaptation to other magnetic field strengths is given
where necessary (see Note 3). No special or additional hardware is
required, except for the following:
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1. A physiological monitoring system that can track the respira-
tion and which is connected to the MRI system such that it can
be used to synchronize DCE-MRI with respiration. Typically,
we use an MRI-compatible rodent monitoring and gating
system equipped with an air-pillow to monitor breath rate
(Small Animal Instruments, New York, USA).
2.4 MRI Techniques DCE-MRI experiments are performed by dynamic acquisitions of a
strongly T1-weighted imaging technique. The acquired signal fol-
lowing the CA administration is converted to relative concentra-
tions of the gadolinium agent using either phantom calibration
scales or by mathematical calculation of the sequence equation
that describes the relationship between signal and MRI sequence
parameters. The MRI sequence parameters, required volume cov-
erage, spatial resolution, and SNR will determine the final temporal
resolution. Several T1 mapping approaches can be exploited for
measuring the longitudinal relation times, a detailed description
of different methods is provided in the chapter by Garteiser P et al.







1. Use a 2D RARE (rapid acquisition with refocused echoes)
sequence with variable repetition times (RAREVTR on a Bru-
ker MR system).
2. Set the acceleration factor (RARE-factor or echo train length,
ETL) to at least 4 in order to shorten the acquisition time; an
acceleration factor of 8–16 can be used to further shorten the
acquisition time by sampling more k-space lines within a single
repetition period (TR). Centric encoding can be exploited to
minimize T2 effects with increasing doses, but at the expenses
or “blurred” images.
3. Set the echo time (TE) as short as possible for pure T1-weight;
in our setup an effective TE of 25 ms (defined by the acquisi-
tion of the central k-space line) was used.
4. Choose enough averages in order to have a sufficient signal to
noise ratio (SNR) of above 30.
5. Repeat the RARE acquisition a number of times by changing
the value of the repetition time (TR) to sample changes in
signal intensities according to the expected T1 values of the
kidneys.
6. Because of the variability of the T1 values inside the kidney
regions, choose the TRs values to span a range large enough to
permit an accurate calculation of T1 by selecting 3–7 TR values
in the range 100–10,000 ms (see Note 4).
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7. For in vivo experiments, keep the overall acquisition time as
short as possible by considering a trade-off between number of
TRs, averages and matrix size (or spatial resolution).
8. For an example of a specific parameter set please see Note 5.
3.1.2 Variable Flip Angle
(VFA) Acquisition for T1
Mapping
1. Use a 2D gradient-echo sequence (FLASH on a Bruker
system).
2. Set the echo time (TE) as short as possible for heavily T1
weighting; in our setup a TE of 1.5 ms was used.
3. In order to have a sufficient signal to noise ratio, at least two
averages have been acquired or enough averages for SNR> 30.
4. Repeat the FLASH acquisition a number of times by changing
the value of the flip angle (FA). The changes in signal intensities
will follow a parabolic curve, thus low flip angles and higher flip
angles are needed to sample both side of this curve. Acquire a
minimum of 2–3 flip angles, considering that experiments with
more flip angles will improve the goodness of the T1 estimate.
5. Set the TR in the range 10–100 ms for providing good T1
weighting. Shorter TR increases T1 weighting, but with detri-
mental SNR values; thus, a trade-off must be chosen, even
considering number of averages and overall acquisition time.
6. For an example of a specific parameter set please see Note 6.




1. Use a T1-weighted sequence as a fast low angle shot (FLASH)
sequence (in Bruker systems, this sequence refers to a dubbed
FLASH sequence).
2. Use short TR to increase T1-weighting, but this will decrease
SNR. Therefore, a good balance should be found between
strongly T1-weighted images and image quality with sufficient
SNR. Besides, TE and FA affect T1-weighting and SNR. A
good TR range could be between 5 and 100 ms (usually
shorter values for 3D imaging and longer for 2D multislice
acquisition).
3. Use the shortest echo time (TE) possible for pure T1 weight.
4. Flip Angle (FA): high FA corresponds to a strong T1 weight-
ing, but at expenses of reduced SNR, therefore a good balance
may result in FAs in the range 10–60.
5. Use Partial Fourier acceleration to reduce the size of the
acquired matrix and improve the time efficiency of data
acquisition.
6. Use a high acquisition bandwidth (BW) to shorten TE, while
keeping an eye on the SNR, which decreases with the square
root of the increasing BW. For the image with the shortest TE
an SNR of at least 30 is recommended.
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7. Employ Fat Saturation modules. It is important to avoid fat
signal overlaying with the kidney due to chemical shift.
8. Respiration trigger: there is no need to use respiratory trigger-
ing (per slice).
9. Adapt the geometry (or slice position) so that animal fits into
FOV in Left-Right direction (approximately 30–40 mm
according to the inner coil diameter) and use frequency encod-
ing in Head-Feet direction. Use a slice with the lowest thick-
ness the SNR allows, typically around 1–2mm. The thinner the
slices the better, as this improves the resolution which can be
readily found on the raw images.
10. Use the highest in-plane resolution that the SNR allows, typi-
cally around 96 96 to 128 128 for FOVof 30 30mm2 or
40  40 mm2. This resolution should be balanced by the need
for sufficient SNR in the images. Zero-filling or use of partial
Fourier techniques in the phase encoding direction can be
helpful to speed up acquisition to minimize motion artifacts
and contrast agent concentration changes during the acquisi-
tion. One may use half-Fourier acquisition schemes in read
direction (asymmetric echo) to further shorten the
TE. Reducing the excitation and refocusing pulse lengths to
below 1.5 ms can then also help to shorten TE.
11. For an example of specific parameter sets for a 7 TMRI system,
please seeNotes 7 and 8, whereas for a scanner operating at 3 T
please see Note 9.
3.2 Preparations
of the Contrast Agent
Injection
and of the Catheter
1. Fill the 1-ml syringe with the contrast agent solution (see
Note 2).
2. Prepare the catheter by filling the PE20 tubing with the con-
trast agent solution, and with 20–40 μl of a heparin solution
(or a saline solution), between the needle (the animal) and the
contrast agent solution to prevent clotting before the contrast
agent will be injected.
3. According to the length of the catheter (usually 60–100 cm to
exit from the magnet bore) the contrast agent solution can be
injected directly from the syringe containing the contrast agent
or by changing the syringe with one filled with a (heparin-free)
saline solution for the postinjection flush.
3.3 Preparations
of the Mouse
1. Place the mouse on a mouse tail illuminator restrainer for
catheterizing the tail vein. The tail vein can be catheterized by
placing a 27/29-G needle in the animal.
2. Induce anesthesia in animals via isoflurane in an induction box.
Then transfer the animal to the MRI system (see Note 10).
3. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit. During imaging, keep
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the animal’s respiration rate at 35–80 breaths per min by
adjusting the dose of anesthesia (approximately 1–1.5% isoflur-
ane with air and oxygen mixed at a 3:1 ratio administered
through a nose cone attached to the animal bed and ophthal-
mic ointment will be applied to the eyes) (see Note 11).
4. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.”
5. Since the AIF should be sampled with the same temporal
resolution of the DCE-MRI experiment, selection of anatomi-
cal slices including large vessels near the kidneys should be
considered.
6. Perform localized shimming on the kidney imaging as
described in the chapter by Pohlmann A et al. “Essential Prac-
tical Steps for MRI of the Kidney in Experimental Research.”
3.4 In Vivo T1
Mapping
Typically, a T1 map is acquired before the injection of Gd-based
agent.
1. Select the same geometry of the anatomical images, with the
same number of slices and position.
2. Load or select one of the several T1 mapping sequences previ-
ously described (3.1). Adapt the same slice orientation as for
the anatomical image with coronal or axial view with respect to
the kidneys.
3. Run the T1-mapping scan. Examples images are shown in
Fig. 1 and Fig. 2.
3.4.1 DCE-MRI
Experiment
1. Load the T1-weighted sequence, adapt the slice orientation to
provide a coronal or axial view with respect to the kidney
(in scanner coordinates this is double-oblique) by importing
the same geometry as for the anatomical (and T1 mapping
sequence).
2. Set the required number of repetitions accordingly to the
sampling time and to the duration of the dynamic acquisition.
Typically, 50–100 repetitions provide enough points to be
exploited by any of the analysis procedures.
3. Initiate the DCE-MRI scan.
4. After some baseline image acquisition (5–10 images before the
injection are enough to derive average baseline values and
signal oscillations) perform an intravenous bolus injection of
the Gd-based CA through the tail vein at a dose of
0.02–0.1 mmol Gd /kg b.w. by using a power injector to
maintain the exact administration rate for each imaged mouse.
5. A demonstration of the signal intensity changes that can be
expected for the DCE-MRI experiment across the kidneys is
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Fig. 2 Representative T1-weighted images in kidneys obtained with VFA T1 mapping approach by varying the
excitation pulse flip angle values: 5 (a), 15 (b), 30 (c), 45 (d), 60 (e), and 75 (f) with a 7 T MRI system.
Acquisition details are provided in Note 6
Fig. 1 Representative T1-weighted images in kidneys obtained with the VTR scheme at different repetition
times (TR) values: 75 ms (a), 534 ms (b), 1076 ms (c), 1738 ms (d), 2589 ms (e), 3782 ms (f), 5791 ms (g),
and 15000 ms (h). Acquisition details are provided in Note 5
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given in Fig. 3 (axial orientation) and Fig. 4 (coronal
orientation).
4 Notes
1. Intramuscular anesthesia can be administered as a mixture of
xylazine 5 mg/kg (Rompun, Bayer, Italy) and tiletamine/zole-
pan 20 mg/kg (Zoletil 100, Virbac, Italy) with a dose depen-
dent on the length of the MRI session. Usually, a 40–80 μl
volume allows for a sleeping time of 30–60 min for a 25 g
mouse.
2. A required dose for DCE-MRI in the kidneys is in the range
0.01–0.1 mmol Gd/kg b.w. that would require too small
volumes of the stock solution. Therefore, it is advisable to
dilute stock solutions to ca. 50 mmol/l. For instance, a 25 g
mouse would receive 50 μl of 50 mmol/l Gd-complex to
achieve a dose of 0.1 mmol Gd/kg. Please avoid the inclusion
of air bubbles in the catheter filled with the saline solution or
with the contrast agent solution that will be injected into the
animals.
3. DCE-MRI experiments are described for Bruker MRI systems,
such as Avance 300 (7 T) and Biospec (3 T), (Bruker, Ettlin-
gen, Germany) or for a Magnetom Skyra 3 T (Siemens Health-
care, Erlangen, Germany). Standard 1H radiofrequency-coils
Fig. 4 Representative DCE-MRI images in kidneys (coronal orientation) at different time points following
Gd-based contrast agent injection with a 7 T MRI scanner. Anatomical T2-weighted (a) and GRE-FLASH
T1-weighted images before (b) and 4 s (bc), 30 s (d), 5 min (e), and 10 min (f) after gadoteridol injection (dose
0.1 mmol Gd/kg b.w.). Acquisition details are provided in Note 8
Fig. 3 Representative DCE-MRI images in kidneys (transversal orientation) at different time points following
Gd-based contrast agent injection with a 7 T MRI scanner. Anatomical T2-weighted (a) and GRE-FLASH
T1-weighted images before (b) and 4 s (c), 30 s (d), 5 min (e), and 10 min (f) after gadoteridol injection (dose
0.1 mmol Gd/kg b.w.). Acquisition details are provided in Note 7
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(birdcage, quadrature) or phased-array 1H coils can be used for
data reception.
4. Within the Bruker method, specific TR values can be suggested
according to the estimated T1 values of the tissue.
5. For estimated T1 of 1–3 s, 10 TR values can be used (580, 810,
1075, 1380, 1740, 2180, 2740, 3525, 4830, and 10,000 ms)
to correctly follow signal intensities recovery until plateau.
With 10 TR values complete acquisition lasted 8:40 min (for
96  96 matrix and 8 slices).
6. For estimated T1 values of 1–3 s, we used six different FA values
(5, 15, 30, 45, 60, and 75). With a TR of 80 ms and
matrix size of 96 96, the single image acquisition lasted more
than 15 s (8 slices). The complete acquisition time of the VFA
T1 map with six FA values is approximately 2 min.
7. Example for DCE-MRI using a FLASH readout at 7 T: TR:
16 ms; TE: 1.6 ms; FA: 30; scan averages: 2; slice thickness:
1.5 mm; slice number: 1; slice orientation: axial; frequency
encoding: head-feet; FOV ¼ 30  30 mm2; matrix
size ¼ 128  128; fat suppression ¼ on; acquisition time per
image: 4 s; number of repetitions: 150.
8. Example for DCE-MRI using a FLASH readout at 7 T: TR:
15 ms; TE: 1.7 ms; FA: 30; scan averages: 2; slice thickness:
1.5 mm; slice number: 1; slice orientation: coronal; frequency
encoding: head-feet; FOV ¼ 30  30 mm2; matrix
size ¼ 128  128; fat suppression ¼ on; acquisition time per
image: 4 s; number of repetitions: 150.
9. Example for DCE-MRI using a 3D time-resolved angiography
with stochastic trajectories (TWIST) sequence at 3 T: TR ¼
3.4 ms, TE ¼ 1.4 ms, FA: 20, FOV ¼ 114  50 mm2,
generalized autocalibrating partially parallel acquisition
(GRAPPA) of factor 2, matrix ¼ 192  84; slice number:
2, voxel resolution ¼ 0.6  0.6  1.2 mm3. TWIST view
sharing: 15% central region, 20% sampling density in the
outer region, nominal temporal resolution 0.9 s per volume.
Images were continuously acquired for 6 min.
10. Mice can be alternatively anesthetized with intramuscular anes-
thesia, tail veins heated with hot water/heater equipment at
37 C and catheter placed in the animal.
11. It is important to monitor the respiration continuously
throughout the entire experiment.
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Renal Blood Flow Using Arterial Spin Labeling (ASL) MRI:
Experimental Protocol and Principles
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Abstract
A noninvasive, robust, and reproducible method to measure renal perfusion is important to understand the
physiology of kidney. Arterial spin labeling (ASL) MRI technique labels the endogenous blood water as
freely diffusible tracers to measure perfusion quantitatively without relying on exogenous contrast agent.
Therefore, it alleviates the safety concern involving gadolinium chelates. To obtain quantitative tissue
perfusion information is particularly relevant for multisite and longitudinal imaging of living subjects.
This chapter is based upon work from the PARENCHIMA COST Action, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter is complemented by two separate chapters describing the basic concept and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Arterial spin labeling (ASL)
1 Introduction
Arterial spin labeling (ASL) is a magnetic resonance imaging (MRI)
method for measuring tissue perfusion [1, 2]. The term perfusion
refers to the delivery of blood to capillary beds, and is quantified by
the amount of blood delivered to the tissue per unit time, per unit
volume or mass of tissue. The quantification of renal tissue perfu-
sion is essential because it determines the rate of nutrients (e.g.,
oxygenation and glucose) to the renal tissue, and the rate of clear-
ance of waste products.
The principle of ASL-MRI is to label the arterial blood as an
endogenous diffusible tracer. Before the blood flows into the target
tissue, the blood proton spins are “labeled” (tagged) by inverting
the longitudinal magnetization using radiofrequency (RF) pulses.
The labeled blood then flows into the kidney tissue, resembling
direct exogenous contrast more than MRI contrast agents that act
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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on relaxation times. The labeled blood, however, loses its contrast
on its way to kidney tissue within a few seconds due to the T1
relaxation of blood. This makes ASL only suitable for probing renal
perfusion, but not later processes in the kidney such as glomerular
filtration. On the other hand, the intrinsic signals from the static
kidney tissue have to be eliminated. For this, a control image
without labeling arterial blood is acquired, and subtraction of the
two images with and without labeling would result in an image
enhanced with only the labeled arterial blood.
The most frequently used ASL technique for kidney imaging is
flow-sensitive alternating inversion recovery (FAIR) which uses an
inversion pulse for spin labeling [3]. Its principle is illustrated in the
chapter by Ku M-C et al. “Noninvasive Renal Perfusion Measure-
ment Using Arterial Spin Labeling (ASL) MRI: Basic Concept.” In
this technique, two acquisitions with different inversions are alter-
natingly applied: one acquisition with selective inversion of a slab that
is slightly larger than the imaging slice (no labeling of in-flowing
blood) and a second acquisition with global inversion of all blood
within the RF coil (nonselective inversion). Subtraction of the image
with global inversion from the image with spatially selective inversion
results in a perfusion-weighted image, as the difference between the
two images is caused by the noninverted blood spins moving from
outside the selective inversion slab into the imaging plane.
Here we describe ASL-MRI using FAIR method for monitoring
of the renal blood flow in the kidney of rodents in a step-by-step
experimental protocol. The rationale for the chosen acquisition
parameters is given in generic terms, together with specific parameter
examples.
This experimental protocol chapter is complemented by two
separate chapters describing the basic concept and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals This experimental protocol is tailored to mice (e.g., wild type
C57BL/6 or disease model in immune-deficient nude mice) with
a body mass of 20–40 g. Some advice for adaptation to other
rodents such as rats is given as Notes when necessary.
2.2 Lab Equipment 1. Anesthesia: For an in-depth description and discussion of anes-
thesia please refer to the chapter by Kaucsar T et al. “Prepara-
tion and Monitoring of Small Animals in Renal MRI.”
Typically 0.5–1.5% isoflurane is used for anesthesia adminis-
tered to the mice using an anesthetic gas vaporizer (Dr€ager
Vapor® FMI Föhr Medical Instruments GmbH, Seeheim-Ober
Beerbach, Germany).
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2. Gases: O2, N2 and compressed air, as well as a gas-mixing system
or general inhalation anesthesia equipment, including an anes-
thetic vaporizer, a flow meter and an induction chamber.
2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter was tailored for
a 7 T MR system (Biospec 70/20, Bruker Biospin, Ettlingen,
Germany) but advice for adaptation to other field strengths is
given where necessary. No special or additional hardware is
required, except for:
1. A physiological monitoring system that can track the respira-
tion, and is connected to the MR system such that it can be
used to trigger the image acquisition. Typically, the
MR-compatible rodent monitoring and gating system (Small
Animal Instruments, New York, USA) equipped with an
air-pillow to monitor breath rate can be used.
2. Mouse cradle and RF-antenna (see Note 1): The 2  2 cardiac
coil array (Bruker), originally designed for mouse heart is
integrated into corresponding animal cradle tips. The combi-
nation of receive-only coil array and a circularly polarized vol-
ume transmitter coil (Bruker) will improve signal to noise ratio
(SNR). Alternatively, a single-loop surface coil could be used
for receiving provided that a volume coil is used for transmit in
any case.
2.4 MRI Sequences 1. Sequence type: For the choice of type of sequence to use for
renal ASL in rodents please refer to the chapter by Ku M-C
et al. “Noninvasive Renal Perfusion Measurement Using Arte-
rial Spin Labeling (ASL) MRI: Basic Concept.” A 2D sequence
composed by FAIR for labeling and EPI for image acquisition
is described in this chapter. This is a standard sequence on
Bruker MRI systems, where it is called “FAIR-EPI.” To mini-
mize the susceptibility artifact and geometric distortion in the
abdomen, spin-echo EPI or RARE acquisition is desirable as
alternative (“FAIR-RARE”).
2. Echo time (TE): To preserve signal from T2/T2* decay, a
minimum TE should always be used (~10 ms) to
maximize SNR.
Avoid crusher gradients: Although they reduce flow-
related artifacts, they require prolongation of the minimum
TE. They would reduce SNR and introduce more T2 (T2*)
contrast into the ASL image. Crusher gradients also remove
potentially important information, such as the presence of
delayed or collateral flow.
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3. Repetition time (TR): There are two considerations on choos-
ing appropriate TR. First, to allow substantial relaxation of
labeled spins between acquisitions, TR should be long enough
(~10,000ms). Since T1 time is field dependent, TR as well. The
long TR (~10,000 ms) is recommended for a 7 T system. For
other field strength this value need to be justified. Second, if
respiratory induced artifact is severe and the respiratory trigger
is needed, a long TR that is at least five times greater than the
tissue T1 (e.g., 10 s) can be used to minimize the variable
T1-weighting due to irregular respiration rate. If the respira-
tory trigger is not needed, a shorter TR that has good signal-
to-noise per time (SNR/t) efficiency could be used. TR will be
limited by the maximum inversion time (TI) and the number of
acquired slices.
4. TR mode: TR must allow tag washout and refreshing, TE
should be short to minimize T2 contamination.
5. Repetition spacing: Choose “Const_Rep” to use the same TR.
6. FAIR Experiment Mode: Choose “Interleaved (TI loop out-
side)” to measure control-label pairs, followed by different TI.
7. Inversion mode (TI Setting): Set for “User” TIR.
8. Inversion time (TI): TI should be long enough to permit
tagging to leave tagging region and ensure tag exchange with
tissue water (i.e., the arterial arrival time), but short enough to
reduce loss of tag. TI should be increased whenever slow
arterial flows (i.e., long arterial arrival time) are expected. For
example, in the case of poor cardiac output. Shorter TI values
are recommended in case of more rapid circulation times (this
depends on the anesthesia level). Unless the arterial arrival time
is known, measurement with multiple TI is recommended,
e.g., from 25, 50, 100, 150, 200, 300, 500, 1000, 1500,
2000, to 5000 ms. The arrival time increases with the selective
inversion slab thickness. For single slice FAIR, the arrival time
is typically very short (see Note 2).
9. Inversion pulse: For inversion, an adiabatic full passage
frequency-selective inversion pulse (e.g., hyperbolic secant-
shaped pulse) should be used with a high bandwidth of
5190 Hz. A calculated adiabatic pulse can be used as well.
10. Inversion slab thickness: This depends on the imaging slice
thickness. Usually at least 2.5 times of slice package thickness.
For example, the slice package margin should be at least
1.5 mm resulting in a 5 mm inversion slice when you use
2 mm slice thickness.
11. Acquisition bandwidth (BW): Use a high BW (e.g., 200 kHz)
for EPI readout to shorten TE. Keep an eye on the SNR while
modifying BW. SNR decreases with increasing BW. Low SNR
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may be balanced out with more averages or repetitions. For
scanning with a short TE, an SNR of at least 60 is recom-
mended (see Note 3).
12. Fat saturation: Turn on. Important to avoid fat signal over-
laying the kidney due to chemical shift.
13. Geometry: this is a tricky part. To cover the whole kidney in one
slice, an oblique coronal slice will be needed. It is important to
avoid the selective inversion slab crossing the feeding arteries
(aorta) as this will reduce the labeled arterial blood spins. Use a
rectangular field of view (FOV) and use a frequency encoding
in H-F direction to avoid aliasing (see Note 4).
14. Respiration trigger: Turn on (per repetition). This is essential
when respiration is very irregular or motion artifact is induced
in multishot imaging such as RARE.
15. Number of slice and thickness: Slice thickness is typically no less
than 1 mm in mice or rats due to the low SNR of ASL. The
number of slices and thickness determines the selective inver-
sion slab thickness. It should be noted that ASL using FAIR is
not suitable for multislice imaging per se, because the labeled
blood magnetization decreases with increasing inversion slab
thickness. This is due to relaxation during transit, but also to
the excitation pulses related to imaging readout in the various
slices. Therefore, usually no more than three slices are recom-
mended. Besides, ASL has generally low SNR due to a rela-
tively small fractional magnetization of available labeled arterial
blood (1–5%). Therefore, rather thick imaging slices (1 mm)
are needed to reduce noise.
16. T1 map: A T1 map is useful to improve the quantification
accuracy as it provides a measured tissue T1 (which is different
in medulla and cortex) and inversion efficiency. It can be
adapted from the ASL sequence by selecting the “nonselective
inversion” mode in “FAIR Experiment.” Set up at least six TI
in logarithmic order (e.g., 10, 50, 200, 1000, 2000, 5000,
9000 ms) with long constant TR (e.g., 10 s). A few (e.g., 3)






1. Anesthetize the animal with isoflurane in an induction box
(approximately 3–3.5% isoflurane for induction with air and
oxygen mixed at a 3:1 ratio) and then transfer the animal to
the scanner (see Note 5).
2. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit. Ophthalmic ointment
should be applied to the eyes of the animal.
Renal ASL: Exp. Protocol 447
3. If isoflurane is used, adjust anesthesia level (e.g., 1.5–2%) to
maintain regular respiration rate around 90 breaths per minute
(bpm) in mouse or 60 bpm in rat during the scan. The level of
isoflurane may need to be adjusted regularly to maintain a
rather constant respiration rate (see Note 6).
4. Carefully position the RF-antenna to be near the kidney and
place it to the magnet isocenter based on the initial anatomical
imaging.
5. Perform coil tuning/matching and global shimming (see
Note 7).
6. Acquire kidney anatomical imaging (i.e., routine respiratory
triggered T2-weighted turbo spin echo sequences in axial and
coronal planes) as described in the chapter by Pohlmann A et al.
“Essential Practical Steps for MRI of the Kidney in Experimen-
tal Research” (see Note 8).
7. In the case of use a sequence with FAIR for labeling and EPI for
image readout (FAIR-EPI), please perform the trajectory





1. Load the ASL (FAIR-EPI) sequence (see Note 10), adapt the
slice orientation to provide either a coronal or axial view with
respect to the kidney (in scanner coordinates this is double-
oblique). Adjust the geometry of a flow saturation slice onto
aorta and perpendicular to the ASL imaging slices (Fig. 1) (see
Note 11).
2. Acquire a pilot scan to evaluate slice location and image quality
by setting repetition and average to 1. Fine tune the slice
position based on the pilot scan to maximize the coverage of
Fig. 1 Anatomical images with 3 planes (coronal, axial and sagittal views of mouse kidneys). Imaging is
performed in a central coronal plane, adjusted to the long axis of the kidneys. The green box outlines slice
position for a saturation slice. The yellow box outlines the imaging slice for a coronal view. The red dotted box
outlines the inversion slab. Please note that the inversion slab has to be thicker than the imaging slice
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kidney while avoiding the selective inversion slab (imaging
slab) to cross the feeding arteries (Fig. 2).
3. Perform subtraction between label and control images to eval-
uate the level of perfusion signal.
4. Acquire ASL scans with multiple repetitions. Increase repeti-
tion if SNR is not optimal (see Note 12).
5. Inspect the acquired image time series. If motion artifacts are
severe, use respiratory trigger and then repeat scans (see Note
13).
6. When use respiration triggering: in the monitoring unit set the
trigger delay so that the trigger starts at the beginning of the
expiratory plateau (no chest motion) and the duration such
that it covers the entire expiratory phase, that is, until just
before the next inhalation starts.
7. Clone (duplicate) the ASL scan and set all the optimized para-
meters. Run the sequence for ASL scanning.






1. Duplicate the ASL (FAIR-EPI) scan.
2. Start of hypoxia: Change the gas flowing through the respira-
tory mask to 10% O2/90% N2.
3. Exactly 5 min after the start of hypoxia run the ASL and
T1-mapping scans.
4. End of Hypoxia: Change the gas flowing through the respira-
tory mask back to air (21% O2).
5. Similarly, hyperoxia and hypercapnia conditions could be
assessed by switching to 100% O2 and 5% CO2 in air,
respectively.
Fig. 2 Left: A resulted ASL image with coronal view from nonselective inversion pulse. Right: A resulted ASL
image with coronal view from selective inversion
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3.2.3 Perfusion Map 1. The demonstration of a perfusion map that can be expected in
physiological condition is shown in Fig. 3. Please note that the
detailed protocol for the image analysis is given in the chapter
by Chuang K-H et al. “Quantitative Analysis of Renal Perfu-
sion by Arterial Spin Labeling.” Briefly, the perfusion-weighted
signals at different TIs, ΔM(TI), can be fitted to a kinetic
function by a nonlinear least square routine in Matlab (Math-
works, MA, USA) [4–6]:
ΔM TIð Þ ¼ 2M 0αf =λ
exp TI=T 1app
  exp TI=T 1αð Þ




where 1/T1app ¼ 1/T1 + f/λ, f is the perfusion (when
lambda is in ml/100 g and T1 in minutes), T1a is the arterial
blood T1, and λ is the blood/tissue partition coefficient. In this
equation, three parameters can be derived from the additional
T1 mapping: M0 represents the equilibrium magnetization, T1
the tissue longitudinal relaxation time, and α the inversion
efficiency. They can be calculated by three-parameter curve
fitting of the inversion recovery T1 mapping data. Please note
that the above equation assumes minimal and negligible arterial
transit time.
2. In the Macro manager, choose Calculate Global T1 Map. Note
that if there is a bug, you need to select each map twice in the
macro.
3. Step through the macro by first loading the ASL experiment.
4. Before selecting Compute Perfusion Map, check the T1 of
blood [7] (Fig. 3).
Fig. 3 A noninvasive, robust, and reproducible functional MRI method to
characterize the physiology of kidney: An example of resulted renal perfusion
maps in C57BL/6 mouse
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4 Notes
1. The ASL technique is SNR limited. Multichannel array coils or
cryoprobes are a better choice. Particularly, as FAIR requires a
global inversion, a volume transmit coil is necessary. Using
surface transmit/receive coil would lead to underestimation
of perfusion. Parallel acceleration should be avoided due to its
SNR penalty. For mice reduce the FOV to the body width and
keep the matrix size the same as that used in rats. The relative
resolution in resolving kidney is then comparable to that in rats.
The SNR would also be similar because the smaller mouse RF
coil gives better SNR, that is, mouse heart four-element surface
coil vs rat heart four-element surface coil.
2. For using CASL or pCASL instead of FAIR, depending on the
field strength and expected flow velocities, the labeling dura-
tion and postlabeling delay should be adapted. Labeling dura-
tions of 1600 ms for (p)CASL with postlabeling
delay < ¼500 ms are suitable.
3. As the labeling effect of ASL on image contrast is weak, SNR
considerations mandate acquisition of images that are of lower
spatial resolution. For ASL in plane matrices are in the range of
64  64 to 128  128. To maintain acceptable SNR at reason-
able imaging times (2–6 min), multiple signal averages/repeti-
tions are required (N > ¼3).
4. In CASL or pCASL but not for FAIR, the labeling plane should
be perpendicular to the feeding artery. As the labeling plane in
CASL is typically designed to be in parallel to the imaging
plane, that would limit the images to be acquired in transverse
planes so that labeling can be perpendicular to the aorta.
5. The renal oxygen (O2) demand is associated primarily with
renal tubular O2 consumption necessary for solute reabsorp-
tion. Increasing O2 delivery such as giving pure oxygen to the
animals makes animal hyperoxia and leads to vasoconstriction
which changes the basal physiology.
6. The respiration rate must be monitored continuously through-
out the entire experiment and if necessary adapt the TR accord-
ingly to ensure full relaxation (~5 times of T1).
7. Shimming is particularly important for nonselective (global)
inversion, since adiabatic condition depends on B0 field homo-
geneity. If localized or high-order shim is used, the global field
uniformity required for nonselective inversion (which is for
labeling arterial spins) will be compromised and leads to infe-
rior inversion (and spin labeling). Shimming should be per-
formed on a global level to optimize uniformity over the whole
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body. Neither the default iterative shimming method nor the
Mapshim technique is recommended.
8. Example for a 25 g mouse at 7 T: Anatomical images can be
acquired with routine respiratory-triggered T2-weighted turbo
spin echo (RARE) sequences in axial and coronal planes. Addi-
tionally, bSSFP is a fast imaging that could be used for acquir-
ing anatomical image with minimal motion artefact, with
parameters such as TR ¼ 3 ms, TE ¼ 1.07 ms, flip angle of
70, matrix ¼ 128  128 and 16 averages (TA ¼ 6.2 s for one
slice without trigger).
9. EPI sequence is highly depending on the gradient system
therefore a good trajectory measurement is recommended.
10. Example for a 25 g mouse at 7 T [4, 5, 8, 9]: a respiratory
triggered, FAIR sequence with an EPI readout:
TR ¼ 16,000 ms; TE ¼ 16.6 ms; TIR ¼ 30, 100, 200,
300, 500, 700, 1000, 1200, 1500, 2000, 3000, 5000,
8000 ms; calculated inversion pulse; effective bandwidth
350 kHz; pulse bandwidth¼ 2000Hz; FOV¼ 3.5 3.5mm2,
slice thickness ¼ 2 mm, inversion slab ¼ 5 mm, IR-spoiler
duration ¼ 10 ms, IR-Spoiler amplitude ¼ 40%. As kidney
has very high perfusion, the perfusion signal is expected to be
high even with just a single pair of ASL scan. If perfusion signal
is weak, the nonselective inversion may not be effective. Try
increasing the bandwidth of the inversion pulse (i.e., from
2000 to 5000 Hz or higher). This will increase the RF power
demand so be mindful about the safe limit of the RF coil and
the amplifier.
11. Optional: The flow saturation slice shown in Fig. 1 is a spatially
selective saturation band applied to suppress unwanted flow
artifacts from vessels entering a slice. This is not the most
optimal way of suppressing when using FAIR, but it reduces
flow artifacts significantly.
12. Use repetition instead of averaging as repetition allows image
registration in post-processing before averaging to minimize
residual motion artefacts, whereas direct averaging on the
scanner may lead to a blurred image in the presence of motion.
13. If SE-EPI readout causes severe distortion, consider using
RARE acquisition instead.
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Chapter 27
Renal pH Mapping Using Chemical Exchange Saturation
Transfer (CEST) MRI: Experimental Protocol
Kowsalya Devi Pavuluri, Lorena Consolino, Dario Livio Longo,
Pietro Irrera, Phillip Zhe Sun, and Michael T. McMahon
Abstract
Chemical exchange saturation transfer (CEST) is recognized as one of the premier methods for measuring
pH with this environmental variable expected to be an excellent biomarker for kidney diseases. Here we
describe step-by-step CEST MRI experimental protocols for producing pH and perfusion maps for
monitoring kidney pH homeostasis in rodents after administering iopamidol as contrast agent. Several
CEST techniques, acquisition protocols and ratiometric approaches are described. The impact of length of
acquisition time on the quality of the maps is detailed. These methods may be useful for investigating
progression in kidney disease in vivo for rodent models.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol is complemented by two separate chapters describing the basic concepts and data
analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Chemical exchange saturation
transfer (CEST), pH imaging, Iopamidol, Contrast agent, Responsive contrast agent
1 Introduction
The kidneys are responsible for filtration of plasma in order to
remove waste and toxins and for maintaining the acid–base balance
of the body through regulation of systemic HCO3
 concentrations
[1]. The kidneys can either reabsorb or generate new HCO3

through acid excretion. Renal control of pH could be impacted
by a number of factors including whether or not there are abnorm-
alities in perfusion, filtration, amino acid metabolism or if renal
tissue edema or inflammation are present. Based on a number of
studies relating changes in acid production, secretion or reduced
NH4
+ with pathological conditions [2–8], pH should be a good
biomarker for assessing renal function. A number of methods are
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now established for determining local pH in vivo, including use of
pH micro electrodes [9–11], fluorescence imaging [12, 13], 1H,
31P, 19F MRS [14–21] hyperpolarized 13C MRS [22],
pH-dependent MR relaxometry [23], and chemical exchange satu-
ration transfer (CEST) MRI [24, 25]. CEST is a novel MRI con-
trast mechanism allowing detection of low concentrations of
contrast agent through the application of saturation radiofrequency
(RF) pulses on their labile protons to destroy their magnetization
with the resulting signal loss transferred to water through chemical
exchange which has now emerged as the premier MRI method for
pH imaging [7, 26–32].
Here we describe CEST MRI for monitoring of the local pH
variation found in the kidney of rodents in a step-by-step experi-
mental protocol. The rationale for the choosing acquisition para-
meters is given in generic terms, together with specific parameter
examples.
Mapping of contrast agent renal perfusion is described as an
optional component of the experiment. Contrast agent perfusion is
a functional parameter that is also sensitive to kidney damage.
Currently CT, SPECT and gadolinium based MR imaging are
available for assessing renal perfusion in patients, each with its
own limitations [33]. CEST MRI contrast enables production of
high resolution images of perfusion without need of using ionizing
radiation making mapping of perfusion a valuable complement to
pH imaging [34].
The protocols contained in this chapter were tested on healthy
control mice using Iopamidol as the contrast agent to standardize
the pHmapping and tested for both an axial slice and a coronal slice
for bench marking. These methods may be useful for investigating
renal pH and perfusion variations found in vivo for various rodent
models with acute kidney injuries or which progress to chronic
kidney disease.
This experimental protocol chapter is complemented by two
separate chapters describing the basic concepts and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals This experimental protocol is tailored for immunocompetent (typ-
ically C57BL/6 and Balb/C) or immunocompromised (nude,
NOD-SCID) mice with a body mass of 15–35 g. Advice for adap-
tation to rats is given as Notes where necessary. All animal studies
have to be carried out in compliance with specific legislation cover-
ing the use of animals for scientific purposes. Therefore, all experi-
ments must be authorized under national regulations.
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2.2 Lab Equipment
and Chemicals
1. Mouse tail illuminator/restrainer for catheterizing the tail vein.
2. Saline solution or heparin solution, 1-ml syringe, catheter (e.g.,
PE 20 polyethylene tubing) of known inner diameter to hold
the saline flush and for contrast agent bolus is required.
3. Anesthesia: please refer to the chapter by Kaucsar T et al.
“Preparation and Monitoring of Small Animals in Renal
MRI” for an in-depth description and discussion of the anes-
thesia. Typically, 0.5–1.5% isoflurane is used for anesthesia
administered to the mice using an anesthetic gas vaporizer
(Leica Biosystems, Maryland, USA). For nonrecovery experi-
ments, urethane solution (Sigma-Aldrich, Steinheim, Ger-
many; 20% in distilled water) can provide anesthesia for
several hours with comparatively few side effects on renal phys-
iology, which is an important issue. For intramuscular anesthe-
sia, please refer to Note 1.
4. Gases: O2, N2, and compressed air, as well as a gas-mixing
system or general inhalation anesthesia equipment, including
an anesthetic vaporizer, a flow meter and an induction
chamber.
5. Mouse cradle.
6. pH imaging contrast agent: typically iodinated-based contrast
media are employed, as Iopamidol (Isovue® 370, Bracco Imag-
ing SpA, Milano, Italy), Iopromide (300 mg iodine/ml Ultra-
vist®, Bayer Healthcare, Germany) or Iobitridol (Omnipaque®,
GE Healthcare, USA). Such clinically available contrast agents
have stock concentrations of 0.9–1 M that can be directly used
(see Note 2).
7. Small Animal Ventilator: animals (rats) needs to be ventilated
so the CEST MRI acquisition can be gated to minimize the
respiratory motion artifacts. We used a TOPO Dual Mode
Rodent/Small Animal Ventilator (Kent Scientific,
Torrington, CT).
8. Syringe Infusion Pump: an MR-compatible single syringe
pump (Harvard Bioscience, Holliston, MA) for contrast agent
administration.
2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter has been tailored
for MR preclinical systems at magnetic fields higher than 3 T but
advice for adaptation to other field strengths is given where neces-
sary (see Note 3). No special or additional hardware is required,
except for the following:
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1. A physiological monitoring system that can track the respira-
tion and which is connected to the MR system such that it can
be used to synchronize CEST MRI with respiration. Typically,
we use the MR-compatible rodent monitoring and gating sys-
tem (Small Animal Instruments, New York, USA) equipped
with an air-pillow to monitor breath rate.
2.4 MRI Sequences The CEST MRI sequence includes continuous wave (CW) RF
saturation followed by fast image readout such as echo planar
imaging (EPI), Rapid Imaging with Refocused Echoes (RARE)
and/or fast imaging with steady-state precession (FISP) [6, 35–
37]. Herein we describe those based on fast refocused multiecho
sequences since they provide the higher SNR in acceptable acquisi-
tion times and are without geometrical distortions. The same
sequence readout is described for B0 mapping, for full






Sequence for External B0
Mapping Using WASSR
1. Select a 2D Rapid Acquisition with Refocused Echoes
sequence in conjunction with a magnetization transfer prepa-
ration module that has a frequency offset which can be incre-
mented within a single scan. This is a standard sequence on
Bruker MRI systems, called “RARE.”
2. Switch on the magnetization transfer module. The magnetiza-
tion transfer pulse parameters are then adjusted to allow detec-
tion of direct water saturation vs. excitation frequency and also
the signal-to-noise >50:1 when the saturation pulse is 500 Hz
or more away from water. Typically, we employN¼ 11,000 ms
rectangular shaped pulse with saturation power (amplitude) of
1–1.5 μT, similar to what was previously described for the
WASSR Scheme [38].
3. Sample several frequency offsets around the frequency of bulk
water signal (commonly set at 0 ppm, in contrast to the
4.8 ppm as in conventional NMR experiments). Usually the
sampled range is between 3 and +3 ppm with different step
size, according to the available acquisition time and expected
B0 inhomogeneity. Please see Note 4 for an example of the
frequency list used in B0 mapping.
4. Choose a repetition time (TR) of ~5–6 s for good signal
stability and signal-to-noise per time (SNR/t) efficiency. TR
will be limited by the length of the saturation pulse, length of
echo train and the number of slices to be acquired, and satura-
tion pulse(s)’s field strength.
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5. Use the shortest echo time (TE) and echo spacing (ΔTE)
possible. One wants to acquire as many lines of k space as
possible to minimize motion distortions of the images. For
that reason, it is advantageous to have ΔTE well below
10 ms. Larger ΔTE are not advisable because the SNR in the
kidney will be so low that these images must be excluded.
Acquisition bandwidth should be considered to shorten the
ΔTE.
6. Set the rare factor as high as possible to reduce scan time. Same
as the CEST acquisition scan (Subheading 3.1.2).
7. Set the acquisition bandwidth (BW) as for the CEST contrast
scan (Subheading 3.1.2).
8. Switch on the fat saturation module.
9. Do not use the respiration trigger since this will increase the
overall acquisition time.
10. Set the same geometry as for the CEST contrast scan (Sub-
heading 3.1.2).
11. Set the matrix size/acceleration the same as for the CEST
contrast scan (Subheading 3.1.2).




1. Select a 2D Rapid Acquisition with Refocused Echoes
sequence with magnetization transfer preparation module.
This is a standard sequence on Bruker MRI systems, called
“RARE.” RARE sequence with centric encoding is used.
More details on CEST sequences for Bruker scanners are
provided in Note 6.
2. Switch on the Magnetization transfer module. The magnetiza-
tion transfer pulse parameters are then adjusted to allow detec-
tion of CEST contrast while keeping the current within limits
given by the RF transmit coil and the 1H RF power amplifier.
For CEST pH mapping, Z-spectra are acquired by applying a
1.5–6 μT continuous wave (CW) block shaped (bp) presatura-
tion pulse for 2–5 seconds or by applying a pulsed saturation
scheme (see Subheading 2.4.3.35).
3. Acquire a series of 30–50 frequencies in the range of 10 ppm
for the whole CEST Z-spectrum acquisition. A macro file
containing the MR frequencies is manually implemented by
the operator in Bruker systems, by creating a list of frequencies
covering the positive and negative side of CEST spectra. At the
resonating frequencies of mobile protons (4.2/4.3 ppm and
5.5 ppm for Iopamidol and Iopromide, 5.6 ppm for Iobitridol)
a denser sampling is usually applied (frequency resolution of
0.1 ppm). Please see Note 7 for an example of the
frequency list.
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4. Choose the Repetition Time (TR) in the range 4–6 s for good
signal stability and signal-to-noise per time (SNR/t) efficiency,
also according to the duration of the saturation pulse.
5. Use the shortest TE and echo spacing (ΔTE) possible.
6. Set the Rare factor to 64–96. Typically, a single shot acquisition
(Rare Factor equal to Matrix Size) to reduce the acquisition
time for each frequency. Partial Fourier acceleration should be
considered to reduce the size of the matrix and improve the
time efficiency of data acquisition and centric encoding to
maximize SNR. Reconstruction to higher matrix size may be
also considered to improve spatial resolution.
7. Use a high acquisition bandwidth (BW) to shorten ΔTE, while
keeping an eye on the SNR, which decreases with
increasing BW.
8. Switch on the fat saturation module. Important to avoid fat
signal overlaying with the kidney due to chemical shift.
9. Set off the respiration trigger.
10. Adapt the geometry of the slice(s) so that animal fits into FOV
in L-R direction (approx. 30–40 mm, according to the coil
inner diameter) and use frequency encoding in H-F direction.
Use a slice with the lowest thickness the SNR allows, typically
around 1.5–2.0 mm. The thinner the slices the better, as this
improves the resolution—which can be readily seen on the raw
images.
11. Use the highest in-plane resolution that the SNR allows. A
typical matrix size of 64  64, 96  96, or 128  128 is used
for CEST images, with in-plane spatial resolution of 468, 312,
or 234 μm (for an FOVof 30 mm). This has to be balanced by
the need for sufficient SNR in the images. Zero-filling or use of
partial Fourier techniques in the phase encoding direction can
be helpful to speed up acquisition to minimize motion artifacts
and contrast agent concentration changes during the
acquisition.
12. For an example of a specific parameter set for mice please see
Note 8 or for rats please see Note 9.
3.1.3 Rapid Acquisition
with Refocused Echoes
Sequence for CEST pH and
Perfusion Measurements
1. Select a 2D rapid acquisition with refocused echoes sequence
(RARE) with magnetization transfer preparation module.
2. Switch on the magnetization transfer module. The magnetiza-
tion transfer pulse parameters are then adjusted to allow detec-
tion of CEST contrast while keeping the current within the
limits given by the RF transmit coil, the 1H RF power amplifier
and the signal-to-noise >50:1 at the frequency of the labile
protons of interest on the CEST agent. Typically, we employ
signal averaging with N ¼ 10, 300 ms rectangular shaped RF
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pulses with an amplitude between 3 and 4 μT. The saturation
frequency is alternated between 4.2 ppm, 5.5 ppm for collec-
tion of signal with saturation on resonance with the two labile
protons in iopamidol and for the last ten images100 ppm for
collection of S0 (signal with no saturation).
3. Choose a repetition time (TR) between 7 and 12 s for good
signal stability and signal-to-noise per time (SNR/t) efficiency.
4. Use the shortest TE and echo spacing (ΔTE) possible (see
Subheading 3.1.2).
5. Use a rare factor of 20–32. Typically, 20–32 TEs are sensible
and allow acquiring a 32  32 matrix slice or 48  48 with
partial Fourier acceleration in a single shot. Partial Fourier
acceleration should be considered to reduce the size of the
matrix and improve the time efficiency of data acquisition.
6. Use a high acquisition bandwidth (BW) to shorten ΔTE, while
keeping an eye on the SNR, which decreases with increasing
BW. For the image with the shortest TE an SNR of at least 60 is
recommended.
7. Switch on the fat saturation module. Important to avoid fat
signal overlaying with the kidney due to chemical shift.
8. Use an FOV saturation of 4 mm thickness above 9–13 mm
from the kidneys for coronal slices. This is not required for axial
slices.
9. Set off the respiration trigger.
10. Adapt the geometry of the acquisition slices so that the animal
fits into FOV in L-R direction (approx. 30–40 mm according
to the coil inner diameter) and use frequency encoding in H-F
direction. Use a slice with the lowest thickness the SNR allows,
typically around 1.5 mm. The thinner the slices the better, as
this improves the resolution—which can be readily seen on the
raw images. For adaptation to rats see Note 10.
11. Use highest in-plane resolution that the SNR allows, typically
around 600  400 um2 for axial slices or 200  500 μm2 for
coronal slices. This has to be balanced by the need for sufficient
SNR in the images. Use zero-filling or partial Fourier techni-
ques in the phase encoding direction to speed up acquisition
and to minimize motion artifacts and contrast agent concen-
tration changes during the acquisition. One may use half Four-
ier in read direction (asymmetric echo) to further shorten the
first TE. Reducing the excitation and refocusing pulse lengths
to below 1.5 ms can then also help to shorten TE.
12. For an example of a specific parameter set please see Note 11.
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3.2 Setting of the pH
Calibration Curve
Prepare multiple vials of Iopamidol phosphate-buffered solution
(PBS 1, 10 mM of inorganic phosphates) or human blood serum
solutions, with pH titrated to physiological relevant renal pH
values: 5.5, 6.0, 6.5, 7.0, 7.5, 8.0 and place them in a plastic
container (e.g., 30–50 ml falcon tube) filled with water. Such a
phantom calibration experiment is crucial for in vivo pH quantifi-
cation at different experimental conditions such as magnetic field
strength and CEST irradiation Schemes [39]. A more detailed
description for pH calibration curve can be found in the chapter
by Kim H et al. “Analysis Protocol for the Quantification of Renal
pH Using Chemical Exchange Saturation Transfer (CEST) MRI.”
1. Acquire the CEST Z-spectrum by sweeping RF saturation to a
series of frequency offsets around the bulk water resonance.
Note that the magnitude of the saturation field (B1) and dura-
tion can be adjusted serially to facilitate Z-spectral acquisition.
For an example of specific parameters at 7 T please seeNote 12,
whereas for an example of specific parameters at 4.7 T please see
Note 13 and for the same at 11.7 T please see Note 14.
3.3 Preparations of
the Contrast Agent
Injection and of the
Catheter
1. Fill the 1-ml syringe with the contrast agent stock solution.
2. Prepare the catheter by filling the PE20 tubing with the con-
trast agent solution, and with 20–60 μl of a heparin solution
(or a saline solution), between the needle (the animal) and the
contrast agent solution to prevent clotting before the contrast
agent will be injected.
3. According to the length of the catheter (usually 60–100 cm to
exit from the magnet bore) the contrast agent solution can be
injected directly from the syringe containing the contrast agent
or by changing the syringe with one filled with a (heparin-free)
saline solution for the postinjection flush.
3.4 Preparation of
the Mouse
1. Place the mouse on a mouse tail illuminator restrainer for
catheterizing the tail vein. Catheterize the tail vein by placing
a 27/29-G needle in the animal.
2. Induce anesthesia via isoflurane in an induction box. Transfer
the animal to the scanner (Note 15).
3. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit. Keep the animal’s
respiration rate during imaging at 35–80 breaths per min by
adjusting the dose of anesthesia (approximately 1–1.5% isoflur-
ane with air and oxygen mixed at a 3:1 ratio administered
through a nose cone attached to the animal bed and ophthal-
mic ointment will be applied to the eyes) (see Note 16).
4. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.”
462 Kowsalya Devi Pavuluri et al.
5. Perform localized shimming on the kidney imaging as
described in the chapter by Pohlmann A et al. “Essential Prac-





1. Load the B0 mapping sequence and adapt the slice orientation
to provide a coronal or axial view of the two kidneys based on
the tripilot/scout and anatomical images collected.
2. Run the B0 mapping scan using 42 offsets from 1.5 to




1. Acquire a full Z-spectrum with some frequency offsets sampled
around 0 ppm to exploit the Z-spectrum for internal measure-
ment of B0 shifts as described in the chapter by Kim H et al.
“Analysis Protocol for the Quantification of Renal pH Using
Chemical Exchange Saturation Transfer (CEST) MRI.”
3.6 CEST Acquisition
for pH Mapping
1. Perform the CEST experiment by acquiring CEST images
before, (during) and after injection of the contrast agent.
Choose among the different pH mapping procedures by con-
ventional ratiometric approach (Subheading 3.5.1), pH
mapping with power ratiometric method (Subheading 3.5.2)
or dynamic CEST perfusion and pH mapping (Subheading
3.5.3).
3.6.1 pH Mapping with
Conventional Ratiometric
Method (Full Z-Spectrum)
1. Load the pH mapping sequence, using the same geometry as
used for anatomical and B0 mapping. Switch off the magneti-
zation module and use this sequence to set the receiver gain.
2. Load the pH mapping sequence, using the same geometry as
used for anatomical and B0 mapping. Set the receiver gain as
calculated by the magnetization off sequence (see Subheading
Fig. 1 Series of ten saturation weighted images of a healthy mouse kidney acquired with a 2D CEST-RARE
sequence at 11.7 T. Images correspond to saturation frequencies ¼1.5,1.2,0.9,0.6,0.3 ppm (top
row) and saturation frequencies ¼ 0, 0.3, 0.6, 0.9, 1.2 ppm (bottom row)
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3.5.1.15). Load the macro file containing the offset frequencies
to be saturated and run the sequence for CEST preinjection
scanning.
3. Clone the pH mapping scans, at least one time for acquiring
one CEST postinjection scan.
4. After the acquisition of the CEST prescan, perform a bolus
injection of iodine contrast agent through the tail vein catheter
at a dose of 1.0–1.5 iodine/kg b.w. (see Note 18).
5. Run the postinjection scans.
6. A demonstration of the acquired images at different offsets and
of CEST contrast that can be expected for the pH mapping
scans are given in Fig. 2 and Fig. 3, respectively.
Fig. 2 Series of saturated weighted images of a healthy mouse kidney acquired with a 2D CEST-RARE
sequence at 7 T before (up panel) and after (bottom panel) the injection of iopamidol at 1.5 mg I/kg
b.w. Images correspond to saturation frequencies of 10, +10, 0, +4.2, and +5.5 ppm
Fig. 3 From left to right: parametric maps of saturation transfer (ST) contrast obtained at 4.2 ppm, at 5.5 ppm,
ratiometric 4.2/5.5 map and calculated pH map in kidney regions. The parametric color maps are super-
imposed on a T2w anatomical image (gray scale)
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3.6.2 pH Mapping with
Power Ratiometric Method
(Full Z-Spectrum)
1. Load the pH mapping sequence, using the same geometry as
used for anatomical and B0 mapping. Switch off the magneti-
zation module and use this sequence to set the receiver gain.
2. Load the pH mapping sequence, using the same geometry as
used for anatomical and B0 mapping. Set the receiver gain as
calculated by the magnetization off sequence (see Subheading
3.6.1.15). Load the macro file containing the offset frequencies
to saturate at a first selected power pulse (1.5 μT) and run the
sequence for CEST preinjection scanning.
3. Clone the scan and set the second selected saturation power
pulse (6 μT). Run the sequence for CEST preinjection
scanning.
4. Clone two times the scans with 1.5 and 6 μT saturation power
pulse for acquiring the postinjection scans.
5. Perform a bolus injection of iodine contrast agent with single
amide exchanging pool (e.g., iobitridol) through the tail vein
catheter at a dose of 1.0–1.5 iodine/kg b.w. (see Note 18).
6. Run the postinjection scans.
3.6.3 pH and Perfusion
Mapping with Two Offset
Sampling
1. Load the pH mapping sequence, using the same geometry as
used for B0 mapping and setting up a collection to run for 1 h,
5 min alternating the saturation frequency between 4.2 ppm
(labile proton #1 for iopamidol), 5.5 ppm (labile proton #2 for
iopamidol), and for the final ten images at 100 ppm (S0
image) (see Note 19).
2. Initiate the pH mapping scans.
3. Exactly 5 min after starting the pH mapping scans, perform a
bolus injection of contrast agent: inject iopamidol through the
tail vein at a dose of 1.0 g iodine/kg using ~100–150 μl.
4. Approximately 1 h after injection, end the pH mapping scan
collection.
5. A demonstration of the contrast changes that can be expected
for the pH mapping scans are given in Fig. 4.
4 Notes
1. Intramuscular anesthesia can be administered as a mixture of
xylazine 5 mg/kg (Rompun, Bayer, Milan, Italy) and tileta-
mine/zolepan 20 mg/kg (Zoletil 100, Virbac, Milano, Italy).
2. To reduce the viscosity of these solutions, hence the pressure
needed to infuse these solutions, syringes can be warmed at
37 C before the injection. Please avoid the inclusion of air
bubbles in the catheter filled with the saline solution or with
the contrast agent solution that will be injected into the
animals.
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3. CEST pH measurements are basically performed on Bruker
MR systems as Biospec 117/20 (11.7 T), Avance 300 (7 T),
Pharmascan 70/16 (7 T), or Biospec (3 T) (Bruker, Ettlingen,
Germany). Standard 1H transmit/receive coils (birdcage,
quadrature) or phased-array coils (4- or 8-channel mouse
body phase array receive coil) to improve SNR can be used.
4. WASSR B0 mapping frequency list (in ppm):1.5,1.4,1.3,
1.2,1.1,1.0,0.9,0.8,0.7,0.6,0.5,0.4,0.3,
0.2, 0.1, 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0,
1.1, 1.2, 1.3, 1.4, and 1.5.
5. Scan acquisition parameters for B0 mapping: TR ¼ 5000 ms;
magnetization transfer power¼ 1.5 μT; magnetization transfer
module time ¼ 3 s; MT offset mode ¼ Sequential_Offset;
effective TE ¼ 3.49 ms; RARE Factor ¼ 32; averages ¼ 1;
Fig. 4 Demonstration of the contrast changes that can be expected in pH mapping. CEST weighted images
(from a 2D RARE acquisition, effective TE¼ 3.5 ms) of the kidneys throughout a pH measurement experiment,
together with a final processed image of perfusion. A moving average filter was applied on the time series data
to remove fluctuations in signal due to motion. The percentage of kidney pixels with >20% of maximum
contrast were calculated to obtain the perfusion or filtration fraction map
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centric encoding; slice thickness ¼ 1.5 mm; slice orienta-
tion ¼ axial; frequency encoding ¼ head-feet;
FOV ¼ 28  19 mm; matrix size ¼ 48  48 reconstructed to
128  128; fat suppression ¼ on.
6. Standard Bruker sequences for the software versions PV5 and
PV6 include only a Magnetization Transfer module that allows
the saturation of a single frequency offset. As a consequence,
full Z-spectrum acquisition can only be acquired by cloning the
same scan and modifying for each scan the irradiated frequency
offset. Therefore, for in vivo experiments this may lead to
acquisition times that are not feasible in reasonable time. Bru-
ker sequences for PV5 and PV6 that have been modified to
accept a frequency list for acquiring the full Z-spectrum in a
single scan are available upon request to the authors (dario.
longo@unito.it; mtmcmaho@gmail.com; pzhesun@emory.
edu). Starting from PV360 a new CEST module has been
implemented with different readout sequences (RARE, EPI,
Spiral) that allows to fix this issue. MR Solutions vendor has
already a CEST module that can be applied with an EPI-based
readout scheme.
7. Frequency list (in ppm) for a full Z-spectrum acquisition
(43 offsets): 0, 0.5, 0.5, 1.0, 1.0, 1.5, 1.5, 2.0, 2.0,
3.0, 3.0, 3.9, 3.9, 4.0, 4.0, 4.1, 4.1, 4.2, 4.2, 4.3,
4.3, 4.4, 4.4, 4.5, 4.5, 5.2, 5.2, 5.3, 5.3, 5.4, 5.4,
5.5, 5.5, 5.6, 5.6, 5.7, 5.7, 5.8, 5.8, 7.5, 7.5, 10.0,
and 10.0.
8. Example for a 30 g mouse at 7 T: TR ¼ 6000 ms; magnetiza-
tion transfer power ¼ 3 μT; magnetization transfer module
time¼ 5 s;MToffset mode¼ from file; effective TE¼ 4.14ms;
RARE Factor ¼ 96; averages ¼ 1; centric encoding; slice
thickness¼ 1.5 mm; slice orientation¼ axial; frequency encod-
ing ¼ head-feet; FOV ¼ 30 mm; matrix size ¼ 96  96 recon-
structed to 128  128; fat suppression ¼ on.
9. Example for a 150 g rat at 4.7 T: Z-spectra are collected with
moderate saturation RF power (B1) levels of 1.0 and 2.0 μT.
The in vivo CEST MRI parameters were as the following: RF
saturation offsets from 7.0 to 7.0 ppm with intervals of
0.125 ppm, and TR, TS and TE were 6 s, 3 s, and 18 ms,
respectively, for an image matrix of 48  48.
10. For rats increase the FOV to the body width and keep the
matrix size the same or similar. The relative resolution is then
identical and the SNR should also be similar, because the larger
rat RF coil provides worse SNR (e.g., eight-channel rat body
phase array receive coil vs eight-channel mouse body phase
array receive coil).
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11. Example for a 30 g mouse at 11.7 T: TR ¼ 9000 ms; magneti-
zation transfer power ¼ 4 μT; magnetization transfer pulse
number¼ 10; magnetization transfer inter pulse delay¼ 10 μs;
magnetization transfer pulse length ¼ 300 ms; magnetization
transfer module time ¼ 3 s; MT offset mode ¼ from file;
effective TE ¼ 3.49 ms; RARE Factor ¼ 32; averages ¼ 1;
centric encoding; slice thickness ¼ 1.5 mm; slice orienta-
tion ¼ axial; frequency encoding ¼ head-feet;
FOV ¼ 28  19 mm2; matrix size ¼ 48  48 using partial
Fourier of 1.5; fat suppression ¼ on.
12. Phantom CEST acquisition parameters at 7 T: RF saturation
offsets from10.0 to 10.0 ppm with intervals of 0.1–0.2 ppm.
TR ¼ 10s, TE ¼ 4.8 ms, saturation ¼ 3 μT  5 s, matrix
size ¼ 64  64, FOV ¼ 30  30 mm2 with centric encoding.
13. Phantom CEST acquisition parameters at 4.7 T: RF saturation
offsets from7 to 7 ppmwith intervals of 0.25 ppm. TR¼ 12 s,
TE ¼ 39.5 ms, saturation: 1, 1.5, 2, 2.5, 3 and 4 μT  5 s,
matrix size ¼ 64  64, FOV ¼48  48 mm with centric
encoding.
14. Phantom CEST acquisition parameters at 11.7 T:: 25 mm
transmit/receive volume coil; TR ¼ 5000 ms; magnetization
transfer power ¼ six different saturation power (B1) from 1 to
6 μT; magnetization transfer module time ¼ 3 s; MT off-
set mode ¼ Sequential_Offset; 71 CEST offsets between
7 ppm plus one at +40 ppm forM0; effective TE ¼ 3.39 ms;
RARE Factor ¼ 16; averages ¼ 1; centric encoding; slice -
thickness ¼ 1.0 mm; slice orientation ¼ axial; frequency
encoding ¼ head-feet; FOV ¼ 28  19 mm2; matrix
size ¼ 64  48.
15. Mice can be alternatively anesthetized with intramuscular anes-
thesia, tail veins heated with hot water/heater equipment at
37 C and catheter placed in the animal.
16. You must monitor the respiration continuously throughout
the entire experiment.
17. B0 Shimming is particularly important, since macroscopic mag-
netic field inhomogeneities affect the exact resonance fre-
quency of the labile protons in a voxel, and can impact the
pH and perfusion measurements and hinder quantitative intra-
and inter-subject comparisons. Shimming should be per-
formed on a voxel enclosing both kidneys using either the
default iterative shimming method or the Mapshim technique
(recommended).
18. Injections can be manually or automatically performed. For
manual injection, keep injection constant within 20–30 s.
Automatic injection can be performed with dedicated injection
pumps, by setting injection speed of contrast agent at 400 μl/
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min. For instance, a 25 g mouse would receive ca 70 μl to
achieve a dose of 1 g iodine/kg b.w. with a stock solution of
370 mg iodine/ml.
19. The exact list of frequencies used here can be adjusted based on
the B0 shimming conditions of the kidneys and the saturation
power applied. For example, if the B0 varies by more than say
0.1 ppm, additional frequencies around each labile proton
should be added to allow B0 correction at the expense of
SNR due to the reduced redundancy of the data collected.
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Farion R, Ballesteros P, Coles JA, Cerdán S,
Ziegler A (2001) Mapping extracellular pH in
rat brain gliomas in vivo by H magnetic reso-
nance spectroscopic imaging: comparison with
maps of metabolites. Cancer Res 61
(17):6524–6531
15. Gillies R, Liu Z, Bhujwalla Z (1994) 31P-MRS
measurements of extracellular pH of tumors
using 3-aminopropylphosphonate. Am J Phys
Cell Phys 267(1):C195–C203
16. Gillies RJ, Morse DL (2005) In vivo magnetic
resonance spectroscopy in cancer. Annu Rev
Biomed Eng 7:287–326
17. Vermathen P, Capizzano AA, Maudsley AA
(2000) Administration and 1H MRS detection
of histidine in human brain: application to
in vivo pH measurement. Magn Reson Med
43(5):665–675
18. Bhujwalla ZM,McCoy C, Glickson J, Gillies R,
Stubbs M (1998) Estimations of intra-and
extracellular volume and pH by 31P magnetic
resonance spectroscopy: effect of therapy on
RIF-1 tumours. Br J Cancer 78(5):606
19. Aoki Y, Akagi K, Tanaka Y, Kawai J, Takahashi
M (1996) Measurement of intratumor pH by
pH indicator used in 19F-magnetic resonance
spectroscopy: measurement of extracellular pH
decrease caused by hyperthermia combined
with hydralazine. Investig Radiol 31
(11):680–689
20. Zhou R, Bansal N, Leeper DB, Glickson JD
(2000) Intracellular acidification of human
melanoma xenografts by the respiratory inhibi-
tor m-iodobenzylguanidine plus
hyperglycemia: a 31Pmagnetic resonance spec-
troscopy study. Cancer Res 60(13):3532–3536
21. Ojugo AS, McSheehy PM, McIntyre DJ,
McCoy C, Stubbs M, Leach MO, Judson IR,
Griffiths JR (1999) Measurement of the extra-
cellular pH of solid tumours in mice by mag-
netic resonance spectroscopy: a comparison of
exogenous 19F and 31P probes. NMR Biomed
12(8):495–504
22. Gallagher FA, Kettunen MI, Day SE, Hu D-E,
Ardenkjær-Larsen JH, Jensen PR, Karlsson M,
Golman K, Lerche MH, Brindle KM (2008)
Magnetic resonance imaging of pH in vivo
using hyperpolarized 13C-labelled bicarbon-
ate. Nature 453(7197):940–943
23. Garcia-Martin ML, Martinez GV,
Raghunand N, Sherry AD, Zhang S, Gillies
RJ (2006) High resolution pHe imaging of
rat glioma using pH-dependent relaxivity.
Magn Reson Med 55(2):309–315
24. McMahon MT, Gilad AA, Bulte JWM, van Zijl
PCM (2017) Chemical exchange saturation
transfer imaging: advances and applications,
1st edn. Pan Stanford Publishing, Singapore
25. Longo D, Aime S (2017) Iodinated contrast
media as pH-responsive CEST agents. In:
McMahon MT, Gilad AA, JBM B, PCM VZ
(eds) Chemical exchange saturation transfer
imaging. Vol. Advances and applications. Pan
Stanford Publishing, Singapore, pp 447–466.
https://doi.org/10.1201/
9781315364421-20
26. Pavuluri K, McMahonMT (2017) pH imaging
using chemical exchange saturation transfer
(CEST) MRI. Isr J Chem 57(9):862–879.
https://doi.org/10.1002/ijch.201700075
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Chapter 28
Sodium (23Na) MRI of the Kidney: Experimental Protocol
James T. Grist, Esben Søvsø Hansen, Frank G. Zöllner,
and Christoffer Laustsen
Abstract
Sodium handling is a key physiological hallmark of renal function. Alterations are generally considered a
pathophysiologic event associated with kidney injury, with disturbances in the corticomedullary sodium
gradient being indicative of a number of conditions. This experimental protocol review describes the
individual steps needed to perform 23Na MRI; allowing accurate monitoring of the renal sodium distribu-
tion in a step-by-step experimental protocol for rodents.
This chapter is based upon work from the PARENCHIMA COST Action, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter is complemented by two separate chapters describing the basic concept and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, 23Na, Sodium
1 Introduction
Sodium is an essential body fluid electrolyte, with serum concen-
tration tightly controlled by the renal proximal and distal tubules,
the loop of Henle, and the collecting duct through a complex
process of active reabsorption via transport proteins [1]. Electrolyte
reabsorption requires large quantities of adenosine triphosphate
(ATP), to move ions against the concentration gradient, produced
via the mitochondrial tricarboxylic acid (TCA) cycle [1–3]. To fuel
TCA activity, oxygen is delivered via a network of arterial vessels to
the renal system. However, should the renal system undergo injury,
for example in acute kidney injury or chronic renal disease, the
delivery of oxygen to local tissues may be disrupted, and subse-
quently the gradient of sodium from the cortex to the medulla
impaired [4].
In this chapter we describe the process of undertaking sodium
MRI for assessing alterations of the corticomedullary sodium
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gradient in the kidney of rodents in a step-by-step experimental
protocol. We also describe the rationale for acquisition parameter
selection, with generic terms, with specific examples for rodent
imaging on a small-bore animal MR system (Bruker Biospin, Ettlin-
gen, Germany), and porcine imaging on whole body human MR
scanner (General Electric, Waukesha, USA). Finally, we discuss the
effects of acute diuretics such as furosemide to demonstrate altera-
tions in renal sodium handling.
This experimental protocol chapter is complemented by two
separate chapters describing the basic concept and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)








1. 5 mL Eppendorf tubes.
2. Agarose.
3. 5 g Sodium chloride.
4. Microwave oven.
5. Beaker (microwave safe).
6. Deionized water.
2.1.2 Process to Make
4% Agarose Phantoms
(Example
60 and 150 mmol/L
Phantoms)
1. Weigh 350 mg sodium chloride.
2. Weight 25 g agarose.
3. Add both to a beaker with 100 mL of deionized water and stir
until dissolved.
4. Heat solution in a microwave oven in 30 s intervals, until
thickened.
5. Pipette 5 mL of solution in to Eppendorf tubes.
6. Repeat for 150 mmol/L phantom, weighing 875 mg sodium
chloride for an equivalent volume of water.
7. Leave Eppendorf tubes to cool for 24 h and seal with Parafilm.
2.2 Animals This experimental protocol is tailored for rats (Wistar, Sprague-
Dawley or Lewis) with a body mass of 300–350 g or pigs 20–40 kg.
2.3 Lab Equipment 1. Anesthesia: please refer to the chapter by Kaucsar T et al.
“Preparation and Monitoring of Small Animals in Renal
MRI” for an in-depth description and discussion of the anes-
thesia. For nonrecovery experiments urethane solution (Sigma-
Aldrich, Steinheim, Germany; 20% in distilled water) can pro-
vide anesthesia for several hours with comparatively fewer side
effects on renal physiology, which is an important issue.
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2. Gases: O2, N2, and compressed air, as well as a gas-mixing
system (FMI Föhr Medical Instruments GmbH, Seeheim-
Ober Beerbach, Germany) to achieve required changes in the
oxygen fraction of inspired gas mixture (FiO2).
3. Device for FiO2 monitoring in gas mixtures: for example,
Capnomac AGM-103 (Datex GE, Chalfont St Gils, UK).
4. A physiological monitoring system that can track the respira-
tion, and which is connected to the MR system such that it can
be used to trigger the image acquisition.
2.4 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter has been tailored
for a 7 and 3 T MR system (Biospec 94/20, Bruker Biospin,
Ettlingen, Germany and MR750, General Electric, Milwaukee,
USA), but advice for adaptation to other field strengths is given
where necessary. An additional dual or single tuned 1H/23Na
surface or volume coil is required, as well as multinuclear capabil-






1. Sequence type: 3D gradient echo sequence. This is a standard
sequence on Bruker MRI systems. See Notes 1–3 for details.
2. Repetition time (TR): Choose 2.5 greater than the T1 of
sodium in free fluid (T1 approx. 70 ms at 7 T).
3. Flip angle (FA): 90.
4. Echo time (TE): The minimum TE achievable on the system is
used to acquire the rapidly decaying signal.
5. Acquisition bandwidth (BW): Use the highest acquisition
bandwidth possible to shorten the echo time; however, this
will lead to a decrease in SNR. Low SNR may be countered by
signal averaging.
6. Respiration trigger: on (per excitation).
7. Geometry: adapt so that animal fits into FOV in L-R direction.
8. Spatial resolution: adapt to the physiological resolution aimed
for in the study at hand. Recommend 1 mm  1 mm in rats.
9. Crushing: Ensure signal is crushed at the end of each readout,
to ensure spoiling of latent T ∗2 signal.
3.1.2 Total Sodium
Imaging (General Electric)
1. Sequence type: Fidall. This is a research pulse sequence from
GE. See Notes 4–6 for sequence details.
2. Calibration can be performed using the inbuilt Bloch–Siegert
calibration sequence.
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3. Readout type: 3D cones. Waveforms can be generated using
code available online (http://www-mrsrl.stanford.edu/
~ptgurney/cones.php).
4. Repetition time (TR): Choose 2.5 greater than the T1 of
sodium in free fluid (T1 approx. 50 ms at 3 T).
5. Flip angle (FA): Ernst-angle (typically 70–90).
6. Echo time (TE): The minimum TE achievable on the system is
used to acquire the rapidly decaying signal.
7. Acquisition bandwidth (BW): Use the highest acquisition
bandwidth possible to shorten TE, however this will lead to a
decrease in SNR. Low SNR may be countered by signal
averaging.
8. Respiration trigger: on (minimum 6 per excitation).
9. Geometry: adapt so that animal fits into FOV in L-R direction.
10. Crushing: Ensure signal is crushed at the end of each readout,
to ensure spoiling of latent T ∗2 signal using crusher gradients.
3.1.3 T∗2 Mapping
(BRUKER)
1. Sequence type: 3D gradient echo sequence. This is a standard
sequence on Bruker MRI systems, where it is called “3D gradi-
ent echo” (see Note 1 for sequence details).
2. Repetition time (TR): Choose 2.5 greater than the T1 of
sodium in free fluid (T1 approx. 70 ms at 7 T).
3. Flip angle (FA): 90.
4. Echo time (TE): The minimum TE achievable on the system is
used to acquire the rapidly decaying signal.
5. Acquisition bandwidth (BW): Use the highest acquisition
bandwidth possible to shorten TE, however this will lead to a
decrease in SNR. Low SNR may be countered by signal
averaging.
6. Geometry: adapt so that animal fits into FOV in L-R direction.
7. Spatial resolution: adapt to the physiological resolution aimed
for in the study at hand. Recommend 1 mm  1 mm in rats.
8. Crushing: Ensure signal is crushed at the end of each readout
to ensure spoiling of latent T ∗2 signal using crusher gradients.
9. Repeat acquisition using same prescan parameters with incre-
mented TE, ensuring at least five echo times are collected. We




1. Sequence type: 2D or 3D chemical shift imaging sequence.
This is a standard sequence on preclinical MRI and clinical
MRI systems. See Notes 7 and 8 for sequence details.
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2. Repetition time (TR): Choose 2.5 greater than the T1 of
sodium in free fluid (T1 approx. 70 ms at 7 T).
3. Echo time (TE): choose the shortest possible for good signal-
to-noise.
4. Flip angle (FA): 90 or according to the Ernst angle.
5. Acquisition bandwidth (BW): Choose BW and NP to ensure
sufficient resolution and acquisition time of approximately
2.5  T ∗2 .
3.1.5 Calibration Scans 1. Perform a reference scan with above given parameters using a
homogeneous phantom to acquire the receive sensitivity of the
RF coils and gradient trajectory (see Note 8).
2. Coregistration of reference and the scans of Subheading 3.1.1–
3.1.4.
3. Obtain sensitivity corrected images by the quotient image of
both coregistered images concentration.
4. For B1 mapping (double angle method) perform a measure-
ment using a homogeneous phantom and scan parameters
reported in Subheading 3.1.1 and flip angles of α1 ¼ 40,
α2 ¼ 80.
3.2 In Vivo Sodium
Imaging
3.2.1 Preparations
1. Anesthetize the animal, obtained venous access (tail vein for rat
and ear vein for pig) and transfer it to scanner.
2. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit.
3. Fixate the sodium phantoms to the animal near the
imaging area.
4. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.”
3.2.2 Baseline Condition 1. Load the 3D GRE sequence, altering the slice orientation to
the desired acquisition plane.
2. Triggering: in the monitoring unit set the trigger delay so that
the trigger starts at the beginning of the expiratory plateau
(no chest motion) and the duration such that it covers the
entire expiratory phase, that is, until just before inhalation
starts.
3. Run the sodium scan. Example images are shown in Fig. 1.
3.2.3 Imaging
Furosemide Action
1. Duplicate the sodium scan.
2. Introduction of furosemide: Inject 10 mg/kg furosemide via
tail vein catheter and begin image acquisition.
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3. Continue to acquire sodium imaging for up to one hour post
the introduction of furosemide.
4. A demonstration of the sodium changes that can be expected in
pathophysiological scenarios is given in Fig. 2.
3.2.4 T∗2 Mapping 1. Load the 3D GRE multiecho sequence, altering the slice ori-
entation to the desired acquisition plane.
2. Triggering: in the monitoring unit set the trigger delay so that
the trigger starts at the beginning of the expiratory plateau
(no chest motion) and the duration such that it covers the entire
expiratory phase, that is, until just before inhalation starts.
3. Run the sodium scan.
Fig. 1 Example 1H (left) and 23Na (right) rodent renal imaging acquired at 9.4 T, acquisition time ¼ 3.5 min
Fig. 2 Example corticomedullary sodium gradient, healthy (black) and impaired
rodent kidney (orange)
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4 Notes
1. Example 3D gradient echo sequence parameters at 4.7 T: 90
sine/cosine adiabatic pulse, echo-time/repetition-time
(TE/TR) of 1.7/60 ms, FOV 12  12  5–8 cm3, and a
matrix of 128  128  16 with ten scans (20 min scan time).
2. Example 3D gradient echo sequence parameters at 7 T: 90 sine/
cosine adiabatic pulse, echo-time/repetition-time (TE/TR) of
1.7/180 ms, FOV 12  12  5–8 cm3, and a matrix of
128  128  16 with ten scans (60 min scan time).
3. Example dynamic imaging protocol at 4.7 T: 90 sine/cosine
adiabatic pulse, echo-time/repetition-time (TE/TR) of 1.7/
60 ms, FOV 12  12  5–8 cm3, and a matrix of
128  128  16 with two scans (4 min scan time).
4. 3D cones sequence parameters at 3 T: TR¼ 48 ms; TE¼ 0.5 ms,
flip angle ¼ 90; pulse length 500 μs; receiver band-
width ¼ 250 kHz; readout length ¼ 30 ms, averages ¼ 10;
slice orientation ¼ coronal oblique;
FOV ¼ (240  240  240) mm; matrix size ¼ 60  60  60
zero-filled to 120  120  120 (10 min scan time).
5. Example dynamic imaging protocol at 3 T: TR ¼ 48 ms;
TE ¼ 0.5 ms, flip angle ¼ 90; pulse length 500 μs; receiver
bandwidth ¼ 250 kHz; readout length ¼ 30 ms, averages ¼ 5;
slice orientation¼ coronal oblique; FOV¼ (240 240 240)
mm; matrix size ¼ 60  60  60 zero-filled to
120  120  120 (5 min scan time).
6. Example 3D radial UTE protocol at 9.4 T: TR ¼ 150 ms;
TE ¼ 185 μs; 90 block pulse length of 350 μs; each radial
projection was recorded in 6.4 ms of read out time (Tro) using
a low acquisition bandwidth of 5 kHz; undersampling factor of
3; number of projections to 4206, nominal anisotropic resolu-
tionof (114)mm3, andFOV¼64mm64mm64mm;
TR ¼ 50 ms.
7. 2D CSI sequence parameters at 9.4 T: Example for a 300 g rat at
9.4 T: TR ¼ 65 ms; TE ¼ 0.65 ms, flip angle ¼ 90; pulse
length 500 μs; receiver bandwidth ¼ 8 kHz; number of
points ¼ 256 complex points, averages ¼ 8; slice orienta-
tion ¼ axial oblique; FOV ¼ (60  60) mm; matrix
size ¼ 32  32 zero-filled to 64  64; 1 slice with 1–2 cm
thickness; TA ¼ 67 s (without triggering).
8. Rapid MR-imaging sequences using non-Cartesian sampling
are known to be sensitive to gradient hardware imperfections
and eddy-current effects that can superimpose acquired data.
This is a common problem on preclinical MRI systems which
compared with human MRI systems are equipped with
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approximately 20-fold stronger (740 mT/m maximal gradient
amplitude) and 30-fold faster gradient systems (6900 T/m/
s gradient slew rate). To overcome this a calibration by measur-
ing the readout trajectory on a phantom should be performed.
For further details please see [5].
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Chapter 29
Hyperpolarized Carbon (13C) MRI of the Kidney:
Experimental Protocol
Christoffer Laustsen, Cornelius von Morze, and Galen D. Reed
Abstract
Alterations in renal metabolism are associated with both physiological and pathophysiologic events. The
existing noninvasive analytic tools including medical imaging have limited capability for investigating these
processes, which potentially limits current understanding of kidney disease and the precision of its clinical
diagnosis. Hyperpolarized 13C MRI is a new medical imaging modality that can capture changes in the
metabolic processing of certain rapidly metabolized substrates, as well as changes in kidney function. Here
we describe experimental protocols for renal metabolic [1-13C]pyruvate and functional 13C-urea imaging
step-by-step. These methods and protocols are useful for investigating renal blood flow and function as well
as the renal metabolic status of rodents in vivo under various experimental (patho)physiological conditions.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers. This experimental
protocol is complemented by two separate chapters describing the basic concept and data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Hyperpolarization, 13C, DNP
1 Introduction
The causal link between renal blood flow (RBF) and glomerular
filtration rate (GFR), tubular reabsorption and thus oxygen/meta-
bolic demand and the development of renal dysfunction is well-
known [1]. Therefore, diagnostic modalities able to image RBF,
GFR, and the metabolic effects have long been sought for.
One such method is hyperpolarized 13C MR, described in the
chapter by vonMorze C et al. “Hyperpolarized Carbon (13C)MRI
of the Kidneys: Basic Concept.” In short, a transient enhancement
of more than 10.000 times in spin polarization of a substrate
molecule, such as [1-13C]pyruvate, is achieved by irradiating a
supercooled mixture of 13C spins and electron spins with a micro-
wave frequency obeying the nuclear Overhauser condition—and
subsequently rapidly dissolved by superheated water [2]. The
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resulting mixture retains the high polarization and allows injection
of metabolic and functional active molecules and subsequent imag-
ing of the substrate and potential metabolic derivatives following
cellular uptake and enzymatic conversion [3, 4]. We will describe
basic experiments using hyperpolarized 13C MRS and MRI for
monitoring of the metabolic conversion of [1-13C]pyruvate and
the intra-renal distribution of 13C-urea in the kidney of rodents in a
step-by-step experimental protocol. The rationale for choosing
acquisition parameters is given in generic terms, together with
specific parameter examples for 3 T, 4.7 T and 9.4 T MRI. Several
imaging sequences to map renal metabolism and function are
described as optional components of the experiment.
This experimental protocol chapter is complemented by two
separate chapters describing the basic concept and data analysis,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals This experimental protocol is tailored for rats (Wistar, Sprague-
Dawley, or Lewis) with a body mass of 200–350 g. Advice for
adaptation to mice is given as Notes where necessary.
2.2 Lab Equipment 1. Anesthesia has been shown to impact renal metabolism using
hyperpolarizedMRI [5]; An appropriate and convenient choice
is the use of gas anesthesia. For in-depth description, see the
chapter by Kaucsar T et al. “Preparation and Monitoring of
Small Animals in Renal MRI.”
2. Gases: O2 with or without additional N2, as well as a gas-mixing
system to achieve required blood oxygen saturation level.
3. Hyperpolarizer equipment, typically the commercial preclinical
polarizer HyperSense (Oxford Instruments Molecular Bio-
tools, Oxford, United Kingdom) or newer variants of this
design [6, 7] as well as the clinical intent polarizer, the
so-called SPINLAB (GE Healthcare, Milwaukee, WI, USA).
4. Vein or artery access, typically tail vein access for fast bolus
infusion of the hyperpolarized substrate either by manual injec-
tion or by infusion pumps [7] (see Note 1).
5. Phantom: A 13C containing phantom is needed to confirm
center frequency and power calibration. A typical phantom
used: 8 M 13C-urea (Sigma, St. Louis, MO, USA) in 90%
H2O and 10% Glycerol with 3 μl/ml Gd contrast agent
(Dotarem; Guerbet, Roissy, France) (see Note 2).
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2.3 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter was tailored for
a 3 T clinical system (GE Healthcare, Milwaukee, WI, USA) and a
9.4 Tesla MR system (Agilent, Yarnton, UK) but advice for adapta-
tion to other field strengths is given where necessary. Additional
hardware is required, for excitation and reception of 13C: X-band
RF amplifiers and signal preamplifiers supporting the resonance
frequency of 13C, 13C transmit and receive RF coils, such as
1H/13C volume RF coils [8–10] as well as transmit/receive
switches adjusted to the resonance frequency of 13C.
1. A physiological monitoring system that can track the respira-
tion, and which is connected to the MR system such that it can





1. Single pulse and acquire sequence to identify 13C phantom
frequency and calibration of the 13C transmitter power for a




1. Sequence type: 2D or 3D chemical shift imaging sequence.
This is a standard sequence on preclinical MRI and clinical
MRI systems [9, 11, 12].
2. Repetition time (TR): choose the shortest possible with suffi-
cient spectral resolution (which is inversely related to the dura-
tion of the data sampling window), for efficient temporal
resolution.
3. Echo time (TE): choose the shortest possible for good signal-
to-noise and reduction of first order phase effects (seeNote 4).
4. Flip angle (FA): adapt to ensure a good compromise between
SNR, T1 relaxation and sufficient signal following repeated
excitations. FA is often a low flip angle of Θ ¼ 5–10 leaving
a factor of cos(θ)n longitudinal magnetization remaining, with
n being the number of excitations (see Note 5).
5. Acquisition bandwidth (BW): set to a value in the typically
range of 4000–20,000 Hz, Number of acquisition points
(NP): 256–2048 [9, 11, 12]. Choose BW and NP to ensure
sufficient resolution and acquisition time of approximately
2.5  T2*.
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6. K-space ordering: use conventional view ordering, which will
result in the center of k-space being sampled late in the acqui-
sition (see Note 6).




1. Sequence type: 2D or 3D echo-planar spectroscopic imaging
(EPSI) with or without double spin echo refocusing. This
approach superimposes an oscillating readout gradient onto
CSI acquisition, replacing one of the phase encoding dimen-
sions needed for CSI. This is not a standard sequence on most
preclinical or clinical MRI systems [9, 13, 14].
2. Spectral bandwidth (BW): set spectral BW in the order of
500–600 Hz. The EPSI readout is limited by gradient switch-
ing and thus only much lower spectral acquisition bandwidths
than CSI are achievable, with outside resonances potentially
aliasing into the spectral window. Spectral bandwidth can be
traded for spatial resolution but is typically in the order of
500–600 Hz (see Note 8) for a spatial resolution of ~5 mm.
3. Flip angle (FA): adapt to ensure a good compromise between
SNR, T1 relaxation, and sufficient signal following repeated
excitations. FA is often a low flip of Θ ¼ 5–10 leaving a factor
of cos(θ)n longitudinal magnetization remaining, with n being
the number of excitations (see Note 5).
4. Respiration trigger: can be added to improve the spatial
localization.
5. Geometry: adapt so that animal fits into FOVand both kidneys
are covered. Axial or coronal directions are most often used.




1. Sequence type: 2D multi-gradient echo sequence. This is a
standard sequence on preclinical MRI systems; alternatively,
single timepoint acquisitions such as EPI or spiral readout can
be used [15–18] (see Note 10).
2. Repetition time (TR): choose the shortest possible with suffi-
cient distinct echo times, for highest temporal resolution.
3. Flip angle (FA): adapt to ensure a good compromise between
SNR, T1 relaxation and sufficient signal following repeated
excitations. FA is often a low flip of Θ ¼ 5–10 utilizing cos
(θ)n of excitations of the nonrecoverable magnetization.
n being the number of excitations.
4. Echo time (TE): set the number of echoes toN + 1 echoes with
N being the number of peaks to be resolved. TE is determined
by the ability to separate the a priori known peaks to resolve.
This can be calculated using the number of signal averages
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(NSA) [17]. A rule of thumb is that minimallyN + 1 echoes are
needed to accurately resolve N peaks.
5. Acquisition bandwidth (BW): use a high BW to shorten ΔTE,
to ensure good separation of the peaks according to NSA.
6. Respiration trigger: on (per slice), can be added to improve the
spatial localization.
7. Geometry: adapt so that animal fits into FOVand both kidneys
are covered. Axial or coronal directions are most often used.
8. For an example of a specific parameter set, please see Note 11.
9. Use double spin echo (DSE) or flow gradients to suppress
flowing spins [19, 20] (optional).
3.1.5 Spectral-Spatial
Imaging
1. Sequence type: 2D spectral-spatial excitation with Cartesian,
EPI or spiral trajectory readout [8, 21–23] or 3D sequences
with or without slice selection and thus spectrally selective
narrow band pulses [24] (see Note 12).
2. Repetition time (TR): adapt to the respiration. If respiration is
triggered, the effective TR will be given by the respiration
trigger and will be the respiration interval, that is, one excita-
tion per breath. Choose TR to be a little shorter (about
100 ms) than the average respiration interval that is displayed
on the physiological monitoring unit (see Note 13).
3. Flip angle (FA): use a low FA (in the range of 3–8) on the
substrate peak ([1-13C]pyruvate) and high FA (in the range of
30–90) on the metabolic derivatives, to preserve magnetiza-
tion for metabolic conversions allowing a longer temporal
window in dynamic studies, and allowing saturation recovery
kinetics to be fitted.
4. For an example of a specific parameter set, please see Note 14.
3.1.6 Perfusion Imaging 1. Sequence type: 2D/3D balanced steady state free precession
(bSSFP) sequence [25–27].
2. Repetition time (TR): use shortest possible TR for high tem-
poral resolution. If triggering respiration, adapt to the respira-
tion. The effective TR will be given by the respiration trigger
and will be the respiration interval, that is, one frame per
breath. Ideally choose NP  TR to be shorter (about
100 ms) than the average respiration interval that is displayed
on the physiological monitoring unit.
3. For perfusion assessment use full saturation of the inflowing
spins or (optional) a lower flip angle (in the range of 10–30)
[28, 29].
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4. Use preparation pulses (optional) to improve magnetization
utilization; typically, α/2 pulses before and after the bSSFP
train to achieve faster pseudo-steady state and to retain the
magnetization for subsequent scans [30].
5. For an example of a specific parameter set, please see Table 1.
3.2 In Vivo 13C MR
3.2.1 Preparations
1. Anesthetize the animal and transfer it to the scanner.
2. Place 13C enriched phantom in the FOV (see Note 15).
3. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit.
4. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.”
5. Perform localized shimming on the kidney imaging as
described in the chapter by Pohlmann A et al. “Essential Prac-
tical Steps for MRI of the Kidney in Experimental Research”
(see Note 16).





1. Load the 13C sequence of choice, adapt the slice orientation to
provide a coronal or axial view with respect to the kidney
(in scanner coordinates this is double-oblique).
2. Triggering (13C): in the monitoring unit set the trigger delay so
that the trigger starts at the beginning of the expiratory plateau
(no chest motion) and the duration such that it covers the
entire expiratory phase, that is, until just before inhalation
starts.
3. Run the 13C imaging scan (see Note 18). Examples of images
are shown in Figs. 1, 2, 3, and 4.
Table 1









angle () Preparation References
2D at 3 T 11.5/
5.7










48  48  48 60 20 15 – [25]
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3.3 Emerging
Sequences
Several novel alternative strategies have been proposed for various
imaging applications and just to mention a few there are control of
the inflowing spins with bolus tracking [31, 32], spatiotemporal
encoding [33], improved resolution by spatially shaped excitations
[32, 34]. Variations of the balanced steady state sequences [35, 36]
hold potential for further improvement by optimally designing the
imaging strategy toward the long T2’s seen in most
13C molecules.
Relaxation contrast is another potential renal contrast mechanism,
showing substantial promise to improve the diagnostic potential of
hyperpolarized MR [37–40].
Fig. 1 Series of axial metabolic maps (color) from a 2D CSI overlaid on 1H anatomical scans (grayscale),
showing the individual metabolites after integration of the individual peaks
Fig. 2 Examples of axial IDEAL spiral sequence in the kidney at 3 T
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4 Notes
1. In order to allow optimal usage of the substrate, keep dead-
volume as small as possible for injection line; injection speed is
typically 0.1 ml/s and up to 2 ml for a rat. If the sequence is
single timepoint imaging method or flow artifacts are corrupt-
ing the images with a minimum of 20 s time delay from start of
injection it is an appropriate choice for intrarenal metabolism
and function of the rodent kidneys.
Fig. 3 Examples of coronal spectral spatial (spsp) excitation sequence in the kidney at 3 T
Fig. 4 2D BSSFP dynamic coronal imaging of hyperpolarized [13C,15N2]urea at 3 T. Using a 180 flip angle,
0.92 mm in plane resolution, no slice select. The imaging durations were 1 s separated by 4 s delays, with
catalyzation/decatalyzation pulses before and after each image
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2. Ensure short enough T1 of the
13C phantom to allow rapid
frequency and power calibration. Caution, due to B0 variation
the reference 13C peak is not always representative of the in vivo
position.
3. Frequency calibration and power calibration can be done in a
similar manner as any 1H experiment with a centering on the
phantom peak and running a power calibration using a stan-
dard nutation experiment. Calibrating with a 180 pulse is
desirable as the signal changes more rapidly as a function of
applied power than with a 90 pulse. Alternatively, a Bloch–
Siegert shift method can be used [41].
4. As the RF pulse length contributes to the TE and the RF flip
often is very low, it is often possible to shorten the TE by
reducing the RF pulse length.
5. Signal decay over the phase encoding steps, either due to T1
decay or consumption of magnetization due to RF pulses (i.e.,
T2). Constant flip angle excitation constitutes a k-space filter
that can introduce significant image blurring. Alternatively, an
increasing flip angle can be employed to compensate for such
effects [42].
6. A variety of CSI sampling patterns can be adopted to optimize
temporal constraints, SNR, and partial volume effects [9].
7. Example for a 300 g rat at 9.4 T: TR ¼ 70 ms; TE ¼ 0.68 ms,
flip angle ¼ 10; pulse length 500 us; receiver band-
width ¼ 8 kHz; number of points ¼ 512 complex points
(i.e., 1024), averages ¼ 1; slice orientation ¼ axial oblique;
FOV ¼ (60  60) mm; matrix size ¼ 16  16 zero-filled to
32  32; 1 slice with 1–2 cm thickness; TA ¼ 17 s (without
triggering).
8. The low bandwidth will typically require prior knowledge of
the peaks of interest and their folding patterns to fully recover
the spectral information [9].
9. Example 3D EPSI for a 300 g rat at 3 T: An EPSI sequence
with double spin echo refocusing (13). Images are acquired
with (8  8  8) mm3 voxel size and a matrix size of
18  10  8, coronal view, with a TR of 215 ms, TE of
140 ms, and a spectral width 543 Hz.
10. The multispectral signals are resolved by fitting to a signal
model with unknown components at known frequency offsets.
B0 offset is typically an important component of the model and
is fitted along with the spectral components or estimated sepa-
rately (see https://github.com/LarsonLab/hyperpolarized-
mri-toolbox).
11. Example: 2D IDEAL-spiral for a 300 g rat at 3 T (18):
TR ¼ 100 ms; TE ¼ 0.9 ms; flip angle ¼ 10; 11 IDEAL
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echoes with ΔTE values 0.9 ms, determined by the NSA for-
malism to resolve [1-13C]pyruvate, [1-13C]lactate, [1-13C]ala-
nine, [1-13C]pyruvate hydrate, [13C]bicarbonate. Slice
orientation ¼ axial oblique; FOV ¼ (80  80) mm2; matrix
size ¼ 32  32; 5 mm  5 mm real spatial resolution; 1 slice
with 1–2 cm thickness covering both kidneys. Dynamic acqui-
sition over 60–80 s.
12. Offset frequencies for individual metabolites must be specified
a priori. It is important to note that the frequency might be
different than the in vivo version of a given phantom metabo-
lite and thus it is important to verify the correct frequency.
13. Monitor the respiration continuously throughout the entire
experiment and if necessary adapt the TR accordingly for the
13C examination.
14. Example: 2D spectral-spatial for a 300 g rat at 3 T (20):
TR ¼ 1 s; TE ¼ 10 ms; flip angle ¼ 90 on [1-13C]lactate,
flip angle¼ 15 on [1-13C]pyruvate;, flip angle¼ 90 on [13C]
bicarbonate and flip angle ¼ 90 on [1-13C]alanine; slice ori-
entation ¼ axial oblique; FOV ¼ (80  80) mm; matrix
size ¼ 32  32; 5 mm  5 mm real spatial resolution; 1 slice
with 1–2 cm thickness covering both kidneys. Dynamic acqui-
sition over 60–80 s.
15. Be careful with the frequency shift between in vivo and ex vivo
phantom conditions.
16. B0 shimming is particularly important, since macroscopic mag-
netic field inhomogeneities shorten T2*, and potentially shift
the peak positions relative to the main magnetic field. Shim-
ming should be performed on a voxel enclosing only the
kidney using either the default iterative shimming method or
manual shimming.
17. It is often possible to retain a similar B1 amplitude for similar
sized animals. 13C Tx gain and Tx/Rx frequency is largely
similar in rats and mice and thus the differences should be
small between experiments (typically below 1 dB and 50 Hz).
18. A good starting point is to use the same relative resolution as
for rats. For this, reduce the FOV to the mouse body width and
keep the matrix size the same.
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Chapter 30
Fluorine (19F) MRI for Assessing Inflammatory Cells
in the Kidney: Experimental Protocol
Min-Chi Ku, Adrian Schreiber, Paula Ramos Delgado,
Philipp Boehm-Sturm, Ralph Kettritz, Thoralf Niendorf,
Andreas Pohlmann, and Sonia Waiczies
Abstract
Inflammation is one underlying contributing factor in the pathology of acute and chronic kidney disorders.
Phagocytes such as monocytes, neutrophils and dendritic cells are considered to play a deleterious role in
the progression of kidney disease but may also contribute to organ homeostasis. The kidney is a target of
life-threatening autoimmune disorders such as the antineutrophil cytoplasmic antibody (ANCA)-associated
vasculitides (AAV). Neutrophils and monocytes express ANCA antigens and play an important role in the
pathogenesis of AAV. Noninvasive in vivo methods that can quantify the distribution of inflammatory cells
in the kidney as well as other organs in vivo would be vital to identify the causality and significance of
inflammation during disease progression. Here we describe an noninvasive technique to study renal
inflammation in rodents in vivo using fluorine (19F) MRI. In this protocol we chose a murine ANCA-
AAV model of renal inflammation and made use of nanoparticles prepared from perfluoro-5-crown-15-
ether (PFCE) for renal 19F MRI.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European Union,
which aims to improve the reproducibility and standardization of renal MRI biomarkers. This experimental
protocol chapter is complemented by two separate chapters describing the basic concept and data analysis.
Key words Magnetic resonance imaging (MRI), Fluorine (19F), Nanoparticles (NPs), Inflammation,
Kidney, Mice
1 Introduction
Inflammation is one underlying contributing factor in the pathol-
ogy of acute and chronic kidney disorders [1]. Studies also suggest
that systemic inflammation can cause ischemic injury in a vital
organ, such as the kidney, which could then result in repercussions
in another distant organ downstream of the ischemic event, such as
the heart [2–4]. Early inflammatory events governed by cells of the
innate immune system, such as macrophages, probably promote
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_30, © The Author(s) 2021
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renal tissue injury but may also support repair [5–8]. Phagocytes
such as dendritic cells (DC) andmacrophages are considered to play
a deleterious role in the inflammatory outcome of chronic kidney
disease but may also contribute to organ homeostasis [9].
The kidney is often a target of systemic autoimmune disorders
that are compounded by complex inflammatory processes
[10]. Examples of life-threatening autoimmune disorders that affect
the kidneys are the antineutrophil cytoplasmic antibody (ANCA)-
associated vasculitides (AAV) manifesting as rapidly progressive nec-
rotizing crescentic glomerulonephritis (NCGN) [11]. Neutrophils
and monocytes express ANCA antigens and ANCA induces neutro-
phil extracellular traps that cause RIPK1-dependent endothelial cell
(EC) damage via activation of the alternative complement pathway
[12]. While the central role of neutrophil activation in ANCA-
associated vasculitis and NCGN is clear, the role of monocytes/
macrophages was only recently uncovered in a renal ANCA-
associated vasculitis model [13].
Noninvasive in vivo methods that can quantify the level of
inflammation in the kidney as well as other organs in system autoim-
mune disorders such as ANCA-associated vasculitides would be vital
to identify the causality and significance of inflammation during the
course of disease. One method to visualize inflammation by MRI
makes use of MR contrast agents that modulate T2
* and that are
easily taken up by phagocytic inflammatory cells [14, 15]. Iron oxide
particles including ultrasmall iron oxide agents (USPIO) have been
used as susceptibility (T2
*) MR contrast agents to target inflamma-
tory cell populations. These particles are engulfed by phagocytic cells
in the blood. Drawbacks of USPIO-based T2
* studies include MR
signal quantification and difficulty to distinguish contrast created by
labeled cells from other intrinsic tissue contrasts [14].
Here we describe an alternative noninvasive technique to study
inflammation in rodents in vivo using fluorine (19F) MRI. 19F MRI
is performed in association with intravenous injections of perfluo-
rocarbon (PFC) nanoparticles (NPs). These NPs are taken up by
cells of the immune system traveling through the circulation into
the inflammatory regions. Thus 19F MRI is ideal for studying
distribution of inflammatory cell in vivo. In this protocol we
chose a murine AAV model of renal inflammation that has been
described in greater depth elsewhere [16] and made use of nano-
particles prepared from perfluoro-5-crown-15-ether (PFCE).
This experimental protocol chapter is complemented by two
separate chapters describing the basic concept (please see the chapter
by Waiczies S et al. “Functional Imaging Using Fluorine (19F) MR
Methods: Basic Concepts”) and data analysis (please see the chapter
by Starke L et al. “Data Preparation Protocol for Low Signal-to-
Noise Ratio Fluorine-19 MRI”), which are both part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
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2 Materials
2.1 Animals This experimental protocol is tailored for mice with a body mass of
20-30 g (e.g., wild type C57BL/6 mice or a disease model of renal
inflammation). Here we describe briefly how to generate the AAV
animal model. More thorough detail on the immunization, bone
marrow transplantation as well purification of mouse MPO is given
in the study establishing the MPO-AAV animal model
[16]. Wild-type (WT) C57BL/6J mice (B6) (Jackson Laboratories,
Bar Harbor, ME) and myeloperoxidase-deficient (MPO/) mice
(generated by Aratani et al. [17]) were used in this protocol.
MPO/ mice were immunized with murine MPO at the age of
8–10 weeks, subjected to lethal irradiation, and then transplanted
with MPO-expressing bone marrow cells. Animal experiments
should be approved by animal welfare authorities and guidelines
to minimize discomfort to animals (86/609/EEC).
2.1.1 Lab Equipment 1. NP preparation: Ultrasonic device with ultrasonic power
(400W) and frequency (24 kHz) for stand-mounted operation
such as UP400S (Hielscher, Teltow, Germany) to prepare
PFCE nanoparticles.
2. NP preparation: Titanium sonotrode for emulsifying samples
from 5 to 200 ml (e.g., H3 from Hielscher, Teltow, Germany).
3. NP characterization: Dynamic light scattering instrument such
as Zetasizer Nano (Malvern Instruments, Malvern, Worcester-
shire, UK) to characterize particle size (Z-average) and poly-
dispersity index (PDI) of the PFCE nanoparticles.
4. NP application: Mouse restrainer for intravenous administer-
ing the PFCE nanoparticles.
5. Anesthesia: Isoflurane inhalation system which can adjust dif-
ferent levels of isoflurane such as Isoflurane Vapor 19.1 (Drae-
ger, Draegerwerk, Luebeck, Germany). The range of isoflurane
level that is used for anesthesia in mice is 0.5–1.5%. Please refer
to the chapter by Kaucsar T et al. “Preparation and Monitoring
of Small Animals in Renal MRI” for an in-depth description
and discussion of the anesthesia.
6. Anesthesia: Mouse chamber connected to isoflurane inhalation
system and gas-mixing system to anesthetize mice by inhalation
narcosis prior to transfer to the MR scanner.
7. Gases: O2, and compressed air, as well as a gas-mixing system
such as FMI (Föhr Medical Instruments GmbH, Seeheim-
Ober Beerbach, Germany) to achieve the required physiologi-
cal O2/air mixture in combination with the isoflurane gas.
(19F) MRI in Renal Inflammation: Exp. Protocol 497
2.2 MRI Hardware The general hardware requirements for renal 1H MRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter was tailored for
a 9.4 T MR system (Biospec 94/20, Bruker Biospin, Ettlingen,
Germany) but advice for adaptation to other field strengths is given
where necessary.
1. 1H/19F dual-tunable volume RF coil (35 mm inner diameter,
50 mm length; Rapid Biomed, Würzburg, Germany).
2. 1H/19F dual-tunable volume RF coil (18 mm inner diameter,
39 mm length) for ex vivo imaging [18].
3. 19F cryogenic quadrature RF surface probe (19F-CRP) oper-
ated at ~28 K (see Note 1).
4. A physiological monitoring system that can track respiration
and temperature during the MR procedure such as the Moni-
toring & Gating System and PC-sam software from SA Instru-
ments (SAII, Stony Brook, NY, USA).
5. Mouse sled with a breathing mask connected to the isoflurane
system.
2.3 MRI Techniques Typically, 19F MR studies applying PFC compounds such as PFCE
to study inflammation in vivo employ the turbo spin echo
(SE) rapid acquisition using relaxation enhancement (RARE)
sequence [18–22]. This method reduces acquisition time by accu-
mulating multiple echoes within a single repetition time [23]. Typi-
cally T1 of these
19F compounds is in the range of 0.5–3 s,
depending on the compound and also magnetic field strength
(B0). However, if employing paramagnetic macrocyclic PFC com-
pounds complexed to lanthanides, T1 values can be reduced to the
order of 1–15 ms and T2* values correspondingly reduced to
0.4–12 ms and a radial zero echo time (ZTE) sequence might be
better suited [24].
1. 1H MR sequence: 2D and 3D FLASH protocols are standard
sequences on Bruker MRI systems, where they are called
“FLASH_2D”, “FLASH_3D” or “1_Localizer_multi_slice”
(see Note 2).
2. 19F spectroscopy sequence: Block pulse for nonlocalized (global)
is a standard sequence on Bruker MRI systems, where it is
called “SINGLEPULSE” (see Note 3).
3. 19F MR sequence: 3D RARE protocol for measurements. This is
a standard sequence on Bruker MRI systems, where it is called
“TurboRARE_3D” in Paravision 5, “T2_TurboRARE_3D” in
Paravision 6 (see Note 4).




3.1.1 19F MR Imaging
Typically T1 of PFC compounds is in the range of 0.5–3 s, depend-
ing on the compound and also magnetic field strength (B0). When
working with a standard diamagnetic PFC such as PFCE that is
documented in the literature, it is recommended that the T1 and T2
of the compound be studied at 37 C before starting with the first
in vivo experiments to study inflammation. According to the
measured relaxation times (T1/T2), the optimal settings for
RARE, namely echo train lengths (ETL) and repetition time
(TR) should be calculated to improve sensitivity thresholds.
1. Repetition time (TR): for RARE, TR will be limited by ETL
and the number of slices. A short TR is desirable for SNR
efficiency (0.8–1.5 s depending on T1) keeping in mind that
T1 will change with changes in oxygenation status (seeNote 5).
2. Flip angle (FA): for the block pulse and RARE sequence, the
FA for the excitation pulse should be at 90. Additionally the
RARE sequence has a refocusing pulse with a FA of 180. To
maximize the SNR and contrast, the flip angle has to be sepa-
rately calculated for FLASH considering the Ernst angle:
αE ¼ cos 1 eTR=T 1
 
which relates FA, T1 and TR (see Note
6).
3. Echo train length (ETL): in RARE, use a value as high as
possible to reduce scan time. In the TurboRARE sequence on
Bruker MRI systems, ETL is referred to as “rare factor”.
4. Echo time (TE): use the shortest effective TE and echo spacing
(ΔTE) possible. Especially for very high ETL, TE can become
very long. Centric encoding can be used to reduce the effective
TE, generally at the cost of introducing minor image artifacts.
5. Acquisition bandwidth (BW): long enough to shorten the ΔTE
without compromising the SNR, which decreases with increas-
ing BW as a result of increased noise level.
6. Geometry: Adapt so that whole abdomen fits into FOV in L-R
direction (approx. 25 mm for mice) and use frequency encod-
ing in H-F- direction. Choose a 3D volume suited to cover the
whole body width and as much of the length of the mouse that
the RF coil can afford as possible. With a typical mouse body
resonator as the one used in this protocol one could use a FOV
of 60  30  30 mm and matrix size of 400  200  200 (for
1H) and 128  64  64 (for 19F).
7. Resolution/acceleration: Use the highest in-plane resolution
that the SNR allows, typically around 100–150 μm for 1H
MR scans and 250–500 μm for 19F MR scans. Zero-filling in
phase encoding direction can be helpful to speed up acquisition
while increasing the number of averages to improve SNR
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especially for 19F MR scans. One may use half Fourier in read
direction (asymmetric echo) to further shorten the first
TE. Reducing the excitation pulse length to below 1 ms
would then also help to shorten TE.
8. For an example of parameters used in this chapter, please see





1. NP preparation: Emulsify 1.2 M PFCE (Fluorochem, Derby-
shire, UK) in Pluronic F-68 (Sigma-Aldrich, Germany) for
10 min using a cell disrupting titanium sonotrode connected
to an ultrasonic device and employing a continuous pulse
program for 60 s. Use ear protection while sonicating the
mixture to avoid hearing damage and loss.
2. NP characterization: Measure mean particle size (in nm), poly-
dispersity index (PdI), and zetapotential (mV) by using a
dynamic light scattering machine such as the one listed above.
Use the z-average diameter for particle size since it gives an
intensity-weighted harmonic diameter and is ideal for compar-
ing different analyses. The nanoparticles should have a
PdI < 0.3 indicating a relatively low polydispersity and narrow
size distribution (see Note 8).
3. NP application: Administer 19F nanoparticles via tail vein at a
dose of 5–80 μmol of PFCE molecules, depending on the
frequency of the bolus injections. Start administering 19F nano-
particles at relevant time-points of your inflammatory model,
for example, in MPO immunized MPO/ mice subjected to
lethal irradiation we started intravenous application of PFCE
nanoparticles 4–8 weeks following transplantation of
MPO-expressing bone marrow cells (see Note 9).
3.3 Preparation Prior
to 19F/1H MRI Scans
Four to 18 h following the last intravenous administration of 19F
nanoparticles prepare the mice for 19F/1H MRI:
1. First anesthetize the mice by inhalation narcosis using a mouse
chamber connected to a isoflurane inhalation system and
gas-mixing system (see Note 10).
2. Adjust the flow rate for air and O2 at 0.2 and 0.1 l/min
respectively and 3% isoflurane (adjusted from a vaporizer) for
about 2 min until the required level of anesthesia is reached
(no response following toe pinch).
3. Transfer mice to the MR scanner. Should a quantification of
inflammation be required, a reference tube with a known con-
centration of 19F nanoparticles should be placed in proximity
to the region of interest. For quantification of signal please
refer to the chapter by Starke L et al. “Data Preparation
Protocol for Low Signal-to-Noise Ratio Fluorine-19 MRI.”
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4. While keeping the flow rate for air and O2 constant, adjust the
isoflurane vaporizer to 0.8–1.5% until an optimal breathing
pattern is reached.
5. Set up the temperature monitoring (rectal probe) and respira-
tory monitoring (balloon on chest) unit. A respiratory rate of
70–90 breaths per minute is recommended. Keep the body
temperature at 36–37 C during the experiment by employing
a warm water (or alternatively warm air) circulation system.
6. Tune the RF coil to both the 1H resonance frequency (e.g.,
400.1 MHz for 9.4 T) and to the 19F resonance frequency
(e.g., 376.3 MHz for 9.4 T) and match the characteristic
impedance of the coil to 50 Ω using the tuning monitor of
the animal MR scanner.
7. Perform anatomical imaging as described in the chapter by
Pohlmann A et al. “Essential Practical Steps for MRI of the
Kidney in Experimental Research.” Set up a 2D FLASH proto-
col for the acquisition of anatomical kidney 1H scans (see Note
7).
8. Perform localized shimming on the kidney imaging as
described in the chapter by Pohlmann A et al. “Essential Prac-
tical Steps for MRI of the Kidney in Experimental Research”
(see Note 11).
9. Save the parameters of all adjustments (such as iterative shim-
ming calculations and reference power values) performed dur-
ing the first 1H scans for application into the 19F scans.
3.4 19F/1H MRI
of the Kidney
3.4.1 In Vivo 19F/1H MRI
Using a Room Temperature
Mouse Body Volume 19F/1H
RF Resonator
Following acquisition of the anatomical 1H kidney scans, in vivo
19F MR images of the kidney can be acquired and later overlaid
onto the 1H MR images. An example of an in vivo 1H/19F MRI is
shown in Fig. 1.
1. Load the SINGLEPULSE FID-sequence with a TR of at least
1000 ms.
2. Set nucleus to 19F (e.g., in “Open Edit Scan” in Bruker’s
Paravision 5.1 or “System” tab in Bruker’s Paravision 6).
Since the 19F MR signal is too low for automatic adjustments,
apply the same settings used for the 1H anatomical scans (see
Note 12).
3. Deselect the automatic reference gain (RG) and set on maxi-
mum (e.g., in Edit Method in Bruker’s Paravision 5.1 or using
the “Instruction” tab (GOP) and “Setup” tab in Paravision 6).
4. Start the SINGLEPULSE sequence using setup mode. If the
19F spectral signal within the acquisition-window is too low,
add more averages until a signal is clearly visible. Adjust the
basic frequency in order to center the 19F spectral peak at 0 Hz
in the acquisition window. Apply this basic frequency, press
Stop and apply.
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5. Setup a TurboRARE 3D protocol for the 19F scans.
6. Use the same geometry used for anatomical 1H imaging but
reduce the matrix size for increased SNR and use a rare factor of
at least 32. Set nucleus to 19F. Deselect automatic adjustments
(as above). For an example of parameters, please see Note 7.
7. When the scans are finished retract the mouse-holder from the
MR scanner. Disconnect the mouse carefully from the holder.
If the mouse is not sacrificed for ex vivo analysis (e.g., high
resolution 19FMRI of the kidney, see below) following the MR
scans, closely monitor until it has completely recovered from
anesthesia. Body temperature regulation might still be affected
after the anesthesia, so during the recovery process, put the
mouse in a separate cage that is placed on a warm temperature
regulated pad. Once the mouse has completely recovered from
anesthesia, you may return it to its holding cage and to the
animal room.
3.4.2 High Spatial
Resolution 19F MRI of Ex
Vivo Kidney Using a 19F
CryoProbe
Kidney inflammation can also be studied with high spatial resolu-
tion ex vivo 19F MRI, for example, by using a transceive 19F
CryoProbe, which we previously used to study brain inflammation
in a model of CNS autoimmunity [25]. An example of a high
resolved ex vivo 1H/19F MRI of the kidney is shown in Fig. 2.
1. At the end of the in vivo experiment, anesthetize mice with a
terminal dose of ketamine and xylazine. Ensure the required
level of anesthesia is reached (no response following toe pinch).
2. Transcardially perfuse mouse with 20 ml PBS followed by
20 ml 4% paraformaldehyde.
Fig. 1 In vivo 19F/1H MRI of a murine ANCA-AAV model of renal inflammation using the 1H/19F dual-tunable
volume RF coil (35 mm inner diameter). Eight weeks following transplantation of bone marrow cells, MPO-AAV
mice were administered one bolus of PFCE nanoparticles (NPs) intravenously (80 μmol in 100 μl) and 19F/1H
MRI was performed 4 h (a) and 12 h (b) thereafter. (1) 1H 2D FLASH protocol: TR ¼ 579.4 ms, TE ¼ 5 ms,
FA ¼ 75, matrix ¼ 256  128. (2) 19F 3D RARE protocol: TR ¼ 800 ms, TE ¼ 6.16 ms,
Matrix ¼ 256  128  128, RARE Factor ¼ 32
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3. Harvest relevant organs (e.g., kidney, liver, and spleen).
4. Transfer organs to a container filled with 4% PFA and store at
4 C.
5. Prior to the high resolution 19F MRI of the kidney, embed the
kidney in 1% low melting agarose in a 1.5 ml Eppendorf tube.
6. 19F-CRP adjustments: since the 19F signal is too low for auto-
matic adjustments, use a 19F calibration phantom (fill highly
fluorinated substance such as trifluoroethanol with water in a
1.5 ml Eppendorf tube. Place the 19F calibration tube under
the 19F-CRP and repeat steps 13–16 to calculate the working
frequency. Load and run a 1_Localizer_multi_slice sequence
(see above). Adjust the reference power using the adjustments
platform: select a coronal slice of 2 mm thickness and place it
close to the RF coil’s surface. Select an initial power two orders
of magnitude smaller than what is usually expected and press
start. Run the rest of the adjustments using the same sequence.
Save the shim settings.
7. 19F-CRP imaging: place the ex vivo kidney embedded in a
1.5 ml Eppendorf tube under the 19F-CRP surface. Run the
working frequency adjustments as per 13–16, load the shim
Fig. 2 Ex vivo 19F/1H MRI of an inflamed kidney from the ANCA-AAV model. (a) Low spatial resolution images
acquired using the 1H/19F dual-tunable volume RF coil (18 mm inner diameter). At this resolution
[0.938  0.938]mm2, a high 19F signal can be achieved already after 1 h acquisition time. However,
anatomical detail is lacking in the 19F MR images. (b) High spatial resolution images acquired with the 19F
cryogenic quadrature RF surface probe (19F-CRP). The gain in SNR achieved by the 19F-CRP was used to
increase the in plane spatial resolution [0.078  0.078]mm2
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calculations, and adjust the reference power as described above.
Set the RG to maximum. Load a 2D FLASH protocol and set it
up for 19F imaging. Examples for high and medium resolution
19F imaging are given in Note 13.
8. Set up a 2D FLASH protocol for the acquisition of anatomical
kidney 1H scans. Use the same geometry used for 19F imaging
(see Note 13).
4 Notes
1. The transceive 19F cryogenic quadrature RF surface probe (19F
CryoProbe) operates at ~28 K with a dual cooled preamplifier
at the base running at ~77 K. It has a similar geometry to the
existing Bruker 1H quadrature CryoProbes. More details on
the 19F CryoProbe are available in our previous study [25].
2. The FLASH_3D protocol is especially adapted for whole-body
imaging of mice (the gradient-system and the volume-
resonator need to have a linear region of about 8 cm).
3. The block pulse program (SINGLEPULSE) contains the nec-
essary elements for a simple transmit/receive experiment,
sending a pulse and acquiring an FID afterward.
4. A 2D version of this sequence is also available, which allows
thicker slices for a general overview but suffers from low SNR
for most in vivo applications.
5. Special attention should be given when studying inflammation
in models where tissue oxygen levels are likely to change, for
example, following ischemic events. In these cases, T1 weight-
ing needs to be reduced at cost of SNR efficiency by increasing
TR T1 (typically TR ¼ 3–5  T1).
6. When using transmit-receive surface coils a B1 correction
should be considered in order to compensate for the intrinsic
spatial gradient in coil sensitivity (B1
) and excitation field (B1
+
inhomogeneity), which results is signification variation in the
excitation FA, decreasing with increasing distance from the RF
coil surface. This severely reduces image homogeneity and
hampers the acquisition of the absolute signal intensity values
for 19F quantification techniques.
7. Example for a 30 g mouse at 9.4 T and FOV of
50  25  25 mm, (1) 1H 2D FLASH protocol:
TR ¼ 579.4 ms, TE ¼ 5 ms, FA ¼ 75, matrix ¼ 256  128.
(2) 19F 3D RARE protocol: TR ¼ 800 ms, TE ¼ 6.16 ms,
Matrix ¼ 256  128  128, RARE Factor ¼ 32–64.
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8. The polydispersity index (PdI) is extrapolated from the DLS
function and quantitatively describes the particle size distribu-
tion best. PdI ranges from 0.01 for monodispersed particles to
0.7 for particles that have a very broad size distribution. The z-
average diameter gives the mean diameter based on intensity of
scattered light and sensitive to presence of large particles, peak
diameter, peak width, and PdI.
9. In MPO-AAV mice we administered one bolus of PFCE nano-
particles intravenously (80 μmol in 100 μl) 8 weeks following
transplantation of bone marrow cells.
10. Mice can be alternatively anesthetized with an intraperitoneal
injection of ketamine and xylazine.
11. Shimming is particularly important, since macroscopic mag-
netic field inhomogeneities affect the exact resonance fre-
quency of the PFCE compounds and might affect
quantification of the 19F MR signal. Shimming should be
performed on a voxel enclosing both kidneys using either the
default iterative shimming method or the Mapshim technique
(recommended). However, the Mapshim technique is not
available for X-nuclei-only RF coils. An alternative in this case
is to use a highly fluorinated sample to calculate the shims.
12. Since the NMR properties of 19F and 1H are similar, the same
MR setup and MR parameter settings can be used for both
nuclei.
13. Example for ex vivo high-resolved 19F MRI at 9.4 T using the
19F-CRP and a 2D FLASH: TR ¼ 11 ms, TE ¼ 2.7 ms,
FA ¼ 30, Avg ¼ 2250, Repetitions ¼ 35, FOV ¼ 20  20,
matrix¼ 256 256, 1 mm slice thickness. Example for ex vivo
low-resolved 19F MRI at 9.4 T using the 1H/19F dual-tunable
volume RF coil (18 mm inner diameter) and a 3D RARE
method: TR ¼ 800 ms, TE ¼ 5 ms, Avg ¼ 256, Repeti-
tions ¼ 13, FOV ¼ 60  30  30, matrix ¼ 64  32  16.
1H 2D FLASH protocol: TR ¼ 18.7 ms, TE ¼ 5.5 ms,
FA ¼ 25, matrix ¼ 171  256, 1 mm slice thickness.
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Chapter 31
Fluorine (19F) MRI to Measure Renal Oxygen Tension
and Blood Volume: Experimental Protocol
Lingzhi Hu, Hua Pan, and Samuel A. Wickline
Abstract
Fluorinated compounds feature favorable toxicity profile and can be used as a contrast agent for magnetic
resonance imaging and spectroscopy. Fluorine nucleus from fluorinated compounds exhibit well-known
advantages of being a high signal nucleus with a natural abundance of its stable isotope, a convenient
gyromagnetic ratio close to that of protons, and a unique spectral signature with no detectable background
at clinical field strengths. Perfluorocarbon core nanoparticles (PFC NP) are a class of clinically approved
emulsion agents recently applied in vivo for ligand-targeted molecular imaging. The objective of this
chapter is to outline a multinuclear 1H/19F MRI protocol for functional kidney imaging in rodents for
mapping of renal blood volume and oxygenation (pO2) in renal disease models.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter is complemented by a separate chapter describing the basic concept of
functional imaging using fluorine (19F) MR methods.
Key words Perfluorocarbon, Fluorine, Oxygenation, Perfusion, MRI, Kidney, Mice, Rats
1 Introduction
In healthy kidneys, the countercurrent design of blood vessels and
tubules maintains the necessary osmolar gradient to permit efficient
urinary concentration, yet the system operates under conditions of
a relatively hypoxic environment in some regions that requires
extensive extraction of oxygen from flowing blood [1, 2]. During
acute and chronic kidney injury, ischemia challenges effective O2
delivery to the capillary beds of the renal tubules where extraction
of extra oxygen is marginal, resulting in heightened susceptibility to
ischemic damage that may culminate in renal failure [3]. Besides the
traditional biochemical metrics for assessing renal failure (e.g.,
blood urea nitrogen, creatinine), 1H/19F imaging offers a multi-
parametric quantifiable approach to functional imaging in kidney
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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injury that avoids the use of potentially nephrotoxic gadolinium
(Gd) based contrast agents [3].
Perfluorocarbon core nanoparticles (PFC NP) are a class of
emulsion agents clinically approved as blood substitutes that have
been applied recently for in vivo for targeted molecular imaging and
noninvasive oxygen tension (pO2) assessment [1–3]. As compared
with standard iodinated or Gd contrast agents, PFC NP are biolog-
ically inert and exhibit a good safety profile with no renal toxicity
reported in both animals and human [3]. Because PFC NP (nomi-
nal size 200–250 nm) are not cleared through glomerular filtration,
they do not increase kidney workload, which is a major risk factor
for kidney failure with the use of other agents that undergo renal
clearance [3]. For imaging purposes, the unique 19F MR signal
emanating from the fluorine core of PFC NP can be measured
directly in vivo in quite sparse concentrations (e.g., picomolar
voxel amounts) with no background signal, as contrasted with
other paramagnetic or superparamagnetic moieties that exert indi-
rect contrast effects on circulating protons [4–6]. PFC NP have
been demonstrated as effective functional probes for regional blood
volume as the detected 19F signal intensity directly reflects the
actual quantity of PFC NP within a voxel. Furthermore, for pO2
measurements, the 19F longitudinal relaxation rate (R1) responds
directly to local oxygen content in a linear manner [1, 2].
Herein we describe 1H/19F MRI for monitoring of renal perfu-
sion in the kidney of rodents in a step-by-step experimental protocol.
The rationale for choosing acquisition parameters is described in
generic terms, together with specific parameter examples.
This experimental protocol chapter is complemented by a sep-
arate chapter describing the basic concept of functional imaging
using fluorine (19F) MR methods, which is part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
2.1 Animals This experimental protocol is applicable to mice and rats.
2.2 Lab Equipment Enumerated below are the contrast agents and equipment compo-
nents needed:
1. Perfluorocarbon Nanoparticle Preparation: PFC NP
(~200–250 nm) can be formulated with a variety of PFC that
are liquid at body temperature. Here we describe either per-
fluorooctylbromide (PFOB) or perfluoro-15-crown-5-ether
(CE). The PFOB or CE emulsions are composed of 20% or
40% (v/v) of PFOB or CE, 2.0% (w/v) of a surfactant com-
mixture, and 1.7% (w/v) glycerin in water (see Note 1).
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2. Gases: O2, N2, and compressed air, as well as a gas-mixing
system to achieve required changes in the oxygen fraction of
inspired gas mixture (FiO2). In addition to room air, the fol-
lowing gas mixtures are required during the experiment: 10%
O2–90% N2 for hypoxia and 100% O2 for hyperoxia.
3. Anesthesia: AnMRI-compatible slow infusion system is needed
for anesthesia with ketamine–xylazine (e.g., syringe pump).
Isoflurane is not recommended for 19F imaging as it could
interfere with the detected 19F MRI signal from PFC NP.
4. Small Animal Monitoring System: An MRI-compatible small
animal physiological monitoring system (e.g., SAI Inc., USA) is
needed for real time respiratory monitoring and respiratory
triggering and/or gating. Respiratory gating is recommended
during 19F MRI acquisition because it reduces motion artifact
and preserves 19F signal intensity in the final images, which
could otherwise be degraded by motion.
5. Small Animal Holder: a dedicated customer built small animal
holder is needed to accommodate animal imaging and for
maintenance of body temperature at 37 C. A warm water
blanket or warm air blower can be used for maintaining body
temperature of animals (see Note 2).
6. Animal Surgery Suite: A fully equipped animal surgery suite
is needed for preparing animal models of renal injury (see
Note 3).
2.3 MRI Hardware The technique described in this chapter is tailored for an 11.7 T
MR system (e.g., Varian, USA) but advice for adaptation to other
field strengths is given where necessary. In general, the MRI scan-
ner should be equipped with a wide band spectrometer and a wide
band RF power amplifier. The scanner needs to be functional at
both 1H and 19F frequencies.
1. 1H/19F dual-tuned Coils: use actively decoupled coil pair for
renal imaging applications. Such coils can be custom-built as
described in our prior publications [7] or obtained from com-
mercial coil manufacturers (see Note 4).
2. Transmit Coils: use a volume transmit coil to generate a homo-
geneous B1 field that covers both kidneys. Tune and match to
the 19F frequency.
3. Receive Coils: Place a surface receive coil on the dorsal side of
the animal to achieve high sensitivity to 19F signal from the two
kidneys. Tune and match to the 19F frequency.
2.4 MRI Techniques 1. 1H MRI: a gradient echo sequence is employed to locate two
imaging slices with 2 mm thickness, positioned 1–2 mm apart,
and centered respectively at the left and right kidney.
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2. 1H MRI: a multiecho gradient-echo blood oxygenation level
dependent (BOLD) scan can be performed. For an example of
parameters used for a specific setting (see Note 5).
3. 19F MRI: For spin density 19F MRI, TR is set to 4 s. For
T1-weighted MRI, TR is set to two respiration periods, or
~300 ms. All other imaging parameters are identical in these
two sets of 19F MRI (see Note 6)
4. 19F MRI Oxygenation Measurement: For PFC NP dependent
oxygenation measurements in fast flowing blood of major
blood vessels, a Blood Flow-Enhanced-Saturation-Recovery
(BESR) sequence [8] can be utilized to minimize in-flow




1. Prepare PFC NP emulsifying 40% (v/v) of CE (Exfluor
Research Corp, Round Rock, TX), 2.0% (w/v) of a surfactant
commixture, and 1.7% (w/v) glycerin, in distilled water using a
microfluidic apparatus (e.g., benchtop LV1 fluidizer, Micro-
fluidics Corporation, Westwood, MA) (see Note 8).
2. Determine size and charge with a submicron particle analyzer
(e.g., Zetasizer, Malvern, UK) [9, 10].
3.2 PFC NP Injection
and Imaging
1. Inject PFC NP for functional perfusion imaging to quantify
blood volume and oxygenation.
2. Prepare an external reference for 19F signal quantification.
Place the external reference close to the animal within the
field of view (see Note 9).
3. Perform 1H and 19F imaging 10 min to 1 h after NP injection.
A shorter circulation time is preferred to maximize the intra-




of 19F Signal Intensity
1. Acquire an RF coil sensitivity map using a saline phantom
positioned at the selected imaging location to correct for the
signal bias created by surface coil receive profile inhomogene-
ity. The saline phantom is prepared to cover the entire region of
imaging FOV (see Note 11).
2. Compensate for the spatial inhomogeneity of the RF coil sen-
sitivity profile by multiplying the correction factor obtained
from the phantom image (see Note 12) with the in vivo
measured image signal intensity at the corresponding locations.
3.4 Calibration of 19F
R1 vs. pO2 Curve
In Vitro
1. Perform an in vitro calibration of 19F relaxation time (R1) as a
function of pO2 using at least three different O2 concentrations
(e.g., 0%, 21%, 100% O2 balanced with N2) by bubbling gas
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mixtures into a PFC emulsion sample for 30 min at 37 C
(Fig. 1).
2. Perform 19F T1 measurements with inversion recovery spec-
troscopy at TR> 10 s, and at least ten different inversion delays
(TI) ranging from 3 ms to 5 s. Use exponential fitting to extract
R1 from T1 measurements and linear fitting to calibrate the
relationship between 19F R1 and pO2.
3.5 Quantification
of 19F Based pO2
Measurement In Vivo
1. Create two sets of images, one using a short TR and one using a
long TR, for T1 mapping (see Note 13).
2. Determine the actual TR using the external 19F standard (see
Note 14).
3. After determining the actual short TR, perform voxel-wise T1







4. Translate T1 values into corresponding pO2 levels according to
the predetermined calibration curve.
4 Notes
1. The CE signal intensity is effectively greater for narrow band
reception as all fluorine atoms contribute to a single spectral
peak, as compared to PFOB where chemical shifts apportion
Fig. 1 In vitro calibration shows the 19F R1 (¼1/T1) of PFC NP as a function of
pO2. Data were collected at 11.7 T using a PFC NP phantom. Temperature of the
PFC NP phantom was maintained at 37 C. The correlation coefficient R > 0.99
(From Hu et al. [1])
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the signal into several peaks (Fig. 2). Suppliers of PFC include
Exfluor Research Corporation (Round Rock, TX). The clear-
ance half-life for PFOB is ~3–5 h depending on species and
whether the PFC contrast material is molecularly targeted or
not [11]. The CE materials exhibit a longer tissue residence
time in bloodstream than PFOB compounds, which makes
them problematic for clinical use or repeat studies. For the
present protocol, no targeting ligands are attached to the sur-
face of the PFC NP to avoid changing the pharmacokinetics of
the contrast agent.
2. Potential MRI in-flow artifacts may be present on 1H but not
19F MR images if a warm water blanket is used. Special atten-
tion should be given when choosing the animal holder and the
MRI coils as reduced animal motion during lengthy MRI
acquisitions will improve image quality.
3. In general, ischemic renal injury can be produced unilaterally or
bilaterally by exposing the kidneys either through the abdomen
or retroperitoneally, and then clamping the renal artery for a
Fig. 2 Chemical structure and magnetic resonance chemical shift of perfluoro-15-crown-5-ether (CE) and
perfluorooctylbromide (PFOB)
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selected interval [1, 2]. The animal surgery suite does not need
to be located in theMRI facility but should be close enough for
imaging a short time after surgery and later for tissue harvest
after imaging is completed if indicated.
4. Despite being slightly off-resonance for 1H imaging, the 19F
coil pair should be sufficient to generate high quality anatomic
images within <1 min scan time. The size of the transmit and
receive coils should be designed to match the animal size, so
that different coil sizes will be needed for imaging mice and
rats. For imaging at field strengths lower than 11.7 T, it is
recommended to use double tuned receive coils that simulta-
neously function at 1H and 19F frequency to assure maximal
detection efficiency while avoiding potential image mismatches
between 1H and 19F images that may occur as a result of
manual coil retuning.
5. The imaging parameters of BOLD at 4.7 T are: TR ¼ 100 ms,
TE ¼ 1.96 ms with 1.75 ms increment for every echo, flip
angle ¼ 10, field of view ¼ 26  26 mm2, voxel
size ¼ 0.2  0.2  2 mm3. Field of view and voxel size should
be adjusted based on animal size to achieve optimal image
quality.
6. ETL ¼ 4, TE ¼ 11.5 ms, receiver bandwidth ¼ 20 kHz, voxel
size ¼ 0.4  0.4  2 mm3, and the field of view is identical to
that for 1H BOLD imaging.
7. For an example of parameters used at 4.7 T, the imaging
parameters of BESR sequence are: TR ¼ 2.5 s; TE ¼ 2.2 ms;
number of points along recovery curve ¼ 8; number of
averages ¼ 16; in plane resolution ¼ 1.5 mm  0.75 mm;
slice thickness ¼ 2 mm
8. PFC NP can be colabeled with Alexa Fluor 594 for ex vivo
fluorescence microscopy examination.
9. As reference, a tube of another PFC NP formulation (e.g.,
perfluorodecalin) at a similar PFC concentration to that admi-
nistered in vivo for the imaging studies can be used.
10. In healthy tissues, PFC NP are generally constrained to the
intravascular space because of their large particle size
(200–250 nm), which ensures that the measured 19F signal
intensity correlates linearly with intravascular blood volume.
One has to also consider that during injury, PFCNPwill escape
from the circulation and will get trapped in tissue compart-
ments. In this case the total fluorine signal would comprise
both stationary (i.e., trapped in tissue) and flowing (i.e., in
blood) PFC NP. Employ spin labeling [12] to eliminate the
signal from trapped PFC NP, leaving only the signal from the
flowing blood compartment. Apply diffusion gradients to sup-
press the signal from flowing blood [13] and acquire distinct
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signal from either compartment. For O2 measurements, a mix-
ture of signals could occur where trapped PFC NP exist under
hypoxic conditions and the flowing PFC NP under more nor-
moxic conditions. In this case the 19F relaxation times would
represent an average of the two situations.
11. At 11.7 T, imaging parameters are as follows: TR ¼ 100 ms,
TE ¼ 1.96 ms, and flip angle ¼ 10. For other field strengths,
minimize TE and select similar TR and flip angle.
12. For each voxel location, the phantom image defines a correc-
tion factor matrix R(x,y,z) that is the inverse of local signal
intensity I(x,y,z): R(x,y,z) ¼ 1/I(x,y,z).
13. In vivo quantification of renal T1 and pO2 is based on the
general assumption that image signal intensity in a fast spin
echo sequence follows a saturation-recovery process (Fig. 3).
Because short TR or T1-weighed
19F MRI is gated with respi-
ration, the actual short TR can vary from animal to animal.
14. Given that the 19F T1 of PFC standard is 0.9–1 s at room air
oxygen tension, the signal acquired with a long TR ¼ 4 s, that
is, >3  T1, should approximate the 19F spin-density signal of
PFC NP at room temperature (Fig. 4).
Fig. 3 (a, b) Representative renal blood volume and pO2 mapping of healthy kidneys determined by
quantitative 19F MRI. (c) Representative 1H T2* (BOLD) mapping of healthy kidneys. (d–f) Quantification of
functional indexes in different anatomical regions. *P < 0.05 compared with cortex (From Hu et al. [1])
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Fig. 4 Imaging of improved renal medullary perfusion after antithrombin PFC NP treatments. Here the thrombin
inhibitor PPACK (phenylalanine-proline-arginine-chloromethylketone) was conjugated to the PFC NP. Mice
were pretreated with PFOB PPACK NP, plain PFOB NP, or saline before ischemia induction. At 3 h after
reperfusion, a single dose of CE NP was injected i.v. for 19F MRI. The 19F signal from circulating CE NP of
uninjured kidney illustrates normal kidney perfusion (a). In contrast, all injured kidneys exhibited reduced 19F
signal in the medulla (b–d) reflecting the severity of regional nonreperfusion. Compared to kidneys pretreated
with saline or plain NP (b, c), the improved medullary perfusion in PPACK NP treated kidneys is visually
appreciable (d). Using in vivo 19F MRI data, the ratio of nonperfused kidney area after reperfusion was
determined. The PPACK NP treated kidneys (n ¼ 4) developed less regional nonreperfusion than did saline
(n ¼ 6) or plain NP (n ¼ 6) treated kidneys. *p < 0.05 compared to saline or plain NP treated kidneys. Note
that the arrow in d indicates the partial overlay of 19F signal from the adjacent spleen (From Chen et al. [2])
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Chapter 32
MR Elastography of the Abdomen: Experimental Protocols
Suraj D. Serai and Meng Yin
Abstract
Application of MRE for noninvasive evaluation of renal fibrosis has great potential for noninvasive assess-
ment in patients with chronic kidney disease (CKD). CKD leads to severe complications, which require
dialysis or kidney transplant and could even result in death. CKD in native kidneys and interstitial fibrosis in
allograft kidneys are the two major kidney fibrotic pathologies where MRE may be clinically useful. Both
these conditions can lead to extensive morbidity, mortality, and high health care costs. Currently, biopsy is
the standard method for renal fibrosis staging. This method of diagnosis is painful, invasive, limited by
sampling bias, exhibits inter- and intraobserver variability, requires prolonged hospitalization, poses risk of
complications and significant bleeding, and could even lead to death. MRE based methods can potentially
be useful to noninvasively detect, stage, and monitor renal fibrosis, reducing the need for renal biopsy. In
this chapter, we describe experimental procedure and step by step instructions to runMRE along with some
illustrative applications. We also includes sections on how to perform data quality check and analysis
methods.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Key words Magnetic resonance elastography (MRE), Stiffness, Kidney, Preclinical imaging, MRI,





Magnetic resonance elastography (MRE) based imaging techniques
are now being routinely used for noninvasive assessment of tissue
mechanical properties. In MRI, elastography encompasses imaging
techniques that noninvasively estimate tissue elasticity and related
mechanical properties through the application of external forces
[1]. MRE induces harmonic vibrations of acoustic-range frequen-
cies in the tissue of interest and images the propagation of these
vibrations in the tissues to calculate quantitative values of mechani-
cal parameters. The desired output is to measure the level of stiff-
ness. The elastogram differentiate if the tissue is hard or soft can
give diagnostic information about the presence of the disease. In
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liver, tissue stiffness has been shown to be elevated with advanced
fibrosis and to correlate with the stage of fibrosis [2–4]. Renal
fibrosis is a pathological process common to all chronic kidney
diseases (CKD) and thereby represents an excellent treatment tar-
get. A large number of molecular pathways involved in renal fibrosis
have been identified in preclinical studies, some of them being
similar among different organs and some with available drugs in
various phases of clinical testing [5]. CKD may lead to end-stage
renal failure, with extensive morbidity, mortality, and increasing
health costs. Primary and secondary prevention requires a better
knowledge of mechanisms underlying renal scarring, the develop-
ment of specific therapies to slow down the progression of the
disease and the development of noninvasive diagnostic tools to
characterize the process.
Among imaging methods, MRE, that has been successfully
demonstrated in the liver, is an attractive alternative for staging of
renal fibrosis. Application of MRE to kidney has been shown to be
possible and initial results are encouraging. MRE methods are
advantageous as compared to ultrasound based elastography meth-
ods because the kidneys are usually located deeply in the body and
therefore there is no direct access to apply an external compression
easily. An increase in the extracellular matrix synthesis, with exces-
sive fibrillary collagens, characterizes the development of chronic
lesions in the glomerular, interstitial, and vascular compartments,
leading progressively to end-stage renal failure [6]. Mechanisms
participating in these processes are increasingly identified and vari-
ous therapeutic interventions have been shown to prevent or to
favor regression of fibrosis in several experimental models. There-
fore, development of new noninvasive MRE based methods for
identification and quantification of fibrosis is worthwhile.
1.2 Modulus
of Elasticity
The shear modulus (μ) and Young’s modulus (E) are two para-
meters often used for describing tissue mechanical properties and
are used as contrast parameters in elasticity imaging. Poisson’s ratio
(ν), another widely used parameter, is the ratio of lateral strain to
longitudinal strain. Among these parameters, only two are inde-
pendent. The shear modulus is known to be related to Young’s
modulus and one can be estimated from the other by knowing the
Poisson’s ratio. In general, soft tissues can be assumed to be incom-
pressible and hence the Poisson’s ratio can be assumed to be 0.5.
The relationship between shear modulus and Young’s modulus can
be written as E ¼ 3μ, which means that the calculation of Young’s
modulus or shear modulus provides the same information. MRE is
a dynamic elasticity imaging technique capable of calculating quan-
titative values of shear modulus of tissues and is clinically approved
to be used for the assessment of liver fibrosis. MRE uses
low-frequency (40–80 Hz) sound waves to induce shear waves in
the liver, visualizes the shear waves by tracking tissue displacement
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using a modified phase-contrast sequence, and measures the speed
of the propagating wave with specialized software called an inver-
sion algorithm [7]. In the commercial version of MRE supplied by
Resoundant, the mechanical waves are generated by a subwoofer
(“active driver”) outside the scan room and are transmitted to a
plastic disk (“passive driver”) via a plastic tube passing through a
wave guide [8]. For preclinical imaging, the same subwoofer active
driver may be used or alternatively a functional generator may be
used for generating a low frequency sinusoidal mechanical motion
(typical range: 20–400 Hz). When the shear stresses (amplitude of
microns) are applied to the top surface of a material with certain
frequency, the induced waves are propagating into the tissue and
every point in the tissue reciprocates in this micromotion. During
clinical MRE image acquisition, the passive driver is secured by an
elastic band over the abdominal organ of interest [8, 9]. In general,
most patients can feel the vibrations generated by the disk but do
not find them uncomfortable. For clinical image postprocessing,
identical MRE hardware and inversion algorithms are commercially
available on scanners manufactured by major MR vendors
[10, 11]. Several studies have shown that MRE is a robust, reliable,
repeatable, and reproducible technique for detection and staging of
liver fibrosis [10]. The accuracy of MRE ranges from 0.85 to 0.99
for differentiating different stages of liver fibrosis [2]. The perfor-
mance of MRE for differentiating mild fibrosis (stage I) from
normal liver or inflammation is lower and the performance is high-
est for diagnosis of cirrhosis (stage 4) [4, 10]. For preclinical MRE,
an actuator, replicating the use of passive driver may be used to
couple to the tissue of interest to generate propagating shear waves
within a soft tissue material [12]. The electrical signal for the drivers
is created by a signal generator synchronized with the MRI pulse
sequence triggered and is amplified by an audio amplifier before
being fed into the mechanical driver. After the mechanical excita-
tion, a phase-contrast based pulse sequence is used to encode the
shear wave motion into the MR phase signal by using a series of
magnetic field gradients called motion-encoding gradients (MEG).
The MEG, synchronized with the mechanical excitations, is applied
after RF excitation [13]. Postprocessing may be done on the scan-
ner or images may be taken offline for analysis. Details of data




Renal fibrosis causes a change in the structure of the kidney wherein
there is an excess accumulation of interstitial extracellular matrix
and reduction in the number of tubules. Increasing evidence has
demonstrated that, unlike cirrhosis, the early stages of fibrosis are
treatable and reversible if appropriate antifibrotic treatment is given
[5, 14]. As antifibrotic therapies evolve, a reliable, noninvasive
assessment of fibrosis is needed to manage patients with chronic
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disease. Being able to noninvasively monitor the progression of
fibrosis would help in understanding the natural history in patients
with chronic disease, determining which patients require antiviral
therapy, predicting the approximate time to the development of
high-grade fibrosis, and discovering new directions of scientific
inquiry. Therefore, there are ongoing investigations using preclini-
cal models with a reliable, noninvasive method to assess organ
inflammation and fibrosis, not only to detect and stage the disease
itself but also to monitor treatment efficacy and optimize dosing.
The feasibility of MRE has been demonstrated on a mouse model
of autosomal recessive polycystic kidney disease (ARPKD) which is
an inherited disorder of the kidneys and liver caused by mutations
in the PKHD1 gene and an important cause of congenital hepatic
fibrosis in humans [3].
1.4 Quest for Renal
MRE
Many different mechanisms induce glomerular injury, including
glomerulonephritis, hypertensive nephrosclerosis and diabetic
nephropathy. However, once renal damage reaches a certain thresh-
old, progression of renal disease is consistent, and largely indepen-
dent of the initial insult. This common pathway to end-stage renal
failure is mainly due to tubulointerstitial damage characterized by
tubular atrophy, loss of peritubular capillaries and interstitial fibro-
sis. Mechanisms leading to kidney failure via tubulointerstitial dam-
age and development of fibrosis are mostly massive proteinuria and
chronic hypoxia. Fibrosis further impairs oxygen diffusion and
supply to tubular cells, rendering a vicious cycle. Thus, in the
assessment of chronic renal failure, fibrosis is a major histological
feature and may be an important surrogate endpoint for prognosis
and monitoring of treatment response. Besides, some investiga-
tions suggest that fibrosis might be reversible, when the cause is
treated, emphasizing the need for an early detection and quantifi-
cation of this fibrosis [14–19]. Currently, the extent of interstitial
fibrosis is evaluated by renal biopsy which has several drawbacks: it
is a semiquantitative approach with wide interobserver variability,
and it is prone to sampling errors and associated with significant
morbidity. Thus a noninvasive, truly quantitative method of inter-
stitial fibrosis monitoring would be desirable. Diffusion-weighted
and blood oxygenation level dependent (BOLD) MRI findings
have been shown to be correlated to renal function, but no data
have been published as to their correlation with the degree of
fibrosis. Blood or urinary markers of fibrosis are also currently
evaluated but none is used in clinical practice yet. MRE based
methods can estimate tissue stiffness (and thus, the degree of
fibrosis) by measuring the velocity of shear waves traveling through
the organ of interest. Clinically, they have been mostly used in liver.
The ultrasound-based transient elastography (Fibroscan™ device)
is able to discriminate the different stages of liver fibrosis with a
quadratic trend of the curve plotting histologic scores versus
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elasticity measurements. Among patients with cirrhosis, stiffness
thresholds predicting the onset of specific complications (ascites,
esophageal bleeding, hepatocarcinoma, etc.) have been identified.
However, this technique is limited by its 1D nature that does not
allow the exploration of the entire liver. MRE has been successfully
used to assess liver fibrosis. The shear stiffness of normal liver was
found to be approximately 2.2 kPa by independent groups, using
vibrating frequencies of 60 Hz [4]. As with ultrasound-based tran-
sient elastography, MRE can discriminate the different stages of
liver fibrosis, with the same quadratic trend of the fibrosis/elasticity
curve [2]. MRE has the advantage of being intrinsically a 2D
technique and can be associated with conventional liver imaging
at the same time. MRE has also been used for applications in the
abdomen such as characterizing focal liver lesions, and in organs
such as pancreas, breast, muscle, prostate, and kidney [9].
Currently, the most definitive means of assessing renal fibrosis is
a kidney biopsy. The invasiveness of a biopsy coupled with its small
sampling size have limited its utility in quantifying and monitoring
changes in renal fibrosis, especially because fibrosis can be hetero-
geneously distributed. Accordingly, a noninvasive modality that
assesses fibrosis on a kidney-wide scale would be of clinical utility.
By replacing soft healthy tissue with stiff extracellular matrix, fibro-
sis stiffens organs, a phenomenon that has led multiple groups to
explore whether tissue stiffness could be used as a surrogate mea-
sure for fibrosis. MRE based technique that measures tissue stiff-
ness, would be a novel application for assessment of renal fibrosis.
During MRE, the organ of interest is gently vibrated by applying
acoustic waves through a pad placed on the overlying skin. The
resulting microscopic vibrational waves passing through the organ
generate shear waves that can be imaged with motion-synchronized
MRI. The velocity of wave propagation is dependent on organ
stiffness, with stiffer fibrotic tissue leading to more rapidly moving
waves with longer wavelength. Capturing shear waves at multiple
time points enables the reconstruction of a quantitative stiffness
map. MRE is already a well-established, gold standard technique
for liver fibrosis imaging, having been shown to accurately reflect
biopsy-derived liver fibrosis measurements. In contrast, MRE for
nonhepatic applications is still early in its development, and its
technique has not yet been standardized. Small pilot studies of
MRE have been performed in native kidneys and kidney allografts,
attempting to correlate kidney stiffness with either fibrosis burden
or kidney function. Although MRE in porcine kidneys showed a
correlation between stiffness and fibrosis in the medulla, the results
of small pilot human studies thus far have been conflicting, and no
studies as yet have assessed whether stiffness measured by MRE
predicts progression of kidney dysfunction. In this chapter, we
provide recommendedMRE protocols for applications in the abdo-
men with a focus on the kidney, and a few illustrative applications of
MRE in preclinical imaging.
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This introduction chapter is complemented by a separate chap-
ter describing the concepts of MRE in the abdomen, which is part
of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
2 Materials
MRE is an MR-based elastography technique that uses mechanical
shear waves to evaluate viscoelastic properties of tissues. Mechanical
shear waves produced by an external driver are propagated into the
organ of interest using a passive abdominal driver placed over the
organ and in contact with the abdominal wall. Tissue displacements
in the range of microns produced by propagating shear waves
because phase shifts that can be detected with motion encoding
gradients in theMRE sequence. The frequency of shear wave applied
ranges from 40 to 400 Hz. In liver, the frequency of shear waves
used for clinical liver MRE is 60 Hz. A lower frequency is used for
organs that are situated deep in the body and a higher frequency may
be used for regions of interest that may be closer to the body surface.
A lower frequency wave has deeper penetration and spatial lower
resolution. A higher frequency wave has higher attenuation and
higher spatial frequency. Once decided on the resolution and fre-
quency, these parameters must stay consistent for the duration of the
study and must not be changed. Stiffness values measured with one
particular frequency are not convertible with those measured with a
different frequency. An inversion algorithm automatically produces
stiffness maps using the phase shift information. Shear stiffness values
can be obtained by drawing regions of interest over the tissue of
interest in the stiffness maps and expressed in kiloPascals (kPa).
2.1 Animals The experimental protocols in this section are tailored for rats (Wis-
tar, Sprague-Dawley or Lewis) with a body mass of 250–350 g.
Advice for adaptation to other smaller animals (e.g., mice) or larger
animals (e.g., pigs) are given in the sections where necessary.
2.2 Lab Equipment 1. Anesthesia: For nonrecovery experiments urethane solution
(Sigma-Aldrich, Steinheim, Germany; 20% in distilled water)
can provide anesthesia for several hours with comparatively few
side effects on renal physiology, which is an important issue.
For an in-depth description and discussion of anesthesia please
refer to the chapter by Kaucsar T et al. “Preparation and
Monitoring of Small Animals in Renal MRI.”
2. Gases: O2, N2, and compressed air, as well as a gas-mixing
system (FMI Föhr Medical Instruments GmbH, Seeheim-
Ober Beerbach, Germany) to achieve required changes in the
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oxygen fraction of inspired gas mixture (FiO2). Besides air, the
following gas mixtures are required during the experiment:
10% O2–90% N2 for hypoxia and 100% O2 for hyperoxia.
3. Device for FiO2 monitoring in gas mixtures: for example Cap-
nomac AGM-103 (Datex GE, Chalfont St Gils, UK).
2.3 MRI Hardware The general hardware requirements for renal 1HMRI on mice and
rats are described in the chapter by Ramos Delgado P et al. “Hard-
ware Considerations for Preclinical Magnetic Resonance of the
Kidney.” The technique described in this chapter is tailored for a
standard 1.5 Tor a 3.0 TMR scanner using a head coil or small flex
coil (for signal reception) or knee RF coil (transmit–receive) is given
where necessary but advice for adaptation to other field strengths
and systems (e.g., 9.4 T MR system Biospec 94/20, Bruker Bios-
pin, Ettlingen, Germany). No special or additional hardware is
required, except for the following:
1. A physiological monitoring system that can track the respira-
tion, and which is connected to the MR system such that it can
be used to trigger the image acquisition.
2. MRE hardware to generate shear waves in the abdomen, details
explained in the following section. The experimental protocols
are tailored for using a FDA approved and commercially avail-
able subwoofer-based system for generating shear waves
(Resoundant, MN, USA). Advice for options on using other




in the Abdomen: Hardware
MRE has received considerable attention due to the flexibility of
MR in acquiring arbitrary 2D images and 3D volumes and its
capability to measure motion in all three directions. Though the
application of excitation to the tissue of interest could be either
internal or external, and either static or dynamic, MRE typically
uses dynamic vibrations of a single frequency (within the audio
frequency range) induced by external drivers. The electrical signal
for these drivers is created signal generator synchronized with MRI
pulse sequence triggered and is amplified by an audio amplifier
before being fed into the mechanical driver. The mechanical vibra-
tions applied to tissue fall into three categories: transient, quasi-
static, or harmonic. It is now well known that the MRE-measured
shear modulus of soft tissue is dependent on the frequency of
applied mechanical waves. That is why the term “shear stiffness”
is often used to describe the shear modulus at a specific frequency.
However, it should be fully understood that the formula that
calculates the shear modulus from the measured velocity of the
waves (μ ¼ ρc2, where μ ¼ shear modulus, ρ ¼ density of tissue,
and c ¼ wave speed) is valid only in purely elastic tissues. MRE
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typically uses harmonic vibrations generated by an external driver
device to perturb the tissue. In harmonic excitation, a
low-frequency acoustic wave (20–400 Hz) is transmitted within
the tissue using a sinusoidal mechanical source. When performing
MR elastography, the goal is to acquire tissue stiffness maps for each
imaging slice, with a large area of the tissue of interest not covered
by the 95% confidence map so that a large portion of the tissue can
be measured. The confidence maps are calculated during the stiff-
ness inversion, as the fit of a smooth polynomial to the phase
images. In a typical MR elastography configuration, to create a
sinusoidal mechanical motion, an active pneumatic wave driver,
which is a subwoofer, is located outside the MR scanner room
and is connected, by way of a flexible plastic (polyvinyl chloride)
tube, to a passive driver that is fastened onto the abdominal wall or
the organ or interest. For the most part, three kinds of active driver
mechanical driving mechanisms have been used in the literature.
They are electromechanical drivers, piezoelectric drivers, and
acoustic speaker-based driver systems [20–22]. Electromechanical
drivers were one of the initially developed driver systems (Fig. 1).
They use the Lorentz force between the induced magnetic moment
created by voice coils, and the static magnetic field of the main MRI
magnet to create the motion [20]. Piezoelectric and needle-based
drivers have commonly been used in preclinical or MRE of tissues
[12, 21]. This is primarily because of the advantages of the ease of
positioning of the driver in comparison to the electromechanical
drivers and the avoidance of an additional magnetic field, leading to
a reduction of artifacts [22]. Also, these drivers can create more
reliable waveforms with less ringing effects, which becomes espe-
cially useful in situations where a single transient wave needs to be
induced in the tissue or sample of interest. Acoustic speaker-based
Fig. 1 For smaller animals, an electromechanical driver setup may be used for shear wave generation.
Rotational vibrations generated by the electromechanical driver are transmitted into the entire body of the
animal. The transmitted shear wave frequency range can be set between 50 and 400 Hz
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driver systems are commercially available and are commonly used
for clinical MRE scans. The vibrations in the acoustic systems are
again produced by the Lorentz force, but the static magnetic field is
from a devoted permanent magnet present in an acoustic speaker.
These speakers, with their own permanent magnets, that are much
weaker than the static field B0 of the MR system, are designed such
that they are placed away from the main magnet. Thus, this system
necessitates an additional component to couple the vibrations pro-
duced by the speakers to the tissue of interest. The active driver is
coupled to a passive driver that is positioned on the abdominal
organ of interest. The passive driver transfers a continuous acoustic
vibration that is transmitted through the entire abdomen, at a fixed
low frequency, which is typically 60 Hz for the liver. Choice of
frequency is a balance between wave penetration and desired spatial
resolution. A higher frequency improves spatial resolution while a
low frequency improves wave penetration. The advantage of this
system is that the passive drivers can be developed according to the
application in different organs and can thus be used to effectively
propagate shear waves within the desired organ of interest with
comfort to the patient. For preclinical images in small animals such
as mice or rats, a frequency of up to 400 Hz may be used to get the
desired spatial resolution. A modified phase-contrast based pulse
sequence with motion encoding gradient pairs synchronized to
oscillate at the same frequency of mechanical waves created by the
passive driver are used to encode the motion of the tissues in the
phase of an MR image. This sequence is then used to image the
micron-level cyclic displacements caused by the propagating shear
waves to create a magnitude image, which provides anatomic infor-
mation, and a phase image, which provides wave motion informa-
tion. The phase or “wave” images, containing wave-propagation
information, are then inverted to calculate quantitative stiffness
maps (elastograms).
2.3.2 Pulse Sequence
for MRE Motion Encoding:
Software
The twomain pulse sequence groups inMRI are spin echo (SE) and
gradient recalled echo (GRE). In the early 1980s, the SE sequence
was the main magnetic resonance sequence in clinical imaging
[23]. Later, the GRE sequence proposed by Mansfield and Mauds-
ley became an essential technique and a good alternative to SE
sequences [24]. The two types of acquisition sequences currently
in use to obtain abdomen organ stiffness values are the GRE based
and the SE based with echo-planar readout; both of which have
been shown to have excellent correlation on both 1.5 and 3.0 T
MRI scanners [13, 25, 26]. The use of GRE-based sequence has
demonstrated to correlate with histological grading of liver fibrosis
in previous studies and a recent meta-analysis [10, 13]. However,
the inherent limitations of GRE-based acquisition on field
strengths of 3.0 T or higher in addition to enhanced sensitivity to
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susceptibility, is the signal drop off due to longer echo time
(TE) and relatively shorter T2 relaxation time of the liver.
GRE-based MRE also has relatively lower accuracy in obese
patients due to the increased distance from the driver to the liver.
Thicker layers of fat can result in signal loss and produce limitations
for encoding shear waves in the deeper areas of the liver, hence
reducing the resulting stiffness measurable area [25]. Since chronic
liver disease is quite frequently associated with obesity, radiologists
should be aware of the limitations of GRE-based acquisition in such
cases. GRE-based MRE acquisition also require relatively longer
periods of acquisition and have higher susceptibility to breathing
motion. Clinically, the current GRE-based protocol, for MRE
image acquisition requires a breath-hold of approximately 20 s for
a single slice. Echo-planar imaging (EPI), on the other hand, is a
fast magnetic resonance imaging technique that obtains all spatial-
encoding information in a single radiofrequency (RF) pulse, allow-
ing for faster acquisition times with less motion artifacts. SE-EPI
MRE has several advantages over the GRE MRE sequence: (1) It
allows for acquisition of multiple slices in a single breath-hold
covering entire kidney as compared to GRE MRE, which allowed
for acquisition of only a single slice per breath-hold; (2) Entire 3D
acquisition with three motion encoding directions can be per-
formed in three breath-holds, which enables completion of the
study in patients who cannot perform more than three breath-
holds and cannot lay flat for longer period of time in the scanner;
(3) SE-EPI MRE can avoid problems such as data misregistration
caused due to multiple breath-holds when acquiring multiple slices
compared to GRE MRE. SE-EPI-based images are also advanta-
geous because it enables measuring larger areas of the organ due to
higher waves encoded per relaxation time (TR). Despite these
advantages, use of SE-EPI MRE sequence has a few limitations
such as it is prone to the distortion artifacts arising from the eddy
currents caused by gradients switching on and off rapidly. These
distortions may cause increase in the apparent wavelength of the
waves propagating through the kidneys thereby causing an increase
in the stiffness estimations. Care must be taken to correct for the
distortions when observed. Additionally, SE-EPI MRE is also very
sensitive to chemical shift and ghosting artifacts. Appropriate steps
need to be taken during acquisition by application of spatial spectral
frequency pulses and phase correction to correct for these artifacts,
respectively for accurate estimate of MRE-derived stiffness values.
The tissue response to the applied harmonic excitation is repre-
sented in terms of waves propagating within the tissue. After the
mechanical excitation, the phase-contrast based pulse sequence is
used to encode the shear wave motion into the MR phase signal by
using a series of magnetic field gradients called MEG. The MEG is
typically applied after RF excitation pulses and before signal







acquisition. From the acquired wave images, inverse reconstruction
algorithms are applied to convert the displacement data to mechan-
ical properties [27]. The mechanical quantity that MRE charac-
terizes typically is shear modulus (μ), which describes the
proportionality relationship between the shear stress and strain. In
MRE excitation is primarily shear and the displacements in MRE
are very small (~microns). Therefore, it is a good approximation to
model tissue as a linear, viscoelastic solid. It can be assumed that
there is no volume change as layers of material move in shear,
perpendicular to the direction of the wave propagation. The shear
stiffness, μ, can be calculated if the wavelength, λ, is measured, as
the frequency is known and the density of most soft tissues is close
to the density of water (1000 kg/m3). Assuming an isotropic
material, this reduces to two independent quantities, the Lame
constants λ and μ related to longitudinal and shear deformation
respectively. If local homogeneity is assumed, λ and μ become single
unknowns, and the equation for harmonic motion becomes an
algebraic matrix equation that can be solved locally:
μ∇2u + (λ + μ)∇ (∇ ·u) ¼ ρω2u [28], with ρ the density, ω the
angular frequency of the mechanical oscillation, and u the displace-
ment vector. Approaches such as local frequency estimation (LFE),
phase gradient (PG), and direct inversion (DI) have been used to
estimate the localized wavelength [28, 29]. The algorithms assume
that the waves are propagating in a uniform, infinite, homogeneous
medium. The LFE algorithm can estimate the spatial frequency of
the propagating shear waves. LFE is a robust method for estimating
isotropic tissue stiffness even in the presence of noise when com-
pared to other methods, as it is performed in the k-space domain.
However, it suffers from edge effects where the estimates values at
the sharp boundaries can be inaccurate. Hence, if LFE is used, the
ROIs on the elastograms must be drawn away from the edges. DI is
another inversion algorithm where lower order polynomials are fit
to the displacement field data to obtain its Laplacian; and solving
the Helmholtz wave equation by plugging the Laplacian generates




Recommended QA: Measurements of organ stiffness (magnitude
of the complex shear modulus) obtained with MRE depend on the
spatial fidelity of the acquired phase images. Therefore, the validity
of the field of view and image linearity should be assessed and
confirmed on an ongoing basis, as is already routine for all clinical
scanners, using manufacturer-recommended procedures.
While other instrumental causes of drift in stiffness measure-
ments have not been documented in the literature, technical fail-
ures such as faulty synchronization of the driver system or incorrect
driver frequency settings can cause incorrect measurement.
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Performing and documenting a routine QA process also helps
in preparation of local institutional research guidelines.
Optional QA: Correct user setup and proper functioning of the
MRE system can be confirmed using a phantom with known stiff-
ness properties. These usually consist of a uniform, tissue-
simulating material with known stiffness and known stability over
time and storage conditions. An MRE phantom can be used to
confirm proper functioning of the MRE system after initial installa-
tion and as a periodic test of correct functioning. There is as yet no
consensus on recommendations for the frequency of phantom
testing. Optional QA testing with a phantom should employ a




1. As described in Subheading 2, in a typical preclinical MRE
study, animals are anesthetized by intraperitoneal injections of
ketamine hydrochloride (50 mg/kg) and xylazine hydrochlo-
ride (5 mg/kg).
2. After shaving and preparation of the abdomen, animals are
placed and fixed on a plastic table in the supine position. It is
important to position the animal as close to the isocenter as
possible to avoid any B0 or B1 inhomogeneity artifacts.
3. Start the temperature monitoring system, apply some surgical
lubricant to the temperature probe and place it in the rectum of
the animal.
4. Attach the respiration sensor to the upper abdomen of the
animal using adhesive tape. Start and setup the respiratory
monitoring system. If necessary, adjust the position of the
respiration sensor until the amplitude of the respiration trace
is sufficiently large for the system to reliably detect the trigger
points at the beginning of expiration.
5. A silver needle (disposable silver acupuncture needles, Asahi
Medical Instrument Co., Kawaguchi, Saitama, Japan) can be
used in lieu of a passive driver and gently inserted gently into
the target tissue through the anterior body wall (Figs. 2 and 3).
The other end of the needle is attached to an electromechanical
driver that generated longitudinally orientated sinusoidal





1. MR image acquisitions may be performed with a standard
1.5 T or a 3.0 T whole body MRI scanner using a receiving
surface coil.
2. Acquire a fast pilot scan to obtain images in the three orthogo-
nal planes x, y, and z.
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3. Acquire anatomical images in several oblique orientations to
facilitate planning a coronal slice orientation with regards to the
long axis of the kidney, as described in the chapter by Pohl-
mann A et al. “Essential Practical Steps for MRI of the Kidney
in Experimental Research.”
4. Perform localized shimming on the kidney as described in the
chapter by Pohlmann A et al. “Essential Practical Steps for MRI
of the Kidney in Experimental Research” (see Note 16).
Fig. 2 (a) Drawing illustrates a typical experimental setup of a mouse or rat MR elastography configuration. A
passive driver, a needle, is used to generate circular shear wave fields. A plastic connecting tube connects the
passive driver to the active driver, which is located behind a wall outside the imaging room. This setup is
relatively easy to apply for preclinical imaging. The active driver used may be a standard commercially
available equipment. (b) Images acquired during a MRE phantom scan. Magnitude and phase images yield raw
data: The magnitude images provide anatomic information, and the phase images provide wave motion
information. After postprocessing, color wave images and (c) stiffness maps, also known as elastograms, are
generated
Fig. 3 A typical experimental setup for a mouse MRE study. A silver needle is used to generate circular shear
wave field in the mouse liver in vivo
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3.3 MRE Imaging 1. A gradient echo (GRE) MRE sequence may be used for wave
image acquisition with the following parameters: matrix size of
256  64, TR/TE of 33.3 ms/17.8 ms, flip angle of 30, slice
thickness of 5 mm, field of view of 10 cm  10 cm, one pair of
1.76 G/cm trapezoidal motion-encoding gradients (MEG) at
120 Hz (8.33 ms duration). The repetition time is typically set
as an integer multiple of the mechanical wave period to allow
for continuous shear wave motion during the scan via the
customary synchronized trigger pulses. Details of protocol
parameters for relevant acquisition sequence choices are
provided in Tables 1, 2 and 3.
2. It should be noted that the trigger pulses are moved during the
scan to obtain images at four different phase offsets between
the motion and the MEG, equally spaced over one cycle of the
motion.
3. Perpendicular to the driving needle, several sequential imaging
planes containing tissue of interest should be chosen for MRE
wave data collection. The number of slices to be acquired
depends on the size of the organ of interest, but is typically 2–4.
4. The MEG should be set to sensitize the shear motion along the
through-plane direction (i.e., the anterior–posterior or slice-
select direction for these coronal images). Typically, respiratory
Table 1
Recommended 2D MRE protocol parameters
Parameter 2D GRE MRE 2D SE-EPI MRE
TR (ms) 50 1000
TE (ms) 23.7 30
Matrix size 128  64 interpolated to 128  128 100  100 (true)
Voxel size (mm) 1.2  1.2 1.5  1.5
Slice thickness (mm) 6 6
Bandwidth (Hz/Px) 399 2380
No. of averages 1 1
No. of slices 4 4
MEG frequency (Hz) 60 60
MEG direction Z axis (slice) Z axis (slice)
Echo spacing (ms) 24.7 0.5
EPI factor NA 100
Acceleration factor 2 2
Scan time (min: s) 1:00 0:11
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or cardiac gating is not needed for lower abdomen organs such
as liver and kidneys but this may be added if significant motion
is observed. With a fixed needle inserted into the liver tissue,
anaesthetized animals only performed shallow and fast upper-
chest breathing instead of deep and slow diaphragm breathing.
Therefore, the tissue do not move much during respiration. In
addition, the phase-encoding direction is chosen to be right-
left (frequency-encoding direction superior-inferior), which
prevents possible motion artifacts from the chest wall and the
heart from corrupting the tissue signal. In preclinical setting,
motion artifacts can also be minimized by using multiple
averages. As a reference for mice MRE imaging, preclinical
MRE studies on ten ARPKD mice, with ages ranging from
3 to 12 months were used in the study by Yin et al. [3].
An accurate and reproducible stiffness measurement of the
kidney, given its small size, and deeply seated location, requires
Table 2
Recommended imaging protocol for propagating shear waves in the
abdomen (small animal 3D MRE protocol parameters)
Parameter 3D MRE
Pulse sequence type 2D SE-EPI
Matrix 128  128
No. of averages 1–16
No. of EPI shots 1
TR (ms) 1000
TE (ms) Minimum
No. of slices 12–20
Slice thickness (mm) 1
Gap (mm) 0, Interleave
No. of phases 3–4
MEG frequency (Hz) 200–400
MEG direction X, Y, and Z axes
MEG Power per axis 25 G/cm
Field of view (cm) 3–4
If available on the scanner, it is strongly recommended to use 3D MRE protocol
parameters
GRE gradient recalled echo, SE-EPI spin-echo echo-planar imaging, 2D two dimen-
sional, MRE magnetic resonance elastography, MEG motion encoding gradients, msec
milliseconds,mmmillimeters,Hz hertz,mT/mmilliTesla/meter, Px pixel,minminutes,
s seconds, NA not applicable
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3D analysis of wave field data. For this reason, if available on the
scanner, 3DMRE is recommended to be utilized for renal imaging.
In 3D MRE, the propagating shear waves are imaged with a 2D
multislice spin-echo echo-planar imaging (SE-EPI) pulse sequence
modified to include the motion encoding gradients (MEG) in the
X, Y, and Z directions. MEGs can be applied in one or more
directions to encode the motion in those specific directions. This
is different from the 2D MRE typically utilized for commercial
MRE imaging in which motion is encoded only in a single
direction.
A typical small animal preclinical 3DMRE protocol is shown in
Table 2.
Figures 4, 5, and 6 show cross sectional spin echo anatomical
images of the animal abdomen, more specifically of the mouse liver
region and its respective wave displacement images along the x, y,
and z directions and the absolute values of the complex shear
modulus.
In 3DMRE, the propagating shear waves are imaged with a 2D
multislice spin-echo echo-planar imaging (SE-EPI) pulse sequence
Table 3
Recommended 3D MRE imaging protocol parameters for clinical renal
imaging
Parameter 3D MRE
Pulse sequence type 2D SE-EPI
Matrix 96  96
No. of averages 1
No. of EPI shots 1
TR (ms) 2400
TE (ms) Minimum
No. of slices 42
Slice thickness (mm) 3.6
Gap (mm) 0, Interleave
No. of phases 3
MEG frequency (Hz) 120
Wave frequency (Hz) 60/90
MEG direction X, Y, and Z axes
No. of breath-holds 6
Acceleration factor 3
Driver amplitude range 30–50%
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modified to include the motion encoding gradients (MEG) in the
X, Y, and Z directions. Since kidney is a viscoelastic material, the
stiffness varies with excitation frequency (i.e., stiffness increases
with an increase in frequency). Once decided, it is important to
keep the MEG frequency consistent for the duration of the study.
Fig. 4 Cross-sectional spin-echo anatomical images of the mouse abdomen, more specifically of the liver
region (Image courtesy of Dr. S. Majumdar and Dr. D. Klatt from the Motion-encoding MRI Lab at the University
of Illinois at Chicago, Chicago, Illinois, USA)
Fig. 5 Wave-displacement images along the x, y, and z directions (Image courtesy of Dr. S. Majumdar and
Dr. D. Klatt from the Motion-encoding MRI Lab at the University of Illinois at Chicago, Chicago, Illinois, USA)
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At a frequency of 60 Hz, the average kidney stiffness range of
3.5–5 kPa has been reported on normals in the literature by multi-
ple groups [30, 31]. At a frequency of 90 Hz, a higher kidney




The raw magnitude and phase images obtained from the MRE
acquisition should be reviewed on the scanner console at the time
of the exam. The magnitude images should show signal loss in the
subcutaneous fat just below the passive driver placement, confirm-
ing that mechanical waves are being applied. The signal loss is due
to the phase images (also known as wave images) should demon-
strate shear waves in the specific abdominal organ of interest. In the
color phase images, red to blue region is a wavelength and this
wavelength becomes longer in the presence of a stiff region for a
given excitation frequency. Then these wave images are converted
into spatial stiffness maps using an inversion algorithm known as
elastograms. If no waves are seen in the tissue of interest, then the
driver system should be checked. A phantom scan of known stiff-
ness may be performed if needed to validate driver system. Shear
wave images represent an instantaneous snapshot of the mechanical
waves propagating through the tissue. After the magnitude and
phase images are created, an inversion algorithm is applied to
processes these raw data images to create several additional images
and maps.
Fig. 6 |G*| or the absolute value of the complex shear modulus (Image courtesy of Dr. S. Majumdar and
Dr. D. Klatt from the Motion-encoding MRI Lab at the University of Illinois at Chicago, Chicago, Illinois, USA)
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3.5 Color Display
of Images
This section is tailored for images acquired using an FDA approved
and commercially available subwoofer-based system for generating
shear waves (Resoundant, MN, USA). For images generated using
other in-house developed hardware and software, image display
should be optimized as recommended by the manufacturer.
For image viewing purposes, the following information should
preferably be generated (Fig. 7).
1. Unwrapped wave images clearly depicting the propagation of
shear waves through the abdomen. Phase wrapping occurs
when the shear wave motion is large. Since MRE is a phase-
based technique, the displacement data typically must be
unwrapped before subsequent processing is performed.
2. A gray-scale elastogram without a superimposed 95%
confidence map.
Fig. 7 Representation of typical postprocessed images generated in a clinical liver MRE study. Additional
postprocessed images may be generated offline depending on the software version of the pulse sequence
installed on the scanner
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3. A gray-scale elastogram with a super imposed 95% confidence
map. The confidence map displayed is a statistical derivation
used to overlay a “checkerboard” on the stiffness map to
exclude regions that have less reliable (i.e., noisy and discon-
tinuous) stiffness data so that a high-quality and valid stiffness
measurement can be obtained.
4. A color elastogram without a superimposed 95% confidence
map. The color elastogram, typically generated in JPEG format
is generally used for qualitative stiffness evaluation and visual
purposes. However, if the color elastograms are generated in
DICOM format, then they can also be used to obtain quanti-
tative measurements.
5. And a color elastogram with a superimposed 95%
confidence map.
The gray-scale elastogram, generated and saved in DICOM
format is commonly used to obtain quantitative stiffness measure-
ment, in kiloPascals (kPa). The color elastogram used clinically has
a stiffness display range of 0–8 kPa. A 0–20 kPa color elastogram
display range may also be created and is useful for appreciating
tissue stiffness heterogeneity across the larger region. For research
purposes, the range may be adjusted as desired.
3.6 Drawing Regions
of Interest to Measure
Stiffness
Mean shear stiffness of the organ is calculated using manually
specified regions of interest (ROIs). Skilled interpretation of the
magnitude and wave images is currently required to select a ROI
from which the average hepatic stiffness can be calculated from the
elastogram. Areas with wave interference and noise, as well as
partial volume effects and hepatic blood vessels, can bias the stiff-
ness calculation and need to be avoided when selecting this ROI.
The ROIs are drawn manually in the largest possible area of organ
parenchyma in which coherent shear waves are visible. To avoid
areas of incoherent waves, avoid regions immediately under the
paddle and stay ~1 cm inside the organ boundary and contain a
minimum of 500 pixels per slice. ROIs should be placed in individ-
ual slices. The ROI should also exclude areas of low confidence, as
seen by the checkerboard pattern in the masked elastogram images.
The procedure needs to be repeated for every slice, with magni-
tude, phase, and elasticity images all needing to be analyzed. The
confidence maps calculated during the stiffness inversion as the fit
of a smooth polynomial to the phase images may be helpful in
guiding the ROIs across multiple slices. The mean value is calcu-
lated from all slices and reported as stiffness in kPa. In practice, the
ROIs may be drawn in a single step, keeping these principles in
mind. If available, an automated tool capable of deriving ROIs from
MRE images and accurately calculating stiffness may be helpful to
reduce measurement variability [32, 33].
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3.7 Image
Interpretation
Overall mean stiffness of organ is reported by recording the mean
stiffness value of each ROI and then calculating the mean value,
weighted by ROI size.
Example: Slice 1: mean stiffness ¼ 2.42 kPa and ROI size ¼
2000 mm2; Slice 2: mean stiffness ¼ 2.55 kPa and ROI size ¼
1800 mm2; Slice 3: mean stiffness ¼ 2.92 kPa and ROI size ¼
800 mm2; and Slice 4: mean stiffness ¼ 4.22 kPa and ROI
size ¼ 1000 mm2; then the weighted mean ¼ ((2.42  2000) +
(2.55  1800) + (2.92  800) + (4.22  1000))/(2000 + 1800 +
800 + 1000) ¼ 2.85 kPa.
3.8 Role
of Preclinical MRE
Since MRE is a relatively new, multistep MR technique, there is
room for improvement of efficacy, expansion and exploration.
There is evidently a need for preclinical applications of the method,
primarily to validate the technique against invasive measures and
better understand changes in different diseases. Preclinical work
helps to realize some of this potential with the exploration of novel
driving and contrast mechanisms to improve the efficiency of MRE





Acute kidney injury (AKI) is a sudden episode of kidney failure or
kidney damage that happens within a few hours or a few days of an
insult such as administration of nephrotoxins. AKI is common in
patients who are hospitalized, have underlying kidney disease and
especially in older adults. Medullary hypoxic injury plays a major
role in the pathogenesis of AKI [34], as has been studied by MRE.
A typical hardware setup for pig MRE is shown in Fig. 8. In a
study by Warner et al., the authors tested the hypothesis that renal
blood flow (RBF) is an important determinant of renal stiffness as
measured by MRE [35]. In this study, in six anesthetized pigs with
renal artery stenosis, MRE studies were performed to determine
cortical and medullary elasticity during acute graded decreases in
RBF (by 20%, 40%, 60%, 80%, and 100% of baseline) achieved by a
vascular occlusion (Figs. 9 and 10). Three sham-operated swine,
that served as control pigs, were anesthetized (telazol 5 mg/kg and
xylazine 2 mg/kg) and maintained with mechanical ventilation of
1–2% isoflurane in room air. An ear vein catheter was introduced for
saline infusions (5 mL/min). MRE studies were performed on a
standard clinical 3.0 T MRI system (GE Healthcare, Waukesha,
WI) using a standard multichannel phased array coil. After localiza-
tion, a renal volume series was performed in the axial plane with a
T2 weighted fast spin echo sequence using the following para-
meters: TR/TE¼ 2000ms/88ms; Flip angle¼ 90; FOV¼ 35 cm;
imaging matrix¼ 384 320 40; thickness ¼ 2.5 mm; NEX¼ 1.
The MRE acquisition sequence used was SE-EPI method. Shear
waves were induced by two cylindrical passive pneumatic drivers
aligned along the posterior body wall. Continuous vibrations at a
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Magnet
Magnet
Multiple axial imaging planes are acquired 
to cover the abdominal organ of interest
Paddle/ mechanical driver to be placed in close 




Receiving RF coil to 
be positioned on 
top of the paddle
Fig. 8 A typical experimental setup for a pig MRE study
Fig. 9 A representative example from one of the pigs’ kidney MRE is shown. The stenosis extent changed
gradually from 0% to 100%. Meanwhile, the systemic blood pressure also rose during the acute decrements in
renal blood flow from 75  3 to 96  3 mmHg. The kidney’s elastograms at six different extents of acute
stenosis are shown. The chart summarizes the mean kidney stiffness measurements in stenotic and
contralateral sides respectively. From the left elastograms and the right chart, the authors observed that
the renal cortex stiffness decreased progressively as the degree of stenosis increased. It is another evidence
that less perfusion causes reduced stiffness. Conversely, the contralateral kidney slightly increased in the
stiffness during the same period. It is caused by increased systemic blood pressure
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motion encoding gradient (MEG) frequency of 120 Hz generated
shear waves throughout the abdominal tissues. MRI parameters
used were: TR/TE ¼ 2334 ms/48 ms; FOV ¼ 35  35 cm2;
Imaging Matrix ¼ 96  96; Slice thickness ¼ 3 mm; NEX ¼ 1;
Number of shots ¼ 2; parallel imaging ASSET factor ¼ 2; four
phase offsets through one cycle of motion, six pairs of tetrahedral
trapezoidal motion encoding gradients in three orthogonal direc-
tions with one motion encoding gradient on each side of the
refocusing pulse synchronized with motion. The main finding of
their study was that acute decreases in renal blood flow with no
fibrosis lead to a decrease in renal cortical shear stiffness. Similarly,
in chronic renal arterial stenosis the decrease in renal blood flow
offsets a likely increase in stiffness secondary to development of
renal fibrosis. Decreased renal stiffness may therefore mask the
presence of renal fibrosis, but nevertheless stiffness is a marker of
renal hypoperfusion.
Fig. 10 (a) Right (stenotic) and left (contralateral) kidneys in experimental renal artery stenosis. (b) 2D axial
magnitude and elastograms for normal (control) and variable renal artery stenosis at 10 weeks. The
elastogram shear stiffness legend is on the far right. Red stars indicate stenotic kidneys. The images were
oriented to show the stenotic kidney on the left
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Fig. 11 MRE paddle placement on dorsal side
Fig. 12 MRE of the kidneys in a normal 15-year-old male volunteer. (a) T2W images in axial plane. (b) Wave
illumination and (c) corresponding stiffness map. Note good illumination of waves in both kidneys (Image
courtesy of Dr. Jonathan R. Dillman, Cincinnati, Ohio, USA)
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Fig. 13 MRE of the kidneys of a 13-year-old female patient with loss of corticomedullary differentiation;
chronic kidney disease. (a) T2W images in axial plane. (b) Wave illumination and (c) corresponding stiffness
map (Image courtesy of Dr. Jonathan R. Dillman, Cincinnati, Ohio, USA)
Fig. 14MRE of the kidneys in a 20-year-old patient with transplant rejection. (a) T2W images in axial plane. (b)
Wave illumination and (c) corresponding stiffness map (Image courtesy of Dr. Jonathan R. Dillman, Cincinnati,
Ohio, USA)
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Renal MRE has also been demonstrated to provide clinical
utility in humans. In clinical renal MRE, the paddle is recom-
mended to be placed on the dorsal side with the patient lying in
supine position (Fig. 11). Preliminary results show successful trans-
mission of waves by placing the driver in this position (Figs. 12, 13,
and 14). In a recent study by Kirpalani et al., the authors examined
whether MRE could noninvasively estimate allograft fibrosis and
predict progression of allograft dysfunction [36]. In this study,
renal MRE was performed on a standard clinical 3.0 TMRI scanner
(Skyra, Siemens Healthineers, USA). Patients were positioned head
first and supine, and they were imaged with a standard 18-channel
torso phased array coil centered over the allograft. The mechanical
vibrations required for MRE were supplied by an active pneumatic
driver system. MRE acquisitions were performed using a MEG of
60 Hz vibrations and a free-breathing, flow-compensated
two-dimensional gradient echo coronal MRE pulse sequence to
derive magnitude images and a corresponding stiffness map. The
imaging orientation was standardized to the coronal plane, with the
frequency encoding direction superior to inferior. Other imaging
parameters were as follows: field of view, 32  40 cm2; acquisition
matrix, 128  128 reconstructed to 1.48  1.48 mm2 in-plane
resolution; no parallel imaging; five two-dimensional slices through
the allograft, with each slice being 5-mm thick with a 1-mm inter-
slice gap; TR/TE ¼ 50 ms/21 ms. Four time points of the motion
and three mutually perpendicular directions of the vector motion
were sampled. The acquisition time per scan was reported to be
approximately 5 min. This study is based on the hypothesis that
fibrosis stiffens organs as soft healthy tissue is replaced by stiff
extracellular matrix and suggests the potential of renal MRE as a
new noninvasive way to assess whole-allograft fibrosis burden; one
that may predict future changes in kidney function.
Renal fibrosis causes an increase in the interstitial extracellular
matrix and reduction in the number of tubules, thereby making the
kidneys stiffer. Previous studies suggest that renal fibrosis is a
distinctive feature of progressive kidney diseases such as chronic
kidney disease (CKD), a change that increases the risk of cardiovas-
cular diseases. Therefore, renal fibrosis is an important hallmark for
diagnosing CKD. Noninvasive MRE is attractive for clinical use in
humans.
Existing imaging technologies have been very successful in the
noninvasive assessment of many focal diseases of the kidneys, but
they have been somewhat less helpful for evaluating diffuse (medi-
cal) renal disease such as glomerulonephritis, and renal biopsy
remains the diagnostic tool of choice in many situations. It is now
feasible to quantitatively image the shear stiffness of both kidneys
with anMRE employing a large, posteriorly located passive acoustic
driver. Wave images and the corresponding elastograms can be
relatively easily acquired in axial, coronal, and sagittal planes.
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Preliminary results provide a basis and motivation for investigating
the potential to use MRE as a diagnostic tool for characterizing
renal parenchyma in diffuse and focal diseases of the kidneys.
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Part V
Protocols for Advanced Analyses
Chapter 33
Subsegmentation of the Kidney in Experimental MR
Images Using Morphology-Based Regions-of-Interest
or Multiple-Layer Concentric Objects
Leili Riazy, Bastien Milani, João S. Periquito, Kathleen Cantow,
Thoralf Niendorf, Menno Pruijm, Erdmann Seeliger,
and Andreas Pohlmann
Abstract
Functional renal MRI promises access to a wide range of physiologically relevant parameters such as blood
oxygenation, perfusion, tissue microstructure, pH, and sodium concentration. For quantitative comparison
of results, representative values must be extracted from the parametric maps obtained with these different
MRI techniques. To improve reproducibility of results this should be done based on regions-of-interest
(ROIs) that are clearly and objectively defined.
Semiautomated subsegmentation of the kidney in magnetic resonance images represents a simple but
very valuable approach for the quantitative analysis of imaging parameters in multiple ROIs that are
associated with specific anatomic locations. Thereby, it facilitates comparing MR parameters between
different kidney regions, as well as tracking changes over time.
Here we provide detailed step-by-step instructions for two recently developed subsegmentation techni-
ques that are suitable for kidneys of small rodents: i) the placement of ROIs in cortex, outer and the inner
medulla based on typical kidney morphology and ii) the division of the kidney into concentrically oriented
layers.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Segmentation, ROI
1 Introduction
The potential of magnetic resonance imaging (MRI) for the diag-
nosis and monitoring of renal disease remains largely untapped.
Functional renal MRI promises access to a wide range of (patho)-
physiologically relevant parameters via techniques such as blood
oxygenation sensitive T2*-mapping (aka blood oxygenation level-
dependent MRI, BOLD), perfusion measurement by arterial spin
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_33, © The Author(s) 2021
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labeling (ASL), and diffusion weighted imaging (DWI). Insights
into microstructural changes can be obtained with DWI and
T1-mapping, for example to probe for renal fibrosis. Emerging
techniques including pH-mapping via chemical exchange satura-
tion transfer (CEST) and sodium (23Na) imaging complement the
renal MRI portfolio. For quantitative comparison of results, repre-
sentative values must be extracted from the parametric maps
obtained with any of these MRI techniques. To improve reproduc-
ibility of results this should be done based on regions-of-interest
(ROIs) that are clearly and objectively defined.
Semiautomated subsegmentation of the kidney in MRI repre-
sents a simple but very valuable approach for the quantitative
analysis of imaging parameters in multiple ROIs that are associated
with specific anatomic locations, for example, the distinct layers:
cortex, outer medulla, and inner medulla. Thereby, it facilitates
comparing MR parameters between different kidney regions, as
well as tracking changes over time. Here we use the term subseg-
mentation in order to make a clear distinction between segmenting
the kidney into smaller subregions and the identification of the
kidney organ borders within an image, for which commonly the
term segmentation is used.
In this chapter we provide detailed step-by-step instructions for
two recently proposed subsegmentation techniques [1, 2], which are
suitable for kidneys of small rodents: (1) the placement of ROIs in
cortex, outer and the inner medulla based on typical kidney mor-
phology (used in [1, 3–8]) and (2) the division of the kidney into
concentrically oriented layers (used in [2, 9–13]). They work inde-
pendent of the actual image contrasts or parameter map values and
hence are well suited for a wide range of MRI mapping techniques.
Both techniques allow for the exclusion of one or several regions in
the kidney from the analysis, for example regions that show obvious
image artefacts. Changes in kidney size are accommodated for by
both techniques, but results should be treated with due caution if the
relative sizes of the renal layers are significantly different from naive
healthy kidneys or change throughout the experiment.
The first method described here is the Segmentation of
Morphology-Based Renal Regions-of-Interest (SOMBRERO)
[1]. Quantitative histomorphological data on the dimensions of
the renal layers were obtained from a number of freshly excised
kidneys of adult male rats, where anatomical structures were iden-
tified to be distributed in certain proportions. The percentages
referring to the corresponding locations exclude the rather broad
(and in case of the cortical–medullary border zone undulating)
transition regions among the layers that are prone to partial volume
effects. The percentages are adapted toMRI images by determining
a standardized location, length, width and angle of the kidney in
the image. Subsequently, ROIs at anatomical locations such as the
cortex, outer medulla, and inner medulla are returned
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automatically in form of masks. These masks can then easily be
applied to the user’s parameter maps.
The strength of this technique is that it creates ROIs whose
positions have been carefully chosen to provide representative
values for the renal cortex, outer medulla and inner medulla, leav-
ing a generous “buffer zone” at the transition regions between the
renal layers. Also, access to five (or three) ROIs in each layer allow
assessment of inter-layer and intra-layer variability. Differences
between the parameters in the three renal layers can be expressed
as ratios, such as T2*(cortex)/T2*(outer medulla). The transition
regions between the renal layers are not accessible with this
approach at present, but such a feature could be included without
difficulty in the future, even by the user. ROI locations have been
defined for rat kidneys in coronal view (with respect to the kidney).
However, this method is in principle applicable to mouse and rat
kidneys in axial, sagittal, and coronal view. An extension to other
orientations or mice would only require some additional careful
morphometric measurements to define the relative ROI positions.
The second technique is the multiple-layer concentric objects
segmentation (MLCO; for human MRI proposed as 12-layer con-
centric objects, TLCO) [2, 9]. A series of concentrically oriented
layers is generated after a manual retracing of the outline of the
kidney in the respective MR image. The desired number of concen-
tric objects (COs) can be freely chosen by the user, although most
publications have used twelve layers in humans thus far.
This technique was developed for human kidney MRI;
although the COs do not refer to specific anatomic locations,
they approximately reflect the layered structure of the kidney
through their concentric nature. This makes it suited for MRI of
rodent kidneys, whose simpler anatomic structure is better repre-
sented by the concentric layers than that of the human kidney.
While the outermost and innermost COs are straightforward to
interpret and are generally considered as a proxy of respectively
cortex and medulla, a clear association of the intermediate concen-
tric objects with the renal layers remains challenging, in particular,
because the broad transition zones and, thereby, probable partial
volume effects are neglected. Differences between the parameters
in the three renal layers can only be indirectly expressed by the slope
of the curve when plotting the COs’ mean values against their
position. This technique is applicable to mouse and rat kidneys in
axial, sagittal, and coronal view (with respect to the kidney). One of
its strengths is its applicability to human kidneys. A direct compari-
son between human results and those from rodent kidneys would,
however, require a carefully calibrated conversion, due to the mor-
phological differences.
Notwithstanding their limitations, both kidney subsegmentation
techniques are very valuable semiautomated tools for the quantitative
analysis of imaging parameters, specifically for comparing MR
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parameters between groups, between different kidney regions and
monitoring changes over time.Use of these objectively definedROIs
(rather than manually drawn ROIs) should help to improve repro-
ducibility and comparability of results in future studies.
This chapter is part of the book Pohlmann A, Niendorf T (eds)






The SOMBRERO method is provided in Python (3.6) program-
ming language. It has been implemented and tested using the
following software, which is available for macOS 10.14.5 (used
for development), Windows and Linux operating systems.
1. Spyder 3.2.4, installed through Anaconda (https://www.ana
conda.com), which is open-source.
The MLCO method requires the following software:
2. The MATLAB® programming environment (MathWorks,
Natick, MA, USA, https://www.mathworks.com/products/
matlab.html). It may also be possible to use the open-source
alternative Octave (https://www.gnu.org/software/octave/),
but this has not been tested and may require some adaptations
in the MLCO toolbox.
2.1.2 Toolboxes The provided software for SOMBRERO requires the installation of
the following packages: numpy, matplotlib, cv2, math, pydicom, os,
and pickle.
These can be conveniently installed one-by-one through the
Anaconda Navigator for Windows. For Linux or MacOS the fol-
lowing line in the terminal will install all them at once:
pip install numpymatplotlib cv2 mathpydicom os pickle
2.1.3 Software SOMBRERO: The software is provided online at GitHub: https://
github.com/lriazy/sombrero/





Common MRI imaging planes are sagittal, coronal, and axial slices
as displayed in Fig. 1. For the sake of this tutorial we will focus on
coronal slices. Other imaging planes are possible for these segmen-
tations as well (see Note 1).
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2.2.2 Input Requirements In this chapter, all input files are assumed to be Dicoms. However,
any way to import an image as a matrix to Matlab or NumPy array








In order to display interactive plots, make sure your graphics back-
end is set on “automatic.”
This can be looked up in Preferences> IPython console>Gra-
phics > Graphics backend.
3.1.2 Loading Images 1. Open the script roirect.py, which is executed cell-by-cell. Run-
ning a cell can be done by a button or by pressing
CTRL + ENTER.
2. The images are loaded by the line:
Fig. 1 Typical MR imaging planes and their resulting kidney shapes. The coronal, axial, and sagittal planes do
not correspond to the scanner coordinate system, but instead are defined with respect to the double-oblique
spatial orientation of the kidney. “C” stands for crescent and “D” doughnut
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im ¼ pydicom.dcmread(’EnIm1.dcm’)
in the script. Modify ’EnIm1.dcm’ to be the path to your
dicom file. In this case, the file is located in the same directory
as the script. Therefore the filename is sufficient.
3.1.3 Definition
of Bounding Box
1. Execute the first cell in roirect.py.
2. Drag on the image to draw a new rectangle (Fig. 2a).
3. Use the edge markers to adjust the height and width of the
rectangle
4. Shift the rectangle using the central marker.
Fig. 2 (a) Manual selection of the kidney with the rectangle tool. (b) Cropped and straightened kidney image
with reference lines. The red boxes are located in the cortex, the yellow box in the outer medulla and the blue
box in the inner medulla. (c) Display of the successful selection of two border points (in green) at the
intersection of the kidney border and the diagonal line. (d) The ROIs after transformation to the locations in the
original image (without cropping or other processing). (e) The final mask of ROIs as an image of the same size
as the original image with coded regional masks
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5. Tip the rectangle using one of the edge markers (Note: A finer
adjustment of the angle can be done by pressing the UP and
DOWN buttons).
6. Press ENTER to end the adjustments and proceed.
3.1.4 Diagonal Boundary
Selection
1. A new window opens up automatically (Fig. 2b).
2. Mark two points marking the end of the kidney on the black
diagonal lines.
3. The resulting image should look like Fig. 2c).
3.1.5 Generation of Mask
for Imaging Series
1. Execute the next section to transform the morphologic ROIs
back to their locations in the original image (Fig. 2d).
2. Execute the next section to generate and visualize the variable
roimask, which contains numbered masks for each ROI
(Fig. 2e).
3.1.6 Saving Mask 1. Generate a path to the file by connecting the path (path¼“ and
filename¼1will save the file 1.pickle in the current folder).
pfile ¼ os.path.join(path,filename+’pickle’)
2. Write the file using the following commands:
with open(pfile,’wb’) as f:
pickle.dump([S, roimask], f)
3.1.7 Loading Mask 1. Generate a path to the file by connecting the path just as in
saving the file:
pfile ¼ os.path.join(path,filename+’pickle’)
2. Read the file into the variables S and roimask:




Given the character of in-house developed programs, the MLCO
toolbox allows the user the freedom and obligation to specify all
details exactly. Subheadings 3.2.1–3.2.4 describe essential steps,
where any of the proposed options have to be chosen. Finally,
Subheading 3.2.5 shows an example for each choice made as in
the preceding sections and composes a script, which is ready to run.
3.2.1 Load an Image or
a List of Images in a Matlab
Array
1. Open the matlab script called demo_script.m.
2. Note that you can execute a cell of a matlab script by pressing
CTRL + ENTER.
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3. Load a list of images by executing for example the following
line:
myImageList ¼ conObjDicomRead(’Dir’ ,’C:\Users\conObj\myGRE\’);
4. This loads the image list stored in C:\Users\conObj\myGRE\.
5. The variable myImageList, is now a three-dimensional array
containing a list of matrices that each corresponds to a gray
scale image.
6. You can visualize this image list by executing the line
conObjImage(myImageList);
This function plots the first image in the image stack. If you
would like to display the mean of all images. The file has to be




7. You can navigate through the images with the up and down
arrow of your keyboard.
3.2.2 Defining
the Number of Layers
In order to realize the concentric object technique, you have to
choose a mask-number, which is the number of masks that will
patch the chosen segmented area of you images. We also call this
number the “number of layers” and we gave the name nLayers to
this number in our script (seeNote 2). If you want 9 layers, execute
the line
nLayers ¼ 9;
The number of layers is inevitably limited by the image resolu-
tion. For experimental MR, 9 layers are recommended, whereas
MR images of human kidneys were usually divided into 12 layers.
3.2.3 Segmenting
the Area of Your Choice
in the Image
In the following, the segmentation of “C”-shaped kidney slices
from MR images will be described. This applies to coronal
(Fig. 3) and axial (Fig. 4) slices as shown in Fig. 1.
1. Execute the line
[myBound_ext,myBound_int]¼conObjBound_C(myImageList);
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2. A matlab figure appears displaying the first image stored in
myImageList.
3. Navigate through the images with the up and down arrow of
your keyboard.
4. Adjust the contrast by pressing on CTRL+D and fix the change
by pressing on CTRL+F.
5. By clicking on the picture, you can manually segment the area
of your choice (Fig. 3a).
6. Note that pressing the key ESC allows you to reset your selec-
tion. You can also zoom in the picture with the available Matlab
tools. If any problem appears during this manual segmentation,
pressing the key ESC often solves the problem!
7. Double click on the picture to close the polygon. You can still
modify the position of its vertices interactively on the picture
(Fig. 3a).
Fig. 3 (a) Closed manual contour of the kidney. Modification of the contour at the blue points is still possible at
this stage. (b) The contour of the kidney turns white, after the contour is finished. The required input of two
points describe the inner and outer borders. (c) After the two points have been entered, the inner and outer
contour can be automatically separated into blue and red contours. (d) Output of the finished MLCO procedure
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8. When you are finished, double-click inside the polygon.
9. The contour of your segmentation will now appear in white
(Fig. 3b).
10. Click near the white line at two different locations to indicate
where the separation between the inner part and the outer part
of the contour should occur. (Note: You do not need to press
exactly on the white line because the program will choose the
location on the white line that is the closest to your click.)
(Fig. 3b)
11. The inner and outer part of the contour appear now in blue and
red respectively (Fig. 3c).
12. You can now close the figure. The polygon of the outer con-
tour is now stored in the variable myBound_ext and the poly-
gon of the inner contour is now stored in myBound_int.
The same procedure can be applied for axial slices (Fig. 4). We
describe in the following how to segment an area that contains a
Fig. 4 (a) Manual contouring of the outer kidney boundary in the MLCO method. (b) The contour of the kidney
turns white, after the contour is finished. (c) After the two points have been entered, the inner and outer
contour can be automatically separated into blue and red contours. (d) Output of the finished MLCO procedure
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hole. The procedure is very similar to the previous one but the
function conObjBound_D has to be used instead of conObj-
Bound_C (C for crescent and D for doughnut).
1. First execute the line
[myBound_ext, myBound_int] ¼ conObjBound_D(myImageList);
2. As previously, segment manually the area of your choice
(Fig. 5a) and double-click in the polygon to validate it. The
contour of the polygon is now white and you can choose
another closed polygon that has to lie inside the first one
(Fig. 5b).
3. Once the second area is segmented, double-click inside it such
that its polygon also appears in white (Fig. 5c).
4. As previously, you have to indicate which contour is the outer
one and which contour is the inner one. For that purpose, click
first near the outer contour and then click near the inner one.
Fig. 5 (a) Outer contour for the “D”-shaped kidneys. (b) Entered contour in white. (c) Inner contour added
manually, which is different from the previous “C”-shape procedure. (d) The required input of two points
describe a radial line
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But the two location you click onmust be approximately on the
same radial line (as on Fig. 5d) to allow the algorithm to work
correctly.
5. Once the two location are chosen, the outer and inner contour
appear in red and blue respectively (Fig. 6a). This closes the
step of the segmentation.
3.2.4 Build the List
of Masks That Realizes
the Concentric Object
Technique
1. Execute the following line:
myCO_mask ¼ conObjMask(myImageList, myBound_ext ,
myBound_int,.nLayers);
2. You can visualize the masks with the command
conObjImage(myCO_mask);
Fig. 6 (a) Inner and outer contour can again be identified after two points are entered. (b) The finished output
from the MLCO method for “D”-shaped kidneys. (c) Exclusion of regions. (d) Result from MLCO method after
excluding the regions specified in (c)
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3. Browse through the different masks with the up and down
arrow of the keyboard. Alternatively, you can visualize the list




The last line results for example in Figs. 3d and 4d for the
segmentation in the crescent shape and in Fig. 6b) for the
segmentation in the doughnut shape.
3.2.5 Basic Script
for Applying the Concentric
Object Technique
Assuming the location of the images to be in the folder ’C:\Users
\conObj\myGRE\’, a basic script could look as follows:
myImageList ¼ conObjDicomRead(’Dir’ ,’C:\Users\con-
Obj\myGRE\’);
[myBound_ext,myBound_int]¼ conObjBound_C(myImageList);




This part describes multiple possibilities, which are optional for
modifying the list. The only steps required are the first and the
second.
1. Create an object of the class conObjExclusion.m in the conObj
folder by executing: myExclusion ¼ conObjExclusion;
2. Manually segment some region of the image to exclude from
the analysis and to store these exclusion regions in the object
myExclusion. For that purpose, execute: myExclusion.stack
(myImageList);
3. A figure appears.
4. Segment the area of your choice.
5. Double-click to close the polygon and double-click again in the
polygon to validate it. (You can execute steps 2–5 as many
times as you want to add new exclusion regions.)
6. Execute myExclusion.show(myImageList);
to visualize all the exclusion mask that are in the object
myExclusion (Fig. 6c).
7. Execute myExclusion.remove[2];
to remove the exclusion mask number 2.
8. Execute myExclusion.clear;
to empty the object myExclusion.
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9. To construct a new list of masks from the previous list of masks
myCO_mask but excluding the region stored in the object
myExclusion, simply execute
myCO_mask_new ¼ myExclusion.crop(myCO_mask);
10. The new list of masks myCO_mask_new can be displayed by
executing the following line
conObjMaskImage(myCO_mask_new);
which results in Fig. 6d.
4 Notes
1. The orientation of the kidney was assumed to be coronal
throughout this chapter. However, the MLCO method does
not refer to specific anatomical locations and can therefore be
used in any of the cases displayed in Fig. 1. The SOMBRERO
method can potentially be used in other planes as well but
would need new percentage values from kidney histology as a
reference.
2. For human renal MRI the use of 12 layers was proposed
[2]. For rats and mice another number of layers may be more
suitable. This also depends on the spatial resolution that can be
achieved with that particular MRI technique and available
hardware, because it would probably not make much sense to
have layers with a width of less than one (noninterpolated)
pixel. As a default we recommend to use the proposed number
of 12 layers.
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Chapter 34
Denoising for Improved Parametric MRI of the Kidney:
Protocol for Nonlocal Means Filtering
Ludger Starke, Karsten Tabelow, Thoralf Niendorf,
and Andreas Pohlmann
Abstract
In order to tackle the challenges caused by the variability in estimated MRI parameters (e.g., T2* and T2)
due to low SNR a number of strategies can be followed. One approach is postprocessing of the acquired
data with a filter. The basic idea is that MR images possess a local spatial structure that is characterized by
equal, or at least similar, noise-free signal values in vicinities of a location. Then, local averaging of the signal
reduces the noise component of the signal. In contrast, nonlocal means filtering defines the weights for
averaging not only within the local vicinity, bur it compares the image intensities between all voxels to
define “nonlocal” weights. Furthermore, it generally compares not only single-voxel intensities but small
spatial patches of the data to better account for extended similar patterns. Here we describe how to use an
open source NLM filter tool to denoise 2D MR image series of the kidney used for parametric mapping of
the relaxation times T2* and T2.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Parametric mapping, T2, T2*,
Diffusion
1 Introduction
Mapping of the transverse relaxation times T2* and T2
(or relaxation rates R2* ¼ 1/T2* and R2 ¼ 1/T2) requires series
of MR images with different echo times TE: The maps are obtained
by fitting the exponential model curve S(TE)¼ S0 exp(TE/T2(*))
to the signal intensities of each image pixel with increasing TE. This
approach is inherently associated with decreasing signal-to-noise
ratio (SNR) for the image volumes obtained for longer echo times.
Similarly, there is a substantial signal attenuation and SNR reduc-
tion in diffusion-weighted MRI versus images acquired without
diffusion-sensitizing gradients. Low SNR basically poses two
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_34, © The Author(s) 2021
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general problems: First, it leads to a variability for the parameter
estimates in the quantitative maps or derived model parameters.
Second, it induces a systematic bias for the estimated parameter
maps [1]. Please see Polzehl and Tabelow [2] for an elaboration of
the issues and possible solutions.
In order to tackle the challenges caused by the variability in the
estimated parameters due to low SNR a number of strategies can be
followed. The obvious one is hardware related and includes
improvements on the MR scanner side, such as dedicated RF coils
or the use of cryogenically cooled RF probes [3]. Then, SNR is
increased by reducing the variability of the measurement. Since the
magnitude of the MR signal is directly related to the voxel volume
[4], SNR increase can be achieved by reducing the spatial resolution
of the image acquisition. This is obviously a very unfavorable
solution. Alternatively, signal variability can be reduced by averag-
ing of the signal over multiple acquisitions. This approach comes at
the cost of prolonged acquisition times. Acceleration techniques
like parallel imaging [5, 6] or compressed sensing [7] allow for
more signal averaging within the same time span. Image postpro-
cessing provides another alternative for reducing the variability of
the data. Within this chapter, we specifically consider a class of
methods that post-processes the acquired data, that is, smoothing.
The basic idea is that MR images (like all images) possess a local
spatial structure that is characterized by equal, or at least similar,
noise-free signal values in vicinities of a location. Then, local aver-
aging of the signal reduces the noise component of the signal. The
simplest approach is the application of a Gaussian filter which per-
forms a local averaging with weights defined by a (Gaussian) kernel
function and a bandwidth. Due to its simple mathematical formu-
lation it can be performed very fast on data volumes independent of
the spatial dimensionality of the data. However, it comes with the
blurring of the images, which is evident at edges between different
tissues, especially hindering the analysis of fine structures within the
volumes.
Alternatively, adaptive smoothing methods have been devel-
oped that aim to take the local properties of the specific data at
hand into account. The specific methods are based on different
methodologies, like anisotropic diffusion [8–11], nonlocal means
[12], penalization techniques [13, 14] wavelet filtering [15],
model-based methods [16, 17], the propagation-separation
approach [18, 19], or other local techniques [20, 21]. Many of
these techniques have been applied to diffusion-weightedMRI data
but are also applicable for relaxometry measurements. Depending
on the specific method and the input data at adaptive smoothing is
performed on each image volume separately or uses the combined
information from all available raw data. In contrast to nonadaptive
filters such as the Gaussian filter, these methods typically require
longer computation times and the choice of one or more
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smoothing parameters. Furthermore, in a similar way as the Gauss-
ian filter induced blurring of images, adaptive filters might impose
artifacts depending on their assumptions on the data like a cartoon-
esque appearance due to a step-function reconstruction of the
images.
Here, we specifically consider the nonlocal means (NLM) filter
[22, 23], which is of proven value for MRI. In contrast to defining
the weights for averaging within the local vicinity of a location
depending on the spatial distance only, it compares the image
intensities between all voxels to define “nonlocal” weights for
averaging intensities. Furthermore, it generally compares not only
single-voxel intensities but small spatial patches of the data to better
account for extended similar patterns. It is related to the bilateral
filtering [24], where the local weights are refined by a factor related
to local intensity differences; nonlocal means can thus be consid-
ered as a bilateral filter with infinite spatial bandwidth making it
nonlocal. The filter can be applied to images in two dimensions but
also in 3D or for multispectral [25] such as multiecho imaging
techniques used in MR relaxometry.
Advantages of the application of the NLM filter are manifold:
As a purely postprocessing method it does not require special
hardware or sophisticated image acquisition techniques but can
be applied offline. Many implementations and extensions of the
original algorithm as open-source software are freely available.
Examples are provided under: https://sites.google.com/site/pier-
rickcoupe/softwares/denoising-for-medical-imaging/dwi-denois-
ing/dwi-denoising-software. Most of the implementations require
MATLAB. Although smoothing parameters need to be tuned,
default settings provide a very good starting point. Images pro-
cessed with the NLMfilter exhibit an improved SNR, show no extra
blurring of the edges and preserve effective spatial resolution.
Occasional and slight introduction of large-scale structures along
the coordinate axis is a recognized limitation of the NLM filter
because the comparison of spatial patches is in favor of these
directions.
In this protocol we describe the application of a purpose-build
implementation of the NLM filter for 2D MRI relaxometry data
(see Note 1 for implementation details). The open source tool
comes in two versions: (1) each echo time is filtered independently
(2D-NLM) (2) similarities between image patches are estimated
jointly for the complete stack of echo images (stackNLM). While
the first is a straightforward block-wise implementation of the
NLM filter, the second proposes a novel method exploiting the
redundancy of information in MR relaxometry data (seeNote 1 for
implementation details). Both filters reduce the noise level in low
SNR relaxometry data with version 2 offering slightly superior
results (seeNote 2 for a detailed example). Additionally, application
of the MATLAB Image Processing toolbox function imnlmfilt is
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described. This function performs similar to 2D-NLM while being
considerably faster. To complete the preprocessing of MRI relaxo-
metry data, correction of the Rician noise bias is described.
This chapter is part of the book Pohlmann A, Niendorf T (eds)





The processing steps outlined in this protocol require the
following:
1. The software development environments MATLAB ® (The
MathWorks, Natick, Massachusetts, USA; mathworks.com)
or Octave (gnu.org/software/octave).
2. The MATLAB/Octave implementation of the NLM filter
downloadable from github.com/LudgerS/
MRIRelaxometryNLM
3. Optional: The MATLAB Image Processing Toolbox release
R2018b or newer.
4. A MATLAB/Octave tool for noise bias correction download-
able from github.com/LudgerS/MRInoiseBiasCorrection.
This tool includes detailed documentation to facilitate adapta-
tion for other software development environments or use with
multichannel coil data.
5. A tool for data import. This tool will depend on the data
format:
DICOM data—MATLAB contains a build in function to
import dicom data: dicomread. For Octave support is
offered by the following package octave.sourceforge.io/
dicom/.
Bruker data—Bruker also offers a toolbox to import data into




1. The following protocol assumes that a pure noise scan was
acquired to reliable estimate the data noise level.
2. See Note 3 for comments on noise scan acquisition.
3 Methods
3.1 Data Import These steps should be executed for both the relaxometry data and
the noise scan data. In the following sections it is assumed that the
relaxometry data was stored in variable relaxData and the noise scan
in variable noiseData.
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3.1.1 DICOM Data 1. To import dicom data execute the command
data ¼ dicomread(filePath);
where ‘filePath’ is a string containing the relative or abso-
lute path of the .dcm file.
3.1.2 Bruker Data For a Linux or MacOS system, substitute the file separator \ by /.
1. Ensure that pvtools is on the search path:
addpath(genpath(. . .\pvtools))
where ‘. . .\pvtools’ specifies the path of the pvtools folder.
2. Store the path to the scan you want to load in variable
scanFolder.
3. Read the visu_pars parameter file:
visuPars ¼ readBrukerParamFile([scanFolder,
’\visu_pars’]);
4. Load the Paravision reconstruction:




The data scaling needs to be corrected in some cases depending on
the data format and vendor if the relaxometry data and noise scan
were acquired with different numbers of averages. For example, in
Bruker data, the individual averages are simply added instead of
computing the mean (seeNote 4 for a procedure to test the scaling
convention). Assuming the noise scan was acquired with a single
average and the relaxometry data with NA averages, use the follow-
ing processing step:
1. relaxData ¼ relaxData/NA
3.3 Noise Level
Estimation
We assume the availability of a pure noise scan. In this case the
complete noise data constitutes a background region. Assuming
that the noise scan was acquired with a single average and the
relaxometry data with NA averages, the noise level can be com-
puted as
1. sigma ¼ std(noiseData(:))/(0.6551*sqrt(NA));
The factor 0.6551 accounts for the different standard devia-
tions in background and high SNR regions in MR magnitude
images [1, 26, 27]. For data from multichannel coils see Note 5.
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3.4 Application




To apply the provided NLM filter implementation, use a loop over
all echo times. It is assumed that the relaxometry images are two
dimensional and that the echoes are stored along the third dimen-
sion of relaxData.
1. Set the parameters of the filter (seeNote 6 for an explanation of
choices)
params.centerDistance ¼ 1; % distance between
individual blocks
params.blockRadius ¼ 1; % size of the blocks;
params.searchRadius ¼ 10; % determines the number
of searched blocks
params.beta ¼ 0.5; % adjusts the filter strength
2. Prealocate memory for the filtered data
filteredData ¼ zeros(size(relaxData));
3. Apply the filter to every echo individually






1. Set the paramters of the filter (see Note 4 for an explanation of
choices)
params.centerDistance ¼ 1; % distance between
individual blocks
params.blockRadius ¼ 1; % size of the blocks;
params.searchRadius ¼ 10; % determines the number
of searched blocks
params.beta ¼ 0.3; % adjusts the filter strength





MATLAB’s imnlmfilt works on 2D images. Again a loop over the
echo times is used:
1. Prealocate memory for the filtered data
filteredData ¼ zeros(size(relaxData));
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2. Apply the filter to every echo individually




3.5 Bias Correction To correct the Rician noise bias, the MRInoiseBiasCorrection tool-
box is used. Importantly, the noise level sigma of the original data
and not that of the filtered image needs to be given as an input
parameter.
1. Ensure that the toolbox is on the search path
addpath(. . .\MRInoiseBiasCorrection)
where ‘. . .\MRInoiseBiasCorrection’ specifies the path of
the toolbox folder.
2. Apply the noise bias correction
correctedImage ¼ correctNoiseBias(imageData,
sigma, 1);
The last argument specifies the number of channels in the
RF coil.
4 Notes
1. The provided tool follows the block-wise implementation of
the NLM filter outlined by Coupé et al. for 3D data [28]. The
noise level σ is expected to be provided by separate means such
as the noise scan described in this protocol. The filtering




, where n is the number of pixels
in the compared blocks and β a parameter which can be con-
trolled by the user (see Note 5). Noise bias correction was not
integrated into the filter but is recommended as a
subsequent step.
2. We present an example application to showcase the potential of
the NLM filter for T2* relaxometry. For this purpose the
kidney of an ex vivo rat phantom was scanned with a multiecho
gradient-echo (MGE) sequence (TR ¼ 50 ms, TE ¼ 2.14 ms,
2.47 ms echo spacing, ten echoes, [38.2  48.5] mm2 FOV,
1mm slice thickness, [202 256] imagematrix, 80 repetitions,
one average per repetition). The average of all 80 repetitions
was used as a reference measurement. T2*maps were computed
from unfiltered data and data filtered following the protocols of
Subheading 3.4.1 (2D-NLM) and Subheading 3.4.2
(stackNLM).
Figure 1 shows maps for a single repetition (NA ¼ 1), the
average of four repetitions (NA ¼ 4) and the reference data
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with 80 averages. Maps showing the deviation from the refer-
ence (ΔT2*) and the magnitude deviation (|ΔT2*|) highlight
the strongly reduced noise level in filtered images for NA ¼ 1.
No bias is introduced and edges are preserved. The filter work-
ing on the complete stack of echoes (stackNLM) is more robust
regarding outliers. For NA ¼ 4 only very little improvement is
achieved due to the already good data quality, yet also no
artifacts are introduced.
The root-mean-square deviations (RMSD) of the T2*
maps from the reference support this visual assessment
(Fig. 2a). At low SNR (low number of averages) the filtered
data outperform the maps computed without filtering. The
improvement exceeds the gain achieved by doubling the mea-
surement time. At higher SNR filtered and unfiltered data
perform similarly. stackNLM consistently performs better
than 2D-NLM. Figure 2b shows selected echoes for NA ¼ 1
and the reference. Here the improved performance of
stackNLM becomes obvious for data acquired with
TE ¼ 19.4 ms where signal is recovered with sharper detail.
Fig. 1 Filtered and unfiltered kidney T2* maps acquired in an ex vivo rat phantom. The reference was
computed from unfiltered data and NA denotes the number of averages. The second row shows the T2*
deviation from the reference while the third row shows the magnitude of the T2* deviation
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Figure 3 shows an in vivo example for both T2* and T2
data. Here little filtering is performed for the high SNR T2*
data, whereas the T2 map is effectively denoised.
3. A pure noise scan is acquired by setting the excitation flip angle
and reference power to zero so that no excitation occurs and
pure noise is acquired. The receiver gain needs to be set identi-
cal to all other scans for which the noise level should be
determined. The number of averages can be reduced to one,
as the resulting change in noise level is easily compensated.
Alternatively, the output of the RF power supply can be dis-
connected following the system adjustments.
4. To determine the employed convention of averaging, acquire
high SNR phantom data with varying numbers of averages
while keeping all other parameters fixed. Import the data as
described in Subheading 3.1. If all scans show the same signal
magnitude, the scaling step described in Subheading 3.2
should be omitted. However if for example doubling the num-
ber of averages also doubles the signal amplitude, rescaling
should be performed.
Fig. 2 (a) Root-mean-square deviation (RMSD) from the reference (NA ¼ 80, unfiltered) for T2* maps
computed from filtered and unfiltered data. (b) Image data for selected echo times (TE). The scaling is set
individually for each row
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5. Assuming a sum-of-squares reconstruction, the factor 0.6551
should be replaced by 0.6824, 0.6953, 0.7014 or 0.7043 for
2, 4, 8 or 16 receive element coil data [29].
6. The block-wise NLM filter compares overlapping square image
patches or blocks. The larger the distance between block cen-
ters (params.centerDistance), the fewer blocks are in the image.
Reducing the number of blocks will accelerate the filter but
might lead to artifacts in the vicinity of contrast edges. params.
blockRadius determines the size of the blocks and must always
be larger than params.centerDistance to ensure overlap. The
block is a square patch of area (params.centerDistance + 1)2.
Increasing the size of blocks will improve performance in
homogeneous areas but prevent the filter from finding similar
blocks in areas with small features. params.searchRadius speci-
fies the number of compared image blocks: each block is com-
pared with the adjacent (params.searchRadius + 1)2 blocks to
determine the corresponding filter weights. In the ideal case
the algorithm would always search the complete image for
similar blocks; however, the computational cost to do so
would be prohibitive while the benefit diminishes fast with
increasing search radius. params.beta specifies the parameter β
introduced inNote 1. While theoretical considerations suggest
a value close to 1, the optimal value of β is known to vary with
the noise level [28]. Increasing the value of β will increase the
smoothing effect. The proposed values of 0.5 for 2D-NLM and
0.3 for stackNLM were found to perform well over a wide
range of noise levels.
Fig. 3 Filtered and unfiltered T2 and T2* maps acquired in a rat in vivo. In this experimental set-up (a healthy
naive rat kidney being imaged using a dedicated 9.4T small animal MR system) the SNR is sufficiently high for
the denoising to have only minor denoisng effect. The parameter β was set to 0.4 for the stackNLM filter to
increase the smoothing effect
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Chapter 35
Analysis Protocols for MRI Mapping of Renal T1
Philippe Garteiser, Gwenaël Pagé, Sabrina Doblas, Octavia Bane,
Stefanie Hectors, Iris Friedli, Bernard E. Van Beers, and John C. Waterton
Abstract
The computation of T1 maps from MR datasets represents an important step toward the precise characteri-
zation of kidney disease models in small animals. Here the main strategies to analyze renal T1 mapping
datasets derived from small rodents are presented. Suggestions are provided with respect to essential
software requirements, and advice is provided as to how dataset completeness and quality may be evaluated.
The various fitting models applicable to T1 mapping are presented and discussed. Finally, some methods are
proposed for validating the obtained results.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, T1 mapping, Processing, Fitting
1 Introduction
The computation of T1 maps fromMR datasets represents an impor-
tant step towards the precise characterization of kidney disease mod-
els in the small animal. Although some concepts pertaining to T1
mapping are relatively general, there are some important points that
need to be observed specifically for each different acquisition strat-
egy. In this section we will describe in more detail the three main
classes of data fitting procedures corresponding to saturation recov-
ery, inversion recovery, and variable flip angle protocols.
This analysis protocol chapter is complemented by two separate
chapters describing the basic concept and experimental procedure,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,





The method described in this chapter does require the following
software tools:
1. For Bruker users, the availability of a Bruker post-processing
station with Bruker Paravision fitting tools (“ISA Tools”)
installed, or if an independent console is not available, the
scanner console. It may not always be possible or practical to
alter the vendor-proposed routines to adapt to a particular
use case.
2. A programming environment capable of applying fitting mod-




3. An image processing software (e.g., Image J, we recommend
using Fiji, which is ImageJ with a wide range of plugins already
included, https://fiji.sc/, open source), as a practical tool for
the image quality check or for measuring the SNR.
4. For region based approaches, analysis can be done in the R
language [1].
5. To speed up computation time, it may be necessary to use






To be able to calculate T1 maps, multiple images with different
repetition times, inversion times or flip angles are needed. It is
necessary to have access to some scan parameters, including matrix
size and number of slices, scaling information (offset and slope),
and the values of the repetition times, inversion times or flip angle.
Additional time delays may also be required. In the case of proto-
cols with multiple acquisitions, the receiver gain should also be
accessible. Consistency in the acquisition parameters is paramount,
especially the parameter that is varied, which should sample the
same interval for each animal in the study. The completeness of the
data needs to be verified ahead of the processing, by checking that
the matrices have the expected size and dimensionality, or in the
case of multiple protocols datasets, by ensuring that each expected
protocol has indeed been acquired.
2.2.2 Physiologic Motion
Check
Physiological motion is an important source of image error.
Because it is difficult to avoid entirely in vivo, even in the presence
of triggered acquisitions, it represents an important determinant of
the dataset quality. The amount of physiologic motion can be
assessed visually or via quantitative estimators (see below). Frames
displaying high respiratory motion may be either discarded alto-
gether, or they may be weighted differently in the fitting procedure.
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In the simplest cases (especially with cartesian sampling schemes),
respiratory motion can be identified as high intensity regions in the
air surrounding the animal, corresponding to smeared projection of
the signal along the phase-encoding direction (Fig. 1). Such
motion may not be immediately visible and instead require to
enhance the image windowing. Varying degrees of physiologic
motion may be tolerated depending on the application. Automated
methods can be put in place, to selectively remove frames where the
noise level in the air region surrounding the animal exceeds a
certain limit, in a retrospective fashion [2].
2.2.3 Acquisition
Geometry Check
The geometry of the acquisition also needs to be set and verified
prior to processing.
1. Verify the slice position and orientation to ensure that an
optimal delineation of the kidneys is possible. A coronal orien-
tation is often chosen, because it enables to have large regions
of interest that depict all the anatomical regions of the kidney in
a single image.






Regardless of the technique which is applied, it is preferable to
acquire a single protocol where the parameter of interest varies.
1. Assume that the acquisition parameters are the same for all
acquired images and move on to the next step.
If such a protocol is not available on the system, the same scan
has to be acquired several times while varying the parameter of
interest. This is the case typically for T1 mapping with variable flip
angle approach.
2. Check that all parameters (other than the varied parameter of
interest) have stayed the same.
Fig. 1 Illustration of physiologic respiration-based noise. Left: original image. Middle: same image with a
different windowing applied. Respiratory noise is evident as a signal smeared in the phase-encoding direction
(vertical) only in the image with a strong windowing applied. Different amounts of noise may be tolerated
depending on the final intended use of the data. Right: image with T1 map overlay on the kidneys (color scale
in ms)
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2.2.5 Receiver Gain
Consistency Check
(Multiple Scans Case Only)
1. Check that the receiver gain setting is identical for each scan
when merging data from separate protocols.
2. If the receiver gain is not the same: contact the manufacturer to
obtain receiver gain amplification tables.
3. Use the receiver gain amplification tables to calculate correct-
ing factors.
4. Apply the correction factors to set each image at a common
amplification level.
This exposes the user to noise compression or amplification and
should only be used as a last resort.
2.2.6 Data Intensity
Scaling Consistency Check
(Multiple Scans Case Only)
The data should also be rescaled to the same intensity mapping.
This ensures comparability of data coming from different datasets.
For Bruker-generated data, it is recommended to use the absolute
mapping option in the reconstruction options. If this has not been
done during acquisition, additionally for Bruker-generated data, at
the console, the user must:
1. Duplicate the processing.
2. Activate “Prototype Reconstruction”.
3. Set output mapping to “User Scale”.
4. Set parameters “Output Slope/Output Offset” accordingly to
the setting of the first scan of the series. The setting of the first
scan of the series can be checked in the “Single Parameter”
parameter editor.
3 Methods
3.1 Data Exclusion 1. Check that all data points have sufficient signal to noise (SNR
of 5 or higher).
2. If not all data points have high SNR then consider the necessity
to only use data points with sufficient signal to noise (see next
two steps).
3. For variable repetition time protocols, eliminate the data points
at low repetition times (TR) that have insufficient SNR.
4. For inversion recovery protocols eliminate the data points close
to the zero-crossing that have sufficient signal to noise.
3.2 Data
Coregistration
To improve dataset quality, coregistration of images can be imple-
mented to correct for respiratory motion, if such tools are available.
The elastix package [3], MATLAB’s built-in imregtform function,
SPM [4], or AIR [5] (among others) can be used toward that
objective.
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3.3 Model Fitting With contemporary computing hardware, fast fitting of the model
to the signal intensity magnitude images can be performed on each
pixel of the initial dataset. A region-based approach (wherein the
fitting procedure is applied to ROI averages), can also be applied,
but by construction it will lack the ability to examine the local
spatial variations of tissue T1.
3.3.1 Fitting Data for
Saturation Recovery
Experiments
1. Select an appropriate fitting equation. For the VTR protocol,
the following equation is applicable (under the assumption of a
perfect pulse) [6]:
S ¼ S0 1 eTR=T 1
 
þ ε ð1Þ
where S is the signal magnitude, S0 is the maximal available
signal magnitude (including amplification factors), TR is the
repetition time, T1 is the longitudinal relaxation time, and ε is
an additive noise component with Rician distribution.
2. If S0 is known, linearize the fitting equation. A plot of ln(1 S/
S0) against TR yields a straight line of slope 1/T1 from which
T1 can be extracted with linear regression (see Note 1).
3. If the longest TR is significantly longer than T1, please refer to
Note 3.
4. If S0 is not known, Eq. 1 can be fitted with nonlinear
regression.
5. Initialize the fit with appropriate starting values for S0 (seeNote
2), using the signal obtained at the longest TR (seeNotes 3 and
4).
6. Initialize the fit with appropriate starting values for T1 (see
Note 2) using the value obtained by linear regression if appli-
cable (see item 2).
7. Perform the fit with the Levenberg-Marquardt, the trust
region or the maximum likelihood algorithms (see Note 5).
3.3.2 Fitting Data for
Inversion Recovery
Experiments
1. Select an appropriate fitting equation. For the inversion-
recovery protocol, the following equation is applicable (assum-
ing perfect pulses and absence of relaxation during pulses)
[6, 7]:





where S is the signal magnitude, S0 is the maximal available
signal magnitude (including amplification factors), TI is the
inversion time, T1 is the longitudinal relaxation time, and ε is
an additive noise component with Rician distribution.
2. If S0 is known, linearize the fitting equation. A plot of ln
((S0  S)/(2∙S0)) against TI yields a straight line of slope
1/T1 from which T1 can be extracted with linear regression
(see Note 1).
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3. Optionally, apply a corrective formula to account for the per-






þ ln cos θð Þð Þ
τ
ð3Þ
4. Optionally, the following equation is also applicable (assuming
perfect pulses and absence of relaxation during pulses) [2, 8–
11] and adds a saturation-correcting factor (seeNotes 7 and 8):
S ¼ S0 1 β∙eTI=T ∗1
 
ð4Þ
5. If S0 is known, linearize fitting Eq. 4. A plot of ln(1  S/S0)
against TI yields a straight line of intercept ln(β) and of
slope  1/T1 from which T1* can be extracted with linear
regression. The actual T1 is subsequently recovered from the
values of T ∗1 and β as follows:
T 1 ¼ T∗1 ∙ β  1ð Þ ð5Þ
6. If S0 is not known, Eqs. 2 and 4 can be fitted with nonlinear
regression using S0, T1 and β as adjustable parameters and if
applicable the correction of Eq. 5.
7. Initialize the fit with appropriate starting values (seeNote 2) for
S0, using the signal obtained at the longest TI (see Notes 3
and 4).
8. Initialize the fit with appropriate starting values (seeNote 2) for
T1 using the value obtained by linear regression if applicable
(see Note 4), or using the graphical procedure outlined in
Note 9.
9. If the longest TR is significantly longer than T1, please refer
to Note 10.
10. Perform the fit with the Levenberg-Marquardt, the trust
region or the maximum likelihood algorithms (see Note 5).
3.3.3 Fitting Data for
Variable Flip Angle
Experiments
1. If only two flip angles are available, use the following simplified
equation involving α1 and α2 the two flip angles used, β the
ratio image obtained between the two flip angles, and TR the
repetition time TR [12] to compute the T1:
T 1 ¼ TR
ln β∙ sin α2ð Þ∙ cos α1ð Þ sin α1ð Þ∙ cos α2ð Þβ∙ sin α2ð Þ sin α1ð Þ
  ð6Þ
2. In the more general case, the following equation is applicable
(see Notes 11 and 12):
S θð Þ ¼ S0∙ sin θð Þ∙ 1 E1ð Þ= 1 E1∙ cos θð Þð Þð Þ ð7aÞ
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where
E1 ¼ exp TR=T 1ð Þ ð7bÞ
3. Determine T1 using linear regression on the linear form of
Eqs. 7a and 7b [13]:
Plot S(θ)/sin(θ) against S(θ)/tan(θ).
4. Retrieve the slope of the plot from the linear regression. This is
E1 (definition in Eq. 7b).
5. Compute the T1 estimate directly as 1/ln(E1).
6. Retrieve the intercept of the plot from the linear regression.
This is S0(1  E1). The S0 value is estimated by dividing the
intercept value that was found by 1 E1 (using for E1 the value
obtained previously).
7. Alternately, determine T1 using a nonlinear fitting procedure.
8. Initialize the fit with starting values (see Note 2) for S0 and T1
obtained using the linearization described previously (see
Note 4).
9. Perform the fit with the Levenberg-Marquardt, the trust
region or the maximum likelihood algorithms (see Note 5).
3.4 Visual Display T1 maps can be shown as gray-scaled or color-coded maps. T1 maps
from the region of interest can be superimposed after coregistration
on a morphological image or on an image acquired with the T1
mapping protocol to better illustrate anatomical location. Window
scales, usually run from T1 ¼ 0 to T1 ¼ 3000 ms, should be
provided with the map and should be kept constant between
figures.
3.5 Quantification The fitting algorithm is usually applied on a voxel-by-voxel basis to
yield a T1 map. Mean T1 is then calculated by averaging T1 values
within a region of interest. It is recommended to define a region of
interest for each anatomical subregion of the kidney, as the pathol-
ogy of interest can affect differently these subregions [14]. Typical
ROIs are cortex, outer medulla and inner medulla, using morpho-
logical images as references to draw these ROIs. Provided sufficient
spatial resolution is available, finer structures such as the outer and
inner stripes of the outer medulla [15], or the corticomedullary
junction [7], may be distinguished. It is also common to report T1
changes relative to baseline or to the contralateral kidney.







Synthetic datasets of various complexities should be generated to
test the validity of the processing solution. Artificial noise can be
added to assess the stability of the fitting procedure. T1 of the
numeric phantom should match the expected T1. This approach
is, however, limited by the signal equation, which may or may not
recapitulate the real situation complexity. Hence, the use of physical
phantoms can also be recommended (see procedure outlines in the
chapter by Irrera P et al. “Dynamic Contrast Enhanced (DCE)
MRI-Derived Renal Perfusion and Filtration: Experimental
Protocol”).
3.6.2 Comparison with
Reference Values from the
Literature
Relatively few studies have reported T1 values for kidney acquired in
animal models at high magnetic fields (4.7 T and higher). Typical
ranges for normal kidney tissue are T1 ¼ 1000–1700 ms at mag-
netic field strengths of 7 or 9.4 T [14–16], with significant differ-
ences reported between mouse strains [16]. Acute kidney injury
and unilateral nephrectomy have been reported to increase T1
values in kidney, up to T1 ¼ 1944 ms at 7 T for severe acute injury
[15] and well above T1 ¼ 2000 ms at 9.4 T for unilateral
nephrectomy [14].
4 Notes
1. The accurate estimation of S0 is, not trivial. Indeed, in Eqs. 1
and 2, signal evolution is asymptotic and even at very high TR
or TI values, the signal only approaches the actual S0 value.
Furthermore, in these protocols, TR or TI directly affect the
acquisition duration. Hence, the precision of the estimation of
S0 directly affects scan duration. In the linearization approach,
the available precision on S0 dictates the precision with which
T1 is recovered (error propagation). Hence with this approach,
increased acquisition time is needed to improve the precision of
the measurement. If the duration of the experiment is a con-
cern (dynamic studies, animal models of severe diseases, diffi-
cult anesthesia), it may be preferable to leave S0 as free
parameter and to use a nonlinear fitting procedure.
2. In nonlinear fitting algorithms it can be advantageous to pro-
vide starting points that are close to the final values. Indeed,
this allows to decrease the number of iterations required to
reach convergence, and hence can limit the computation time.
Furthermore, using starting values close to the true values also
helps identifying the global minimum rather than a distant
local minimum. Hence, strategies can be adopted to provide
as accurate as possible initial estimates for the free parameters of
the nonlinear fitting procedure.
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3. In some cases, an initial S0 estimate for fitting initialization can
be obtained from the highest signal available (at the latest
saturation or inversion recovery delays for instance). This esti-
mate will only be precise if the longest delay that is sampled is
sufficiently long.
4. The outlined strategies for determining reasonable starting
values may not work in all cases. For instance, in the presence
of high experimental noise or in the case of poorly controlled
acquisition conditions, the initial estimates may prove unreli-
able. In this case, reasonable starting values for the T1 may be
alternately obtained from the literature. Special care should be
taken to select literature reference values from studies where
similar magnetic field strength, protocol type and experimental
disease models were used.
5. Careful comparison of the performance of the fitting algo-
rithms should be conducted on datasets obtained on the dis-
ease model and hardware setup used in the study. The various
algorithms may be compared in terms of computation speed
and goodness-of-fit figures of merit such as the root-mean-
squared error before a final choice is made.
6. In inversion recovery protocols, the T1 relaxation process is
sampled several times after an inversion RF pulse using small
gradient echo shots, EPI readouts or FISP readouts. Thus, the
natural longitudinal recovery is perturbed by the application of
the imaging RF pulses of flip angle θ and separated by a repeti-
tion interval τ. The effect can be accounted for by correcting
T ∗1 , the apparent T1 resulting from the fit, using the expression
given in Eq. 3 [17–19].
7. With inversion-recovery protocols followed by multiple shots,
it would be preferable to use long delays between the imaging
RF pulses, to drive down the saturation effect of the fast
repeating gradient echo excitation RF pulses. This is not always
practical, since short delays are required to fit a large number of
imaging shots within a single inversion recovery interval. This
is linked to the requirement that no transverse magnetization
remains at the end of an imaging shot once the subsequent
imaging shot is acquired, that is, that the condition of spoiled
magnetization is applicable. The generally accepted condition
is thus to ensure that τ  T ∗2 . Thus, although not ideal, it is
acceptable to shorten the repetition time between imaging RF
pulses, to reach an optimal situation where the two conflicting
constraints of having both a large number of imaging shots per
inversion recovery and a sufficiently good spoiling of magneti-
zation between consecutive imaging shots are met. Similarly, it
can be advantageous to work at low flip angle, to minimize the
perturbation to the natural magnetization recovery relative to
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the ideal case when no imaging RF pulses are applied after the
inversion RF pulse. This comes at a disadvantage of having a
smaller signal to noise ratio. However, this may be preferable
when exactness of the recovered T1 is important. In conclusion,
the selection of the most appropriate fitting equation should be
guided by careful examination of the specific acquisition proto-
col that was used, and of values of the imaging delays, flip
angles, and typical expected tissue magnetic properties in the
disease model at hand.
8. More complete correction schemes can be applied in the case of
Look–Locker protocols. In particular, the delay between the
inversion RF pulse and the first imaging RF pulse may be
different than the delay between subsequent sequential imag-
ing RF pulses. The imperfections in the inversion profile may
also be modelled in the equation. Expressions taking this delay
into account are available. Furthermore, in inversion recovery
protocols, some variants may be segmented. For instance, par-
tial k-space segments can be acquired by groups of imaging
shots at several times post inversion. The various individual
shots in a segment are used to reconstruct an image at a single
inversion delay (the delay between the inversion RF pulse and
the half of the imaging segment). Imaging segments may be
separated by arbitrary delays. Expressions are available to take
into account these delays [20–22].
9. In the case of inversion recovery protocols, a simpler method
may be used to provide a reasonable estimate of T1 to be used as
starting point. Indeed, the signal has the typical shape where
the image magnitude first drops down to zero, then comes
back up (see Fig. 2). This is due to the fact that the image
magnitude is gotten from the transverse component of the
magnetization, without discerning whether the magnetization
is below or above the transverse plane. This offers a graphical
way to determine rapidly the T1 by identifying the point at
which the signal is minimal. The recovery delay at which this
condition is verified is an approximation of the time when the
longitudinal magnetization crosses the transverse plane. The
precision of this estimate will be improved if the sampling of
inversion times is dense around this point. The delay of the
zero-crossing is equal to T1  ln(2). Hence the true T1 can be
identified by dividing the zero crossing delay by ln(2). This can
be useful to obtain a rapid estimate of the T1 during parameter
optimization. This computation can be performed very simply
at each voxel by identifying the index of the signal vector where
the smallest signal intensity is obtained. This strategy is, how-
ever, limited when only few points are available along the
regrowth or when the signal to noise is low. Both cases can
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alter the accuracy of the estimation of the delay time yielding
zero crossing.
10. Depending on the acquisition conditions, images are available
at TI (or TR)  T1. In that case, Eqs. 1 and 2 collapse to
S ¼ S0. Such images can be used to normalize the data, and the
nonlinear fitting procedure can be carried out on S/S0 rather
than S. By suppressing the free parameter S0 from the fitting
procedure, the numeric stability of the fit is improved, at the
expense of the longer acquisition time required for the acquisi-
tion of the TI  T1 protocol. This approach is also subject to
the problem of error propagation from the S0 estimation into
the T1 term exposed previously.
11. The true signal behavior may differ significantly from this
expression, especially if the applied flip angle is not homoge-
neous. In that case, a corrective, smoothly spatial-varying
ζ Bþ1
 
term may need to be applied to account for excitation
radiofrequency field heterogeneity. The effectively obtained
flip angles, θeff, are in that case a modulation of the prescribed
Fig. 2 Inversion recovery plot depicting the graphical method to identify T1. An estimate of T1 is obtained by
identification of the inversion time yielding the smallest available signal, and dividing this value by ln(2).
Although this quantification is not optimally accurate, it may prove useful in determining sufficiently close
values to serve as a good initialization point for nonlinear fitting procedures
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flip angle series, θ, such that θeff ¼ ζ Bþ1
 
· θ. The evaluation of
the ζ field is not trivial, and becomes especially important at
higher field strengths. Post-processing methods based on large
scale features in the image such as low pass filtering, or fitting of
slowly spatially varying functions, can be proposed, but only
extract the combined effects of transmit (Bþ1 ) and receive (B

1 )
heterogeneities [23]. The modulation fields can be subtracted
out before performing the fit, provided that the reception field
is sufficiently homogeneous. Of note, this assumption is quite
difficult to validate, especially at high field strengths or when
single receive RF coil elements are used as the detection
circuitry.
12. Alternately, a reference T1 map acquired with a Look–Locker
protocol at lower spatial resolution and short acquisition time
can be used to correct B1 heterogeneity. Indeed, such protocol
is much less prone to B1 heterogeneity artifacts, hence the T1 it
provides can be assumed to be precise [19]. This low spatial
resolution reference T1 map is fed into a separate fit of Eq. 7a
expressed as function of θeff ¼ ζ Bþ1
 
· θ rather than merely θ,
and letting ζ as free parameter. Finally, the modulation map ζ
determined in that way can be injected back into Eq. 7a, this
time letting T1 and S0 as free parameters to be determined, and
operating at the full spatial resolution of the VFA dataset. This
approach enables a more precise quantification of T1 because
the B1
+ and B1
 effects are effectively separated out into the ζ
and the S0 maps, respectively. However, this approach is more
complex and requires to acquire separate reference T1 map,
increasing the overall scan time duration.
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Chapter 36
Analysis Protocols for MRI Mapping of the Blood
Oxygenation–Sensitive Parameters T2* and T2 in the Kidney
João S. Periquito, Ludger Starke, Carlota M. Santos, Andreia C. Freitas,
Nuno Loução, Pablo Garcı́a Polo, Rita G. Nunes, Thoralf Niendorf,
and Andreas Pohlmann
Abstract
Renal hypoxia is generally accepted as a key pathophysiologic event in acute kidney injury of various origins
and has also been suggested to play a role in the development of chronic kidney disease. Here we describe
step-by-step data analysis protocols for MRI monitoring of renal oxygenation in rodents via the deoxyhe-
moglobin concentration sensitive MR parameters T2* and T2—a contrast mechanism known as the blood
oxygenation level dependent (BOLD) effect.
This chapter describes how to use the analysis tools provided by vendors of animal and clinical MR
systems, as well as how to develop an analysis software. Aspects covered are: data quality checks, data
exclusion, model fitting, fitting algorithm, starting values, effects of multiecho imaging, and result
validation.
This chapter is based upon work from the PARENCHIMA COST Action, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
experimental protocol chapter is complemented by two separate chapters describing the basic concept and
data analysis.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, T2, T2*, BOLD
1 Introduction
The parametricmapping of the transverse relaxation timesT2* andT2
(or relaxation ratesR2*¼ 1/T2* andR2¼ 1/T2) has the potential to
yield inferences regarding renal oxygenation, since both parameters
are sensitive to blood oxygenation [1]. The underlying mechanism
rests on the inherent difference in the magnetic properties of oxyge-
nated hemoglobin (diamagnetic) vs. deoxygenated hemoglobin
(paramagnetic) [2]. The presence of deoxyhemoglobin in a voxel
decreases both relaxation times, T2* and T2, which are the time
constants governing the exponential signal decays due to spin
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_36, © The Author(s) 2021
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dephasing in gradient-echo (GRE) and spin-echo (SE)MRmeasure-
ments, respectively.
Possible sources for this dephasing are magnetic field inhomo-
geneities ranging from the microscopic to the macroscopic scale,
which can be classified with respect to the echo time into micro-
scopic dynamic spin–spin interactions—T2, that is, typically ranging
a time span between 1 and 100 ms (Fig. 1) and static mesoscopic
interactions—T2
0. In fact, T2* includes the dynamic (irreversible)
dephasing effects described by T2 plus the additional effects that are
due to static (reversible) dephasing effects described by T2
0. Blood
oxygenation affects primarily T2* (often referred to as Blood Oxy-
genation Level Dependent, BOLD), but to a lesser extend also T2,
via water diffusion effects in the proximity of blood vessels due to
local magnetic field gradients [1].
Calculation of T2* and T2 requires a series of MR images with
different echo times. Repeated measurements with a single echo
Fig. 1 Spin dephasing due to dynamic (irreversible; represented by the parameter T2) and static (reversible;
represented by the parameter T2
0) sources can be quantified by calculation of T2* and T2 from series of MRI
images with different echo times using 1/T2* ¼ 1/T2 + 1/T20. The possible sources for this dephasing range
from the microscopic to the macroscopic scale and their level dictates the observed attenuation in the signal
intensity. Blood oxygenation affects primarily T2* (often referred to as Blood Oxygenation Level Dependent,
BOLD), but to a lesser extend also T2 via diffusion effects in the proximity of blood vessels. USPIO: Ultra-small
Superparamagnetic Particles of Iron Oxide, which can be used as intravascular contrast agents
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sequence using either a GRE or SE method and variable echo times
(TE) would provide the most accurate T2* and T2 values but would
require very long acquisition times [2]. In order to address this
shortcoming fast multiecho MRI methods are commonly used for
in vivo studies: multi-gradient-echo (MGE) for T2* andmulti-spin-
echo (also called “MSME”) for T2. They provide relaxation times
that slightly underestimate T2* and overestimate T2 (see Note 1).
The core of T2
(*) mapping consists of fitting the exponential
model curve S(TE) ¼ S0 exp.(TE/T2(*)) to the signal intensities
of each image pixel at increasing TE. For the calculation of such
parameter maps from a series of T2
(*)-weighted images software
tools and plugins are provided by the MR system vendors but they
may lack some features instrumental for precise T2
(*) mapping. For
example, some important preprocessing steps may not be available,
such as eliminating the first echo of T2 data, removing echoes
acquired at high TEs that may have too low signal-to-noise ratio
(SNR) or applying Rician noise bias correction. Also, details about
the used processing and curve fitting algorithms may not be avail-
able. It is also a limitation that the algorithms are fixed and cannot
be modified for specific purposes. Therefore, depending on appli-
cation, it may be advantageous to develop a dedicated analysis
software program in-house. The analysis software is developed
assuming 2D data was acquired, for 3D data (multiple slices) data
set are separated into individual slices.
The pixel-wise signal fitting with a monoexponential model is
known to introduce T2 bias, and so for studies that require an
extremely rigorous T2 value (error < 1%) a dictionary-based
method has been suggested. In dictionary-matching methodolo-
gies, T2 maps are calculated by matching the T2 signal decay to
precomputed Echo Modulation Curve (EMC), therefore account-
ing for all echo pathways. The use of dictionary-based methods has
been suggested to improve T2 accuracy, accounting for the stimu-
lated echoes and effective B1
+ field [3]. The use of dictionary-based
methods is still fairly novel and its implementation and use is not
covered in this chapter.
This chapter will describe both how to use the vendor’s analysis
tools and how to develop your own analysis software conceptually.
An example of a MATLAB script described in this chapter together
with a data sample (T2analysis.m and data.mat) can be down-
loaded from https://github.com/JoaoPeriquito/T2-s-Mapping.
This data analysis protocol is complemented by two separate
chapters describing the basic concept and experimental, which are
part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.





To calculate the parametric maps using existing tools, a software
such as the following is required:
1. MR system software ParaVision (version 5 or higher; Bruker
Biospin, Ettlingen, Germany).
2. MR system software Syngo (versions MR B17 or higher; Sie-
mens Healthineers, Erlangen, Germany). The optional toolbox
MapIt is not necessary.
3. MR system software Ready View (General Electric Healthcare,
Milwaukee, USA).
4. MR system software from Philips (Philips Medical Systems,
Best, Netherlands).
To develop custom software for calculating the parametric
maps one of the following, or other equivalent, software develop-
ment environments (SDE) is required:
5. MATLAB® including the Curve Fitting toolbox (The Math-




8. A MATLAB tool for Rician noise bias correction can be down-
loaded from https://github.com/LudgerS/
MRInoiseBiasCorrection. It is also compatible with Octave
and includes detailed documentation to facilitate adaptation
for, for example, Python.
2.1.2 Optional Tools An image processing software for checking data quality, such as
ImageJ (free Java-based image processing program developed at
the National Institutes of Health and the University of Wisconsin;
https://imagej.net/). We recommend and describe here the use of
Fiji (https://fiji.sc/ [4]), which is ImageJ packaged with a wide




Before the analysis it is highly recommended to check the image
quality. This check should include SNR measurements, particularly
for the images with longest echo times, and the assessment of
geometric image distortions, motion artifacts, or susceptibility
artifacts.
The steps in this section can be performed either on the scanner
console using the MR vendors system viewing software, or offline
using a software such as Fiji (recommended as a practical tool).
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2.2.1 Input Requirements As already mentioned, in order to be able to calculate T2
(*)-maps,
multiple images acquired with different echo times are needed. As
an example, please refer to Fig. 2 and Fig. 3, where a series of T2*-
and T2-weighted images suitable for mapping is presented (see
Note 2). Access to specific acquisition parameters is also necessary,
namely the TE of each image and in some cases the image intensity
scaling parameters (offset, slope) used when storing the image data.
2.2.2 Open/Import
Images
When using the scanner console:
1. Open the T2
(*)-weighted image series in the image viewer.
When using Fiji for DICOM images:
2. Import the DICOM image series using the DICOM import
plugin.
When using Fiji for images in Bruker format:
Fig. 2 Series of nine T2*-weighted images of a healthy rat kidney acquired with a 2D MGE sequence at 9.4 T.
From left to right and top to bottom, images correspond to TE ¼ 2.14, 4.28, 6.42 ms (top row), TE ¼ 8.56,
10.70, 12.84 ms (middle row), and TE ¼ 14.98, 17.12, 19.26 ms (bottom row)
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3. Browse to the data directory for the scan containing the T2
(*)-
weighted image series: /opt/PV6.0.1/data/[user_name]/
[session_name]/[scan_number]/.
4. Open the “method” file of the scan in a text editor or by
dragging it to the Fiji window.
5. Get the following parameters: number of slices, matrix size
(e.g., 128  128) image type (e.g., little-endian) and byte
order (e.g., 16-bit unsigned).
6. Load the image series using the RAW import function
(Import > RAW) and providing the above parameters. The
MR data file is called 2dseq and located in the subfolder
“pdata/nr” (number of reconstruction) of the data directory.
2.2.3 Motion
Artifacts Check
Abdominal imaging comes with complex bulk physiological
motion due to the interplay of respiratory and bowel movement.
If respiratory triggering of the data acquisition was used (recom-
mended) there should only be minor motion artifacts. Check
Fig. 3 Series of seven T2-weighted images of a healthy rat kidney acquired with a 2D MSME sequence at
9.4 T. Images correspond to TE ¼ 10.0, 20.0, 30.0 ms (top row), TE ¼ 40.0, 50.0, 60.0 ms (middle row), and
TE ¼ 70.0 ms (bottom row)
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images for artifacts from motion (nontriggered acquisition) or
possible residual motion (triggered acquisition).
In the image viewer or Fiji go to the central slice and scroll
rapidly from the first to the last echo image.
1. Check for motion between the echoes. If motion is noticeable
then information close to structure boundaries may not be
reliable and image registration should be used for motion





Kidney regions adjacent to bowels or in close proximity to skin/
fat/muscle boundaries or air cavities are particularly challenging to
T2* imaging and prone to loss of anatomical integrity due to
geometric distortions and signal loss created by susceptibility arti-
facts induced by the air-filled bowels, cavities and tissue interfaces
surrounding the kidneys.
1. Scroll to the images acquired at the later echoes, where suscep-
tibility artifacts are more severe.
2. Check areas affected by susceptibility artifacts, that is, areas in
the kidney with unusual and severe hypointensities (typically in
the form of spherical dark “shadows”; Fig. 4).
3. Make a record of areas affected by such artifacts (notes, screen-
shots). They must be excluded from the analysis or at least be
considered during interpretation of the result.
2.2.5 Signal-to-Noise
Ratio Check
Before the analysis it is highly recommended to define an SNR
acceptance threshold (see Note 3).
1. Draw a region-of-interest (ROI) over the inner medulla in the
first echo image (in Fiji use the “Freehand Selection” tool) (see
Note 4).
Fig. 4 T2*-weighted image of a rat kidney that shows a susceptibility artifact at
the caudal end (white arrow); image acquired with TE¼ 10.70 ms at B0 ¼ 9.4 T
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2. Measure the mean signal intensity of the ROI (in Fiji: Ana-
lyze > Set Measurements; select mean and standard deviation;
Analyze > Measure).
3. Draw an ROI over a region in the background that contains
only noise without any signal or artifacts (see Note 5).
4. Measure the standard deviation of the signal within this back-
ground ROI.
5. Divide this value by 0.655 to obtain the noise standard devia-
tion. This is necessary because the background noise in MR
magnitude images differs from noise in signal regions (seeNote
6 if you use a multichannel RF array).
6. Calculate the SNR by dividing the mean signal of the inner
medulla ROI by the noise standard deviation.
7. If the SNR is significantly below your predefined acceptance
threshold, this indicates that there might be a technical prob-
lem or that the animal is not positioned correctly relative to the
receiver RF coils. For more information on adequate SNR
thresholds refer to Note 7.
3 Methods
Tools for calculating T2
(*)-maps are provided by most MRI ven-
dors, but, as mentioned in the introduction, we recommend creat-
ing your own analysis tool to have the maximum level of control
over the processing steps and freedom to adapt them to your
specific needs. Hence, this section will describe both how to use
vendor’s analysis tools and how to develop your own analysis
software.
In both cases, mapping of T2 and T2*, it may be required to
exclude some data from the analysis, such as data points with
insufficient SNR in the tail of the exponential decay. In the case of
T2-mapping from data acquired with a MSME method, it is also




When using the Siemens scanner console this is currently not
possible, but one can manually select the echo images that should
be included when computing the fit. Using this feature, one can
exclude entire images at high TEs. We recommend using a cut-off
for echo images with low SNR. Please exclude all echo images with
SNR < 2.6 in the ROI of interest (see Note 7). When performing
T2-mapping, the first echo should also be excluded from the data
analysis (see Note 8).
1. Load image series in the Viewing Task Card.
2. Using the ROI tool to draw an ROI on the image with the
largest TE over the region of interest, and register the mean
signal.
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3. On the same image, use the ROI tool draw an ROI on the
background, and register the standard deviation of the signal.
Divide this value by 0.655 to obtain the noise standard devia-
tion (see Note 6 if you use a multichannel RF array).
4. Calculate the SNR by dividing the mean signal ROI by the
noise standard deviation. If the SNR is below 2.6 this image
should be excluded on step “8” (see Note 7).
5. Select a 3  3 or 4  4 layout in the View tab of the Control
Area (right panel) in order to see all acquired echo images.
6. Select all echo images for T2*-mapping or all echo images
except the first for T2-mapping (Fig. 5).
7. In the Control Area choose Eval > T2 > OK. Two new images
will appear in the viewer, the T2
(*)-map and the S0-map.
8. Exclude all echo images that have a SNR < 2.6 (see Note 7).
Fig. 5 Selection of echo images for T2
(*)-mapping of a rat kidney in Siemens Syngo. Here T2-mapping was
performed, for which the first echo image must be excluded. Then start the T2
(*)-map calculation with the T2
button in the Eval tab in the Control Area panel on the bottom right
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9. In the Control Area choose Eval > T2 > OK. A T2
(*)-map will






On a GE system a similar tool is used for mapping of T2 and T2*.
The Ready View T2 Map protocol post processes data sets acquired
using the Cartigram (T2 Map) application. The T2 Map layout is
comprised of four viewports: upper-left Map viewport: source
image, upper-right viewport: curve displaying signal intensity (ver-
tical axis) and the echo number (horizontal axis). A data point for
each echo is plotted when an ROI is deposited on any of the three
images. Lower left viewport: T2 Map Preset-1 parametric image.
Lower right viewport: T2 Map Preset-2 parametric map.
Use these steps to post-process data sets acquired using the
Cartigram application. The T2
(*) relaxation time color map is
Fig. 6 T2-map of a rat kidney calculated using the T2-analysis tool of Siemens Syngo from data acquired with
a clinical 3 T scanner
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coded to capture T2
(*) values from the TE range of the acquired
images. Blue and green reflect the longer T2
(*) values, yellow the
intermediate T2
(*) values, and red and orange the shorter T2
(*)
values. The functional T2
(*) map units are ms.
1. Open ReadyView and start the T2map protocol.
2. Adjust theW/L (window width and level) and magnification—
to adjust the W/L, middle-click and drag over the image. To
adjust the magnification factor, place the cursor over the red
DFOV and middle-click and drag right to left.
3. Locate the desired images to view—press the Up and Down
arrows to move through the images to locate the image with
the area of interest. Or click and drag the red slice Location
annotation. Press the Right and Left arrows to select the
desired echo or click and drag the red echo annotation.
4. Open the T2 Map Settings screen.
5. Adjust the settings on the T2Map Settings screen. Typically, the
Preset Color Level sliders for both the T2
(*) map and para-
metric image are within a 10 and 90 ms range and the Thresh-
old is 20. Typically, the Confidence Level is 0.05. A default
smoothing kernel of 2 is recommended.
6. Click Compute.
7. If necessary, use the Clip Min & Max values. By default
(25–75).
8. In the measurements panel, select the ROI icon and draw the
desired region of interest. An annotation with the area, mean
value and standard deviation of the ROI will appear.
3.3 Model Fitting
(Philips)
1. When acquiring a T2
(*) (mTSE/MGE) dataset, select the Post-
proc tab and choose the option T2(*) or R2(*) (1/T2
(*)) under
the field Calculated images (Fig. 7).
2. Insert the maximum expected T2
(*) or its reciprocal (1/T2
(*))
under the field T2 clip value or its reciprocal R2(*) clip value to
specify the maximum calculated T2
(*)/R2
(*) value for the SE
sequence. Larger T2
(*)/R2
(*) values are clipped to this value.
3. By default, T2/T2* reconstruction includes the first echo and
performs a MLE fitting of the signal curve. Research customers
can modify these parameters under the Scan Control Para-
meters panel select Reconstruction and choose the option
Include first echo for (SE) T2,R2 calc (yes/no), and reconstruc-
tion method (MLE [5, 6] or Least squares (RLSQ)) for T2
(*),
R2
(*). If available we recommend to use Include first echo ¼ no
and the default MLE calculation method (see Note 9)—Warn-
ing: changing these options affects every scan until reset of the
system (Fig. 8). After the acquisition, drag and drop the images
in the viewer.




The following custom program for T2
(*) relaxometry contains code
examples following MATLAB syntax. These were tested to be
compatible with Octave and should be easily reproducible in
Python or an equivalent SDE.
3.4.1 Data Import
and Exclusion of First TE
(Only for T2)
1. Import your scan with the images obtained for different TEs.
Bruker data: inMATLAB use the import function provided
by Bruker’s pvtools—to obtain Bruker’s pvtools send an e-mail
to Bruker mri-software-support@bruker.com.
DICOM data: in MATLAB use the dicomread function—
https://mathworks.com/help/images/ref/dicomread.html;
in Python use dcmread from the pydicom package—https://
pydicom.github.io/). As input you need to provide a string
containing the full path of the DICOM file.
Fig. 8 Philips acquisition software Scan Control Parameters panel—only accessible for research customers.
Here under the Reconstruction tab select no on the option Include first echo for (SE) T2/R2 calc. to exclude the
first echo image on T2 mapping and select MLE for T2(*), R2(*) calculation method (see Note 9)
Fig. 7 Philips acquisition software Postproc tab. Here T2-mapping can be performed by choosing the option T2
or R2 (1/T2) under the field Calculated images
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2. As previously explained, when performing T2-mapping using a
multiecho sequence, the first echo must be excluded from data
analysis (see Note 8). For example, that could mean that for a
series of T2 weighted data acquired at TE ¼ 10.0, 20.0, 30.0,
40.0, 50.0, 60.0, 70.0 ms one would only be able to fit the
model curve to the TE ¼ 20.0, 30.0, 40.0, 50.0, 60.0 ms data
points: store your data in a different variable excluding the first
TE (imgData_forAnalysis ¼ imgDataT2w(:,:,2:end);
TE_forAnalysis ¼ TE(2:end)).
3.4.2 Rician Noise Bias
Correction
MR signal intensities are overestimated in low SNR magnitude
images. This bias is due to the Rician distribution of noisy MR
magnitude data and can be corrected in post-processing. We can
understand the processing step as multiplication with a signal-level
dependent correction factor, which approaches 1 as higher SNRs
are reached. To incorporate Rician noise bias correction into our
custom program, we first need to determine the noise level and
then utilize a MATLAB/Octave tool provided for this book under
https://github.com/LudgerS/MRInoiseBiasCorrection:
1. Add the downloaded noise correction tool to the search path.
Addpath(genpath(‘. . .\MRInoiseBiasCOrrection)).
2. Compute unbiased data by executing the following:
imgData_corrected¼correctNoiseBias(imgData_forA-
nalysis,sigma,1)
If you work with data from amultichannel RF array, change
the last argument of the function to the number of receive
elements.
3.4.3 Fitting Model The most common method is to iteratively fit the model of the
T2
(*) decay to the signal intensity (SI) data of each pixel using the
following equation:






where S0 is a scaling factor that includes many parameters such as
the proton density together with the signal gain of the system.
3.4.4 Starting Values An important step of the curve fitting process is the choice of
suitable starting values for each parameter that will be determined
by the fitting algorithm (NB: different starting values may lead to
different results!). Here we describe how to derive starting values
from the SI of each pixel.
1. Step through all pixels in the images using for loops for the
pixel coordinates x and y.
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2. Store the SI of that pixel at all TEs in a vector (in MATLAB:
SI_vector ¼ imgData_forFitting(xPix, yPix,:)).
3. As starting value for the parameter S0 use the first and largest SI
(startVal_S0 ¼ SI_vector(1)).
For estimating a starting value for T2
(*), one can exploit the fact
that at TE ¼ T2(*) the SI has fallen to 37% of its value at TE ¼ 0.
Estimate the starting value by determining the TE whose SI is
closest to 37% of the largest SI value:
4. Normalize the SI vector to a maximum value of 1 (divide by the
largest SI value).
5. Subtract 0.63 from the SI vector.
6. Get the absolute values of the SI vector (resulting in only
positive values).
7. Find the index of the smallest value in the vector (in MATLAB:
[min_Value,min_Index] ¼ min(SI_norm_abs_37pct)).
8. Get the respective echo from your echoes using the index from
the last step (startVal_T2¼TE_forFitting(min_Index)).
3.4.5 Fitting Algorithm Least squares algorithms, such as the Levenberg–Marquardt [7]
and Trust-region methods [8], are the most commonly used curve
fitting algorithms for T2
(*)-mapping. They work by minimizing a
cost function, which describes the deviation of the fitted curve from
the corresponding data points. With starting values near the opti-
mal solution they quickly converge, but with starting values far
away from the solution, the Levenberg–Marquardt algorithm will
slow down significantly. Also, there is the risk that it may converge
to a local minimum (rather than the global minimum) and hence
produce an erroneous result.
In contrast, the Trust-region method (a further development
of the Levenberg–Marquardt algorithm) will quickly converge,
even with suboptimal starting values, and it will always find the
global minimum. However, it does require the definition of lower
and upper limits for the parameters to be fitted. Hence, for T2
(*)-
mapping, where such limits can easily be defined, the Trust-region
method is well suited (see Note 10)
1. Create for loops for pixel coordinates x and y to step through all
pixels of the image.
2. Store the SI of that pixel at all TEs in a vector (in MATLAB:
SI_vector ¼ imgData_forFitting(xPix, yPix,:)).
3. Define the model for the function using Equation1
(in MATLAB: T2model ¼ fittype(‘a*exp.(x*b)’,
‘independent’, ‘x’, ‘dependent’, ‘y’)) .
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4. Choose the function for the fitting algorithm, that is, Trust-
region or, if not available, then Levenberg–Marquardt
(in MATLAB: opts.Algorithm ¼ ‘Trust-Region’).
5. Provide the starting values for S0 and T2
(*) (in MATLAB, e.g.,
opts.StartPoint ¼ [startVal_S0 startVal_T2]).
6. Define lower and upper limits for the fit parameters. Use for
T2* [0.1 150], for T2 [1 1000], and for S0 the possible range of
SI in the image data (this depends on the system; for 16-bit
integer it may be [1 65536]). In MATLAB, for example,
opts.Lower ¼ [1 0.1]; opts.Upper ¼ [65,536 150].
7. Execute the curve fitting for each pixel data (in MATLAB:
[fitresult, gof] ¼ fit(TE_forFitting, SI_vector,
T2model, opts);).
8. Save the fit result for each variable in parameter maps: mapS0
(xPix, yPix) ¼ fitresult.a; mapT2(xPix,
yPix) ¼ fitresult.b; rsquare(xPix, yPix) ¼ gof.
rsquare.
3.4.6 Visual Display 1. Display the parameter map, which is amatrix with floating point
numbers, as an image (in MATLAB: imagesc(mapT2);).
2. Remove axis labels and ensure that the axes are scaled such that
the aspect ratio of the image is identical to that of the acquired
FOV (For the case of square pixels in MATLAB: axis off;
axis equal;).
3. Select the color map and display a color bar (in MATLAB:
colormap(jet(256)); colorbar;) (see Note 11).
4. Set the display range for the color coding, for example, for T2*
[0 25]; and for T2 [0 80]; (in MATLAB: caxis([0 25]);).
An example is shown in Fig. 9.
3.5 Quantification Quantitative values can be obtained from the parameter maps using
manually drawn ROI for the different morphological regions (cor-
tex, outer medulla, and inner medulla). Because manual ROI draw-
ing can introduce unwanted additional variability or bias, we
recommend the use of semiautomated methods, such as the con-
centric objects technique [9] or the morphology-based ROI place-
ment technique [10]. For further details and step-by-step protocols
for these two techniques please refer to the chapter by Riazy L et al.
“Subsegmentation of the Kidney in Experimental MR Images
Using Morphology-Based Regions-of-Interest or Multiple-Layer
Concentric Objects.”







A simple approach to validate the data analysis procedure is to
generate synthetic image data and then evaluate how close the
results produced by the analysis are to the known true value. A
series of artificial images could be created (using an in-house soft-
ware program) that mimic a multiecho MR experiment. Each
image could represent a chosen TE for which the signal intensity
in a virtual phantom (could simply be a circle in the center of the
image) has been calculated using the known exponential equation
that describes the T2
(*) relaxation. Alternatively, more sophisticated
simulation approaches as previously described in [3] could be used,
accounting for the timings and characteristics of the used RF pulses
so as to evaluate the effect of using the simpler monoexponential
decay model. Having generated the images, Rician noise is added.
This synthetic data could then be analyzed, evaluating both accu-
racy (how close the resulting T2
(*) is to the true T2
(*)) and precision
(evaluating dispersion over multiple instances with the same level
of SNR).
Fig. 9 T2
(*) in ms and R2
(*) in ms1 maps of an healthy rat kidney calculated using a custom program
developed in MATLAB (displayed using colormap parula) from data acquired with a preclinical 9.4 T scanner
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3.6.2 Comparison
with Reference Values from
the Literature
The obtained values can be compared with those reported for
healthy animals in the literature. Table 1 provides ranges of T2*
and T2 for different magnetic field strengths based on current
literature.
4 Notes
1. With increasing echo number additional diffusion weighting is
added due to the repeated magnetic field gradients used for
spatial encoding (NB: this effect is much more pronounced in
small animal systems, which use much stronger gradients than
clinical systems). A greater bias is introduced by the superposi-
tion of stimulated echoes in multi-spin-echo imaging, which
leads to significant overestimation of T2. It also demands the
exclusion of the first echo (pure spin echo) from the analysis,
because its magnitude is usually much smaller than that of the
following echoes, which are combinations of spin-echoes and
stimulated echoes. Although these biases depend on the acqui-
sition parameters, they are fixed and reproducible for each
protocol and hence acceptable in studies focusing on relative
differences/changes, where precision is far more important
than accuracy. If needed, more accurate T2 values can be
obtained from multiecho data using sophisticated post-
processing, such as dictionary-matching methodologies [3].
2. Make sure your data is ordered from the lowest to the highest
TE as in Figs. 2 and 3.
3. When establishing the MR technique, define an SNR accep-
tance threshold. The aim is to have at least three (preferably five
or more) number of echoes with an SNR > 5. This threshold
will depend on the expected T2
(*) values, which in turn depend
on parameters like the magnetic field strength, shim quality,
and tissue properties (pathology). Example: for a rat imaged at
9.4 T using a 4-element rat heart array receiver surface RF coil
Table 1
Typical values of T2 and T2* for each specific renal tissue for a healthy rat at 9.4 T [11] and 3 T [12]
Map Inner medulla Outer medulla Cortex
9.4 T [8]
R2 [1 s
1] 11.0–14.6 20.0–23.2 23.0–27.3
R2* [1 s
1] 32.1–47.2 73.9–101.1 64.8–93.6
3.0 T [9]
R2 [1 s
1] 5.5–7.0 9.6–12.5 13.8–16.3
R2* [1 s
1] 12.8–19.8 28.3–30.3 29.5–37.5
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together with a volume resonator for excitation in combination
with interventions leading to strong hypoxia an SNR > 60 was
needed for the image with the lowest TE. Always draw the ROI
over the same region of the kidney, that is, cortex, outer
medulla, or inner medulla (we use the inner medulla, which is
the brightest region of the kidney). If reaching a sufficiently
high SNR is a problem, consider creating ROIs and performing
the T2
(*)-fitting on the average values of these ROIs in order to
boost the SNR (SNR scales with the square root of the number
of pixels). Another option is to modify the acquisition proto-
col, reducing the attained spatial resolution to gain SNR.
4. As a good practice you should always save your ROIs for later
reference.After creating anROIclickonAnalyze>Tools>ROI
Manager> Add. Then rename your ROI to a meaningful name
(using the button “Rename on the ROI Manager).
5. When you create an ROI over a region with no signal make sure
no artifacts are present. Click on Image > Adjust > Brightness
and Contrast and drag the scroll bar “Minimum” to the left.
6. Sum-of-squares reconstruction of multichannel data changes
the distribution of noisy MR magnitude data. Substitute the
factor 0.655 by 0.682 or 0.695 for two channel and four
channel data, respectively [13].
7. The Rician distribution of MR magnitude images introduces a
signal level-dependent positive bias. The relative error intro-
duced by this bias increases with decreasing SNR. For single
receive element coils, an error of 10% is reached at SNR ¼ 2.6.
For two-channel or four-channel coils, the corresponding
threshold is at SNR ¼ 4.2 or 6.4, respectively, assuming sum-
of-squares reconstruction. Under pathophysiological condi-
tions T2
(*) can become significantly shorter and images
acquired at high TEs may have a rather low SNR or may even
reach noise level. This could result in a poor model curve fit and
overestimate the calculated T2
(*). Therefore, data points at
high TEs below a predefined SNR threshold should be
excluded from the data analysis. Data exclusion can be done
either during the acquisition (by not acquiring some echoes) or
performed prior to data analysis. The latter is advantageous
because the SNR cutoff to exclude data from the fitting can
also be adjusted for each pixel individually.
8. When a multiecho sequence is used for T2-mapping, the first
echo must be excluded from the data analysis. The reason is
that the first echo is a pure spin echo, unlike all following
echoes, which are superpositions of spin-echoes and stimulated
echoes. As a result, the first echo has significantly smaller
amplitude than the second echo and fitting the model curve
to all data points would produce a poor curve fit and an
inaccurate T2 value [10].
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9. MLE option refers to “Maximum-likelihood estimator” that
takes into account the Rician noise. The noise level is measured
as part of the scan. This approach should be robust against
noise floor estimation bias and therefore there is no need to
exclude later echoes from the analysis [5, 6].
10. An approach to increase the speed of the curve fitting is using a
fast mono exponential fit [14]. The MATLAB implementation
of the following fit can be downloaded from https://github.
com/JoaoPeriquito/T2-s-Mapping under the name fastExpo-
Fit.m. The result of a simulation comparing the recommended
fast mono exponential fit and the trust-region can be found at
the same location under the name fastExpoFit_Simulation.png.
11. Pseudocolor representations can be extremely useful for ana-
lyzing T2
(*)-maps, since they generally enhance the perception
of differences within the value range of the parameter. But one
needs to be careful when choosing a color map. Parameter
maps displayed as images in pseudocolor can potentially be
misleading. Small differences in the underlying values may be
artificially emphasised by a change in color hue, or a significant
parameter difference that can easily be seen in a gray-scale
image may be flattened or hidden if there is little change of
hue or brightness over a certain range of the color-scale. It is
recommended to always use the same color map and scale to
improve comparability.
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Chapter 37
Analysis of Renal Diffusion-Weighted Imaging (DWI) Using
Apparent Diffusion Coefficient (ADC) and Intravoxel
Incoherent Motion (IVIM) Models
Neil Peter Jerome and João S. Periquito
Abstract
Analysis of renal diffusion-weighted imaging (DWI) data to derive markers of tissue properties requires
careful consideration of the type, extent, and limitations of the acquired data. Alongside data quality and
general suitability for quantitative analysis, choice of diffusion model, fitting algorithm, and processing
steps can have consequences for the precision, accuracy, and reliability of derived diffusion parameters. Here
we introduce and discuss important steps for diffusion-weighted image processing, and in particular give
example analysis protocols and pseudo-code for analysis using the apparent diffusion coefficient (ADC) and
intravoxel incoherent motion (IVIM) models. Following an overview of general principles, we provide
details of optional steps, and steps for validation of results. Illustrative examples are provided, together with
extensive notes discussing wider context of individual steps, and notes on potential pitfalls.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
This analysis protocol chapter is complemented by two separate chapters describing the basic concepts and
experimental procedure.
Key words MRI, Kidney, Diffusion, Diffusion-weighted imaging (DWI), Apparent diffusion coeffi-
cient (ADC), Intravoxel incoherent motion (IVIM), Mouse, Rat, Analysis, Algorithm
1 Introduction
Diffusion-weighted imaging (DWI) can be implemented in many
forms, and similarly analysis of DWI data is more complex than for
other common quantitative modalities such as T1, T2, and T2*
[1, 2]. The overall goal of deriving robust biomarkers for renal
function, disease identification and response, as well as monitoring
of transplants and so forth [3] relies not only on the suitability of
the acquisition for the question being asked, but also how that data
are handled in post-processing and analysis.
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_37, © The Author(s) 2021
611
The basic concepts underlying DWI, and example experimental
protocols, are discussed in the chapters by Jerome NP et al. “Renal
Diffusion-Weighted Imaging (DWI) for Apparent Diffusion Coef-
ficient (ADC), Intravoxel Incoherent Motion (IVIM), and Diffu-
sion Tensor Imaging (DTI): Basic Concepts” and by Periquito J et
al. “Renal MRI Diffusion: Experimental Protocol” of this book.
This chapter will cover general elements of data quality and analysis,
with a view to providing example protocols for the main models
employed for renal DWI. As mentioned in the chapter by Jerome
NP et al. “Renal Diffusion-Weighted Imaging (DWI) for Apparent
Diffusion Coefficient (ADC), Intravoxel Incoherent Motion
(IVIM), and Diffusion Tensor Imaging (DTI): Basic Concepts,”
however, it is critical to note that analysis choices are intrinsically
linked to the acquisition strategy itself, most prominently in num-
ber and direction of chosen b-values used, which means not only
that the available choices of analysis are limited by the type of data
collected but also that intended analysis should be an integral part
of study planning. Analysis itself is naı̈ve to the suitability of the
choices of model and algorithm used, for example, and so this
responsibility rests with the researcher.
Alternative diffusion models, as well as other mathematical
signal representations without explicit physiological meaning, to
the ones discussed here are numerous, and include the increasingly
popular stretched exponential and kurtosis descriptions, and this
field is constantly developing [4–8]. In addition to general consid-
erations, this chapter provides explicit methods for two common
diffusion models, namely, the apparent diffusion coefficient (ADC)
and the intravoxel incoherent motion (IVIM) models, and
describes the estimation of the corresponding diffusion parameters.
While the assumption has been made that suitable data has been
acquired (see the chapter by Periquito J et al. “Renal MRI Diffu-
sion: Experimental Protocol”), no two datasets are alike, and these
protocols are presented as guidelines that claim to be neither com-
plete nor sufficient, and are intended only to provide a basic frame-
work whereby a full analysis protocol can be developed. The
advantages of more sophisticated algorithms than are presented
here are becoming more apparent, and while the full details of
these techniques are beyond the scope of this chapter, the reader
is encouraged to investigate their potential when considering both
analysis protocols and, where possible, study design. When retro-
spective analysis is performed outside the original study plan,
understanding associated limitations and potential problems is cru-
cial to delivering sound conclusions.
Once DWI data has been acquired, an appreciable portion of
the available choices has already been made about how the data are
presented and packaged. Analysis is thus a purely computational
process that can be performed either “manually” using routines
developed in-house, ideally in collaboration with specialist MR
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physicists or mathematicians, or by using commercially available
software packages (including those available on the scanners them-
selves). The pros and cons of these two approaches are inversions of
each other, essentially revolving around transparency of the pro-
cesses and the ability to design bespoke interrogations of the data,
versus using more developed and optimized analysis using tools
that require less “up-front” investment of time but which can act as
inscrutable “black boxes.”
While many of the same issues arise for renal imaging, is it
useful to remember that much of current DWI acquisition and
analysis development has been in the brain and for neurological
applications. While this affords a large amount of literature and
advanced techniques, translating from one tissue to another
requires a certain degree of circumspection regarding assumptions
and reoptimization, if not protocol redesign. Finally, it should be
remembered that no level of analysis can ever provide more infor-
mation than is contained in the data itself, and care should be taken
to avoid over-interpretation.
This analysis protocol chapter is complemented by two separate
chapters describing the basic concepts and experimental procedure,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)





MRI, including DWI, data are stored as either a manufacturer-
specific format (e.g., Bruker) or as a medical imaging standard
(e.g., DICOM, NifTI), but in essence contains a series of matrices
of intensity values constituting the images, with each image indexed
against the acquisition parameters including the diffusion-weighting
b-value. The exact details of where the b-value is stored varies by
image format, or the b-value may need to be explicitly added (see
Note 1). Commonly, DWI schemes acquire a set of three images for
nonzero b-valuemagnitudes, with the diffusion-sensitizing gradients
applied in orthogonal directions; this allows for calculation of a trace
image, where any anisotropy of diffusion is averaged out by taking
the geometric mean of the intensities. If possible, the separate images
should be used for analysis, since this allows for finer quality control
before processing, and will retain the intrinsic weighting (i.e., more
data at nonzero points) assumed by fitting algorithms.
A brief visual inspection should identify corrupted data or
individual images that need to be excluded on account of severe
artifacts or signal dropout, or from insufficient signal-to-noise
(SNR). Images and/or cases that display gross motion or distortion
may require additional processing steps before being included [9],
or can be excluded (see Fig. 1).
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Fig. 1 Examples of images that might be considered for exclusion from analysis.
(a) Signal drop, which can be uneven across the image, may arise from
excessive movement during image readout; these images are the same b-
value and were acquired in the same sequence, but show markedly different
signal in each kidney. (b) Three images from the same sequence showing
different degrees of distortion around the kidney edge; distortion is a dominant
artifact in DWI where EPI is used, and is most prominent at magnetic suscepti-
bility boundaries. (c) Imperfect fat suppression in the diffusion-weighted image
across the body, combined with the chemical shift displacement of fat protons,
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2.2 Software
Requirements
Many common mathematical algorithms used for signal fitting are
available across many software platforms with limited expertise
needed to implement them, meaning analysis routines can be
designed and written as needed. Commercial software such as
Matlab include curve fitting toolboxes, whereas platforms such as
Python and R contain equivalent functions and, being freely avail-
able, may present a more accessible or portable choice. In addition,
these environments have the ability to handle image data (reading,
sorting, displaying) and create figures, though a basic level of
programming ability is required. The trade-off is more direct con-
trol versus the extra investment required to obtain proficiency with
the software environment.
Several freely available software packages are able to perform
both image processing and curve fitting, but attempt to give a more
intuitive graphical user interface that allows out-of-the-box use,
perhaps at the expense of tailored functionality. Environments
such as Fiji (based on ImageJ, with additional plugins), as well as
the brain-centric FSL and the OSX-only DICOM viewersHoros and
OsiriX, provide different degrees of functionality and automation,
and the option for bespoke plugins to at least some degree. TheMR
scanner itself and associated workstations also offer some options
for processing of diffusion images, for example ParaVision on
Bruker scanners or SyngoVia on Siemens, although the available
choices and customizability on these systems can be limited.
In the following we present detailed instructions for imple-




In well-behaved systems with high quality data and appropriate
models, choice of fitting algorithm is unlikely to influence the
resulting parameters. In many cases, however, data are sufficiently
noisy, or there may be cross-correlation between parameters in the
model being used, which can mean that choice of fitting algorithm
and initialization values can affect the result. These choices are
subjective and are made as part of the analysis procedure, so should
be reported in publications. Similarly, whether parameters are con-
strained to physical or anticipated physiological limits may have an
effect on reported metrics. Analysis protocols should critically con-
sider these choices as well as report them in scientific articles so that
the results can be communicated within the appropriate context.
It is difficult to prescribe “best practice” in diffusion-weighted
image processing, since organs and pathologies give a wide-ranging
spectrum of situations. Given the highly perfused nature of the

Fig. 1 (continued) may give incorrect intensities from overlap of fat signal with
target areas; here, the subcutaneous fat around the abdomen (overlay in yellow;
T1w is given for comparison) is shifted up in the image (overlay in red), and will
alter the observed image intensity seen for part of the kidney
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kidney, together with the tubular structures, models such as IVIM
that attempt to quantify pseudodiffusion (see Note 2) are poten-
tially more informative than simple ADC measurements, although
the analysis is more complex commensurate with the model, and
may not give sufficient repeatability for detection of small changes
[10]. Overall, standardization of protocols across studies has a value
to be balanced against optimization at a local level, where transla-






The steps listed here outline a general approach for DWI analysis
(Fig. 2). The sections immediately following give more specific
instructions for the ADC and IVIM models respectively, which
are sufficiently different in complexity to warrant separate presenta-
tion and discussion. Notes at the end of the chapter, referenced
throughout, give further detail on aspects that may need to be
considered.
1. Retrieve DWI data to analysis platform: verify b-value informa-
tion, and expected number of images (see Note 1).
2. Initial quality check: SNR threshold (see Notes 3 and 4) for
exclusion of poor images, excessive signal drop-out, distortion,
motion, failed fat suppression, and so on.
3. Preprocessing: motion correction, distortion correction, and
registration if desired/applicable (see Note 5).
4. Fitting of the model to observed signal intensities against their
acquisition parameters, normally b-value magnitude (see
Note 6).
Fig. 2 General overview of the diffusion-weighted imaging pipeline, left to right: Export from the scanner gives
the diffusion-weighted images, which should be reviewed for quality (SNR, artifacts, excessive motion, or
distortion). The resulting data matrix can be preprocessed using registration, and corrections for eddy
currents, distortion, and motion if desired. The fitting algorithm for the chosen model is run either on a region
of interest, or on the whole image and the ROI drawn on the parameter maps. A further quality check on the
maps and extracted results is recommended
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5. Second quality check: visual inspection of parameter maps,
extreme values, visualization of fitted curves against the data
(see Note 7).
6. Extraction of diffusion parameters. Summary statistics, histo-
gram moments, and so on from a region of interest (see Notes
8 and 9).
The example protocols below are the constituent parts of a
custom-made analysis program, designed to illustrate each step
clearly and explicitly (and are thus not optimized for speed), and
are presented in pseudo-code using functions and syntax in Matlab
(Mathworks, Natick, USA). The wide number of equivalent
choices and flexibility of some steps involved in DWI analysis are
ignored in favor of presenting the main thread of a workflow that is
easy to recreate, and so the reader is encouraged to appreciate the
purpose of each step, which can usually be performed in a number







of Image Data for Fitting
1. Retrieve the data to the required folder structure and verify
contents.
2. Load image data to matrix structure, aiming to create a 3D
matrix of stacked images for each slice (a single slice is pre-
sented for simplicity here), with b-value in the 3rd dimension
(see Note 10).
DICOM: matrix(:,:,i) = dicomread(<i_th_DICOM_filename>);
Bruker: [img,hdr] = read_2dseq(<series/pdata/1>);
3. Create a ‘bVals’ vector variable with the corresponding b-
values, checking for the correct number of repetitions and the
correct order (see Notes 11 and 12).
4. Review the images for quality: sufficient SNR, artifacts, and so
on. Identify and remove any nonqualifying images from the
img matrix, and correct bVals to match.
exclude = [0 0 0 1 0 0 0 1 1 0 0];
img = img(:,:,~logical(exclude));
bVals = bVals(~logical(exclude));
Optional steps at this stage include distortion, eddy cur-
rent, and motion correction, and image registration (see Notes
5 and 13).




1. Define the model for fitting, where the two variables inX are S0
and ADC (see Note 14):
curveADC = @(X,bVals) (X(1)*exp(-bVals*X(2)));
2. Assign empty matrices for the two resulting maps, using the
dimensions of the images (see Note 15):
S0map = NaN(nRows,nCols);
ADCmap = NaN(nRows,nCols);
3. For each voxel, loop through each row (i) and column ( j) and
extract the signal data
for i = 1:nRows; for j = 1:nCols;
Sb = img(i,j,:);
4. Estimate initial values for the variables to be fitted; use the
b ¼ 0 s/mm2 value for S0, and approximate ADC by taking
the gradient of the log signal between two points (seeNotes 16
and 17). See also Subheading 3.2.4 for discussion of lineariza-




X_est = [S0_est ADC_est];
5. Run the least-squares curve fitting routine, using the initial
estimates and providing lower and upper boundaries for the
estimates if desired (see Note 18). Assign the results to the
allocated results maps:




end; end; % close the row/column loops
Some of the options available for least-squares curve fitting
include the choice of algorithm, boundary conditions, stopping
criteria, number of iterations, and so forth. In general, for well-
behaved data the initial estimates will be good and the fitting
should converge quickly.
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3.2.3 Extraction
of Parameter Results
1. Review the results maps to visually inspect the results. Data
plotted against a signal curve generated from the fitted values
for any voxel in the image (i,j) should alert to any issues with





plot(bVals, Sb, ‘o’); % show the data
% show the fitted curve
plot(0:max(bVals), S0*exp(-ADC*(0:max(bVals))), ‘r-‘);
2. Define the region of interest on the ADC map and use this to
create a list of voxel coordinates within the ROI. For display,
creating a binary mask is also useful (Fig. 3).
imagesc(ADCmap);
roi = impoly(); % draw ROI on image
mask = createMask(roi);
ADCmask = ADCmap .* mask;
3. Extract the ADC values from the ROI to a single matrix for






Fitting of DWI to the monoexponential ADC model can be
achieved with either nonlinear fitting of the signal directly, as
above, but can also be treated as a linear regression fitting problem
(which is computationally faster) if the natural log of the signal
intensities is used (see Note 17). For the minimal acquisition of
Fig. 3 Example maps from a healthy volunteer illustrating the steps for ADC analysis. (a) Initial linear estimate
of ADC gives initial values for least-squares fitting. (b) Resulting ADC map. (c) A binary mask for the region-of-
interest drawn on the ADC image. (d) ADC values ready for extraction
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only two b-values, there is no ambiguity and the initial estimate
calculation shown in Subheading 3.2.2 gives the result.
Taking the signal logarithm also allows for the use of matrix
manipulations to perform the linear fitting, which again is compu-




Following calculation of S0 and ADC maps, it becomes possible to
create synthetic images at any desired b-value based on these values,
which may increase conspicuity of lesions at higher b-values where
noise would dominate in experimentally acquired images. Exten-
sion of this technique using an additional echo time TE allows
similar control for computed T2 weighting, which may assist with




Fitting of the more complex IVIM model introduces associated
complexity on the analysis, in particular the initialization and algo-
rithm used for fitting [13]. Notably, the fitting for IVIM is inher-
ently nonlinear, and cannot be easily linearized for speed. While
more advanced fitting routines become popular (see Subheading
3.3.6), the major obstacle to successful IVIM fitting is ultimately
the appropriateness of the model to the quality of data available.
In the protocol below, which shares much with the ADC
protocol in Subheading 3.2, we present the segmented method as
a method of initializing a full least-squares fit. The segmented
method benefits from speed and stability, and can be used as an
estimator in its own right, although it relies on prior assumptions.
Parameters from segmented fitting may be fixed for the
subsequent least-squares fitting if desired [14–16]. In all cases,
the user is strongly encouraged to critically examine the results
from IVIM fitting.
3.3.1 Preparation
of Image Data for Fitting
This is identical to the preparation steps for ADC in Subheading
3.2.1.
1. Retrieve the data to the required folder structure and verify
contents.
2. Load image data to matrix structure, aiming to create a 3D
matrix of stacked images for each slice (a single slice is pre-
sented for simplicity here), with b-value in the third dimension
(see Note 10).
DICOM: matrix(:,:,i) = dicomread(<ith_DICOM_filename>);
Bruker: [img,hdr] = read_2dseq(<series/pdata/1>);
3. Create a bVals vector variable with the corresponding b-values,
checking for the correct number of repetitions and the correct
order (see Notes 11 and 12).
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4. Review the images for quality: sufficient SNR, artifacts, and so
on. Identify and remove any nonqualifying images from the
img matrix, and correct bVals to match.
exclude = [0 0 0 1 0 0 0 1 1 0 0];
img = img(:,:,~logical(exclude));
bVals = bVals(~logical(exclude));
Optional steps at this stage include distortion, eddy current,
and motion correction, and image registration (see Notes 5
and 13).
3.3.2 Segmented Fitting
for Diffusion Coefficient D
This section is largely the same as fitting for ADC in Subheading
3.2.2, with the exception that it is on a subset of the data in order to
derive D. The parameter SD is the equivalent of S0 but for the
D compartment only, and is used to estimate f in the next section.
1. Choose a threshold b-value beyond which it is assumed that the
pseudodiffusion signal contribution is negligible; this is com-
monly around 200 s/mm2. Create a new (not overwritten)
data matrix containing only these images, and matching bVals
vector.
Bcut = 200;
imgD = img(:,:,[find(bVals >= Bcut)]);
bValsD = bVals(find(bVals >= Bcut));
2. Define the model for fitting, directly analogous toADC, where
the two variables in X are SD and D:
curveD = @(X,bVals) (X(1)*exp(-bVals*X(2)));
3. Assign empty matrices for the two resulting maps, using the
dimensions of the images (see Note 15):
SDmap = NaN(nRows,nCols);
Dmap = NaN(nRows,nCols);
4. For each voxel, loop through each row (i) and column ( j) and
extract the signal data:
for i = 1:nRows; for j = 1:nCols;
Sb = imgD(i,j,:);
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5. Estimate initial values for SD and D by taking the gradient of
the log signal between two points (see Note 16).
SD_est = Sb(1);
D_est = (log(max(Sb))-log(min(Sb))). . .
/(max(bValsD)-min(bValsD));
X_est = [SD_est D_est];
6. Run the least-squares curve fitting routine, using the initial
estimates and providing boundaries for the estimates if desired
(see Note 18). Assign the results to the allocated results maps:








The calculation (not strictly a fitting) of f, similar to fitting for D*
that follows, can also be performed on a voxelwise basis within the
loops used for the fitting of D. The presentation here is to empha-
size the stepwise nature of this procedure.
1. Derive estimate of f by calculating the fraction of S0 (the signal
at b ¼ 0 s/mm2) that does not arise from the D component.
Use the mean b ¼ 0 s/mm2 image if there are more than one.
b0img = mean(img(:,:,find(bVals == 0)),3);




Having estimated D and f using the segmented method above, D*
can be estimated by a second fitting process of the residuals after
subtracting the calculated signal from the D component. Though
not exactly equivalent, it is common to fix the D and f values and
perform a least-squares fit only for D* using all the data (see Note
20). These estimates can be sufficient on their own to provide a
result, or they can be used as initial estimates for subsequent
nonlinear fitting of all the parameters in the IVIM model (see
Subheading 3.3.5).
The dependency of IVIM parameters on the specific details of
the fitting process is not simple [17], and pseudodiffusion para-
meters in particular are known to be less repeatable [18]. It is worth
reiterating here that DWI acquisition and analysis are closely inter-
woven, and the utility of derived parameters is ultimately reliant on
the acquisition of suitable data.
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1. Allocate a matrix for the D* values (see Note 21) and the
pseudodiffusion fraction signal intensity.
Dsmap = NaN(nRows,nCols); SDsmap = NaN(nRows,nCols);
2. Define the IVIM model for fitting of D* (see Note 20). Note
that this uses the fixed values for SD and D so is placed inside
the voxel loops.
for i = 1:nRows; for j = 1:nCols;
SD = SDmap(i,j); D = Dmap(i,j); F = fmap(i,j);
curveDs = @(X,bVals) ( X(1)*exp(-bVals*X(2)) +. . .
SD*exp(-bVals*D) );
3. Extract the voxel data for the fitting.
Sb = img(i,j,:);
4. Estimate initial values for the fitted parameters; in this case D*
can be initialized as 10 D, and SDs is derived from f from the
b ¼ 0 s/mm2 image.
SDs_est = F*b0img(i,j); Ds_est = 10*D;
X_est = [SDs_est Ds_est];
5. Run the fitting routine, assign the results to maps, and close the
loops.
limL = [0 0]; limU = [Inf Inf];
res = lsqcurvefit(curveDs,X_est,bVals,Sb,limL,limU);
SDsmap(i,j) = res(1); Dsmap(i,j) = res(2);
end; end;
3.3.5 Least-Squares
Fitting for Full IVIM Model
The segmented fitting described above should provide good initial
values for a full least-squares fitting, using the same framework.
Approximation of f andD* is more challenging than forD (Fig. 4).
1. Define model.
curveIVIM = @(X,bVals) ( X(1)*(X(2)*exp(-bVals*X(3)) +. . .
(1-X(2))*exp(-bVals*X(4)) ));
2. Assign matrices for maps.
S0full = NaN(nRows,nCols);
ffull = NaN(nRows,nCols);
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Dsfull = NaN(nRows,nCols);
Dfull = NaN(nRows,nCols);
3. Begin voxel loop and assign initial values.
for i = 1:nRows; for j = 1:nCols;
X_est = [b0img(i,j) fmap(i,j) Dsmap(i,j) Dmap(i,j)];
4. Run fitting routine.
Sb = img(i,j,:);
limL = [0 0 0 0]; limU = [Inf Inf Inf Inf];
res = lsqcurvefit(curveIVIM,X_est,bVals,Sb,limL,limU);
Fig. 4 IVIM parameter maps derived from (top row) segmented approach and (middle row) least-squares using
segmented values for initialization. Box plots of the parameter values for the ROI (bottom row, outliers
indicated in red) show the voxel spread in more detail and illustrate the relationship between returned
parameters and the specifics of the analysis protocol, although the summary parameters are largely similar
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Another class of algorithms that have found promising applications
for IVIM data are Bayesian methods that utilize additional infor-
mation not normally considered in conventional fitting strategies
[19, 20]. If each voxel is fitted independently, as for the segmented
and least-squares approaches outlined above, it is implicitly
assumed there is no interrelation between different voxels; in real-
ity, voxels that are either adjacent or within the same tissue
(or lesion) are likely to share diffusion and pseudodiffusion char-
acteristics, at least to some degree.
The assumption of spatial similarity can be leveraged against the
IVIM model with the view to improving the performance of the
fitting, by allowing cross-talk between voxels throughout a series of
iterations. These algorithms, by their nature, require many more
calculations and so take substantially longer to run; nevertheless,
they require no extra data to be acquired and so can be performed
retrospectively, and have been shown to produce not only more
visually appealing parameter maps but also more meaningful results
[17, 21].
4 Methods for Results Validation
4.1 Validation
of Fitting Algorithm
One simple way to validate the fitting procedure is to run (and
initially develop) the code on synthetic data, generated using
known parameters, and to compare the results [21, 22]. A more
rigorous validation of the entire pipeline, including data acquisition
and transfer, can be performed by scanning a test object with
known diffusion parameters [23] using the study protocol.
Curve fitting routines should be able to supply additional
output, such as stopping condition and number of iterations
used, and these may be useful for troubleshooting, for example




Generating signal curves using the derived parameters, and com-
paring against the original data, is a straightforward way of validat-
ing results, and allows examination of areas of interest or apparently
spurious results (extreme or suspect values commonly arise from
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partial volume or motion in voxels at tissue boundaries, see Fig. 5).
Identification of particular issues may suggest changes to the analy-
sis routine or, in more severe cases, amendments to the analysis or
acquisition protocols. In particular for IVIM results, if the under-
lying pseudodiffusion fraction is limitingly small (or very large,
though this is not expected), the parameter D* can take essentially
any value without affecting the associated signal curve and thus the
quality of the fit. This is an intrinsic problem with the model
performance in this region of the parameter space, and cannot be
solved by acquiring better data.
4.3 Residuals
and Systematic Bias
Examining the residuals from the fitting, which are expected to be
normally distributed if the model correctly describes the underlying
signal, may also highlight bias in the model. Systematic deviation of
the residuals over b-values is an indication that the selected signal
representation is not optimal, though this does not necessarily




It may become apparent, from examination of the data, that origi-
nal assumptions made about the applicability of different models
may not be valid. Comparisons of different models must take
account of the complexity of the model (number of variable para-
meters) as well as the number of samples, since additional para-
meters will always provide a better fit if only residual signal is
considered.
There are several forms of such measures, the dominant one
being the Akaike information criteria (AIC), formulated using the
Fig. 5 Typical fitted curves overlaid on the experimental data from voxels in the healthy kidney, with locations
indicated in the calculated S0 map shown. (a) Good fitting within the kidney parenchyma. (b) A voxel near the
boundary is susceptible to respiratory motion, with some samples coming from within the liver tissue; the ADC
from all the data (red curve) is an underestimation compared to excluding images with substantial motion
(blue curve). (c) A similar effect is responsible for returning an incorrect curve for a voxel in the renal hilum.
Note that exclusion of the same four images would avoid both of these problems, or alternatively registration
may ameliorate it to some degree
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residual sum-of-squares differences between the observed data and
the fitted values at those points (RSS) and the number of data
points k:
AIC ¼ 2∙ ln RSSð Þ þ 2k ð1Þ
The AIC thus gives a numerical value that can be compared
across models, with lower (or more negative) values being pre-
ferred, although the relationship of the AIC to model validation is
not straightforward and is sometimes criticised for being too liberal
in favoring overly complex models. Nevertheless, it can often pro-
vide evidence for questioning assumptions about suitability. Note
that an assessment by AIC indicates only which model is best
supported by the data, and is not a validation of the model (Fig. 7).
Fig. 6 Example sample fits for synthetic monoexponential (left column, data in red) and biexponential (right
column, data in blue) data, fitted with the ADC (top row, curve in red) and IVIM (bottom row, curve in blue)
models. Residual signal from each fitting are inset. Where the model matches the underlying signal curve, in
(a) and (d), the residuals are normally distributed. Underfitting the model in (b) shows bias in the residuals.
Overfitting the data in (c) gives a visually acceptable curve and comparable residuals to ADC, but returns
f ¼ 0.98, D* ¼ 0.0012 mm2/s, and D ¼ 0.005 mm2/s, which should be flagged as problematic; critical
assessment of results should highlight such issues
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4.5 Covariance
and Repeatability
It is critical in quantitative studies to assess the robustness of the
derived metrics, and the gold standard for this is to include repeat-
ability studies where the same objects are measured (at least, but
commonly only) twice in the same way, and the resulting metrics
compared [24]. This is more achievable in preclinical studies, and
helps to establish the scale of changes in metrics that can be reliably
interpreted as arising from underlying physiological changes. Pre-
vious work on the ADC in extracranial cancer has shown it to be
generally robust [25], whereas there is less certainty about the
repeatability of parameters arising from more complex models
[10, 18].
Without the benefit of repeated measurements, analyzing the
covariance matrix of fitted parameters—that is to say, the extent to
which combinations of parameters have the same effect on the
fitted curve, can be illuminating. The covariance matrix is a stan-
dard output frommany fitting routines; high values indicate redun-
dancy between parameters, which in itself is not disqualifying but
may indicate a mis-match between the chosen model and the
available information in the data.
4.6 Final Analysis
Quality Check
Critical assessment of DWI results, no less than the principles of
good study design, is essential to avoid wasted time and effort, not
to mention the animals used for study, in generating meaningless
results. Diffusion-weighted imaging is extremely sensitive to spin
motion, which is not simple, and the complexity of the diffusion
signal curve is compounded by the additional subtleties of model-
ing and analysis. In general, mistakes arise as a result of incorrect
Fig. 7 Comparison of models using the Akaike information criterion (AIC) illustrates what complexity of model
is supported by the data but does not necessarily indicate the underlying truth if the data are not of high
quality. For (a) monoexponential and (b) biexponential synthetic data with low noise, the appropriate model fit
gives the favorable (lower) AIC value for ADC and IVIM models, respectively, indicated by the lower AIC values
in the legend. In (a), ADC and IVIM curves are identical, but the simpler ADC model (fewer variables) is
favoured. (c) With enough noise added, however, the underlying biexponential nature is obscured, and the
monoexponential fit with fewer parameters is favored. Axes shown are x: b-value (mm2s-1) and y: signal (a.u.)
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assumptions; a review of such assumptions—including attempting
to identify those made unconsciously, for example the role of para-
meters automatically set by the scanner (seeNote 22)—is therefore
a vital part of any diffusion analysis protocol.
5 Notes
1. Location of b-values. For Bruker data, the method file in the
experiment directory contains the full acquisition parameter
list; this file is human-readable but is best treated as a reference
list where b-values can be found by searching for the text
“Bval.” Export of Bruker data to DICOM varies by software
version but may not include the b-value in the export. For
DICOM files extracted from clinical scanners, the b-value is
normally located in a private field—for example (0019,100c) in
Siemens data—and can be accessed using functions such as
dicominfo(<DICOM_filename>) with an appropriate dictio-
nary file. NIfTI files do not contain b-value information as
standard in their header.
2. Pseudodiffusion, rather than perfusion, is a more accurate name
for the volume fraction and coefficient associated with the
second compartment of the IVIM model, given that it
describes only the phenomenon and avoids physiological infer-
ence. Particularly in the kidney, the pseudodiffusion observed
may arise from both vascular and tubular structures. Even in
tissues without the complication of tubular or ductal struc-
tures, the term pseudodiffusion should be used, since the
apparent pseudodiffusion fraction is known to be dependent
on acquisition parameters [26].
3. A review of images prior to processing should be performed to
ensure that assumptions made about the format and packaging
of the data are valid. This includes any naming and/or export
order conventions; incorrect assumptions about data presenta-
tion and provenance may also introduce errors into results or
interfere with smooth processing.
4. Signal-to-noise (SNR) for the relevant region is calculated as the
mean of the signal divided by the standard deviation of the
background noise signal, found from a comparable region
containing only noise (i.e., outside the object). This should
be tested at the highest b-values in particular; it is common to
require SNR above a suitable threshold (e.g., 5) for inclusion in
the calculation, unless a noise contribution is explicitly
included in the model.
5. Image registration to account for motion and distortion is a
large topic in its own right and there are many strategies
available, essentially divided into rigid and non-rigid
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techniques. It is useful to avoid averaging within the scanner,
for example of separate diffusion directions to form trace
images, which can lock in motion errors. Prospective motion
correction acquisitions (e.g., gating to respiration) may still
require motion correction; more efficient sampling with
increased averaging alleviates this problem overall, and allows
a wider range of processing options [27, 28].
6. Conventionally, all parameters except b-value remain constant
through the acquisition, and so b-value is the only independent
variable. For more complex acquisitions, fitting across several
parameters such at TE or Δ are needed [26, 29]. For DTI,
direction of diffusion-weighting is fitted as well as b-value.
7. An additional quality or “sanity” check is advised after the
fitting procedure; invalid assumptions about model applicabil-
ity or data quality should become apparent either in the result-
ing values, or from visual inspection of the parameter maps or
fitted curves. Resulting values should always be critically
assessed and not just accepted.
8. Region of interest definition. Depending on the research ques-
tion, it may be appropriate to define a region of interest (ROI)
based on a calculated parameter map (e.g., ADC) or a repre-
sentative high-b-value image, or to transfer an ROI from
another modality (e.g., DCE). In the latter cases, it is not
necessary to perform diffusion modeling over the whole
image, which can save considerable computation where more
complex models and algorithms are used. In general, calcula-
tion of the parameter map across the whole image gives a better
visual overview and may reveal features otherwise missed.
9. The definition of regions of interest (ROIs) can be done before
or after the model fitting. If done before, the signal through
the ROI can be summed (or averaged) and fitted to give a
single parameter set to reflect the entire ROI. This approach
minimizes the influence of noise, but is predicated on all ROI
voxels being the same class of tissue and discards spatial infor-
mation. Conversely, calculation of entire-image parameter
maps can highlight spatial features and help guide to ROI
definition. Summary statistics drawn from voxel-wise maps
after fitting also discards spatial information, and each voxel
fit will be subject to more noise but allows for reporting and
analysis of ROI histogram moments.
10. Reading Bruker format data into Matlab is not a standard
function; the read_2dseq suggested here is available for down-
load from Mathworks [30]. Another alternative, with more
direct equivalents in other programming languages, is to read
the file directly:
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file = fopen(‘<2dseqFile>’, ‘r’);




Other platforms are able to read Bruker format directly, or
convert to a more accessible format (e.g., NIfTI).
11. The order of b-values is irrelevant for the fitting, but it is con-
vention to handle them in a consistent (usually ascending)
order. If the b-values are known but without assignation to
specific images, the correct assignment can be inferred from the
overall image signal intensity if there is sufficient change in
contrast between successive images. b-value magnitude cannot
be inferred from the images if the values are not recorded.
12. b-values are usually specified as nominal values entered on the
console (e.g., 100 s/mm2) but, in reality, are modified by the
use of the imaging readout gradients themselves (which, like
the diffusion-encoding gradients pulses, have both magnitude
and direction). It is more correct to use the full b-value matrix
in the fitting [31], although the imaging gradient contribu-
tions are often considered small (e.g., “100” ¼ 105 s/mm2).
13. Registration and/or motion correction can be applied within
the diffusion series, or to a separate reference image (e.g.,
T2w). Distortion correction from eddy currents in EPI images
can also be ameliorated by registration to T2w images, or by
using phase reversed image pairs if acquired [32].
14. The S0 maps from ADC and IVIM fitting are expected to be
qualitatively similar to the b ¼ 0 s/mm2 images (for DWI
acquisitions with two b-values they are equivalent) and are
often not considered to be interesting. Nevertheless, the S0
map is generated using all data and thus may have less influence
from confounding factors (noise, distortion, etc.) and may
highlight issues arising from the fitting process.
15. When using custom fitting routines, certain programming prac-
tices such as memory preallocation can save substantial com-
putation time and are worth the extra investment of effort. Full
optimization of code is a much larger task, and will give dimin-
ishing returns beyond a certain level.
16. Division by zero, for example in voxels outside the object (and
which are not of interest), may result in infinities or errors that
halt the routine. These can be excluded from the fitting loop,
assigned an arbitrary default value, or values in Sb can be
incremented to an arbitrary small value (e.g., 1) that will not
appreciably affect the outcome.
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Sb = 1 + img(i,j,:);
17. Normalization of signal data to the b ¼ 0 s/mm2 value is not
necessary, and may introduce inaccuracy if the observed signal
value at b¼ 0 s/mm2 is not representative of the underlying S0
(e.g., in the presence of appreciable perfusion).
18. Imposing limits on fitted variables, perhaps to physiological or
physical, is possible in many fitting algorithms. One potential
pitfall with this approach is if limit values returned from a failed
fitting are treated as legitimate (i.e., converged) values, they
may bias summary measures. This is an easy oversight if sum-
mary statistics are taken and parameter maps/histograms are
not examined.
19. Matrix inversion is an efficient implementation of linear regres-
sion (using the log signal). The whole image can be used at
once, although since the 3D data matrix is reshaped for the
calculation, care must be taken to reconstruct the resulting








20. Segmented fitting for D* can take many flavors, essentially
revolving around which parameters are allowed to be free and
which are fixed. For example in this implementation, f is
already fixed but could be recalculated following fitting for
SDs. The use of the segmented method as initialization for a
full least-squares fitting is an iterative process and can minimize
the influence of noise in the b ¼ 0 s/mm2 image, and uncer-
tainty in choosing a suitable Bcut threshold [33].
21. One major need in the IVIM community is the standardization
of terminology, including the exact formulation of the model,
and even the parameter symbols. This article usesD* to denote
pseudodiffusion coefficient, but owing to the use of the asterisk
in Matlab to denote the product, D* is written Ds in the code.
22. The effect of diffusion time (delay between the gradient-
encoding pulses, Δ) is yet to be fully described, although it is
known to influence IVIM parameters in a similar way to echo
time, TE [26, 29]. It is thus important to fix, record, and
report this during acquisition, similar to TE.
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Chapter 38
Analysis Protocol for Dynamic Contrast Enhanced (DCE) MRI
of Renal Perfusion and Filtration
Frank G. Zöllner, Walter Dastrù, Pietro Irrera, Dario Livio Longo,
Kevin M. Bennett, Scott C. Beeman, G. Larry Bretthorst,
and Joel R. Garbow
Abstract
Here we present an analysis protocol for dynamic contrast enhanced magnetic resonance imaging
(DCE-MRI) data of the kidneys. It covers comprehensive steps to facilitate signal to contrast agent
concentration mapping via T1 mapping and the calculation of renal perfusion and filtration parametric
maps using model-free approaches, model free analysis using deconvolution, the Toft’s model and a
Bayesian approach.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Keywords Magnetic resonance imaging (MRI), Dynamic contrast enhanced (DCE), Contrast agent,
Kidney, Mice, Rats, Deconvolution, Toft’s model, T1 mapping, Perfusion, Filtration
1 Introduction
Contrast enhanced imaging is based on the use of endogenous
tracers (or contrast agents) with para- or ferromagnetic properties
and was proposed in the mid-1980s. The aim was to measure or
derive the tissue perfusion and capillary permeability from the
signal changes caused by the tracer. Based on the employed imaging
technique, this concept is called dynamic susceptibility contrast
(DSC) or dynamic contrast-enhanced (DCE) MRI whereby the
first is used in conjunction with T2-weighted imaging techniques
whereas the latter is used in T1-weighted imaging. During such
DCE-MRI exams a signal time curve (STC) is recorded that reflects
the passage of the tracer through tissue and therefore also the
perfusion and filtration of the renal tissue. To analyze the tracer
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_38, © The Author(s) 2021
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kinetics and the STC various approaches were proposed comprising
semiquantitative, model-free, and model based approaches which
will be outlined in this chapter [1–6].
Theoretical considerations and acquisition protocols are
detailed in the chapters by Pedersen M et al. “Dynamic Contrast
Enhancement (DCE) MRI–Derived Renal Perfusion and Filtra-
tion: Basic Concepts” and by Irrera P et al. “Dynamic Contrast
Enhanced (DCE) MRI-Derived Renal Perfusion and Filtration:
Experimental Protocol.”
A typical workflow for analyzing DCE-MRI data and for calcu-
lating parametric maps of renal perfusion and filtration comprises
the segmentation of the kidney and the delineation of the arterial
input function (AIF), calculation of T1 maps to convert voxel-wise
STCs to concentration time curves (CTC), model selection, and
eventually the calculation of perfusion and filtration parameters [7–
10]. There are several existing software packages that can calculate
renal perfusion and filtration from a dynamic contrast enhanced
MRI scan. However, none of the packages provide a complete
solution so that the user has to select the package(s) that fit(s) his
needs most.
This analysis protocol chapter is complemented by two separate
chapters describing the basic concept and experimental procedure,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)





The methods described in this chapter require the following soft-
ware tools:
1. A recent version of the DICOM workstation OsiriX (www.
pixmeo.com) or Horos (https://horosproject.org/).
2. UMMPerfusion Plugin version 1.5.3 (http://www.opossumm.
de/redmine/projects/ummperfusion).
3. Bayesian Data-Analysis Toolbox (a working manual of the
entire Bayesian Data-Analysis Toolbox, including server- and
client-side installation and operation instructions, descriptions
and operating instructions for software packages and an over-
view of Bayesian Probability Theory can be found at: http://
bayes.wustl.edu/Manual/BayesManual.pdf). Information on
server-side and client-side configurations may be found below
in Notes 1 and 2.





To analyze preclinical data with UMMPerfusion, the image data
need to be converted into DICOM prior to the analysis [11, 12]. It
is recommended to convert DICOM to NIFTI first, then use the
NIFTI images for all processing within ROCKETSHIP [13]. Data
can be imported into DCE@ur-Lab from DICOM format, Bruker
Biospin MRI data format (http://www.bruker.com/products/
mr/mri.html), as well as from binary unformatted data
[14]. MITK-model fit can import various data formats like
DICOM or NIFTI [15].
2.2.2 Prequality Check Visual inspection is required to check that all slices are aligned as
time advances. Slices with clear motion artifacts should be removed.
More robustly, data with slight movements can be recovered by
coregistration images to suitable baseline image(s).
3 Methods
3.1 Segmentation For the calculation of whole kidney GFR it is necessary to segment
the kidneys and to determine their volume.
3.2 T1 Mapping According to the software chosen for performing the analysis the
series of images acquired may be converted to a convenient format
(e.g., DICOM).
The calculations should be performed only on the pixels
obtained from renal segmentation (see Subheading 3.1).
More detailed descriptions of T1 mapping calculations are
described in the chapter by Garteiser P et al. “Analysis Protocols
for MRI Mapping of Renal T1.”
3.2.1 VTR Analysis For the analysis of the VTR images a pixel-by-pixel fitting proce-
dure is used to fit the intensities of every renal pixel in the images as
a function of TR against the following signal equation
S ¼ A þ So 1 eTR=T 1
 
ð1Þ
where TR is the repetition time, A is a bias intensity, and S0 is the
intensity once reached a plateau.
For every pixel a T1 value can be obtained according to the
fitting of Eq. 1 (an example of T1 map fitting within the Bruker
Paravision® software is shown in Fig. 1).
3.2.2 VFA Analysis For the analysis of the VFA images a pixel by pixel fitting procedure
is used to fit the intensities of every renal pixel in the images as a
function of FA against the following signal equation
S ¼ A þ So
sin FA  1 eTR=T 1 
1 cos FA  eTR=T 1
" #
ð2Þ
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where FA is the flip angle, TR is the repetition time, A is a bias
intensity and S0 is the intensity reached a plateau.
For every pixel a T1 value can be obtained according to the
fitting of Eq. 2.
3.3 Model Selection
and Quantification
Several methods for DCE-MRI analysis have been proposed, with
different mathematical representation of physiologic system inter-
pretation through kinetic modeling [1]. Due to the large number
of these methods and models, herein we describe only those that
are mostly used and that can be easily exploited due to the availabil-
ity of free software for these analyses. Among them we will consider
deconvolution approaches (see Subheading 3.4) and extended
Toft’s model (see Subheading 3.5). In addition, a description on
how to select the best model based on Bayesian approaches accord-
ing to the acquired data is also provided (see Subheading 3.6).
3.4 Deconvolution
Approach
The following steps are based on the UMMPerfusion plugin [12]
and the DICOM workstation OsiriX.
1. Open the dataset in the Osirix 4D-viewer (see Note 3):
2. OsiriX will check if the data selected are a 4D data set
(3D spatial plus 1D temporal), however, sometimes this inter-
nal check fails. Therefore, an intermediate step might be
Fig. 1 T1 map fitting under the VTR scheme performed within the Bruker Paravision 5.1
® software for a
selected ROI
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necessary to load the data into the UMMPerfusion plugin. To
do so, select the series in the database window. Press the
Alt-Key and click the 2D-viewer’s icon at the same time. A
window will open. Select/click on the 4D-viewer button, the
series will appear within the 4D viewer, although it was not
designed for it initially.
3. Start the plugin via the Osirix plugin menu (see Fig. 2):
Plugins ! image filter ! UMMPerfusion
4. Select algorithm from the tool bar (see Fig. 3).
Fig. 2 Selecting the UMMPerfusion plugin from the plugin menu of OsiriX
Fig. 3 UMMperfusion drop down menu to select a perfusion model
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5. Place a ROI on a clearly visible artery in order to receive an
arterial input function.
6. For ensuring correct results all algorithms require an arterial
input function (AIF). This function is defined by using the
Osirix ROI-tool and by placing/designating a “region of inter-
est” (ROI) on the abdominal artery. An oval is used as a
standard, however all ROI-tools offered by Osirix are sup-
ported by UMMPerfusion.
7. Upon placing a ROI, a chart will appear on the right-hand side
of the plugin window, depicting the arterial input function.
The aif-color corresponds to the current ROI border color,
whereas the vertical line, the base line will always be in red.
When a ROI is created, it will be attached to the popup-menu.
If several ROIs have been created within this dataset, the
desired ROI has to be assigned to its determined position. If
only one pixel shall be the source of the AIF, the ROI-Brush-
Tool with the size of 1px is to be used in order to specify the
smallest ROI possible (Fig. 4).
Fig. 4 Example of placing a ROI to select the AIF. The AIF is displayed as a chart next to the plugin
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8. Make sure that the desired ROI is selected in the popup menu
called “Arterial.”
9. A good ROI selection can be recognized by a large peak on the
chart to the right of the plugin-window.
10. Drag the baseline to a desired position or simply enter the value
in the respective text field.
11. The length of baseline represents the number of images during
a certain period of time that are used for signal normalization.
For attaining correct results, the baseline should be chosen in a
way that the tracer is not yet visible at that point of time. The
easiest way to set the baseline is to drag the baseline with the
mouse to its desired timeframe in the AIF-chart. The value can
alternatively be inserted into the baseline textfield (see Note 4,
and Fig. 5).
12. Set limits to the relevant scope by using the trim-sliders if
necessary.
Fig. 5 Selection of the baseline
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13. Before hitting the generate-button, there is the opportunity to
activate the autosave-checkbox to automatically save the results
and to generate a report.
14. The calculation begins after using the generate-button.
15. As a result, three new views/viewers are created in which the
calculated data are presented. Each viewer shows one para-
metric map calculated by the deconvolution approach: blood
flow (perfusion) in ml/100 ml/min, the blood volume
(ml/100 ml) and the mean transit time (s) (Fig. 6).
16. If the autosave function has not been activated before using the
generate button, it is still possible to save the results as well as
the report after the calculation. In this case, use the export
button next to the generate-button.
3.5 Toft’s Model Three open source packages for renal perfusion and filtration quan-
tification implement the Toft’s model, namely, UMMPerfusion
[12], ROCKETSHIP [13], MITK-model fit [15], and DCE@ur-
LAB [14]. In the following, the processing steps are given for
UMMPerfusion; however, the other three tools can be used in
exchange. For details on using them please refer to the respective
documentation.
1. Open the dataset in the Osirix 4D-viewer.
Fig. 6 Example of the result of the deconvolution model implemented in UMMPerfusion. Besides the original
DCE-MRI data (top left), three additional viewers are opened presenting parametric maps of blood flow, blood
volume, and mean transit time
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2. Start the plugin via the Osirix plugin menu:
Plugins ! image filter ! UMMPerfusion.
3. Select algorithm from the tool bar.
UMMperfusion implements the extended Toft’s model. It
can be calculated either ROI-based (see Note 5) or pixel-wise.
The latter is described in the following.
4. Place a ROI on a clearly visible artery in order to receive an
arterial input function. The recommended shape of the ROI
is oval.
Please see Subheading 3.4 for more details.
5. Place a rectangular ROI on the relevant tissue. When using the
pixel-based compartment model algorithms, only a rectangular
ROI shape is supported at the moment by UMMPerfusion.
6. The pixelwise calculation might require some time to calculate.
To save time, the ROI should be accurately fitting around the
tissue that is to be analyzed (see Fig. 7).
7. The arterial-ROI and the tissue-ROI do not have to be on the
same slice.
8. Make sure that the desired arterial-ROI is selected in the popup
menu called “Arterial.”
9. Make sure that the desired tissue-ROI is selected in the popup
menu called “Tissue.”
Fig. 7 Example of rectangular ROI placed tight around the kidney. Within this ROI, a voxel-wise fit of the Toft’s
model is performed, all pixels outside the ROI are not considered
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10. Select the tracer approximation, baseline, and spatiotemporal
trimming of the data as described in Subheading 3.4.
11. The calculation begins after using the generate-button. A new
window will appear, in which the desired viewers (parametric
maps) can be chosen.
12. Upon approval with the OK button the selected viewers will
appear and show the specified area (see Fig. 8).
13. If the autosave function has not been activated before using the
generate button, it is still possible to save the results, as well as
the report. In that case, use the export button next to the





of Interest Data Using
the Enter ASCII Model
Package
From the client-side Java interface:
1. Select the “enter ASCII Model” option under the
“Package” menu.
2. Load your signal model.
l Your own signal model can be loaded using the “User”
button (links to the client-side .../Bayes/BayesAsciiModels
folder, where you should store you model and parameter
files).
Fig. 8 Example of different parametric maps calculated by the Toft’s model. Based on the ROI drawn around
the kidney, only voxels within this ROI are used during model fit. Voxels outside the ROI are not taken into
account
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l A prepackaged “System” model can be loaded using the
“System” button (links to Server-side models).
3. Load ASCII data using widgets.
l File ! Load ASII ! File.
l Data file must be in ASCII format.
l Data are typically in 2-column ASCII format (abscissa, ordi-
nate), however, the software package allows both multicol-
umn abscissas and ordinates.
4. Build your model using the “Build” button.
5. OPTIONAL: If you believe that your data contains outliers,
you can check the “Find Outliers” option under “Analysis
Options.”
6. Under the “Prior Viewer” tab, review your user-defined prior
probability distributions and parameter ranges.
7. If you have multiple servers running the Bayesian Data-Analysis
Toolbox, select the desired server for processing the analysis
using the “Select” button.
8. OPTIONAL: You can check the status of the selected server
using the “Status” button.
9. Run the analysis using the “Run” button.
10. You can monitor the status of the analysis using the Status
button or the button bearing a picture of an eye at the bottom
left of the window.
11. Once the analysis is complete, retrieve the results using the
“Get Job” button or the job will be automatically retrieved
when the job status is checked and the job is completed.
3.6.2 Model Selection
and Analysis of Region
of Interest Data Using
the Enter ASCII Model
Selection Package
From the client-side Java interface:
1. Select the “enter ASCII Model Selection” option under the
“Package” menu.
2. Load all of the signal models that you would like to compare.
l Your own signal models can be loaded using the “User”
button (links to the client-side ../Bayes/BayesAsciiModels
folder, where a model and parameter files are stored).
l Prepackaged “System” models can be loaded using the
“System” button (links to Server-side models).
3. Load your data.
l File ! Load ASII ! File.
l Data file must be in ASCII format.
l Data are typically in 2-column ASCII format (abscissa, ordi-
nate), however, the software package allows for
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multicolumn data and abscissaes (See the Bayesian Data-
Analysis Toolbox manual, Appendix A for details).
4. Build your models using the “Build” button.
5. OPTIONAL: If you believe that your data contain outliers, you
can check the “Find Outliers” option under “Analysis
Options.”
6. Under the “Fortran/C Model Viewer” ! “Parameters” tabs,
review your user-defined prior probability distributions.
7. If you have multiple servers running the Bayesian Data-Analysis
Toolbox, select desired server for processing the analysis using
the “Select” button.
8. OPTIONAL: You can check the status of the selected server
using the “Status” button.
9. Run the analysis using the “Run” button.
10. You can monitor the status of the analysis with the Button
bearing a picture of an eye at the bottom left of the window,
or using the status button.
11. Once the analysis is complete, retrieve the results using the
“Get Job” button. The job is automatically retrieved when the




Data Using the Analyze
Image Pixels Package
From the client-side Java interface:
1. Select the “Analyze Image Pixels” option under the
“Package” menu.
2. Load your signal model.
l Your own signal model can be loaded using the “User”
button (links to the client-side ../Bayes/BayesAsciiModels
folder, where you should store you model and parameter
files).
l A prepackaged “System” model can be loaded using the
“System” button (links to Server-side models).
3. Load your data.
l File ! Load Image.
l Select the file format of your data.
4. Load an abscissa file (your vector specifying the time at which
data were collected, b-values, echo times, etc.).
5. Set the noise standard deviation of the data.
l An acceptable approximation of the noise standard deviation
for this purpose would be to draw an ROI in a region of no
signal of an image and input the RMS value of this ROI.
Tools to make this measurement are available in the main
window once data have been loaded—Do not use the stan-
dard deviation of the data.
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6. Compile your signal model using the “Build” button.
7. OPTIONAL: If you believe that your data contains outliers,
you can check the “Find Outliers” option under “Analysis
Options.”
8. OPTIONAL: If you want a much faster analysis, you can select
the “Max Probability” option. The option comes at the cost of
only returning the max probability parameter value. No poste-
rior probability distribution information is available if you use
this option.
9. Under the “Prior Viewer” tab, review the prior probability
distributions.
10. If you have multiple servers running the Bayesian Data-
Analysis Toolbox, select desired server for processing the anal-
ysis using the “Select” button.
11. OPTIONAL: You can check the status of the selected server
using the “Status” button.
12. Run the analysis using the “Run” button.
13. You can monitor the status of the analysis with the status
button or the button bearing a picture of an eye at the bottom
left of the window.
14. Once the analysis is complete, retrieve the results using the
“Get Job” button. The job is automatically retrieved when the
job status is checked and the job is completed.
3.7.2 Model Selection
and Analysis of Image Data
Using the Image Model
Selection Package
From the client-side Java interface:
1. Select the “Analyze Image Pixels” option under the
“Package” menu.
2. Load all of the signal models that you would like to compare.
l Your own signal models can be loaded using the “User”
button (links to the client-side ../Bayes/BayesAsciiModels
folder, where you should store you model and parameter
files).
l Prepackaged “System” models can be loaded using the
“System” button (links to Server-side models).
3. Load your data.
l File ! Load Image.
l Select the file format of your images.
4. Load an abscissa file (your vector specifying the time at which
data were collected, b-values, echo times, etc.).
5. Set the noise standard deviation of the data.
l An acceptable approximation of the noise standard deviation
for this purpose would be to draw an ROI in a region of no
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signal of an image and input the RMS value of this ROI.
Tools to make this measurement are available in the main
window once data have been loaded.
6. Build your signal models using the “Build” button.
7. Under the “Fortran/C Model Viewer” ! “Parameters” tabs,
review your user-defined prior probability distributions.
8. If you have multiple servers running the Bayesian Data-Analysis
Toolbox, select desired server for processing the analysis using
the “Select” button.
9. OPTIONAL: You can check the status of the selected server
using the “Status” button.
10. Run the analysis using the “Run” button.
11. You can monitor the status of the analysis using the status
button, or with the Button bearing a picture of an eye at the
bottom left of the window.
12. Once the analysis is complete, retrieve the results using the
“Get Job” button. The job is automatically retrieved when the







UMMPerfusion has been in-house certified by the authors and
comes with a set of simulated data to test the technical validity of
the algorithms. Also, the other software packages provide example
data for testing. The Bayesian Data-Analysis Toolbox provides an
estimation of uncertainty, even for a single measurement and it has
been validated with simulated data for which ground truth is
known [4].
Table 1
Values of renal blood flow (RBF) reported in the literature for different







Lewis rats 3 Zimmer et al. [16]
Healthy 542  85
AKI 407  119
SD rats 3 Sadick et al. [17]
Healthy 440  86
PKD 156  40
PCK 69  23
Swiss mice 7 Oostendorp et al.
[18]Healthy 481  26
AKI 451  24
AKI acute kidney injury, PKD polycystic kidney disease, PCK autosomal polycystic
kidney disease
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3.8.2 Comparison
with Reference Values from
the Literature
Table 1 surveys reference values from the literature for renal blood
flow in small rodents. Please note that these values might vary
versus those obtained by the reader following this chapter due to
different AIF selection and acquisition parameters.
4 Notes
1. Recommended server configuration and server-side installation
of the Bayesian Data-Analysis Toolbox: Multicore LinuxPC
(32 or 64 cores); 32- or 64-bit processor; Operating system:
Linux (CentOS 4.7 or higher) or Sun Solaris 9 or 10; Installing
Fortran and C is strongly recommended (required to build and
analyze data with your own signal model). Server-side installa-
tion instruction can be found at: http://bayesiananalysis.wustl.
edu/install.html.
2. Recommended client-side configuration for the Bayesian Data-
Analysis Toolbox: any operating system that can run Java 6 or
higher. Note that the client machine only runs a Java graphical
user interface that the sends and receives jobs from the server-
side Bayesian Data-Analysis Toolbox. Through this interface,
data can be loaded and visualized, mathematical models can be
written in Fortran and tested, jobs can be sent to the server-side
software for analysis, and completed jobs can be retrieved from
the server-side Bayesian Data-Analysis Toolbox and visualized.
3. If T1-mapping is available, please convert signal intensities to
concentrations beforehand and save this back into DICOM
files.
4. If concentration time curves are used, please select the option
“Signal enhancement.”
5. For examples to perform ROI based analysis with UMMperfu-
sion please see http://www.opossumm.de/redmine/projects/
ummperfusion/wiki/Tutorials__How_to_.
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Chapter 39
Quantitative Analysis of Renal Perfusion by Arterial Spin
Labeling
Kai-Hsiang Chuang, Frank Kober, and Min-Chi Ku
Abstract
The signal intensity differences measured by an arterial-spin-labelling (ASL) magnetic resonance imaging
(MRI) experiment are proportional to the local perfusion, which can be quantified with kinetic modeling.
Here we present a step-by-step tutorial for the data post-processing needed to calculate an ASL perfusion
map. The process of developing an analysis software is described with the essential program code, which
involves nonlinear fitting a tracer kinetic model to the ASL data. Key parameters for the quantification are
the arterial transit time (ATT), which is the time the labeled blood takes to flow from the labeling area to the
tissue, and the tissue T1. As ATT varies with vasculature, physiology, anesthesia and pathology, it is
recommended to measure it using multiple delay times. The tutorial explains how to analyze ASL data
with multiple delay times and a T1 map for quantification.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Key words Magnetic resonance imaging (MRI), Kidney, Rodent, ASL, Blood flow, Perfusion
1 Introduction
The signal intensity differences measured by an arterial-spin-label-
ling (ASL) magnetic resonance imaging (MRI) experiment are
proportional to the local perfusion, which can be quantified with
kinetic modeling. To calculate the perfusion map, an additional T1
relaxation map should be obtained from inversion recovery data
acquired with the same image acquisition method (eg, Spin-Echo
EPI or RARE) and geometry setting.
Creation of perfusion maps involves nonlinear fitting of a tracer
kinetic model to the ASL data. Depending on the type of ASL
sequence—pulsed or (pseudo)continuous—the model is slightly
different. Two key parameters in the quantification are the arterial
transit time (ATT), which is the time the labeled blood taken to
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_39, © The Author(s) 2021
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flow from the labeling area to the tissue, and the tissue T1. As ATT
varies with vasculature, physiology, anesthesia, and pathology, it is
recommended to measure it using multiple delay times (i.e., multi-
ple TI in pulsed ASL, or multiple postlabeling delays in continuous
ASL). In the kidney, the cortex and medulla have different T1. T1
could also change depending on the pathological conditions.
Therefore acquiring a T1 map is desirable. This chapter focuses
on how to analyze ASL data with multiple delay times and a T1
map for quantification.
This analysis protocol chapter is complemented by two separate
chapters describing the basic concept and experimental procedure,
which are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)





The method described in this chapter provides a detailed description
for a solution in MATLAB, but can be adopted to other platforms:
1. A programming environment capable of applying fitting mod-
els, such as Python, Octave, R or MATLAB®.
2. A software to convert the data format from DICOM or vendor
proprietary format (eg, Bruker 2dseq) to the NifTi format,
such as dcm2nii (for DICOM; https://people.cas.sc.edu/
rorden/mricron/dcm2nii.html), or Bru2Nii (for Bruker
2dseq; https://github.com/neurolabusc/Bru2Nii).
3. An image viewing software such as Fiji (www.fiji.sc) or MRIcro
(https://www.mccauslandcenter.sc.edu/crnl/mricro).




To be able to calculate perfusion maps, ASL data with interleaved
control and label images and multiple delay times, and a T1
mapping acquired with inversion recovery are needed. For more
details on the basic concept of ASL please refer to the chapter by Ku
M-C et al. “Noninvasive Renal Perfusion Measurement Using
Arterial Spin Labeling (ASL) MRI: Basic Concept.” The data
acquisition is described in a step-by-step manner in the chapter by
Chuang K-H et al. “Renal Blood FlowUsing Arterial Spin Labeling
(ASL) MRI: Experimental Protocol and Principles.”
2.2.2 Intensity Scaling
of Multiple Delay ASL Data
If the ASL data of multiple delay times was acquired by separate
scans (eg, one delay time for one scan) but not all within the same
scan, there could be a difference in the intensity scaling among
separate scans due to changes in receiver gain and/or internal
scaling factor during image reconstruction. Such a difference
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could lead to artifactual intensity among delay times leading to bias
in the model fitting and inaccurate perfusion quantification.
On Bruker MRI systems, the default intensity scaling is set to
maximize the dynamic range of the output format. Therefore scans
with lower signal would be magnified. The intensity scaling method
in the “Reconstruction” class should be changed to “User Scaling”
with a scaling factor of 1 for all the scans.
To ensure the same intensity scaling of the ASL data, the
receiver gain may be extracted from the header information
(“RG” variable in the “acqp” file) and used to rescale the data.
2.2.3 Format Conversion Convert all data into 4D NifTi format. Consider magnifying the
voxel size by 10 in the image header if motion correction tools




During the ASL image acquisition, movement of the body or
kidney itself can occur. Artifacts may also arise from ASL labeling
pulses. In order to construct accurate perfusion maps, it is impor-
tant to ensure that the scan series don’t show severe movement,
spikes, banding artifacts, or sudden changes in SNR. Scans with
poor quality or large movement should be discarded.
1. Open each dataset by a NifTi image viewer.
2. Adjust the window/level (or reduce the maximum intensity
range) to visualize the image better.
3. Scroll through each time frame to visually check whether there
are sudden changes in intensity or movement.
3.2 Motion
Correction
ASL perfusion imaging, due to its subtraction between label and
control images, is very sensitive to movement. Despite respiratory
trigger, slight movement between scans could still be present.
Motion artifact maybe reduced by rigid-body motion correction
tools in many software packages. Since most motion correction
algorithms (regardless correlation or square error based cost func-
tion) rely on intensity changes for detecting movement, the inten-
sity changes between control and label images and between scans of
different delay times (particularly for FAIR ASL) could lead to
pseudo motion. Besides, the T1 mapping data should also be cor-
egistered to the ASL data. Therefore, it is recommended to realign
images to the same reference target, (e.g., the M0 image or an
averaged image). Additionally, use “cost functions” that are less
dependent on the global intensity difference, such as normalized
correlation or mutual information, and avoid using least square
error (see Note 2).
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1. Use FSL mcflirt to do motion correction on the ASL data
(ASL_DATA_TI1.nii) using the mean image as the reference
target, normalized correlation as the cost function, and spline
for interpolation:
mcflirt -in ASL_DATA_TI1.nii -out rASL_DATA_TI1
-cost normcorr -meanvol -spline_final.
2. Do motion correction on another ASL data set (ASL_DA-
TA_TI2.nii). This time using the mean image generated from
the first step as the reference target:
mcflirt -in ASL_DATA_TI2.nii -out rASL_DATA_TI2
-cost normcorr -reffile ASL_DATA_TI1_meanvol.nii
-spline_final.
3. Repeat the same procedures until all the ASL data are
coregistered.
4. Similarly, do motion correction on T1 mapping data (T1MAP.
nii) also using the mean image generated from the first step as
the reference target:
mcflirt -in T1MAP.nii -out rT1MAP -cost normcorr -reffile
ASL_DATA_TI1_meanvol.nii -spline_final.
3.3 Quantification
of M0 and T1
3.3.1 Model Equations
Both M0 and T1 are important parameters needed in ASL kinetic
model. Besides, the inversion efficiency will be used for FAIR ASL
quantification to correct its “labeling efficiency.”
The most common method to obtain these parameters is to fit
the model of an inversion recovery experiment to the signal inten-
sity data of each pixel at various TI, M(TI), using the following
equation:





whereM0 is the fully relaxed magnetization signal which is a scaling
factor that includes many parameters such as the proton density
together with the coil sensitivity and the signal gain of the system. α
is the inversion efficiency of the inversion pulse (α ¼ 1 for a perfect
inversion), and T1 is the longitudinal relaxation time.
3.3.2 Starting Values An important step of the curve fitting process is the choice of
suitable starting values for each parameter that will be determined
by the fitting algorithm (NB: different starting values may lead to
different results!). Here we describe how to derive starting values
from the SI of each pixel.
1. Step through all pixels in the images using for loops for the
pixel coordinates x and y.
2. Store the SI of that pixel at all TIs in a vector (in Matlab:
SI_vector ¼ imgData_forFitting(xPix, yPix,:)).
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3. As starting value for the parameter M0 use the largest SI
(in Matlab: startVal_M0 ¼ max(SI_vector)).
4. For estimating a starting value for T1, one can exploit the fact
that the null point of an inversion recovery, where the SI is 0, is
TI ¼ ln2  T1 ¼ 0.693  T1. Estimate the starting T1 value by
finding the TI whose SI is minimal:
5. Find the index of the smallest value in the vector (in Matlab:
[min_Value,min_Index] ¼ min(SI_vector)).
6. Get the respective TI using the index from the last step and
divide by ln2 to estimate T1 (in Matlab: startVal_T1 ¼ TI_for-
Fitting(min_Index)/0.693).
As for a starting value for α, one can assume that is close to
1 (in Matlab: startVal_alpha ¼ 1).
3.3.3 Fitting Algorithm Least squares algorithms, such as the Levenberg–Marquardt and
Trust-region methods, are the most commonly used curve fitting
algorithms for T1-mapping. They work by minimizing a cost func-
tion, which describes the deviation of the fitted curve from the data
points. With starting values near the optimal solution they quickly
converge, but with starting values far away from the solution, the
Levenberg–Marquardt algorithm will slow down significantly. Also,
there is the risk that it may converge to a local minimum (rather
than the global minimum) and hence produce a wrong result.
In contrast, the Trust-region method (a further development
of the Levenberg–Marquardt algorithm) will quickly converge,
even with suboptimal starting values, and it will always find the
global minimum. However, it does require the definition of lower
and upper limits for the parameters to be fitted. Hence, for
T1-mapping, where such limits can easily be defined, the Trust-
region method is well suited (see Note 3).
1. Create for loops for pixel coordinates x and y to step through all
pixels of the image.
2. Store the SI of that pixel at all TIs in a vector (in Matlab:
SI_vector ¼ imgData_forFitting(xPix, yPix,:)).
3. Define the model for the function using Eq. 1 (in Matlab:
T1model ¼ fittype(‘abs(a*(1-2*c*exp.(x*b)))’, ‘indepen-
dent’, ‘x’, ‘dependent’, ‘y’)).
4. Initialize the fitting options in Matlab: opts ¼ fitoptions
(T1model);
5. Choose the function for the fitting algorithm, that is, Trust-
region or, if not available, then Levenberg–Marquardt
(in Matlab: opts.Algorithm ¼ ‘Trust-Region’).
6. Provide the starting values forM0 and T1 (in Matlab, e.g., opts.
StartPoint ¼ [startVal_M0 startVal_T1 startVal_alpha]).
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7. Define lower and upper limits for the fit parameters. Use T1
[1 9000], α [0 1] and for M0 the possible range of SI in the
image data (this depends on the system; for 16-bit integer
it may be [1 65536]). In Matlab, for example, opts.
Lower ¼ [1 1 0]; opts.Upper ¼ [65536 9000 1].
8. Execute the curve fitting for each pixel data (in Matlab: [fitre-
sult, gof] ¼ fit(TI_forFitting, SI_vector, T1model, opts);).
9. Save the fit result for each variable in parameter maps: mapM0
(xPix, yPix) ¼ fitresult.a; mapT1(xPix, yPix) ¼ fitresult.b;
mapAlpha(xPix, yPix) ¼ fitresult.c; rsquare(xPix, yPix) ¼ gof.
rsquare.
Besides usingMatlab, inversion recovery T1 curve fitting can be
done by using ImageJ. QuickVol II (http://www.quickvol.com/
launch2.html) is a powerful ImageJ plugin that supports fitting the
inversion recovery data and other user defined equation. The reader
should refer to the user’s manual on how to use the plugin.
3.3.4 Visual Display 1. Display the parameter map, which is a matrix with floating
point numbers, as an image (in Matlab: imagesc(mapT1);).
2. Remove axis labels and ensure that the axes are scaled equally,
so that pixels are square and not rectangular (in Matlab: axis
off; axis equal;).
3. Select the color map and display a color bar (in Matlab: color-
map(jet(256)); colorbar;) (see Note 4).
4. Set the display range for the color coding, for example, for T1





The pairwise subtracted perfusion-weighted signals at different TIs,
ΔM(TI), can be fitted to the following kinetic function [1] (see
Fig. 1):
ΔM TIð Þ ¼ 2M 0αf =λ
exp TI=T 1app
  exp TI=T 1að Þ




where 1/T1app ¼ 1/T1 + f/λ, f is the quantified perfusion in
ml/100 g/min, λ is the blood–tissue partition coefficient. In the
above equation, M0 represents the equilibrium magnetization
derived from T1 mapping, T1 the tissue longitudinal relaxation
time, and α (the inversion efficiency) are all determined from the
curve fitting of the inversion recovery T1 mapping data. λ is a value
typically derived from literature which ranges between 0.52 and
0.94 have been reported in [2]. Here, λ ¼ 0.9 ml/g can be used
based on studies in the brain [3]. However, the suitable value for
the kidney remains to be determined. T1a is the longitudinal relax-
ation time of arterial blood, which is field strength dependent. A
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value of 2.21 s can be used at 7 T [4]. And the blood T1 at other




The first step is to generate the ΔM image of each TI, and then
concatenate the results of different TI together to form a 4D time-
series data:
1. Use the following FSL command to do pairwise subtraction:
asl_file --data = rASL_DATA_TI1 --ntis = 1 --iaf = tc --diff
--out = rASL_DeltaM_TI1 --mean = rASL_DeltaM_TI1_mean
Note that the --iaf option is to specify the order of label–
control pair where tc means the label (tag) image is acquired
first and then followed by control image. Use --iaf ¼ ct if the
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Fig. 1 Fitting perfusion-weighted signal from ROIs in the renal cortex and
medulla to the FAIR-ASL kinetic model described in Eq. 2
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2. Concatenate the mean difference images of all the TIs
together:
fslmerge -t rASL_DeltaM_mean rASL_DeltaM_TI1_mean rASL_Del-
taM_TI2_mean . . . rASL_DeltaM_TIn_mean
where n is the number of TI.
3. If the data is acquired with varying TIs in one scan, the com-
mand could be:
asl_file --data = rASL_DATA --ntis = n --iaf = tc --diff --out
= rASL_DeltaM --mean = rASL_DeltaM_mean
The resulted rASL_DeltaM_mean image will then be used
in the following fitting process.
3.4.3 Starting Values Deriving the starting value of perfusion from the SI of each pixel is
not trivial. Therefore one can just use a literature value (e.g.,
300 ml/100 g/min).
1. The starting value for perfusion (startVal_f ¼ 300).
3.4.4 Fitting Algorithm Similar to T1 fitting, the Trust-region method can be used.
1. Create for loops for pixel coordinates x and y to step through all
pixels of the image.
2. Store the SI of that pixel at all TIs in a vector (in Matlab:
SI_vector ¼ imgData_forFitting(xPix, yPix,:)).
3. Change T1 value from millisecond to second (in Matlab:
mapT1(xPix,yPix) ¼ mapT1(xPix,yPix)/1000).
4. The model for the function using Eq. 2 (in Matlab: FAIR-
model ¼ fittype(‘mapM0(xPix,yPix) * mapAlpha(xPix,yPix) *
a * (exp(x * (1/mapT1(xPix,yPix) + a)) – exp.(x/0.221))/
(1/0.221 – (1/mapT1(xPix,yPix) + a)) ‘, ‘independent’, ‘x’,
‘dependent’, ‘y’)).
5. Initialize the fitting options in Matlab: opts ¼ fitoptions
(FAIRmodel);
6. Choose the function for the fitting algorithm, that is, Trust-
region or, if not available, then Levenberg–Marquardt
(in Matlab: opts.Algorithm ¼ ‘Trust-Region’).
7. Provide the starting values for perfusion (in Matlab, e.g., opts.
StartPoint ¼ [startVal_f]).
8. Define lower and upper limits for the fit parameters. Assuming
perfusion will be below 900 ml/100 g/min, use for f [0 900/
6000]. In Matlab, for example, opts.Lower ¼ [0]; opts.
Upper ¼ [0.15] (see Note 6).
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9. Execute the curve fitting for each pixel data (in Matlab: [fitre-
sult, gof] ¼ fit(TI_forFitting, SI_vector, FAIRmodel, opts);).
10. Save the fit result in parameter maps and rescale by 2/λ and
unit conversion factor: mapF(xPix, yPix)¼ fitresult.a * 0.9/2 *
6000; rsquare(xPix, yPix) ¼ gof.rsquare (see Note 6).
3.4.5 Visual Display 1. Display the parameter map, which is a matrix with floating
point numbers, as an image (in Matlab: imagesc(mapF);) (see
Fig. 2).
2. Remove axis labels and ensure that the axes are scaled equally,
so that pixels are square and not rectangular (in Matlab: axis
off; axis equal;).
3. Select the color map and display a color bar (in Matlab: color-
map(jet(256)); colorbar;) (see Note 4).
4. Set the display range for the color coding, for example, for
perfusion [0 500] (in Matlab: caxis([0 500]);).
3.5 Regional
Analysis
To obtain quantitative medulla and cortex perfusion, the kidney
can be manually or automatically segmented based on the T1 map




with Tissue Values Under
Hypercapnia or Hyperoxia
Further validation of imaging derived results can be performed
using datasets acquired under physiological manipulations that
alter blood flow, such as hypercapnia or hyperoxia. As CO2 is a
potent vasodilator, the blood flow under hypercapnia condition
should be higher than that in normal gas condition. Hyperoxia is
expected to lead to the opposite result with O2 acting like a vaso-
constrictor (see Fig. 2).
3.6.2 Comparison
with Reference Values from
the Literature
Obtained values for both cortex and medulla tissue segmentation
can be compared against reference values, shown in Table 1. It
should be noted that blood flow is also modulated by anesthesia.
For example, the commonly used isoflurane is a vasodilator and can
increase blood flow depending on dosage. Therefore, the
Fig. 2 Quantitative perfusion maps show lower perfusion under hyperoxia than that under carbogen (5%
CO2 + 95% O2). Anatomical image was acquired with TrueFISP showing contrast between the cortex (dark)
and medulla
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comparison with literature values should be done with comparable
anesthesia dosage.
4 Notes
1. Processing is typically performed in software packages such as
MATLAB (The MathWorks, MA) or open source platforms as
R programming language (http://r.org). The data can either
be processed as DICOM images or if available as the raw data
format from the scanner. As some motion correction tools
(e.g., FSL, SPM) works on NiFti format, the data may need
to be converted to that format during the processing. At the
end of the processing pipeline, finalizing the data in the
DICOM format would allow for further analysis and compari-
son to other image data on clinical viewers.
2. To correct for respiratory induced motion, resulted ASL
images can be coregistered using Elastix (open source software,
http://elastix.isi.uu.nl/) and a rigid registration algorithm.
3. An approach that is frequently used to increase the speed of the
curve fitting, is to fit a linear model to the log of the SI data.
This only requires a few simple modifications to the protocol
described here. We recommend using exponential fitting
(unless speed is very important), because the log-scaling leads
to the noise error at each TI being scaled differently and this
will impact on the fitted curve. If you do want to use linear
fitting it would be good to initially perform both, exponential
and linear fitting, on a few data sets and compare the results so
as to better appreciate the impact of this choice.
4. Pseudocolor representations can be extremely useful for ana-
lyzing T1-maps or perfusion maps, since they generally enhance
Table 1




(ml/100 g/min) Animal strain, anesthesia and gas Reference
338–452 123–240 C57BL/6 mouse, 1–1.5% isoflurane in 100% O2 [5]
550–750 140–230 C57BL/6J mouse, 1.5% isoflurane (gas unknown) [6]
344–575 ND C57BL/6N mouse, isoflurane (dose and gas
unknown)
[7]
288.4  51.3 ND Spraque-Dawley rat, 1.5% isoflurane (gas unknown) [8]
750  80 ND Fisher 344 rat, thiobutabarbitural, 69-135 mg/kg
(gas unknown)
[9]
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the perception of differences within the value range of the
parameter. But one needs to be careful when choosing a color
map. Parameter maps displayed as images in pseudocolor can
potentially be misleading. Small differences in the underlying
values may be artificially emphasized by a change in color hue,
or a significant parameter difference that can easily be seen in a
gray-scale image may be flattened or hidden if there is little
change of hue or brightness over a certain range of the color-
scale. It is recommended to always use the same color map and
scale to improve comparability.
5. The transit time is ignored in the above equation as the delivery
of spins is almost instantaneous with a small gap between the
imaging and inversion slices used in FAIR ASL. Whether the
transit time is negligible can be verified by adding the transit
time into the kinetic model.
6. To get the correct unit, the T1, T1a and T1app should be
expressed in “second” and the perfusion value, f, will need to
be multiplied by 6000 to convert to per 100 g/min.
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Chapter 40
Analysis Protocol for the Quantification of Renal pH Using
Chemical Exchange Saturation Transfer (CEST) MRI
Hahnsung Kim, Yin Wu, Daisy Villano, Dario Livio Longo,
Michael T. McMahon, and Phillip Zhe Sun
Abstract
The kidney plays a major role in maintaining body pH homeostasis. Renal pH, in particular, changes
immediately following injuries such as intoxication and ischemia, making pH an early biomarker for kidney
injury before the symptom onset and complementary to well-established laboratory tests. Because of this, it
is imperative to develop minimally invasive renal pH imaging exams and test pH as a new diagnostic
biomarker in animal models of kidney injury before clinical translation. Briefly, iodinated contrast agents
approved by the US Food and Drug Administration (FDA) for computed tomography (CT) have demon-
strated promise as novel chemical exchange saturation transfer (CEST) MRI agents for pH-sensitive
imaging. The generalized ratiometric iopamidol CEST MRI analysis enables concentration-independent
pH measurement, which simplifies in vivo renal pH mapping. This chapter describes quantitative CEST
MRI analysis for preclinical renal pH mapping, and their application in rodents, including normal condi-
tions and acute kidney injury.
This publication is based upon work from the COST Action PARENCHIMA, a community-driven
network funded by the European Cooperation in Science and Technology (COST) program of the
European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers.
This analysis protocol chapter is complemented by two separate chapters describing the basic concepts and
experimental procedure.
Key words Chemical exchange saturation transfer (CEST), Magnetic resonance imaging (MRI), pH,
Rats, Mice, Iopamidol, Kidney, Contrast agents, pH imaging
1 Introduction
Chemical exchange saturation transfer (CEST) MRI provides a
sensitive means to image microenvironment properties such as
tissue pH, temperature, metabolites, and enzyme activities via
dilute labile protons [1–12]. Endogenous CEST MRI has been
increasingly adopted for imaging a host of disorders including
acute ischemic stroke [13–22], tumor [23–27], and epilepsy
[28, 29]. In addition, CEST MRI contrast agents have been devel-
oped for exogenous CEST imaging that may provide more sensitive
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_40, © The Author(s) 2021
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CEST detection which is specific to the administered agents [30–
34]. This is because the labile proton exchange rate and chemical
shifts can be designed/preselected to optimize these for exogenous
CEST MRI contrast [35–38]. There has been an emerging library
of iodinated-based CEST agents such as iopamidol, iobitridol,
iopromide, and iodixanol, which have been approved by the
U.S. Food and Drug Administration (FDA) for computed tomog-
raphy (CT) head and body imaging applications [39–47]. Such
FDA-approved iodinated contrast agents are promising for transla-
tional CEST imaging to characterize renal dysfunction, diagnose
regional kidney injury before symptom onset, and help guide treat-
ment before irreversible damage [48–50].
Because the CEST MRI effect depends on not only
pH-dependent exchange rates but also on the labile proton ratio,
relaxation rates and experimental conditions such as magnetic field
strength, saturation power, and duration, CEST-weighted MRI
contrast is often complex [51–55]. As such, it remains challenging
to quantify CEST MRI toward tissue indices such as absolute pH
and/or total protein concentration. Persistent progress has been
achieved toward simplified and quantitative in vivo pH mapping
[56–61]. In particular, ratiometric CEST MRI refers to a specific
type of CEST MRI analysis that takes multiple CEST measure-
ments, the ratio of which normalizes common confounding factors
such as tissue labile proton concentration and relaxation effects,
therefore enabling quantitative in vivo CESTmapping [42, 56, 62–
67]. Although pH imaging is more straightforward at high mag-
netic fields (B0  7 T) due to the large frequency shift difference
between labile and bulk tissue water protons, it is important to
extend pH MRI to magnetic fields such as 3 and 4.7 T
[68, 69]. Due to the complexity of the source of the MRI CEST
signal, multiple approaches have been established for a better quan-
tification of the CEST contrast [54, 60]. In this chapter, we
describe variant ratiometric pH CEST MRI analysis techniques,
image down-sampling expedited adaptive least-squares (IDEAL)
fitting algorithm, smoothing splines interpolation algorithm and
use of iodinated CEST agents for mapping renal pH in vivo
[50, 70].
This analysis protocol chapter is complemented by two separate
describing the basic concepts and experimental procedure, which
are part of this book.
This chapter is part of the book Pohlmann A, Niendorf T (eds)
(2020) Preclinical MRI of the Kidney—Methods and Protocols.
Springer, New York.





1. Matlab/Python: The method described in this chapter requires
MATLAB (MathWorks, Natick, MA, https://www.mathworks.
com/products/matlab.html) for data analysis of applying fit-
ting models and measuring ratiometric. Because Matlab func-
tions used in the data processing can also be implemented in
python (https://www.python.org/), python can be used
instead.
2. An image processing software (e.g., Image J, we recommend
using Fiji, which is ImageJ with a wide range of plugins already
included, https://fiji.sc/, open-source), as a practical tool for
the image quality check or to measure SNR.
2.1.2 Optional Tools A statistical analysis software (e.g., SPSS, SPSS Inc., Chicago, IL or







The CEST images can be retrieved directly from the MRI scanner
as raw binary images or in DICOM format (seeNote 1). To be able
to perform CEST analysis different scans are needed:
– Anatomical image (optional).
– Unsaturated image (optional).
– CEST images or Z-spectra.
– CEST images (Z-spectra) before and after contrast agent
(CA) injection for in vivo acquisitions.
Information about some scan acquisition parameters is also
necessary as is the frequency offsets vector.
2.2.2 Background
Removal
In order to avoid the analysis outside the object of interest and to
shorten the analysis duration a first segmentation between the
background and the imaged object is suggested. Manual thresh-
olding or automatic thresholding (as by the Otsu method) can be




If needed, postprocessing motion correction can be applied to
coregister images to correct for motion artifacts.
3.2 Z-Spectra
Analysis
Z-spectra can be analyzed as mean contribution inside one or more
regions of interest, that can be drawn on an anatomical image
reference, or preferentially, by a voxel-by-voxel analysis. Different
approaches for Z-spectra analysis will be described in detail.
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3.2.1 Multi Pool
Lorentzian Fitting
The Z-spectra are numerically described using a multipool Lorent-
zian model [24, 71–74]:





Li ωð Þ ð1Þ
where ω is the frequency offset from the water resonance, N is the
total number of proton pools, and Li is the Lorentzian spectrum of
the ith pool. The Lorentzian lineshape is represented by the fol-
lowing equation:
L ωð Þ ¼ A
1þ 4 ωω0σ
 2 ð2Þ
where A, ω0, and σ are the amplitude, center frequency, and line-
width of the ith saturation transfer effects, respectively.
1. Map B0 inhomogeneity with water saturation shift referencing
(WASSR) using external acquired B0 maps, by field maps or by
interpolation procedures looking to the minimum of the
Z-spectrum (internal B0 mapping) [75–79].
2. Shift CEST MRI Z-spectrum based on the field inhomogene-
ity, per voxel, for correction.
3. Normalize the Z-spectra (iz) by the signal without RF irradia-
tion (M0).
4. Fit the Z-spectrum using a five pool Lorentzian model (two
pools for iopamidol amide groups at 4.3 and 5.5 ppm, one for
bulk tissue water (0 ppm), and two pools for the hydroxyl
groups at 0.8 and 1.8 ppm) [80, 41]. Representative multipool





1. Initially down-sample the B0 field inhomogeneity-corrected
CEST images to one or a few pixels and calculate the global
Z-spectrum by averaging the Z-spectra of all voxel within an
ROI to substantially improve the signal-to-noise ratio (SNR)
for the numerical fitting.
2. Set the boundaries to be between 1% and 100 times of the
initial values for the amplitude and linewidth of each chemical
pool, with their peak frequency shift within 0.2 ppm of the
initial chemical shift. The relaxed boundary constraints ensure
that the initial fitting provides a reasonable estimation of the
multiple Lorentzian pools under the condition of sufficiently
high SNR.
3. Fit the down-sampled image exploiting.
4. Resample the CEST images to 2  2 matrix size.
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5. Take the initial values for the fitting of each voxel of the
resampled image from the results of the previous image with
lower spatial resolution.
6. Set the boundary constraints relatively loose albeit narrower
than the initial fitting, to be 10% and ten times of the initial
values.
7. Use a nonlinearly constrained fitting algorithm with twofold
overweighting applied for Z-spectra between 4.0 and 5.8 ppm
to increase the fitting accuracy of Iopamidol CEST effects at
4.3 and 5.5 ppm.
8. Resample the CEST images, 4  4, 8  8, 12  12, 24  24
until the original resolution of 48 48 or voxel-wise multipool
Lorentzian fitting and repeat from step 5 until you get the
desired final resolution.
9. Figure 2 shows the flowchart of the IDEAL fitting algorithm.
3.2.3 Smoothing Splines
Interpolation
The cubic smoothing splines estimate the interpolating function f,





y j  f x j
 
2 þ 1 pð Þ
Z
D2f tð Þ 2dt ð3Þ
The first addend represents the mean square error between data
yj and the interpolating cubic spline f(xj) calculated in xj measure
Fig. 1 Multipool Lorentzian fitting of representative CEST Z-spectra from a 40 mM iopamidol solution vial with
a pH of 7.0. CEST Z-spectrum obtained from under (a) B1 ¼ 1 μT and (b) 2 μT under body temperature. A five-
pool Lorentzian model was used to describe the CEST spectrum [Adapted with permission from Magnetic
Resonance in Medicine 2018 (A generalized ratiometric chemical exchange saturation transfer (CEST) MRI
approach for mapping renal pH using Iopamidol, Volume: 79, Issue: 3, Pages: 1553–1558, DOI: https:/doi.org/
10.1002/mrm.26817)]
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points. The second term consists of the integral of the squared
second-order derivative of f and is a measure of function flexibility.
p is a smoothing parameter and determines the relative weight
you would like to place on the contradictory demands of having
Raw CEST Z spectra
B0 correction
Define a mask for the image region of
interest (phantom, brain, etc.)
Calculate the global Z spectrum by averaging
the Z spectra of all voxels within the mask
Multi-pool Lorentzian fitting of the global Z spectrum
with loosely constrained bounds to determine
starting points for the fine fitting
B0 corrected Z spectral images downsampled to a
smaller matrix size (DS_Matrix) to achieve higher
spatial SNR for the following voxel-wise fitting
Voxel-wise multi-pool Lorentzian fitting of the downsampled
Z spectral images with starting points determined by previous
fitting results and tightly constrained bounds
Increase DS_Matrix (until it reaches the original matrix
size) and downsample the original B0 corrected Z spectral














Fig. 2 Illustration of the Image Downsampling Expedited Adaptive Least Squares (IDEAL) CEST analysis
algorithm. (a) Flow chart of data processing steps of the IDEAL fitting algorithm. (b) The intermediate fitting
results of iteratively less downsampled images from a two-compartment CEST phantom [Adapted with
permission from Scientific Reports. 2017 (Quantitative chemical exchange saturation transfer (CEST) MRI of
glioma using Image Downsampling Expedited Adaptive Least-squares (IDEAL) fitting, Volume: 7, Issue:
1, Pages: 84, DOI: https:/doi.org/10.1038/s41598-017-00167-y)]
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f be smooth vs having f be close to the data. Its value ranges
between 0 and 1. For p ¼ 1, the curvature constraint is nullified, f
passes for all data points and converges to the interpolating spline,
while, at the other extreme, for p ¼ 0, f curvature is minimized and
f results in a linear least square fit.
1. Normalize pre- and postinjection Z-spectra to the maximum
intensity value of the free water signal, generally corresponding
to the most distant offset or to the unsaturated image
(M0) [79].
2. Interpolate each voxel Z-spectra data with a cubic spline func-
tion paying action to regularization factor selection (see Note
2) and ignoring the background pixels/voxels (in Matlab use
csasp function).
3. Find in the fitted spectra the absolute minimum corresponding
to bulk water frequency offset (in Matlab use fnmin function).
4. Use the minimum position (corresponding to water peak shift
from zero) to correct B0 inhomogeneity shifting the frequency
offsets vector.
5. Save minimum position in a matrix to construct the B0
shift map.
To exclude noisy data points from the analysis a filtration step is
suggested:
6. Construct R2 matrix evaluating the distance of the interpolat-
ing function to data in each pixel.
7. Define a R2 threshold (in our application R2 ranges between
0.97 and 0.99).
8. Ignore pixel for which theR2 value is lower than the threshold.
Smoothing spline algorithm workflow is described in Fig. 3.
3.3 CEST
Quantification
After having fitted the Z-spectra by smoothing splines or Lorenzian
fitting, CEST contrast quantification can be evaluated and ratio-
metric values (ratio between two CEST contrast quantifications to




The CEST ratio (CESTR) is calculated by asymmetry analysis:
CESTR ωð Þ ¼ Mz ωð Þ Mz ωð Þ
M 0
ð4Þ
where ω is the labile proton chemical shift from the bulk water
resonance (for Iopamidol ω ¼ 4.2 ppm and 5.5 ppm). For the
in vivo images, contrast was calculated by subtracting contrast after
CA injection from the contrast before the injection at the different
frequency offsets.
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1. Calculate CEST contrast according to Eq. 4 for the two pools




1. Calculate CESTcontrast from the amplitude obtained from the
Lorentzian fitting according to Eq. 4 for the two pools of




Because the direct saturation is relatively small at the magnetic field
at or above 7 T, the coupling between multiple CEST effects is
relatively small, and a ratiometric analysis of two CEST effects
obtained under the same RF irradiation power level can be calcu-
lated for pH calibration, as
RST pHð Þ ¼ CESTR δ1ð ÞCESTR δ2ð Þ ð5Þ
3.3.4 RF Power-based
Ratiometric CEST Analysis
For CEST agent of a single labile proton group, the conventional
ratiometric analysis does not apply. It has been shown that the
ratiometric analysis can be generalized by taking the ratio of
CEST effects obtained under two RF power levels as [42].
RST pHð Þ ¼ CESTR B1bð ÞCESTR B1að Þ ð6Þ
If the direct water saturation is not negligible, the saturation
effect can be calculated/removed to improve the precision of RF
power-based ratiometric analysis [56, 64].
Fig. 3 Representative z-spectra from in vitro (bottom) and in vivo (top) images showing the analysis steps for
data normalization, smoothing splines interpolation and B0 shift correction (from left to right)
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When CEST MRI is performed at lower magnetic field strengths
(B0 < 7.0 T) or the RF saturation power induces nonnegligible
direct saturation effect, the coupling between multiple CEST
effects (i.e., CEST and direction water saturation) become nonne-
gligible. Under such conditions, the routine ratiometric analysis
(chemical shift- and RF power-based methods) may be susceptible
to the coupling. In addition, the coupling depends on the trans-
verse relaxation rate, which may be the difference between phan-
tom calibration and in vivo experiments. To minimize such
confounding coupling effect, the CEST effect can be decoupled
with the multipool Lorentzian model, and their ratio is more
reproducible and specific to pH. As such, the ratiometric analysis
is generalized to a ratio of CEST effects of different chemical shift
obtained under different saturation power levels.
RST pHð Þ ¼ CESTR δ1,B1bð ÞCESTR δ2,B1að Þ ð7Þ
1. Calculate the ratiometric values following one of the previously
described Eqs. 5–7.
3.4 Set-Up of pH
Calibration Curve
To investigate the relation between the RST value and the pH a
calibration is needed. In the following steps the calibration done for
Iopamidol on a pH varying phantom is described. Two examples of
pH calibration curves obtained at 7 T and at 4.7 T are shown in
Fig. 4.
1. Acquire CEST spectra images of the pH varying phantom;
2. Draw the ROI including only the pH compartment;
3. Evaluate mean CESTR at 4.2 and 5.5 ppm inside each
compartment;
4. Calculate RST;
5. Fit the RST as function of the titrated pH (usually a polynomial
fit of the third order is selected).
It is worth to observe that by decoupling the CEST effects at
4.2 and 5.5 ppm, the generalized ratiometric CEST MRI index
provides an extended range of pH measurement at 4.7 T (Fig. 4b).
Note that such a calibration experiment is important to ensure that
the pH dynamic range is sufficient to cover tissue pH of interest.
The polynomial regression enables the derivation of the absolute
pH map of renal images.
6. From the calculated ratiometric value derives the pH value
according to the used calibration curve.




3.5.1 pH Mapping by
Lorentzian Fitting or IDEAL
Approach
1. Obtain two representative in vivo CEST Z-spectra from a
normal rat (or mouse) kidney during Isovue infusion under
two RF saturation power levels of 1 and 2 μT at 4.7 T as shown
in Fig. 5.
2. Apply the IDEAL algorithm and perform Lorentzian decou-
pling to resolve Iopamidol CEST effects at 4.3 and 5.5 ppm.
3. Outline the renal cortex, medulla, and calyx based on
T2-weighted MRI.
4. Z-spectra are broadened at a higher RF power level due to
more prominent direct RF saturation effect. Notably, the
CEST effect increases from the cortex, medulla to calyx. This
is because pH gradually reduces from the cortex, medulla to
the calyx, which causes a persistent reduction in the Iopamidol
CESTexchange rate. As such, the saturation efficiency increases
when the exchange rate becomes comparable to the saturation
field. In addition, the kidney concentrates and excretes Isovue,
resulting in a concentration gradient across the kidney.
5. Describe the CEST effect by a six-pool Lorentzian model (i.e.,
five-pool model plus semisolid macromolecule magnetization
transfer (MT) effect in tissue). Corresponding parametric
images for CEST contrast and pH mapping in rat kidneys are
shown in Fig. 6.
Fig. 4 Comparison of ratiometric analysis of Iopamidol at high magnetic field of 7 T (a) and at sub-high
magnetic field of 4.7 T (b). Note that the routine RST of 5.5 and 4.3 ppm provides a limited pH MRI range below
pH ¼ 7 due to the CEST MRI effect coupling at high pH. In comparison, the modified approach extends the pH
imaging range to 7.5 [Adapted with permission from Magnetic Resonance in Medicine 2018 (A generalized
ratiometric chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH using Iopamidol,
Volume: 79, Issue: 3, Pages: 1553–1558, DOI: https:/doi.org/10.1002/mrm.26817)]
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Fig. 5 Demonstration of regional CEST Z-spectra of calyx (a, b), medulla (c, d), and cortex (e, f) at 1 and 2 μT,
respectively [Adapted with permission from Magnetic Resonance in Medicine 2018 (A generalized ratiometric
chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH using Iopamidol, Volume:
79, Issue: 3, Pages: 1553–1558, DOI: https:/doi.org/10.1002/mrm.26817)]
3.5.2 pH Mapping by
Using the Smoothing
Splines Approach
1. Import your scans (anatomical image, pre- and postinjection
CEST images) and save them in a matrix.
2. Use cubic spline algorithm to interpolate both pre- and post-
injection Z-spectra as described in Subheading 3.2.3.
3. Use cubic spline interpolated Z-spectra to calculate CESTR at
specific ω (+4.2 and +5.5 ppm for Iopamidol) or/and B1 levels
before and after the CA injection and save CEST contrast
values in a matrix to construct CESTR maps (in Matlab use
fnval function to evaluate interpolating cubic spline values at ω
corrected for calculated B0 shift).
Fig. 6 Demonstration of a renal pH map from a representative rat following Iopamidol injection at 4.7 T. The
resolved maps of ST effects at 5.5 ppm (a) and 4.3 ppm (b) were obtained with the IDEAL fitting algorithm,
from which the ratiometric map was obtained (c). (d) pH map overlaid on the corresponding T2-weighted
image show the renal pH gradually decreasing from the cortex, medulla to calyx
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4. To remove endogenous effects and to isolate contrast agent
contribution, subtract postinjection CEST contrast map to
preinjection CEST contrast map (Fig. 7a, b).
5. Calculate the ratio map ratioing difference CESTcontrast maps
obtained at different ω values (Fig. 7c) or/and B1 levels.
6. Derive pH map from the ratio map using the experimental
calibration curve calculated in Subheading 3.4, step 6
(Fig. 7d).
3.6 Representation The obtained Z-spectra and pH maps can be represented as aver-
aged values in a region of interest (ROI) or as parametric pixel-by-
pixel maps. Before the representation, in order to remove residual
noise, contrast and pHmaps can be filtered, by applying a threshold
Fig. 7 Demonstration of a physiologic renal pH map from a representative mouse following Iopamidol injection
at 7 T. The resolved maps of ST effects at 4.2 ppm (a) and 5.5 ppm (b) were obtained with the smoothing
splines algorithm, from which the ratiometric map was obtained (c). (d) pH map overlaid on the corresponding
T2-weighted anatomical image show the renal pH gradually decreasing from the cortex, medulla to calyx
Quantitative Analysis of Renal pH with CEST-MRI 679
corresponding to the measured signal intensities variability of the
exploited MRI scanner to discriminate between enhanced and
nonenhanced voxels, following CA injection (see Note 3).
1. Select a noise threshold.
2. Set to 0 or to NaN all pixels inside the map for which the
contrast increment is lower than the threshold.
3. Use the anatomical image (or alternatively the first CEST
image) to identify and draw one or more ROIs (in Matlab use
the roipoly function).
4. Create a mask from the ROI(s), a matrix that contains 1 value
inside the region of interest and 0 or NaN values outside.
For representing mean Z-spectra:
5. Calculate mean Z-spectra (pre- and postinjection), ignoring
values outside the ROI.
For representing parametric maps:
6. Represent contrast and pH maps overimposed to the anatomi-
cal image for having a morphological reference.
Representative mean spectra are shown in Fig. 8, whereas
parametric images for CEST contrast quantification and pH values
calculated in rat kidneys at 4.7 T and in murine kidneys at 7 T are
shown in Fig. 6 and Fig. 7, respectively.
3.7 Quantitative
Analysis
Statistics values as mean, median, and standard deviation can be
obtained evaluating maps inside different ROI (cortex, medulla,





The quality of CEST fitting can be evaluated by the following three
methods: (1) coefficient of variation (standard deviation/mean)
within ROI, (2) contrast-to-noise ratio (CNR) between the two
vials in the phantom study calculated by CNR ¼
S1  S2j j=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
σ12 þ σ22ð Þ
p
, where S1, 2 are the mean values for the
two ROIs and σ1, 2 are their standard deviations, and (3) goodness
of fit (R2) maps.
3.8.2 Comparison
with Reference Values from
the Literature
It has been documented that kidney pH values are heterogeneous,
with a gradient from the cortex, medulla to calyx due to filtration
and blood volume difference. MRI-based pH imaging reveals sig-
nificant different pH values among the three layers, with more
neutral pH values (7–7.4) for the cortex region, mild acidic pH
values (6.6–7.0) for the medulla, and acidic pH values for the calyx
(6.3–6.7). Please consider Table 1 for average pH values measured
in specific kidney regions.
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Fig. 8 Demonstration of regional CEST Z-spectra and contrast of calyx (a, b), medulla (c, d), and cortex (e, f) at
3 μT. Described CEST contrast became higher from calyx, trough medulla, to cortex, due to pH variation
Table 1
Typical pH values for each specific renal tissue for healthy mice and rats (literature values)
pH
Field strength, T ReferenceInner medulla Outer medulla Cortex
6.3  0.45 7.0  0.29 7.3  0.13 4.7 [81]
6.6  0.2 6.85  0.15 7.0  0.11 7 [69]
6.5  0.2 6.8  0.1 7.0  0.1 4.7 [80]
6.6  0.1 6.7  0.08 6.8  0.1 7 [49, 50]
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4 Notes
1. Data are stored in the 2dseq file for Bruker scanners or in .img
file for ASPECTMRI instrumentations. In both cases metadata
files (method, acqp and reco for Bruker scanner or dat file for
Aspect systems) need to be read for retrieving all the informa-
tion needed to correctly read the raw binary file. Bruker import
file plugins are available in ImageJ for directly opening raw
Bruker files (for PV5). Matlab-based scripts for importing
Bruker images and for the CEST analysis described in this
chapter can be made available upon sending a request to the
authors (dario.longo@unito.it; mtmcmaho@gmail.com; pzhe-
sun@emory.edu). More information on the software can be
found at the following links: http://www.cim.unito.it/
website/research/research_processing.php http://godzilla.
kennedykrieger.org/CEST/.
2. The choice of the regularization factor plays a key role in
calculating CEST spectra and contrast; in particular, a trade-
off between the “zero” estimation, noise suppression and peak
identification is needed for an optimal choice [78]. Z-spectra
and resulting CEST contrast obtained with different p values
are shown in Fig. 9: when the regularization factor increases,
the flexibility of the interpolating curve increases, yielding
more evident peaks, but at the same time the smoothing of
the raw data decreases. In our application p ranged between
0.90 and 0.99.
3. Signal variations (or fluctuations), as a measure of scanner
instability, can be evaluated by repeating the same CEST acqui-
sition (without saturation) several times (10–100 repetitions)
and then evaluating the oscillation (or standard deviation) of
Fig. 9 Z-Spectra (a) and CEST contrast (b) obtained with different smoothing factors. The contrast decreases
with a decrease of the smoothing factor value
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the average signal along the repetition. Such value can be
exploited to set a threshold for evaluating CEST contrast
increase following contrast agent injection due to the contrast
agent itself and not due to signal oscillation (i.e., it acts as a
detection threshold). Signal fluctuation can be expected to be
less than 0.2–1% with slight constant increase with the age of
the scanner.
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Chapter 41
Analysis Protocol for Renal Sodium (23Na) MR Imaging
James T. Grist, Esben Søvsø Szocska Hansen, Frank G. Zöllner,
and Christoffer Laustsen
Abstract
The signal acquired in sodium (23Na) MR imaging is proportional to the concentration of sodium in a
voxel, and it is possible to convert between the two using external calibration phantoms. Postprocessing,
and subsequent analysis, of sodium renal images is a simple task that can be performed with readily
available software. Here we describe the process of conversion between sodium signal and concentration,
estimation of the corticomedullary sodium gradient and the procedure used for quadrupolar relaxation
analysis.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Key words Magnetic resonance imaging (MRI), Kidney, Rats, 23Na, Sodium
1 Introduction
The signal acquired in sodium (23Na) MR imaging is proportional
to the concentration of sodium in a voxel, and it is possible to
convert between the two using external calibration phantoms. To
calculate sodium concentration maps, an imaging volume including
the tissue of interest and external calibration phantoms is required,
using a gradient echo (GRE) sequence for data acquisition. T ∗2
relaxation maps can be calculated from multiecho GRE data
acquired in the same acquisition. Theoretical considerations and
acquisition protocols are detailed in the chapters by Grist JT et al.
“Sodium (23Na) MRI of the Kidney: Basic Concept” and “Sodium
(23Na) MRI of the Kidney: Experimental Protocol.” Creation of
sodium concentration maps can be performed with several com-
mercially available software packages (see Note 1). In general, a
linear fit is performed between the mean signal intensity of each
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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calibration phantoms and a region of noise. The fitting coefficients
are used to convert sodium signal to sodium concentration. This
chapter focuses on how to do this, conceptually.
This analysis protocol chapter is complemented by two separate
chapters describing the basic concept and experimental procedure,




1. To calculate parameter maps: A programming environment
capable of applying fitting models, such as Python (www.
python.org), Octave (www.gnu.org/software/octave) or
MATLAB (The MathWorks, Natick, MA, USA) with a curve
fitting capability. The method described in this chapter pro-
vides a detailed description for a solution in MATLAB, but can
be adopted to other platforms.






To be able to calculate sodium concentration maps, images includ-
ing sodium calibration phantoms acquired during an experiment
are required, as well as the known absolute concentration of sodium
in the calibration phantoms.
2.2.2 Data Exclusion When sodium imaging is acquired, it commonly has a low signal-
to-noise ratio (SNR). In order to construct accurate sodium T2*
maps, it is important to ensure that the signal of kidneys is greater
than that of the background noise, else a poor fit will occur.
Therefore, data with SNR lower than a threshold (e.g., SNR < 5)
should be discarded.
This step should be avoided for concentration mapping, as a
region of noise is required to calculate an assumed 0mmol/L signal
value.
2.2.3 SNR Check for T2*
Mapping
To check SNR in renal sodium imaging in MATLAB (NB: example
code for SNR measurements assumes a single slice and absolute
value data):
1. Draw an ROI, using the “roipoly” command, over a region of
background noise free of artefacts.
Region = poly2mat(roipoly(mat2gray(image_slice)));
Masked_Region = Region .* image_slice;
2. Calculate the standard deviation of the noise using the “std”
command.
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NoiseSTD = std(Masked_Region(Masked_Region >0));
3. Divide the original image by 0.66 multiplied by the standard
deviation of the noise to produce SNR maps.
Image_SNR = image_slice ./ (sqrt(2)*NoiseSTD);
4. SNR maps can then be used to form a mask to remove signal
less than a predefined SNR value (e.g., 5).
Image_SNR(Image_SNR<5) = 0;
Image_SNR(Image_SNR>1) = 1;
Masked_Image_Slice = Image_slice .* Image_SNR
2.2.4 Dual Flip Angle B1
Mapping for Sodium
Concentration Mapping
Furthermore, if local send and receive RF coils are used, B1
mapping to correct for signal inhomogeneity due to coil profiles





The mean signal from phantoms in the images can be derived using
regions of interest (ROIs). Furthermore, a mean image noise value
should be defined on a slice by slice basis using signal outside of
the body.
Once the mean signal of each phantom, as well as noise, has
been calculated, a linear fit should be performed between the
known concentration values and the phantom/noise signal (assum-
ing noise represents 0 mmol/L sodium).
The coefficients derived from the fit (offset and slope) can then
be used to convert each voxel in the image from signal intensity to
concentration using Eq. 1, below.
Sodium concentration mmolL1






1. Define region of noise on a slice-by-slice basis using either
automated (selecting voxels in a specific region of each image)
or via ROI placement on a slice-by-slice basis.
2. Calculate the mean of each noise region and store this value in a
vector (e.g., meannoise).
3. Segment sodium calibration phantoms using ROIs and calcu-
late the mean signal for each phantom.
4. Perform concentration mapping by calculating a linear fit
between the noise, phantom signals, and the known
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concentrations of the phantoms (example code presented
below) on a slice by slice basis
3.1.2 Example
Matlab Code





Image(:,:,zslice) = (Image(:,:,zslice) - offset)./slope;
End
Example sodium concentration mapping data of the porcine
kidney can be seen in Fig. 1.
3.1.3 Biexponential T2*
Mapping
In order to map the biexponential T∗2 of the kidney (separating the
restricted quadrupolar spins and the freely moving spins), a more
complicated process of signal fitting is required. Utilizing multi-
echo GRE data, acquired in the same imaging acquisition, a non-
linear fitting routine is employed to determine the behavior of the
sodium signal, as described in Eq. 2.
s TEð Þ ¼ a e
 TE
T∗






where a and b are the relative pool sizes, and T∗2,Short and T
∗
2,Long are
the pool T∗2 constants (ms), with the constraints that a + b¼ 1, and
T∗2,Short > T
∗
2,Long. Assuming five or more data sets are acquired, the
following MATLAB code can be used to fit the above curve. An
example fit is shown in Fig. 2.
Fig. 1 Example images of sodium signal in the healthy porcine kidney, acquired
at 3T, demonstrating increase sodium signal in the medulla, in comparison to the
cortex
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3.1.4 Algorithm for T2*
Mapping
1. Perform SNR thresholding as detailed in Subheading 2.2.3.
2. Loop biexponential curve-fitting code (example Matlab code
presented below) over all SNR masked regions in the image.
The fit algorithm used here is trust region reflective.




%% List of echo times acquired during imaging
TE_List = [TE1, TE2, TE3,...];





% Fit curve equation
ft = fittype(’a*exp(-x/b) + (1-a)*exp(-x/c),’coefficients’,
{’a’, ’T21’,’T22’},’independent’,’x’,’options’,fopts);













Fig. 2 Example fit of biexponential data acquired from an agar phantom
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%% Fitting loop core
for zslice = 1:Number_Of_Z_Slices
for yvoxel = 1:Number_Of_Y_Voxels
for xvoxel = 1:Number_Of_X_Voxels
if (Masked_Image_Slice ~= 0)
% Extract data vector for one pixel
Data_Vector = Imaging_Data (xvoxel,yvoxel,zlice,:);
% Do curve fitting for one voxel
[Fit,gof] = fit(TE_List,Data_Vector, ft);
% Store results
ShortPoolSize(xvoxel,yvoxel,zvoxel) = Fit.a;







If data are acquired at higher magnetic field strengths
(B0  3T), it is advisable to alter the pool constraints for the




3.2 Visual Display There is no current consensus on the best colour map to use when
displaying sodium concentration images. T1- or T2-weighted
images acquired in the same slice position can provide guidance
for the interpretation as well as base layer for presenting the images
as a set of fused images, see Fig. 1.
An example display option for MATLAB is described below:
1. Display the parameter map, which is a matrix with floating
point numbers, as an image (in MATLAB: imagesc
(ShortPoolRelaxation)).
2. Remove axis labels and ensure the axis are scaled equally, so that
pixels are square and not rectangular (in MATLAB: axis off;
axis equal;).
3. Select the color map and display a color bar (in MATLAB:
colormap(hot(256)); colorbar;).
4. Set the display range for the color coding, for example, for
short and long T2* [0 5] and [5 60], respectively;
(in MATLAB: caxis([0 5]);).
3.3 Quantification In order to obtain quantitative medulla and cortex values from
sodium concentration maps, the kidney can be segmented using
either concentric objects or semiautomated ROI placement
[1, 2]. To assess the corticomedullary sodium gradient, a linear fit
can be performed across concentration values derived from the
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concentric objects method, providing the slope of the gradient. An
example corticomedullary sodium gradient in both healthy and




with Tissue Values from
Biopsy
Further validation of imaging derived results can be performed
using biopsy derived tissue samples, using methods such as flame
photometry, mass spectrometry, or ex vivo spectroscopy.
3.4.2 Comparison
with Reference Values from
the Literature
If biopsy derived results cannot be obtained, for example due to
longitudinal studies, obtained values for both tissue segmentation
can be compared against reference values, shown in Table 1.
4 Notes
1. Processing is typically performed in software packages such as
MATLAB (The MathWorks, MA) or open source platforms as
python programming language (python.org). The data can either
Fig. 3 Example corticomedullary sodium gradient, healthy (black) and impaired
rodent kidney (orange)
Table 1
Example sodium concentration values from renal compartments, derived
from post-sacrifice kidneys [5]
Tissue type Total sodium concentration (mmol/L)
Cortex 29  7
Outer-medullar 75  20
Inner-medullar 161  29
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be processed as DICOM images or if available as the raw data
format from the scanner (dicomstandard.org/using/cds/). Fina-
lizing thedata in theDICOMformatpipelines thedata for further
analysis and comparison to conventional MRI images.
2. The linear proportionality of theNMR signal to the spin density
allows for the absolute quantification of the Total SodiumCon-
centration (TSC) on the basis of a known concentration refer-
ence. However, TSC measurements are distorted by hardware-
dependent influences and by typical 23Na-NMR properties.
This can be determined and corrected with the help of B1
mapping methods [3]. Mapping methods which allow short
TE are the double-angle and the phase-sensitive method [4].
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Chapter 42
Analysis Methods for Hyperpolarized Carbon (13C) MRI
of the Kidney
Galen D. Reed, Natalie J. Korn, Christoffer Laustsen,
and Cornelius von Morze
Abstract
Hyperpolarized 13C MR is a novel medical imaging modality with substantially different signal dynamics as
compared to conventional 1H MR, thus requiring new methods for processing the data in order to access
and quantify the embedded metabolic and functional information. Here we describe step-by-step analysis
protocols for functional renal hyperpolarized 13C imaging. These methods are useful for investigating renal
blood flow and function as well as metabolic status of rodents in vivo under various experimental
physiological conditions.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Key words Magnetic resonance imaging (MRI), Kidney, Mice, Rats, Hyperpolarization, 13C,
Dynamic nuclear polarization (DNP)
1 Introduction
Hyperpolarized 13C imaging experiments can yield a wide variety of
metabolic, structural, and functional information which is extracted
via analysis of time-varying NMR signals. The choice of analysis
strategy depends on numerous factors, including the imaging
agent, the organ of interest, the acquisition strategy, and imaging
parameter being measured. In general, much of the image-
formation pipelines are nearly identical to those for 1H MRI;
particularly, the steps of Fourier transforming k-space data, recon-
structing under-sampled data using parallel imaging afforded by RF
coil arrays, etc. are nearly identical and will not be discussed in detail
here. Instead, we describe some of the applications more specific to
hyperpolarized 13C data analysis, and we guide the reader through
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
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details and attempt to point out pitfalls. We select a few applications
which will be interesting for researchers studying renal physiology
and function in a preclinical setting, and where available, we point
to links to source code for image processing pipelines.
Beginning at the steps of image formation, there are some key
attributes differentiating hyperpolarized from conventional MRI.
One of the primary differences is the constant depolarization of the
contrast agent during imaging. Image encoding requires radio
frequency (RF) excitation of z polarization that is typically nonre-
newable, meaning it does not recover with T1 relaxation. Instead,
T1 relaxation imposes an exponential decay envelope which
decreases the z polarization over time. In addition to potentially
degrading image resolution, this window has the consequence that
physiological parameters calculated from the time course of image
pixel intensity may be biased, either by RF flip angle (θ) nonunifor-
mity or by influence of relaxation times which are almost never
known precisely beforehand in vivo. In some of the subsequent
examples of this chapter, this effect is accounted for, or it may be
compensated for through the use of acquisition-based signal com-
pensation. However, a thorough error propagation of parameter
estimation is extremely difficult as is the estimation of all ancillary
parameters influencing the measurements. For instance, although
precise flip angle knowledge is key to the estimation of virtually
every parameter measured here, θ is typically estimated using an
external reference phantom during imaging. Furthermore, it is
extremely difficult to map out the transmitter profile due to the
low natural 13C abundance in vivo. In general, the nuances of
hyperpolarized MRI may complicate image processing and could
potentially bias parameters that are calculated from images if not
properly taken into account.
This analysis protocol chapter is complemented by two separate
chapters describing the basic concept and experimental procedure,




There are numerous publicly shared, open-source MRI processing
code written on the MATLAB platform which can be directly
ported to the open source platform GNU Octave. Processing
requiring nonlinear optimization, signal processing, image manip-
ulations, or DICOM reading/writing will require installation of
additional toolboxes. Octave and MATLAB provide excellent pro-
totyping platforms since the file input/output interface for most
vendors’ raw data formats can be found on online repositories or via
the vendor directly. For example, the files for reading the GE P-file
format are distributed with the EPIC software development kit
(SDK) software release via the MR collaboration community portal
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[1]. Within this SDK is the set of MATLAB scripts in the folder
read_MR that may be invoked as
[rawdata, header] = read_MR_rawdata(filename)
Where filename is the name of the raw file (P-file), and rawdata
and header are the parsed outputs. The variable rawdata is parsed as
rawdata(yres, xres, phases, echoes, slices, receivers)
Note that GE P-files are stored on the scanner directory /usr/
g/mrraw. An example 2D Fourier Transform reconstruction of a
single slice, single coil image will look like
singleSliceImage = abs(fftnc(rawdata(:, :, 1, 1, sliceIndex,
coilIndex)));
Aside from vendor-specific items, the vast majority of publicly
shared source code is on a github repository. To interact with this
code base, git should be loaded on your localhost. OnMac, this can
be done with theMacPorts utility (www.macports.org) via terminal
command
sudo port install git
Note that all MacPorts-installed code can be conveniently
updated via the single command sudo port selfupdate. The example
code-base for this book chapter [2] can be cloned from the github
repository by running the following in your terminal:
git clone https://github.com/galenreed/renalC13MRIBook.git
This will clone the repository and create a folder called





Noninvasive determination of perfusion has been of significant
interest in contrast-enhanced MRI and has numerous applications
in oncology and cerebral blood flow mapping. Unlike contrast-
enhanced MRI using gadolinium (Gd) based agents, hyperpolar-
ized 13C images contain no background signal contribution and
thus have the desirable characteristic that their signal intensity is
proportional to the agent concentration. Commonly used hyper-
polarized 13C perfusion targets are [13C]urea [3], [13C, 15N]urea
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[4], bis-1,1-(hydroxymethylcyclopropane-D8) (commonly referred
to as HP001) [5], and [13C]tert-butanol [6]. These molecules
differ greatly in their tissue permeability [7], biodistribution, and
relaxation time-based contrast [4]. Furthermore, the endogenous
nature of many hyperpolarized probes makes them highly attractive
as a potential agent which may be delivered to patients with
impaired renal function. Data for perfusion imaging typically con-
sist of time- and space resolved magnitude images of nonexchan-
ging molecular probes which are acquired with gradient echo
(GRE) or steady state free precession (SSFP) pulse sequences.
Since the initial tissue uptake is an important piece of the curve
for data processing, data acquisition is typically initiated before or at
the beginning of contrast agent injection, and temporal resolution
should be adequate to encode the uptake and washout curves.
In this section, we walk through the processing script exam-
ple_perfusion.m that contains the essential processing elements of





CaðτÞRðt  τÞdτ ð1Þ
for the product of the residue function R(t) and flow rate F. This
model uses the bolus tracking theory which is described in depth in
ref. 8. In this approach, the concentration of the tracer in the tissue
CVOI(t) is modeled as a convolution integral with the arterial input
functionCa(t) and the residue function. SinceCVOI(t) andCa(t) are
measured directly off the time course images, the F∙R(t) can be
estimated via deconvolution. The product F∙R(t) serves as the
tissue impulse response in this framework. The essential steps in
the processing pipeline are as follows:
1. Delineate the arterial pixels. In the example code, a single
coordinate from the center of the artery is stored in the array
AIFPixels with a single index per slice. Note that this proces-
sing script creates a rectangular ROI centered around the pixel
coordinate to reduce noise. The intensity of these pixels is used
as the function Ca(t).
2. Create the matrix A which whose columns consist of Ca(t),
where each subsequent column is translated one time point
(see line 58 in example_perfusion.m and equation 11 in ref. 8).
This is for discretizing the convolution integral in order to
recast it as a matrix multiplication, which can then be inverted
to measure the product F∙R(t). See refs. 8–10 for details
3. Loop through all pixels within the image and create the tem-
poral curve to create CVOI(t)
4. Invert the linear system to estimate F∙R(t). The code example
gives two examples of how to do this: the first uses Tikhonov
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regularization, the second uses singular value decomposition
(SVD)-based thresholding.
5. Compute the maximum of this function to obtain the flow rate,
then normalize by Δt to recast the value in standard mL/mL/
s units.
A few nuances of the computation are discussed. The tissue
residue function R(t) tends to have a monotonically decreasing
shape and is often approximated as a single exponential decay in
model-dependent deconvolution techniques. By definition, R
(0) ¼ 1, since it depends on the cumulative distribution of the
tracer transit times in the tissue. Therefore, the flow F can be solved
for once R(t) is estimated.
F ¼ max FR tð Þð Þ
Δt
ð2Þ
Note that the maximum operation is used rather than taking
the valueR(t¼ 0) to account for possible imaging/infusion delays.
Hyperpolarized 13C images are proportional to the concentration
which simplifies the estimation ofCvol(t) and Ca(t) since they can be
directly measured from image ROIs. However, the polarization
level constantly decreases post injection, so the signal proportion-
ality is not constant over time. To compensate this effect, R(t) has
been modelled as a product Rt(t)P(t), where Rt(t) is the true
residue function and P(t) is an exponential decay which models
the T1 decay and RF depolarization [9]. Alternatively, an
acquisition-based compensation using progressively increasing flip
angles on subsequent time-points can be used to offset this signal
decay over a fixed horizon [10]. As ref. 8 points out, it is highly
important to handle noise amplification in this inversion by using
techniques such as singular value decomposition- (SVD) based
thresholding or regularization. Figure 1 shows the effects of Tikho-
nov regularization on the calculated flow images and highlights its
importance. When no regularization is used, the estimated F∙R(t)
product shows large oscillations over the time course. Adding
regularization not only smooths the time-course curve but also




Preliminary measurements of NMR relaxation times (T1 and T2) of
hyperpolarized 13C contrast agents show interesting in vivo renal
tissue contrast. The T2 of [1-
13C]lactate after injection of hyperpo-
larized [1-13C]pyruvate has been shown to increase in tumor
regions in preclinical models [11]. The T2 of [
13C, 15N]urea has
been shown to greatly increase in the rat kidney [4], and this signal
change has been linked to the glomerular filtration process
[12]. Anatomically, an inward, cortex-to-medulla T2 gradient is
observed. This gradient becomes disrupted in diabetic nephropathy
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[13] as well as in ischemic injury [14]. T2 mapping is performed on
magnitude images which are spatially and echo-time-resolved.
Acquisitions are based on multiple spin-echo acquisitions that
must be specifically tailored to the hyperpolarized experiment. To
best utilize the nonrenewable magnetization, acquisitions start
with a 90 excitation followed by a train of spin echo RF pulses
and encoding gradients. Hyperpolarized 13C T2 values reported in
the literature are long compared to those of 1H, ranging from
hundreds of milliseconds to several seconds. The effective T2
measured can have some dependence on the inhomogeneity of
the transmit field (B1
+), but the dependency is not strong unless
the deviation from 180 is very large [12].
Modeling multiexponential T2, decay in NMR signals is typi-
cally performed by matching the signal to an expression of the form





Fig. 1 Estimating blood flow from dynamic hyperpolarized [13C]urea images of a rat kidney. The top and
bottom panels show the problem solved with and without using regularization. The blood flow maps (left) are
calculated from solving the deconvolution of the arterial input function (AIF) and the tissue uptake curves
(center). Note that there is a dip in the AIF due to a chase infusion of saline. The curves on the right highlight
the need for some degree of regularization. The top solution, derived without regularization, shows large-
amplitude fluctuations, while the bottom curve, derived with regularization, shows a much cleaner curve more
closely resembling an exponential decay. Regularization does slightly decrease curve fit/data consistency; this
can be seen on the orange curves in the center plot, where the regularized curve (bottom) deviates slightly
more from the nonregularized curves (top). However, it generally produces cleaner images with reduces noise
sensitivity
702 Galen D. Reed et al.
where S0 is a bias term, ai is the signal amplitude of the ith T2
component, and T2,i is the decay time constant. Typically, ai and T2,
i are all unknown beforehand and must be solved for. If SNR is
sufficiently high, the bias term can be ignored. The T2NNLS algo-
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Note that this is a standard problem of the form
y ¼ Ax ð5Þ
where the matrixA is constructed from selecting m logarithmi-
cally spaced T2 values from within a defined range, then computing
an idealized T2 decay curve sampled at each acquired echo time.
These idealized single-exponential decays constitute the columns of
the A matrix. The column vector x contains the amplitudes which
are solved for, and y contains the measurements. Equation 5 is
solved for using regularized, nonnegative least squares.
argmin
x
Ax  yk k2 þ λ xk k2 ð6Þ
Similar to the perfusion measurement, the use of the L2 norm
for the regularization term is required as detecting multiple T2
values that are different but close in value can be exceedingly
susceptible to noise amplification.
In the example script example_t2nnls.m, the following steps are
used to demonstrate the T2 nonnegative least squares algorithm on
rat kidney data:
1. Reconstruct spatially and echo-time-resolved magnitude
images.
2. Is spatial resolution is sufficient to resolve respiratory motion,
an image alignment via rigid translation may be applied [12].
3. Create a list of echo times (TElist in the script) corresponding
to the TE of each image.
4. Create a T2 axis which is a vector of logarithmically spaced T2
values spanning the expected solution range.
5. Create the matrix A from Eqs. 4 and 5 as is performed in the
script t2nnls.m (where the matrix is stored as the variable
T2DecayMatrix).
6. Extract signal intensity of a single pixel over TEs (S(TE)1. . .S
(TE)n).
7. Compute the best fit solution S(T2). This function can be
created at each pixel. Figure 2 shows example S(T2)
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distributions calculated from a single pixel within the kidney
calculated differing values of the regularization parameter.
8. S(T2) can be treated as a spectrum, so the signal intensity within
some given T2 bounds may be integrated to find the intensity
within that range. Alternatively, the expectation value hT2i can
be calculated by treating S(T2) as a probability distribution
function and computing moments. This is demonstrated in
Eq. 2, ref. 16 for estimating water content in vivo.
Fig. 2 Multiexponential analysis of a hyperpolarized T2 mapping experiment. Left: coronal [
13C, 15N]urea
image of a rat at the earliest echo time (500 ms). Right, top: T2 decay curve from a single pixel inside the
kidney. Right, bottom: multiexponential analysis using the T2NNLS algorithm. Using L2 regularization penalty
causes broadened peaks in the T2 spectrum. Note that bias offsets are captured as signal at the high
extremum of the T2 domain. Hyperpolarized [
13C, 15N]urea images of the rat kidney show two distinct decay
modes representing the vascular and renal filtrate pools of the contrast agent




A key component of renal function is the glomerular filtration rate
(GFR), and nearly all hyperpolarized 13C probes are sufficiently
small to be freely filtered at the glomerulus. Molecules which are
metabolically inert, not appreciably reabsorbed in the nephron, and
have T1 values sufficiently long to be detected in the renal medulla
may be good targets for GFR measurement. Although urea is
reabsorbed to some degree, there is a strong appeal of using this
molecule as a hyperpolarized GFR marker due to its extremely low
toxicity. Data for GFR estimation are spatially and temporally
resolved magnitude images with spatial resolution sufficient to
resolve the renal cortex from the medulla and temporal resolution
sufficient to trace the medullary uptake curve with several data
points. Since the current example uses data only from the uptake
phase, the effects of transmitter-based depolarization are likely
small.
GFR estimation using hyperpolarized 13C imaging has been
demonstrated by retrospectively processing datasets using the Bau-
mann–Rudin model [17]. This technique was originally developed
for measuring renal clearance of Gd agents in rats [18] and uses the
time-varying signals from the renal cortex (Ccortex) and medulla
(Cmedulla) to estimate an effective exchange rate.
dCmedulla
dt
¼ KCcortex tð Þ: ð7Þ
Here the constant K represents the one-way exchange rate
from cortex to medulla. Although one-way exchange is an invalid
assumption for probes that are reabsorbed, the model is assumed to
hold true in the initial uptake phase. Solving Eq. 7 analytically
requires initial conditions for the concentration variables which,
therefore, requires an additional arterial input model parameter. To
avoid this computational complexity, this model can instead be
solved algebraically by normalizing the mean slope (dCmedulla/dt)
during the uptake phase by the mean cortex signal and scaling by
the medullary volume [19]. The script example_GFR.m demon-
strates the following steps for calculating GFR from a dynamic set
of [13C]urea images
1. Time-dependent, magnitude images are reconstructed.
2. The renal cortical and medullary ROIs are delineated, and a
mean taken over these ROIs is used to create Cmedulla(t) and
Ccortex(t).
3. The initial uptake period of the time domain is isolated (upta-
keInds in the script).
4. A linear fit is performed on Cmedulla(t) to estimate its slope
dCmedulla
dt during the uptake period. These curves and the slope
estimates are shown in Fig. 3.
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5. The parameter K from Eq. 7 is estimated via K ¼
dCmedulla
dt =hCcortexðtÞi, where hCcortex(t)i is the mean value of
Ccortex(t) during the uptake phase.
6. The GFR can then be estimated as GFR¼K∙Vmedulla∙60, where




The estimation of the metabolic flux from a hyperpolarized sub-
strate to some metabolic products which are distinguished from the
substrate via chemical shift is a topic of paramount interest. The
metabolic conversion of hyperpolarized 13C substrates can be an
extremely complex process. For instance, the conversion of hyper-
polarized [1-13C]pyruvate to hyperpolarized [1-13C]lactate
depends on arterial input to the tissue, the monocarboxylate
transporter-mediated transport into the cell where the substrate
undergoes a Michaelis–Menten exchange with lactate. Therefore,
the net conversion of the substrate depends not only on the rate of
each transport step but also the availability of the enzyme and
Fig. 3 Estimating glomerular filtration rate from dynamic [13]C urea images of a rat. The top frame shows
every other time point of the acquisition, and the bottom plot gives the uptake curves from the renal cortex and
medulla. The yellow trace shows the best linear fit of the medulla signal during uptake; the rate from this fit is
used for GFR estimation
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cofactor, and the size of the steady-state lactate pool [20]. Using
hyperpolarized 13C NMR to capture this effect requires fitting
signal amplitudes of data acquired from a spectroscopic readout.
The data may be spatially resolved, but frequently a “slice dynamic”
acquisition is used which greatly simplifies setting up the acquisi-
tion protocol and maximizes the probability of detecting low SNR
metabolic products. A typical in vivo experiment will acquire a
spectrum over 1–10 kHz sweep width using a slice selective pulse,
and this acquisition is repeated until the polarization is presumed to
be depleted. This type of acquisition gives data of the form S( f,t),
where f is the Fourier transform of the FID domain, and t is a
variable proportional to the number of repetitions. The substrate
and products have time-dependent signals S(t) and P(t), respec-




¼  kSP þ 1T 1,S
 
S tð Þ þ kPSP tð Þ þ u tð Þ, ð8Þ
dP tð Þ
dt
¼  kPS þ 1T 1,P
 
P tð Þ þ kSPS tð Þ ð9Þ
where T1,S and T1,P are the spin lattice relaxation times of the
substrate and product, respectively, kSP and kPS are the forward and
reverse rate constants, and u(t) is a function that models substrate
delivery to the tissue. A frequently made simplification made when
modeling conversion of [1-13C]pyruvate to [1-13C]lactate is to
assume both molecules have nearly identical relaxation times (T1,
P ¼ T1,S) and that no significant backward flux occurs during
measurement (kPS ¼ 0). This reduces the number of unknowns to
be fitted from 4 to 2 and greatly improves the noise conditioning of
the problem.
Typical steps in processing 2D, slice-dynamic spectroscopy and
estimating metabolic conversion metrics are summarized here:
1. Raw spectra are typically apodized in the spectral domain using
a filter matched to the T2* of the compound (on the order of
50–500 ms) to reduce noise.
2. Apodized spectra are Fourier transformed along the FID axis
giving spectra of the form S( f,t, coils).
3. If data are displayed in magnitude, then a sum-of-squares over
the coil axis may be performed giving |S( f, t)| Phase sensitive
detection may be used, but it requires phasing each channel
individually before combination. Although phase-sensitive
processing adds complexity, it simplifies detection of
low-SNR metabolites, and may reduce contamination of large
amplitude resonance on neighboring peaks due to apparent
line-narrowing.
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4. A further de-noising step may be performed on the 2D |S( f, t)|
data by using SVD-thresholding [21]. This step can be moti-
vated by subsequent processing steps which can greatly
enhance noise if poorly conditioned.
5. The peak amplitudes are then tracked over time to generate 1D
curves of substrate S(t) and product P(t). This may be per-
formed by taking the maximum value or integrating over a
small frequency band.
6. A flip angle correction may be applied to account for
RF-induced depolarization, but this requires accurate knowl-
edge of the flip angle applied at each time point (see ref. 22 for
an in-depth treatment of this topic).
7. Estimating the forward rate constant kSP requires fitting the
experimental data to the kinetic models such as those given in
Eqs. 8 and 9. However, a frequently applied model free analysis
of Hill et al. vastly simplifies the analysis of hyperpolarized
metabolic kinetic data [23]. The model free approach is based
on the fact that integrating S(t) and P(t) over time and taking
their ratios gives a value proportional to this rate constant, so
no deconvolution or curve fitting is required. This model free
approach is simply implemented by taking the area under the
curve (AUC) of the product and normalizing this value to the
AUC of the substrate (see Fig. 4, right, for example traces of
such an experiment).
8. For a more detailed treatment, the readers are referred to the
open source hyperpolarized MRI toolbox scripts from UCSF.
Fig. 4 Left: a typical slab-dynamic spectroscopy acquisition on a 3T scanner captures the conversion of
[1-13C]pyruvate (large peak on resonance) to [1-13C]lactate (left, at 390 Hz) and [13C]bicarbonate. Right: the
traces of these three metabolites over time generated by integrating over the line width at each point. A simple
measure of metabolic flux can be derived from these traces by taking the area under the curve (AUC) of a
metabolic product and dividing it by the AUC of the substrate
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A review paper covers the topics of kinetic modeling in great
detail [22]. This toolbox can be cloned via git clone https://
github.com/LarsonLab/hyperpolarized-mri-toolbox.git
9. Within this toolbox, the subfolder kinetic_modeling contains
numerous scripts for fitting kinetic curves with a variety of
options. See example_exchangeModel.m for a sample invoca-
tion of the main wrapper function fit_kPL() in the toolbox.
3.5 Results
Validation
Most of the analysis methods outlined here will output values in
physical units, so cross referencing measurements with values
quoted in the literature is the chief method for validation of results.
For instance, renal blood flow measurements in the range
4–10 mL/mL/min have been reported using hyperpolarized con-
trast agents [17]. Preliminary results show hyperpolarized-MRI-
derived GFRmeasurements in the range of 2–3 mL/min for the rat
kidney which are in close agreement with GFRmeasured with other
modalities. A wider variation of relaxation times has been reported.
For instance, [13C, 15N]urea T2 values have been reported ranging
from 400–800 ms to greater than 4 s [12, 13]. A further study is
required to elucidate the influence of acquisition on the variance of
findings in the literature.
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Chapter 43
Data Preparation Protocol for Low Signal-to-Noise Ratio
Fluorine-19 MRI
Ludger Starke, Thoralf Niendorf, and Sonia Waiczies
Abstract
Fluorine-19 MRI shows great promise for a wide range of applications including renal imaging, yet the
typically low signal-to-noise ratios and sparse signal distribution necessitate a thorough data preparation.
This chapter describes a general data preparation workflow for fluorine MRI experiments. The main
processing steps are: (1) estimation of noise level, (2) correction of noise-induced bias and (3) background
subtraction. The protocol is supplemented by an example script and toolbox available online.
This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network
funded by the European Cooperation in Science and Technology (COST) program of the European
Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This
analysis protocol chapter is complemented by two separate chapters describing the basic concept and
experimental procedure.
Key words Magnetic resonance imaging (MRI), Fluorine, Data preparation, Mice, Rats
1 Introduction
Fluorine-19 (19F) MR methods have found their application in a
wide range of biomedical research areas including renal imaging [1–
8]. The sensitivity constraints, low signal-to-noise ratio (SNR) and
sparse signal distribution typical of fluorine-19 MRI necessitate a
thorough data preparation. The main processing steps are: (1) esti-
mation of noise level, (2) correction of noise-induced bias and
(3) background subtraction. While variations on this theme are
common in fluorine MRI studies, a standardized method of data
preparation and analysis with well-documented implementation
will improve accuracy and reproducibility of reported results.
Estimating the noise level is a prerequisite for all subsequent
processing steps. Assuming data from a single channel RF coil, the
signal in MR magnitude images follows a Rician distribution
[9, 10] (see Note 1 for information on multichannel RF coils). At
SNR > 10, this distribution closely resembles a Gaussian
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1_43, © The Author(s) 2021
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distribution. Yet, when analyzing low SNR fluorine MRI data, its
diverging properties need to be taken into account. The MRI
magnitude signal is computed from complex data, which contain
signal with positive and negative values, and is corrupted by zero
mean Gaussian noise. Mapping positive and negative signals to the
positive magnitude results in a pronounced upward bias at low
SNRs. Additionally, the standard deviation of the measured signal
is reduced (Fig. 1a). To ensure accurate measurement of signal
intensities, the noise-induced bias must be corrected. It is also
essential to consider the signal level-dependence of the measured
standard deviation for correct noise level estimation.
Background subtraction is the process of classifying image
voxels as either signal or noise. Most fluorine MRI studies are
dealing with signals that are close to the detection threshold; in
this case the background subtraction method strongly influences
the sensitivity of the measurement and most importantly the reli-
ability and reproducibility of the obtained results. Ideally, reporting
of the used background subtraction method should include the
expected false positive rate (FPR).
In this chapter we present a data preparation protocol for low
SNR fluorineMRI data (Fig. 2). An open source toolbox is used for
bias correction (Fig. 2b) of the magnitude data (Fig. 2a). We
expand upon the common method of SNR-based thresholding
[2, 4, 11] (Fig. 2c) by proposing an additional outlier removal
processing step (Fig. 2d). The shown example is based on a dataset
with fluorine nanoparticle labeled immune cells showing the sites of
inflammation in a mouse model of multiple sclerosis (see Setup 4 in
Starke et al. [12] for details). The data preparation protocol is
equally applicable to low SNR 19F MRI of the kidney.
A self-contained script reproducing Fig. 2 and illustrating the
data preparation step-by-step, from noise level estimation to gener-
ation of a proton/fluorine-19 overlay is provided online together
with the example data.
This analysis protocol chapter is complemented by separate
chapters describing the basic concept and experimental procedure,




The processing steps outlined in this protocol require:
1. A software development environment. The provided code
examples follow the syntax of MATLAB® (The MathWorks,
Natick, Massachusetts, USA; mathworks.com) and Octave
(gnu.org/software/octave). The code could also be adapted
for other scientific software development environments like
Python (python.org/) or Julia (julialang.org/).
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2. A MATLAB / Octave tool for noise bias correction download-
able from github.com/LudgerS/MRInoiseBiasCorrection.
This tool includes detailed documentation to facilitate adapta-
tion for other software development environments or use with
multichannel RF coil data.
3. A collection of data preparation specific MATLAB / Octave
subfunctions found under github.com/LudgerS/
19fMRIdataPreparation. It is provided together with a script
Fig. 1 (a) Mean measured signal and mean measured standard deviation (std.) of MR magnitude data. σ
denotes the signal level independent standard deviation of the Gaussian noise in the underlying complex data.
(b) The size of the used background region determines the uncertainty of the standard deviation estimate. The
relative standard error (SE) shown here is defined as the standard deviation of the standard deviation estimate
divided by σ itself. Note the logarithmic scale of the x-axis. (c) Histogram of simulated Rician data for true
signal ¼ 3σ (blue). The corrected data was computed using the tool described in Subheading 3.3 (red). The
circles and bars indicate the mean and standard deviations of the two distributions. (d) Expected false positive
rate (FPR) for different SNR thresholds with and without outlier detection. The FPR is defined as number of
false positive voxels divided by number of true negative voxels. Without outlier detection background
subtraction is performed by simple thresholding. The expected FPR can be computed by the steps in Note
5. Outlier detection is performed by removing all groups of less than three connected signal voxels after SNR
based thresholding. In 2D 8-connectivity is used and in 3D 18-connectivity. Here simulated data is shown
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Fig. 2 Example analysis for fluorine-19 MRI data acquired in a mouse model of multiple sclerosis. Immune
cells were labeled in situ with fluorine-19 nanoparticles such that fluorine signal shows sites of inflammation.
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collecting all processing steps of this protocol as well as an
example dataset allowing the reproduction of Fig. 2.
4. The MATLAB Image Processing toolbox is needed to run the
function fluorineOverlay.m which creates proton/fluorine
overlays and is part of the aforementioned 19fMRIdataPre-
paration repository.
5. A tool for data import. This tool will depend on the data
format:
DICOM data—MATLAB contains a built-in function to
import dicom data: dicomread. For Octave, Python and Julia,
dicom support is offered by supplemental packages (octave.
sourceforge.io/dicom/, pydicom.github.io/, github.com/
JuliaIO/DICOM.jl).
Bruker data—Bruker also offers a toolbox to import data
into MATLAB directly. To obtain Bruker0s pvtools, contact




These steps should be executed for both the fluorine MRI data and
the noise scan data. In the following sections it is assumed that the
fluorine data was stored in variable imageData and the noise scan
in variable noiseData.
3.1.1 DICOM Data 1. To import dicom data execute the command
data = dicomread(‘filePath’);
where ‘filePath’ is a string containing the relative or
absolute path of the .dcm file.
3.1.2 Bruker Data For a Linux or MacOS system, substitute the file separator \ by /.
1. Ensure that pvtools is on the search path:
addpath(genpath(‘. . .\pvtools’))
where ‘. . .\pvtools’specifies the path of the pvtools
folder.

Fig. 2 (continued) Acquisition parameters: 2D-RARE, ETL ¼ 32, [20  20] mm2 FOV, 128  128 matrix,
3.2 mm slice thickness. The noise level was determined from a corresponding noise scan. Details regarding
the animal model and acquisition can be found in Starke et al. [12] under Setup 4. (a) Fluorine-19 MRI
magnitude data. (b) Data after application of the Rician noise bias correction. (c) Thresholding was performed
at SNR¼ 3.5. (d) Removal of groups of<3 connected pixels. (e) Overlay of the fluorine data on an anatomical
image
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2. Store the path to the scan you want to load in variable
scanFolder.
3. Read the visu_pars parameter file:
visuPars = readBrukerParamFile([scanFolder, ’\visu_pars’]);
4. Load the Paravision reconstruction:




There are vendor-specific conventions regarding the averaging of
multiple image acquisitions. In some cases, for example in Bruker
data, the individual acquisitions are simply added instead of com-
puting the mean. To ensure comparability between different scan
times, determine the employed convention (see Note 2) and if
necessary divide the data by the number of averages. This proces-
sing step will be required if a pure noise scan has been employed to
determine the noise level.
1. Assuming nAverages is the number of averages acquired for





The amount of random variation in MR magnitude images, as
measured by the standard deviation, is signal level dependent
(Fig. 1a). By convention, the noise level is reported as the asymp-
totic standard deviation at high SNR, which we denote by σ
[13, 14]. This value is equal to the standard deviation of the
Gaussian noise in the underlying complex data. While a larger
number of noise level estimation methods has been proposed
[13], two are of practical relevance for fluorine MRI: estimation
based on a background region, which is known to be without
signal, or estimation based on a dedicated pure noise scan.
Although the former yields adequate results for most applications,
we strongly recommend the use of a noise scan due to its indepen-
dence of user input and improved accuracy. The uncertainty of the
standard deviation estimate depends on the number of samples n.
For n > 10, we can approximate the standard error as SEσ  σffiffiffiffi2np
(Fig. 1b) [15].
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3.3.1 Estimation Based
on a Background Region
The largest possible background region free of major signal artifacts
should be used to improve accuracy (also see Note 3). However,
point spread function artifacts can corrupt image regions even distal
from signal features without being necessarily visible (Fig. 3a). We
recommend using quadratic regions in all four corners of the
image.
1. Create a mask of the background region for logical indexing
backgroundMask = createBackgroundMask(size(imageData),
cornerSize);
The argument size(imageData) determines the dimen-
sions of the mask and cornerSize sets the size of the four
corners (Fig. 3b).
2. The noise level can then be computed as
sigma = std(imageData(backgroundMask))/0.6551;
where the factor 0.6551 accounts for the ratio between the
background standard deviation and σ (Fig. 1a) [13]. It needs to
be adjusted for data from multichannel RF coils (see Note 4).
3.3.2 Estimation Based
on a Noise Scan
In this case the complete noise image constitutes the background
region. It is not necessary to acquire the noise scan with multiple
averages, as the dependence of the noise level on the number of
Fig. 3 (a) Point spread function artifacts can corrupt background regions without being visually obvious. In this
water phantom example, the RARE image with echo train length 8 (ETL ¼ 8, top left) does not show artifacts.
However rescaling (bottom left) shows that a noise level estimate based on a background region would lead to
erroneous values if the region is not chosen just in the corners of the image. The example on the right
(ETL ¼ 32) shows an exaggerated case where the effect is obvious in the image itself. (b) The red regions
show a background mask that would yield reliable values for the example shown in Fig. 2
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averages is well understood mathematically (see Note 5 for further
comments on noise scan acquisition).
1. If the noise scan was acquired with a single average and the
number of averages of the image data is given by nAverages,
the noise level can be computed as
sigma = std(noiseData(:))/(0.6551*sqrt(nAverages));
3.4 Bias Correction Rician noise leads to a systematic upward bias in MR magnitude
images at low SNR. Signal intensities need to be multiplied with a
correction factor<1 to achieve correct signal estimation on average
(Fig. 1a, c). While the expected measured signal E[M] for a given
true signal levelA and noise level σ is known, there is no established
inverse functionA(E[M], σ) [9, 10, 14]. The provided toolbox thus
uses a lookup table to compute the correction factor [9]. Signal
intensities below the mean background level are set to zero
(Fig. 1c). Alternatively, the correction scheme of Koay and Basser
could be used [14]. See Note 6 for a comment on averaging over
regions of interest (ROIs).
1. After determining the noise level, the corrected image (Fig. 2b)
can simply be computed as
correctedImage = correctNoiseBias(imageData, sigma, 1);
where the last argument specifies the number of receive
elements in the RF coil (see Note 1).
3.5 Background
Subtraction
In fluorine MRI, background subtraction commonly involves
thresholding by removing all voxels below a certain SNR
(Fig. 2c). However, the threshold necessary to prevent the occur-
rence of false positives could compromise sensitivity, especially for
larger datasets such as those from 3DMR data (Fig. 1d, seeNote 7
for an analytical formula). Based on the assumption that all relevant
fluorine features should at least comprise a minimum of three
connected voxels, we recommend an additional outlier correction
that excludes isolated voxels (Fig. 2d). To determine features with a
minimum of three connected voxels, we recommend to use
8-connected neighborhoods (connection via edges or corners) for
2D images and 18-connected neighborhoods (connection via faces
or edges but not corners) for 3D images. This additional processing
step drastically reduces the expected FPR. In the 2D case, for
example, thresholding at SNR ¼ 2.74 with outlier detection
reduces the FPR to the same level as thresholding at SNR ¼ 4
without outlier detection (Fig. 1d).
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1. Copy the bias corrected image to a new variable
thresholdedImage = correctedImage;
2. Set all voxels below the chosen threshold snrThreshold to
zero
thresholdedImage(thresholdedImage < snrThreshold*sigma) = 0;
3. Then apply the provided function for outlier removal on the
thresholded image:
cleanedImage = removeIsolatedVoxels(thresholdedImage, 3);




In order to locate the source of fluorine signal within an in vivo
context, it will need to be coregistered with an anatomical image.
While it might be appealing to overlay transparent fluorine images
to avoid concealing of anatomical detail, we advise against this
practice for quantification purposes, as manipulation of the data
will result in ambiguous readings. If no external standard is used to
determine fluorine concentrations, it is best practice to show the
fluorine signal in terms of the SNR as this also conveys a standard
means of information. For the provided function the anatomical
image should be acquired with the same field of view as the fluorine
MR image.
1. An overlay of fluorine on proton MR images (Fig. 2e) can be
achieved simply by calling
fluorineOverlay(anatomyData, cleanedImage, colorMap, resi-
zeF, fileName)
anatomyData is the anatomical image, colorMap speci-
fies the fluorine color map in the conventional MATLAB for-
mat, resizeF is a factor by which the image size is increased to
ensure faithful display and fileName the file name of the saved
image.
2. To complement the fluorine image with a corresponding color
bar (Fig. 2e) execute
plotFluorineColorBar(colorMap, fileNameCB, max(cleanedImage
(:))/sigma, ’Fluorine-19 SNR’)
fileNameCB states the path and file name of the saved
color bar image. The third argument specifies the range of the
color map. Dividing the maximum of the fluorine image by σ
establishes the SNR scaling. The fourth argument determines
the label of the color bar.
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4 Notes
1. In the case of multichannel RF coil data and sum-of-squares
reconstruction, the MR signal follows a noncentral chi distri-
bution instead of a Rician distribution. This case is described
thoroughly in Constantinides et al. [16]. The bias correction
toolbox used in this protocol also handles the more general
case. It should be noted that the bias effects become more
pronounced with increasing number of receive elements.
2. To determine the employed convention of averaging, acquire
high SNR phantom data with varying numbers of averages
while keeping all other parameters fixed. Import the data as
described in Subheading 3.1. If all scans show the same signal
magnitude, the scaling step described in Subheading 3.1
should be omitted. However, if, for example, doubling the
number of averages also doubles the signal amplitude, rescaling
should be performed.
3. Be aware that some vendors include heavy filtering and/or
background masking into the automated reconstruction pipe-
line. This has a major impact on the background noise or sets
background values to zero and hence renders estimation based
on a background region not suitable for noise assessment.
4. Assuming a sum-of-squares reconstruction, the factor 0.6551
should be replaced by 0.6824, 0.6953, 0.7014 or 0.7043 for
2, 4, 8 or 16 receive element RF coil data [16].
5. A pure noise scan is acquired by setting the excitation flip angle
and reference power to zero so that no excitation occurs and
pure noise is acquired. The receiver gain needs to be set identi-
cal to all other scans for which the noise level should be
determined. The number of averages can be reduced to one,
as the resulting change in noise level is easily compensated.
Instead of setting the reference power to zero in preparation
of the noise scan, the output of the RF power supply can be
disconnected following the system adjustments.
6. In a background region without true signal, the Rice distribu-
tion reduces to the Rayleigh distribution [10], which is equiv-
alent to a chi-squared distribution. Thus the expected FPR can
be computed via the cumulative distribution function of the
chi-squared distribution. First calculate the expected signal
[17] for the chosen SNR cutoff snrThreshold
thresholdExpectation ¼ sigma  sqrt(pi/2)  laguerreL
(1/2,0,-snrThreshold.^2./(2  sigma^2)).
Then calculate the expected FPR as
FPR ¼ 1  gammainc((thresholdExpectation/sigma)^2/
2, 1, ‘lower’).
This formula is valid for simple thresholding without out-
lier removal and data from single receive element RF coils.
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7. Often fluorine-MRI studies involve calculating signal-to-noise
ratios for specific regions of interest (ROIs). Averaging over all
pixels in the region should be performed before applying the
noise bias correction. This is particularly relevant for phantom
studies where the number of voxels in the assumed to be
homogeneous ROI is large enough to obtain accurate values
even for regions with SNR < 2. See Note 8 for a comment on
the uncertainty of SNR estimates.
8. SNR is conventionally reported as the bias corrected signal
level divided by the asymptotic standard deviation σ
[14]. The uncertainty of the SNR estimate is determined by
the signal level, the size of the ROI and the uncertainty of the







, where m denotes the number of voxels
in the ROI and n the number of voxels in the background
region used to estimate the noise level. At high SNRs the
uncertainty of the SNR estimate is dominated by the uncer-
tainty of the noise level estimate.
Derivation: The standard errors of the mean ROI signal S
and noise level σ are SES ¼ σffiffiffimp and SEσ  σffiffiffiffi2np [15]. Assuming
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Schwitter J, Stuber M (2012) Fluorine-19
magnetic resonance angiography of the
mouse. PLoS One 7(7):e42236
12. Starke L, Pohlmann A, Prinz C, Niendorf T,
Waiczies S (2019) Performance of compressed
sensing for fluorine-19 magnetic resonance
imaging at low signal-to-noise ratio conditions.
Magn Reson Med 84(2):592–608
13. National Electrical Manufacturers Association
(2001) Determination of signal-to-noise ratio
(SNR) in diagnostic magnetic resonance imag-
ing. NEMA standards publication MS 1-2001.
NEMA, Arlington, VA
14. Koay CG, Basser PJ (2006) Analytically exact
correction scheme for signal extraction from
noisy magnitude MR signals. J Magn Reson
179(2):317–322
15. Ahn S, Fessler A (2003) Standard errors of
mean, variance, and standard deviation estima-
tors. EECS Department, The University of
Michigan, Ann Arbor, MI. http://web.eecs.
umich.edu/fessler/papers/files/tr/stderr.pdf
16. Constantinides CD, Atalar E, McVeigh ER
(1997) Signal-to-noise measurements in mag-
nitude images from NMR phased arrays. Magn
Reson Med 38(5):852–857
17. Aja-Fernández S, Vegas-Sánchez-Ferrero G
(2016) Statistical analysis of noise in MRI.
Springer International Publishing, Cham
18. Ku HH (1966) Notes on the use of propaga-
tion of error formulas. J Res Natl Bur Stand 70
(4):263–273
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution
and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter’s Creative Commons license,
unless indicated otherwise in a credit line to the material. If material is not included in the chapter’s Creative
Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder.
722 Ludger Starke et al.
INDEX
A
Acute kidney injury (AKI) ....................... 5, 9, 28, 31–36,
46, 51, 57, 60, 62, 69, 89, 90, 101, 164–166, 181,
218, 221, 231, 241, 249, 250, 257, 263, 264,
274, 282, 327, 328, 403, 473, 539, 584
ADC, see Apparent diffusion coefficient (ADC)
AKI, see Acute kidney injury (AKI)
Anesthesia .............. 15, 34, 46–52, 77, 78, 90, 111, 121,
122, 125, 126, 179, 221, 310, 318, 329, 336,
344, 350, 353, 354, 371, 372, 375, 400, 405,
408, 420, 421, 424, 431, 435, 436, 438,
444–446, 448, 457, 462, 465, 468, 474, 482,
497, 500, 502, 511, 523, 584, 656, 663, 664
Animal models............................................ 15, 16, 28–34,
36–38, 58, 90, 110, 111, 122, 131, 164, 165,
206, 218, 221, 231, 232, 236, 273, 337, 370,
384, 389, 403, 497, 511, 584
Apparent diffusion coefficient (ADC) ...........6, 9, 17, 19,
187–200, 420, 422–424, 426, 611–633
Arterial spin labeling (ASL)..........................6, 10, 17–19,
132, 146, 165, 218, 221, 230, 231, 234, 237,
358, 429, 443–452, 550, 655–665
ASL, see Arterial spin labelling (ASL)
B
B0 ........................................ 76, 132–136, 138, 139, 146,
148, 149, 151, 158, 159, 164, 178, 235, 236,
249, 259, 291, 292, 317, 360, 362, 363, 366,
367, 378, 386, 389, 393, 394, 398, 406, 408,
412, 416, 424, 427, 451, 458, 463, 465, 466,
469, 488–490, 498, 499, 530, 537, 597, 668,
670, 673–675, 678, 695
Blood flow .................................................... 6, 18, 33, 35,
36, 48, 49, 51, 58, 59, 90, 93–96, 98, 102, 110,
111, 116–119, 122, 123, 125, 128, 171–173,
206, 210, 216–218, 220, 229–231, 234, 236,
268, 282, 315, 316, 328, 330, 331, 337, 338,
340, 345, 363–365, 403, 443–452, 481, 539,
541, 644, 650, 651, 656, 663, 699, 707
Blood oxygenation level dependent MRI
(BOLD) ............................................ 10, 117, 132,
133, 140, 148, 264, 404, 429, 512, 515, 522,
549, 592
BOLD, see Blood oxygenation level dependent
MRI (BOLD)
C
Carbon (13C).............................................. 18–20, 61, 99,
481–490, 697–707
CEST, see Chemical exchange saturation transfer (CEST)
Chemical exchange saturation transfer (CEST) ........... 17,
18, 20, 241–252, 429, 455–469, 550, 667–683
Chronic kidney disease (CKD)................................5–7, 9,
36–39, 45, 57, 89, 90, 116, 182, 198, 221, 263,
264, 319, 327, 328, 403, 456, 496, 520, 544
CKD, see Chronic kidney disease (CKD)
Contrast agents (CAs) ......................................36, 58, 84,
111, 117, 122, 125, 126, 128, 164, 178,
206–210, 212, 213, 215, 219, 221, 222, 236,
243–248, 264, 280, 284, 289, 349, 384, 390,
392, 394, 430, 431, 434, 436, 443, 456, 457,
460–465, 468, 483, 496, 510, 514, 637,
667–669, 679, 683, 698, 700, 707
D
DCE, see Dynamic contrast-enhanced (DCE)
Deconvolution ............................................. 62, 218, 221,
640, 641, 644, 700, 701, 708
Diffusion...............................................17–19, 60, 65, 91,
172, 179, 187–201, 264, 289, 309, 358, 404,
405, 419–427, 429, 515, 522, 550, 566, 592,
607, 612, 613, 615, 617–621, 624, 628–631, 633
Diffusion-tensor imaging (DTI) .................................... 17
Diffusion-weighted imaging (DWI) ...................... 10, 17,
19, 132, 140, 146, 187, 341, 355, 358, 419–422,
424–425, 429, 550, 611
DNP, see Dynamic nuclear polarization (DNP)
Doppler.................................................95, 116–119, 123,
125, 128, 231, 316
DTI, see Diffusion-tensor imaging (DTI)
DWI, see Diffusion-weighted imaging (DWI)
Dynamic contrast-enhanced (DCE) .......................17–19,
132, 146, 159, 205–221, 384, 429–438, 637–651
Dynamic nuclear polarization (DNP)..........................269
F
Fibrosis..........................6, 28, 35–38, 46, 157, 164–166,
173, 181, 188, 198, 206, 230, 268, 302, 304,
305, 308–312, 314–319, 383, 386, 520–523,
526, 541, 544, 550, 695
Andreas Pohlmann and Thoralf Niendorf (eds.), Preclinical MRI of the Kidney: Methods and Protocols,
Methods in Molecular Biology, vol. 2216, https://doi.org/10.1007/978-1-0716-0978-1, © The Author(s) 2021
723
Filtration .............................................17–19, 28, 33, 172,
177, 205–223, 230, 242, 250, 283, 384,
429–439, 444, 455, 510, 637–651, 673, 680, 700
Fitting ..........................................14, 162, 175, 193, 195,
196, 215, 378, 390, 391, 394, 414, 420, 450,
489, 513, 565, 577, 578, 581–588, 593, 594,
598, 599, 601–605, 608, 609, 613, 615–624,
626, 628, 630–632, 639, 640, 645, 655–660,
662–664, 668–672, 674, 676, 680, 690,
692–694, 707–709
Fluorine (19F)........................18, 19, 495–505, 509–516,
711–713, 715, 716, 718
G
GFR, see Glomerular filtration rate (GFR)
Glomerular filtration rate (GFR) ....................... 5, 32, 35,
36, 38, 59, 60, 132, 205, 208, 218, 220–222,
229, 263, 268, 270, 370, 481, 639, 705–707
H
Hardware ................................ 7, 13, 17, 76, 79, 81, 132,
147, 151, 191, 233, 258, 280, 290–293, 308,
330, 350, 351, 372, 405, 421, 431, 445, 457,
475, 479, 483, 498, 511, 521, 525–528, 537,
539, 562, 566, 567, 581, 585
Hyperoxia .............................................65, 102, 178, 181,
329, 335, 337, 341, 404, 405, 411, 449, 451,
511, 525, 663
Hyperpolarization ................................................ 146, 269
Hypoxia ......................................... 35, 47, 57, 60, 65, 89,
92, 93, 100–102, 140, 173, 174, 178–182, 237,
281, 284, 309, 327, 329, 335, 337, 341, 378,
403–406, 411, 413, 449, 511, 522, 525, 608
L
Longitudinal relaxation time, see T1
I
Inflammation ..................................... 28, 35, 36, 46, 157,
164, 166, 173, 188, 231, 281, 284, 285, 290,
308, 383, 386, 455, 495–500, 502, 503, 521,
522, 712
Intravoxel incoherent motion (IVIM)................... 17, 19,
194, 195, 420, 422, 424, 612, 620–624
Invasive probes .......................................6, 15, 17, 18, 62,
65, 89–103, 181, 327–345, 363
Iopamidol .......................................... 243, 245, 246, 250,
456, 457, 459, 461, 462, 464, 465, 668, 670,
671, 673–679
Ischemia reperfusion injury (IRI) ....................28, 31, 33,
34, 36, 47–52, 165, 250
IVIM, see Intravoxel incoherent motion (IVIM)
M
Magnetic field strength, see B0
Magnetic resonance elastography (MRE) ..................302,
519–530, 532–534, 537–539, 544, 545
Mouse ........................................ 9, 14, 30–32, 34, 36–39,
52, 76–79, 83, 84, 100, 101, 121, 124, 135, 140,
142, 143, 147, 149, 150, 161, 164–166, 180,
216, 221, 231, 233, 235–237, 243, 245, 249,
250, 317, 330, 350, 351, 360, 366, 371, 372,
378, 379, 384, 397–400, 404, 405, 407, 413,
415, 420, 421, 425–427, 430, 431, 434–436,
438, 444, 445, 447, 448, 451, 452, 456, 457,
460, 462, 466–469, 475, 482, 483, 490,
497–503, 505, 510, 515, 522, 523, 525, 527,
533, 534, 551, 562, 584, 643, 676, 712
MRE, see Magnetic resonance elastography (MRE)
N
Nanoparticles (NPs)..................................... 62, 126, 280,
281, 283, 287–289, 496, 497, 500, 502, 505,
510, 512, 712
O
Oxygenation ........................................... 6, 10, 17–19, 28,
46–48, 57–62, 65, 67, 69, 89–103, 132, 133,
146, 171–183, 236, 242, 281, 282, 310,
327–345, 349, 372, 403–416, 429, 430, 443,
499, 512, 522, 549, 591–609
P
Perfluorocarbon (PFC).............................. 282, 496, 498,
499, 510–516
Perfusion...........................................6, 10, 17–19, 28, 35,
46, 47, 58–60, 62, 65, 77–80, 89–103, 111, 117,
122, 125, 128, 132, 140, 146, 165, 172, 173,
178, 188, 191, 194, 195, 205–222, 229–237,
242, 281, 282, 284, 315–316, 318, 328–330,
349, 350, 358, 363, 364, 384, 395, 396, 420,
424, 429–438, 443–445, 448–452, 455, 456,
460, 461, 463, 465, 468, 485, 510, 512, 549,
629, 632, 637–651, 655–657, 660–665, 699,
700, 703
pH................................................18, 147, 178, 242, 281,
429, 455, 550, 667
Phantoms................. 15, 17, 75–85, 262, 385, 399, 406,
432, 462, 468, 474, 477, 480, 482, 483, 486,
489, 490, 503, 512, 516, 530, 533, 571–573,
584, 606, 675, 680, 689–692, 698, 720, 721
pH imaging .................17, 241–250, 456, 457, 668, 680
Photoacoustic imaging (PA) .................. 15, 17, 109–128
Preclinical models.......................110, 149, 164, 167, 700
Pulse sequence, see Sequence
724
PRECLINICAL MRI OF THE KIDNEY: METHODS AND PROTOCOLS
Index
R
Radio frequency coils (RF coils) ........................ 139–143,
290, 330
Rat........................................................................ 9, 30, 31,
34, 35, 38, 39, 62, 65, 76–79, 81, 84, 101, 102,
142, 143, 149, 150, 164, 166, 174, 179, 181,
182, 221, 231, 236, 250, 259, 270, 273, 283,
285, 330, 332, 333, 335–337, 339, 340, 351,
354, 360, 361, 363–366, 371, 372, 378, 379,
396–399, 410, 413–415, 426, 427, 448, 451,
467, 477, 479, 488–490, 551, 571, 572, 607,
676, 680, 700, 703, 707
Region-of-interest (ROI) .......................... 412, 538, 539,
551, 555, 581, 597–599, 601, 605, 608, 642,
643, 645, 648–651, 690, 691, 694, 700, 721
Responsive contrast agent ............................................251
RF coils, see Radio frequency coils (RF coils)
ROI, see Region-of-interest (ROI)
S
Segmentations .................. 263, 373–375, 394, 550–562,
605, 638, 639, 663, 669, 695
Sequence....................................................... 4, 75, 81, 83,
84, 95, 134, 138, 149, 159–163, 175, 177, 188,
199, 200, 207–209, 211–213, 233, 234, 259,
261, 264, 280, 289, 290, 292, 303–305, 312,
351–353, 358, 363, 371–376, 378–380,
384–387, 389, 391–396, 398–400, 406–409,
412, 414, 420–422, 424–426, 430, 432, 433,
435, 438, 445, 447–449, 452, 458–461,
463–465, 467, 475–479, 482–489, 498, 499,
501, 503, 511, 512, 515, 516, 521, 523,
525–528, 532, 534, 539, 544, 571, 592, 601,
603, 608, 655, 689, 700
Shimming ........................................................13, 76, 133,
138, 139, 151, 234, 337, 350, 351, 353,
358–363, 376, 380, 393, 398, 400, 409, 411,
416, 424, 427, 435, 448, 451, 452, 463, 468,
469, 486, 490, 501, 505, 531
Sodium (23Na) .....................................17, 19, 20, 59, 67,
69, 146, 158, 257–264, 399, 429, 473–480, 550,
689–696
Spin-lattice relaxation time, see T1
Spin-spin relaxation time, see T2, T2*
Stiffness................................................................ 302–305,
308–312, 314–319, 519, 520, 522, 523,
525–530, 533, 535, 536, 538, 539, 541, 544
T
T1 ....... 4, 132, 157, 188, 206, 235, 259, 269, 279, 304,
340, 349, 374, 383, 406, 430, 444, 475, 483,
498, 510, 546, 573, 607, 631, 649, 688, 692
T2 ..............4, 5, 11, 12, 18, 19, 62, 132, 146, 160, 163,
164, 178, 188, 192, 193, 195, 199, 210, 235,
262, 270, 280, 289, 290, 304, 357, 358,
371–378, 380, 386, 403–416, 430, 432, 437,
445, 446, 448, 452, 489, 499, 512, 550, 577,
611, 637, 655, 694, 698
T2* .....................5, 47, 58, 90, 132, 175, 206, 235, 261,
283, 304, 329, 349, 375, 397, 404, 445, 483,
498, 516, 538, 549, 565, 591, 611, 637, 676,
690, 701
Test interventions........................ 6, 17, 57–69, 102, 179,
328, 329, 332, 335, 337, 341
Time-of-flight angiography (TOF).................... 350, 352,
363–365
Tissue oxygenation........................ 6, 28, 46, 61, 90, 101,
117, 172, 281, 289, 329, 330, 403
T1 mapping................................157–167, 210, 211, 349,
383–400, 432, 433, 435, 436, 449, 450, 513,
550, 577, 578, 583, 588, 638–640, 651,
656–660, 663, 664
T2 mapping................................406, 407, 409–414, 573,
593, 598–603, 608, 702, 704
T2* mapping .................... 133, 146, 171–182, 261, 340,
343, 357, 359, 405–413, 549, 571, 574, 599,
690–691
TOF, see Time-of-flight angiography (TOF)
Toft’s model ......................................................... 640, 641
U
Ultrasound imaging (US).......................... 109–111, 116,
117, 122, 125, 372
V
Volume.............9, 18, 19, 31, 47, 49, 60–62, 67, 78, 95,
99, 101, 102, 111, 116, 117, 119, 122, 123, 128,
139, 140, 142, 143, 147, 150, 176–178, 217,
221, 229, 231–234, 258, 259, 261, 262, 282,
290, 316, 330, 335, 337, 360–363, 366,
369–381, 384, 396, 398–400, 404, 413, 431,
432, 436, 438, 443, 445, 451, 468, 474, 475,
483, 489, 498, 499, 501, 502, 505, 509–517,
525, 529, 538, 539, 550, 551, 565, 566, 608,
626, 629, 639, 644, 680, 689, 705, 706
PRECLINICAL MRI OF THE KIDNEY: METHODS AND PROTOCOLS
Index 725
